Citrus Sinensis ID: 003919
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 786 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.328 | 0.314 | 0.477 | 1e-70 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.324 | 0.273 | 0.471 | 1e-70 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.361 | 0.310 | 0.383 | 8e-56 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.337 | 0.353 | 0.414 | 2e-55 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.319 | 0.390 | 0.409 | 2e-54 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.319 | 0.363 | 0.406 | 1e-52 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.320 | 0.155 | 0.391 | 7e-51 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.319 | 0.152 | 0.390 | 1e-49 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.316 | 0.193 | 0.373 | 3e-49 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.388 | 0.782 | 0.344 | 8e-48 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 268 bits (686), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 126/264 (47%), Positives = 181/264 (68%), Gaps = 6/264 (2%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 580
++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE + +F E++I+
Sbjct: 542 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L RR+L M D+ +G
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 641 LMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + + S+AGTPEWMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + RLEIP +
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 781
Query: 756 RLIADCWA-EPQERPSCEEILSRL 778
+I CW EP +RPS I+ L
Sbjct: 782 AIIEGCWTNEPWKRPSFATIMDLL 805
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (686), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 124/263 (47%), Positives = 180/263 (68%), Gaps = 8/263 (3%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
E I +++L + R+G+G +GEV+ W+GT+VA+K FL+QD + + +F +E+ I+ R
Sbjct: 661 ECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRR 720
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K + RR++KM D+ G+
Sbjct: 721 LRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--KSHIDERRRIKMALDVAMGM 778
Query: 642 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ ++ + S+AGTPEWMAPE+
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 838
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756
+RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV + RLEIP + +GR
Sbjct: 839 LRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGR 898
Query: 757 LIADCW-AEPQERPSCEEILSRL 778
+I +CW +P RPS ++ L
Sbjct: 899 IILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (557), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 118/308 (38%), Positives = 183/308 (59%), Gaps = 24/308 (7%)
Query: 476 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 535
SP++Y + G+ S V+E P Q + + + I FSEL + ++
Sbjct: 624 SPNQYNNQGNILKNSG-------------SVVEPPSQQQQ---YFSDIEISFSELKISSK 667
Query: 536 VGIGFFGEVFRGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
+G G FG V++G+W G+ VAIK + + +D+ + +E+F E++ILSRLRHPN++L + AC
Sbjct: 668 LGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAAC 727
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
T PP L ITEY+ GSLY +H +K K++ + K+ I +G+ +H ++HRD+
Sbjct: 728 TAPPNLCFITEYLPGGSLYDALH--SKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDI 785
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 714
KS N L+++H VKICDFGLS++ + S + S G+P WM+PEL+ E +TEK D+++
Sbjct: 786 KSLNLLLDEHMNVKICDFGLSKLKSKS-TEMTKSIGSPIWMSPELLMGEDYTEKVDVYAF 844
Query: 715 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS 770
G+I+WEL T P+ G+ ++ AV + R IP L LI CW +P +RPS
Sbjct: 845 GIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPS 904
Query: 771 CEEILSRL 778
EIL+ L
Sbjct: 905 FTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 117/282 (41%), Positives = 166/282 (58%), Gaps = 17/282 (6%)
Query: 509 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 568
SP+ + +E ID SE+ V R+G G EVF G W G VAIK + L E+
Sbjct: 470 SPLLKTDYKTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIK---KAKLLNED 526
Query: 569 MEDFCNEI----SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 624
EDF NE+ +I+S+LRHPN+ FLG C PP + ++ EYM LGSLY ++H
Sbjct: 527 DEDFLNELAQEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILH--DPSIS 584
Query: 625 LSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
L W R M DI +G+ +H ++HRDLKS N LV++H+ VKI DFGLS
Sbjct: 585 LDWPRMKSMALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHL 644
Query: 683 MRDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740
+ + + GTP W APE++RN+P+TEK D+FS +++WE+ T P++G+ ++V +V
Sbjct: 645 DKKTAMTPVGTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISV 704
Query: 741 ANEGSRLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 778
R +P P RLI +CW+E PQ+RPS +EI+ RL
Sbjct: 705 GQHKLRPIVPPQVSAPFTRLITECWSEDPQQRPSFQEIVKRL 746
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (545), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 107/261 (40%), Positives = 165/261 (63%), Gaps = 10/261 (3%)
Query: 524 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
+ID ++ +G R+G G +GEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPNVI FLG+C PP + + TEYM GSLY ++H Q +L W +KM+ D +G++
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH--DQALQLQWSLLIKMMIDAAKGVIY 485
Query: 644 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 486 LHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 543
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 758
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R +P+ GP +L+
Sbjct: 544 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLL 603
Query: 759 ADCWAE-PQERPSCEEILSRL 778
DC E P RP+ E+ L RL
Sbjct: 604 IDCLNENPSHRPTMEQCLERL 624
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 106/261 (40%), Positives = 164/261 (62%), Gaps = 10/261 (3%)
Query: 524 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
+ID ++ +G R+G G FGEV+ G W G+ VA+K ++ +++F EI+++ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPNVI FLG+C P + + TEYM GSLY ++H +K K+SW +M+ D +G++
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILH--NEKIKISWSLVKRMMIDAAKGIIY 502
Query: 644 IHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+H I+HRDLKS N LV+++W VK+ DFGLS I + ++ GTP W +PE++R
Sbjct: 503 LHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPCWTSPEVLR 560
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE-GP--LGRLI 758
++ +TEK D++S G+I+WE T P+ G+ P +V++AV EG R P+ GP +L+
Sbjct: 561 SQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLL 620
Query: 759 ADCWAE-PQERPSCEEILSRL 778
DC E P +RP+ E+ L L
Sbjct: 621 KDCLNENPSQRPTMEQCLEIL 641
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 103/263 (39%), Positives = 159/263 (60%), Gaps = 11/263 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W I++ E+++G ++G+G +G VF G W G DVA+K F++Q L+ + +F E++ LS L
Sbjct: 1357 WIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSEL 1416
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+H N++ F+GAC K P + ++TEYM +G+L + L K+++ KLK+L G+
Sbjct: 1417 KHSNIVTFIGACIKKPNICIVTEYMRMGNLRDV--LKNPDIKITFANKLKLLYGAAMGID 1474
Query: 643 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
+H IVHRD+K AN LV++H+ VKI DFG +RI D+ + GTP W APE+I
Sbjct: 1475 YLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNTTM--TRCGTPCWTAPEVI 1532
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
R E + EK D+FS GV+MWE+ T P+ +V + EG R IP +L
Sbjct: 1533 RGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDIL-EGGRPIIPSDCPHEFAKL 1591
Query: 758 IADCW-AEPQERPSCEEILSRLL 779
I CW A+ +RP+ E++ +L+
Sbjct: 1592 IKKCWHAKAHKRPTMTEVVQQLM 1614
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 103/264 (39%), Positives = 164/264 (62%), Gaps = 13/264 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W I++ ++ +G ++G+G +G V G W +VA+K F++Q + + M +F EI+ LS+L
Sbjct: 1387 WIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFLSQL 1446
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
RHP++IL +GAC K P + ++TE+M GSL ++I + K W+ K+KML G+
Sbjct: 1447 RHPHIILMIGACLKRPNICIVTEFMGNGSLRNVI----KTTKPEWKLKIKMLYQTALGIG 1502
Query: 643 CIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
+H I+HRD+K +N LV+ VKI DFG +RI ++ + + GTP W APE+I
Sbjct: 1503 YLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSVM--TRCGTPCWTAPEII 1560
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLG--RL 757
R E +TEK D+FS G++MWE+ T P+ G +V + EG+R +IP + P+ +L
Sbjct: 1561 RGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDIL-EGARPQIPSDCPIDFTKL 1619
Query: 758 IADCW-AEPQERPSCEEILSRLLD 780
+ CW A+P +RPS E+++ L D
Sbjct: 1620 MKQCWHAKPDKRPSMEDVIMGLND 1643
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 97/260 (37%), Positives = 157/260 (60%), Gaps = 11/260 (4%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
EW + SE+ +G R+G G +G+VFRG W GT+VA+K+ ++ + + D E+ +L +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCK 902
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRHPN++LF+GACT+P ++TEY+ GSL ++ L + ++ W +L++ D RG+
Sbjct: 903 LRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI--LLDESIEMDWGLRLQLGFDCARGM 960
Query: 642 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H I+HRDLK+ N LV+ W VK+ DFGL+ + + + + + GT W+APE+
Sbjct: 961 TYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAK--TMCGTTGWVAPEV 1018
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 756
+ E +TEK D++S +++WEL T P+ G +VV ++ + G RL +P
Sbjct: 1019 LAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAA 1077
Query: 757 LIADCW-AEPQERPSCEEIL 775
L+ CW +P RPS EIL
Sbjct: 1078 LMNRCWETDPTHRPSFPEIL 1097
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 110/319 (34%), Positives = 174/319 (54%), Gaps = 14/319 (4%)
Query: 472 SLPSSPHEYGSHGSERGGSSGYMANSEF--VSTWNKVLESPMFQNKPLLA--YEEWNIDF 527
SLP+ P S + R + M F + +W+ +LES + EEW D
Sbjct: 24 SLPNLPCNPSSSKTNRYAEAETMEKKRFDSMESWSMILESENVETWEASKGEREEWTADL 83
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFL----EQDLTAENMEDFCNEISILSRLR 583
S+L +G + G ++RGI+ VA+K+ +++ A+ + F +E+++LSRL
Sbjct: 84 SQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLF 143
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPN++ F+ AC KPP +ITEYM G+L ++ + LS L++ DI RG+
Sbjct: 144 HPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLN-KKEPYSLSIETVLRLALDISRGMEY 202
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+H ++HRDLKS N L+N VK+ DFG S + T + GT WMAPE+I+ +
Sbjct: 203 LHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQC-REAKGNMGTYRWMAPEMIKEK 261
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 760
P+T K D++S G+++WEL T P++G+ P + +AVA + R +P + L LI
Sbjct: 262 PYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKR 321
Query: 761 CWAE-PQERPSCEEILSRL 778
CW+E P +RP I++ L
Sbjct: 322 CWSENPSKRPDFSNIVAVL 340
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 786 | ||||||
| 255575293 | 810 | protein kinase, putative [Ricinus commun | 0.987 | 0.958 | 0.814 | 0.0 | |
| 224131388 | 822 | predicted protein [Populus trichocarpa] | 0.998 | 0.954 | 0.799 | 0.0 | |
| 225446619 | 817 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.954 | 0.787 | 0.0 | |
| 356543914 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.955 | 0.776 | 0.0 | |
| 356549852 | 813 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.955 | 0.773 | 0.0 | |
| 356543086 | 816 | PREDICTED: uncharacterized protein LOC10 | 0.994 | 0.958 | 0.769 | 0.0 | |
| 356517339 | 812 | PREDICTED: uncharacterized protein LOC10 | 0.984 | 0.953 | 0.75 | 0.0 | |
| 356543916 | 791 | PREDICTED: uncharacterized protein LOC10 | 0.963 | 0.957 | 0.757 | 0.0 | |
| 357474617 | 803 | Tyrosine-protein kinase ABL2 [Medicago t | 0.972 | 0.951 | 0.750 | 0.0 | |
| 356517341 | 768 | PREDICTED: uncharacterized protein LOC10 | 0.935 | 0.957 | 0.742 | 0.0 |
| >gi|255575293|ref|XP_002528550.1| protein kinase, putative [Ricinus communis] gi|223532052|gb|EEF33862.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1347 bits (3487), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 668/820 (81%), Positives = 718/820 (87%), Gaps = 44/820 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD G AEQG NA WW+ DFIE F SVSL SQE++LSNKESPRN+E+D LSSQTA
Sbjct: 1 MEETRDDVGPAEQGPSNALWWSSDFIEKFESVSLLSQEDSLSNKESPRNYEEDNLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSE IPNGFYSV+P+KRLKELFDSIPT D+LHALG EG +ADII VD+KKD
Sbjct: 61 SQILWSTGMLSERIPNGFYSVVPEKRLKELFDSIPTFDDLHALGAEGFKADIIFVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETS--HMFET 178
KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLV+D YKRP+VESPAKAALEETS HMFE
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVSDVYKRPNVESPAKAALEETSHVHMFEN 180
Query: 179 RGVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLN 238
RG+QLLGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDGT+EC DS+KHMSVIVVLN
Sbjct: 181 RGIQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTVECADSFKHMSVIVVLN 240
Query: 239 SVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVD 298
SVELLVDLMRFPGQLIPR+T+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG SERVD
Sbjct: 241 SVELLVDLMRFPGQLIPRTTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSERVD 300
Query: 299 PDSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSR 358
PDS+EKDES Q RKLE N+SGP+LRNMMLR A S+DRKLS SHSEPNIATTFWRRSR
Sbjct: 301 PDSAEKDESLQFHRKLE--GNVSGPALRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSR 358
Query: 359 RKVIAEQRTASS--------------------------------RSEGASTSEARRIRRR 386
+KVIAEQRTASS RS GAS SE RRIRRR
Sbjct: 359 KKVIAEQRTASSSPEHPSFRARGRSMLSGDRHSIRDYADDEAAPRSVGASASETRRIRRR 418
Query: 387 SISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGT 446
SIS+TPEIGDDIVRAVRAMNE+LKQNRLL+ER + DN +D +N SN L
Sbjct: 419 SISMTPEIGDDIVRAVRAMNESLKQNRLLRERDD--------KDNGTDFQRNVSNLDLDG 470
Query: 447 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 506
HD+ISGGRSALY L RD +NSQKAISLPSSPH+Y SH S+R G SG+ N E VSTWNKV
Sbjct: 471 HDDISGGRSALYTLQRDHINSQKAISLPSSPHQYRSHISDRRGPSGHAVNDELVSTWNKV 530
Query: 507 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 566
LESPMF NKPLL ++EWNIDF+ELTVGTRVGIGFFGEVFRG+WNGTDVAIKVFLEQDLTA
Sbjct: 531 LESPMFNNKPLLPFQEWNIDFTELTVGTRVGIGFFGEVFRGVWNGTDVAIKVFLEQDLTA 590
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626
ENMEDFCNEISILSRLRHPNVILFLGAC KPP LSM+TEYME+GSLY+LIHLSGQKK+LS
Sbjct: 591 ENMEDFCNEISILSRLRHPNVILFLGACMKPPHLSMVTEYMEMGSLYYLIHLSGQKKRLS 650
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI+T++P+RDS
Sbjct: 651 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIMTETPIRDS 710
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVYAVANE SR
Sbjct: 711 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYAVANERSR 770
Query: 747 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
L+IPEGPLGRLI+DCW EP ERPSCEEIL+RLLDCEYSLC
Sbjct: 771 LDIPEGPLGRLISDCWGEPHERPSCEEILARLLDCEYSLC 810
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131388|ref|XP_002321072.1| predicted protein [Populus trichocarpa] gi|222861845|gb|EEE99387.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1324 bits (3426), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 658/823 (79%), Positives = 717/823 (87%), Gaps = 38/823 (4%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDD+G AEQG N+ WW DFIE F SVSL SQE+TL NKES +N+E+DGLSSQTA
Sbjct: 1 MEETRDDSGPAEQGPSNSVWWGSDFIEKFESVSLLSQEDTLRNKESHKNYEEDGLSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ+LWSTGMLSE IPNGFYSVIPDKRLKELF +IPT+DELH+LG EG +ADIILVD+KKD
Sbjct: 61 SQVLWSTGMLSEQIPNGFYSVIPDKRLKELFVNIPTLDELHSLGAEGCKADIILVDAKKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLIV LVKGLNSNPAAMIKKIAGLVADFYKRP+VESPAKAALEE SHM E RG
Sbjct: 121 KKLSMLKQLIVPLVKGLNSNPAAMIKKIAGLVADFYKRPNVESPAKAALEEASHMLENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQLLGQIRHGSCRPRAI FKVLAD+VGLESRL+VGLPNDG +ECVDSYKHMSVIV+LNSV
Sbjct: 181 VQLLGQIRHGSCRPRAIFFKVLADSVGLESRLVVGLPNDGIVECVDSYKHMSVIVMLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMR PGQL+PRST+AIFM+HISAAGESDSAENDSCDSPLEPNSP+YG +ERVDPD
Sbjct: 241 ELLVDLMRSPGQLMPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPMYGFAERVDPD 300
Query: 301 SSEKDE-SFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRR 359
S+EKDE S QV RKLE +N+ GPSLRNMMLR A S+DRKLS SHSEPNIATTFWRRSR+
Sbjct: 301 SAEKDEGSLQVHRKLEASSNVLGPSLRNMMLRSATSIDRKLSLSHSEPNIATTFWRRSRK 360
Query: 360 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 385
KVIAEQRTASS RSEGAS SEARR+RR
Sbjct: 361 KVIAEQRTASSSPEHPSFRGRGRSMLSGDRHSIRHYADDVAISSHRSEGASMSEARRMRR 420
Query: 386 RSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRS--SNDNTSDLPKNASNFH 443
RSIS+TPEIGDDIVRAVRAMNETLKQNRLL E+G+DR FT + DN +DL KN SNF
Sbjct: 421 RSISMTPEIGDDIVRAVRAMNETLKQNRLLMEQGDDRLFTNNLGDKDNGTDLQKNVSNFS 480
Query: 444 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 503
L DEISGGRSALY L R+++NSQKAISLPSSPHEY S SER G SG++A+ + VSTW
Sbjct: 481 LDGRDEISGGRSALYTLERNRINSQKAISLPSSPHEYRSQTSERSGPSGFVADDQLVSTW 540
Query: 504 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 563
NKVLESP+F N P L ++EW+IDFSELTVGTRVGIGFFGEVFRGIWNGT+VA+KVFLEQD
Sbjct: 541 NKVLESPLFHNNPPLPFQEWHIDFSELTVGTRVGIGFFGEVFRGIWNGTEVAVKVFLEQD 600
Query: 564 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 623
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSLY+LIH SGQ K
Sbjct: 601 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLYYLIHSSGQ-K 659
Query: 624 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
KLSWRR+LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN H T+KICDFGLSR++TD P+
Sbjct: 660 KLSWRRRLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNNHKTIKICDFGLSRVMTDIPI 719
Query: 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743
RDSSSAGTPEWMAPELIRNEP TEKCDIFSLGVIMWELCTL+RPWEGV P+RVV AVANE
Sbjct: 720 RDSSSAGTPEWMAPELIRNEPVTEKCDIFSLGVIMWELCTLSRPWEGVPPKRVVDAVANE 779
Query: 744 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
GSRLEIPEGPLGRLI+DCWAEP RPSC EIL+RLLDCEY+ C
Sbjct: 780 GSRLEIPEGPLGRLISDCWAEPDLRPSCGEILTRLLDCEYTSC 822
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225446619|ref|XP_002280724.1| PREDICTED: uncharacterized protein LOC100255804 [Vitis vinifera] gi|302143427|emb|CBI21988.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1301 bits (3368), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/823 (78%), Positives = 708/823 (86%), Gaps = 43/823 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETRDDAG AEQG P TWW DFIE FGSVSL SQEE LSNK S N EQD LSSQTA
Sbjct: 1 MEETRDDAGPAEQGSPVTTWWPSDFIERFGSVSLVSQEEILSNKNSNSNTEQDELSSQTA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILWSTGMLSEPIPNGFYSVIPDK+LKE+FD IPT+DEL+ALG EG RADIILVD+ +D
Sbjct: 61 SQILWSTGMLSEPIPNGFYSVIPDKKLKEIFDDIPTLDELYALGSEGVRADIILVDAVRD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVE-SPAKAALEETSHMFETR 179
KKLSMLKQLIVALVKGLNSNPAA+IKKIAGLV+DFYKRP++E SPAKAALEETSH+ E R
Sbjct: 121 KKLSMLKQLIVALVKGLNSNPAAVIKKIAGLVSDFYKRPNLELSPAKAALEETSHVSENR 180
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNS 239
QLLGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG + CVDSYKHMSVIV+LNS
Sbjct: 181 VAQLLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIGCVDSYKHMSVIVMLNS 240
Query: 240 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 299
ELLVDLMRFPGQLIPRST+AIFM+HISAAGESDSAENDSCDSPLEPNSPLYG S+RVDP
Sbjct: 241 GELLVDLMRFPGQLIPRSTRAIFMTHISAAGESDSAENDSCDSPLEPNSPLYGFSDRVDP 300
Query: 300 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRR 359
DS+EKDE Q QR+LE +N+SGPSLRN+MLR S+DRKLS SHSEPNIATTFWRRSRR
Sbjct: 301 DSTEKDEGLQFQRRLEASSNVSGPSLRNVMLRSTPSIDRKLSLSHSEPNIATTFWRRSRR 360
Query: 360 KVIAEQRTASS----------------------------------RSEGASTSEARRIRR 385
KVIAEQRTASS RS+GASTS + R
Sbjct: 361 KVIAEQRTASSSPEHPSFRARGRSMLSGDRKSFRDYADDIAASSYRSDGASTSTSETRRI 420
Query: 386 RSISIT--PEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFH 443
R SI+ PEIGDDIVRAVRAMNETLK NRL++++G+DR F SSN D+ KN S+FH
Sbjct: 421 RRRSISITPEIGDDIVRAVRAMNETLKANRLMRDQGDDRAF--SSN---PDIQKNVSDFH 475
Query: 444 LGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 503
L H EIS G S++Y L R+Q++SQKAISLPSSPHE+ S S R G+S + N E VS W
Sbjct: 476 LDGHGEISHGSSSMYTLPREQISSQKAISLPSSPHEFRSQTSGRSGTSD-IVNDEMVSIW 534
Query: 504 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 563
N+VLE PMF +KPLL ++EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD
Sbjct: 535 NRVLEKPMFHSKPLLPFQEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD 594
Query: 564 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 623
LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME+GSLY+LIHLSGQKK
Sbjct: 595 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEIGSLYYLIHLSGQKK 654
Query: 624 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
KLSWRR++KMLRDICRGLMCIHRMKIVHRD+KSANCLVNKHWTVKICDFGLSR++TD+P+
Sbjct: 655 KLSWRRRIKMLRDICRGLMCIHRMKIVHRDIKSANCLVNKHWTVKICDFGLSRVMTDTPL 714
Query: 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS G+IMWELCTLNRPWEGV PERVVYAVA+E
Sbjct: 715 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGMIMWELCTLNRPWEGVPPERVVYAVAHE 774
Query: 744 GSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
GSRL+IPEGPLG LIADCWAEP +RPSCE+ILSRL DCEY+LC
Sbjct: 775 GSRLDIPEGPLGMLIADCWAEPHQRPSCEDILSRLQDCEYTLC 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543914|ref|XP_003540403.1| PREDICTED: uncharacterized protein LOC100803469 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 638/822 (77%), Positives = 702/822 (85%), Gaps = 45/822 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
S+EK+E+ Q R+ E +N+SG SLRN+M + LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVM----LRSNSSLSLSHSEPNIATAFGRRSRRK 355
Query: 361 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 389
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRR 415
Query: 390 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHL 444
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHL 475
Query: 445 GTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWN 504
HDE RSALY+ RDQ SQKA+SLPSSPH+YG S+R GSS Y N E STWN
Sbjct: 476 DGHDE----RSALYSFQRDQGASQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWN 531
Query: 505 KVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 564
KVLESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL
Sbjct: 532 KVLESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 591
Query: 565 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 624
TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKK
Sbjct: 592 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKK 651
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
L+WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMR
Sbjct: 652 LNWRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMR 711
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744
DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEG
Sbjct: 712 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEG 771
Query: 745 SRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
SRLEIPEGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 772 SRLEIPEGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549852|ref|XP_003543304.1| PREDICTED: uncharacterized protein LOC100810612 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1271 bits (3290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/822 (77%), Positives = 700/822 (85%), Gaps = 45/822 (5%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N WW DF+E FGSVSLGSQ+ETLSNKESPR+ +D LSS A
Sbjct: 1 MEETREDAGPAEQGPSNVLWWPSDFVEKFGSVSLGSQDETLSNKESPRHVVEDVLSSLKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW TGMLSEPIPNGFYSVIP+ RLKELF SIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWQTGMLSEPIPNGFYSVIPETRLKELFYSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLKQLI+ALV+GLN+NPAA+IKKIAGLV+DFYKRP+VESPAKAAL+ETSHMFE RG
Sbjct: 121 KKLSMLKQLIMALVRGLNANPAAIIKKIAGLVSDFYKRPNVESPAKAALDETSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNS+
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSL 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTK++FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+D +
Sbjct: 241 EMLVDLMRFPGQLLPRSTKSVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDSN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
S+EK+E+ Q R+ E +N+SG SLRN+MLR ++ LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVMLRSNSN----LSLSHSEPNIATAFGRRSRRK 355
Query: 361 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 389
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFTDDQATSSYRSDGTSSSEARRIRRR 415
Query: 390 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSD--LPKNASNFHL 444
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD L KN SNFHL
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSDANLQKNVSNFHL 475
Query: 445 GTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWN 504
HDE RSALY+ RDQ SQKA+SLPSSPH+Y SER G S Y N E STWN
Sbjct: 476 DGHDE----RSALYSFQRDQGTSQKAMSLPSSPHDYRGQASERSGPSRYGVNDEMESTWN 531
Query: 505 KVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 564
KVLESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL
Sbjct: 532 KVLESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL 591
Query: 565 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 624
TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+L+HLSGQKKK
Sbjct: 592 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLMHLSGQKKK 651
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
L+WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMR
Sbjct: 652 LNWRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMR 711
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744
DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VA+EG
Sbjct: 712 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVAHEG 771
Query: 745 SRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
SRLEIPEGPLGRLI++CWAE +RPSCEEILSRL+D EYSLC
Sbjct: 772 SRLEIPEGPLGRLISECWAECHQRPSCEEILSRLVDIEYSLC 813
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543086|ref|XP_003539994.1| PREDICTED: uncharacterized protein LOC100807193 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1256 bits (3249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/820 (76%), Positives = 696/820 (84%), Gaps = 38/820 (4%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AE+ N +WW DF+E F SVSL SQ+ETL+NKESPR+ +D +S Q A
Sbjct: 1 MEETREDAGPAERRPSNMSWWPSDFVEKFESVSLSSQDETLNNKESPRHSNRDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVI +KRLK+LFDSIPT++EL ALGGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVILEKRLKKLFDSIPTLEELQALGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYKR +VESPAKAALEE+SHMFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKRSNVESPAKAALEESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQIRHGSCRPRAILFKVLADTVGLESRLM+G PNDG ECVDSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIRHGSCRPRAILFKVLADTVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPK 300
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
EK+E+ Q R+ E +N+SG LRNMMLR SLDR SFSHSEPNIAT F RRSRRK
Sbjct: 301 CVEKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNWSFSHSEPNIATAFGRRSRRK 360
Query: 361 VIAEQRTASS--------------------------------RSEGASTSEARRIRRRSI 388
VIAEQRTASS +S+GAS+SEARRIRRRSI
Sbjct: 361 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTSFRDFADDQSSYKSDGASSSEARRIRRRSI 420
Query: 389 SITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNFHLGT 446
SITPEIGDDI RAVRAMN+TLKQ RL +E+G D + S D TS DL KN SNFHL
Sbjct: 421 SITPEIGDDIARAVRAMNKTLKQKRLPREQGGDSSLSHSPIDRTSSLDLQKNVSNFHLDG 480
Query: 447 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 506
H E RS LY L RD + SQKA+SLPSSPH+Y SER +S Y N E STWNK+
Sbjct: 481 HHE----RSPLYLLHRDPVTSQKAMSLPSSPHDYRVQASERSEASEYTTNDELESTWNKI 536
Query: 507 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 566
LESPMF N+PLL YEEWNIDF+EL VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA
Sbjct: 537 LESPMFSNRPLLPYEEWNIDFTELNVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 596
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626
ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQKKKLS
Sbjct: 597 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQKKKLS 656
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
WRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRIIT+SPMRDS
Sbjct: 657 WRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIITESPMRDS 716
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
SSAGTPEWMAPELIRNEPF+EKCDIFSLGVIMWELCTLNRPWEGV PERVVY VANEG+R
Sbjct: 717 SSAGTPEWMAPELIRNEPFSEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYTVANEGAR 776
Query: 747 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
L+IPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 777 LDIPEGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 816
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517339|ref|XP_003527345.1| PREDICTED: uncharacterized protein LOC100806527 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1254 bits (3244), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 618/824 (75%), Positives = 690/824 (83%), Gaps = 50/824 (6%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG E+ N +WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MEETREDAGQPERRPSNMSWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD
Sbjct: 61 SQILWRTGMLSEPIPNGFYSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
++LSMLKQLIVALV+GLNSNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RG
Sbjct: 121 RRLSMLKQLIVALVRGLNSNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQIRHGSC PRAILFKVLAD+VGLESRLM+G PNDG ECVDSYKHMSVIVVLN+V
Sbjct: 181 VQMLGQIRHGSCCPRAILFKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRSTK+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE V
Sbjct: 241 ELLVDLMRFPGQLLPRSTKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSESV--- 297
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
EK+E+ Q R+ E +N+SG LRNMMLR SLDR LSFSHSEPNIAT F RRSRRK
Sbjct: 298 --EKEENLQFHRRFEVSSNVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRK 355
Query: 361 VIAEQRTASS------------------------------------RSEGASTSEARRIR 384
VIAEQRTASS +S+GAS+SEARRIR
Sbjct: 356 VIAEQRTASSSPEHPSLRAHGRSKLSGDRTAFRDFADDQSTLRSSYKSDGASSSEARRIR 415
Query: 385 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 442
R SISITPEIGDDI RAVRAMNETLKQNRLL+E+G D + S D TS DL KN SNF
Sbjct: 416 R-SISITPEIGDDIARAVRAMNETLKQNRLLREQGGDSSLSHSPIDRTSSADLQKNVSNF 474
Query: 443 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 502
HL H E RS LY RD + SQKA+SLPSSPH+Y SER +S Y+ N E T
Sbjct: 475 HLDNHHE----RSPLY--LRDPVTSQKAMSLPSSPHDYRGQASERSKASEYILNDELEFT 528
Query: 503 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 562
WNK+LESPMF N+PLL YEEWNIDF+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 529 WNKILESPMFSNRPLLPYEEWNIDFTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 588
Query: 563 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 622
DLT ENMEDFCNEISILSRLRHPNVILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 589 DLTTENMEDFCNEISILSRLRHPNVILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQK 648
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
KKLSWRR+LKML+DICRGLM IHRMKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP
Sbjct: 649 KKLSWRRRLKMLQDICRGLMHIHRMKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESP 708
Query: 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 742
RDSSSAGTPEWMAPELIRNEPFTEKCDIFS GVI+WELCTLNRPWEGV PERVVY VAN
Sbjct: 709 TRDSSSAGTPEWMAPELIRNEPFTEKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVAN 768
Query: 743 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
EG+RL+IP+GPLGRLI++CWAEP ERPSCEEILSRL+D EYS+C
Sbjct: 769 EGARLDIPDGPLGRLISECWAEPHERPSCEEILSRLVDIEYSMC 812
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543916|ref|XP_003540404.1| PREDICTED: uncharacterized protein LOC100803469 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1238 bits (3204), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/820 (75%), Positives = 688/820 (83%), Gaps = 63/820 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
MEETR+DAG AEQG N +WW DF+E FGSVSLGSQ+E LSNKESPR+F++D LSSQ A
Sbjct: 1 MEETREDAGPAEQGPSNVSWWPSDFVEKFGSVSLGSQDEILSNKESPRHFDKDVLSSQKA 60
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQ LW G+LSEPIPNGFYSVIP+ RLKELFDSIPT+DELHALGGEG +ADIILVDS+KD
Sbjct: 61 SQTLWRIGVLSEPIPNGFYSVIPETRLKELFDSIPTLDELHALGGEGFKADIILVDSEKD 120
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
KKLSMLK+LI+ALV+GLNSNPAA+IKKIAGLV+DFYK P+VESPAKAAL+E+SHMFE RG
Sbjct: 121 KKLSMLKKLIMALVRGLNSNPAAIIKKIAGLVSDFYKCPNVESPAKAALDESSHMFENRG 180
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLMVGLPNDG +EC DSYKHMSVIVVLNSV
Sbjct: 181 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMVGLPNDGAIECQDSYKHMSVIVVLNSV 240
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
E+LVDLMRFPGQL+PRSTKA+FM+HIS AGESDSAENDSCDSPLEPNSPL+GVSER+DP+
Sbjct: 241 EMLVDLMRFPGQLLPRSTKAVFMTHIS-AGESDSAENDSCDSPLEPNSPLFGVSERLDPN 299
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
S+EK+E+ Q R+ E +N+SG SLRN+M + LS SHSEPNIAT F RRSRRK
Sbjct: 300 SAEKEENLQFHRRFEASSNVSGLSLRNVM----LRSNSSLSLSHSEPNIATAFGRRSRRK 355
Query: 361 VIAEQRTASS-------RSEGASTSEARRIRRRSIS------------------------ 389
VIAEQRTASS R+ G S R R +
Sbjct: 356 VIAEQRTASSSPEHPSFRARGRSMLSGDRTTFRDFADDQATSSYRSDNTSSSEARRIRRR 415
Query: 390 ---ITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGT 446
ITPEIGDDIVRAVRAMNETLKQNRLL+ERG+D F S N+++SD
Sbjct: 416 SISITPEIGDDIVRAVRAMNETLKQNRLLRERGDDNSFPNSPNNSSSD------------ 463
Query: 447 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 506
NL ++ ++SQKA+SLPSSPH+YG S+R GSS Y N E STWNKV
Sbjct: 464 -----------ANLQKN-VSSQKAMSLPSSPHDYGGQASKRSGSSRYGVNDEMESTWNKV 511
Query: 507 LESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 566
LESPMF NKPLL YE+WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA
Sbjct: 512 LESPMFNNKPLLPYEKWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 571
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626
ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYMELGSLY+LIHL+GQKKKL+
Sbjct: 572 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMELGSLYYLIHLNGQKKKLN 631
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
WRR+L+MLRDIC+GLMCIHRMK+VHRDLKSANCLVNKHWTVKICDFGLSRI+T+SPMRDS
Sbjct: 632 WRRRLRMLRDICKGLMCIHRMKVVHRDLKSANCLVNKHWTVKICDFGLSRIMTESPMRDS 691
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV PERVVY+VANEGSR
Sbjct: 692 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVPPERVVYSVANEGSR 751
Query: 747 LEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
LEIPEGPLGRLI++CWAE ERPSCEEILSRL+D EYSLC
Sbjct: 752 LEIPEGPLGRLISECWAECHERPSCEEILSRLVDIEYSLC 791
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357474617|ref|XP_003607593.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] gi|355508648|gb|AES89790.1| Tyrosine-protein kinase ABL2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 618/823 (75%), Positives = 680/823 (82%), Gaps = 59/823 (7%)
Query: 1 MEETRDDAGSAEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTA 60
ME TR+DA DFI FGSVSLG+Q+ETL+NKESPR+ QD +S Q A
Sbjct: 1 MERTREDAR-----------MPSDFIGKFGSVSLGTQDETLNNKESPRHSNQDFMSPQRA 49
Query: 61 SQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKD 120
SQILW TGMLSEPIPNGFYSV+P+KRLK+LFDSIPT+DEL ALGGEG RAD+I+VD+KKD
Sbjct: 50 SQILWHTGMLSEPIPNGFYSVVPEKRLKKLFDSIPTLDELQALGGEGFRADVIVVDAKKD 109
Query: 121 KKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRG 180
+KLSMLKQLIV LVKGLN+NP A+IKKIAGLV+DFYKRP+VESPAKAALEE+SHMFE+ G
Sbjct: 110 RKLSMLKQLIVTLVKGLNTNPGAIIKKIAGLVSDFYKRPNVESPAKAALEESSHMFESHG 169
Query: 181 VQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSV 240
VQ+LGQI+HGSCRPRAILFKVLADTVGLESRLM+G P DG +CVDSYKHMSVIV LNSV
Sbjct: 170 VQMLGQIKHGSCRPRAILFKVLADTVGLESRLMMGFPTDGAADCVDSYKHMSVIVALNSV 229
Query: 241 ELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPD 300
ELLVDLMRFPGQL+PRS K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSE
Sbjct: 230 ELLVDLMRFPGQLLPRSIKSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSE----- 284
Query: 301 SSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRK 360
S+EKD++ Q R+ E +N+S P LRNMMLR LDRKLSFSHSEPNIAT+F RRSRRK
Sbjct: 285 SAEKDDNLQFHRRFEASSNVSSPPLRNMMLRSNTCLDRKLSFSHSEPNIATSFGRRSRRK 344
Query: 361 VIAEQRTASS------------------------------------RSEGASTSEARRIR 384
VIAEQRTASS +S+GAS+S RRIR
Sbjct: 345 VIAEQRTASSSPEHPSFQARGQSKLGGEKTAFRDFADDQATSRSSYKSDGASSSGPRRIR 404
Query: 385 RRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTS--DLPKNASNF 442
RRSISITPEIGDDI RAVRAMNE LKQNRLL+E+G+D S ND TS +L KN SNF
Sbjct: 405 RRSISITPEIGDDIARAVRAMNEKLKQNRLLREQGDDSSLPHSPNDRTSSAELQKNLSNF 464
Query: 443 HLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVST 502
L H+ S LY L RD + SQKA+SLPSSPH+Y SE GY N E ST
Sbjct: 465 RLDGHET-----SPLYPLYRDNVPSQKAVSLPSSPHDYRRQTSETSRPLGYELNDELEST 519
Query: 503 WNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 562
WNK+LES M NKPLL YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ
Sbjct: 520 WNKILESSMADNKPLLPYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 579
Query: 563 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 622
DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM+TEYME+GSL++LIH+SGQK
Sbjct: 580 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMVTEYMEMGSLFYLIHVSGQK 639
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
KKLSWRR+LKMLRDICRGLM IHRMKI+HRD+KSANCLV+KHWTVK+CDFGLSRIIT+SP
Sbjct: 640 KKLSWRRRLKMLRDICRGLMHIHRMKIIHRDVKSANCLVDKHWTVKVCDFGLSRIITESP 699
Query: 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 742
MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC L+RPWEGV PERVVY VAN
Sbjct: 700 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCNLSRPWEGVPPERVVYTVAN 759
Query: 743 EGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSL 785
EGSRLEIPEGPLGRLI++CWAEP ERPSCEEILSRL+D EYS+
Sbjct: 760 EGSRLEIPEGPLGRLISECWAEPNERPSCEEILSRLVDIEYSM 802
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517341|ref|XP_003527346.1| PREDICTED: uncharacterized protein LOC100806527 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1212 bits (3136), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/800 (74%), Positives = 664/800 (83%), Gaps = 65/800 (8%)
Query: 19 TWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQTASQILWSTGMLSEPIPNGF 78
+WW DF++ F SVSL +Q+ETL+NKESPR+ QD +S Q ASQILW TGMLSEPIPNGF
Sbjct: 2 SWWPSDFVDKFESVSLSAQDETLNNKESPRHSNQDVMSPQKASQILWRTGMLSEPIPNGF 61
Query: 79 YSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQLIVALVKGLN 138
YSVIP+KRLK+LFDSIPT+DEL A+GGEG RAD+I+VD++KD++LSMLKQLIVALV+GLN
Sbjct: 62 YSVIPEKRLKKLFDSIPTLDELQAMGGEGFRADVIVVDAEKDRRLSMLKQLIVALVRGLN 121
Query: 139 SNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAIL 198
SNP AMIKKIAGLV+DFYK P+VESPAKAALEE+ +MFE RGVQ+LGQIRHGSC PRAIL
Sbjct: 122 SNPPAMIKKIAGLVSDFYKPPNVESPAKAALEESCNMFENRGVQMLGQIRHGSCCPRAIL 181
Query: 199 FKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRST 258
FKVLAD+VGLESRLM+G PNDG ECVDSYKHMSVIVVLN+VELLVDLMRFPGQL+PRST
Sbjct: 182 FKVLADSVGLESRLMMGFPNDGAAECVDSYKHMSVIVVLNTVELLVDLMRFPGQLLPRST 241
Query: 259 KAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDPDSSEKDESFQVQRKLETPA 318
K+I M+HISAAGESDSAENDSCDSPLEPNSPLYGVSER+DP EK+E+ Q R+ E +
Sbjct: 242 KSILMTHISAAGESDSAENDSCDSPLEPNSPLYGVSERLDPKRVEKEENLQFHRRFEVSS 301
Query: 319 NISGPSLRNMMLRPAASLDRKLSFSHSEPNIATTFWRRSRRKVIAEQRTASS-------- 370
N+SG LRNMMLR SLDR LSFSHSEPNIAT F RRSRRKVIAEQRTASS
Sbjct: 302 NVSGLPLRNMMLRSNTSLDRNLSFSHSEPNIATAFGRRSRRKVIAEQRTASSSPEHPSLR 361
Query: 371 ------------------------RSEGASTSEARRIRRRSISITPEIGDDIVRAVRAMN 406
+S+GAS+SEARRIRR SISITPEIGDDI RAVRAMN
Sbjct: 362 AHGRSKLSGDRTAFRDFADDQSSYKSDGASSSEARRIRR-SISITPEIGDDIARAVRAMN 420
Query: 407 ETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMN 466
ETLKQNRLL+E+G D S LY RD +
Sbjct: 421 ETLKQNRLLREQGGDSSL------------------------------SPLY--LRDPVT 448
Query: 467 SQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNID 526
SQKA+SLPSSPH+Y SER +S Y+ N E TWNK+LESPMF N+PLL YEEWNID
Sbjct: 449 SQKAMSLPSSPHDYRGQASERSKASEYILNDELEFTWNKILESPMFSNRPLLPYEEWNID 508
Query: 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 586
F+ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT ENMEDFCNEISILSRLRHPN
Sbjct: 509 FTELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTTENMEDFCNEISILSRLRHPN 568
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
VILFLGACT+PPRLSM+TEYME+GSL++LIH+SGQKKKLSWRR+LKML+DICRGLM IHR
Sbjct: 569 VILFLGACTRPPRLSMVTEYMEMGSLFYLIHVSGQKKKLSWRRRLKMLQDICRGLMHIHR 628
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
MKI+HRD+KSANCLV+KHW VKICDFGLSRI+T+SP RDSSSAGTPEWMAPELIRNEPFT
Sbjct: 629 MKIIHRDVKSANCLVDKHWIVKICDFGLSRIVTESPTRDSSSAGTPEWMAPELIRNEPFT 688
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQ 766
EKCDIFS GVI+WELCTLNRPWEGV PERVVY VANEG+RL+IP+GPLGRLI++CWAEP
Sbjct: 689 EKCDIFSFGVIIWELCTLNRPWEGVPPERVVYTVANEGARLDIPDGPLGRLISECWAEPH 748
Query: 767 ERPSCEEILSRLLDCEYSLC 786
ERPSCEEILSRL+D EYS+C
Sbjct: 749 ERPSCEEILSRLVDIEYSMC 768
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 786 | ||||||
| TAIR|locus:2076416 | 809 | AT3G58640 [Arabidopsis thalian | 0.568 | 0.552 | 0.694 | 6.9e-301 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.969 | 0.983 | 0.654 | 3.1e-264 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.318 | 0.242 | 0.511 | 1.3e-80 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.332 | 0.296 | 0.477 | 2.8e-80 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.324 | 0.257 | 0.498 | 3.7e-80 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.338 | 0.285 | 0.460 | 7.4e-80 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.342 | 0.327 | 0.474 | 5.9e-76 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.342 | 0.365 | 0.45 | 5.6e-65 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.329 | 0.335 | 0.456 | 1.2e-60 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.328 | 0.337 | 0.441 | 1.5e-58 |
| TAIR|locus:2076416 AT3G58640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1620 (575.3 bits), Expect = 6.9e-301, Sum P(2) = 6.9e-301
Identities = 318/458 (69%), Positives = 355/458 (77%)
Query: 331 RPAASLDRKLSFSHSEPNIATTFWRRSRRKVIAEQRTASSRSEGXXXXXXXXXXXXXXXX 390
R A+S LSF ++ + + R + T+S +S G
Sbjct: 361 RTASSSPEHLSFRARTKSMLSGD-KNLARDFTGDVATSSCKSVGGAKMETKRIRRRSISI 419
Query: 391 XXXXGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNT--SDLPKNASNFHLGTHD 448
GDDIVRAVRAMNE LKQNRL +E+G+D S ND T S L KN S FHL HD
Sbjct: 420 TPEIGDDIVRAVRAMNEALKQNRLSKEQGDDDSSPNSPNDRTESSHLQKNVSGFHLDAHD 479
Query: 449 EISGGRSALYNLSRDQMNSQKAISLPSSPXXXXXXXXXXXXXXXXMANSEFVSTWNKVLE 508
++SGGRS L SR+ ++ QKAISLPSSP +++ W+KVL
Sbjct: 480 QVSGGRSTL---SREPLDPQKAISLPSSPQNYRSQYEQSGSSHRNISH-----IWDKVLG 531
Query: 509 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 568
SPMFQNKPLL YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN
Sbjct: 532 SPMFQNKPLLPYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 591
Query: 569 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 628
MEDFCNEISILSRLRHPNVILFLGACTKPPRLS+ITEYME+GSLY+L+HLSGQKK+LSWR
Sbjct: 592 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSLITEYMEMGSLYYLLHLSGQKKRLSWR 651
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688
RKLKMLRDICRGLMCIHRM IVHRD+KSANCL++ WTVKICDFGLSRI+T + MRD+ S
Sbjct: 652 RKLKMLRDICRGLMCIHRMGIVHRDIKSANCLLSNKWTVKICDFGLSRIMTGTTMRDTVS 711
Query: 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 748
AGTPEWMAPELIRNEPF+EKCDIFSLGVIMWELCTL RPWEGV PERVVYA+A EG+RLE
Sbjct: 712 AGTPEWMAPELIRNEPFSEKCDIFSLGVIMWELCTLTRPWEGVPPERVVYAIAYEGARLE 771
Query: 749 IPEGPLGRLIADCWAEPQERPSCEEILSRLLDCEYSLC 786
IPEGPLG+LIADCW EP++RPSC EILSRLLDCEYSLC
Sbjct: 772 IPEGPLGKLIADCWTEPEQRPSCNEILSRLLDCEYSLC 809
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2542 (899.9 bits), Expect = 3.1e-264, P = 3.1e-264
Identities = 523/799 (65%), Positives = 599/799 (74%)
Query: 1 MEETRDDAGS-AEQGHPNATWWTQDFIENFGSVSLGSQEETLSNKESPRNFEQDGLSSQT 59
MEE RDD S QG + E +S SQ E LS K+SPR+ EQD Q
Sbjct: 1 MEERRDDESSPTHQG--------SELAERVKLLSFESQGEALS-KDSPRSVEQDCSPGQR 51
Query: 60 ASQILWSTGMLSEPIPNGFYSVIPDKRLKELFDSIPTVDELHALGGEGHRADIILVXXXX 119
ASQ LW TG+LSEPIPNGFYSV+PDKR+KEL++ +PT ELHALG EG R ++ILV
Sbjct: 52 ASQHLWDTGILSEPIPNGFYSVVPDKRVKELYNRLPTPSELHALGEEGVRIEVILVDFQK 111
Query: 120 XXXXXXXXQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETR 179
QLI LV G +NPA +IKKIAG V+DFYKRP++ESP+K ALEE + +FE
Sbjct: 112 DKKLAMLKQLITTLVSGSGTNPALVIKKIAGTVSDFYKRPTLESPSKLALEENAFLFENH 171
Query: 180 GVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNS 239
G QLLGQI+ G CR RAILFKVLADTVGLESRL+VGLP+DGT+ C+DS KHMSVIVVLNS
Sbjct: 172 GAQLLGQIKRGCCRARAILFKVLADTVGLESRLVVGLPSDGTVNCMDSNKHMSVIVVLNS 231
Query: 240 VELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAENDSCDSPLEPNSPLYGVSERVDP 299
VELLVDL+RFPGQL+PRS KAIFMSHIS AGESDSAENDSCDSPLEPNSPLY ER DP
Sbjct: 232 VELLVDLIRFPGQLVPRSAKAIFMSHISPAGESDSAENDSCDSPLEPNSPLY---ERRDP 288
Query: 300 DSSEKDESFQVQRKLETPANISGPSLRNMMLRPAASLDRKLS-FSHSEPNIATTFWRRSR 358
+S+EKDE+ Q RKLE N SG SLR++MLRP+ +++RKLS SHSEPN+AT FWRRSR
Sbjct: 289 ESTEKDENLQFYRKLEGYPNASGSSLRSLMLRPSTAIERKLSNTSHSEPNVATVFWRRSR 348
Query: 359 RKVIAEQRTASSRSEG-XXXXXXXXXXXXXXXXXXXXGDDIVRAVRAMNETLKQNR---- 413
RKVIAEQRTASS E G+ + + +E K R
Sbjct: 349 RKVIAEQRTASSSPEHPSMRRGRSMLSTGRNSFRDYTGEASSPSSSSTSEIRKTRRRSFR 408
Query: 414 LLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDE----ISGGRSALYNLSRDQMNSQK 469
+ E G+D S+ + K + G DE I S L+ L D++NS+K
Sbjct: 409 ITPEIGDD---IASAVREMYEKSKQ-NRLLQGREDENSSVIDNNVSGLH-LD-DELNSKK 462
Query: 470 AISLPSSPXXXXXXXXXXXXXXXXMANSEFV--STWNKVLESPMFQNKPLLAYEEWNIDF 527
+SLPSSP SEF TWNKV+ES QN+PLL Y+EW+IDF
Sbjct: 463 TMSLPSSPHAYRCQTFGRR------GPSEFAVKDTWNKVVESSTLQNQPLLPYQEWDIDF 516
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587
SELTVGTRVGIGFFGEVFRG+WNGTDVAIK+FLEQDLTAENMEDFCNEISILSR+RHPNV
Sbjct: 517 SELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSRVRHPNV 576
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+LFLGACTKPPRLSMITEYMELGSLY+LIH+SGQKKKLSW R+L+MLRDICRGLMCIHRM
Sbjct: 577 VLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGLMCIHRM 636
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 707
KIVHRDLKSANCLV+KHWTVKICDFGLSRI+TD M+D+SSAGTPEWMAPELIRN PFTE
Sbjct: 637 KIVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPELIRNRPFTE 696
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQE 767
KCDIFSLGVIMWEL TL +PWEGV PE+VV+AVA+EGSRLEIP+GPL +LIADCWAEP+E
Sbjct: 697 KCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPDGPLSKLIADCWAEPEE 756
Query: 768 RPSCEEILSRLLDCEYSLC 786
RP+CEEIL LLDCEY+LC
Sbjct: 757 RPNCEEILRGLLDCEYTLC 775
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 1.3e-80, Sum P(2) = 1.3e-80
Identities = 132/258 (51%), Positives = 185/258 (71%)
Query: 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 586
+ E+TVG R+G+G +GEV+RG W+GT+VA+K FL+QDLT E +E+F +E+ I+ +LRHPN
Sbjct: 745 WEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLRHPN 804
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++LF+GA T+PP LS++TE++ GSLY LIH + L RR+L+M D RG+ +H
Sbjct: 805 IVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERRRLRMALDAARGMNYLHS 862
Query: 647 MK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE++RNEP
Sbjct: 863 CNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLRNEP 922
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGRLIADC 761
EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IP+ P + LI+ C
Sbjct: 923 ADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLISKC 982
Query: 762 W-AEPQERPSCEEILSRL 778
W + + RPS EI++ L
Sbjct: 983 WQTDSKLRPSFAEIMASL 1000
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 129/270 (47%), Positives = 186/270 (68%)
Query: 516 PLLAYE-EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN 574
PLL +W I + +L +G R+GIG +GEV+R WNGT+VA+K FL+QD + + + F +
Sbjct: 594 PLLGEAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKS 653
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
EI I+ RLRHPNV+LF+GA T+PP S++TE++ GSLY L+H + L +R+++M
Sbjct: 654 EIEIMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQ--LDEKRRMRMA 711
Query: 635 RDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
D+ +G+ +H +VHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGTP
Sbjct: 712 LDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTP 771
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 752
EWMAPE++RNEP EKCD++S GVI+WEL T PW+G+ P +VV AV + RLEIP+
Sbjct: 772 EWMAPEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDD 831
Query: 753 ---PLGRLIADCW-AEPQERPSCEEILSRL 778
+ ++I +CW EP RPS +++ L
Sbjct: 832 IDLTVAQIIRECWQTEPHLRPSFTQLMQSL 861
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 680 (244.4 bits), Expect = 3.7e-80, Sum P(2) = 3.7e-80
Identities = 131/263 (49%), Positives = 184/263 (69%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
E I + E+TV R+G+G +GEV+RG W+GT VA+K F++QD+T E +E+F +E+ ++ R
Sbjct: 707 ECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRR 766
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRHPN++LF+GA T+PP LS++TE++ GSLY LIH + L R++L+M D RG+
Sbjct: 767 LRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQ--LDERKRLRMALDAARGM 824
Query: 642 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H IVHRDLKS N LV+K+W VK+CDFGLSR+ + + S+AGT EWMAPE+
Sbjct: 825 NYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEV 884
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GP-LGR 756
+RNEP EKCD++S GVI+WEL TL +PW + P +VV AV + RL+IPE P +
Sbjct: 885 LRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIAD 944
Query: 757 LIADCW-AEPQERPSCEEILSRL 778
+I CW +P+ RPS EI+ L
Sbjct: 945 IIRKCWQTDPRLRPSFGEIMDSL 967
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 7.4e-80, Sum P(2) = 7.4e-80
Identities = 128/278 (46%), Positives = 189/278 (67%)
Query: 507 LESPMFQNKPLLAYE----EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ 562
L+S ++N P + + E I +++L + R+G+G +GEV+ W+GT+VA+K FL+Q
Sbjct: 642 LDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQ 701
Query: 563 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 622
D + + +F +E+ I+ RLRHPNV+ FLGA T+PP LS++TE++ GSLY ++H K
Sbjct: 702 DFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRP--K 759
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680
+ RR++KM D+ G+ C+H IVHRDLK+ N LV+ +W VK+ DFGLSR+ +
Sbjct: 760 SHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHN 819
Query: 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740
+ + S+AGTPEWMAPE++RNEP EKCD++S GVI+WEL TL PW G+ P +VV AV
Sbjct: 820 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAV 879
Query: 741 ANEGSRLEIPE--GPL-GRLIADCW-AEPQERPSCEEI 774
+ RLEIP+ P+ GR+I +CW +P RPS ++
Sbjct: 880 GFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQL 917
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.9e-76, Sum P(2) = 5.9e-76
Identities = 131/276 (47%), Positives = 187/276 (67%)
Query: 510 PMFQNKPL-LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN 568
P N+ L L ++ +I + +L + ++G G FG V R W+G+DVA+K+ +EQD AE
Sbjct: 530 PNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER 589
Query: 569 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 628
+ +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L+H SG +++L R
Sbjct: 590 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER 649
Query: 629 RKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
R+L M D+ +G+ +H IVHRDLKS N LV+K +TVK+CDFGLSR+ + +
Sbjct: 650 RRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 709
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P +VV AV + R
Sbjct: 710 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 769
Query: 747 LEIPEG--P-LGRLIADCWA-EPQERPSCEEILSRL 778
LEIP P + +I CW EP +RPS I+ L
Sbjct: 770 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 805
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 5.6e-65, Sum P(3) = 5.6e-65
Identities = 126/280 (45%), Positives = 184/280 (65%)
Query: 508 ESPMFQ-NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA 566
+SP+ Q N L+ I + +L +G VG G F V RG+WNG+DVAIKV+ + D A
Sbjct: 445 QSPVNQRNNRLVTDSSCEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNA 504
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGA-CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL 625
+ + EI+I+ +LRHPNV+LF+GA CT+ + ++I EYM GSL+ ++H + Q L
Sbjct: 505 MTLTECKKEINIMKKLRHPNVLLFMGAVCTEE-KSAIIMEYMPRGSLFKILHNTNQP--L 561
Query: 626 SWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
+R+L+M D+ RG+ +HR IVHRDLKS+N LV+K+W VK+ DFGLS+ + +
Sbjct: 562 DKKRRLRMALDVARGMNYLHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFL 621
Query: 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743
S GTP+WMAPE++R+EP EKCD+FS GVI+WEL T PW+ + +VV V
Sbjct: 622 STKSGKGTPQWMAPEVLRSEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFM 681
Query: 744 GSRLEIPEG--P-LGRLIADCW-AEPQERPSCEEILSRLL 779
RL++PEG P + +I DCW +P +RPS EE++S+++
Sbjct: 682 DRRLDLPEGLNPRIASIIQDCWQTDPAKRPSFEELISQMM 721
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
Identities = 122/267 (45%), Positives = 179/267 (67%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
E+ I + +LT+G +VG G G V+ G+W G+DVA+KVF +Q+ +AE +E F E+ ++ R
Sbjct: 486 EYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKR 545
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRHPNV+LF+GA T P RL +++E++ GSL+ L+ S KL WRR++ M DI RG+
Sbjct: 546 LRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKS--TSKLDWRRRIHMALDIARGM 603
Query: 642 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H I+HRDLKS+N LV+K+WTVK+ DFGLSRI ++ + S GTP+WMAPE+
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEV 663
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 756
+RNE EK DI+S GV++WEL T PWE + +V+ AV RLEIP+ R
Sbjct: 664 LRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWIS 723
Query: 757 LIADCW-AEPQERPSCEEILSRLLDCE 782
L+ CW ++ + RP+ +E++ +L D +
Sbjct: 724 LMESCWHSDTKLRPTFQELMDKLRDLQ 750
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 1.5e-58, P = 1.5e-58
Identities = 118/267 (44%), Positives = 178/267 (66%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
++ I + +LT+G ++G G G V+ G+W G+DVA+KVF +Q+ + E + F E+S++ R
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLMKR 538
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRHPNV+LF+GA P RL ++TE++ GSL+ L L K KL RR++ M DI RG+
Sbjct: 539 LRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRL--LQRNKSKLDLRRRIHMASDIARGM 596
Query: 642 MCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H I+HRDLKS+N LV+++WTVK+ DFGLSRI ++ + ++ GTP+WMAPE+
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLT-TNGRGTPQWMAPEV 655
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA 759
+RNE EK D++S GV++WEL T PWE + +V+ AV RLE+P+ + IA
Sbjct: 656 LRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQWIA 715
Query: 760 ---DCW-AEPQERPSCEEILSRLLDCE 782
CW +EPQ RPS +E++ +L + +
Sbjct: 716 LMESCWHSEPQCRPSFQELMDKLRELQ 742
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 786 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-77 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-75 | |
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-75 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-73 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-54 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-47 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-46 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-44 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-42 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-42 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-42 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-42 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-40 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-40 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-40 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-39 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-39 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-38 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-37 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-37 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-37 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-37 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-37 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-36 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-36 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-36 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-36 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-36 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-35 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-34 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-34 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-32 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-32 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-31 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-31 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-30 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-29 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-29 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-27 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-26 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-26 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-26 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-25 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-25 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-22 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-21 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-21 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-19 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-17 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 8e-77
Identities = 100/262 (38%), Positives = 148/262 (56%), Gaps = 17/262 (6%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
L +G ++G G FGEV++G G T VA+K L++ + E E+F E SI+ +L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPN++ LG CT+ L ++TEYM G L L +KL+ + L+M I +G+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIR 701
+ VHRDL + NCLV ++ VKI DFGLSR I D R P +WMAPE ++
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 702 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
+ FT K D++S GV++WE+ TL +P+ G+ E V+ + +G RL PE L L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 758 IADCWAE-PQERPSCEEILSRL 778
+ CWA P++RP+ E++ L
Sbjct: 237 MLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 2e-75
Identities = 100/261 (38%), Positives = 146/261 (55%), Gaps = 16/261 (6%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPNV+ LG CT+ L ++ EYME G L L +L + KLS L I RG+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL--LSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 703 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
FT K D++S GV++WE+ TL +P+ G+ E V+ + N G RL P L L+
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNCPPELYDLM 236
Query: 759 ADCWAE-PQERPSCEEILSRL 778
CWAE P++RP+ E++ L
Sbjct: 237 LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 2e-75
Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 54 GLSSQTASQILWSTGMLS--EPIPNGFYSVIPDKRLKEL--FDSIPTVDELHALGGEGHR 109
S++ S W G LS + IP+GFY + +L F IP++++L A+
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 110 ADIILVDSKKDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAAL 169
+++LVD + D KL L+QL LV G +N AA+++K+AGLV+D P ++ + A
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAESMLAR 120
Query: 170 EE--TSHMFETRGVQLLGQIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDS 227
+ ++ + E GV LG ++ G CR RA+LFKVLAD++GL RL+ G C
Sbjct: 121 WKECSNELKENSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKY-----CGSD 175
Query: 228 YKHMSVIVVLNSVELLVDLMRFPGQLIP 255
+++ + E LVDLM PG LIP
Sbjct: 176 DDASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 94/261 (36%), Positives = 142/261 (54%), Gaps = 15/261 (5%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
LT+G ++G G FGEV++G G +VA+K L++D + + +E+F E I+ +L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPN++ LG CT+ L ++ EYM G L + + K+LS L I RG+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEY 118
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ +HRDL + NCLV ++ VKI DFGLSR + D P WMAPE ++
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 703 EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
FT K D++S GV++WE+ TL P+ G+ V+ + G RL P L +L+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELYKLM 237
Query: 759 ADCWAE-PQERPSCEEILSRL 778
CWAE P++RP+ E++ L
Sbjct: 238 LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 98/261 (37%), Positives = 144/261 (55%), Gaps = 20/261 (7%)
Query: 536 VGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FGEV++G G T+VA+K L++D + E +DF E ++ +L HPNV+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 591 LGACTKPPRLSMITEYMELGSLYHLI------HLSGQKKKLSWRRKLKMLRDICRGLMCI 644
LG CT+ L ++ EYME G L + S +K LS + L I +G+ +
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTP-EWMAPELIRN 702
K VHRDL + NCLV + VKI DFGLSR + D R + P WMAPE +++
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
FT K D++S GV++WE+ TL P+ G+ E V+ + +G RL PE L L+
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYELM 240
Query: 759 ADCWA-EPQERPSCEEILSRL 778
CW +P++RP+ E++ RL
Sbjct: 241 LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 9e-69
Identities = 79/253 (31%), Positives = 127/253 (50%), Gaps = 13/253 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ ++G G FG+V+ T VAIKV +++ ++ E EI IL +L+HPN++
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+L ++ EY E G L+ L+ ++ +LS LR I L +H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
IVHRDLK N L+++ VK+ DFGL+R + + GTPE+MAPE++ + + +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAPEVLLGKGYGKA 176
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEGPLGR----LIADCWA 763
DI+SLGVI++EL T P+ G ++ + PE + LI
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 764 -EPQERPSCEEIL 775
+P++R + EE L
Sbjct: 237 KDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 4e-66
Identities = 83/248 (33%), Positives = 123/248 (49%), Gaps = 38/248 (15%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G FG V+ T VAIK+ ++D + +E+ EI IL +L HPN++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
L ++ EY E GSL L+ + KLS L++L I GL +H I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 654 LKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTEKCDI 711
LK N L++ + VK+ DFGLS+++T + GTP +MAPE++ + ++EK DI
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 770
+SLGVI++EL L LI +P++RPS
Sbjct: 178 WSLGVILYELPELKD------------------------------LIRKMLQKDPEKRPS 207
Query: 771 CEEILSRL 778
+EIL L
Sbjct: 208 AKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 81/258 (31%), Positives = 129/258 (50%), Gaps = 15/258 (5%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587
+ ++G G FG V++ GT VA+K+ ++ ++ + EI IL RL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ + A L ++ EY E G L+ + + LS K+ I RGL +H
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFT 706
I+HRDLK N L++++ VKI DFGL++ + S ++ GTP +MAPE++ +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---LEIPEGPLGR-----LI 758
K D++SLGVI++EL T P+ G + + + P+ G LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 759 ADCWA-EPQERPSCEEIL 775
C +P +RP+ EEIL
Sbjct: 238 KKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 6e-54
Identities = 88/260 (33%), Positives = 132/260 (50%), Gaps = 18/260 (6%)
Query: 529 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 586
E T G +G G FG V+ + G +A+K + E +E EI ILS L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 587 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWR--RKLKMLRDICRGLM 642
++ + G+ + L++ EY+ GSL L+ + KL RK R I GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPVIRKY--TRQILEGLA 115
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPELI 700
+H IVHRD+K AN LV+ VK+ DFG ++ + D + + GTP WMAPE+I
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--PLGRL 757
R E + DI+SLG + E+ T PW + P +Y + + G EIPE +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235
Query: 758 -IADCWA-EPQERPSCEEIL 775
+ C +P++RP+ +E+L
Sbjct: 236 FLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 90/265 (33%), Positives = 134/265 (50%), Gaps = 12/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I L + ++G G FGEV+ G WNG T VA+K ++ E F E I+ +
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRH ++ C++ + ++TEYM GSL + SG+ KKL + + M I G+
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGM 116
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
+ +HRDL + N LV ++ KI DFGL+R+I D A P +W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
FT K D++S G+++ E+ T R P+ G+ V+ V G R+ P L
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYD 235
Query: 757 LIADCW-AEPQERPSCEEILSRLLD 780
L+ CW +P+ERP+ E + S L D
Sbjct: 236 LMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-50
Identities = 79/254 (31%), Positives = 128/254 (50%), Gaps = 10/254 (3%)
Query: 529 ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 586
+G +G G FG V++G+ G VAIK + + E ++ EI +L L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ ++G+ L +I EY E GSL +I G + + +GL +H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHE 117
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
++HRD+K+AN L K VK+ DFG++ + D D+S GTP WMAPE+I +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA 763
DI+SLG + EL T N P+ + P ++ + + +PEG L + C+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQ 236
Query: 764 -EPQERPSCEEILS 776
+P RP+ +++L
Sbjct: 237 KDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 1e-48
Identities = 77/249 (30%), Positives = 131/249 (52%), Gaps = 8/249 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G FG+V+ R +G +K +++ + ED NE+ IL +L HPN+I + +
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ +L ++ EY + G L I ++ K + L +C L +H KI+HR
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K N + + VK+ DFG+S++++ + + GTP +++PEL +N+P+ K DI+
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGRLIADC-WAEPQER 768
SLG +++ELCTL P+EG + + G IP L L++ +P+ER
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNLVSSLLQKDPEER 246
Query: 769 PSCEEILSR 777
PS +IL
Sbjct: 247 PSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 94/262 (35%), Positives = 141/262 (53%), Gaps = 13/262 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
ID SELT +G G FG V G W G DVAIK+ E + + +DF E ++ +L
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLS 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPN++ G CTK + ++TEYM G L L +L +K KL L M D+C +
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCL--LNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ +HRDL + NCLV + VK+ DFGL+R + D S P +W PE+
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY 175
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 758
F+ K D++S GV+MWE+ + + P+E VV +V+ G RL P+ + ++
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234
Query: 759 ADCWAE-PQERPSCEEILSRLL 779
CW E P++RP+ +++LS+L
Sbjct: 235 YSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 99/266 (37%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT-----DVAIKVFLEQDLTAENMEDFCNEISIL 579
ID S +T+ +G G FGEV RG DVAIK L+ + + DF E SI+
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIM 59
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ HPN+I G TK + +ITEYME GSL L K + + + MLR I
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKF--LRENDGKFTVGQLVGMLRGIAS 117
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTP-EWMAP 697
G+ + M VHRDL + N LVN + K+ DFGLSR + DS + P W AP
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GP 753
E I FT D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSA 236
Query: 754 LGRLIADCW-AEPQERPSCEEILSRL 778
L +L+ DCW + ERP+ +I+S L
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 86/264 (32%), Positives = 134/264 (50%), Gaps = 31/264 (11%)
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRH 584
T+ +G G FGEV++ I T+ VAIKV LE+ + +ED EI LS+ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRS 58
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
P + + G+ K +L +I EY GS L+ KL +LR++ GL +
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYL 114
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
H +HRD+K+AN L+++ VK+ DFG+S +T + + ++ GTP WMAPE+I+
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 764
+ EK DI+SLG+ EL P + P RV++ IP+ L + +++
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---------LIPKNNPPSLEGNKFSK 225
Query: 765 -------------PQERPSCEEIL 775
P+ERPS +E+L
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-46
Identities = 78/254 (30%), Positives = 134/254 (52%), Gaps = 12/254 (4%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587
++G G GEV++ T +VAIK L +N E NEI I+ +HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPNI 77
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ + + L ++ EYM+ GSL +I + +++ + + R++ +GL +H
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 707
++HRD+KS N L++K +VK+ DFG + +T + +S GTP WMAPE+I+ + +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA 763
K DI+SLG++ E+ P+ P R ++ + +G L+ PE + C
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 764 -EPQERPSCEEILS 776
+P++RPS EE+L
Sbjct: 256 KDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 86/261 (32%), Positives = 145/261 (55%), Gaps = 13/261 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W I+ EL +G +G G FG+V G + G VA+K L+ D TA + F E S+++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKC-LKDDSTA--AQAFLAEASVMTTL 57
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
RHPN++ LG + L ++TEYM GSL + G + ++ ++L D+C G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGME 116
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
+ VHRDL + N LV++ K+ DFGL++ ++ S +W APE +R
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALRE 173
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
+ F+ K D++S G+++WE+ + R P+ + + VV V G R+E PEG + +++
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232
Query: 759 ADCW-AEPQERPSCEEILSRL 778
DCW +P +RP+ +++ +L
Sbjct: 233 KDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 83/249 (33%), Positives = 134/249 (53%), Gaps = 12/249 (4%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G FGEV++ G +VAIKV + + E E NEI IL + +HPN++ + G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ K L ++ E+ GSL L+ + Q S + +++ +GL +H I+HR
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV--CKELLKGLEYLHSNGIIHR 122
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K+AN L+ VK+ DFGLS ++D+ R+ + GTP WMAPE+I +P+ K DI+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-TMVGTPYWMAPEVINGKPYDYKADIW 181
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 767
SLG+ EL P+ + P + ++ +A G L PE + C P++
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEK 241
Query: 768 RPSCEEILS 776
RP+ E++L
Sbjct: 242 RPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 85/267 (31%), Positives = 136/267 (50%), Gaps = 16/267 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENM--EDFCNEISIL 579
W ID + + + ++G G FGEV+ G+WN T VA+K L M +DF E I+
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT-----LKPGTMDPKDFLAEAQIM 55
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+LRHP +I CT + ++TE M+ GSL + G + L + + M +
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVAS 114
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 698
G+ + +HRDL + N LV ++ K+ DFGL+R+I + A P +W APE
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 754
F+ K D++S G+++ E+ T R P+ G+ V+ V +G R+ P G L
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233
Query: 755 GRLIADCW-AEPQERPSCEEILSRLLD 780
++ DCW +P +RP+ E + +L D
Sbjct: 234 YDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 88/262 (33%), Positives = 139/262 (53%), Gaps = 13/262 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
ID +LT +G G FG V G W G DVAIK+ E ++ + +F E ++ +L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
H ++ G CTK + ++TEYM G L L +L K+ + L+M +D+C G+
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCL--LNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ + +HRDL + NCLV+ VK+ DFGLSR + D S + P W PE++
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY 175
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGPLGRLIA-- 759
F+ K D+++ GV+MWE+ +L + P+E V V+ +G RL P ++ A
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234
Query: 760 -DCWAE-PQERPSCEEILSRLL 779
CW E +ERP+ +++LS +
Sbjct: 235 YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-42
Identities = 83/260 (31%), Positives = 144/260 (55%), Gaps = 13/260 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILS 580
W ++ +++T+ ++G G +GEV+ G+W VA+K E + +E+F E +++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMK 57
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
++HPN++ LG CT+ P +ITE+M G+L + +++++ L M I
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSA 116
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 699
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
+ F+ K D+++ GV++WE+ T P+ G+ + VY + +G R+E PEG +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPKVY 235
Query: 756 RLIADCWA-EPQERPSCEEI 774
L+ CW P +RPS EI
Sbjct: 236 ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 92/261 (35%), Positives = 139/261 (53%), Gaps = 13/261 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
I+ SELT +G G FG V G W VAIK E A + EDF E ++ +L
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLS 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HP ++ G CT+ L ++TE+ME G L + +L ++ KLS L M +D+C G+
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ R +HRDL + NCLV+ VK+ DFG++R + D SS A P +W PE+
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF 175
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 758
++ K D++S GV+MWE+ T + P+E VV ++ G RL P+ + ++
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVM 234
Query: 759 ADCWAE-PQERPSCEEILSRL 778
CW E P+ RP+ E+L +
Sbjct: 235 YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 89/281 (31%), Positives = 142/281 (50%), Gaps = 27/281 (9%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
W + ++T+ +G G FG V+ G+ G T VAIK E E +E F NE
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNE 59
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK---------LS 626
S++ +V+ LG + ++ E M G L +L ++ + +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS--YLRSRRPEAENNPGLGPPT 117
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMR 684
++ ++M +I G+ + K VHRDL + NC+V + TVKI DFG++R I TD +
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 743
WMAPE +++ FT K D++S GV++WE+ TL +P++G+ E V+ V +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236
Query: 744 GSRLEIPEGP---LGRLIADCWA-EPQERPSCEEILSRLLD 780
G L++PE L L+ CW P+ RP+ EI+S L D
Sbjct: 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 85/250 (34%), Positives = 141/250 (56%), Gaps = 15/250 (6%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILF 590
+G G +G V+RG T VA+K+ + D +++ D E+++LS+LR PN+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKI-INLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
G+ K PRL +I EY E GS+ L+ ++ + ++R++ L IH++ ++
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 709
HRD+K+AN LV VK+CDFG++ ++ + + S+ GTP WMAPE+I + + K
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRLIADCW-AEP 765
DI+SLG+ ++E+ T N P+ V R + + ++ RLE L +A C EP
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243
Query: 766 QERPSCEEIL 775
+ER S EE+L
Sbjct: 244 KERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 581
W E T+ ++G G+FGEV+ G+W VAIK+ L+ D +DF E+ L R
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKI-LKSD-DLLKQQDFQKEVQALKR 58
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRH ++I C+ + +ITE ME GSL + S + + L + M + G+
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGM 117
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
+ +HRDL + N LV + K+ DFGL+R+I + + SS P +W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAA 176
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LGR 756
+ F+ K D++S G++++E+ T + P+ G+ V + G R+ P + P + +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYK 235
Query: 757 LIADCW-AEPQERPSCEEILSRL 778
++ +CW AEP++RPS + + L
Sbjct: 236 IMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 16/267 (5%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISIL 579
I ++T+G +G G FG+V++G++ VA+K + + E F E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIM 61
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ HP+++ +G T+ P + ++ E LG L +L K L + +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRS--YLQVNKYSLDLASLILYSYQLST 118
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 698
L + + VHRD+ + N LV+ VK+ DFGLSR + D +S P +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PL 754
I FT D++ GV MWE+ L +P++GV V+ + N G RL +P L
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTL 237
Query: 755 GRLIADCWA-EPQERPSCEEILSRLLD 780
L+ CWA +P +RP E+ ++L D
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 10/251 (3%)
Query: 536 VGIGFFGE--VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G FGE ++R + + V K L+ + D NEI ILS L+HPN+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVHR 652
L + EY G+LY I QK +L L L I + IH+ I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K+ N + K +K+ DFG+S+I+ + GTP +M+PEL + + K DI+
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER 768
+LG +++EL TL R ++ P +V + +G+ + L L+ +P++R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKIV-QGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 769 PSCEEILSRLL 779
P+ +E+L + L
Sbjct: 245 PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 13/261 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
I SELT+ +G G FG V+ G W VAIK E A + EDF E ++ +L
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMSEEDFIEEAQVMMKLS 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HP ++ G CT+ + ++ E+ME G L +L Q+ K S L M D+C G+
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRN 702
+ ++HRDL + NCLV ++ VK+ DFG++R + D S+ P +W +PE+
Sbjct: 116 LESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF 175
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLI 758
++ K D++S GV+MWE+ + + P+E VV + N G RL P + L+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRLYKPRLASQSVYELM 234
Query: 759 ADCWAE-PQERPSCEEILSRL 778
CW E P++RPS +L +L
Sbjct: 235 QHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 77/254 (30%), Positives = 134/254 (52%), Gaps = 16/254 (6%)
Query: 535 RVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
++G G FG+V++G+ T+VA+K L + F E IL + HPN++ +G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-CRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
C + + ++ E + GSL L L +K +L+ ++ L+M D G+ + +HRD
Sbjct: 61 CVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEKC 709
L + NCLV ++ +KI DFG+SR + + S G + W APE + +T +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 710 DIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-E 764
D++S G+++WE +L + P+ G+ ++ + G R+ P+ + RL+ CWA +
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYD 235
Query: 765 PQERPSCEEILSRL 778
P+ RPS EI + L
Sbjct: 236 PENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 77/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G +G V++ I G VAIKV E++++ EISIL + P ++ + G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
K L ++ EY GS+ ++ ++ K L+ +L +GL +H K +HRD
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124
Query: 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIF 712
+K+ N L+N+ K+ DFG+S +TD+ M ++ GTP WMAPE+I+ + K DI+
Sbjct: 125 IKAGNILLNEEGQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQE 767
SLG+ E+ P+ + P R ++ + N+ L PE + C +P+E
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243
Query: 768 RPSCEEILS 776
RPS ++L
Sbjct: 244 RPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 9e-39
Identities = 92/265 (34%), Positives = 135/265 (50%), Gaps = 13/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I L + ++G G FGEV+ G WNG T VA+K ++ E+ F E I+ +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKK 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRH ++ ++ P + ++TEYM GSL + G+ + L + M + G+
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGM 115
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
I RM +HRDL+SAN LV KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
FT K D++S G+++ EL T R P+ G + R V G R+ P+ L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 757 LIADCW-AEPQERPSCEEILSRLLD 780
L+ CW +P+ERP+ E + S L D
Sbjct: 235 LMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 1e-38
Identities = 95/265 (35%), Positives = 136/265 (51%), Gaps = 13/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I L + ++G G FGEV+ G WNGT VAIK + E F E I+ +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKK 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
LRH ++ ++ P + ++TE+M GSL + G K L + + M I G+
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGM 115
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
I RM +HRDL++AN LV + KI DFGL+R+I D+ A P +W APE
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P+G L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHE 234
Query: 757 LIADCW-AEPQERPSCEEILSRLLD 780
L+ CW +P ERP+ E I S L D
Sbjct: 235 LMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 82/281 (29%), Positives = 127/281 (45%), Gaps = 50/281 (17%)
Query: 536 VGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG+V ++ VA+K L ++ DF EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 590 FLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ G C KP L +I EY+ GSL +L + +++ +R L IC+G+ +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRD--YLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------------DSPMRDSSSAGTPEWM 695
+ +HRDL + N LV VKI DFGL++++ +SP+ W
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---------WY 179
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVAN----- 742
APE +R F+ D++S GV ++EL T P + + V
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 743 -EGSRLEIPEG-P--LGRLIADCW-AEPQERPSCEEILSRL 778
EG RL P P + L+ CW AEPQ+RPS +++ +
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 94/266 (35%), Positives = 143/266 (53%), Gaps = 15/266 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 581
W + L + ++G G FGEV+ G +NG T VAIK + ++ E F E +++ +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQ 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L+HP ++ T+ P + +ITEYME GSL + + + KL+ + + M I G+
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPEGIKLTINKLIDMAAQIAEGM 115
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVL-PERVVYAVANEGSRLEIPEG---PLG 755
FT K D++S G+++ E+ T R P+ G+ PE V G R+ P+ L
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELY 233
Query: 756 RLIADCWAE-PQERPSCEEILSRLLD 780
L+ CW E P+ERP+ E + S L D
Sbjct: 234 ELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/261 (31%), Positives = 145/261 (55%), Gaps = 15/261 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W ++ +LT+G +G G FG V +G + G VA+K ++ D+TA+ F E +++++L
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQA---FLEETAVMTKL 56
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
H N++ LG L ++ E M G+L + + G + +S + L+ D+ G+
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGME 114
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
+ K+VHRDL + N LV++ K+ DFGL+R+ M +S +W APE +++
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKH 171
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
+ F+ K D++S GV++WE+ + R P+ + + V V +G R+E PEG + L+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLM 230
Query: 759 ADCW-AEPQERPSCEEILSRL 778
CW EP++RPS ++ +L
Sbjct: 231 TSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 82/256 (32%), Positives = 134/256 (52%), Gaps = 18/256 (7%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
V ++G G +G V++ + + A+K ++ + ED NEI IL+ + HPN+I
Sbjct: 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-----SWRRKLKMLRDICRGLMC 643
+ A +L ++ EY G L I +K+KL WR +++ RGL
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQA 118
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+H KI+HRDLKSAN L+ + VKI D G+S+++ + + + GTP +MAPE+ +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEVWKGR 176
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 760
P++ K DI+SLG +++E+ T P+E + + Y V G IP L I
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNFIRS 235
Query: 761 CW-AEPQERPSCEEIL 775
+P+ RP+C++IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 96/267 (35%), Positives = 137/267 (51%), Gaps = 17/267 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 579
ID S + + +G G FGEV G VAIK L+ T + DF +E SI+
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKT-LKAGYTEKQRRDFLSEASIM 59
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ HPN+I G TK + ++TEYME GSL L + + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF--LRKHDGQFTVIQLVGMLRGIAS 117
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMA 696
G+ + M VHRDL + N LVN + K+ DFGLSR++ D P ++ G W A
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 752
PE I FT D++S G++MWE+ + RP+ + + V+ A+ EG RL P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPA 236
Query: 753 PLGRLIADCW-AEPQERPSCEEILSRL 778
L +L+ DCW + ERP E+I+S L
Sbjct: 237 ALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-37
Identities = 85/267 (31%), Positives = 135/267 (50%), Gaps = 22/267 (8%)
Query: 534 TRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENME-DFCNEISILSRLRHP 585
T +G G FGEVF G + V +K + EN++ +F E+ + +L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHK 68
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICR 639
NV+ LG C + MI EY +LG L + + K LS ++K+ + I
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPE 698
G+ + + VHRDL + NCLV+ VK+ LS+ + +S +A P W+APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 754
++ + F+ K D++S GV+MWE+ T P+ G+ E V+ + L +PEG L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 755 GRLIADCWA-EPQERPSCEEILSRLLD 780
+L+ CWA P++RPS E++S L +
Sbjct: 249 YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-37
Identities = 79/264 (29%), Positives = 136/264 (51%), Gaps = 18/264 (6%)
Query: 528 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
+EL +G G FG V++G+W VAIKV L ++ + + ++ +E +++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV-LREETSPKANKEILDEAYVMAS 65
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ HP+V+ LG C ++ +IT+ M LG L L ++ K + + L I +G+
Sbjct: 66 VDHPHVVRLLGICLSS-QVQLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAKGM 122
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 699
+ ++VHRDL + N LV VKI DFGL++++ D + P +WMA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLG 755
I + +T K D++S GV +WEL T +P+EG+ P + + +G RL P +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVY 241
Query: 756 RLIADCWAEPQE-RPSCEEILSRL 778
++ CW E RP+ +E+++
Sbjct: 242 MVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-37
Identities = 96/266 (36%), Positives = 141/266 (53%), Gaps = 15/266 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I L + ++G G FGEV+ G WNGT VAIK ++ E F E ++ +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRG 640
LRH ++ ++ P + ++TEYM GSL L L G+ K L + + M I G
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 699
+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ A P +W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP-EGP--LG 755
FT K D++S G+++ EL T R P+ G++ V+ V G R+ P E P L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLH 233
Query: 756 RLIADCW-AEPQERPSCEEILSRLLD 780
L+ CW EP+ERP+ E + + L D
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 97/296 (32%), Positives = 139/296 (46%), Gaps = 59/296 (19%)
Query: 528 SELTVGTRVGIGFFGEV----------------FRGIWNG--TDVAIKVFLEQDLTAENM 569
L ++G G FGEV VA+KV L D +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDASDNAR 63
Query: 570 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-----YHLIHLSG---Q 621
EDF E+ ILSRL PN+ LG CT P L MI EYME G L H+ SG
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 622 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681
K LS+ L M I G+ + + VHRDL + NCLV K++T+KI DFG+SR + S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 682 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR--PW 728
P+R WMA E + FT K D+++ GV +WE+ TL R P+
Sbjct: 184 DYYRVQGRAPLPIR---------WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 729 EGVLPERVV----YAVANEGSRLEIPEGP-----LGRLIADCWA-EPQERPSCEEI 774
E + ++V+ + ++G ++ +P P + L+ +CW + ++RP+ EI
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 93/258 (36%), Positives = 135/258 (52%), Gaps = 18/258 (6%)
Query: 536 VGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FGEVFRGI VAIK L+ T + +DF +E SI+ + H N+I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-LKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
G TK +ITEYME G+L +L + S + + MLR I G+ + M V
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP---EWMAPELIRNEPFTE 707
HRDL + N LVN + K+ DFGLSR++ D P +++G W APE I FT
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 708 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW- 762
D++S G++MWE+ + RP+ + V+ A+ N+G RL P + +L+ CW
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 763 AEPQERPSCEEILSRLLD 780
+ RP +I++ LLD
Sbjct: 249 QDRARRPRFVDIVN-LLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 79/259 (30%), Positives = 116/259 (44%), Gaps = 16/259 (6%)
Query: 535 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
++G G FG V RG W G VA+K L+ D ++ M+DF E +I+ L H N+I
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC-LKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
G P L M+TE LGSL + I G+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTP-EWMAPELIRNEPFT 706
+HRDL + N L+ VKI DFGL R + P W APE +R F+
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 707 EKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW 762
D++ GV +WE+ T PW G+ +++ + EG RLE PE + ++ CW
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238
Query: 763 A-EPQERPSCEEILSRLLD 780
A P +RP+ + L +
Sbjct: 239 AHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 85/286 (29%), Positives = 147/286 (51%), Gaps = 30/286 (10%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 573
EW + LT+G +G G FG+V + G D VA+K+ L+ D T +++ D
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLV 63
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLS 619
+E+ ++ + +H N+I LG CT+ L ++ EY G+L
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 620 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679
++ L+ + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 680 DSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 736
R +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ G+ P
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEE 242
Query: 737 VYAVANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 778
++ + EG R+E P+ L L+ DCW E P +RP+ ++++ L
Sbjct: 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 89/284 (31%), Positives = 143/284 (50%), Gaps = 37/284 (13%)
Query: 530 LTVGTRVGIGFFGEVFR-------GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
L +G +G G FG+V + G T VA+K+ E ++E D +E ++L ++
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQV 60
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------- 621
HP+VI GAC++ L +I EY + GSL + S +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 622 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--T 679
++ L+ + I RG+ + MK+VHRDL + N LV + +KI DFGLSR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVY 738
DS ++ S +WMA E + + +T + D++S GV++WE+ TL P+ G+ PER ++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LF 239
Query: 739 AVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ G R+E PE + L+ CW EP +RP+ +I L
Sbjct: 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 83/271 (30%), Positives = 135/271 (49%), Gaps = 25/271 (9%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEISILSRL 582
+T+ +G G FGEV+ G++ G D VA+K L + + ++ DF E I+S+
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEALIMSKF 66
Query: 583 RHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDI 637
H N++ +G + PR ++ E M G L + + + L+ + L RD+
Sbjct: 67 NHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRDSSSAGTP- 692
+G + +HRD+ + NCL+ KI DFG++R I S R A P
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 751
+WM PE + FT K D++S GV++WE+ +L P+ G + V G RL+ P+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG-RTNQEVMEFVTGGGRLDPPK 244
Query: 752 G---PLGRLIADCW-AEPQERPSCEEILSRL 778
G P+ R++ DCW P++RP+ IL R+
Sbjct: 245 GCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 87/246 (35%), Positives = 140/246 (56%), Gaps = 10/246 (4%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ K +L +I EY+ GS L+ + L + +LR+I +GL +H K +HR
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K+AN L+++H VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 185
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIP-EGPLGRLIADCW-AEPQERP 769
SLG+ EL P + P +V++ + N LE PL + C EP RP
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 770 SCEEIL 775
+ +E+L
Sbjct: 246 TAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVA---IKVFLEQDLTAENMEDFCNEISILSRLRHP 585
+ ++G G F V++ I +G VA +++F D A+ +D EI +L +L HP
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHP 62
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCI 644
NVI +L + + L+++ E + G L +I H QK+ + R K +C L +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
H +I+HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LGRL 757
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L L
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240
Query: 758 IADCW-AEPQERPSCEEILS 776
++ C +P++RP +L
Sbjct: 241 VSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 35/272 (12%)
Query: 536 VGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG VF+ G T VA+K+ L+++ +A+ DF E ++++ HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 589 LFLGACTKPPRLSMITEYMELGSLYH-LIHLS------------------GQKKKLSWRR 629
LG C + ++ EYM G L L H S LS
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSS 687
+L + + + G+ + K VHRDL + NCLV ++ VKI DFGLSR I D +
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 746
A WM PE I +T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV-RDGNV 250
Query: 747 LEIPEG-PLG--RLIADCWA-EPQERPSCEEI 774
L P+ PL L+ CW+ P +RPS I
Sbjct: 251 LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 18/255 (7%)
Query: 533 GTRVGIGFFGEVFRGI--WNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 587
G +G G FG V+ G+ +G A+K + E ++ EI++LS+L+HPN+
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML--RDICRGLMCIH 645
+ +LG + L + E + GSL L+ KK S+ + L R I GL +H
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLL-----KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-P 704
VHRD+K AN LV+ + VK+ DFG+++ + + S G+P WMAPE+I +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA-KSFKGSPYWMAPEVIAQQGG 178
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRL-IADC 761
+ DI+SLG + E+ T PW + V+ + IP+ + I C
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKC 238
Query: 762 W-AEPQERPSCEEIL 775
+P RP+ E+L
Sbjct: 239 LQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 82/261 (31%), Positives = 132/261 (50%), Gaps = 30/261 (11%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
R+G G +G+V+ R I G VAIKV LE ++ E EIS+L RHPN++ +
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYF 66
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICRGLMCIH 645
G+ + +L ++ EY GSL + ++ R L + R+ +GL +H
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVT--------RGPLSELQIAYVCRETLKGLAYLH 118
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RN 702
+HRD+K AN L+ + VK+ DFG+S +T + + S GTP WMAPE+ R
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---RLEIPE--GPLGRL 757
+ KCDI++LG+ EL L P + P R ++ ++ +L+ E P+
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238
Query: 758 -IADCWA-EPQERPSCEEILS 776
I C +P++RP+ ++L
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 88/269 (32%), Positives = 137/269 (50%), Gaps = 33/269 (12%)
Query: 536 VGIGFFGEVFRG-----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587
+G G FGEV+ G + G+ VA+K L + T + ++F E ++S HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT-LRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------LSWRRKLKMLRDICRGL 641
+ LG C +I E ME G L +L + + L+ + L + D+ +G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLS--YLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 642 MCIHRMKIVHRDLKSANCLV-----NKHWTVKICDFGLSRIITDSPMRDSSSAG--TPEW 694
+ + +M +HRDL + NCLV + VKI DFGL+R I S G W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE-- 751
MAPE + + FT + D++S GV+MWE+ TL +P+ + + V+ V G RL+ PE
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RLQKPENC 238
Query: 752 -GPLGRLIADCWA-EPQERPS---CEEIL 775
+ +L+ +CWA +P ERP+ +EIL
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 535 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM-----EDFCNEISILSRLRHPNVIL 589
+G G FG V + K+ + +++ NM + +E++IL L+HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 590 FLGACTKPP--RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
+ L ++ EY E G L LI ++K + ++L + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 647 -----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
++HRDLK AN ++ + VK+ DFGL++I+ + GTP +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEG---PL 754
+ + EK DI+SLG +++ELC L+ P+ L ++ EG IP L
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRYSSEL 238
Query: 755 GRLIADCWA-EPQERPSCEEIL 775
+I +P +RPS EE+L
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 85/268 (31%), Positives = 132/268 (49%), Gaps = 27/268 (10%)
Query: 536 VGIGFFGEVFRG----IWNGTD---VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG+VF G + D VA+K L++ + + +DF E +L+ +H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREAELLTNFQHENIV 71
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDI 637
F G CT+ M+ EYME G L + G +L+ + L++ I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWM 695
G++ + VHRDL + NCLV VKI DFG+SR + T R P WM
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-P 753
PE I FT + D++S GV++WE+ T + PW G+ E V+ + +G L+ P P
Sbjct: 192 PPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-TQGRLLQRPRTCP 250
Query: 754 LG--RLIADCW-AEPQERPSCEEILSRL 778
++ CW +PQ+R + ++I RL
Sbjct: 251 SEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 34/269 (12%)
Query: 528 SELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 585
S+L +G G G V++ G A+K D E + E+ L P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHV-DGDEEFRKQLLRELKTLRSCESP 59
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
V+ GA K +S++ EYM+ GSL L+ + K+ + R I +GL +H
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 646 RM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
I+HRD+K +N L+N VKI DFG+S+++ ++ + ++ GT +M+PE I+ E
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLIAD 760
++ DI+SLG+ + E G P + + S E I +GP L A+
Sbjct: 177 YSYAADIWSLGLTLLECAL------GKFP----FLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 761 CWA-------------EPQERPSCEEILS 776
++ +P++RPS E+L
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 94/269 (34%), Positives = 136/269 (50%), Gaps = 19/269 (7%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISIL 579
ID S + + +G G FGEV RG VAIK L+ T + DF +E SI+
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIM 59
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDIC 638
+ HPN+I G TK + +ITE+ME G+L + + GQ + + + MLR I
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIA 116
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGT-P-E 693
G+ + M VHRDL + N LVN + K+ DFGLSR + D P SS G P
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 752
W APE I FT D++S G++MWE+ + RP+ + + V+ A+ + +
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236
Query: 753 P--LGRLIADCWA-EPQERPSCEEILSRL 778
P L +L+ DCW + RP +I+S L
Sbjct: 237 PTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 84/255 (32%), Positives = 140/255 (54%), Gaps = 10/255 (3%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
R+G G FGEV++GI N T VAIK+ ++ + + +ED EI++LS+ P + + G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ K +L +I EY+ GS L+ + L +LR+I +GL +H + +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAV-ANEGSRLEIPEG-PLGRLIADCW-AEPQERP 769
SLG+ EL P + P RV++ + N LE P + C +P+ RP
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
Query: 770 SCEEILSRLLDCEYS 784
+ +E+L Y+
Sbjct: 246 TAKELLKHKFITRYT 260
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 85/255 (33%), Positives = 138/255 (54%), Gaps = 28/255 (10%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
R+G G FGEVF+GI N T VAIK+ ++ + + +ED EI++LS+ P V + G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ K +L +I EY+ GS L+ +G + + ML++I +GL +H K +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEF---QIATMLKEILKGLDYLHSEKKIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K+AN L+++ VK+ DFG++ +TD+ ++ ++ GTP WMAPE+I+ + K DI+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD-----------C 761
SLG+ EL P + P RV++ IP+ L + C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLF---------LIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 762 W-AEPQERPSCEEIL 775
+P RP+ +E+L
Sbjct: 237 LNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 92/282 (32%), Positives = 136/282 (48%), Gaps = 34/282 (12%)
Query: 524 NIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEI 576
+ F E +G G FG+V++G G T VAIK L+++ + ++F E
Sbjct: 6 AVRFLE-----ELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLS------------GQKK 623
++S L+HPN++ LG CTK M+ EY+ G L+ L+ S K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 624 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682
L L + I G+ + VHRDL + NCLV + TVKI DFGLSR I +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 683 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAV 740
R S + P WM PE I FT + DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 741 ANEGSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSRL 778
L PE + L+ +CW E P RP ++I +RL
Sbjct: 240 -RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 20/259 (7%)
Query: 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
G ++G G FG+V+ + G +A+K QD + +++ +E+ +L L+HPN++ +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
G ++ + EY G+L L+ + R L GL +H IV
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL---LEGLAYLHSHGIV 121
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMAPELIRNEPFT 706
HRD+K AN ++ + +K+ DFG + + ++ S AGTP +MAPE+I
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 707 EK---CDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPE----GPLG-RL 757
DI+SLG ++ E+ T RPW + E ++++ V G + IP+ P G
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGKDF 240
Query: 758 IADCWA-EPQERPSCEEIL 775
+ C +P++RP+ E+L
Sbjct: 241 LDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (331), Expect = 2e-33
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 16/268 (5%)
Query: 529 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNV 587
+ ++G G FGEV+ + VA+KV ++ + ++ +E F EI IL+ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 588 IL-FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
I+ L ++ EY++ GSL L+ G+K LS L +L I L +H
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 647 MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDS------PMRDSSSAGTPEWMAPEL 699
I+HRD+K N L+++ VK+ DFGL++++ D P S+S GTP +MAPE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 700 IR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 756
+ + DI+SLG+ ++EL T P+EG E+ A + + P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSLA 236
Query: 757 LIADCWAEPQERPSCEEILSRLLDCEYS 784
+ ++L +LL +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPK 264
|
Length = 384 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 79/272 (29%), Positives = 129/272 (47%), Gaps = 45/272 (16%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592
+G G +G+V++ T VAIK+ D+ + E+ E +IL + HPN+ F G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 593 ACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRDICRGLMC 643
A K +L ++ E GS+ L+ G++ K W + LR+ RGL
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI--LRETLRGLAY 128
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 700
+H K++HRD+K N L+ K+ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 LHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188
Query: 701 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 757
+ + + D++SLG+ EL P + P R ++ +IP P L
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---------KIPRNPPPTLK 239
Query: 758 ------------IADCWAE-PQERPSCEEILS 776
I++C + ++RP EE+L
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 83/265 (31%), Positives = 136/265 (51%), Gaps = 12/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I + + ++G G FGEV+ G + N T VA+K ++ ++ F E +++
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L+H ++ TK + +ITEYM GSL + S + K+ + + I G+
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-SDEGGKVLLPKLIDFSAQIAEGM 116
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
I R +HRDL++AN LV++ KI DFGL+R+I D+ A P +W APE I
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
FT K D++S G++++E+ T + P+ G+ V+ A+ G R+ E L
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYD 235
Query: 757 LIADCWAE-PQERPSCEEILSRLLD 780
++ CW E +ERP+ + + S L D
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 83/250 (33%), Positives = 126/250 (50%), Gaps = 24/250 (9%)
Query: 554 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 612
VA+K+ L D+T DF EI I+SRL++PN+I LG C L MITEYME G L
Sbjct: 47 VAVKM-LRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 613 --------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664
+ +S L M I G+ + + VHRDL + NCLV H
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165
Query: 665 WTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 722
+T+KI DFG+SR + + R A P WMA E I FT D+++ GV +WE+
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225
Query: 723 TL--NRPWEGVLPERVVYAVA----NEGSRLEIPE-----GPLGRLIADCWA-EPQERPS 770
TL +P+ + E+V+ N+G ++ + + P+ +L+ CW+ + ++RP+
Sbjct: 226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
Query: 771 CEEILSRLLD 780
+I L +
Sbjct: 286 FNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 21/263 (7%)
Query: 535 RVGIGFFGEVFRGIW---NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG V +G++ +G +VA+K L+Q+ A ++F E S++++L HP ++
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKT-LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK-MLRDICRGLMCIHRMK 648
+G C P L ++ E LG L + +K++ LK + + G+ +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 649 IVHRDLKSANCL-VNKHWTVKICDFGLSRII-TDSPMRDSSSAGT-P-EWMAPELIRNEP 704
VHRDL + N L VN+H KI DFG+SR + S +++AG P +W APE I
Sbjct: 116 FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 761
F+ K D++S GV +WE + G + V A+ G RL PE + ++ C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 762 WA-EPQERPSCEEILSRLLDCEY 783
W P++RP+ E+ S
Sbjct: 235 WKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 80/262 (30%), Positives = 137/262 (52%), Gaps = 15/262 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E S++++L
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQA---FLAEASVMTQL 56
Query: 583 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 115
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+ VHRDL + N LV++ K+ DFGL++ S +D+ +W APE +R
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV-KWTAPEALR 172
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
+ F+ K D++S G+++WE+ + R P+ + + VV V G +++ P+G + +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231
Query: 758 IADCWA-EPQERPSCEEILSRL 778
+ CW + RPS ++ +L
Sbjct: 232 MKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 80/254 (31%), Positives = 133/254 (52%), Gaps = 19/254 (7%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G FG+++ + + IK + + E E+ +L++++HPN++ F +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ RL ++ EY + G L I+ L + + LSW I GL IH K
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDRK 121
Query: 649 IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE 707
I+HRD+KS N ++K+ V K+ DFG++R + DS + GTP +++PE+ +N P+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-A 763
K DI+SLG +++ELCTL P+EG ++V + +G I L LI+ +
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLFKV 240
Query: 764 EPQERPSCEEILSR 777
P++RPS IL R
Sbjct: 241 SPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 84/276 (30%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 518 LAYEE-WNIDFSELTVGTRVGIGFFGEVFRGIWNG---TDVAIKV---FLEQDLTAENME 570
L Y+ W + L+ G +G G FG+V G +D +KV L+ + E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 571 DFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 629
+E+ I+S L H N++ LGACT + +ITEY G L + + ++ L+
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLED 142
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSS 688
L + +G+ + +HRDL + N L+ VKICDFGL+R I+ DS +
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 689 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSR 746
A P +WMAPE I N +T + D++S G+++WE+ +L P+ G+ + Y + EG R
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262
Query: 747 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRL 778
+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 25/274 (9%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 584
L +G +G G FG V G + D VA+K T +E+F +E + + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 585 PNVILFLGAC------TKPPRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLR 635
PNV+ +G C K P+ +I +M+ G L+ + L G +KL + LK +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 693
DI G+ + +HRDL + NC++ + TV + DFGLS+ I + R A P +
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 752
W+A E + + +T K D+++ GV MWE+ T + P+ GV +Y G+RL+ PE
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRLKQPED 239
Query: 753 PLGRL---IADCW-AEPQERPS---CEEILSRLL 779
L L + CW A+P++RP+ E+L +L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 84/269 (31%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHP 585
L +G +G G FG V G N D VA+K T MEDF +E + HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 586 NVILFLGACTKP------PRLSMITEYMELGSLYHLI---HLSGQKKKLSWRRKLKMLRD 636
NV+ +G C + P +I +M+ G L+ + L + L + +K + D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EW 694
I G+ + +HRDL + NC++N++ V + DFGLS+ I + R A P +W
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEGP 753
+A E + + +T K D++S GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRLKQPPDC 239
Query: 754 LG---RLIADCWA-EPQERPSCEEILSRL 778
L L++ CW P++RPS E + L
Sbjct: 240 LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/197 (28%), Positives = 110/197 (55%), Gaps = 3/197 (1%)
Query: 535 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G FG VF+ + + A+K + E+ +E +L++L +I +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ +L+++ EY E G L+ L+ + + L + + I GL +H KI+HR
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+KS N ++ + VKI D G++++++D+ ++ GTP +++PEL ++P+ EK D++
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVW 185
Query: 713 SLGVIMWELCTLNRPWE 729
+LGV+++E CT P++
Sbjct: 186 ALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 35/273 (12%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISI 578
+ W I EL G G FG+V++ T + A K+ + E +EDF EI I
Sbjct: 5 DIWEI-IGEL------GDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDI 55
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------ 632
LS +HPN++ A +L ++ E+ + G+L ++ L R L
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM--------LELERGLTEPQIRY 107
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
+ R + L +H K++HRDLK+ N L+ VK+ DFG+S + + + GTP
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167
Query: 693 EWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSR 746
WMAPE++ ++ P+ K DI+SLG+ + EL + P + P RV+ + +E
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT 227
Query: 747 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 775
L+ P + C +P +RP+ E+L
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 87/265 (32%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 581
W I L + ++G G FGEV+ +N T VA+K ++ +E F E +++
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L+H ++ TK P + +ITE+M GSL + S + K + + I G+
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGM 115
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
I + +HRDL++AN LV+ KI DFGL+R+I D+ A P +W APE I
Sbjct: 116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
FT K D++S G+++ E+ T R P+ G+ V+ A+ G R+ PE L
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYN 234
Query: 757 LIADCW-AEPQERPSCEEILSRLLD 780
++ CW P+ERP+ E I S L D
Sbjct: 235 IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 76/265 (28%), Positives = 129/265 (48%), Gaps = 21/265 (7%)
Query: 529 ELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC----NEISILSRL 582
E G ++G G F + R + GT +A+K T+ E+ EI +++RL
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HP++I LGA + ++ E+M GS+ HL+ G K+ + + RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLS 117
Query: 643 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFG----LSRIITDSPMRDSSSAGTPEWMAP 697
+H +I+HRD+K AN L++ ++I DFG L+ T + GT +MAP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEIPE--G 752
E++R E + CD++S+G ++ E+ T PW +++ +A+ + IPE
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 753 PLGRLIA-DCW-AEPQERPSCEEIL 775
P R + C +P++RP E+L
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 83/249 (33%), Positives = 126/249 (50%), Gaps = 23/249 (9%)
Query: 554 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613
VA+K+ L +D DF EI I+SRL+ PN+I L C L MITEYME G L
Sbjct: 49 VAVKM-LREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 614 HLIH--------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665
+ +S+ + M I G+ + + VHRDL + NCLV K++
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 666 TVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
T+KI DFG+SR + + R A P WM+ E I FT D+++ GV +WE+ T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
Query: 724 L--NRPWEGVLPERVVYAVA----NEGSRLEIPEGP-----LGRLIADCW-AEPQERPSC 771
L +P+ + E+V+ ++G ++ +P+ L +L+ CW +ERPS
Sbjct: 228 LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287
Query: 772 EEILSRLLD 780
+EI + LL+
Sbjct: 288 QEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 82/286 (28%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 573
W +LT+G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLV 68
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG------------ 620
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128
Query: 621 -QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679
++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R +
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 680 DSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 736
+ ++ G +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ P
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEE 247
Query: 737 VYAVANEGSRLEIP---EGPLGRLIADCW-AEPQERPSCEEILSRL 778
++ + EG R++ P L ++ DCW A P RP+ ++++ L
Sbjct: 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 81/262 (30%), Positives = 131/262 (50%), Gaps = 27/262 (10%)
Query: 536 VGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FG V+ G +D A+K L + E +E F E I+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 591 LGACTKPPRLSMIT-EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
LG C ++ YM+ G L + I + + + + + +G+ + K
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR--SETHNPTVKDLIGFGLQVAKGMEYLASKKF 119
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP-EWMAPELIRNEPF 705
VHRDL + NC++++ +TVK+ DFGL+R I D + + + A P +WMA E ++ + F
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 706 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV--YAVAN---EGSRLEIPE---GPLGRL 757
T K D++S GV++WEL T G P V + + +G RL PE PL +
Sbjct: 180 TTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 758 IADCW-AEPQERPSCEEILSRL 778
+ CW +P+ RP+ E++SR+
Sbjct: 235 MLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 9e-31
Identities = 90/279 (32%), Positives = 144/279 (51%), Gaps = 23/279 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
W + ++T+ +G G FG V+ GI G T VAIK E E +E F NE
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNE 59
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 628
S++ +V+ LG ++ +I E M G L +L L + + S +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 686
+ ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R I TD +
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 745
WM+PE +++ FT D++S GV++WE+ TL +P++G+ E+V+ V EG
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGG 238
Query: 746 RLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLD 780
L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 592
+G G FG+V R G A+KV ++ + + E +ILSR+ HP ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
A +L ++ EY G L+ + ++ + S R +I L +H + I++R
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
DLK N L++ +K+ DFGL++ ++ R ++ GTPE++APE++ + + + D +
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 752
SLGV+++E+ T P+ + + + L PE
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEF 215
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 71/255 (27%), Positives = 124/255 (48%), Gaps = 16/255 (6%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G+G V+ I N VAIK ++ + ++++ E+ +S+ HPNV+ + +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
L ++ Y+ GSL ++ S + L +L+++ +GL +H +HRD
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----AGTPEWMAPELIRNEP-FTEK 708
+K+ N L+ + +VKI DFG+S + D R GTP WMAPE++ + K
Sbjct: 128 IKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERV-VYAVANEGSRLEIPE--GPLGR----LIADC 761
DI+S G+ EL T P+ P +V + + N+ LE + +I+ C
Sbjct: 188 ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLC 247
Query: 762 W-AEPQERPSCEEIL 775
+P +RP+ EE+L
Sbjct: 248 LQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 84/258 (32%), Positives = 119/258 (46%), Gaps = 37/258 (14%)
Query: 554 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613
VA+K+ L D DF E+ ILSRL+ PN+I LG C L MITEYME G L
Sbjct: 49 VAVKI-LRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 614 HLI---HL-------------SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657
+ HL + +S+ L + I G+ + + VHRDL +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 658 NCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLG 715
NCLV ++ T+KI DFG+SR + R A P WMA E I FT D+++ G
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227
Query: 716 VIMWELCTLNR--PWEGVLPERVVYAVANEG------------SRLEIPEGPLGRLIADC 761
V +WE+ L + P+ + E+V + N G R L L+ C
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQV---IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQC 284
Query: 762 WA-EPQERPSCEEILSRL 778
W+ + +ERPS +I + L
Sbjct: 285 WSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 76/256 (29%), Positives = 119/256 (46%), Gaps = 17/256 (6%)
Query: 533 GTRVGIGFFGEVF--RGIWNGTDVAIKVF----LEQDLTAENMEDFCNEISILSRLRHPN 586
G +G G FG V+ + G ++A+K + E + EI +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE-VNALECEIQLLKNLQHER 65
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ + G LS+ EYM GS+ + G L+ K R I G+ +H
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHS 122
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIRNE 703
IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I E
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--PLGR-LIAD 760
+ K D++S+G + E+ T PW ++ +A + + ++P P R +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 761 CWAEP-QERPSCEEIL 775
+ E ++RPS EE+L
Sbjct: 243 TFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 539 GFFGEVFRGIWNGT------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
G FG +F GI +V +K ++ + + E +L L H N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKT-VKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 593 ACTKPPRLSMITE-YMELGSLYHLI----HLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 646
C + + YM G+L + + LS ++ + M I G+ +H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIR 701
++H+D+ + NC++++ VKI D LSR + PM D G E WMA E +
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLF--PM-DYHCLGDNENRPVKWMALESLV 192
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 757
N+ ++ D++S GV++WEL TL + P+ + P + A +G RL P L +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPDELFAV 251
Query: 758 IADCWA-EPQERPSCEEILSRLLD 780
+A CWA +P+ERPS +++ L D
Sbjct: 252 MACCWALDPEERPSFSQLVQCLTD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 83/270 (30%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 536 VGIGFFGEVFRG-------IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG+VF + VA+K ++ + +DF E +L+ L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIV 70
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK------------LSWRRKLKMLRD 636
F G CT+ L M+ EYM G L + G K L+ + L +
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEW 694
I G++ + + VHRDL + NCLV + VKI DFG+SR I TD + W
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-- 751
M PE I FT + DI+S GV++WE+ T + PW + + + +G LE P
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-TQGRELERPRTC 249
Query: 752 -GPLGRLIADCWA-EPQERPSCEEILSRLL 779
+ ++ CW EPQ+R ++I SRL
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDL-----TAENMEDFCNEISILSRLRHPN 586
++G G +G V++ T VA+K L+ + TA EIS+L L+HPN
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ L +L ++ EY ++ L + + LS ++ + RGL H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 701
+I+HRDLK N L+N+ +K+ DFGL+R P+R T E W APE++
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTY----THEVVTLWYRAPEILL 171
Query: 702 NEPF-TEKCDIFSLGVIMWELCTLNRP 727
+ DI+S+G I E+ T +P
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMIT-GKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 2e-29
Identities = 83/262 (31%), Positives = 133/262 (50%), Gaps = 22/262 (8%)
Query: 528 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSR 581
+EL +G G FG V++GIW VAIK+ E N+E F +E I++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMAS 65
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ HP+++ LG C P + ++T+ M G L +H K + + L I +G+
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQIAKGM 122
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPEL 699
M + ++VHRDL + N LV VKI DFGL+R++ D ++ P +WMA E
Sbjct: 123 MYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL- 757
I FT + D++S GV +WEL T +P++G+ P R + + +G RL P+ P+ +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL--PQPPICTID 239
Query: 758 ----IADCWA-EPQERPSCEEI 774
+ CW + RP +E+
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/250 (28%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G FG+ + +G IK ++ + E+ E+++LS ++HPN++ +
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIHRMKIVH 651
+ + L ++ +Y E G LY I + Q+ L + L IC L +H KI+H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RD+KS N + K T+K+ DFG++R++ + + GTP +++PE+ N P+ K DI
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWAE-PQE 767
++LG +++E+CTL +E + +V + GS + L L++ + P++
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRD 243
Query: 768 RPSCEEILSR 777
RPS IL +
Sbjct: 244 RPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 14/255 (5%)
Query: 527 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLR 583
+ + ++G G F EV+R + +G VA+K DL A+ D EI +L +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 642
HPNVI + + + L+++ E + G L +I H QK+ + + K +C L
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 755
+ K DI+SLG +++E+ L P+ G + +Y++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 756 RLIADCW-AEPQERP 769
+L+ C +P++RP
Sbjct: 239 QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 84/286 (29%), Positives = 146/286 (51%), Gaps = 32/286 (11%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDFC 573
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM-LKSDATEKDLSDLI 71
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-------------S 619
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 620 GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII- 678
+++LS++ + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 679 -TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV 736
D + ++ +WMAPE + + +T + D++S GV++WE+ TL P+ GV P
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEE 250
Query: 737 VYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
++ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 84/291 (28%), Positives = 146/291 (50%), Gaps = 35/291 (12%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 572
+W L +G +G G FG+V R G D VA+K+ L+ + T +++ D
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM-LKDNATDKDLADL 64
Query: 573 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL------------- 618
+E+ ++ + +H N+I LG CT+ L +I EY G+L +
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124
Query: 619 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678
+++LS++ + + RG+ + + +HRDL + N LV + +KI DFGL+R +
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 679 TDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 735
D +S G +WMAPE + + +T + D++S G++MWE+ TL P+ G+ P
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 736 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPS---CEEILSRLL 779
++ + EG R++ P L L+ +CW A P +RP+ E L ++L
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 83/292 (28%), Positives = 151/292 (51%), Gaps = 32/292 (10%)
Query: 517 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAE 567
L A +W + + LT+G +G G FG+V G D VA+K+ L+ D T +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM-LKDDATDK 59
Query: 568 NMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------Y 613
++ D +E+ ++ + +H N+I LGACT+ L ++ EY G+L Y
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 614 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673
+++L+++ + + RG+ + K +HRDL + N LV + +KI DFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 674 LSRIITDSPMRDSSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEG 730
L+R + + ++ G +WMAPE + + +T + D++S GV++WE+ TL P+ G
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 731 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+ P ++ + EG R++ P L ++ +CW A P +RP+ ++++ L
Sbjct: 240 I-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 535 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
R+G G FGEVF G + T VA+K E L + F E IL + HPN++ +G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
CT+ + ++ E ++ G L L + +L + ++M+ + G+ + +HR
Sbjct: 61 VCTQKQPIYIVMELVQGGDF--LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WMAPELIRNEPFTEK 708
DL + NCLV + +KI DFG+SR D +S+ G + W APE + ++ +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 709 CDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA- 763
D++S G+++WE +L P+ + ++ A+ +G RL PE + RL+ CW
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 764 EPQERPS 770
+P +RPS
Sbjct: 236 DPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 75/250 (30%), Positives = 130/250 (52%), Gaps = 11/250 (4%)
Query: 536 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
+G G FGEVF+G + + T VA+K ++DL E F +E IL + HPN++ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
T+ + ++ E + G L L +K +L ++ +K D G+ + +HRDL
Sbjct: 62 TQRQPIYIVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFS 713
+ NCLV ++ +KI DFG+SR D S P +W APE + ++ + D++S
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179
Query: 714 LGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQER 768
G+++WE +L P+ G+ ++ V +G R+ P+ + +++ CW +P+ R
Sbjct: 180 YGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
Query: 769 PSCEEILSRL 778
P E+ L
Sbjct: 239 PKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 71/255 (27%), Positives = 129/255 (50%), Gaps = 14/255 (5%)
Query: 527 FSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 583
+ + ++G G F EV+R + + VA+K V + + + A+ +D EI +L +L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLM 642
HPNVI +L + + L+++ E + G L +I + QK+ + R K +C +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
+H +++HRD+K AN + VK+ D GL R + S GTP +M+PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-------LG 755
+ K DI+SLG +++E+ L P+ G + ++++ + + + P P L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 756 RLIADC-WAEPQERP 769
L++ C + +P +RP
Sbjct: 239 ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVILF 590
++G G +G V++ T VAIK + EI +L L HPN+I
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA--LREIKLLKELNHPNIIKL 63
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
L L ++ E+M+ LY LI +++ L L + +GL H I+
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKC 709
HRDLK N L+N +K+ DFGL+R + T + APEL+ + +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 710 DIFSLGVIMWELCTLNRPWEGV 731
DI+S+G I EL + + G
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 77/247 (31%), Positives = 123/247 (49%), Gaps = 8/247 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
VG G FG V R + V IK + +T + NE +L L HPN+I +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
+ L ++ EY G+L I L L I L +H I+HRD
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRD 126
Query: 654 LKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
LK+ N L++KH V KI DFG+S+I++ S + + GTP +++PEL +P+ +K DI+
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 713 SLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEGP-LGRLIADCWA-EPQERP 769
+LG +++EL +L R +E LP V+ ++ + + P L +LI +P +RP
Sbjct: 186 ALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRP 245
Query: 770 SCEEILS 776
+I++
Sbjct: 246 QLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 30/278 (10%)
Query: 524 NIDFSELTVGTRVGIGFFGEVFRG-IWNGTD------VAIKVFLEQDLTAENMEDFCNEI 576
+I ++ + +G G FG+VF +N + VA+K + L A +DF E
Sbjct: 1 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREA 58
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYH---------LIHLSGQ----KK 623
+L+ L+H +++ F G C L M+ EYM+ G L +I + GQ K
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 624 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682
+L + L + I G++ + VHRDL + NCLV + VKI DFG+SR + +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 683 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAV 740
R P WM PE I FT + D++S GVI+WE+ T + PW + V+ +
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 741 ANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEI 774
+G LE P + ++ CW EPQ+R + +EI
Sbjct: 239 -TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 8/218 (3%)
Query: 565 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK 624
++ +ED E +L++++HPN++ F + L ++ EY + G L I L Q+ K
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGK 95
Query: 625 LSWRRK-LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
L L+ +C G+ IH +++HRD+KS N + ++ VK+ DFG +R++T
Sbjct: 96 LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155
Query: 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743
+ GTP ++ PE+ N P+ K DI+SLG I++ELCTL P++ + ++ V +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-Q 214
Query: 744 GSRLEIPEG---PLGRLIADCWAE-PQERPSCEEILSR 777
GS +P L LI + P+ RPS ILSR
Sbjct: 215 GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 44/236 (18%)
Query: 526 DFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 582
DF G +G G F V + AIK+ ++ L E + E +L+RL
Sbjct: 2 DFK---FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 583 -RHPNVI-LFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
HP +I L+ T L + EY G L I G L K R
Sbjct: 59 NGHPGIIKLY---YTFQDEENLYFVLEYAPNGELLQYIRKYG---SLD----EKCTRFYA 108
Query: 639 RGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----------- 683
++ +H I+HRDLK N L++K +KI DFG ++++ +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 684 ---------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
R +S GT E+++PEL+ +P + D+++LG I++++ T P+ G
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 21/264 (7%)
Query: 529 ELTVGTRVGIGFFGEVFRGIWN-GTDVAIK-VFLE---QDLTAENMEDFCNEISILSRLR 583
E T G +G G +G V+ G+ N G +A+K V L+ + E E+ +L L+
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
H N++ +LG C +S+ E++ GS+ +++ G + + K + I G+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC---KYTKQILDGVAY 117
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-------TDSPMRDSSSAGTPEWMA 696
+H +VHRD+K N ++ + +K+ DFG +R + T S M S GTP WMA
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMA 176
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPE---G 752
PE+I + K DI+S+G ++E+ T P + ++ + + +P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 753 PLGRLIADCWAEPQ-ERPSCEEIL 775
+ C Q ERPS ++L
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 72/254 (28%), Positives = 118/254 (46%), Gaps = 32/254 (12%)
Query: 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM--ITEYME 608
G VA+K Q TAE++ DF EI IL L+H N++ + G C R ++ + EY+
Sbjct: 33 GEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668
GSL +L +++L R+ L IC+G+ + + VHRDL + N LV VK
Sbjct: 91 YGSLRD--YLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVK 148
Query: 669 ICDFGLSRIITDSPMRDSSSAGTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL-- 721
I DFGL++++ ++ P W APE + F+ D++S GV+++EL
Sbjct: 149 IGDFGLTKVLPQD--KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
Query: 722 -CTLNRPWEGVLPER---------VVYAVAN---EGSRLEIPEG---PLGRLIADCWA-E 764
+ +VY + RL P G + ++ +CW +
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNND 266
Query: 765 PQERPSCEEILSRL 778
P +RPS E+ ++
Sbjct: 267 PSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 78/270 (28%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 536 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 592
+G G+FG+V G G A V E +A E F E+ L HPNV+ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLI-----HLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
C + ++ E+ LG L + + ++ +K +M ++ GL+ +H+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLHQA 119
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPEL------ 699
+H DL NC + +VKI D+GL + D + A W+APEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 700 -IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 757
+ + T+K +I+SLGV MWEL T ++P+ + E+V+ V E +++P+ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLK 238
Query: 758 IAD--------CWAEPQERPSCEEILSRLL 779
+D CW +P+ RP+ EE+ LL
Sbjct: 239 YSDRWYEVMQFCWLDPETRPTAEEV-HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 85/279 (30%), Positives = 140/279 (50%), Gaps = 23/279 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
W + ++T+ +G G FG V+ G T VA+K E E +E F NE
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNE 59
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK------LSWR 628
S++ +V+ LG +K ++ E M G L +L L + + + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDS 686
++M +I G+ ++ K VHRDL + NC+V +TVKI DFG++R I TD +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 745
WMAPE +++ FT D++S GV++WE+ +L +P++G+ E+V+ V + G
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 746 RLEIPEGPLGR---LIADCWA-EPQERPSCEEILSRLLD 780
L+ P+ R L+ CW P+ RP+ EI++ L D
Sbjct: 240 -LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 78/270 (28%), Positives = 136/270 (50%), Gaps = 22/270 (8%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRH 584
T+G +G G FG V D VA+K+ ++ ++E+F E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 585 PNVILFLG------ACTKPPRLSMITEYMELGSLYHLIHLS--GQKK-KLSWRRKLKMLR 635
PNVI +G A + P +I +M+ G L+ + +S G++ L + ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-E 693
DI G+ + +HRDL + NC++N++ TV + DFGLS+ I + R ++ P +
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 752
W+A E + + +T D+++ GV MWE+ T + P+ GV +Y +G+RL+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKGNRLKQPPD 239
Query: 753 PLG---RLIADCW-AEPQERPSCEEILSRL 778
L L+ CW EP+ RPS + + +L
Sbjct: 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 18/264 (6%)
Query: 528 SELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSR 581
+EL +G G FG V++GIW +G + VAIKV E N E +E +++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE-ILDEAYVMAG 65
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ P V LG C + ++T+ M G L L ++ K ++ + L I +G+
Sbjct: 66 VGSPYVCRLLGICLTST-VQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPEL 699
+ +++VHRDL + N LV VKI DFGL+R++ D + P +WMA E
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIP---EGPLG 755
I + FT + D++S GV +WEL T +P++G+ P R + + +G RL P +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVY 241
Query: 756 RLIADCWA-EPQERPSCEEILSRL 778
++ CW + + RP E++
Sbjct: 242 MIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 18/211 (8%)
Query: 533 GTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAEN-------MEDFCNEISILSRLR 583
G +G G FG V+ G+ +G +A+K ++A + ++ EI++L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
H N++ +LG+ L++ EY+ GS+ L++ G ++ R +R I +GL
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---NFVRQILKGLNY 121
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR------IITDSPMRDSSSAGTPEWMAP 697
+H I+HRD+K AN LV+ +KI DFG+S+ + T + S G+ WMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
E+++ +T K DI+SLG ++ E+ T P+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 19/197 (9%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
VG G +G V R G VAIK F E + + + E+ +L +LRH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 593 ACTKPPRLSMITEYMELGSLYHLIH-----LSGQK-KKLSWRRKLKMLRDICRGLMCIHR 646
A + RL ++ EY+E +L L+ L + W+ + + + H
Sbjct: 68 AFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCHS 118
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEP 704
I+HRD+K N LV++ +K+CDFG +R + P + W APE L+ +
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 705 FTEKCDIFSLGVIMWEL 721
+ + D++++G IM EL
Sbjct: 179 YGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 78/253 (30%), Positives = 122/253 (48%), Gaps = 21/253 (8%)
Query: 537 GIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
G G G V G +A+K + LE + + E+ IL + P ++ F GA
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ--ILRELDILHKCNSPYIVGFYGA 67
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHR 652
+S+ EYM+ GSL + L + ++ R K+ + +GL +H KI+HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+K +N LVN +K+CDFG+S + +S + GT +MAPE I+ ++ K DI+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--FVGTSSYMAPERIQGNDYSVKSDIW 183
Query: 713 SLGVIMWELCTL-------NRPWEGVLPERVVYAVANEGSRL--EIPEGPLGRLIADCW- 762
SLG+ + EL T N P +G+ E + Y V RL + C
Sbjct: 184 SLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLI 242
Query: 763 AEPQERPSCEEIL 775
+P+ERPS +E+L
Sbjct: 243 KDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 29/280 (10%)
Query: 527 FSELTVGTRVGIGFFGEVFRGI----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
+ ++ +G G FG+V R + + AIK+ L++ + + DF E+ +L +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKM-LKEFASENDHRDFAGELEVLCKL 59
Query: 583 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWR 628
HPN+I LGAC L + EY G+L + S G L+ +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688
+ L+ D+ G+ + + +HRDL + N LV ++ KI DFGLSR + ++ +
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYVKKTMG 178
Query: 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 747
WMA E + +T K D++S GV++WE+ +L P+ G+ +Y +G R+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237
Query: 748 EIP---EGPLGRLIADCWAE-PQERPSCEEI---LSRLLD 780
E P + + L+ CW + P ERP +I LSR+L+
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 58/196 (29%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 539 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVILFLGACT 595
G +G VF + G AIKV + D+ +N D E ILS+ + P V+ +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 655
L ++ EY+ G L L+ G + R + +I L +H I+HRDLK
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR---IYIAEIVLALEYLHSNGIIHRDLK 120
Query: 656 SANCLVNKHWTVKICDFGLSRI--------ITDSPMRDSSSAGTPEWMAPELIRNEPFTE 707
N L++ + +K+ DFGLS++ + D D GTP+++APE+I + ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 708 KCDIFSLGVIMWELCT 723
D +SLG I++E
Sbjct: 181 TVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL-RHPNVILFL 591
+G G FG+V + +G + + ++ +++ DF E+ +L +L HPN+I L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDIC 638
GAC L + EY G+L + S LS ++ L D+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ + WMA E
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIE 181
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754
+ +T D++S GV++WE+ +L P+ G+ +Y +G RLE P + +
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEV 240
Query: 755 GRLIADCWAE-PQERPSCEEI---LSRLLD 780
L+ CW E P ERPS +I L+R+L+
Sbjct: 241 YDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 74/255 (29%), Positives = 126/255 (49%), Gaps = 22/255 (8%)
Query: 536 VGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG V++G+W VAIK E N E +E +++ + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHVCR 73
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
LG C + +IT+ M G L L ++ K + + L I +G+ + ++
Sbjct: 74 LLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTP-EWMAPELIRNEPFTE 707
VHRDL + N LV VKI DFGL++++ D + P +WMA E I + +T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 708 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEGPLGR-----LIADC 761
+ D++S GV +WEL T ++P++G+ P + ++ +G RL P+ P+ ++ C
Sbjct: 191 QSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL--PQPPICTIDVYMIMVKC 247
Query: 762 WA-EPQERPSCEEIL 775
W + RP E++
Sbjct: 248 WMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 76/266 (28%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 533 GTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQ-------DLTAENMEDFCNEISILSRL 582
G +G G +G V+ + G +A+K V L + ++ +EI L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
H N++ +LG T LS+ EY+ GS+ + G+ ++ R + GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR---FFTEQVLEGLA 122
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELI 700
+H I+HRDLK+ N LV+ KI DFG+S+ D ++ S G+ WMAPE+I
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 701 RN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------G 752
+ + ++ K DI+SLG ++ E+ RPW ++ + N+ S IP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 753 PLGR--LIADCWAEPQERPSCEEILS 776
P+ L A P RP+ E+L
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 69/231 (29%), Positives = 96/231 (41%), Gaps = 75/231 (32%)
Query: 536 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 585
+G G +G V + G VAIK VF DL EI +L LRH
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLI------DAKRILREIKLLRHLRHE 59
Query: 586 NVI----LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
N+I + +PP ++TE ME L+ +I S Q L
Sbjct: 60 NIIGLLDIL-----RPPSPEDFNDVYIVTELMET-DLHKVIK-SPQP-----------LT 101
Query: 636 D---------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
D I RGL +H ++HRDLK +N LVN + +KICDFGL+R +
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE---- 157
Query: 687 SSAGTPEWM----------APELIRNEP-FTEKCDIFSLGVIMWELCTLNR 726
++ APEL+ + +T+ DI+S+G I EL L R
Sbjct: 158 ---DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL--LTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/212 (32%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 589
R+G G +G+V+ R + G AIKV + E EDF EI ++ +H N++
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKV-----IKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
+ G+ + +L + E+ GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 706
+HRD+K AN L+ + VK+ DFG+S IT + + S GTP WMAPE+ R +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 738
+ CDI+++G+ EL L P + P R ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILS 580
++++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 62
Query: 581 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLS 626
+L HPN+I LGAC L + EY G+L + S LS
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 181
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 745
WMA E + +T D++S GV++WE+ +L P+ G+ +Y +G
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGY 240
Query: 746 RLEIP---EGPLGRLIADCWAE-PQERPSCEEILSRL 778
RLE P + + L+ CW E P ERPS +IL L
Sbjct: 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 23/265 (8%)
Query: 536 VGIGFFGEVFRG-IWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FG+VF +N + + V +D + +DF E +L+ L+H +++ F
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQK----------KKLSWRRKLKMLRDICRG 640
G C + L M+ EYM+ G L + G +L+ + L + + I G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPE 698
++ + VHRDL + NCLV ++ VKI DFG+SR + TD + WM PE
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PL 754
I FT + D++SLGV++WE+ T + PW + V+ + +G L+ P +
Sbjct: 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-TQGRVLQRPRTCPKEV 251
Query: 755 GRLIADCWA-EPQERPSCEEILSRL 778
L+ CW EP R + +EI S L
Sbjct: 252 YDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 7/195 (3%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ R+G G G VF + G VA+K + L EI L +HP V+
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L ++ EYM L ++ ++ L + +R + +G+ +H
Sbjct: 63 KLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP-FT 706
I+HRDLK AN L++ +KI DFGL+R+ ++ R S T + APEL+ +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 707 EKCDIFSLGVIMWEL 721
D++++G I EL
Sbjct: 180 PGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLRHPNVIL 589
RVG G +G+V+ R + G A+K+ + E +DF EI ++ +H N++
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKI-----IKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
+ G+ +L + EY GSL + H++G LS + + R+ +GL +H
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFT 706
+HRD+K AN L+ + VK+ DFG++ IT + + S GTP WMAPE+ +N +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 741
+ CDI+++G+ EL L P + P R ++ ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/250 (30%), Positives = 128/250 (51%), Gaps = 11/250 (4%)
Query: 536 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
VG G +GEV R +G IK ++ + + E +LS+L+HPN++ + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 594 CT-KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK-LKMLRDICRGLMCIHRMKIVH 651
+ L ++ + E G LYH L QK KL + ++ I L +H I+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYH--KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILH 125
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK+ N + + +K+ D G++R++ + S+ GTP +M+PEL N+P+ K D+
Sbjct: 126 RDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQE 767
++LG ++E+ TL + +VY + EG +P+ LG LIA + P++
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLSKRPEK 244
Query: 768 RPSCEEILSR 777
RPS + IL +
Sbjct: 245 RPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 80/268 (29%), Positives = 133/268 (49%), Gaps = 42/268 (15%)
Query: 536 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 593 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
A K PP +L ++ E+ GS+ LI + G K W + R+I RGL +H
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLSHLH 128
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 701
+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 702 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 760
+ + K D++SLG+ E+ P + P R ++ IP P RL +
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPAPRLKSK 239
Query: 761 CWAEP-------------QERPSCEEIL 775
W++ +RP+ E+++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 19/217 (8%)
Query: 536 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595
+G G FG+V++ T + + + E +ED+ EI IL+ HP ++ LGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 649
+L ++ E+ G++ ++ L R L ++ ICR L +H MKI
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM--------LELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 704
+HRDLK+ N L+ +K+ DFG+S + R S GTP WMAPE++ ++ P
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 741
+ K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 74/248 (29%), Positives = 128/248 (51%), Gaps = 13/248 (5%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G G VF + G +VAIK Q + + NEI ++ L++PN++ FL
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLD 83
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGR-LIADCWA-EPQE 767
SLG++ E+ P+ P R +Y +A G+ L+ PE P+ R + C + ++
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259
Query: 768 RPSCEEIL 775
R S +E+L
Sbjct: 260 RGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 79/262 (30%), Positives = 137/262 (52%), Gaps = 21/262 (8%)
Query: 536 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
+G G FG V +G++ DVAIKV L+ + ++ E I+ +L +P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
G C + L ++ E G L LSG+K +++ ++++ + G+ + VH
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKF--LSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 652 RDLKSANCL-VNKHWTVKICDFGLSRII--TDSPMRDSSSAGTP-EWMAPELIRNEPFTE 707
RDL + N L VN+H+ KI DFGLS+ + DS + S+ P +W APE I F+
Sbjct: 119 RDLAARNVLLVNQHYA-KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 708 KCDIFSLGVIMWELCTL-NRPWEGVL-PERVVYAVANEGSRLEIP-EGP--LGRLIADCW 762
+ D++S G+ MWE + +P++ + PE V + +G RL+ P E P + L+ DCW
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 763 A-EPQERPSCEEILSRLLDCEY 783
+ ++RP+ ++ R+ Y
Sbjct: 236 IYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 533 GTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL--TAENMEDFCNEISILSRLRHPNV 587
G +G G FGEV+ G ++A+K V + D T++ + EI +L LRH +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 588 ILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
+ + G C + P +LS+ EYM GS+ + G L+ + R I +G+ +
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYL 122
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 701
H IVHRD+K AN L + VK+ DFG S+ I M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
E + K D++S+ + E+ T PW ++ +A + ++ +P+G +
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 759 ADCWAEPQERPSCEEIL 775
+ E + RP+ E +L
Sbjct: 243 KQIFVEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 528 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRH 584
+ +G G FG V R +G A+K+ + + + NE IL +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRG 640
P ++ G+ L ++ EY+ G L+ + SG R + R +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLA 113
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H + IV+RDLK N L++ +KI DFG ++ + R + GTPE++APE+I
Sbjct: 114 LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLCGTPEYLAPEII 170
Query: 701 RNEPFTEKCDIFSLGVIMWEL 721
++ + + D ++LG++++E+
Sbjct: 171 LSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 60/225 (26%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 567 ENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKK 624
+++ D +E++I+ +LRHPN++ + + RL ++ + +E L H L +K++
Sbjct: 50 KSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 625 LSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682
+ R + + L +H+ K IVHRDL N ++ + V I DFGL++ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPE 167
Query: 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVY 738
+ +S GT + PE+++NEP+ EK D+++ G I++++CTL P+ L ++V
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 739 AV---ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 780
AV EG E + + + + RP ++ + + D
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLT---PDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISILSRLRHPNV 587
++G G +G+V++ T VA+K EN ++ EI +L +LRHPN+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 588 ILFLGACTKPPR--LSMITEYME--LGSLYH--LIHLS-GQKKKLSWRRKLKMLRDICRG 640
+ T + + M+ EYM+ L L + + Q K ++ + G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY--------MKQLLEG 112
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APEL 699
L +H I+HRD+K +N L+N +K+ DFGL+R T D ++ W PEL
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 700 IRNEP-FTEKCDIFSLGVIMWEL 721
+ + + D++S+G I+ EL
Sbjct: 173 LLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 536 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595
+G G FG+V++ T V + + E +ED+ EI IL+ HPN++ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK--MLRDICR----GLMCIHRMKI 649
L ++ E+ G++ ++ L R L +R +C+ L +H KI
Sbjct: 73 YENNLWILIEFCAGGAVDAVM--------LELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-----RNEP 704
+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++ ++ P
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA 741
+ K D++SLG+ + E+ + P + P RV+ +A
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 80/268 (29%), Positives = 131/268 (48%), Gaps = 42/268 (15%)
Query: 536 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592
VG G +G+V++G + G AIKV D+T + E+ EI++L + H N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 593 ACTK--PP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
A K PP +L ++ E+ GS+ L+ + G K W + R+I RGL +H
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI--CREILRGLAHLH 138
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR---- 701
K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+I
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198
Query: 702 -NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD 760
+ + + DI+SLG+ E+ P + P R ++ IP P +L +
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---------IPRNPPPKLKSK 249
Query: 761 CWAEP-------------QERPSCEEIL 775
W++ RPS E++L
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 77/270 (28%), Positives = 119/270 (44%), Gaps = 25/270 (9%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEISIL 579
+D + + +G G FGE+ RG VAI L + + F E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHT-LRAGCSDKQRRGFLAEALTL 60
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ H N++ G T+ + ++TEYM G+L L + +L + + ML +
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF--LRKHEGQLVAGQLMGMLPGLAS 118
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD------SPMRDSSSAGTPE 693
G+ + M VH+ L + LVN KI F R+ D + M S
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV---L 173
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP-- 750
W APE I+ F+ D++S G++MWE+ + RP+ + + V+ AV +G RL P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRN 232
Query: 751 -EGPLGRLIADCW-AEPQERPSCEEILSRL 778
L +L+ DCW E ERP +I S L
Sbjct: 233 CPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 77/258 (29%), Positives = 121/258 (46%), Gaps = 18/258 (6%)
Query: 533 GTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPNV 587
G +G G FG V+ + G ++A K E T++ + EI +L L+H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 588 ILFLGACTK---PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
+ + G C + L++ EYM GS+ + G + R K R I G+ +
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR---KYTRQILEGMSYL 122
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS---SSAGTPEWMAPELIR 701
H IVHRD+K AN L + VK+ DFG S+ + M + S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE--GPLGRLIA 759
E + K D++SLG + E+ T PW ++ +A + + ++P R
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 760 DC-WAEPQERPSCEEILS 776
C + E + RPS EE+L
Sbjct: 243 GCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 590
+G G + V++ T VAIK + L + A++ +F EI +L L+HPN+I
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIH 645
L ++++ E+ME L +I L+ K S+ + M RGL +H
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK-SY---MLMT---LRGLEYLH 119
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EP 704
I+HRDLK N L+ +K+ DFGL+R + + T + APEL+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH 179
Query: 705 FTEKCDIFSLGVIMWELCTLNRP 727
+ D++S+G I EL L P
Sbjct: 180 YGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 28/248 (11%)
Query: 550 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSMITEYM 607
G A+K D + + E+ I + P ++ + GA + + EY
Sbjct: 25 TGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83
Query: 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC----RGLMCIHRMKIVHRDLKSANCLVNK 663
E GSL + + KK R K+L I +GL +H KI+HRD+K +N L+ +
Sbjct: 84 EGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140
Query: 664 HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
VK+CDFG+S + +S + GT +MAPE I+ +P++ D++SLG+ + E+
Sbjct: 141 KGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV-A 197
Query: 724 LNR---PWEGVLP----ERVVYAVANEGSRLEIPEG-------PLGRLIADCWA-EPQER 768
NR P EG P E + Y V L+ G I C +P R
Sbjct: 198 QNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257
Query: 769 PSCEEILS 776
P+ ++L
Sbjct: 258 PTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 16/257 (6%)
Query: 532 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFL---EQDLTAENMEDFCNEISILSRLRHPN 586
+G +G G FG V+ G ++A+K E T++ + EI +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 587 VILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
++ + G P LS+ E+M GS+ + G L+ K R I G+ +
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYL 122
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR---IITDSPMRDSSSAGTPEWMAPELIR 701
H IVHRD+K AN L + VK+ DFG S+ I S S GTP WM+PE+I
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758
E + K DI+S+G + E+ T PW ++ +A + + +P +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 759 ADCWAEPQERPSCEEIL 775
+ E + RPS +E+L
Sbjct: 243 KRIFVEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 76/258 (29%), Positives = 127/258 (49%), Gaps = 33/258 (12%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
+G G G V++ +A+KV D+T E + +E+ IL + P +I F GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIP-LDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 594 CTKPPRLSMITEYMELGSL--YHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
R+S+ TE+M+ GSL Y I H+ G ++ + +GL + +KI
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLTYLWSLKI 116
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
+HRD+K +N LVN VK+CDFG+S + +S + + GT +MAPE I E +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHS 174
Query: 710 DIFSLGVIMWELCTLNRPWEGV-------LPERVVYAVANEGSRLEIPEG----PLGRLI 758
D++SLG+ EL P+ + +P +++ + +E + +P G I
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-LPVGQFSEKFVHFI 233
Query: 759 ADCW-AEPQERPSCEEIL 775
C +P+ERP+ E ++
Sbjct: 234 TQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 632
NE IL L HP ++ + + ++ + + G L YHL QK K S +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKF 104
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
+ +I L +H I+HRD+K N L+++ V I DF ++ +T + S+S GTP
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS-GTP 163
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+MAPE++ + ++ D +SLGV +E RP+ G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G G V+ I G +VAIK Q + + NEI ++ ++PN++ +L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 83
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 751
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 78/260 (30%), Positives = 122/260 (46%), Gaps = 30/260 (11%)
Query: 535 RVGIGFFGEVFRGIWNGTDV--AIKVFLE---QDLTAENMEDFCNEISILSRLRHPNVIL 589
R+G G FG V+ +KV E +L E +LS+L HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 590 FLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
F + + +ITEY E L L L K LS + + + G+ +H+ +
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
I+HRDLK+ N + + +KI DFG+SR++ S ++ GTP +M+PE ++++ + K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA----- 763
DI+SLG I++E+C L +EG VV L I EGP L + ++
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSVV---------LRIVEGPTPSL-PETYSRQLNS 235
Query: 764 --------EPQERPSCEEIL 775
+P RPS EIL
Sbjct: 236 IMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 46/228 (20%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFL---EQDL---TAENMEDFCNEISILSRLR 583
+ ++G G FGEV++ I G VA+K L E+D TA EI IL +L+
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR------EIKILKKLK 65
Query: 584 HPNVILFLG-ACTKPPRLS-------MITEYME--LGSLYH--LIHLSGQKKKLSWRRKL 631
HPNV+ + A +P + M+T YM+ L L + L+ + K
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC------ 119
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--------- 682
+ + G+ +H I+HRD+K+AN L++ +KI DFGL+R P
Sbjct: 120 -YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 683 -MRDSSSAGTPEWM-APELIRNEP-FTEKCDIFSLGVIMWELCTLNRP 727
R ++ W PEL+ E +T DI+ +G + E+ T RP
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 34/272 (12%)
Query: 536 VGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG+V ++ + VA+K L+++ +N + EI+IL L H N++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 590 FLGACTKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ G C++ L +I EY+ LGSL + K KL+ + L + IC G+ +H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPE-WMAPELIRNEP 704
+HRDL + N L++ VKI DFGL++ + + R +P W A E ++
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 705 FTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEIP 750
F+ D++S GV ++EL T + P +G + + + G RL P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 751 EG-PLG--RLIADCW-AEPQERPSCEEILSRL 778
+ P L+ +CW E + RP+ ++ L
Sbjct: 247 KNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 48/274 (17%)
Query: 536 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFLG 592
+G G+FG+V G + +G A V E ++A E F E L+H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMK 648
CT+ ++ E+ LG L +L +K L+ +I GL+ +H+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKG--YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSR--------IITDS---PMRDSSSAGTPEWMAP 697
+H DL NCL+ TVKI D+GLS + D P+R W+AP
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---------WIAP 171
Query: 698 ELIRNEPF--------TEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 748
EL+ +E T++ +++SLGV +WEL L ++P+ + E+V+ E +L+
Sbjct: 172 ELV-DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLK 229
Query: 749 IPEGPLGRLIAD--------CWAEPQERPSCEEI 774
+P+ L ++D CW +P++RPS EE+
Sbjct: 230 LPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 77/265 (29%), Positives = 120/265 (45%), Gaps = 29/265 (10%)
Query: 541 FGEVFRG--IWNGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
FG++++G G D VAIK L+ + +F E S+++ L HPN++ LG
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKT-LKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRG 640
T+ + M+ EY+ G L+ + + K L L + I G
Sbjct: 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAG 136
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDSSSAGTP-EWMAPE 698
+ + VH+DL + N L+ + VKI D GLSR I + R + P WM PE
Sbjct: 137 MEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE 196
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEGPLGR- 756
I F+ DI+S GV++WE+ + +P+ G + V+ V L E R
Sbjct: 197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCSEDCPPRM 255
Query: 757 --LIADCWAE-PQERPSCEEILSRL 778
L+ +CW E P RP ++I +RL
Sbjct: 256 YSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE--QDLTA-ENMEDFCNEISILSRL 582
+EL +G G FG V +GIW G + I V ++ QD + + ++ + + + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
H ++ LG C L ++T+ LGSL L H+ + L +R L I +G+
Sbjct: 67 DHAYIVRLLGICPGA-SLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMAPELI 700
+ ++VHR+L + N L+ V+I DFG++ ++ D S TP +WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE---GPLGR 756
+T + D++S GV +WE+ + P+ G+ P V + +G RL P+ +
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYM 242
Query: 757 LIADCWA-EPQERPSCEEILS 776
++ CW + RP+ +E+ +
Sbjct: 243 VMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 5e-22
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 8/213 (3%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G G V+ I G +VAIK Q + E NEI ++ +HPN++ +L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKHPNIVNYLD 83
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 139
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745
SLG++ E+ P+ P R +Y +A G+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 73/204 (35%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCN--EISILSRL-RHP 585
V ++G G FG V+ G VAIK ++ + E+ N E+ L +L HP
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK---FYSWEECMNLREVKSLRKLNEHP 58
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
N++ + L + EYME G+LY L+ + K S ++ I +GL IH
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE-LIRNE 703
+ HRDLK N LV+ VKI DFGL+R I P D S T + APE L+R+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS--TRWYRAPEILLRST 174
Query: 704 PFTEKCDIFSLGVIMWELCTLNRP 727
++ DI++LG IM EL TL RP
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 534 TRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHP 585
++G G FGEVF R VA+K V +E + +TA EI IL L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA------LREIKILQLLKHE 71
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLI-----H-----LSGQKKKLSWRRKLKMLR 635
NV+ + C T Y ++L+ H LS + K + K+++
Sbjct: 72 NVVNLIEICRTKA-----TPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI----ITDSPMRDSSSAGT 691
+ GL IHR KI+HRD+K+AN L+ K +K+ DFGL+R P R ++ T
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 692 PEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT 723
+ PEL+ E + D++ G IM E+ T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 78/252 (30%), Positives = 120/252 (47%), Gaps = 17/252 (6%)
Query: 534 TRVGIGFFGEVF--RGIWNGTDVAIKVFL-EQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FG V+ R + VAIK + E +D E+ L +LRHPN I +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
G + ++ EY LGS ++ + KK L + +GL +H + +
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNE-PFTE 707
HRD+K+ N L+ + TVK+ DFG + ++ SP +S GTP WMAPE+I +E +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLV--SPA--NSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGPLG--RLIADCWA- 763
K D++SLG+ EL P + +Y +A N+ L + + C
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQK 253
Query: 764 EPQERPSCEEIL 775
PQ+RPS EE+L
Sbjct: 254 IPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 536 VGIGFFGEVF------RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG+V G G VA+K L+ + ++ D EI IL L H N++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 590 FLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ G CT+ + +I E++ GSL +L K K++ +++LK IC+G+ +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKE--YLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRNE 703
+ VHRDL + N LV VKI DFGL++ I ++D + W APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV-FWYAPECLIQS 187
Query: 704 PFTEKCDIFSLGVIMWELCT--------------LNRPWEGVLPERVVYAVANEGSRLEI 749
F D++S GV ++EL T + P G + + V EG RL
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247
Query: 750 PEG---PLGRLIADCW-AEPQERPSCEEIL 775
P + +L+ CW +P +R + + ++
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 536 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 592
+G G +G+VF+ + NG+ A+K+ D + E+ E +IL L HPNV+ F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 593 ACTKPP-----RLSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
K +L ++ E GS+ L+ + +++ +L + GL +H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 703
K +HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202
Query: 704 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE---GPLGRL 757
+ +CD++SLG+ EL + P + P R ++ + N L PE
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDF 262
Query: 758 IADCWAEPQE-RPSCEEIL 775
I C + E RP+ ++L
Sbjct: 263 IRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 1e-21
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 9/220 (4%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
++G G G V+ + G +VAI+ Q + + NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD 84
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++HR
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
D+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE 751
SLG++ E+ P+ P R +Y +A G+ L+ PE
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 19/258 (7%)
Query: 534 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G FG V +G++ VA+K+ + ++ E +++ +L +P ++
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
+G C + ++ E ELG L + + K ++ + +++ + G+ +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 650 VHRDLKSANCL-VNKHWTVKICDFGLSRIIT-DSPMRDSSSAGT-P-EWMAPELIRNEPF 705
VHRDL + N L V +H+ KI DFGLS+ + D + + G P +W APE + F
Sbjct: 117 VHRDLAARNVLLVTQHYA-KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 706 TEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 761
+ K D++S GV+MWE + +P++G+ V + + G R+E P+ + L+ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLC 234
Query: 762 WA-EPQERPSCEEILSRL 778
W ERP + RL
Sbjct: 235 WTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 14/265 (5%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 579
E+ ++ E +G G +G V+ R + +AIK E+D + ++ EI++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALH 59
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
S L+H N++ +LG+ ++ + E + GSL L+ K + + + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 697
GL +H +IVHRD+K N LVN + VKI DFG S R+ +P ++ + GT ++MAP
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178
Query: 698 ELIRNEP--FTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEGSRLEIPE--- 751
E+I P + DI+SLG + E+ T P+ E P+ ++ V EIPE
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238
Query: 752 GPLGRLIADCWA-EPQERPSCEEIL 775
I C+ +P +R S ++L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCNEIS 577
I+ S + +G FG+V++G GT VAIK L+ E+F +E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT-LKDKAEGPLREEFKHEAM 60
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKK 624
+ SRL+HPN++ LG TK LSMI Y L+ + + K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSP 682
L + ++ I G+ + +VH+DL + N LV VKI D GL R + D
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVA 741
+S WM+PE I F+ DI+S GV++WE+ + +P+ G + V+ +
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 742 NEGSRLEIPEGP--LGRLIADCWAE-PQERPSCEEILSRL 778
N + P + L+ +CW E P RP ++I SRL
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 22/259 (8%)
Query: 536 VGIGFFGEVFR--GIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592
+G G +G+V++ +G+ A+K+ D ++ E+ E +IL L HPNV+ F G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 593 ACTKPPRLS-----MITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
K +L ++ E GS+ L+ L ++L +L GL +H
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--- 703
+I+HRD+K N L+ VK+ DFG+S +T + +R ++S GTP WMAPE+I E
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 704 --PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG---PLGRL 757
+ +CD++SLG+ EL + P + P + ++ + N L PE
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHF 266
Query: 758 IADCWAEPQE-RPSCEEIL 775
I+ C + E RPS +L
Sbjct: 267 ISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-21
Identities = 50/151 (33%), Positives = 86/151 (56%), Gaps = 7/151 (4%)
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 694
+ +G+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 751
MAPE I + +T + D++S GV++WE+ +L P+ GV + EG+R+ P+
Sbjct: 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307
Query: 752 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 780
+ + + DCW EP +RP+ E++ L +
Sbjct: 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-21
Identities = 60/169 (35%), Positives = 93/169 (55%), Gaps = 16/169 (9%)
Query: 627 WRRKLKMLRDIC------RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680
W+ L M IC RG+ + K +HRDL + N L++++ VKICDFGL+R I
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 681 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVV 737
P +R S+ +WMAPE I ++ +T + D++S GV++WE+ +L P+ GV
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286
Query: 738 YAVANEGSRLEIPE---GPLGRLIADCW-AEPQERPSCE---EILSRLL 779
+G+R+ PE + R++ CW +P+ERP+ EIL LL
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 71/208 (34%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 527 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMED-----FCNEISIL 579
SEL R+G G G V++ I T A+KV N ED C EI IL
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSL--YHLIHLSGQKKKLSWRRKLKMLRDI 637
+ HPNV+ + ++ E+M+ GSL H+ ++ L+ + R I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLA-----DVARQI 177
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 697
G+ +HR IVHRD+K +N L+N VKI DFG+SRI+ + +SS GT +M+P
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 237
Query: 698 ELIR---NEPFTEKC--DIFSLGVIMWE 720
E I N + DI+SLGV + E
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 49/172 (28%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 551 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609
G VA+K + DL + E NE+ I+ +HPN++ + L ++ E++E
Sbjct: 44 GRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100
Query: 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669
G+L ++ +++ + + + + L +H ++HRD+KS + L+ VK+
Sbjct: 101 GALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKL 156
Query: 670 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
DFG ++ R S GTP WMAPE+I P+ + DI+SLG+++ E+
Sbjct: 157 SDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 18/261 (6%)
Query: 526 DFSELTVGT-RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSR 581
D E+ VG +G G FG V+ + T+ VA+K + T E +D E+ L +
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L+HPN I + G K ++ EY LGS L+ + KK L + +GL
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGL 134
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI- 700
+H ++HRD+K+ N L+ + VK+ DFG + + + +S GTP WMAPE+I
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVIL 190
Query: 701 --RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPE--GPLG 755
+ K D++SLG+ EL P + +Y +A N+ L+ E
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFR 250
Query: 756 RLIADCWAE-PQERPSCEEIL 775
+ C + PQERP+ E+L
Sbjct: 251 GFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 65/247 (26%), Positives = 131/247 (53%), Gaps = 18/247 (7%)
Query: 544 VFRGIWNGTDVAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNVI----LFLGACTKPP 598
+++GI+N +V I+ F + ++ NEI L R+ N++ + P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSA 657
RLS+I EY G L ++ ++K LS++ KL M D C+GL +++ +++L S
Sbjct: 96 RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 658 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLG 715
+ LV +++ +KI GL +I++ P ++ + + +++ + +T K DI+SLG
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKN---VNFMVYFSYKMLNDIFSEYTIKDDIYSLG 209
Query: 716 VIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGP--LGRLIADCWA-EPQERPSC 771
V++WE+ T P+E + + + + N+ + L++P + P + ++ C + + +RP+
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269
Query: 772 EEILSRL 778
+EIL L
Sbjct: 270 KEILYNL 276
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 35/265 (13%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592
+G G FG V+ R + N VAIK + + E +D E+ L +LRHPN I + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ ++ EY LGS L+ + KK L + +GL +H ++HR
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNEPFTEKC 709
D+K+ N L+++ VK+ DFG + I+ + + GTP WMAPE+I + K
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE----- 764
D++SLG+ EL P + +Y +A E P L + W+E
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------ESPA--LQSGHWSEYFRNF 246
Query: 765 --------PQERPSCEEILSRLLDC 781
PQ+RP+ E +L
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 52/151 (34%), Positives = 87/151 (57%), Gaps = 7/151 (4%)
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--MRDSSSAGTPEW 694
+ RG+ + K +HRDL + N L++++ VKICDFGL+R I P +R + +W
Sbjct: 182 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLEIPE-- 751
MAPE I ++ +T + D++S GV++WE+ +L P+ GV + EG+R+ PE
Sbjct: 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA 301
Query: 752 -GPLGRLIADCW-AEPQERPSCEEILSRLLD 780
+ ++ DCW P++RP+ E++ L D
Sbjct: 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 78/263 (29%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 527 FSELTVGTRVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDLTAENMEDFCNEISILSRLR 583
F++L +G G FG V+ R + VAIK + + E +D E+ L R++
Sbjct: 27 FTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HPN I + G + ++ EY LGS L+ + KK L + +GL
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAY 140
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI--- 700
+H ++HRD+K+ N L+ + VK+ DFG + I + + +S GTP WMAPE+I
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPEVILAM 196
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEGP--LGRL 757
+ K D++SLG+ EL P + +Y +A NE L+ E
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 758 IADCWAE-PQERPSCEEILSRLL 779
+ C + PQ+RP+ EE+L +
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIK---VFLEQDLTAENMEDFCNEISILSRLR--- 583
+G G +G V++ + G VA+K V L ++ + EI++L +L
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFE 59
Query: 584 HPNVILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
HPN++ L C P L+++ E+++ +L K L ++R +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLL 117
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
RG+ +H +IVHRDLK N LV VKI DFGL+RI + M +S T + APE
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPE 176
Query: 699 LIRNEPFTEKCDIFSLGVIMWEL 721
++ + D++S+G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 72/209 (34%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 536 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRHPNVIL 589
+G G +G V G VAIK ++ + FC EI IL R +H N+I
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRRFKHENIIG 67
Query: 590 FLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
L P S + E ME LY LI + + LS L I RGL I
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYI 122
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-----AGTPEWMAPEL 699
H ++HRDLK +N L+N + +KICDFGL+RI P D + T + APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD--PEHDHTGFLTEYVATRWYRAPEI 180
Query: 700 IRN-EPFTEKCDIFSLGVIMWELCTLNRP 727
+ N + +T+ DI+S+G I+ E+ + NRP
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLS-NRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 539 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRH-PNVILFLGAC 594
G FG V+ + G AIKV + D+ A+N + + E +I+ P V +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
L ++ EY+ G LI G W ++ + ++ G+ +H+ I+HRD+
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQ--YIAEVVLGVEDLHQRGIIHRDI 123
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSL 714
K N L+++ +K+ DFGLSR ++ GTP+++APE I + D +SL
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENK----KFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 715 GVIMWELCTLNRPWEGVLPERV 736
G +++E P+ P+ V
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 591
+G G FG+V GTD A+KV L++D L +++E E +L+ + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV-LKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 592 GACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
+C + RL + EY+ G L I SG + R +I GL +H I+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
+RDLK N L++ +KI DFG+ + + S+ GTP+++APE++ +P+ D
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 711 IFSLGVIMWELCTLNRPWEGV 731
++LGV+++E+ P+EG
Sbjct: 179 WWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 10/201 (4%)
Query: 536 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FG+VF G G A+KV + L + E IL+ + HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIHRMKI 649
A +L +I +++ G L+ LS K+ + +K L ++ L +H + I
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLF--TRLS--KEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE++ T+
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179
Query: 710 DIFSLGVIMWELCTLNRPWEG 730
D +S GV+M+E+ T + P++G
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 536 VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENME--DFCNEISILSRLRHPNVILFLG 592
+G G+FG+V I+ T VA V E A + E +F + L+HPN++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-KMLRDICRGLMCIHRMKIVH 651
C + ++ EY ELG L + ++ S L +M +I G+ +H+ +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 652 RDLKSANCLVNKHWTVKICDFGL--SRIITDSPMRDSSSAGTPEWMAPELIRN------- 702
DL NC + TVK+ D+G+ SR D + W+APEL+
Sbjct: 123 SDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLIT 182
Query: 703 EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIAD- 760
T+ ++++LGV +WEL +P+ + V+ V + ++++ + L ++
Sbjct: 183 AEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD-QQVKLFKPQLELPYSER 241
Query: 761 -------CWAEPQERPSCEEILSRLL 779
CW P++R + EE+ RLL
Sbjct: 242 WYEVLQFCWLSPEKRATAEEV-HRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 35/266 (13%)
Query: 537 GIGFFGEVFRGIW--NGTD----------VAIKVFLEQDLTAENMEDFCNEISILSRLRH 584
G G F +++G+ V +KV L D + F S++S+L H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDH--RDSLAFFETASLMSQLSH 60
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
+++ G C + + M+ EY++ G L +H L W KL + + + L +
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 645 HRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 697
K+VH ++ N LV ++ +K+ D G+ + R W+AP
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP----WIAP 173
Query: 698 ELIRNEP--FTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE-GP 753
E IRN T D +S G + E+C+ P + + RL +P+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAE 232
Query: 754 LGRLIADCWA-EPQERPSCEEILSRL 778
L LI CW +P +RPS IL L
Sbjct: 233 LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 65/197 (32%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
VG G +G+V T VAIK +A + + E+ +L + H NVI L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 594 CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
T L ++T M L +++ + +KLS ++ I RGL IH
Sbjct: 83 FTPASSLEDFQDVYLVTHLMG-ADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFT 706
I+HRDLK +N VN+ +KI DFGL+R TD M T + APE++ N +
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTG--YVATRWYRAPEIMLNWMHYN 194
Query: 707 EKCDIFSLGVIMWELCT 723
+ DI+S+G IM EL T
Sbjct: 195 QTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIK----VF--LEQDLTAENMEDFCNEISILSRLR-HP 585
++G G F EV + G AIK F LEQ EI L RL HP
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-------LREIQALRRLSPHP 58
Query: 586 NVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
N++ + K RL+++ E M++ +LY LI G+K+ L +R + + + L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDM-NLYELIK--GRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRN 702
+HR I HRD+K N L+ +K+ DFG R I P + T + APE L+ +
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLTD 173
Query: 703 EPFTEKCDIFSLGVIMWELCTLN 725
+ K DI+++G + +E+ +L
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 18/161 (11%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 627
E+ I+ R P ++ F GA + M E+M+ GSL + G K ++
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
L L ++ HR I+HRD+K +N LVN +K+CDFG+S + +S +
Sbjct: 113 VEGLTYLYNV-------HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DT 161
Query: 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
GT +M+PE I+ +T K D++SLG+ + EL P+
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-18
Identities = 48/136 (35%), Positives = 79/136 (58%), Gaps = 7/136 (5%)
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 707
+HRDL + N L+ KICDFGL+R I DS +A P +WMAPE I N +T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 708 KCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW- 762
+ D++S G+++WE+ +L + P+ G+ + Y + EG R+ PE + ++ CW
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWD 355
Query: 763 AEPQERPSCEEILSRL 778
A+P +RP+ ++I+ +
Sbjct: 356 ADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 34/214 (15%)
Query: 536 VGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDF----CNEISILSRLRHPNV 587
+G G +G V++ +G + AIK F + D E C EI++L L+H NV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGD--KEQYTGISQSACREIALLRELKHENV 64
Query: 588 I----LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW-RRKLK-MLRDICRGL 641
+ +FL K + ++ +Y E L+ +I Q K++S +K +L I G+
Sbjct: 65 VSLVEVFLEHADK--SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 642 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAG----TPE 693
+H ++HRDLK AN LV + VKI D GL+R+ ++P++ + T
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADLDPVVVTIW 180
Query: 694 WMAPELI---RNEPFTEKCDIFSLGVIMWELCTL 724
+ APEL+ R+ +T+ DI+++G I EL TL
Sbjct: 181 YRAPELLLGARH--YTKAIDIWAIGCIFAELLTL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 49/137 (35%), Positives = 82/137 (59%), Gaps = 5/137 (3%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIR 701
+H ++HRD+KSAN L+ + VK+ DFG S++ + D + GTP ++APE+ R
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSRLEIPEGPLGRLIAD 760
+P+++K D+FSLGV+++EL TL RP++G E V++ +A L P + I
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 761 CW--AEPQERPSCEEIL 775
++P+ RPS ++L
Sbjct: 279 ALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 8/192 (4%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
VG G +G V + G VAIK FLE + + EI +L +LRH N++ +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
+ RL ++ E+++ L L L R K L I RG+ H I+HRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP-FTEKCDI 711
+K N LV++ VK+CDFG +R + +P + W APEL+ + + DI
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184
Query: 712 FSLGVIMWELCT 723
+++G ++ E+ T
Sbjct: 185 WAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 581
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVIIQDDDVECTMVEKRVLAL 56
Query: 582 LRHPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
P + L +C RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIG 113
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H I++RDLK N +++ +KI DFG+ + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 65/246 (26%), Positives = 118/246 (47%), Gaps = 17/246 (6%)
Query: 550 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608
+G VA+K+ DL + + NE+ I+ +H NV+ + L ++ E+++
Sbjct: 45 SGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101
Query: 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668
G+L ++ + +L+ + + + + L +H ++HRD+KS + L+ VK
Sbjct: 102 GGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157
Query: 669 ICDFGL-SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
+ DFG ++I D P R S GTP WMAPE+I P+ + DI+SLG+++ E+ P
Sbjct: 158 LSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
Query: 728 WEGVLPERVVYAVANE---GSRLEIPEGPLGRLIADCW--AEPQERPSCEEILSR--LLD 780
+ P + + + + + P+ R + EPQER + +E+L LL
Sbjct: 217 YFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276
Query: 781 CEYSLC 786
C
Sbjct: 277 TGLPEC 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 13/165 (7%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK- 632
+E+ L+ H ++ +L +I EY G L I K++L +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQE 168
Query: 633 -----MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 685
+ I L +H K++HRDLKSAN + +K+ DFG S+ +DS D
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
SS GTP ++APEL + +++K D++SLGVI++EL TL+RP++G
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 632 KMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690
K+ I + L +H ++ ++HRD+K +N L+N++ VK+CDFG+S + DS + + AG
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAG 165
Query: 691 TPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWE--GVLPERVVYAVANEG 744
+MAPE I E + K D++SLG+ M EL T P++ +++ V E
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EE 223
Query: 745 SRLEIPEGPLGRLIAD-----CWAEPQERPSCEEIL 775
++P D +ERP+ E+L
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 34/203 (16%)
Query: 539 GFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDF----CNEISILSRLRHPNVI--- 588
G +G V+R T VA+K + +E + E F EI+IL +L+HPN++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME-----KEKEGFPITSLREINILLKLQHPNIVTVK 70
Query: 589 -LFLGACTKPPRLSMITEYME--LGSLYHLIH---LSGQKKKLSWRRKLKMLRDICRGLM 642
+ +G + ++ M+ EY+E L SL + L + K L + + G+
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------MLQLLSGVA 120
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIR 701
+H I+HRDLK++N L+N +KICDFGL+R SP++ + W APEL+
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELLL 179
Query: 702 NEP-FTEKCDIFSLGVIMWELCT 723
++ D++S+G I EL T
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 7/190 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 592
+G G FGEV + G A K ++ L E NE IL ++ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 593 ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
A L ++ M G L YH+ ++ + R + I GL +H+ +IV+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK N L++ H V+I D GL+ + + AGTP +MAPE+++ E + D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 712 FSLGVIMWEL 721
F+LG ++E+
Sbjct: 178 FALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSA 689
L + RG+ + VHRDL + N L+ + VKICDFGL+R I+ DS S
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 690 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 747
P +WMAPE I + +T D++S G+++WE+ +L P+ G++ + Y G R+
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 748 EIPE---GPLGRLIADCW-AEPQERPS---CEEILSRLL 779
P+ + ++ CW +EP++RPS +I+ LL
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 48/141 (34%), Positives = 78/141 (55%), Gaps = 10/141 (7%)
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTE 707
+HRD+ + N L+ KICDFGL+R I+ DS +A P +WMAPE I + +T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 708 KCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE-GPLG--RLIADCWA 763
+ D++S G+++WE+ +L + P+ G+L Y + G ++ P+ P ++ CW
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353
Query: 764 -EPQERPSCEEI---LSRLLD 780
EP ERP+ +I + R L
Sbjct: 354 LEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 29/204 (14%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIK-VFLEQDL-----TAENMEDFCNEISILSRLRHPN 586
++G G +G V+ R G VA+K + LE + TA EIS+L L HPN
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA------IREISLLKELNHPN 59
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 645
++ L +L ++ E+++L ++ +K L + +G+ H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLD---PPLIKSYLYQLLQGIAYCH 116
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-L 699
+++HRDLK N L+++ +K+ DFGL+R P+R T E W APE L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVR----TYTHEVVTLWYRAPEIL 171
Query: 700 IRNEPFTEKCDIFSLGVIMWELCT 723
+ + ++ DI+S+G I E+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRH 584
+ + T+VG G +G+VF T VA+K + L N + E IL+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
++ L A L + EY+ G L++ G + R M + +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYMAEMFE-AVDAL 117
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIRNE 703
H + +HRDLK N L++ +K+ DFGLS+ I+T +S G+P++MAPE++R +
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK 173
Query: 704 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERV 736
+ D +SLG +++E LC P+ G P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFP-PFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 73/210 (34%), Positives = 101/210 (48%), Gaps = 43/210 (20%)
Query: 536 VGIGFFGEVFRGIWNGTD------VAIK----VFLEQDLTAENMEDFCNEISILSRLRHP 585
+G G FG V W+ TD VA+K VF Q+L + + E+ +L +H
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVF--QNLVS--CKRVFRELKMLCFFKHD 59
Query: 586 NVILFLGA--CTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
NV L A +PP + ++TE M+ S H I +S Q LS L I
Sbjct: 60 NV---LSALDILQPPHIDPFEEIYVVTELMQ--SDLHKIIVSPQP--LSSDHVKVFLYQI 112
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 693
RGL +H I+HRD+K N LVN + +KICDFGL+R + P D S T E
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR--VEEP--DESKHMTQEVVTQ 168
Query: 694 -WMAPELIRNEP-FTEKCDIFSLGVIMWEL 721
+ APE++ +T DI+S+G I EL
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 581
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 582 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
P + L +C + RL + EY+ G L + I G+ K+ + + +I G
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVG 113
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +HR I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+P+ + D ++ GV+++E+ P++G
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 536 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI----L 589
VG+G FG V R G +VAIK ++ T + E+ +L LRH N+I +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
F+ + +TE + L+ L+ + L + L I RGL +H +
Sbjct: 78 FISPLED---IYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEK 708
VHRDLK +N L+N++ +KICDFGL+R I D M S T + APE++ + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVS--TRYYRAPEIMLTWQKYDVE 186
Query: 709 CDIFSLGVIMWEL 721
DI+S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWN---GTDVAIKVFLEQDLT--AENMEDFCNEISI 578
+F L V +G G +G+VF R + G A+KV + + A+ E E +
Sbjct: 1 NFELLRV---LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57
Query: 579 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
L +R P ++ A +L +I +Y+ G L+ HL Q++ + + +I
Sbjct: 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF--THLY-QREHFTESEVRVYIAEI 114
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMA 696
L +H++ I++RD+K N L++ V + DFGLS+ + + R S GT E+MA
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 697 PELIRNEP--FTEKCDIFSLGVIMWELCT 723
PE+IR + D +SLGV+ +EL T
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 9/189 (4%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLG 592
VG G FG V R + A+KV + + + + NE +L + HP +I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
L M+ EY+ G L+ + SG + S L +I L +H +IV+R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIF 712
DLK N L++K +K+ DFG ++ + D R + GTPE++APE+I+++ + D +
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 713 SLGVIMWEL 721
+LG++++E+
Sbjct: 183 ALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSR 581
DF+ L V +G G FG+V GTD AIK+ L++D+ ++ + C E +L+
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKI-LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 582 LRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
P + L +C + RL + EY+ G L + I G+ K+ + +I G
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE---PHAVFYAAEIAIG 113
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H I++RDLK N +++ +KI DFG+ + + + GTP+++APE+I
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+P+ + D ++ GV+++E+ P+EG
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/236 (26%), Positives = 115/236 (48%), Gaps = 21/236 (8%)
Query: 550 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608
+G VA+K + DL + + NE+ I+ +H NV+ + L ++ E++E
Sbjct: 44 SGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 609 LGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667
G+L ++ H +++++ + + + L +H ++HRD+KS + L+ V
Sbjct: 101 GGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155
Query: 668 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
K+ DFG ++ R S GTP WMAPELI P+ + DI+SLG+++ E+ P
Sbjct: 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 728 WEGVLPERVVYAVA-NEGSRLE-------IPEGPLGRLIADCWAEPQERPSCEEIL 775
+ P + + + N +L+ +G L RL+ +P +R + E+L
Sbjct: 216 YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV---RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 537 GIGFFGEVFRGIWNGTD--VAIKVFLEQDLTA-ENMEDFCNEISIL---SRLRHPNVILF 590
G G FG+V + T AIK + D+ A + +E E I + RHP ++
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP-FLVN 66
Query: 591 LGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
L AC + + + EY G L IH S R + + GL +H KI
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKI 122
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
V+RDLK N L++ VKI DFGL + R S+ GTPE++APE++ +T
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
D + LGV+++E+ P+ G E V ++ N+ R
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 40/149 (26%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E ++L+++ P ++ + P +L ++ ++ G L+H HL + + R +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH--HLQREGRFDLSRARFYTA 100
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 694
+C L +H+ +++RDLK N L++ + +CDFGL ++ + ++ GTPE+
Sbjct: 101 ELLC-ALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCT 723
+APEL+ +T+ D ++LGV+++E+ T
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 11/214 (5%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILS-RLRHPNVI-L 589
+G G FG+V GT+ AIK L++D+ E+ + C E +L+ HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKA-LKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
F TK L + EY+ G L I + R +I GL +H+ I
Sbjct: 62 FCTFQTKE-HLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
++RDLK N L++K +KI DFG+ + + + S+ GTP+++APE+++ + + E
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743
D +S GV+++E+ P+ G + + ++ N+
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 534 TRVGIGFFGEVF--RGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLRHPNVIL 589
+++G G +G VF R G VAIK F+ E D + + EI +L +L+HPN++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVN 64
Query: 590 FLGACTKPPRLSMITEYMELGSLYHL-IHLSG----QKKKLSWRRKLKMLRDICRGLMCI 644
+ + +L ++ EY + L L + G KK+ W+ + +
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ--------TLQAVNFC 116
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE- 703
H+ +HRD+K N L+ K +K+CDFG +RI+T + T + APEL+ +
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ D++++G + EL T W G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+G G FG+V R +G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ RL + EY+ G L+ HLS +++ S R +I L +H KIV+R
Sbjct: 63 SFQTKDRLCFVMEYVNGGELF--FHLS-RERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 653 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
DLK N +++K +KI DFGL + ITD+ + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATM-KTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 712 FSLGVIMWEL 721
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 536 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLG 592
+G+G FG V + A+K ++ + ++ +E IL HP ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM-CI------- 644
+ M+ EY G L+ ++ R + R + C+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL-----------RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
H I++RDLK N L++ + VK+ DFG ++ + S + + GTPE++APE+I N+
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFCGTPEYVAPEIILNKG 168
Query: 705 FTEKCDIFSLGVIMWELCTLNRP 727
+ D +SLG++++EL T P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQD-LTAENMEDFCNEISI 578
W + S+ +G +G G FG V GT AIK +++ L + ++ E SI
Sbjct: 14 SWKL--SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L L HP ++ + + R+ + E++ G L+ HL R+ + D+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELF--THL---------RKAGRFPNDVA 120
Query: 639 R--------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690
+ +H I++RDLK N L++ VK+ DFG ++ + D R + G
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCG 177
Query: 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
TPE++APE+I+++ + D +++GV+++E
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-16
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 536 VGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVILF 590
VG G +G V + G VAIK + +L A+ E+ +L ++H NVI
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY---RELRLLKHMKHENVIGL 79
Query: 591 LGACTKPPRLSMITEY--------MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
L T L ++ +LG L + +KLS R ++ + +GL
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-------KHEKLSEDRIQFLVYQMLKGLK 132
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
IH I+HRDLK N VN+ +KI DFGL+R TDS M + T + APE+I N
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEM--TGYVVTRWYRAPEVILN 189
Query: 703 -EPFTEKCDIFSLGVIMWELCT 723
+T+ DI+S+G IM E+ T
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 18/219 (8%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCN--EISILSRLR-HPNVILF 590
+G G FG+V GTD AIKV L++D+ ++ + C E IL+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV-LKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
RL + EY+ G L I S +K R ++ LM +HR ++
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
+RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVD 178
Query: 711 IFSLGVIMWELCTLNRPWEG---------VLPERVVYAV 740
++LGV+M+E+ P+E +L + V+Y V
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 550 NGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608
G VA+K + DL + + NE+ I+ H NV+ + L ++ E++E
Sbjct: 46 TGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102
Query: 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668
G+L ++ +++ + + + R L +H ++HRD+KS + L+ +K
Sbjct: 103 GGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158
Query: 669 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
+ DFG ++ + S GTP WMAPE+I P+ + DI+SLG+++ E+ P+
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTDV--AIK-VFLEQDLTAENMEDFCNEISILSRLRH 584
E+ V +G G +G V++ + T V A+K + LE D + N E+ IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVS 58
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
P ++ F GA + M EYM+ GSL L + + ++ + +GL +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 645 -HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
I+HRD+K N LVN + VK+CDFG+S + S + ++ G +MAPE I++
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSG 176
Query: 704 ------PFTEKCDIFSLGVIMWEL 721
+T + D++SLG+ + E+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +G V++G T VA+K + LE + TA EIS+L L+HPN
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA------IREISLLKELQHPN 60
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ + RL +I E++ + +L L + + K L I +G++ H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-SYLYQILQGILFCHS 119
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEP- 704
+++HRDLK N L++ +K+ DFGL+R P+R + W APE++ P
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 705 FTEKCDIFSLGVIMWELCTLNRP 727
++ DI+S+G I E+ T +P
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 575 EISILSRLRHPNVILFLG-ACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 632
E IL+++ H I+ L A L ++ M G L YH+ ++ + R
Sbjct: 43 EKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
I GL +H+ +I++RDLK N L++ V+I D GL+ + D + AGTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
+MAPEL++ E + D F+LGV ++E+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 532 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENME-DFCNEISILSRLRHPNVI 588
V +G G FGEV+ R G A+KV + D+ N E IL+ P ++
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD---------ICR 639
+ L ++ EYM G L ++ + + + +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------------ 681
L +H++ +HRD+K N L++ +K+ DFGL + + +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 682 ----------PMRDSSSA-GTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 720
++S GTP+++APE++R P+ +CD +SLGVI++E
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+G G FG+V R G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
A RL + EY G L+ HLS +++ + R +I L +H +V+R
Sbjct: 63 AFQTHDRLCFVMEYANGGELF--FHLS-RERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 653 DLKSANCLVNKHWTVKICDFGLSR--IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
D+K N +++K +KI DFGL + I + M+ + GTPE++APE++ + + D
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 711 IFSLGVIMWEL 721
+ LGV+M+E+
Sbjct: 178 WWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-15
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 551 GTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYME 608
G +VAIK+ E+ F E ++ +RL HPN++ L + PP L + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-----K 663
+L ++ G L +++ + L C H IVHRDLK N +V+
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 664 HWTVKICDFGLSRIITDSPMRDSSSA-------GTPEWMAPELIRNEPFTEKCDIFSLGV 716
H K+ DFG+ ++ D ++ GTP + APE +R EP T D+++ G+
Sbjct: 120 H--AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 717 IMWELCTLNRPWEGVLPERVVY 738
I E T R +G ++Y
Sbjct: 178 IFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E +L + HP+VI M+ + LY +L+ + + L + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY--TYLTKRSRPLPIDQALIIE 163
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 694
+ I GL +H +I+HRD+K+ N +N V I D G ++ +P AGT E
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET 222
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWEL 721
APE++ + + K DI+S G++++E+
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 71/256 (27%), Positives = 122/256 (47%), Gaps = 28/256 (10%)
Query: 536 VGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRH-PNV 587
+G G +G+VF G +G A+KV + + A+ E E +L +R P +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ A +L +I +Y+ G L+ HLS Q+++ + +I L +H++
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELF--THLS-QRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMAPELIR--NEP 704
I++RD+K N L++ + V + DFGLS+ D R S GT E+MAP+++R +
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE 764
+ D +S+GV+M+EL T P+ + S+ EI R++
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFT---------VDGEKNSQAEISR----RILKSEPPY 231
Query: 765 PQE-RPSCEEILSRLL 779
PQE ++I+ RLL
Sbjct: 232 PQEMSALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 536 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G G +G V I +G VAIK F L + E+ IL +H N+I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR----ELKILRHFKHDNIIA 68
Query: 590 FLGACTKPPRLSMITEY--MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
+PP Y M+L L+H+IH S Q R L + RGL IH
Sbjct: 69 IR-DILRPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYF--LYQLLRGLKYIH 124
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPELIR 701
++HRDLK +N LVN+ ++I DFG++R ++ SP T + APEL+
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 702 NEP-FTEKCDIFSLGVIMWEL 721
+ P +T D++S+G I E+
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 56/195 (28%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+G G FG+V++ T A+KV ++++ A+ + E +IL R +G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 593 ---ACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ L ++T+YM G L+ HL + + S R + ++ L +H+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 707
IV+RDLK N L++ + +CDFGLS+ ++ GT E++APE++ +E +T+
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 708 KCDIFSLGVIMWELC 722
D +SLGV+++E+C
Sbjct: 177 HVDFWSLGVLVFEMC 191
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSR-LRHPNVILFL 591
+G G FG+V + +G+ A+KV ++ L + E ++L + L+HP ++
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
+ +L + +Y+ G L+ HL ++ L R + ++ + +H + I++
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVASAIGYLHSLNIIY 119
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK N L++ V + DFGL + + S+ GTPE++APE++R EP+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 712 FSLGVIMWEL 721
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-14
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 536 VGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 590
+G G GEV+ VA+K E DL +EN + F E I + L HP ++
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIRE-DL-SENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL--------SWRRKLKMLRDICRGLM 642
C+ + Y+E +L L+ QK+ L S L + IC +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---------DSPMRDSSSA---- 689
+H ++HRDLK N L+ V I D+G + D R+ +
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 690 -----GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
GTP++MAPE + P +E DI++LGVI++++ TL+ P+
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 49/132 (37%), Positives = 69/132 (52%), Gaps = 15/132 (11%)
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS--SAGTP----EWMAPELIRNE 703
VHRDL + N L+ + VKICDFGL+R I MRDS+ S G+ +WMAPE I N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDI----MRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 704 PFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759
+T D++S G+++WE+ TL P+ + Y G R+ P + ++
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQ 376
Query: 760 DCWAEPQE-RPS 770
CW E E RP
Sbjct: 377 KCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 18/156 (11%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 627
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+ K ++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
R L LR+ KI+HRD+K +N LVN +K+CDFG+S + DS M + S
Sbjct: 109 LRGLTYLREK---------HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN-S 157
Query: 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
GT +M+PE ++ +T + DI+SLG+ + E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 575 EISILSRLRHPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSWR 628
EI +L L H NVI + PP + ++ E M+ L+ +I S Q LS
Sbjct: 54 EIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIR-SSQT--LSDD 108
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688
L + RGL IH ++HRDLK +N L+N + +KICDFGL+R ++ +
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168
Query: 689 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 721
T + APEL+ N +T D++S+G I EL
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEY---MEL--GSLYHLIHLSGQKKKLSWRR 629
E+ ++ + H N+I L T L + MEL +L +I + +++S+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY-- 122
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 123 ---LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----- 174
Query: 690 GTPE-----WMAPELIRNEPFTEKCDIFSLGVIMWEL 721
TP + APE+I + E DI+S+G IM E+
Sbjct: 175 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 9/210 (4%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILS-RLRHPNVILF 590
+G G FG+VF GT+ AIK L++D L +++E E +LS HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
L + EY+ G L I S K L R +I GL +H IV
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLP--RATFYAAEIICGLQFLHSKGIV 118
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
+RDLK N L++ +KI DFG+ + + + GTP+++APE++ + + D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178
Query: 711 IFSLGVIMWELCTLNRPWEGVLPERVVYAV 740
+S GV+++E+ P+ G E + ++
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE--NMEDFCNEISILSRLRHPNVILF 590
++G G + V++G G VA+K E L AE EIS++ L+H N++
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALK---EIHLDAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
+L ++ EYM+ L + G + L + +G+ H +++
Sbjct: 64 HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEKC 709
HRDLK N L+NK +K+ DFGL+R S+ T + AP+ L+ + ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182
Query: 710 DIFSLGVIMWELCT 723
DI+S+G IM E+ T
Sbjct: 183 DIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 12/232 (5%)
Query: 532 VGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVI 588
V + VG G FGEV R G A+KV + L A E + F E ILS P +
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
A L ++ EY G L L L+ + + L ++ + +H+M
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSL--LNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR------ 701
VHRD+K N L+++ +K+ DFG + R+ + + GTP+++APE++
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 753
+ +CD +SLGVI +E+ P+ + + N L+ PE P
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 532 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN------------EIS 577
G +G G +G+V + G VAIK +++ + +D E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
I++ ++H N++ + + ++++ + M L + +K +L+ + +L I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQI 128
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG------- 690
GL +H+ +HRDL AN +N KI DFGL+R P D+ S
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 691 --TPE----WM-APELIRN-EPFTEKCDIFSLGVIMWELCT 723
T + W APEL+ E + D++S+G I EL T
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLG 592
+G G FG+V R G A+K+ ++ + A + + E +L RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ RL + EY G L+ HLS +++ S R +I L +H +V+R
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 653 DLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
DLK N +++K +KI DFGL + I+D + GTPE++APE++ + + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 712 FSLGVIMWEL 721
+ LGV+M+E+
Sbjct: 179 WGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
++HRD+K +N L++ VK+CDFG+S + DS + SAG +MAPE I K
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPK 194
Query: 709 CDI----FSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIPEGPLG-------- 755
DI +SLG+ + EL T P++ E V+ + E E P P
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE----EPPSLPPNEGFSPDFC 250
Query: 756 RLIADCWA-EPQERPSCEEIL 775
+ C + ++RP E+L
Sbjct: 251 SFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 54/157 (34%), Positives = 77/157 (49%), Gaps = 17/157 (10%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 627
E+ +L ++H NVI L T E +Y + HL G +KL+
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPA------RSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
++ I RGL IH I+HRDLK +N VN+ +KI DFGL+R TD M +
Sbjct: 120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEM--TG 176
Query: 688 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCT 723
T + APE++ N + + DI+S+G IM EL T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E+ +L P ++ F GA +S+ E+M+ GSL ++ + K++ K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVS 109
Query: 635 RDICRGLMCI-HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
+ RGL + + +I+HRD+K +N LVN +K+CDFG+S + DS +S GT
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRS 167
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP--------WEGVLPERVVYAVANEGS 745
+M+PE ++ ++ + DI+S+G+ + EL P E + VV E
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 746 RLEIPEGPLGRLIA 759
+ P GR ++
Sbjct: 228 SISPRPRPPGRPVS 241
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 48/190 (25%), Positives = 93/190 (48%), Gaps = 7/190 (3%)
Query: 536 VGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMED--FCNEISILSRLRHPNVILFL 591
+G G FG+V + A+KV ++ + + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
+ +L + +Y+ G L++ HL ++ L R + +I L +H + IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFY--HLQRERCFLEPRARF-YAAEIASALGYLHSLNIVY 119
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK N L++ + + DFGL + + S+ GTPE++APE++ +P+ D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 712 FSLGVIMWEL 721
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 46/162 (28%), Positives = 85/162 (52%), Gaps = 9/162 (5%)
Query: 572 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 631
F E I++ P V+ A L M+ EYM G L +L +S W +
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL--MSNYDVPEKWAKFY 147
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAG 690
++ L IH M ++HRD+K N L++KH +K+ DFG + ++ M R ++ G
Sbjct: 148 TA--EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 691 TPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPW 728
TP++++PE+++++ + +CD +S+GV ++E+ + P+
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 4/157 (2%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 632
NE IL ++ V+ A L ++ M G L +H+ H+ + R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVF 106
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
+IC GL +H+ +IV+RDLK N L++ H ++I D GL+ + + GT
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTV 165
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 729
+MAPE+++NE +T D ++LG +++E+ P++
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 531 TVGTRVGIGFFG----EVFRGIWNGTDVAIKVFLEQDLTAENMEDFC---NEISILSRLR 583
+ T +G F + + T VA+K +L + + ED EI +L+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGL 641
HPN++ ++ + L +++ M GS L+ H +L+ +L+D+ L
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNAL 114
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS----------RIITDSPMRDSSSAGT 691
IH +HR +K+++ L++ V + S R++ D P SS
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK---SSVKN 171
Query: 692 PEWMAPELIRN--EPFTEKCDIFSLGVIMWEL 721
W++PE+++ + + EK DI+S+G+ EL
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 14/195 (7%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
R+G G +G V+R + VA+K V ++ + + EI++L LRHPN++
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 592 GACTKPPRLS--MITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
S ++ EY E L SL L S + ++ + RGL +H
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASL-----LDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFT 706
I+HRDLK +N L+ +KI DFGL+R + T + APEL+ +T
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187
Query: 707 EKCDIFSLGVIMWEL 721
D++++G I+ EL
Sbjct: 188 TAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 590
++G G + V++GI NG VA+KV + E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
L+ + EYM ++I G + R L M + + RGL IH I+
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVR--LFMFQ-LLRGLAYIHGQHIL 125
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 708
HRDLK N L++ +K+ DFGL+R P + SS W P L+ ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 709 CDIFSLGVIMWELCTLNRPWEGV--LPERV-----VYAVANEG-----SRL-----EIPE 751
DI+ G I E+ + GV + E++ V V E S+L E
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244
Query: 752 GPLGRLIADCWAEPQERPSCEEILSRLL 779
+ + W P E++ S++L
Sbjct: 245 PCKPQQLRVVWKRLSRPPKAEDLASQML 272
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 18/160 (11%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSW 627
E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+ K ++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
+ L LR+ + KI+HRD+K +N LVN +K+CDFG+S + DS +S
Sbjct: 113 IKGLTYLRE---------KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 161
Query: 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
GT +M+PE ++ ++ + DI+S+G+ + E+ P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
++G G + V++G TD VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 592 GACTKPPRLSMITEYME------LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
L+++ EY++ L + I++ K L + RGL H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---------FLFQLLRGLNYCH 121
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNE 703
R K++HRDLK N L+N+ +K+ DFGL+R P + S+ W P L+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 704 PFTEKCDIFSLGVIMWELCTLNRP 727
++ + D++ +G I +E+ T RP
Sbjct: 181 DYSTQIDMWGVGCIFYEMST-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 536 VGIGFFGEV----FRGIWNGTDVAIK----VFLEQDLTAENMEDFCNEISILSRLR-HPN 586
+G G +G V VAIK VF ++ L + E+ +L R H N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 587 VI-LFLGACTKPPRLSMITEYMEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
+ L+ P + + Y EL L+ +I SGQ L+ + I GL
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQP--LTDAHFQSFIYQILCGLKY 120
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS----SSAGTPEWMAPE- 698
IH ++HRDLK N LVN +KICDFGL+R +++P ++ T + APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 699 LIRNEPFTEKCDIFSLGVIMWEL 721
++ + +T+ D++S+G I+ EL
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 632
NE IL ++ V+ A L ++ M G L +H+ ++ R +
Sbjct: 49 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVF 106
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGT 691
+I GL +HR +IV+RDLK N L++ + ++I D GL+ I + +R GT
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR--GRVGT 164
Query: 692 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+MAPE+++NE +T D + LG +++E+ P+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 37/128 (28%), Positives = 69/128 (53%), Gaps = 8/128 (6%)
Query: 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN 662
I +Y++ G L+ L+ ++ KLS K++R + L +H+ I+H D+K N L +
Sbjct: 87 IMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 663 KH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
+ + +CD+GL +II D GT ++ +PE I+ + D +++GV+ +EL
Sbjct: 144 RAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYEL 199
Query: 722 CTLNRPWE 729
T P++
Sbjct: 200 LTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 508 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---VAIKVFLEQDL 564
+ P +NK + YE++N + +G G FG V + D VAIK F + +
Sbjct: 19 KEPKRKNK--MKYEDFNFIRT-------LGTGSFGRVILATYKNEDFPPVAIKRFEKSKI 69
Query: 565 TAENMEDFC-NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKK 623
+ D +E IL+ + HP + G+ L ++ E++ G + +
Sbjct: 70 IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------- 122
Query: 624 KLSWRRKLKMLRD--------ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675
RR + D I + + IV+RDLK N L++K +K+ DFG +
Sbjct: 123 ----RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
+++ R + GTPE++APE++ N + D ++LG+ ++E+
Sbjct: 179 KVVD---TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF-----RGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISI 578
+F L V +G G +G+VF G G A+KV + L A+ +E E ++
Sbjct: 1 NFELLKV---LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57
Query: 579 LSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
L +R P ++ A +L +I +Y+ G ++ HL Q+ S +I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF--THLY-QRDNFSEDEVRFYSGEI 114
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITDSPMRDSSSAGTPEWMA 696
L +H++ IV+RD+K N L++ V + DFGLS+ +++ R S GT E+MA
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 697 PELIRNEPFTEKC-DIFSLGVIMWELCTLNRPW 728
PE+IR + K D +SLG++++EL T P+
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 589
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
A P +L I + M G L++ HLS Q S + +I GL +H +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHY--HLS-QHGVFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI-RNEPFTEK 708
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE++ + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 709 CDIFSLGVIMWELCTLNRPW 728
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 6/189 (3%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
VG G +G V + T VAIK F + + E E E+ +L L+ N++ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
+ +L ++ EY+E L L + R + L + + H+ IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---IKAIHWCHKNDIVHRD 125
Query: 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELIRNEPFTEKCDIF 712
+K N L++ + +K+CDFG +R +++ + + W +PEL+ P+ + D++
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMW 185
Query: 713 SLGVIMWEL 721
S+G I+ EL
Sbjct: 186 SVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED---FCNEISILSRLRHPNVILF 590
+G G FG+V + +G A+KV L++ + E +L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKV-LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
+ +L + +++ G L+ HL ++ R + +I L +H + IV
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARF-YAAEIASALGYLHSINIV 118
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
+RDLK N L++ V + DFGL + ++ GTPE++APE+IR +P+ D
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178
Query: 711 IFSLGVIMWEL 721
+ LG +++E+
Sbjct: 179 WWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 536 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRLRHPNVILFLG 592
+G G FGEV R A+K+ + ++ + F E I++ P V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
A L M+ EYM G L +L +S W R ++ L IH M +HR
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNL--MSNYDVPEKWARFYTA--EVVLALDAIHSMGFIHR 166
Query: 653 DLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRNEP----FTE 707
D+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++++ +
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 708 KCDIFSLGVIMWELCTLNRPW 728
+CD +S+GV ++E+ + P+
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 7/225 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+G G FG+V + G A+K+ ++ + A++ + E +L RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVH 651
+ RL + EY G L+ HLS +++ S R +I L +H K +V+
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK N +++K +KI DFGL + + GTPE++APE++ + + D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 756
+ LGV+M+E+ P+ E++ + E R P +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 536 VGIGFFGEVFR-----GIWNGTDVAIKVFLEQDLTAENMEDFCN---EISILSRLRHPNV 587
+G G +G+VF+ G G A+KV L++ N +D + E +IL ++HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKV-LKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-------LRDICRG 640
+ + A +L +I EY+ G L+ +HL R + M L +I
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELF--MHLE--------REGIFMEDTACFYLSEISLA 112
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H+ I++RDLK N L++ VK+ DFGL + + GT E+MAPE++
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ D +SLG +M+++ T P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 30/87 (34%), Positives = 55/87 (63%), Gaps = 4/87 (4%)
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI---RNE 703
+KI+HRD+K +N L++++ +K+CDFG+S + DS + + AG +MAPE I +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARD 185
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ + D++SLG+ ++E+ T P+
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 533 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 588
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQ 64
Query: 589 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 641
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHSDR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 642 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 695
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 696 -APELIRN-EPFTEKCDIFSLGVIMWELCT 723
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 49/190 (25%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISIL-SRLRHPNVILFL 591
+G G FG+V + +G A+KV ++ + + + E ++L ++HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
+ +L + +Y+ G L+ HL ++ R + +I L +H + I++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFF--HLQRERSFPEPRARF-YAAEIASALGYLHSLNIIY 119
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RDLK N L++ V + DFGL + + S+ GTPE++APE++R +P+ D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 712 FSLGVIMWEL 721
+ LG +++E+
Sbjct: 180 WCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKNLKHANIVTLH 69
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
L+++ EY++ L + G + K+ M + + RGL H+ KI+H
Sbjct: 70 DIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKRKILH 126
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 709
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 710 DIFSLGVIMWELCTLNRP 727
D++ +G I++E+ T RP
Sbjct: 186 DMWGVGCILYEMAT-GRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 526 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRL 582
DF + V +G G FGEV R + A+K+ + ++ + F E I++
Sbjct: 44 DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
++ A L M+ EYM G L +L +S W R ++ L
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL--MSNYDIPEKWARFYTA--EVVLALD 156
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 701
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 702 NE----PFTEKCDIFSLGVIMWEL 721
++ + +CD +S+GV ++E+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 533 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI--- 588
G +VG G +G V++ +G D + + T +M C EI++L L+HPNVI
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQ 64
Query: 589 -LFLGACTKPPRLSMITEYMELGSLYHLIHL----SGQKKKLSWRRKL--KMLRDICRGL 641
+FL + ++ ++ +Y E L+H+I KK + R + +L I G+
Sbjct: 65 KVFLSHADR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 642 MCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD--SPMRDSSSAGTPEWM 695
+H ++HRDLK AN LV + VKI D G +R+ P+ D W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 696 -APELIRN-EPFTEKCDIFSLGVIMWELCT 723
APEL+ +T+ DI+++G I EL T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS------MIT 604
G +VA+K + + E+ +L + H N+I L T L ++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664
E M+ +L +IH+ +++S+ +L + G+ +H I+HRDLK +N +V
Sbjct: 106 ELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 159
Query: 665 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
T+KI DFGL+R + M + T + APE+I + E DI+S+G IM EL
Sbjct: 160 CTLKILDFGLARTACTNFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 40/131 (30%), Positives = 70/131 (53%), Gaps = 3/131 (2%)
Query: 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 658
RL ++ EY+ G L + H+ Q+K L +IC L +H I++RDLK N
Sbjct: 70 RLFLVIEYVNGGDL--MFHMQRQRK-LPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126
Query: 659 CLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 718
L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV+M
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186
Query: 719 WELCTLNRPWE 729
+E+ P++
Sbjct: 187 FEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NEISILSRLRHPNVILFL 591
++G G +G V+ R G VA+K + D E + EIS+L L HPN++ L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 592 GACTKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
+L ++ E++ +L LSG L ++L+ GL H ++
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ----GLAFCHSHRV 121
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRNEPFTE 707
+HRDLK N L+N +K+ DFGL+R P+R + W APE L+ + ++
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 708 KCDIFSLGVIMWELCT 723
DI+SLG I E+ T
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLR-HPNVILF 590
+G G FG+V R +G A+KV L++D L +++E E ILS R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV-LKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
P RL + E++ G L I S ++ R +I LM +H I+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKGII 118
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
+RDLK N L++ K+ DFG+ + + S+ GTP+++APE+++ + D
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVD 178
Query: 711 IFSLGVIMWELCTLNRPWEG---------VLPERVVY 738
+++GV+++E+ + P+E +L + VVY
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 555 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613
A+K +Q+L N ++ E IL+ +P V+ + L M+ EY+E G
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 614 HLIHLSGQKKKLSWRRKLKMLR----DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669
L+ G + M R + L +H IVHRDLK N L+ +K+
Sbjct: 90 TLLKNIGA-------LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKL 142
Query: 670 CDFGLSRI------------ITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSL 714
DFGLS+I + R D GTPE++APE+I + + + D +++
Sbjct: 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202
Query: 715 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 752
G+I++E P+ G PE + V ++ +E PEG
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISD--DIEWPEG 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC-NE---ISILSRLRHPNVIL 589
+G G FGEV+ R G A+K ++ + + E NE +S++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
A P +LS I + M G L++ HLS Q S +I GL +H +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNEPFTEK 708
V+RDLK AN L+++H V+I D GL+ S + +S GT +MAPE L + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 709 CDIFSLGVIMWELCTLNRPWEG 730
D FSLG ++++L + P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
++G G + VF+G T+ VA+K + LE + A E+S+L L+H N++
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHANIVTLH 70
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
L+++ EY++ L + G +S L I RGL HR K++H
Sbjct: 71 DIVHTDKSLTLVFEYLD-KDLKQYMDDCGNI--MSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEKC 709
RDLK N L+N+ +K+ DFGL+R P + S+ W P L+ + ++ +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 710 DIFSLGVIMWELCTLNRP 727
D++ +G I +E+ + RP
Sbjct: 187 DMWGVGCIFFEMAS-GRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFL 591
+G G FG+V G A+K L++D L +++E E +L+ L N L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKA-LKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTH 60
Query: 592 GACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
CT L + E++ G L I K + R +I GL +H I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
++RDLK N ++++ +KI DFG+ + R S+ GTP+++APE+++ +T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 710 DIFSLGVIMWELCTLNRPWEG 730
D +S GV+++E+ P+ G
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 535 RVGIGFFGEVFRG---IWNGTDVAIKVFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +G V++ + N T K+ LEQ+ TA EIS+L ++H N
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA------IREISLLKEMQHGN 62
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM-LRDICRGLMCIH 645
++ RL ++ EY++L H+ K R +K L I RG+ H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP---RLIKTYLYQILRGIAYCH 119
Query: 646 RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWM-APE-LIRN 702
+++HRDLK N L+++ +K+ DFGL+R P+R + W APE L+ +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRP 727
++ DI+S+G I E+ +P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 24/202 (11%)
Query: 534 TRVGIGFFGEVFRGI--WNGTDVAIKVF---LEQDLTAENMEDFCNEISILSRLRHPNVI 588
+VG G +G V I G VAIK + ++ A+ E+++L ++H NVI
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY---RELTLLKHMQHENVI 77
Query: 589 LFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
L T ++ YM+ L + G LS + ++ + GL
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHP--LSEDKVQYLVYQMLCGLK 131
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
IH I+HRDLK N VN+ +KI DFGL+R D+ M + T + APE+I N
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM--TGYVVTRWYRAPEVILN 188
Query: 703 -EPFTEKCDIFSLGVIMWELCT 723
+ + DI+S+G IM E+ T
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 82/297 (27%), Positives = 120/297 (40%), Gaps = 71/297 (23%)
Query: 536 VGIGFFGEVFRGIWN--GTDVAIK----VFLEQDLTAENMED---FCNEISILSRLRHPN 586
+G G +G V I G VAIK VF E++ D EI +L LRHP+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF-------EHVSDATRILREIKLLRLLRHPD 60
Query: 587 VILFLGACTKPPR-----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
++ P R + ++ E ME L+ +I L+ L + R L
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEHHQFFLYQLLRAL 116
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI-ITDSPMRD--SSSAGTPEWMAPE 698
IH + HRDLK N L N +KICDFGL+R+ D+P + T + APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 699 LIRN--EPFTEKCDIFSLGVIMWELCTLNRP----------------WEGVLPERVVYAV 740
L + +T DI+S+G I E+ T +P G + V
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 741 ANEGSRLEI----PEGP-----------------LGRLIADCWAEPQERPSCEEILS 776
NE +R + + P L RL+A +P++RP+ EE L+
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA---FDPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIK-VFLEQDLTAENMEDFC-NEISILSRLRHPNVILF 590
++G G +G VF+ VA+K V L+ D E + EI +L L+H N++
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRL 64
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
+L+++ EY + + +G + + + +GL H ++
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---SFMFQLLKGLAFCHSHNVL 121
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 708
HRDLK N L+NK+ +K+ DFGL+R P+R S+ W P L + ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 709 CDIFSLGVIMWELCTLNRP 727
D++S G I EL RP
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 67/267 (25%), Positives = 119/267 (44%), Gaps = 36/267 (13%)
Query: 536 VGIGFFGEVFRGI---------WNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 585
+G G F ++F+GI + T+V +KV D + N E F S++S+L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL---DKSHRNYSESFFEAASMMSQLSHK 59
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
+++L G C M+ EY++ GSL + + +SW KL++ + + L +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 646 RMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDSPMRDSSSAGTPEWMAP 697
+ H ++ + N L+ + +K+ D G+S IT P ++ P W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLP-KEILLERIP-WVPP 173
Query: 698 ELIRN-EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---G 752
E I N + + D +S G +WE+ + ++P + ++ + R ++P
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---DRHQLPAPKWT 230
Query: 753 PLGRLIADC-WAEPQERPSCEEILSRL 778
L LI C EP RPS I+ L
Sbjct: 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 4/156 (2%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKM 633
E IL ++ P ++ A L ++ M G L YH+ ++ ++ L R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLEMERVIHY 100
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
I G++ +H M IV+RD+K N L++ ++ D GL+ + D + AGT
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 729
+MAPE+++ EP++ D F++G ++E+ P++
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 536 VGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-----FCNEISILSRLR---HP 585
+G+G +G V+ R +G VA+K + + ED E+++L RL HP
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK-----SVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 586 NVILFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
N++ + C + +++++ E+++ +L + + L +R RG
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDL--MRQFLRG 120
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H IVHRDLK N LV VK+ DFGL+RI + M + T + APE++
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVL 179
Query: 701 RNEPFTEKCDIFSLGVIMWEL 721
+ D++S+G I E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 68/263 (25%), Positives = 106/263 (40%), Gaps = 44/263 (16%)
Query: 526 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 582
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
V+ + L +I E++ G + L+ +K LS + + +
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAID 115
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRD----- 685
IH++ +HRD+K N L++ VK+ DFGL R +T +P D
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 686 ------------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 728 WEGVLPERVVYAVANEGSRLEIP 750
+ P+ V N L P
Sbjct: 236 FCSETPQETYRKVMNWKETLVFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-------KKLSW 627
E+ +L ++H NVI L T + E +Y + +L G +KLS
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNE------VYLVTNLMGADLNNIVKCQKLSD 117
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
++ + RGL IH I+HRDLK +N VN+ ++I DFGL+R D M +
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEM--TG 174
Query: 688 SAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 721
T + APE++ N + + DI+S+G IM EL
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 536 VGIGFFGEVF--RGIWNGTD-VAIKVFLEQDLTAENME-DFCNEISILSRLR---HPNVI 588
+G G +G+VF R + NG VA+K Q E M E+++L L HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 589 LFLGACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
CT + +L+++ E+++ +L + + + M+ + RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 125
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE++
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQS 184
Query: 704 PFTEKCDIFSLGVIMWEL 721
+ D++S+G I E+
Sbjct: 185 SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 27/84 (32%), Positives = 55/84 (65%), Gaps = 6/84 (7%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 701
+H++ VHRD+K N L++K+ +++ DFG R++ D ++ + + GTP++++PE+++
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 702 ----NEPFTEKCDIFSLGVIMWEL 721
+ +CD +SLGV M+E+
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 628
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY- 123
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M +
Sbjct: 124 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPY 178
Query: 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
T + APE+I + E DI+S+G IM E+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 3/148 (2%)
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HP ++ RL + EY+ G L + H+ Q+K L +I L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-LPEEHARFYSAEISLALNY 111
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE++R E
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 171
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGV 731
+ D ++LGV+M+E+ P++ V
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPNV 587
+G G +G+V++ T VA+K V L+ + +TA EI IL +L H N+
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA------IREIKILRQLNHRNI 68
Query: 588 ILFLGACT----------KPPRLSMITEYME---LGSLYH-LIHLSGQKKKLSWRRKLKM 633
+ T ++ EYM+ +G L L+H S K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SF 121
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
++ + GL H+ +HRD+K +N L+N +K+ DFGL+R+ R ++
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 694 WMAPE--LIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
W P L+ E + D++S G I+ EL T +P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 6/159 (3%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 633
NE IL ++ V+ A L ++ M G L I+ G R L
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFY 107
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS--SSAGT 691
+I GL +HR V+RDLK N L++ + ++I D GL+ I P +S GT
Sbjct: 108 AAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIRGRVGT 164
Query: 692 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+MAPE++ N+ +T D + LG +++E+ P+ G
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-10
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 40/169 (23%)
Query: 575 EISILSRLR-HPNVILFLGACTKPPR------LSMITEYMELGSLYHLIHLSGQKKKLSW 627
EI L L HPN++ L + + ++ EYME L+ +I + +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVI----KAENDKDIYLVFEYME-TDLHAVI-----RANI-- 103
Query: 628 RRKLKMLRDI---------CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678
L D+ + L IH ++HRDLK +N L+N VK+ DFGL+R +
Sbjct: 104 ------LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
Query: 679 TDSPMRDSSSAGT----PEWM-APE-LIRNEPFTEKCDIFSLGVIMWEL 721
++ + T W APE L+ + +T+ D++S+G I+ E+
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 5/150 (3%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E IL + HP++I G T +I + LY +L+ K+ ++ L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLY--CYLAA-KRNIAICDILAIE 188
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 693
R + R + +H +I+HRD+K+ N +N V + DFG + D + + AGT
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
APEL+ +P+ DI+S G++++E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWR 628
E+ ++ + H N+I L T L ++ E M+ +L +I + +++S+
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY- 130
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688
+L + G+ +H I+HRDLK +N +V T+KI DFGL+R S M
Sbjct: 131 ----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
T + APE+I + E DI+S+G IM E+
Sbjct: 187 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 4/156 (2%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLK 632
NE IL ++ V+ A L ++ M G L +H+ ++ +R +
Sbjct: 49 NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIF 106
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
++C GL + R +IV+RDLK N L++ ++I D GL+ I + GT
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTV 165
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728
+MAPE+I NE +T D + LG +++E+ P+
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 45/161 (27%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS------ 686
+H+M +HRD+K N L+++ +K+ DFGL R DS +DS
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 687 --------------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 720
S GTP ++APE++ +T+ CD +S+GVI++E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 721 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADC 761
+ P+ P V N + L IP +L +
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHIP--SQAKLSREA 275
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 3/133 (2%)
Query: 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656
RL + E++ G L + H+ +++KL +I L +H I++RDLK
Sbjct: 68 ESRLFFVIEFVSGGDL--MFHMQ-RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKL 124
Query: 657 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 716
N L++ +K+ D+G+ + S+ GTP ++APE++R E + D ++LGV
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 717 IMWELCTLNRPWE 729
+M+E+ P++
Sbjct: 185 LMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 532 VGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G +G G FG V+ I T VAIK L QD +N E+ I+ L H N+I
Sbjct: 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QDPQYKN-----RELLIMKNLNHINIIF 123
Query: 590 ----FLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ C K L+++ E++ ++ H + L +CR L
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 642 MCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
IH I HRDLK N L+ N H T+K+CDFG ++ + + R S + + APEL
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLL-AGQRSVSYICSRFYRAPEL 241
Query: 700 IRNEP-FTEKCDIFSLGVIMWEL 721
+ +T D++SLG I+ E+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 38/116 (32%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS------------RIITDSPMRDS----- 686
IH++ +HRD+K N L++ +K+ DFGL RI++ + +
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 687 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
S+ GTP+++APE+ + ++CD +SLGVIM+E+
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCNEISILSRLRHPNV----- 587
+G G G VF + + D VA+K + L ++++ EI I+ RL H N+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 588 ILFLGACTKPPRLSMIT---------EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+L + +T EYME L ++ Q +L M + +
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQ-LL 124
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDS---SSAGTPEW 694
RGL IH ++HRDLK AN +N V KI DFGL+RI+ D S +W
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKW 183
Query: 695 M-APELI---RNEPFTEKCDIFSLGVIMWELCT 723
+P L+ N +T+ D+++ G I E+ T
Sbjct: 184 YRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 537 GIGFFGEVFRGIWNGTD--VAIKVF-LEQD----LTAENMEDFCNEISILSRLRHPNVIL 589
G G + V++G T VA+K LE + TA E S+L L+H N++
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA------IREASLLKDLKHANIVT 67
Query: 590 FLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L+++ EY++ Y G LS L + RGL H+ +
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFLFQLLRGLAYCHQRR 123
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFT 706
++HRDLK N L+++ +K+ DFGL+R P + S+ W P L+ + ++
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 707 EKCDIFSLGVIMWELCT 723
D++ +G I +E+ T
Sbjct: 183 TSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
EI IL + H +I + A + M+ + L+ + SG L + + +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSG---PLPLEQAITIQ 191
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 692
R + L +H I+HRD+K+ N +++ + DFG + + P + +GT
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
E +PEL+ +P+ K DI+S G++++E+ N G
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 30/113 (26%), Positives = 61/113 (53%), Gaps = 6/113 (5%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR- 701
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 702 ----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 45/274 (16%)
Query: 526 DFSELTVGTRVGIGFFGEV--FRGIWNGTDVAIKVFLEQD-LTAENMEDFCNEISILSRL 582
DF L V +G G FGEV + G A+K+ + D L E + E IL
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
V+ + L +I E++ G + L+ +K L+ + + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAID 115
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGL---------------------------- 674
IH++ +HRD+K N L++ VK+ DFGL
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 675 --SRIITDSPMRDS-----SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
S+ ++ R+ S+ GTP+++APE+ + + CD +SLGVIM+E+ P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 728 WEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 760
+ P+ V N L PE P+ D
Sbjct: 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKD 269
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 53/265 (20%)
Query: 536 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+GIG FGEV R + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L + +Y+ G + L+ G + R + L C + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL--TC-AVESVHKMGFIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGLS---RIITDS--------PMRDS--------------- 686
D+K N L+++ +K+ DFGL R DS +DS
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 687 ---------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN 725
S GTP ++APE++ +T+ CD +S+GVI++E+
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 726 RPWEGVLPERVVYAVANEGSRLEIP 750
P+ P V N + L IP
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK--L 631
NEI L RL H N++ MIT+ + LY ++ + W+ + L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMY----DEAFDWKDRPLL 266
Query: 632 KMLRDICRGLMC----IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 686
K R I + L+C IH K++HRD+K N +N + + DFG + D
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
GT +PE++ + + E DI+S G+I+ ++
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 6e-09
Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 32/240 (13%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEIS 577
Y++ +E V ++G G FGEVF T K + L E++
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 578 ILSRLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKML 634
++ L+H N++ ++ +L ++ E+ + G L I + K+ + +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 635 RDICRGLMCIHRMK-------IVHRDLKSANCLV-----------------NKHWTVKIC 670
R + L H +K ++HRDLK N + N KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPW 728
DFGLS+ I M S GTP + +PEL+ +E + +K D+++LG I++ELC+ P+
Sbjct: 185 DFGLSKNIGIESMA-HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 31/113 (27%), Positives = 60/113 (53%), Gaps = 6/113 (5%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIRN 702
IH++ VHRD+K N L++ + +++ DFG ++ D ++ S + GTP++++PE+++
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 703 E-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750
+ +CD +SLGV M+E+ P+ + N R + P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 13/193 (6%)
Query: 535 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC--NEISILSRLRHPNVILF 590
++G G + V++G NG VA+KV Q+ E F E S+L L+H N++L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVLL 68
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
L+++ EY+ ++ G L L + RGL IH+ I+
Sbjct: 69 HDIIHTKETLTLVFEYVHTDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRYIL 125
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE--LIRNEPFTEK 708
HRDLK N L++ +K+ DFGL+R P S+ W P L+ + ++
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 709 CDIFSLGVIMWEL 721
D++ +G I E+
Sbjct: 185 LDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610
GT V +++ ++ T E+++ NE+ + RHPN++ T L +I+ +M G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 611 SLYHLIHL---SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667
S L+ G + L +L RGL +H+ +HR++K+++ L++ V
Sbjct: 85 SANSLLKTYFPEGMSEALIG----NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140
Query: 668 KICDFGLS------------RIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFS 713
+ GLS +++ D P S++ P W++PEL+R + + K DI+S
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFP--QFSTSVLP-WLSPELLRQDLYGYNVKSDIYS 195
Query: 714 LGVIMWELCTLNRPWEGVL 732
+G+ EL T P++ +L
Sbjct: 196 VGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 55/266 (20%)
Query: 536 VGIGFFGEV--FRGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLG 592
+GIG FGEV + A+K ++D+ N + E IL+ + V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
+ L + +Y+ G + L+ ++ R + ++ + +H+M +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF---YIAELTLAIESVHKMGFIHR 125
Query: 653 DLKSANCLVNKHWTVKICDFGL----------------SRIITDSPMRDS---------- 686
D+K N L++ +K+ DFGL S I DS M S
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS-MEPSDLWDDVSNCR 184
Query: 687 ----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL 724
S GTP ++APE++ + +T+ CD +S+GVI++E+
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 725 NRPWEGVLPERVVYAVANEGSRLEIP 750
P+ P V N + L IP
Sbjct: 245 QPPFLAPTPTETQLKVINWENTLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 8e-08
Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 48/131 (36%)
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-------------RIIT----------- 679
+H++ +HRD+K N L+++ +K+ DFGLS +++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 680 DSPMRDS-----------------------SSAGTPEWMAPELIRNEPFTEKCDIFSLGV 716
+S DS S+ GTP+++APE+ + + ++CD +SLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 717 IMWELCTLNRP 727
IM+E C + P
Sbjct: 237 IMFE-CLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 535 RVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED------FCNEISILSRLRHPN 586
++G G +G+V+ R G VA+K T M++ EIS+L L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK------TRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 587 VILFLGAC------TKPPRLSMITEYM--ELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
I+ L P L ++ EY+ +L + + G + L + + +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKK-FMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWM-A 696
+G+ H+ ++HRDLK N LV+K + KI D GL R + P++ + W A
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-IPVKSYTHEIVTLWYRA 179
Query: 697 PE-LIRNEPFTEKCDIFSLGVIMWELCTLN 725
PE L+ + ++ DI+S+G I E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 46/206 (22%), Positives = 83/206 (40%), Gaps = 49/206 (23%)
Query: 555 AIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613
A+KV ++++ N ++ E IL+ L HP + + L ++ +Y G L+
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 614 HLIHLSGQKKKLSWRRKLKMLRD---------ICRGLMCIHRMKIVHRDLKSANCLVNKH 664
L+ R+ K L + + L +H + IV+RDLK N L+++
Sbjct: 90 RLLQ----------RQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139
Query: 665 WTVKICDFGLS----------RIITDSPMRDSSSA-------------------GTPEWM 695
+ + DF LS R SS GT E++
Sbjct: 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199
Query: 696 APELIRNEPFTEKCDIFSLGVIMWEL 721
APE+I + D ++LG++++E+
Sbjct: 200 APEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 21/157 (13%)
Query: 574 NEISILSRLRHPNVILFLG-------ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626
+E +L RL HP V+ L C P+ LY +L + + L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--------SDLY--TYLGARLRPLG 258
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG---LSRIITDSPM 683
+ + R + + IH I+HRD+K+ N LVN + + DFG +R +P
Sbjct: 259 LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 720
AGT + APE++ +P+T DI+S G++++E
Sbjct: 319 H-YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 633
+EI+ + +L+HPN++ +G C +I EY+E +L ++ + LSW R+ K+
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785
Query: 634 LRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690
I + L +H +V +L +++ + L ++ SSA
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA- 843
Query: 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
++APE + TEK DI+ G+I+ EL T
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLT 873
|
Length = 968 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 6/142 (4%)
Query: 539 GFFGEVF--RGIWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVILFLGACT 595
G FG+V+ R N A+KV + D+ +NM E L+ + P ++ +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK 655
+ ++ EY+ G + L+H+ G +K + ++ L +HR I+HRDLK
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 656 SANCLVNKHWTVKICDFGLSRI 677
N L++ +K+ DFGLS++
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 9/100 (9%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
E+W L G +G G FG+V G VA+K+ L+ + E
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKM-LKASAHTDEREALM 89
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL 612
+E+ ILS L +H N++ LGACT + +ITEY G L
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 45/196 (22%), Positives = 85/196 (43%), Gaps = 24/196 (12%)
Query: 550 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609
G V ++ + T E + E+ + HPN++ + L ++T +M
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83
Query: 610 GSLYHLI--HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667
GS LI H +L+ +L+ + + L IH M VHR +K+++ L++
Sbjct: 84 GSAKDLICTHFMDGMSELAIAY---ILQGVLKALDYIHHMGYVHRSVKASHILISVDG-- 138
Query: 668 KICDFGL------------SRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFS 713
K+ GL R++ D P S W++PE+++ + + K DI+S
Sbjct: 139 KVYLSGLRSNLSMINHGQRLRVVHDFP---KYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 714 LGVIMWELCTLNRPWE 729
+G+ EL + P++
Sbjct: 196 VGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 9/103 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
W + L +G +G G FG V +G VA+K+ ++E + +E
Sbjct: 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK-QALMSE 90
Query: 576 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 617
+ I+S L H N++ LGACTK + +ITEY G L +H
Sbjct: 91 LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 572 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 631
F S++S++ H ++ G C + M+ E++E G L + + ++W K+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLV-------NKHWTVKICDFGLSRIITDSPMR 684
+ + + L + +VH ++ + N L+ +K+ D G+S R
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---R 177
Query: 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLP---ERVVYA 739
+ P W+APE + + D +S G + E+C P + P ER
Sbjct: 178 EERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-- 234
Query: 740 VANEGSRLEIPEGP-LGRLIADCWA-EPQERPSCEEILSRL 778
+ RL P L LI+ C EP +RPS IL L
Sbjct: 235 --EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 574
+W L +G +G G FG+V G D VA+K+ L++ TA + +
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKM-LKEGATASEHKALMS 59
Query: 575 EISILSRL-RHPNVILFLGACTKPP-RLSMITEYMELGSL 612
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 572 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 631
F S++ ++ H +++L G C + M+ E++E G L +H W K
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDFGLSRIITDSPMR 684
K+ + + L + +VH ++ + N L+ + +K+ D G+ + R
Sbjct: 109 KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---R 165
Query: 685 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELC 722
P W+APE + + + D +S G +WE+C
Sbjct: 166 QECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEIC 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
W L +G +G G FG+V G G VA+K+ ++E + +E
Sbjct: 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK-QALMSE 90
Query: 576 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 617
+ I++ L H N++ LGACTK + +ITEY G L + +H
Sbjct: 91 LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +HR IV RDL N L++ +++ F + DS ++ + APE+
Sbjct: 98 LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN---MYCAPEVG 154
Query: 701 RNEPFTEKCDIFSLGVIMWELCT 723
TE CD +SLG I++EL T
Sbjct: 155 GISEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 574
+W L +G +G G FG+V + G + VA+K+ L++ TA +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKM-LKEGATASEYKALMT 59
Query: 575 EISILSRL-RHPNVILFLGACTKP--PRLSMITEYMELGSL 612
E+ IL + H NV+ LGACTKP P L +I EY + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 10/100 (10%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFCN 574
+W L +G +G G FG+V G D VA+K+ L++ T +
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMS 59
Query: 575 EISILSRL-RHPNVILFLGACTKP-PRLSMITEYMELGSL 612
E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 20/41 (48%), Positives = 26/41 (63%)
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673
++R + GL +HR+ IVHRD+K N LV VKI DFG
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 35/150 (23%)
Query: 543 EVFRGIWNGTDVAIKV---------FLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593
++ + G +K L++ L E E IL++ R G
Sbjct: 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTR---REARILAKARE------AGV 61
Query: 594 CT------KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
P ++ EY+E G L K + +LR++ R + +H+
Sbjct: 62 PVPIVYDVDPDNGLIVMEYIE-GELL---------KDALEEARPDLLREVGRLVGKLHKA 111
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
IVH DL ++N +++ I DFGL
Sbjct: 112 GIVHGDLTTSNIILSGGRIYFI-DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 16/34 (47%), Positives = 25/34 (73%)
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 720
S P +MAPE+I+ + +TEK DI+SLG+ ++E
Sbjct: 63 QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 786 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.48 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.81 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.62 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.62 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.29 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.63 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.37 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.33 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.27 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.2 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.8 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 95.69 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.43 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.15 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.07 | |
| PLN02236 | 344 | choline kinase | 94.75 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.17 | |
| COG1305 | 319 | Transglutaminase-like enzymes, putative cysteine p | 94.16 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.0 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.84 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 90.13 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-61 Score=486.05 Aligned_cols=196 Identities=38% Similarity=0.602 Sum_probs=179.3
Q ss_pred Cchhhhhhhhhcccccc--cccCCcceeeecCc---chhhhcCCCCChhhhhhcCCCCceeEEEEEecccchhHHHHHHH
Q 003919 55 LSSQTASQILWSTGMLS--EPIPNGFYSVIPDK---RLKELFDSIPTVDELHALGGEGHRADIILVDSKKDKKLSMLKQL 129 (786)
Q Consensus 55 ~~~~~~~~~~~~~~~~~--~~~~~gfy~~~~~~---~~~~~~~~~p~~~~l~~~~~~~~~~e~i~vd~~~d~~~~~l~~l 129 (786)
+++|++|||||++|+|| |+||||||+|+|++ .|++.+++||||++|++++++++++|||||||+.|++|.+|+|.
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~ 80 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQR 80 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHH
Confidence 47899999999999999 99999999999995 67778999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHhhhCCCCCCChhh--hhhHHHHHHHhhcc-eeeeccccccccchhhHHHHHHhhhc
Q 003919 130 IVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAK--AALEETSHMFETRG-VQLLGQIRHGSCRPRAILFKVLADTV 206 (786)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~a~lv~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~g~~~~g~~r~ra~lfk~lad~~ 206 (786)
+.+++++++++++++|++||++||++|||+ +..++. ..|++.++.|+++. ++|||+|++|+|||||||||||||+|
T Consensus 81 a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~-~~~~~~~~~~w~~~s~~lk~~s~~vplG~l~~G~~rhRALLFKvLAD~i 159 (204)
T PF14381_consen 81 AHELSKGLSTNTKELVQKLAKLVADRMGGP-VSDAEDMLFRWELRSEKLKENSGVVPLGSLRIGLCRHRALLFKVLADRI 159 (204)
T ss_pred HHHHHhccccCHHHHHHHHHHHHHHHhCCC-CCcchhhhHHHHHHHHHHHhCCCeEEEeeecccchHHHHHHHHHHHHhc
Confidence 999999999889999999999999999999 443333 88999887666654 99999999999999999999999999
Q ss_pred CCccccccccCCCCccccccccccceEEEeeCCeeeeeeeccCCccccc
Q 003919 207 GLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIP 255 (786)
Q Consensus 207 ~l~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (786)
|||||||||+|++|+ +..+|+.+|+..+++|||||||++||+|+|
T Consensus 160 glpCrLvrG~~y~g~----~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 160 GLPCRLVRGCYYCGW----DDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred CCCceEEeeccCCcc----CCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 999999999999988 555566666666889999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=443.52 Aligned_cols=359 Identities=29% Similarity=0.509 Sum_probs=290.3
Q ss_pred HHHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCccc-CCCcccccccccccccccccCCCCCCCC
Q 003919 401 AVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEIS-GGRSALYNLSRDQMNSQKAISLPSSPHE 479 (786)
Q Consensus 401 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~-g~rs~~~~l~R~~~~sq~~~slPSsp~~ 479 (786)
-+++|.|.+++++|+++++..|+|++|+++ ..|+.+.+++.+++... +...+||.+.......... .++....
T Consensus 84 f~~~isR~~ae~~ll~p~~~~G~flvR~se----~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~--~~~~~~~ 157 (468)
T KOG0197|consen 84 FFGKISREEAERQLLAPENKEGAFLVRESE----SDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYP--YIDEREL 157 (468)
T ss_pred hhccccHHHHHHhhcCCCCCccceeeeccc----CCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeec--CCCHHHh
Confidence 578999999999999999999999999999 89999999998877554 7788888876542211110 0111111
Q ss_pred CCC------CCC-CCCCCCCCCCCchhhhhhhhhccCCcc------CCCCccccccccccCCCeeEeeEEeecCcEEEEE
Q 003919 480 YGS------HGS-ERGGSSGYMANSEFVSTWNKVLESPMF------QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFR 546 (786)
Q Consensus 480 ~~s------~sS-~~~~ss~~~~~s~~~s~~~~il~sp~~------~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYk 546 (786)
+.+ +.+ .+.+.. ..+..|.. ...+....+.|+++.+.+++.+.||+|.||+||.
T Consensus 158 F~~l~~lv~~~~~~~~gl~-------------~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~ 224 (468)
T KOG0197|consen 158 FSSLQQLVNYYSKNADGLC-------------TRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWL 224 (468)
T ss_pred hhhHHHHHhhhhccCcchh-------------hcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEE
Confidence 100 000 000000 01111111 1112223788999999999999999999999999
Q ss_pred EEECCe-eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccc
Q 003919 547 GIWNGT-DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKL 625 (786)
Q Consensus 547 g~~~G~-~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~L 625 (786)
|.+++. +||+|.++...+.. +.|.+|+++|++|+|+|||+++++|..+..+|||||||+.|+|.++|+. ..+..+
T Consensus 225 g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l 300 (468)
T KOG0197|consen 225 GKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLL 300 (468)
T ss_pred EEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCcc
Confidence 999877 99999998765543 6799999999999999999999999998899999999999999999974 356789
Q ss_pred hHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCCcccCccccccCC
Q 003919 626 SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIRNEP 704 (786)
Q Consensus 626 s~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-~~~GT~~Y~APEvl~~~~ 704 (786)
...+.+.++.|||+||+||+++++|||||.+.||||+++..+||+|||||+...+..+... ...-+..|+|||.+..+.
T Consensus 301 ~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~ 380 (468)
T KOG0197|consen 301 NLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK 380 (468)
T ss_pred chHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC
Confidence 9999999999999999999999999999999999999999999999999997766655433 334456899999999999
Q ss_pred CCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 705 FTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 705 ~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
|+.|+|||||||+||||+| |+.||.+.+..+++..+ ..+++++.|+ ..+.+||..||. +|++||||+.+...|+
T Consensus 381 FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 381 FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 9999999999999999997 67899999998888765 5577777774 469999999999 9999999999999998
Q ss_pred hhhh
Q 003919 780 DCEY 783 (786)
Q Consensus 780 ~i~~ 783 (786)
++..
T Consensus 460 ~~~~ 463 (468)
T KOG0197|consen 460 DFFT 463 (468)
T ss_pred Hhhh
Confidence 8754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=420.63 Aligned_cols=264 Identities=46% Similarity=0.768 Sum_probs=240.2
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEECCee-EEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~-VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..++.++..++.+.+.||+|+||+||+|.+.|+. ||||++..........+.|.+|+.+|.+++|||||+|+|+|.++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567777888888889999999999999999998 999999877766665789999999999999999999999999987
Q ss_pred -ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc-eeeccCCcccEEEcCCC-eEEEEecCcc
Q 003919 599 -RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANCLVNKHW-TVKICDFGLS 675 (786)
Q Consensus 599 -~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-IIHrDLKpsNILLd~~g-~VKL~DFGLA 675 (786)
.+.+||||+++|+|.++++.. ....+++..++.++.||++||+|||+++ |||||||++|||++.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 799999999999999999843 4678999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 752 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~- 752 (786)
+.............||+.|||||++. ..+|+.|+||||||++||||+||+.||.+..+..+...+...+.++.+|..
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 88765433444578999999999999 669999999999999999999999999999998889999889999988753
Q ss_pred --HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 753 --PLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 753 --~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
.+..|+..||. ||..||++.+|+..|+.+...
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 68999999999 999999999999999988764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=417.29 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=228.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..|..++.||+|+|+.||.+++ .|..||+|++.+..+ .....+...+||++.+.|+|||||+|+++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999976 699999999987654 3445678899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|+|..++|..+++ .++.+++..++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||||..+..+...
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999997 5689999999999999999999999999999999999999999999999999999999877677
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~~CL~ 763 (786)
..+.||||.|+|||++....++..+||||+|||||.|++|++||+.....+.+..+....+..+-. ..+.++||.++|.
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999999999999999998877766543 4468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
||.+|||+++||.+
T Consensus 255 ~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDH 269 (592)
T ss_pred CCcccCCCHHHHhcC
Confidence 99999999999976
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=389.27 Aligned_cols=246 Identities=32% Similarity=0.505 Sum_probs=218.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc-eE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~-l~ 601 (786)
+..+++..++.||+|..|+||++++ +++.+|+|++. -..+....+++.+|+++++.++||+||.+||+|..+.. ++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 4456778889999999999999988 48899999993 44566777999999999999999999999999999985 99
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||++|+|.+++. ..+.+++..+-.++.+|++||.|||+ ++||||||||+|||++..|.|||||||.+..+.+
T Consensus 155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999997 33679999999999999999999995 9999999999999999999999999999999876
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCCC----
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIPE---- 751 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~-----~~~~~l~~i~~~~~~~~ip~---- 751 (786)
. ...+.+||..|||||.+.+..|+.++||||||++++||++|+.||... ...+.+..+.. ...+..|.
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS 308 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFS 308 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCC
Confidence 5 557899999999999999999999999999999999999999999774 45555555554 44444554
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+++.+|..|++ ||.+||++.|+++|
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 369999999999 99999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=388.02 Aligned_cols=247 Identities=27% Similarity=0.519 Sum_probs=218.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.++||.|+||+||+|++ ++..||||.+.+..+..+..+.+..|+.+|+.++|||||.|++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999987 5789999999988888888899999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC------CeEEEEecCccccc
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------WTVKICDFGLSRII 678 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~------g~VKL~DFGLA~~l 678 (786)
|||.||+|.++++ ..+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999998 45689999999999999999999999999999999999999865 46999999999998
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC----hHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE----GPL 754 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~----~~L 754 (786)
... ....+.||+|.|||||++..++|+.|+|+||+|+|||+|++|+.||...+..+....+.......+.++ ..+
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 754 345688999999999999999999999999999999999999999999999888876665555444433 245
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+|+...++ +|..|.++.+...+
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhh
Confidence 677777777 88888877765543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=384.39 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=221.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+.+.||+|+||+||+++. +++-||+|++++..... ...+....|..+|..++||.||+++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 4568999999999999999999965 68899999998776633 35678889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+|+||+.||.|+.+|+ +.+.+++..++-|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++.....
T Consensus 102 lVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999997 5678999999999999999999999999999999999999999999999999999976555
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCC-CChHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEI-PEGPLGRLIA 759 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~i-p~~~L~~LI~ 759 (786)
.....+.|||+.|||||++.+..|+..+|.||||+++|||++|.+||.+.+.......+..... .++. -+...++|+.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 5556678999999999999999999999999999999999999999999999999998887662 2222 3457899999
Q ss_pred Hhhh-CCCCCC----CHHHHHH
Q 003919 760 DCWA-EPQERP----SCEEILS 776 (786)
Q Consensus 760 ~CL~-DP~kRP----Sa~EIL~ 776 (786)
++++ ||.+|. ++.+|.+
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhc
Confidence 9999 999995 4555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.46 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=211.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-----HHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-----ENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
.+.|.+.+.||+|+||.|-+|.. +|+.||||++.+..... .......+|+++|++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 46788899999999999999976 68999999997765432 122345699999999999999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC---CeEEEEecCccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSR 676 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~ 676 (786)
.||||||+.||.|++.+- .++.+.+..-+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999987 56788888889999999999999999999999999999999876 789999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC--
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP-- 750 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~ip-- 750 (786)
.... .....+.||||.|.|||++.++. +..+.|+||+||+||-+++|.+||.+..... ...++....+....+
T Consensus 328 ~~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGE-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 9874 44667899999999999997654 3358899999999999999999998877666 555555444433322
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+....+||..||. ||++|||+.++|+|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3357789999999 99999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=379.26 Aligned_cols=252 Identities=29% Similarity=0.524 Sum_probs=223.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEec-ccccCCc-eEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG-ACTKPPR-LSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g-~~~~~~~-l~L 602 (786)
..+|.+.++||+|.||+||++.. +|..+|.|.++...++....+....|+.+|++|+|||||++++ -+.+++. +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46789999999999999999965 7999999999988888888899999999999999999999998 3444444 899
Q ss_pred EEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhh--cc--eeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 603 ITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHR--MK--IVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs--~g--IIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
|||||.+|+|..+++.. ..++.+++..+++++.|++.||..||+ .+ |+||||||.||+|+.+|.|||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999998644 345679999999999999999999999 55 99999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGP 753 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip----~~~ 753 (786)
+........+.+|||.||+||.+...+|+.|+||||+||++|||+.-+.||++.+-..+...+.+. ..+++| +..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcHHHhhhH
Confidence 988777778899999999999999999999999999999999999999999999888887777665 444455 446
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
+..||..|+. ||..||+...+++.+.
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHHHHH
Confidence 9999999999 9999999666655544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=382.87 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=220.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
....+|..++.||+|+|++|++|+. .++.||||++.+..+. ...++-+..|-.+|.+| .||.|++||..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3468999999999999999999976 6889999999766553 33356677899999999 799999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+|+||+++|.|.++++ +.+.|++..++.++.||+.||+|||++|||||||||+|||||.++++||+|||-|+.+..
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999998 557999999999999999999999999999999999999999999999999999998854
Q ss_pred CCCC---------C----CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Q 003919 681 SPMR---------D----SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL 747 (786)
Q Consensus 681 ~~~~---------~----~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~ 747 (786)
.... . ..++||..|.+||+|..+..+..+|||+||||||+|+.|.+||.+.+.-.+.+.+....+.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 2111 1 34789999999999999999999999999999999999999999999988888887655544
Q ss_pred CCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 EIP-EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~ip-~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.- +....+||+++|. ||.+|+++++|.+|
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 321 3468899999999 99999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=385.99 Aligned_cols=262 Identities=36% Similarity=0.701 Sum_probs=228.4
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..++|++..+++.++..||+|.||+||+|.|.| .||||++.......+..+.|++|+.++++-+|.||+-|.|||..++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 348899999999999999999999999999998 5999999999999999999999999999999999999999999887
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
. .||+-+|.|-+|+.+++. ....+...+.+.|+.||+.||.|||.++|||||||..||+|.+++.|||+||||+..-
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred e-eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 6 999999999999999984 4478999999999999999999999999999999999999999999999999998654
Q ss_pred cC--CCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 679 TD--SPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 679 ~~--~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
.- .........|...|||||+++- .+|++.+|||||||++|||+||..||.....+++++.+-.+...+...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 21 1222234457788999999964 579999999999999999999999999777777776665543233221
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
...+++|+..||. ++++||.+.+||..|+++..+
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2368999999999 999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.45 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=213.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|..+.++|+|+||+||++++ +|+.||||++.....++..-+-.++|+.+|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677788999999999999977 68999999998776666666778899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
||+..-|.++-+ ....++...+..|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+..+....
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999855555443 44578899999999999999999999999999999999999999999999999999998666666
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 003919 686 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------- 745 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------------- 745 (786)
+.++.|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|++.+.-..++.+...-.
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 78899999999999987 7899999999999999999999999999988877776653211
Q ss_pred CCCCCC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RLEIPE-------------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~~ip~-------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+++.|. ..+-+|++.|++ ||.+|++.++++.|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 135689999999 99999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=374.39 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=217.7
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC---hHHHHHHHHHHHHHhhcC-CCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR-HPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~---~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~ 599 (786)
....|.+++.||+|+||+|++|.+ .|..||+|++..+... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457899999999999999999977 6899999977654221 123456668999999999 9999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRII 678 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l 678 (786)
+|+||||+.||.|++++. ..+.+.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999997 35788999999999999999999999999999999999999999 99999999999987
Q ss_pred cCCCCCCCCCCCCCcccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEP-FT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPL 754 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~-~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--~~~L 754 (786)
........+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+...+.......+.. ...+
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 43334567899999999999999987 86 78999999999999999999999988888887766555444432 5578
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..|+.+|+. ||.+|+++.+|+.+
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhC
Confidence 999999999 99999999999954
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.33 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=211.9
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 594 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~ 594 (786)
|.+..++|.+.++||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.++..+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 567778999999999999999999964 24579999986433 233457799999999999 899999999988
Q ss_pred ccC-CceEEEEEeeccchhHHHHHhhcC----------------------------------------------------
Q 003919 595 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 621 (786)
Q Consensus 595 ~~~-~~l~LV~Ey~~gGSL~dlL~~~~~---------------------------------------------------- 621 (786)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 458999999999999999864211
Q ss_pred -------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCC
Q 003919 622 -------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTP 692 (786)
Q Consensus 622 -------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~ 692 (786)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... ......+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999999999999999999999999999999986543211 112334667
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 767 (786)
.|+|||++.+..++.++|||||||+||||++ |..||.+.............+.....+ ...+.+|+.+||. ||.+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 320 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 8999999999999999999999999999997 999998765444443444434333333 3468999999999 9999
Q ss_pred CCCHHHHHHHHHhhhh
Q 003919 768 RPSCEEILSRLLDCEY 783 (786)
Q Consensus 768 RPSa~EIL~~L~~i~~ 783 (786)
|||+.+|++.|+++..
T Consensus 321 RPs~~el~~~l~~~~~ 336 (338)
T cd05102 321 RPTFSALVEILGDLLQ 336 (338)
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.42 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=221.4
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.++++||+|+||.||+|+. +|..+|+|++++..+ ....++.+..|-.+|....+|+||+||..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3568999999999999999999965 688999999987775 4456788899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
|||||++||++..+|. ..+.|++..++.++.+++-||+.+|++|+|||||||+|+|||..|++||+||||+..+...
T Consensus 218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999997 5679999999999999999999999999999999999999999999999999998643210
Q ss_pred ----------------------CCC-------------------------CCCCCCCCcccCccccccCCCCchhhHHHH
Q 003919 682 ----------------------PMR-------------------------DSSSAGTPEWMAPELIRNEPFTEKCDIFSL 714 (786)
Q Consensus 682 ----------------------~~~-------------------------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSL 714 (786)
... ....+|||.|+|||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 023479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-----HHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003919 715 GVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-----PLGRLIADCWAEPQERP---SCEEILSR 777 (786)
Q Consensus 715 GvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~-----~L~~LI~~CL~DP~kRP---Sa~EIL~~ 777 (786)
|||+|||+.|.+||.+.++.++...+.+....+..|.+ +..+||.+|+.||++|. .++||.+|
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999988877766643 68899999999999996 47776654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.50 Aligned_cols=265 Identities=32% Similarity=0.541 Sum_probs=214.3
Q ss_pred CCccccccccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecc
Q 003919 515 KPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593 (786)
Q Consensus 515 ~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~ 593 (786)
...+++.++..++++|...+.||+|+||.||+|... |+.||||++....... ..+|.+|+.++.+++|||+|+|+||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 355788999999999999999999999999999874 5899999876544432 3569999999999999999999999
Q ss_pred cccCC-ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc---eeeccCCcccEEEcCCCeEEE
Q 003919 594 CTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNKHWTVKI 669 (786)
Q Consensus 594 ~~~~~-~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g---IIHrDLKpsNILLd~~g~VKL 669 (786)
|.+.+ ..++||||+++|+|.++|+..... .++|.++.+|+.++|+||+|||... |||||||++|||||+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99998 499999999999999999843322 8999999999999999999999853 999999999999999999999
Q ss_pred EecCccccccCCCCCCCCC-CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHHh
Q 003919 670 CDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---P---ERVVYAVAN 742 (786)
Q Consensus 670 ~DFGLA~~l~~~~~~~~~~-~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~---~---~~~l~~i~~ 742 (786)
+|||+|+............ .||.+|+|||++..+..+.|+||||||++|+||+||+.|..... . .........
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999997654311222223 89999999999999999999999999999999999998876432 1 111111222
Q ss_pred cCCCC----------CCCC-hH---HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 743 EGSRL----------EIPE-GP---LGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 743 ~~~~~----------~ip~-~~---L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+... ..+. .. +..+..+|++ +|.+||+|.+|++.|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 21111 1111 22 4457788999 9999999999999996543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.52 Aligned_cols=244 Identities=27% Similarity=0.476 Sum_probs=212.8
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCceEEEEEeec
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEYME 608 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~l~LV~Ey~~ 608 (786)
..||+|+++.||+|.++|+.||||++...... ....+.|.+|+.+|++++|||||++++++.+ ...++++|||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 57999999999999999999999998655433 2335788899999999999999999999866 356899999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
+|+|.+++. ....+++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||++..+.... ..
T Consensus 106 ~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 999999997 34578899999999999999999998 599999999999999999999999999998764432 24
Q ss_pred CCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 688 SAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......+..+ +..+.+|+.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568899999999976 679999999999999999999999999988887777776665555554 346999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhh
Q 003919 763 A-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+ ||++|||+.++++.|+++.+
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9 99999999999999998865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=378.74 Aligned_cols=246 Identities=28% Similarity=0.493 Sum_probs=225.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||+|.. +.+.||+|.+.+........+.+.+|+++++.++|||||.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6789999999999999999955 67789999998887777788999999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.| +|+.++. ..+.+++++++.++++++.||.|||+++|+|||+||.|||++.+|++|+||||+|+.+.......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9987 9999997 56789999999999999999999999999999999999999999999999999999998776677
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHHhhh-
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIADCWA- 763 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~~CL~- 763 (786)
+...|||.|||||++.+++|+..+|+||+|||+|||++|++||....--+.+..|......++.. ...+.+++..++.
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 78899999999999999999999999999999999999999999988888888877665544432 3468999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003919 764 EPQERPSCEEILSR 777 (786)
Q Consensus 764 DP~kRPSa~EIL~~ 777 (786)
||..|.+..+++.|
T Consensus 238 dP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGH 251 (808)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.51 Aligned_cols=249 Identities=34% Similarity=0.547 Sum_probs=210.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC--ceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~--~l~L 602 (786)
..++..++.||+|+||.||++.+. |...|||......... .+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 355777899999999999999874 7899999987653222 677899999999999999999999855544 5999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCccccccC-
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITD- 680 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~- 680 (786)
+|||+++|+|.+++...+ ..+++..++.++.||++||+|||++||||+||||+|||++. ++.+||+|||+++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999997432 27999999999999999999999999999999999999999 79999999999987763
Q ss_pred --CCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCCCh---H
Q 003919 681 --SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRLEIPEG---P 753 (786)
Q Consensus 681 --~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~-~~~~~~l~~i~~~~~~~~ip~~---~ 753 (786)
.........||+.|||||++.++ ....++|||||||++.||+||+.||.. ......+..+......+.+|+. .
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11223457899999999999953 334599999999999999999999988 5666666666666656666643 6
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.++++..|+. ||++|||+.++|+|--
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 8999999999 9999999999998843
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=349.88 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=216.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
...++|...+.||.|+||+|.+++. +|.-+|+|++.++.. ...+++...+|..+|+.+.||+++++++.|.+...+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 3468899999999999999999976 688999999977664 4455678889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
|||||++||.|+.+++ +.+.+++..++.++.||+.||+|||+++|++|||||+|||||++|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999998 5678999999999999999999999999999999999999999999999999999988653
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~~ 760 (786)
..+.||||.|+|||++..+.|+.++|.|+|||++|||+.|.+||...++..++..+.......+-. ...+++|+..
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 457899999999999999999999999999999999999999999999999999998766555432 4579999999
Q ss_pred hhh-CCCCC
Q 003919 761 CWA-EPQER 768 (786)
Q Consensus 761 CL~-DP~kR 768 (786)
+++ |-.+|
T Consensus 275 LL~vD~t~R 283 (355)
T KOG0616|consen 275 LLQVDLTKR 283 (355)
T ss_pred HHhhhhHhh
Confidence 999 88888
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=378.90 Aligned_cols=251 Identities=37% Similarity=0.634 Sum_probs=228.0
Q ss_pred cccccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 518 ~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
...+.|++.|+.+..++-||.|+-|-||+|+..++.||||++... -..+|.-|++|+||||+.|.|+|...
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 356889999999999999999999999999999999999986421 12478889999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++||||||..|-|...|+ ....++......|..+||.||.|||.+.|||||||.-||||..+..|||+|||-++.
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999999999999997 567888999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 754 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~L 754 (786)
..+. ...-.++||..|||||++++.+.++|+|||||||+||||+||..||.+.....++..+-.+...+++|.. -+
T Consensus 262 ~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 262 LSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence 7654 3345789999999999999999999999999999999999999999999988888888777777888754 48
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+-|+++||+ .|..||+|.+||.||.-.
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 889999999 999999999999998743
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.76 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=211.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||.||+|.+ +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4788999999999999999987 488999999865433 2234567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 9999999999986 3457899999999999999999999999999999999999999999999999999876442
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~CL~ 763 (786)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+. .+..+.+|+.+||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 23457899999999999988999999999999999999999999998887777766654432221 24468999999999
Q ss_pred -CCCCCCC-----HHHHHHH
Q 003919 764 -EPQERPS-----CEEILSR 777 (786)
Q Consensus 764 -DP~kRPS-----a~EIL~~ 777 (786)
||.+||+ ++++++|
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHccCCccCCHHHHhcC
Confidence 9999995 9999877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=374.10 Aligned_cols=244 Identities=32% Similarity=0.528 Sum_probs=220.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
..|....+||+|+.|.||.+.. .++.||||.+........ +-+++|+.+|+..+|+|||++++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4566778999999999999966 677899999976655443 668899999999999999999999998899999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|++||+|.+.+. ...+++.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.......
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999999996 3459999999999999999999999999999999999999999999999999999987766566
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p---~~~L~~LI~~C 761 (786)
.+.+|||+|||||++....|++|.||||||++++||+-|++||-..++.+.++.+..++..... + ...+++++.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 7889999999999999999999999999999999999999999999999999988877654432 2 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. |+.+|+++.++|+|
T Consensus 507 L~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcchhcCCCHHHHhcC
Confidence 99 99999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.32 Aligned_cols=246 Identities=22% Similarity=0.403 Sum_probs=212.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 368899999999999999999987 578899999875433 22345678999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+|||+.+++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999999999886 34578899999999999999999999999999999999999999999999999998764432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 761 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~C 761 (786)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+|+.+|
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 245799999999999999999999999999999999999999998887777666654432221 2245689999999
Q ss_pred hh-CCCCCCC-----HHHHHHH
Q 003919 762 WA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPS-----a~EIL~~ 777 (786)
|+ ||.+||+ +.+++.|
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcC
Confidence 99 9999986 7888866
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=358.11 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=224.3
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
..+|..+.++|.+...||.|..++||+|.. .+..||||++...+.+.. ++.+.+|+..|+.++||||++++..|..+
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 345667789999999999999999999977 688999999988877665 78999999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+|+||.||.+|++.+++... -...+++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~-~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTY-YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHH-ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999999744 345699999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCCC----CCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003919 678 ITDSPMRD----SSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 749 (786)
Q Consensus 678 l~~~~~~~----~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-- 749 (786)
+.+..... .+.+||+.|||||++.. ..|+.|+||||||++..||.+|+.||....+.+++...+++......
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 75543221 46689999999999654 36999999999999999999999999999999888777765543211
Q ss_pred --C-------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 --P-------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 --p-------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ ...++.++..|++ ||.+|||+++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 2258889999999 99999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.83 Aligned_cols=241 Identities=25% Similarity=0.383 Sum_probs=206.7
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+||.||++.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999977 588999999875433 2344567889999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 690 (786)
+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 9998886 3457899999999999999999999999999999999999999999999999999764333333345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003919 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 691 T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 768 (786)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......+ .-...+.+|+.+||. ||++|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9999999999999999999999999999999999999998877776666554433221 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003919 769 P-----SCEEILSR 777 (786)
Q Consensus 769 P-----Sa~EIL~~ 777 (786)
| ++.++++|
T Consensus 238 ~~~~~~~~~~ll~h 251 (323)
T cd05571 238 LGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 9 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=343.06 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||++.+ +++.||+|++..........+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3689999999999999999988 47789999987655544556788899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 684 (786)
|++++.+..+.. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++..+..... .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999887765543 345689999999999999999999999999999999999999999999999999987643321 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 746 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~------------------ 746 (786)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457899999999999888999999999999999999999999877654443332211000
Q ss_pred -CC--------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -LE--------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -~~--------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+ .-+..+.+|+.+||. ||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 012358899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.10 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=211.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+|.+.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 4789999998755332 234567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~ 154 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---Y 154 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---c
Confidence 9999999999986 345789999999999999999999999999999999999999999999999999986643 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---------ChHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---------EGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---------~~~L~ 755 (786)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.........+ ...+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999999999999999999999999999999999888777666555433222111 34688
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|+.+||. +|.+||++.+++++
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhC
Confidence 99999999 89999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=370.14 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=220.5
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcC-CCceeEEecccccCC
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 598 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~ 598 (786)
..+..++|.+.++||+|+||+|+++.. +++.||||++++... ....++..+.|..|+.... ||.+++++.+|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 456678999999999999999999977 567899999988775 5566889999999998885 999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
++|+||||+.||++.++. +.+.+++..++-|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999999965554 3568999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRL 757 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~L 757 (786)
-.......+.||||.|+|||++.+..|+..+|.|+|||+||||+.|+.||.+.+.+++...|.+.....++- ..+...|
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAI 598 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHH
Confidence 545556778999999999999999999999999999999999999999999999999999998877665543 4578899
Q ss_pred HHHhhh-CCCCCCCH
Q 003919 758 IADCWA-EPQERPSC 771 (786)
Q Consensus 758 I~~CL~-DP~kRPSa 771 (786)
+++++. +|++|.-+
T Consensus 599 l~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhccCcccccCC
Confidence 999999 99999744
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=373.80 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=221.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecc-ccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQ-DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~-~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.-|++++.||.|+.|.|-+|++ +|+.+|||++.+. .........+.+||-+|+.+.|||++++|++++++.++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467889999999999999988 7999999999766 445555678889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|.|++++- .++++++..+.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|.....+ ..
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 9999999999997 5678999999999999999999999999999999999999999999999999999876543 34
Q ss_pred CCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 762 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~CL 762 (786)
..+.||.|.|.|||++.+.+|+ .++||||.|||||.|+||+.||.+.+-..++..+..+.+.++- -....++|+.+|+
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 5688999999999999999985 7899999999999999999999999888888887765554431 1346899999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003919 763 A-EPQERPSCEEILSRL 778 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L 778 (786)
. ||.+|.|+++|++|-
T Consensus 248 ~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHP 264 (786)
T ss_pred ccCccccccHHHHhhCc
Confidence 9 999999999999984
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.98 Aligned_cols=247 Identities=27% Similarity=0.452 Sum_probs=213.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||+|.+. |+.||||++....... .....+..|+.++..++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999884 8899999987654322 44577889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999873 3678999999999999999999999999999999999999999999999999998765432
Q ss_pred ---------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003919 683 ---------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 735 (786)
Q Consensus 683 ---------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~ 735 (786)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 12234579999999999999999999999999999999999999999888777
Q ss_pred HHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC-HHHHHHH
Q 003919 736 VVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS-CEEILSR 777 (786)
Q Consensus 736 ~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS-a~EIL~~ 777 (786)
....+.........| +..+.+||.+|+.||.+||+ +.+++++
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence 766666522222222 45689999999999999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=357.37 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=211.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999987 588999999975433 2334567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999986 345799999999999999999999999999999999999999999999999999876532110
Q ss_pred -------------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003919 684 -------------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR 726 (786)
Q Consensus 684 -------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~ 726 (786)
.....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003919 727 PWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 777 (786)
Q Consensus 727 PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---a~EIL~~ 777 (786)
||.+.+.......+.........+ ...+.+||.+|+.+|.+|++ +.+++++
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcC
Confidence 999988877777666544433333 34688999999989999997 9999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.42 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=207.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.+ +++.||||++..... .......+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999977 578999999875433 2334567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999987 345789999999999999999999999999999999999999999999999999876432100
Q ss_pred ----------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003919 684 ----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 729 (786)
Q Consensus 684 ----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~ 729 (786)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003919 730 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA---EPQERPSCEEILSR 777 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~---DP~kRPSa~EIL~~ 777 (786)
+.........+........+| .....+++.+++. ++..||++++|++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 988887777766543333333 2357788877554 34467999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=368.75 Aligned_cols=266 Identities=33% Similarity=0.611 Sum_probs=231.6
Q ss_pred CccccccccccCCCeeEeeEEeecCcEEEEEEEEC---C--ee-EEEEEEec-cccChHHHHHHHHHHHHHhhcCCCcee
Q 003919 516 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN---G--TD-VAIKVFLE-QDLTAENMEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 516 ~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---G--~~-VAVKvl~~-~~~~~~~~~~f~~EI~iL~~L~HPNIV 588 (786)
.......|++.-++..+.++||+|+||+||+|... + .. ||||.... .....+..++|++|+++|++++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 44466789999999999999999999999999762 2 23 89998875 336677889999999999999999999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
+|||++.....+++|||+|+||+|.++|+.. ...++..+...++++.+.||+|||++++|||||.++|||++.++.+|
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999999999732 23699999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003919 669 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 747 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~ 747 (786)
|+||||++.............-+..|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+++.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 9999998765421111112235679999999999999999999999999999998 788999999999999988888888
Q ss_pred CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 EIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..|. ..+..++.+||. +|+.||+|.++.+.|+.+..
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 7764 368889999999 99999999999999988764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=334.86 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=212.1
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
++..+|++.+.||+|+||.||+|.++ +..||+|++.... .......|.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45678999999999999999999752 5689999986543 23445789999999999999999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999863 23578999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 680 DSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 680 ~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. +...+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHH
Confidence 2211 1112345678999999999999999999999999999775 9999998887776665543 3333333 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+++.+||+ +|.+||++.+|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=340.59 Aligned_cols=254 Identities=32% Similarity=0.533 Sum_probs=206.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC------------------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~------------------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI 587 (786)
...+|.+.++||+|+||.||+|.++ +..||+|++.... .......|.+|+.++.+++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3568999999999999999999752 3369999986543 34446789999999999999999
Q ss_pred eEEecccccCCceEEEEEeeccchhHHHHHhhc----------------CCccchHHHHHHHHHHHHHHHHhhhhcceee
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG----------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~----------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIH 651 (786)
+++++++.+.+..+++|||+.+++|.+++.... ....+++..++.++.||+.||+|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886321 1134788899999999999999999999999
Q ss_pred ccCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 003919 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRP 727 (786)
Q Consensus 652 rDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT--G~~P 727 (786)
|||||+|||++.++.+||+|||++..+..... ......++..|+|||++.+..++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986643321 1123445788999999998889999999999999999987 5678
Q ss_pred CCCCChHHHHHHHHh----cCC-----CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 728 WEGVLPERVVYAVAN----EGS-----RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 728 F~~~~~~~~l~~i~~----~~~-----~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
|...........+.. ... .....+..+.+|+.+||. ||.+|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 887766655443321 111 111123468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.65 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=206.2
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 588999999875432 2344567889999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 690 (786)
+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............|
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9998886 3457899999999999999999999999999999999999999999999999998764333333345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003919 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 691 T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 768 (786)
|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......+ .-...+.+|+.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 9999999999999999999999999999999999999998887776666654433222 224578999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003919 769 P-----SCEEILSR 777 (786)
Q Consensus 769 P-----Sa~EIL~~ 777 (786)
| ++.+++++
T Consensus 238 ~~~~~~~~~~~l~h 251 (323)
T cd05595 238 LGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCHHHHHcC
Confidence 8 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.75 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=204.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..++|.+.++||.|+||+||+|.. +++.||+|++...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 357899999999999999999977 5788999998644322 2235678999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EeCCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 999985 88887753 234578899999999999999999999999999999999999999999999999987644333
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003919 684 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 747 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~--------------- 747 (786)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+.+..+......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 3345678999999999865 568999999999999999999999998877666554443211100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+....+|+.+|++ ||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0012357789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.24 Aligned_cols=247 Identities=23% Similarity=0.289 Sum_probs=203.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|.+.+.||+|+||+||++.+ +|+.||+|++...... ......+.+|+.+++.++|+||+++++++.+.+.++++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999976 6889999998755432 2233568899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.||+||||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 99999998877532 23468999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCC---CChHHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLEI---PEGPLGRLIAD 760 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~--~~~~~~i---p~~~L~~LI~~ 760 (786)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....... ....+.+|+.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 356789999999999999999999999999999999999999987654322221111 1111112 23468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003919 761 CWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPS-----a~EIL~~ 777 (786)
||. ||.+||+ +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 999 9999997 8999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.41 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=227.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+.+.||+|.||.|.++.. .|+.||||.+.+... +..++-.+.+||+||..|+||||+.+|.+|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36788999999999999999965 699999999987765 455567888999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||..+|.|++++. ..+.|++..++.++.||..|+.|||.++++|||||.+|||||+++++||+||||+..+.+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 99999999999997 56789999999999999999999999999999999999999999999999999999887654
Q ss_pred CCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL 762 (786)
..+++||+|.|.+||++++.+|. +..|-|||||+||.|+.|..||.+.+-..++.++..+.++.+-.+....-||+.||
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWML 287 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHH
Confidence 44689999999999999999985 78999999999999999999999999999999998888877666667888999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003919 763 A-EPQERPSCEEILSRL 778 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L 778 (786)
. ||.+|.|+++|..|-
T Consensus 288 mVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHW 304 (668)
T ss_pred hcCcccchhHHHHhhhh
Confidence 8 999999999999874
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.28 Aligned_cols=239 Identities=22% Similarity=0.405 Sum_probs=204.1
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||+|+||+||++.+ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999987 477899999865432 334457788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99886 345789999999999999999999999999999999999999999999999999986543333334567999
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCCC-
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQERP- 769 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kRP- 769 (786)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+|+.+||. ||.+||
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 99999999999999999999999999999999999998887777666655433222 224568999999999 999997
Q ss_pred --CHHHHHHH
Q 003919 770 --SCEEILSR 777 (786)
Q Consensus 770 --Sa~EIL~~ 777 (786)
++.++++|
T Consensus 238 ~~~~~e~l~h 247 (312)
T cd05585 238 YNGAQEIKNH 247 (312)
T ss_pred CCCHHHHHcC
Confidence 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=381.51 Aligned_cols=262 Identities=32% Similarity=0.563 Sum_probs=228.4
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEe
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~ 591 (786)
.....++..++....+.||+|+||+||+|... .+.||||.++.... ....++|.+|++++..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34566677899999999999999999999652 45699999876544 44578999999999999999999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC-----------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-----------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
|+|.+++.++||+|||..|+|..+|..... ..+|+..+.+.|+.|||.||+||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999999999999999999999999974321 223889999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCCCC--CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003919 661 VNKHWTVKICDFGLSRIITDSPMRDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 737 (786)
Q Consensus 661 Ld~~g~VKL~DFGLA~~l~~~~~~~~--~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l 737 (786)
|.++..|||+||||++......|... ...-..+|||||.+..++|+.++|||||||+|||+++ |+.||++..+++++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999999998766554432 3345679999999999999999999999999999996 78899999999999
Q ss_pred HHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 738 YAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 738 ~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+..... +..|+. .++.||..||+ +|.+||+|.||-..|++..
T Consensus 716 e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 716 ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 88766554 777754 69999999999 9999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.77 Aligned_cols=249 Identities=20% Similarity=0.368 Sum_probs=214.2
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC---CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~---G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..+..++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456789999999999999999999763 35799999865433 2334577889999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+.+|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999987 3457899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRL 757 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip~~~L~~L 757 (786)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+....... ...+..+.++
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 432 235679999999999999889999999999999999999999999888877766666543322 2224568999
Q ss_pred HHHhhh-CCCCCC-----CHHHHHHH
Q 003919 758 IADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
+.+|+. ||.+|+ +++++++|
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999 999995 89999876
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.05 Aligned_cols=261 Identities=28% Similarity=0.519 Sum_probs=215.5
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
...|.+..++|.+++.||+|+||+||+|.+ .+..||||++..... ....+.+.+|+.++..+ +|||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 345667778999999999999999999964 245799999864432 23356789999999999 899999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC--------------------------------------------------
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 621 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 621 (786)
++|...+..++||||+++|+|.+++.....
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 999999999999999999999988863211
Q ss_pred ----------------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 622 ----------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 622 ----------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1247888999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC---CChH
Q 003919 680 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI---PEGP 753 (786)
Q Consensus 680 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~ 753 (786)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...............+..... .+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 33211 112335567999999999999999999999999999998 88899887665555555555444333 3457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+.+|+.+||+ ||++||++.+|++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.03 Aligned_cols=241 Identities=25% Similarity=0.388 Sum_probs=205.5
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 588999999875433 3344578889999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 690 (786)
+|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9998886 3457899999999999999999999999999999999999999999999999998764333233345679
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCC
Q 003919 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 691 T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kR 768 (786)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......+ .-...+.+|+.+||. ||.+|
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 9999999999998999999999999999999999999988877666655543332221 123468999999999 99999
Q ss_pred C-----CHHHHHHH
Q 003919 769 P-----SCEEILSR 777 (786)
Q Consensus 769 P-----Sa~EIL~~ 777 (786)
+ ++.+++++
T Consensus 238 ~~~~~~~~~~il~h 251 (328)
T cd05593 238 LGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCCHHHHhcC
Confidence 7 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.69 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=211.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCC-ceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP-RLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~-~l~L 602 (786)
.++|.+.++||.|.||.||+|+. .|..||||.++++....+. -.=++|+..|++|+ |||||++.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 57899999999999999999976 6889999998776655433 23357999999998 999999999999888 8999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
|||||+ .+|+++++. .++.+++..++.|++||++||+|+|++|+.|||+||+|||+..+..+||+|||||+.+...+
T Consensus 88 VfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999998 599999974 37899999999999999999999999999999999999999989999999999999886543
Q ss_pred CCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------------
Q 003919 683 MRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI------------ 749 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i------------ 749 (786)
..+.++.|.+|+|||++. .+.|+.+.|+|++|||++|+++-++-|.|.+..+.++.+..--..+..
T Consensus 165 -PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 165 -PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred -CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 346889999999999875 567999999999999999999999999999988888777642222211
Q ss_pred --------C-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 --------P-----------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 --------p-----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ .....+||.+|+. ||.+|||+.+.|++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 1235678999999 99999999999976
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=335.72 Aligned_cols=255 Identities=34% Similarity=0.591 Sum_probs=213.7
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECC-------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+..++|++.+.||+|+||.||+|...+ ..+|+|.+.... .......|.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345689999999999999999997632 469999886443 334457799999999999999999999999988
Q ss_pred CceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~ 664 (786)
...+++|||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 899999999999999999864321 1458889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003919 665 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 741 (786)
Q Consensus 665 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~ 741 (786)
+.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543221 1233456788999999988889999999999999999998 999999888877666554
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 742 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 742 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
. ......+ +..+.+|+.+||+ ||.+||++.+|+++|+++
T Consensus 241 ~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 S-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred c-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 3 3333333 3479999999999 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=330.14 Aligned_cols=254 Identities=30% Similarity=0.555 Sum_probs=215.4
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|.+..++|++.++||+|+||.||+|.+ +++.||+|.+..... ..+.|.+|+.+++.++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 567788999999999999999999977 567899998764332 3478999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999998643 3456888999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHH
Q 003919 682 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGR 756 (786)
Q Consensus 682 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~L~~ 756 (786)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.... ..+. .+..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RMPRMENCPDELYD 235 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 221 123345678999999988889999999999999999998 999998887777666655432 2222 1346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+||. +|++||+++++++.|+++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.30 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=197.4
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----CceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~l~ 601 (786)
+|.+.+.||+|+||.||+|++ +|+.||||++............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 578999999865433334456789999999999999999999987543 2489
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+. ++|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999996 57888775 3456899999999999999999999999999999999999999999999999999865322
Q ss_pred C---CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q 003919 682 P---MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------- 743 (786)
Q Consensus 682 ~---~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~------------- 743 (786)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 11234579999999999876 67899999999999999999999999876543322211110
Q ss_pred -------------CCCCC------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -------------GSRLE------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -------------~~~~~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..... .-+..+.+++.+||. ||++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 012347789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.31 Aligned_cols=262 Identities=28% Similarity=0.539 Sum_probs=216.8
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
.+.|.+..++|.+++.||+|+||.||+|++. +..||||++..... ....+.+.+|+.+++.+ +|+|||+++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 4567777889999999999999999998752 24799999865443 23457789999999999 899999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC--------------------------------------------------
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 621 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 621 (786)
++|...+.++++|||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 999999999999999999999998853211
Q ss_pred -----------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 622 -----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 622 -----------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||++..+.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 12478889999999999999999999999999999999999999999999999986543221
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...............+.....+ +..+.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112335568999999998899999999999999999997 999998876655555555544433333 35799999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 759 ADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+||+ ||.+||++.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.73 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=211.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~L 602 (786)
.+.|..+.+||+|.||.||++++ +|+.||+|++..............+||.||++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 46688889999999999999987 688899999988877777778888999999999999999999998776 67999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
|+|||+. +|.-++. ...-.+++.+++.|+.||+.||+|||.+||+|||||.+|||||++|.+||+|||||+++....
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999997 6776664 345689999999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------CCC--
Q 003919 683 MR-DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------EIP-- 750 (786)
Q Consensus 683 ~~-~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~--------~ip-- 750 (786)
.. .+..+-|.+|.|||++.+. .|+..+|+||.||||.||++|++.|++.+..+.+..|...-..+ .+|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 32 5677889999999999874 79999999999999999999999999998887777665422111 111
Q ss_pred --------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 --------------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 --------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+...-+|+..+|. ||.+|.|+.+.|+.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0123357888999 99999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=334.43 Aligned_cols=245 Identities=34% Similarity=0.644 Sum_probs=203.3
Q ss_pred eEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 531 TVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++.+.||.|.||.||+|.+. +..|+||++.. .......+.|.+|++.+++++||||++++|++...+.+++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999886 67899999854 344455789999999999999999999999999888899999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++|+|.+++... ....+++.++..++.||+.||+|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999743 346789999999999999999999999999999999999999999999999999987732211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
..........|+|||.+.+..++.++||||||+++|||++ |+.||...........+ ....+...+ +..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHH
Confidence 1223446678999999999889999999999999999999 68999998888877776 444444443 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L 778 (786)
.+||. ||.+||++.+|++.|
T Consensus 239 ~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHT-SSGGGS--HHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHhcC
Confidence 99999 999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.81 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=207.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|++.+.||+|+||+||++.+ .++.||||++..... .....+.+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 578999999865432 2233567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC---
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--- 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~--- 681 (786)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999986 3457889999999999999999999999999999999999999999999999997532100
Q ss_pred ----------------------------------------CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHH
Q 003919 682 ----------------------------------------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721 (786)
Q Consensus 682 ----------------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~EL 721 (786)
.......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003919 722 CTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERP---SCEEILSR 777 (786)
Q Consensus 722 lTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRP---Sa~EIL~~ 777 (786)
++|+.||.+.........+.........+ ...+.+++.+|+.+|.+|+ ++.++++|
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCC
Confidence 99999999888777666655433333332 2357788888877999999 99999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.84 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=207.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.+ +++.||||++..... .....+.+.+|+++++.++|||||++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999977 688999999865432 3344577889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999886 34578899999999999999999999999999999999999999999999999986432100
Q ss_pred -----------C----------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHH
Q 003919 683 -----------M----------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 717 (786)
Q Consensus 683 -----------~----------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 717 (786)
. .....+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCC---CCCHHHHHHH
Q 003919 718 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQE---RPSCEEILSR 777 (786)
Q Consensus 718 L~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~k---RPSa~EIL~~ 777 (786)
+|||++|..||.+.........+.........| ...+.+|+.+|+.+|.+ |+++.+++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcC
Confidence 999999999999888777666665544334433 24688999999986655 5699999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=354.57 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=206.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+.|.+++.||+|+||+||+|.+ +++.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 577899999976543 3345678999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999986 34568899999999999999999999999999999999999999999999999975431100
Q ss_pred ---------------------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHH
Q 003919 683 ---------------------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 717 (786)
Q Consensus 683 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 717 (786)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhh--h-CCCCCCCHHHHHHH
Q 003919 718 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCW--A-EPQERPSCEEILSR 777 (786)
Q Consensus 718 L~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL--~-DP~kRPSa~EIL~~ 777 (786)
+|||++|+.||...........+........++ ...+.+|+.+|+ . ++..||++.++++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999887766666655433333333 346788888754 3 66679999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=336.25 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc---CCCceeEEecccc-----c
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 596 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~-----~ 596 (786)
++|.+.+.||+|+||+||+|.+ .++.||+|++............+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4688999999999999999976 367899999875544333345667788887766 6999999999874 3
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...++++|||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 456899999997 5888887632 33468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 747 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~--------- 747 (786)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.+......+..+......+
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 76543 23345678999999999998889999999999999999999999999887766665554321100
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..-+..+.+|+.+||+ ||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012346789999999 99999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=355.81 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=207.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+.|.+.+.||+|+||+||+|.+ +++.||+|++..... .....+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 3688999999999999999987 578899999875433 2344567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999886 33568899999999999999999999999999999999999999999999999975331000
Q ss_pred ---------------------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHH
Q 003919 683 ---------------------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVI 717 (786)
Q Consensus 683 ---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvI 717 (786)
......+||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00123469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003919 718 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERPS---CEEILSR 777 (786)
Q Consensus 718 L~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRPS---a~EIL~~ 777 (786)
||||++|+.||.+.++......+.........| .....++|.+|+.+|.+|++ +.++++|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcC
Confidence 999999999999888877776666544444333 23577888887679999987 8988875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=345.35 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=205.5
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHH---hhcCCCceeEEecccccCCceEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISIL---SRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL---~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
|.+.+.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 578999999875432 223345677777665 466799999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|...+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999988774 34689999999999999999999999999999999999999999999999999876433333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
.....+|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+.......+ .-+..+.+++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 34456799999999999999999999999999999999999999998888777776665443322 12456889999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003919 763 A-EPQERP-----SCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRP-----Sa~EIL~~ 777 (786)
. ||.+|| ++.+++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhC
Confidence 9 999999 67888765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.44 Aligned_cols=248 Identities=33% Similarity=0.600 Sum_probs=209.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+.++|.+.+.||+|+||.||++.++ +..+|+|.+...... .+.|.+|+.+++.++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4567899999999999999999874 558999987644333 357889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|.++++.. ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999999988632 246889999999999999999999999999999999999999999999999999866433222
Q ss_pred C-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003919 685 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 760 (786)
Q Consensus 685 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~--~~ip~~~L~~LI~~ 760 (786)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+...... +......+.+|+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1 22345568999999998889999999999999999999 89999988877777766543321 12223468999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L 778 (786)
||. +|.+||++.++++.|
T Consensus 237 c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 237 CWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.05 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=199.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.. +++.||||++...... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 5889999998654322 22346788999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+. ++|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9997 566666652 3456888999999999999999999999999999999999999999999999999765443333
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC----------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSR---------------- 746 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~---------------- 746 (786)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... .+..+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 345678999999999865 458899999999999999999999998754322 22221110000
Q ss_pred -----CCC------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -----LEI------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -----~~i------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ....+.+|+.+|++ ||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 01346789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=346.44 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=204.8
Q ss_pred eEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 534 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+.||+|+||.||++.. .++.||||++..... .......+.+|+.+++.++||||+++++++..++.+|++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 477899999875432 222345678999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+.+. ..+.+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999886 345688889999999999999999999999999999999999999999999999876543333334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-C
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-E 764 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-D 764 (786)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......+ .-...+.+|+.+||. |
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 56799999999999988899999999999999999999999998887777766655432221 123468999999999 9
Q ss_pred CCCCC-----CHHHHHHH
Q 003919 765 PQERP-----SCEEILSR 777 (786)
Q Consensus 765 P~kRP-----Sa~EIL~~ 777 (786)
|++|| ++.+++++
T Consensus 239 p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HhHcCCCCCCCHHHHhcC
Confidence 99999 88988875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.06 Aligned_cols=254 Identities=27% Similarity=0.491 Sum_probs=212.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccc-cChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~-~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||.||+|.. +++.||||.+.... ........|.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999976 68899999876533 34455577999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 605 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
||+++++|.+++.... ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999998885332 234688999999999999999999999999999999999999999999999999987654332
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC----ChHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP----EGPLGRL 757 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~--~~~l~~i~~~~~~~~ip----~~~L~~L 757 (786)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.. ...+..+ ...+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCCCChhhcCHHHHHH
Confidence 23345688899999999888899999999999999999999999965432 333333322 2222222 2468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+||. +|.+||++.++++.|+++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999 9999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.52 Aligned_cols=247 Identities=26% Similarity=0.497 Sum_probs=215.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|+||.||++.+ +++.|++|.+..........+.+.+|+.+++.++||||+++++++.+.+.++++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 578889999999999999987 588999999876666666778899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..+........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999999998743 345789999999999999999999999999999999999999999999999999987755443344
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...|++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+... ....++ +..+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG-VFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCccccCHHHHHHHHHHcc
Confidence 557889999999999988999999999999999999999999888766665555433 233333 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 239 KDYRQRPDTFQLLRN 253 (256)
T ss_pred CCcccCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=344.33 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=206.9
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCC-ceeEEecccccCCceEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHP-NVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HP-NIVkL~g~~~~~~~l~LV~ 604 (786)
+|.+.+.||+|+||.||+|.+. ++.||||++..... .....+.+..|+.++..+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999874 66899999875432 234457788999999999764 6889999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999998886 3456889999999999999999999999999999999999999999999999998754332223
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~ 763 (786)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 3456799999999999999999999999999999999999999998888777776665433221 224468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003919 764 -EPQERPSC-----EEILSR 777 (786)
Q Consensus 764 -DP~kRPSa-----~EIL~~ 777 (786)
||.+|++. .+++++
T Consensus 238 ~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcC
Confidence 99999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.55 Aligned_cols=254 Identities=31% Similarity=0.655 Sum_probs=215.0
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
|++...+|.+.+.||+|+||.||+|.+ .++.+|+|++.... ...+.+.+|+++++.++||||+++++++...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 567778899999999999999999977 47889999986432 2356799999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+|||+++++.+||+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 78 YIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEEeCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999988632 345689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003919 681 SPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 755 (786)
Q Consensus 681 ~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~ 755 (786)
...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+. .......+ +..+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 322211 2234568999999999999999999999999999998 899998877766555443 33333333 34799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 756 RLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+++.+||. ||++||++.++++.|+++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=326.71 Aligned_cols=254 Identities=30% Similarity=0.594 Sum_probs=214.5
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++..++|++.+.||+|+||.||+|.+ .++.||+|.+...... .++|.+|+.++++++||||+++++++...+.++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456778899999999999999999987 4668999998654332 467889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999998632 2346899999999999999999999999999999999999999999999999999877533
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
.... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+... .....+ ...+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 11223457999999998899999999999999999999 99999988877766655433 222222 357899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+|++ +|.+||++.+|++.|+++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=342.61 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=207.0
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+..++|.+.+.||+|+||.||++++ .|..+|+|++.... .....+.|.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999988 47789999986542 33445789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999986 345688999999999999999999986 6999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------------- 742 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~------------------- 742 (786)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22356789999999999999999999999999999999999999976554433221110
Q ss_pred --------------------------cCCCCCC----CChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 743 --------------------------EGSRLEI----PEGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 743 --------------------------~~~~~~i----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
....+.. -...+.+||.+||+ ||++|||+.+|+++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0011111 12468899999999 999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.11 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=211.8
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
|.+..++|++.+.||+|+||.||+|.+. +..+|+|++..... .....+|.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 5567789999999999999999998764 35799998754332 234567999999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcC-------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
.....+++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.|++|+||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 99999999999999999999864321 12467888999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003919 669 ICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~ 745 (786)
|+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999987654332211 12345678999999998889999999999999999999 6889988877766665554332
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
...+ ...+.+++.+||+ ||++|||+.++++.|++
T Consensus 240 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 -LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 2222 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=343.45 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=207.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+|.+.+.||+|+||+||+|.+ +++.||||++..... .....+.+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999987 467899999875432 233345677888888877 5899999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999998886 3456889999999999999999999999999999999999999999999999999765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~ 763 (786)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+ .....+.+|+.+|++
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 4456799999999999999999999999999999999999999999888877777665443222 124568899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003919 764 -EPQERPSC-----EEILSR 777 (786)
Q Consensus 764 -DP~kRPSa-----~EIL~~ 777 (786)
||.+|++. .+++++
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcC
Confidence 99999984 666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.57 Aligned_cols=241 Identities=24% Similarity=0.380 Sum_probs=205.2
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 688999999975443 2334567889999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
+|..++. ....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 9998886 34578999999999999999999997 7999999999999999999999999999876433323334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+|+.+||. ||++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 99999999999999999999999999999999999999998877766665554333222 224468999999999 9999
Q ss_pred CC-----CHHHHHHH
Q 003919 768 RP-----SCEEILSR 777 (786)
Q Consensus 768 RP-----Sa~EIL~~ 777 (786)
|+ ++.++++|
T Consensus 238 R~~~~~~~~~~il~h 252 (325)
T cd05594 238 RLGGGPDDAKEIMQH 252 (325)
T ss_pred hCCCCCCCHHHHhcC
Confidence 96 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=360.27 Aligned_cols=260 Identities=31% Similarity=0.670 Sum_probs=231.5
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.+++|+....++.+.++||-|.||+||.|+|+ .-.||||.++...+ .+++|+.|+.+|+.++|||+|+|+|+|..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 35899999999999999999999999999996 45799999876544 36899999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+|||+|||..|+|.++|... .+..++...++.++.||..||+||..+++|||||.+.|+|+.++..||++||||++
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999999865 35567888889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCh--
Q 003919 677 IITDSPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 752 (786)
Q Consensus 677 ~l~~~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~~~~~~~ip~~-- 752 (786)
++....+... ...-.+.|+|||.+....++.|+|||+|||+|||+.|. -.||.+.+..+ ++.++.+++++.-|++
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-VY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-HHHHHhccccccCCCCCC
Confidence 9987765432 33456789999999999999999999999999999874 56999987755 4567788999988865
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 753 -PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 753 -~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.++.||+.||+ .|..||++.+|-+.++++..
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 48999999999 99999999999999988754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.31 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=205.7
Q ss_pred eEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 534 TRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
+.||+|+||.||++.. .|+.+|+|++............+.+|++++++++||||+++++++.+.+.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 47899999997655444445678889999999999999999999999999999999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 688 (786)
+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999886 34578999999999999999999999999999999999999999999999999998765443333456
Q ss_pred CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCC
Q 003919 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQ 766 (786)
Q Consensus 689 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~ 766 (786)
.|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......+ .-+..+.+|+.+||+ ||.
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 799999999999988899999999999999999999999998888777766654433221 124568999999999 999
Q ss_pred CCCC-----HHHHHHH
Q 003919 767 ERPS-----CEEILSR 777 (786)
Q Consensus 767 kRPS-----a~EIL~~ 777 (786)
+||+ +.+++++
T Consensus 239 ~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 239 NRLGAGPDGVEEIKRH 254 (318)
T ss_pred HcCCCCCCCHHHHhCC
Confidence 9999 5556543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.02 Aligned_cols=243 Identities=31% Similarity=0.418 Sum_probs=197.6
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.+++|...+.||+|+||+||++.+ +++.||||++.... .....+.|.+|+++++.++|+||+++++++...+.++++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 456788889999999999999987 58899999986443 334457899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+.+++|.... ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999999886432 345677889999999999999999999999999999999999999999999987654333
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCC---CCh
Q 003919 684 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEI---PEG 752 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~---~l~~i~~~~~~~~i---p~~ 752 (786)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||....... ....+.. ...... ...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-SQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCCCccCH
Confidence 3345679999999998743 234568999999999999999999997433222 1111111 112222 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||++||++.|++++
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 69999999999 99999999999987
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.49 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=206.1
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ .++.||||++..... .....+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 467899999875432 233456788899999876 799999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
++|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99998886 345788999999999999999999999999999999999999999999999999976544333344567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.......+ .-+..+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 99999999999999999999999999999999999999999888887777765443322 124578999999999 9999
Q ss_pred CC-------CHHHHHHH
Q 003919 768 RP-------SCEEILSR 777 (786)
Q Consensus 768 RP-------Sa~EIL~~ 777 (786)
|| ++.+++++
T Consensus 238 R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 238 RLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCCCCCCCCHHHHhcC
Confidence 99 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.44 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=211.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.+ +|+.||+|++..... .....+.+..|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999987 588999999976543 3334567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999998732 35789999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----Ch
Q 003919 684 RDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EG 752 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~ 752 (786)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.........| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223357899999999986 4567899999999999999999999999888777766665543333222 34
Q ss_pred HHHHHHHHhhhCCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWAEPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~DP~kRPSa~EIL~~ 777 (786)
.+.+|+.+|+.+|.+||++.++++|
T Consensus 239 ~~~~li~~ll~~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLCGQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHccChhhCCCHHHHhCC
Confidence 6889999999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.44 Aligned_cols=241 Identities=24% Similarity=0.383 Sum_probs=204.6
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ +++.||||++..... .....+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 478899999875432 233456788899998877 699999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876533333344567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.......+ .....+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999999888877777665433222 224568999999999 9999
Q ss_pred CCCH------HHHHHH
Q 003919 768 RPSC------EEILSR 777 (786)
Q Consensus 768 RPSa------~EIL~~ 777 (786)
||++ +++++|
T Consensus 238 R~~~~~~~~~~~~~~h 253 (320)
T cd05590 238 RLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCCCHHHHHcC
Confidence 9998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=330.96 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=212.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.+|...++||+|.||.||+|.+ +|+.||||++.........--...+||..|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999987 68899999997766544444678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|++ .+|...++ .+...++..+++.++.++++||+|||.+.|+||||||.|+|++.+|.+||+|||+++.+..+....
T Consensus 82 fm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 998 58888886 456789999999999999999999999999999999999999999999999999999998765555
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------CC-----
Q 003919 686 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------IP----- 750 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------ip----- 750 (786)
...+-|.+|.|||.+.| +.|+...|+||.|||+.||+-|.+-|.+.+.-+.+..+...-..+. +|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 55688999999999977 4799999999999999999999999999887776666554322221 11
Q ss_pred ---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ---------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ---------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....-+|+.+++. ||.+|+++.|.|++
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1134578999999 99999999999976
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=363.96 Aligned_cols=335 Identities=27% Similarity=0.488 Sum_probs=257.0
Q ss_pred ccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCchhhhhh
Q 003919 424 FTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTW 503 (786)
Q Consensus 424 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~s~sS~~~~ss~~~~~s~~~s~~ 503 (786)
.++..+||++|+++|+|.+-++. + -.. +-++....++ ++|+-|..... +..+..+-. .+.....+
T Consensus 304 ssl~~aesmAdLiDGYcrL~n~~-~-------~~~-iih~~k~~e~--slp~iP~lal~--~~~s~~s~~--~~~etDdY 368 (974)
T KOG4257|consen 304 SSLELAESMADLIDGYCRLYNQR-D-------SSF-IIHPIKRGET--SLPAIPNLALT--MHESTISPK--TPNETDDY 368 (974)
T ss_pred ChhhHHHHHHHHHHHHHHHHcCC-C-------ceE-EEeccccccc--ccccccchhhh--ccccccCCC--CCCccchh
Confidence 34556699999999999996655 1 111 2222223333 67776665321 111111110 11122223
Q ss_pred hhhccCCccCCCCccccccccccCCCeeEeeEEeecCcEEEEEEEEC----Ce--eEEEEEEeccccChHHHHHHHHHHH
Q 003919 504 NKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN----GT--DVAIKVFLEQDLTAENMEDFCNEIS 577 (786)
Q Consensus 504 ~~il~sp~~~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~----G~--~VAVKvl~~~~~~~~~~~~f~~EI~ 577 (786)
..+... +....+...+++..+.+.+.+.||.|.||.||+|++. |. .||||..+.+. ...+.+.|+.|.-
T Consensus 369 AEI~de----ty~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~ 443 (974)
T KOG4257|consen 369 AEIGDE----TYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEAS 443 (974)
T ss_pred hhcccc----cccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHH
Confidence 222221 1112233456677788888899999999999999873 33 48888876544 4455789999999
Q ss_pred HHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 578 iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+|+++.|||||+++|+|.+.. .|+|||.++-|.|..+|+. ....|+......+++||+.||+|||+.++|||||...
T Consensus 444 iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaR 520 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAAR 520 (974)
T ss_pred HHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhh
Confidence 999999999999999998875 8999999999999999973 4567888999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 735 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~ 735 (786)
|||+.....|||+||||++.+.+..+... ...-+..|||||.++...++.++|||.|||.+||+++ |..||.+..+.+
T Consensus 521 NiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 521 NILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred heeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 99999999999999999999987765543 3345568999999999999999999999999999874 888999988877
Q ss_pred HHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 736 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 736 ~l~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
++-.+ .++.+++.|+. .++.|+.+||. +|.+||.+.+|...|.++.
T Consensus 601 VI~~i-EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 601 VIGHI-ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred eEEEe-cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 66544 56777777765 48899999999 9999999999999888764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.42 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=211.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChH------------HHHHHHHHHHHHhhcCCCceeEEe
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------------NMEDFCNEISILSRLRHPNVILFL 591 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~------------~~~~f~~EI~iL~~L~HPNIVkL~ 591 (786)
..++|.+++.||+|.||.|-++.+ +++.||||++.+...... ..+...+||.+|++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 467899999999999999999987 688999999976543221 246889999999999999999999
Q ss_pred cccccC--CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEE
Q 003919 592 GACTKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669 (786)
Q Consensus 592 g~~~~~--~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL 669 (786)
++..+. +.+|||+|||..|.+...-. ....+++.+++.|+.+++.||+|||.+|||||||||+|+||+++|+|||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 998765 56999999999988865432 2233999999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCC-----CCCCCCCCCCcccCccccccC---C-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 003919 670 CDFGLSRIITDSP-----MRDSSSAGTPEWMAPELIRNE---P-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740 (786)
Q Consensus 670 ~DFGLA~~l~~~~-----~~~~~~~GT~~Y~APEvl~~~---~-~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i 740 (786)
+|||.+....... ......+|||.|+|||...++ . .+.+.||||+||+||.|+.|+.||-+.....+...|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999998763321 112347899999999998763 2 357899999999999999999999999998888888
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 741 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 741 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.+....++.. ...+++||++||. ||+.|.++.+|..|..
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 8766544433 2368999999999 9999999999988754
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=351.93 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=213.4
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
.+....++|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4455678999999999999999999987 578999999865432 2233456789999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999998852 35788889999999999999999999999999999999999999999999999876
Q ss_pred cCCCC-CCCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 679 TDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 679 ~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........|
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 44322 22356799999999998653 47899999999999999999999999988877777766544333333
Q ss_pred --ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003919 751 --EGPLGRLIADCWA-EPQE--RPSCEEILSR 777 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 777 (786)
+..+.+||.+|+. +|.+ |+++.++++|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 3468899999999 8887 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.94 Aligned_cols=253 Identities=31% Similarity=0.605 Sum_probs=215.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
....+|++.++||.|+||.||+|.+ .++.+|+|++..... .....+.+|+.+++.++||||+++++++.+...++++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4456799999999999999999987 467899999865433 2346788999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++... ....+++.+++.++.||+.||+|||+.||+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999999743 345689999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
......++..|+|||.+....++.++||||||+++|+|++ |+.||...........+.. ......+ +..+.+++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHH
Confidence 3334456778999999988889999999999999999998 8999988877766665553 3333322 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhh
Q 003919 760 DCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+||+ ||.+|||+.+|++.|+++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhcC
Confidence 9999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.75 Aligned_cols=252 Identities=37% Similarity=0.595 Sum_probs=212.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..++|++.+.||+|+||.||+|.+. ...+|||++.... .......|.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3567999999999999999999873 3478999876443 344457899999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.++|+|||++..+..
T Consensus 81 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999863 234789999999999999999999999999999999999999999999999999988752
Q ss_pred CC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
.. .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ...+.+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHH
Confidence 21 11222345678999999998889999999999999999998 99999888777666655432 222222 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+|+.+||+ +|++||++.+|+++|.++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.19 Aligned_cols=241 Identities=23% Similarity=0.403 Sum_probs=201.0
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ +++.||||++..... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 467899999875432 223345667777777654 799999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999986544333444567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.......+ .....+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999999888777766654332221 124568899999999 9999
Q ss_pred CCCHH-HHHHH
Q 003919 768 RPSCE-EILSR 777 (786)
Q Consensus 768 RPSa~-EIL~~ 777 (786)
||++. +++++
T Consensus 238 R~~~~~~l~~h 248 (316)
T cd05592 238 RLGVDGDIRQH 248 (316)
T ss_pred cCCChHHHHcC
Confidence 99875 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=322.79 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=210.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC---hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~---~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
++|.+.+.||+|+||.||++.. .++.+|+|.+...... ....+.+.+|++++++++||||+++++++.+...+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 5889999998654332 2234678899999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
++||+++++|.+.+. ....+++..+..++.|++.||.|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999886 33568899999999999999999999999999999999999999999999999987653321
Q ss_pred CCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 683 MRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 683 ~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....................++ ...+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 111 23567889999999999889999999999999999999999998876666655555444444444 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
++.+||. +|.+||++.+++++
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhC
Confidence 9999999 99999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.58 Aligned_cols=244 Identities=26% Similarity=0.545 Sum_probs=206.2
Q ss_pred EEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 535 RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+||+|+||.||+|.+ ++..+|+|++..........+.|.+|+.+++.+.||||+++++++.. ...+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 46789999987665555667889999999999999999999998864 4678999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC---CCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DSS 687 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~~~ 687 (786)
+|.+++. ....+++..+..++.|++.||+|||++||+|+||||.||+++.++.+||+|||++..+...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999986 3346899999999999999999999999999999999999999999999999999876443221 122
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
..++..|+|||.+....++.++|||||||++|||++ |+.||...........+. .+..+..| +..+.+||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 334578999999988889999999999999999998 999999887766655544 33334443 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003919 764 -EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 764 -DP~kRPSa~EIL~~L~~i~~ 783 (786)
||++||++.+|.+.|+++.|
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYYY 257 (257)
T ss_pred cCchhCcCHHHHHHHHhcccC
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=328.38 Aligned_cols=254 Identities=28% Similarity=0.521 Sum_probs=211.4
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+.+++|++.+.||+|+||+||+|.+ .+..+|+|.+.... .......|.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3567899999999999999999974 35689999986433 3444578999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcC--------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQ--------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~--------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~ 664 (786)
..+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999998853211 2357889999999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003919 665 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 741 (786)
Q Consensus 665 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~ 741 (786)
+.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987643221 1223445678999999988889999999999999999998 899998887766555544
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 742 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 742 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
. ......+ +..+.+++.+||+ ||.+||++.+|+++|..
T Consensus 241 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 K-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred c-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3 3233333 3468999999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=327.47 Aligned_cols=255 Identities=31% Similarity=0.582 Sum_probs=214.2
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
|++..++|.+.+.||+|+||.||+|.+. +..+|+|.+.... .......|.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 4567789999999999999999999763 2579999975443 3334567899999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcC-------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
.....+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.||+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 99999999999999999999864321 23478889999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003919 669 ICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 669 L~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~ 745 (786)
|+|||+++.+..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...........+. .+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 999999987644322 1223456788999999988889999999999999999998 899999888777766655 333
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
....| +..+.+++.+||+ +|++|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 33333 3468999999999 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=325.03 Aligned_cols=251 Identities=31% Similarity=0.566 Sum_probs=206.1
Q ss_pred eeEeeEEeecCcEEEEEEEEC--Ce--eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------Cc
Q 003919 530 LTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 599 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~--G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~~ 599 (786)
|.+++.||+|+||.||+|.+. +. .+|+|.+..........+.|.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999873 32 589999876555566678899999999999999999999986432 24
Q ss_pred eEEEEEeeccchhHHHHHhhc---CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 600 LSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.++++||+.+|+|.+++.... ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 789999999999998774221 23458999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 677 IITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 677 ~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
.+...... .....+++.|++||.+.+..++.++|||||||++|||++ |+.||.+.........+.... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCC
Confidence 76543221 122346678999999999999999999999999999999 789998877766665554433 22222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
...+.+++.+||+ ||++|||+.+|++.|.++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.17 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=208.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.. .++.||||++..... .......+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999987 578999999875432 2344567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999986 34578999999999999999999999999999999999999999999999999987543210
Q ss_pred ---------------------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003919 683 ---------------------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE 729 (786)
Q Consensus 683 ---------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~ 729 (786)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhhCCCCCC---CHHHHHHH
Q 003919 730 GVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWAEPQERP---SCEEILSR 777 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~DP~kRP---Sa~EIL~~ 777 (786)
+.++......+........+| ...+.+||.+|+.||.+|+ ++.++++|
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcC
Confidence 988887777666544333332 3467888888767999998 47888766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=356.41 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=227.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc-eEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR-LSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~-l~LV 603 (786)
.++|.+++++|+|+||.++++.+ +++.+++|.+..............+|+.++++++|||||.+++.|.+++. ++|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 56889999999999999998866 57789999998887766666788999999999999999999999999998 9999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|+|++||+|.+.+.... +..++++++..|+.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999997543 67899999999999999999999999999999999999999999999999999999987665
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 760 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~ 760 (786)
...+..||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+....+..+..... .++| ...++.||..
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~-~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY-SPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC-CCCCccccHHHHHHHHH
Confidence 66789999999999999999999999999999999999999999999999999888877663 3333 4579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
|+. +|..||++.++|.+
T Consensus 241 ~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRR 258 (426)
T ss_pred HhhcCCccCCCHHHHhhC
Confidence 999 99999999999976
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.74 Aligned_cols=245 Identities=33% Similarity=0.530 Sum_probs=206.6
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|++++.||+|+||+||++.. +++.+|+|++..............+|+.++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78899999999999999988 4668999999877665555455667999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
.+++|.+++. ....+++..+..++.|+++||++||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 4567899999999999999999999999999999999999999999999999999865333334456
Q ss_pred CCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCC-----CChHHHHHH
Q 003919 688 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV---ANEGSRLEI-----PEGPLGRLI 758 (786)
Q Consensus 688 ~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i---~~~~~~~~i-----p~~~L~~LI 758 (786)
..++..|+|||.+. +..++.++||||||+++|+|++|..||...........+ ......... ....+.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 77899999999998 788999999999999999999999999987332222222 211111111 125799999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
..||+ ||++||++.+++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999 99999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=357.13 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=214.6
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC----
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP---- 598 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~---- 598 (786)
....+|.+.+.||+|+||+||++.+ +|+.||||++............+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999976 6889999999877666666778999999999999999999988764332
Q ss_pred ----ceEEEEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 599 ----RLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 599 ----~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.+++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 368999999999999988643 234578999999999999999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 674 LSRIITDS--PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 674 LA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
+++.+... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...... .++
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCC
Confidence 99876432 11233567999999999999999999999999999999999999999988877776666543332 222
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 --EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+.+|+.+||. ||.+||++.+++++
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3469999999999 99999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.60 Aligned_cols=241 Identities=24% Similarity=0.419 Sum_probs=204.4
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ +++.||||++..... .......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999875532 233456778899999888 699999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|...+. ....+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99998886 345789999999999999999999999999999999999999999999999999876433222334557
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ ..+..+.+||.+||. ||.+
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 89999999999999999999999999999999999999998887777666654433222 124578999999999 9999
Q ss_pred CCCH-----HHHHHH
Q 003919 768 RPSC-----EEILSR 777 (786)
Q Consensus 768 RPSa-----~EIL~~ 777 (786)
||++ .+++++
T Consensus 238 R~s~~~~~~~~ll~~ 252 (318)
T cd05570 238 RLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCCCCCCHHHHhcC
Confidence 9999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.92 Aligned_cols=251 Identities=31% Similarity=0.639 Sum_probs=214.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
|.+...+|.+.+.||.|+||.||++...|+.+|+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 345567899999999999999999999999999999865432 45789999999999999999999999998899999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+|||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999999998633 22368999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
.....+..|+|||.+....++.++||||||+++|+|++ |..||...........+.. ......+ +..+.+++
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHH
Confidence 13345568999999988889999999999999999997 9999988877666554443 3233322 35689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 759 ADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+||. +|.+||++.++++.|+++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 233 KDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhccChhhCcCHHHHHHHHhcC
Confidence 99999 999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.86 Aligned_cols=252 Identities=27% Similarity=0.547 Sum_probs=208.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..+|++.+.||+|+||.||+|.+ ++. .||+|++... ......+.|.+|+.+++.++||||++++++|... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46799999999999999999976 333 4899998643 2334457899999999999999999999999775 57
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 899999999999999873 234688899999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+... +.........+ ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCCCCCCHHH
Confidence 3221 122334678999999999999999999999999999997 999998877665443 33334333332 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+++.+||. +|.+||++.+++..|.++..
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 899999999 99999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=322.84 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=209.3
Q ss_pred eeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc-----
Q 003919 530 LTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 599 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~----- 599 (786)
|++++.||+|+||.||+|... +..+|+|++............+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999762 3679999987665555667889999999999999999999998866544
Q ss_pred -eEEEEEeeccchhHHHHHhhc---CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 600 -LSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 600 -l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
.++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+|+|+||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 799999999999998885332 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 676 RIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 676 ~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
+.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+... .....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcC
Confidence 8765432221 12235678999999988889999999999999999999 88999888777766555433 333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
...+.+++.+||. ||++||++.++++.|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.22 Aligned_cols=260 Identities=32% Similarity=0.589 Sum_probs=212.9
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 594 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~ 594 (786)
|++..++|++.+.||+|+||.||+|.+. ++.||+|++.... .....+.+.+|+.++.++ +|+||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 6777789999999999999999999642 3679999986433 233456788999999999 799999999987
Q ss_pred cc-CCceEEEEEeeccchhHHHHHhhcC----------------------------------------------------
Q 003919 595 TK-PPRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 621 (786)
Q Consensus 595 ~~-~~~l~LV~Ey~~gGSL~dlL~~~~~---------------------------------------------------- 621 (786)
.. ...+++++||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4568899999999999998863211
Q ss_pred ------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCc
Q 003919 622 ------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPE 693 (786)
Q Consensus 622 ------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~ 693 (786)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..... ......++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 13688999999999999999999999999999999999999999999999999987643221 1223445678
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCC
Q 003919 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 694 Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kR 768 (786)
|+|||++.+..++.++|||||||+||||++ |..||.+....+..............+ ...+.+++.+||+ +|++|
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999998 999998765544444444444443333 3468999999999 99999
Q ss_pred CCHHHHHHHHHhhhh
Q 003919 769 PSCEEILSRLLDCEY 783 (786)
Q Consensus 769 PSa~EIL~~L~~i~~ 783 (786)
|++.+|+++|.++..
T Consensus 321 Ps~~ell~~l~~~~~ 335 (337)
T cd05054 321 PTFSELVEILGDLLQ 335 (337)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.74 Aligned_cols=247 Identities=27% Similarity=0.466 Sum_probs=205.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||.||+|.+ +++.+|+|++..... .....+.+|+.+++.++||||+++++++...+.+++++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 678899999864432 23456889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.++++ ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..+......
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999999876443323
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------ChHHH
Q 003919 685 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip------~~~L~ 755 (786)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||....+......+.......... +..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 34456889999999884 3457889999999999999999999997665544333322222221111 34688
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
+++.+||. +|++||++++|+++|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999 999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=378.89 Aligned_cols=257 Identities=32% Similarity=0.596 Sum_probs=223.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE---CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW---NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~---~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
++.++.+..+.||+|+||+||.|.+ .|. .||||.+.+. .+.+...+|++|..+|+.++|||||+++|+|.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4567788899999999999999976 233 3888887543 3456678999999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcC----CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
...++++|||.+|+|..+|+.... ...++....+.++.+||+|++|||++++|||||.++|+||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999999985421 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCC--CCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 674 LSRIITDSPMRDSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 674 LA~~l~~~~~~~~~~--~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
+|+.+....+..... .-...|||||.+..+.|+.|+|||||||+|||++| |..||.+.++.++...+...+ +++.|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P 926 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP 926 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC
Confidence 999765554443332 23458999999999999999999999999999998 678999999999888777766 77766
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 751 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 751 ~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
. +.+.+||..||+ +|++||++..|++.+.++.+
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 4 468999999999 99999999999999887765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=349.36 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=216.2
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g 592 (786)
..|.++.++|.+++.||+|+||.||+|.+. +..||||++.... .....+.|.+|+++++++. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 467777899999999999999999999763 2369999986443 3344578999999999996 999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcC---------------------------------------------------
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------------------------------------- 621 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------------------------------------- 621 (786)
+|.+.+.+|+||||+++|+|.+++.....
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999988864210
Q ss_pred ------------------------------------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccE
Q 003919 622 ------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 659 (786)
Q Consensus 622 ------------------------------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNI 659 (786)
...+++..++.++.||+.||+|||+.+|+|+||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12477888999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003919 660 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 736 (786)
Q Consensus 660 LLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~ 736 (786)
|++.++.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999987643221 1223456788999999998889999999999999999997 9999987665555
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 737 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 737 l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.......+.....+ ...+.+++.+||+ ||++||++.+|.+.|.++.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 54444444444333 3468999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.18 Aligned_cols=240 Identities=23% Similarity=0.400 Sum_probs=200.4
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHH-HHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~-iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ +|+.||+|++..... .....+.+..|.. +++.++||||+++++++.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999988 588999999875433 2223355666655 46789999999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 99998886 345789999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+........ .....+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 99999999999999999999999999999999999999998887777766655433221 124568999999999 9999
Q ss_pred CCCHH----HHHH
Q 003919 768 RPSCE----EILS 776 (786)
Q Consensus 768 RPSa~----EIL~ 776 (786)
||++. ++++
T Consensus 238 R~~~~~~~~~il~ 250 (323)
T cd05575 238 RLGAKDDFLEIKN 250 (323)
T ss_pred CCCCCCCHHHHHc
Confidence 99874 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.52 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=212.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
..+....++|.+.+.||+|+||.||++.+ +++.+|+|++.+... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34455678999999999999999999987 477899999865332 223345688999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999998852 3578899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 678 ITDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 678 l~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
+..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+.+.......+.........|
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 643322 22356799999999999764 37889999999999999999999999888877777776544444443
Q ss_pred ---ChHHHHHHHHhhh-CCC--CCCCHHHHHHH
Q 003919 751 ---EGPLGRLIADCWA-EPQ--ERPSCEEILSR 777 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~--kRPSa~EIL~~ 777 (786)
...+.+++.+|+. ++. .|+++.++++|
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 3358899999998 443 38899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=324.51 Aligned_cols=249 Identities=31% Similarity=0.600 Sum_probs=209.1
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEECC-eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~G-~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+.++|.+.+.||+|+||+||++.+.+ ..+|+|.+...... .+.|.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 35679999999999999999998754 46999988654332 367899999999999999999999999888899999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+++|.+++... ...+++.+++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||+++........
T Consensus 79 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999999988632 236899999999999999999999999999999999999999999999999998876443222
Q ss_pred C-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003919 685 D-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 760 (786)
Q Consensus 685 ~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~--~~ip~~~L~~LI~~ 760 (786)
. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...... .......+.+++.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1 12335568999999998889999999999999999998 99999888776666655543221 12234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L~ 779 (786)
||. +|.+||++.+|++.|+
T Consensus 237 cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 237 CWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HcCCCcccCCCHHHHHHhhC
Confidence 999 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.27 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=200.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l 600 (786)
+|.+.+.||+|+||+||++.. .++.||+|++..... .....+.+..|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999865 477899999865432 2233467889999999994 99999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999886 345789999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCChH
Q 003919 681 SP-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEGP 753 (786)
Q Consensus 681 ~~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~----~~~~l~~i~~~~~~~-~ip~~~ 753 (786)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+....... ......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 122346799999999999865 47889999999999999999999996432 222333333222111 122446
Q ss_pred HHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
+.+++.+||. ||++|| ++++++++
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 8999999999 999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=328.48 Aligned_cols=260 Identities=29% Similarity=0.581 Sum_probs=217.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g 592 (786)
..|.+..++|.+.+.||+|+||.||++.+. ...+|+|++.... .......+.+|+++++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 356777889999999999999999999763 2578999986543 334457799999999999 7999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhh-------------cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccE
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 659 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~-------------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNI 659 (786)
++...+.++++|||+++|+|..++... .....+++..++.++.|++.||+|||+.||+|+||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998642 1245689999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003919 660 LVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 736 (786)
Q Consensus 660 LLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~ 736 (786)
|++.++.+||+|||+++.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 9999999999999999876543221 122335578999999988889999999999999999997 9999988877666
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 737 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 737 l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
...+.. ......+ ...+.+|+.+||. ||++|||+.++++.|.++.
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 554433 3333333 3468899999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=339.58 Aligned_cols=240 Identities=24% Similarity=0.383 Sum_probs=200.7
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ .++.||||++..... .....+.+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 467899999876532 123345677788888764 899999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999886 345688999999999999999999999999999999999999999999999999876433222334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....... ...+..+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999999999999999999999999999999999888777666654433222 1224568899999999 9999
Q ss_pred CCCHH-HHHH
Q 003919 768 RPSCE-EILS 776 (786)
Q Consensus 768 RPSa~-EIL~ 776 (786)
||++. ++++
T Consensus 238 R~~~~~~l~~ 247 (316)
T cd05619 238 RLGVKGDIRQ 247 (316)
T ss_pred cCCChHHHHc
Confidence 99997 6665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.88 Aligned_cols=254 Identities=30% Similarity=0.549 Sum_probs=212.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+|.+.+.||+|+||.||+|.+. ++.||||++..... .+..+.|.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 3567889999999999999999752 36799999864433 334578999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhc-----------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeE
Q 003919 599 RLSMITEYMELGSLYHLIHLSG-----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~-----------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~V 667 (786)
..+++|||+++++|.+++.... ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999986432 23458899999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003919 668 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 668 KL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~ 744 (786)
+|+|||++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976533221 1223446788999999999999999999999999999998 999998888777766655332
Q ss_pred CCC--CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 745 SRL--EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 745 ~~~--~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
... ......+.+++.+||. ||++||++.+|++.|.+
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 222 1224579999999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=335.88 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=220.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+-..||+|.|+.||++.+ .|+.+|+|++..+.+.....+++.+|+.|.+.|+|||||++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 6788889999999999999977 68999999998887777778899999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~~ 682 (786)
+|.|+.|..-+- .+-..++..+-.+++||+++|.|||.+||||||+||.|+||-+ ..-+||+|||++..+. ..
T Consensus 91 ~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 91 LVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred cccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 999999974443 2257889999999999999999999999999999999999954 3469999999999987 44
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
......+|||.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...++..+....+..+-| ....++|
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 45567899999999999999999999999999999999999999999999999999988777655443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L 778 (786)
+++||. ||.+|+|+.|.|+|=
T Consensus 247 vrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred HHHHhccChhhhccHHHHhCCc
Confidence 999999 999999999999763
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.17 Aligned_cols=241 Identities=22% Similarity=0.367 Sum_probs=200.6
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||.||+|.+ +|+.||+|++..... .....+.+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 577899999875432 123345677788888755 899999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99998886 345788999999999999999999999999999999999999999999999999875432222334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+ .....+.+|+.+||. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999998887766665544332221 224578999999999 9999
Q ss_pred CCCHH-HHHHH
Q 003919 768 RPSCE-EILSR 777 (786)
Q Consensus 768 RPSa~-EIL~~ 777 (786)
||++. ++++|
T Consensus 238 R~~~~~~~~~h 248 (316)
T cd05620 238 RLGVVGNIRGH 248 (316)
T ss_pred cCCChHHHHcC
Confidence 99984 66643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.33 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=213.1
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++..++|++.++||+|+||.||+|.. +++.+|+|.+...... ...|.+|+.++++++|+||+++++++. ...++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 456678899999999999999999977 6788999998755443 367889999999999999999999874 45689
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+.+++|.+++... ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999988633 3457899999999999999999999999999999999999999999999999999876532
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+.......+.. ......+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYE 234 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 221 223345678999999998889999999999999999999 9999998877666655533 3333333 347999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+||. +|++||++++++..|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.09 Aligned_cols=250 Identities=29% Similarity=0.572 Sum_probs=211.1
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc-ccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~-~~~~~l~ 601 (786)
|.++..+|.+.+.||+|+||.||++...|+.+|+|.+.... ..+.|.+|+.++++++|+||+++++++ ......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 55677899999999999999999999999999999975432 246789999999999999999999975 4556789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+++||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEECCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999999998632 2345889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRL 757 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~L 757 (786)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ......+ +..+.++
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPVVYDV 231 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence 1 23345678999999998889999999999999999997 9999988777666555433 3233322 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+.+||. +|++|||+.++++.|+++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.14 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=198.6
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||+|+||+||++.+ +++.+|+|++...... ....+.+..|+.+++.++|+||+++++++.....++++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999977 5789999998654432 22346788999999999999999999999999999999999999999
Q ss_pred HHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCC
Q 003919 613 YHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 691 (786)
Q Consensus 613 ~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT 691 (786)
.+.+... .....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 8877432 234578999999999999999999999999999999999999999999999999998765543334456789
Q ss_pred CcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-
Q 003919 692 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRLEIP---EGPLGRLIADCWA- 763 (786)
Q Consensus 692 ~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~----~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~- 763 (786)
+.|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+... ....+ +..+.+++.+||+
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999765432 122222111 11222 3468999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 003919 764 EPQERP-----SCEEILSR 777 (786)
Q Consensus 764 DP~kRP-----Sa~EIL~~ 777 (786)
||++|| +++++++|
T Consensus 239 ~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.53 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=203.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||+|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 588999999865544444456788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+. ++|.+++.....+..+++..++.++.||+.||+|||++||+|+||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 57887776444456799999999999999999999999999999999999999999999999999976644332333
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------------
Q 003919 687 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------- 746 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~------------------- 746 (786)
...+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+.........+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 45678899999988654 5789999999999999999999999876654433332211000
Q ss_pred -----------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -----------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -----------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+..+.++|.+||. ||.+|||+.+|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00113357789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.59 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=212.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+|++.+.||+|+||.||+|.. +|+.+|+|.+..... .....+.+.+|+.++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 588999998865333 3344678999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 605 EYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
||+++++|..++.... ....+++.+++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999999886432 345689999999999999999999999999999999999999999999999999887654333
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP----EGPLGRL 757 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--~~~~l~~i~~~~~~~~ip----~~~L~~L 757 (786)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.... .......+.. +.....+ ...+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHHHH
Confidence 3344568899999999998889999999999999999999999996543 2223333222 2222233 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+||. +|++||++.+|++.|+++.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 999999 9999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.83 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=199.5
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHH-HHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~-iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||++.+ +++.||+|++...... ......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 4678999998754321 222344555554 46788999999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999886 345688889999999999999999999999999999999999999999999999976543333344567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+........ .....+.+++.+|++ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 99999999999999999999999999999999999999998888777666654433221 224568999999999 9999
Q ss_pred CCCHHHHHHHH
Q 003919 768 RPSCEEILSRL 778 (786)
Q Consensus 768 RPSa~EIL~~L 778 (786)
||++.+.+..+
T Consensus 238 R~~~~~~~~~i 248 (325)
T cd05602 238 RLGAKDDFMEI 248 (325)
T ss_pred CCCCCCCHHHH
Confidence 99887544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=356.05 Aligned_cols=246 Identities=33% Similarity=0.523 Sum_probs=217.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
..|+....||+|.||.||+|.+ .++.||+|++...... ..++++.+|+.+|.+++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4566668999999999999987 5788999999765443 346889999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
||.||++.+++. ....+.+..+..++.+++.|+.|||..+.+|||||+.|||+..+|.|||+|||.+..+.......
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999997 44566888889999999999999999999999999999999999999999999999998877777
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA 763 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i--p~~~L~~LI~~CL~ 763 (786)
.+.+|||.|||||++.+..|+.|+||||||++.+||++|.+||....+..+++.+.+......- -...++++|..||.
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 8899999999999999889999999999999999999999999999997777665543322211 12359999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
||+.||++.++|+|
T Consensus 249 k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKH 263 (467)
T ss_pred cCcccCcCHHHHhhh
Confidence 99999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.54 Aligned_cols=249 Identities=26% Similarity=0.338 Sum_probs=211.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--C-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--N-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
...|.+.+.||+|+||.||++.. + ++.||+|.+... .......+.+|+.+++.++|||||++++++...+.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 45599999999999999999976 3 667888876433 233446778899999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 604 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
|||+++|+|.+++... .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887532 234578999999999999999999999999999999999999999999999999998765432
Q ss_pred C--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCChHHHHHH
Q 003919 683 M--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--IPEGPLGRLI 758 (786)
Q Consensus 683 ~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--ip~~~L~~LI 758 (786)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........ .....+.+||
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 1 23356799999999999999999999999999999999999999998888777776655433221 1234689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+||. ||++||++.+++.+
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHhccChhhCcCHHHHHhC
Confidence 99999 99999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=338.35 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=205.0
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+..++|.+.+.||+|+||.||++.+ .+..+|+|++.... .....+.|.+|+++++.++||||++++++|.+.+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3457899999999999999999988 47789999876542 33445779999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||||+++++|.+++. ..+.+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999986 345688999999999999999999975 7999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------------- 740 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i--------------------- 740 (786)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 223457899999999999988999999999999999999999999765443322111
Q ss_pred ----------------------HhcCCCCCC----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 741 ----------------------ANEGSRLEI----PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 741 ----------------------~~~~~~~~i----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.. .+..+.+|+.+||+ ||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 001111111 13468899999999 99999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.71 Aligned_cols=254 Identities=31% Similarity=0.494 Sum_probs=211.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+++++|.+.+.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45677889999999999999999763 4679999986443 233456789999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC
Q 003919 598 PRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~ 664 (786)
...++++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999999885321 12357888899999999999999999999999999999999999
Q ss_pred CeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 003919 665 WTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVA 741 (786)
Q Consensus 665 g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~ 741 (786)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999886543221 1123446778999999988889999999999999999998 888998888777666655
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 742 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 742 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
.... ...+ +..+.+|+..||+ +|.+||++.+|+..|++
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 4332 2233 3468999999999 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=337.47 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=206.4
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+|...+.||+|+||+||++.+ +|+.||+|++..... .....+.+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467889999999999999987 578999999875432 2334567888999998886 577888999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999998765433333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~ 763 (786)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+++.+||.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 3456799999999999999999999999999999999999999999888777777665443222 224468899999999
Q ss_pred -CCCCCCCH-----HHHHHH
Q 003919 764 -EPQERPSC-----EEILSR 777 (786)
Q Consensus 764 -DP~kRPSa-----~EIL~~ 777 (786)
+|.+|++. .+++++
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcC
Confidence 99999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=340.30 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=197.5
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||.||++.+ +++.||+|++...... ......+..|+.++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999987 5788999999765432 33456788999999988 699999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99998876 345799999999999999999999999999999999999999999999999999875433223334568
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------PER-VVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--------~~~-~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ... ....+.......+ .-...+.+++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999996321 112 2222222222211 11346889999
Q ss_pred Hhhh-CCCCCCC------HHHHHHH
Q 003919 760 DCWA-EPQERPS------CEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPS------a~EIL~~ 777 (786)
+||. ||.+|++ +.++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999 9999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.52 Aligned_cols=246 Identities=30% Similarity=0.525 Sum_probs=211.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||.|+||.||++.+ ++..+|+|.+..... ....+.+.+|+.+++.++|+||+++++++.+.+.+++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 578899999999999999987 578899999864433 33457888999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999887532 345688999999999999999999999999999999999999999999999999987755443344
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..... ...+ ...+.+|+.+||.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHHh
Confidence 56789999999999988899999999999999999999999998877666665544332 2222 3468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
||.+||++.+|+..
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.87 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=211.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|++.+.||+|+||.||++.+ +++.+|||.+..... .....+.|.+|+.+++.++||||+++++++..++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999986 688999998865433 3344578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 605 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
||+++++|.+++... .....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999988632 2345689999999999999999999999999999999999999999999999999887654433
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCCCCCC----CChHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RVVYAVANEGSRLEI----PEGPLGRL 757 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~--~~l~~i~~~~~~~~i----p~~~L~~L 757 (786)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.+.... .....+.... .... .+..+.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC-CCCCCcccccHHHHHH
Confidence 334557889999999999888999999999999999999999999755432 2222222211 2222 23469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+.+||. ||++|||+.+|++.++++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999 999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.66 Aligned_cols=246 Identities=35% Similarity=0.645 Sum_probs=206.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
..+|++.+.||+|+||.||++.+. +..+|+|++...... ...|.+|+++++.++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 457889999999999999999874 457999998654433 2568899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++... ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||+++...+.....
T Consensus 80 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 80 YMANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred cCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999998632 3468999999999999999999999999999999999999999999999999998764432211
Q ss_pred -CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHHHH
Q 003919 686 -SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLIAD 760 (786)
Q Consensus 686 -~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~---ip~~~L~~LI~~ 760 (786)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. ..... ..+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHH
Confidence 12233457999999998889999999999999999999 7999988777666655543 22222 234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L 778 (786)
||. +|++|||+.++++.|
T Consensus 237 cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhcCChhhCcCHHHHHHHh
Confidence 999 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.91 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=215.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||.|+||.||.+.. +++.+++|.+............+.+|++++++++|+||+++++++.+...++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488999999999999988866 688899999877766666678899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++... ....+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999999998633 245689999999999999999999999999999999999999999999999999987755433334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA- 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--~~~L~~LI~~CL~- 763 (786)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.........+ ...+.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 5678999999999988889999999999999999999999999888777776665443332211 3468899999998
Q ss_pred CCCCCCCHHHHHHHH
Q 003919 764 EPQERPSCEEILSRL 778 (786)
Q Consensus 764 DP~kRPSa~EIL~~L 778 (786)
+|.+||++.++++++
T Consensus 240 ~p~~R~s~~~ll~~~ 254 (256)
T cd08221 240 DPEKRPTADEVLDQP 254 (256)
T ss_pred CcccCCCHHHHhhCc
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.80 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=199.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------ 598 (786)
..+|.+.+.||+|+||.||++.+ .|..||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999977 5789999998765545555678889999999999999999999886443
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|++|||+.+ +|...+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999986 4555543 24788889999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--------------- 743 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~--------------- 743 (786)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 332 2234567899999999999999999999999999999999999999876543322211110
Q ss_pred -------CCCC---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -------GSRL---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -------~~~~---------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.... ......+.+|+.+||. ||++|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0012357899999999 99999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.17 Aligned_cols=258 Identities=30% Similarity=0.545 Sum_probs=212.8
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
|++..++|++.+.||+|+||.||+|... +..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6677889999999999999999998642 44799998764432 233456889999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcC-------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
+....+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999964321 23456778899999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003919 669 ICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~ 745 (786)
|+|||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG- 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999988654322211 22345678999999998889999999999999999998 788998887777665554332
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
....+ +..+.+++.+||+ ||++|||+.++++.|++..
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22222 3469999999999 9999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.37 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=209.8
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~l~LV~E 605 (786)
.|.+.+.||.|+||.||++.+ +++.+|+|.+..........+.+.+|++++++++|+|++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999977 57789999987665555556788999999999999999999988764 445899999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++... ....+++.+++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..+.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99999999988632 34568999999999999999999999999999999999999999999999999998775443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....+++.|+|||.+.+..++.++|||||||++++|++|+.||...+.......+.... ....+ +..+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCccccCHHHHHHHHHHh
Confidence 45578899999999999999999999999999999999999998877666655544322 22222 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||++||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 239 SKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCcccCCCHHHHhcC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.02 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=204.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|++.+.||+|+||+||++.+ +++.||+|++....... .....+.+|+.+++.++||||+++++++...+.++++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999987 58899999986544322 223567889999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+|+|.+++... ....+++..+..++.|++.||+|||+.||+|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI 158 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence 99999999887532 33568999999999999999999999999999999999999999999999999998764322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---CChHHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI---PEGPLGRLIAD 760 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~--~~~~~i---p~~~L~~LI~~ 760 (786)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+... ...... .+..+.+|+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 3457899999999999888999999999999999999999999876554332222111 111112 24468999999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003919 761 CWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRP-----Sa~EIL~~ 777 (786)
||. ||.+|| ++.+++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 999 999999 89899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.59 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=198.7
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHH-HHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~-iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||++.+ +|+.+|+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 588999999865432 2233456666665 46778999999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99998876 445789999999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........ .....+.+++.+|+. ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 99999999999999999999999999999999999999998887777666654332221 123468899999999 9999
Q ss_pred CCCHHHHH
Q 003919 768 RPSCEEIL 775 (786)
Q Consensus 768 RPSa~EIL 775 (786)
||++.+.+
T Consensus 238 R~~~~~~~ 245 (325)
T cd05604 238 RLGAKEDF 245 (325)
T ss_pred cCCCCCCH
Confidence 99875433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.33 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=214.7
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
++.++|.+.+.||+|+||.||++.. ++..+|+|.+... .....+.|.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4567899999999999999999974 2346889987543 234457899999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhc----------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeE
Q 003919 598 PRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~----------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~V 667 (786)
+.+++++||+++++|.+++.... ....+++.+++.++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986332 12358999999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC
Q 003919 668 KICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 668 KL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~ 744 (786)
+|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999986643221 1223345778999999998889999999999999999998 899998888777666665433
Q ss_pred CCC--CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 745 SRL--EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 745 ~~~--~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
... ...+..+.+|+.+||+ ||.+|||+.++++.|+++..
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 221 1223579999999999 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.88 Aligned_cols=253 Identities=33% Similarity=0.587 Sum_probs=211.3
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|.+..++|.+.++||+|+||.||+|.. .+..+|+|.+...... .+.|.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 456677899999999999999999977 4668999998654443 3578999999999999999999998754 5589
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+||++++++.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999998632 3446899999999999999999999999999999999999999999999999999876443
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
.... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+... ...+.+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 2211 22345668999999988889999999999999999999 89999888777666655442 233333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
|+.+||. +|.+|||+.++++.|+++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.49 Aligned_cols=261 Identities=30% Similarity=0.569 Sum_probs=215.1
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
..|++..++|.+++.||+|+||.||++.+. +..+|+|.+.... .......+..|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346666789999999999999999999752 2469999986543 334457788999999999 79999999
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
++++...+..|++|||+++++|.+++..... ...+++.+++.++.|++.||+|||++|++|+||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 9999999999999999999999999974321 235889999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||++.......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9999999999999999987664322111 12234568999999998889999999999999999998 88899887765
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 735 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.....+ ........+ ...+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 250 ~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 555444 334333333 3478899999999 99999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.49 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=214.3
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 596 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~- 596 (786)
.+..++|.+.+.||+|+||.||+|.+. +..|++|++.. .......+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345688999999999999999999873 47789998753 3344556789999999999999999999998766
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCC-----ccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEe
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQK-----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 671 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~-----~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~D 671 (786)
+...+++++|+++++|.+++...... ..+++..++.++.|++.||+|||+++++|+||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 46789999999999999998643222 5689999999999999999999999999999999999999999999999
Q ss_pred cCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003919 672 FGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 748 (786)
Q Consensus 672 FGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ 748 (786)
||+++.+...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....+......+.. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-GYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc-CCCCC
Confidence 9999866433221 122345678999999998889999999999999999999 9999988877665544433 33332
Q ss_pred CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 749 IP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 749 ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+ +..+.+++.+||. ||++|||+.++++.|.++..
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22 3468999999999 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.97 Aligned_cols=254 Identities=32% Similarity=0.595 Sum_probs=214.1
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++..++|.+.+.||+|+||.||++.+ +++.+|||.+...... .+++.+|+.+++.++|+||+++++++.....++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 456788999999999999999999977 4567999998754433 367899999999999999999999999888999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 78 ~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999998632 2346899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
... .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+... .....+ +..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 111 112334568999999998889999999999999999998 99999888777666665443 222222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+||. +|.+||++.++++.|+++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhcC
Confidence 9999999 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.08 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=213.0
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
...+....++|.+.+.||+|+||.||++.+ .++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 345566678999999999999999999987 577899999865332 23334568899999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999998852 357888999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+.........|
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 7654322 22356799999999998754 37899999999999999999999999988877777766544333333
Q ss_pred ----ChHHHHHHHHhhhCCCC---CCCHHHHHHHH
Q 003919 751 ----EGPLGRLIADCWAEPQE---RPSCEEILSRL 778 (786)
Q Consensus 751 ----~~~L~~LI~~CL~DP~k---RPSa~EIL~~L 778 (786)
...+.+||..|+.+|.. |+++.+|+++.
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 34688999999984433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.00 Aligned_cols=236 Identities=22% Similarity=0.381 Sum_probs=196.3
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHH-HHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEIS-ILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~-iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.+ +++.||+|++..... .......+..|.. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 578999999875433 2223345666654 57889999999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
++|...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 99988876 345788899999999999999999999999999999999999999999999999876433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~k 767 (786)
||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.......+.......+ .....+.+++.+||+ ||.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 99999999999998999999999999999999999999998887776666654332221 123468899999999 9999
Q ss_pred CCCHH
Q 003919 768 RPSCE 772 (786)
Q Consensus 768 RPSa~ 772 (786)
||++.
T Consensus 238 R~~~~ 242 (321)
T cd05603 238 RLGAK 242 (321)
T ss_pred cCCCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.67 Aligned_cols=254 Identities=33% Similarity=0.594 Sum_probs=210.9
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++...+|.+.++||+|+||.||+|.++ ...+|+|++...... .+.|.+|+++++.++||||+++++++.+ ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4566788999999999999999999874 457999998654332 3578999999999999999999998754 4589
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++..+...
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999998632 2346789999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC-CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMRD-SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
.... ....++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.... ....+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCCCccccCHHHHH
Confidence 2221 23346678999999988889999999999999999999 888998887776665554322 22221 346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
|+.+|++ ||++||++.++++.|+++-
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 9999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.92 Aligned_cols=255 Identities=31% Similarity=0.546 Sum_probs=212.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+|.+.+.||+|+||.||+|++. +..+++|.+.... ....+.|.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4567999999999999999999752 3458888875432 333467899999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 599 RLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999986432 123588999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003919 666 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 742 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~ 742 (786)
.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...........+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999976543321 1233456788999999999999999999999999999999 9999988877766655543
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 743 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 743 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.. ....+ +..+.+++.+||+ +|++||++.+|++.|.++..
T Consensus 241 ~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 241 GR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 32 22222 3468999999999 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=338.15 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=196.3
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||++.+ +++.+|+|++..... .....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 577899999976533 234456788899988777 799999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99988876 345789999999999999999999999999999999999999999999999999976433333334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------C-hHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------L-PERVVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~--------~-~~~~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
||+.|+|||++.+..++.++|||||||++|+|++|+.||... . .......+.......+ .....+.+|+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999999999999999521 1 1112222222222211 12346889999
Q ss_pred Hhhh-CCCCCCC------HHHHHHH
Q 003919 760 DCWA-EPQERPS------CEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPS------a~EIL~~ 777 (786)
+||. ||.+||+ +.++++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999 9999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=344.79 Aligned_cols=262 Identities=29% Similarity=0.523 Sum_probs=218.7
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~ 591 (786)
...|.+..++|.+++.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.++.++. |||||+++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 4568888999999999999999999999863 35799999965433 333467999999999997 99999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC--------------------------------------------------
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------------------------------------------- 621 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------------------------------------------- 621 (786)
++|...+..++|+||+++|+|.++++....
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 999999999999999999999999864311
Q ss_pred ---------------------------------------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCc
Q 003919 622 ---------------------------------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656 (786)
Q Consensus 622 ---------------------------------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKp 656 (786)
...+++..++.++.||+.||+|||+.+|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 12467778899999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003919 657 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 733 (786)
Q Consensus 657 sNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~ 733 (786)
+|||++.++.+||+|||+++.+..... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533211 1223456788999999998889999999999999999998 8899987766
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 734 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..........+.++..| ...+.+|+.+||. +|.+||++.+|++.|+++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 66555555555444444 3479999999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.63 Aligned_cols=254 Identities=35% Similarity=0.572 Sum_probs=208.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEECC------------------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWNG------------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~G------------------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI 587 (786)
+..+|.+.+.||+|+||.||++.+.+ ..||+|++..... ....+.|.+|++++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45689999999999999999987632 4589999865433 3456789999999999999999
Q ss_pred eEEecccccCCceEEEEEeeccchhHHHHHhhc--------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccE
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSG--------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 659 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~--------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNI 659 (786)
+++++++..++..++++||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999986432 123689999999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHH
Q 003919 660 LVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPER 735 (786)
Q Consensus 660 LLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT--G~~PF~~~~~~~ 735 (786)
+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ +..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543321 1223456778999999988889999999999999999998 677898776666
Q ss_pred HHHHHHhc----CCCC--CC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 736 VVYAVANE----GSRL--EI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 736 ~l~~i~~~----~~~~--~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
........ .... .. .+..+.+|+.+||+ ||.+||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 55544432 1111 11 13479999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.66 Aligned_cols=242 Identities=29% Similarity=0.585 Sum_probs=201.6
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccch
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGS 611 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGS 611 (786)
+.||+|+||.||+|.+ +++.+|+|.+... ...+....|.+|+++++.++||||+++++++.....+++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999977 6889999987533 334445789999999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCC
Q 003919 612 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSA 689 (786)
Q Consensus 612 L~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~ 689 (786)
|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999863 23468899999999999999999999999999999999999999999999999987654321111 1112
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-C
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-E 764 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-D 764 (786)
.+..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ......+ +..+.+|+.+||+ +
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999998889999999999999999998 8889987777665554443 2222333 3468899999999 9
Q ss_pred CCCCCCHHHHHHHHH
Q 003919 765 PQERPSCEEILSRLL 779 (786)
Q Consensus 765 P~kRPSa~EIL~~L~ 779 (786)
|++||++.++++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=321.34 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=204.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|++.+.||+|+||.||++.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999987 48899999986544333334568899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|..++. ....+++..++.++.||+.||+|||+.|++|+||||+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999988887765 34468999999999999999999999999999999999999999999999999998775543233
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------
Q 003919 686 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------- 745 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------------- 745 (786)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999999876 5578999999999999999999999987766554443321100
Q ss_pred CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~~-------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ..+..+.+|+.+||+ +|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012357899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.28 Aligned_cols=253 Identities=35% Similarity=0.610 Sum_probs=209.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++...+|.+...||+|+||.||++.+. +..+|+|.+...... .+.|.+|+.+++.++||||+++++++.. +..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 4455678999999999999999999874 457999987644332 3678899999999999999999998754 5688
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999998632 3345889999999999999999999999999999999999999999999999999876443
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.. ......+ +..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHH
Confidence 221 123345678999999998889999999999999999999 8999998877666655543 3233322 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+||. ||.+||++++|++.|+++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.75 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=206.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.. .++.||+|++.+... .....+.|.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999987 578999999865332 2334567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999863 2456889999999999999999999999999999999999999999999999998766443222
Q ss_pred -CCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003919 685 -DSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 752 (786)
Q Consensus 685 -~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip------~~ 752 (786)
.....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+........++ ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 223469999999999863 457889999999999999999999999887777666665443333322 34
Q ss_pred HHHHHHHHhhh---CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA---EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~---DP~kRPSa~EIL~~ 777 (786)
.+.+++.+|+. ++..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 68899999886 33447899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.33 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=201.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||.||+|.+ .++.+|+|.+...... .....+.+|+.++++++||||+++++++..++..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 57899999999999999999977 5778999998654332 22356788999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+ +|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99985 77776652 2346888999999999999999999999999999999999999999999999999765443333
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 745 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------------ 745 (786)
.....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+.......+.....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 345568899999998865 4689999999999999999999999987766544333321100
Q ss_pred ---CCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 ---RLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ---~~~----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... .-+..+.+|+.+|+. ||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000 012357789999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.69 Aligned_cols=244 Identities=37% Similarity=0.682 Sum_probs=209.0
Q ss_pred eEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 534 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
+.||+|+||.||++.+. +..+++|++....... ..+.+.+|+..++.++|+||+++++++.....++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999874 7789999987654433 46789999999999999999999999999999999999999
Q ss_pred cchhHHHHHhhcC------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 609 LGSLYHLIHLSGQ------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 609 gGSL~dlL~~~~~------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+++|.+++..... ...+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 9999999874311 3679999999999999999999999999999999999999999999999999998775432
Q ss_pred --CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 683 --MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 683 --~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
.......+++.|+|||.+....++.++|||||||++|+|++ |..||...........+.. +.....+ +..+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYE 238 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHH
Confidence 12234567889999999988889999999999999999999 5999998887777666654 3333333 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
++.+||. +|.+|||+.+++++|+
T Consensus 239 li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 239 LMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999 9999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.55 Aligned_cols=254 Identities=30% Similarity=0.564 Sum_probs=208.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--Ce--eEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~ 601 (786)
+++|++.+.||+|+||.||+|... +. .+++|.+... ......+.|.+|++++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 368999999999999999999763 33 4688876532 2334457899999999999 7999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 602 MITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
+++||+++++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986422 113588999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003919 669 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 747 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~ 747 (786)
|+|||++...... ........+..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. +...
T Consensus 160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-~~~~ 237 (297)
T cd05089 160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRM 237 (297)
T ss_pred ECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCC
Confidence 9999998643221 11112233457999999998889999999999999999997 9999998887776665543 2223
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+ +..+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222 3468999999999 99999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.34 Aligned_cols=260 Identities=28% Similarity=0.579 Sum_probs=215.7
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE---------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW---------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~---------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
.|.+...+|.+.+.||+|+||.||++.+ ++..+|+|.+... ........+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3556678999999999999999999964 2346899987643 2334457899999999999 799999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCccc
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 658 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsN 658 (786)
+++......+++|||+++++|.+++..... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 999999999999999999999999874321 2357888999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003919 659 CLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 735 (786)
Q Consensus 659 ILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~ 735 (786)
||++.++.+||+|||++..+...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+...
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999999876443221 123345678999999998889999999999999999998 788998887777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 736 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 736 ~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
....+.. ......+ ...+.+|+.+||. +|.+||++.++++.|.++..
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 LFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 6665533 3333333 3468999999999 99999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.48 Aligned_cols=251 Identities=27% Similarity=0.528 Sum_probs=206.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..+|++.+.||+|+||+||+|.+ +++ .+++|.+... .......++..|+.+++.+.||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 46788899999999999999987 444 4777776432 223345678889999999999999999998764 457
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999863 345789999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
.. .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ ..+.....+ ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHHH
Confidence 22 12233456778999999998889999999999999999998 99999887766554433 344433332 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..++.+||. ||++|||+.++++.|..+.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 889999999 9999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.63 Aligned_cols=252 Identities=36% Similarity=0.591 Sum_probs=210.1
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
...+|++.+.||+|+||.||+|.+. +..+|+|.+.... .....+.|.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3568899999999999999999762 3368999876433 334467899999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ....+++.++..++.|++.||+|||++|++|+||||+|||++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999863 235689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 681 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 681 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
..... ....++..|+|||.+.+..++.++|||||||++|++++ |+.||...........+... ...+.+ +..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHH
Confidence 32211 12223568999999998889999999999999999886 99999887776665555433 233322 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+.+++.+||+ +|.+||++.++++.|.++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 8999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.96 Aligned_cols=260 Identities=29% Similarity=0.581 Sum_probs=215.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
.|.+...+|.+.+.||+|+||.||++.+. ...+|+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 45666789999999999999999999752 3468999876433 344467899999999999 599999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCccc
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 658 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsN 658 (786)
+++.....++++|||+++|+|.+++.... ....+++..+..++.|++.||+|||++||+|+||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999899999999999999999986432 12458899999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 003919 659 CLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPER 735 (786)
Q Consensus 659 ILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~ 735 (786)
||++.++.+||+|||+++......... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998764322211 12234467999999998889999999999999999999 889998887766
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 736 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 736 ~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
....+.. ......+ ...+.+|+.+||. +|++||++.++++.|.++..
T Consensus 245 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 6655443 3333333 3468899999999 99999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.46 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=201.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-----ceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-----~l~ 601 (786)
+|.+.+.||+|+||.||++.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 6889999998654444445678899999999999999999999998776 789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+++||+. ++|...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 46776664 4457899999999999999999999999999999999999999999999999999865432
Q ss_pred C-CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------------
Q 003919 682 P-MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE---------------- 743 (786)
Q Consensus 682 ~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~---------------- 743 (786)
. .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 2 122345688999999998774 4799999999999999999999999887765544433221
Q ss_pred -------CCCCC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -------GSRLE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -------~~~~~----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..... .....+.+|+.+||+ ||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 11000 013357889999999 99999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.86 Aligned_cols=253 Identities=29% Similarity=0.552 Sum_probs=207.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+|.+.+.||+|+||.||+|.+. +..||+|.+... ........|.+|+.+++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4577999999999999999999874 357888877533 23334567999999999999999999999999888
Q ss_pred ceEEEEEeeccchhHHHHHhhcC----CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEe
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICD 671 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~D 671 (786)
..+++|||+++++|.+++..... ...+++..++.++.||+.||+|||+++++|+||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999874321 13589999999999999999999999999999999999998654 699999
Q ss_pred cCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC
Q 003919 672 FGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE 748 (786)
Q Consensus 672 FGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ 748 (786)
||+++.+...... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...........+... ....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC
Confidence 9999876432221 112233568999999998889999999999999999997 99999988777665554432 2222
Q ss_pred CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 749 IP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 749 ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
.+ +..+.+++.+||+ +|++||++.+|+++|.+
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 22 3468899999999 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.37 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=219.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|.||.||+|.. ++.-||+|++.+.... ....+++.+|+++-..|+||||+++|++|-+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 57899999999999999999977 4668999999766542 23346889999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+||.++|.|+..|.. +....+++.....++.|++.||.|||..+||||||||+|+|++.++.+||+|||.+..-. ..
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SN 177 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CC
Confidence 999999999998863 356679999999999999999999999999999999999999999999999999987654 33
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+.+..+.......+ .......++|.+|+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLL 257 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHh
Confidence 45688999999999999999999999999999999999999999999988888888776554433 22456899999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003919 763 A-EPQERPSCEEILSRL 778 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L 778 (786)
. +|.+|.+..|++.|=
T Consensus 258 ~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHP 274 (281)
T ss_pred ccCccccccHHHHhhhH
Confidence 9 999999999999873
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.53 Aligned_cols=247 Identities=27% Similarity=0.523 Sum_probs=212.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||+|+||.||++.. +|+.+|+|.+..........+++.+|+.+++.++||||+++++++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 688999999876655555567899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+.+++|.+++... ....+++.+++.++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999999988632 234678999999999999999999999999999999999999999999999999987654333333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...|++.|+|||.+.+..++.++|+|||||++++|++|+.||...........+..... ...+ ...+.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHhh
Confidence 45688899999999988899999999999999999999999988777777666654333 2222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.31 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=197.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc---CCCceeEEeccccc-----CC
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTK-----PP 598 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~~-----~~ 598 (786)
+|.+.+.||+|+||+||+|.+ +++.||+|.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999987 578899999865443332234566777777666 69999999998754 24
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++++||+.+ +|.+++... ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 58999999985 787777532 2345899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 5332 2234578999999999998889999999999999999999999998776665544443211000
Q ss_pred -----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+|+.+|++ ||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0012347899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.43 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------C
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~ 598 (786)
.++|.+.+.||+|+||.||++.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999987 578899999876554455567888999999999999999999987543 3
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+++ +|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999985 5655553 24778889999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 177 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 443 22345678999999999999999999999999999999999999998876655444433211000
Q ss_pred --------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+|+.+|++ ||.+|||+.++|+|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0012357789999999 99999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.96 Aligned_cols=253 Identities=29% Similarity=0.557 Sum_probs=208.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
...+|.+.+.||+|+||+||+|.+ +|+ .||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 356889999999999999999976 444 48999986443 344457899999999999999999999998754 4
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++++|+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+++.+.
T Consensus 83 ~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 7899999999999998863 23568999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 680 DSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 680 ~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+ ........+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCccCCHH
Confidence 33221 122345678999999998889999999999999999998 89999877766555433 333333332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+.+++.+||. ||+.||++.++++.|.++..
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 8899999999 99999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.91 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------C
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~ 598 (786)
.++|.+.+.||+|+||.||++.+ .++.+|||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 57899999999999999999976 588999999876555555567888999999999999999999987543 3
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|++|||+++ +|.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999986 5555553 24788899999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--------------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-------------- 744 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~-------------- 744 (786)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 443 22345678999999999999999999999999999999999999998766443332221100
Q ss_pred --------CC---C------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 --------SR---L------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 --------~~---~------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. . ......+.+|+.+|+. ||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0 0012347899999999 99999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.64 Aligned_cols=246 Identities=28% Similarity=0.481 Sum_probs=219.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~L 602 (786)
...|.+++.||+|.||.||+++. +|+.+|+|++.+.... ....+.+.+|+++|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 46799999999999999999987 5889999999776653 234578899999999998 9999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC----CeEEEEecCccccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFGLSRII 678 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~l 678 (786)
|||++.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998743 39999999999999999999999999999999999999643 57999999999988
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGP 753 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~ 753 (786)
.. .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+.........+ ...
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 76 456678899999999999999999999999999999999999999999999888888887766544332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+++|..|+. ||.+|+|+.++|+|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcC
Confidence 8899999999 99999999999997
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.97 Aligned_cols=247 Identities=30% Similarity=0.526 Sum_probs=209.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||.|+||.||+|.+ .++.+++|++...... ..+.+.+|+.++++++||||+++++++.....++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 36799999999999999999987 4678999998755332 4578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++.. ....+++..+..++.|++.||+|||++||+|+||+|+||+++.++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 99999999998863 2357899999999999999999999999999999999999999999999999999876543223
Q ss_pred CCCCCCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---C---ChHHH
Q 003919 685 DSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---P---EGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---p---~~~L~ 755 (786)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....+......+......... + +..+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3445788899999999776 8899999999999999999999999888776666555444222211 1 23588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+++.+||. +|..||++.+|+.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=322.79 Aligned_cols=253 Identities=33% Similarity=0.599 Sum_probs=209.2
Q ss_pred CeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+|++.+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999763 2468888876443 2344578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhc---------------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 602 MITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~---------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
+++||+.+++|.+++.... ....+++..++.++.|++.||+|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999886321 1235789999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003919 661 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 737 (786)
Q Consensus 661 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l 737 (786)
+++++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999765332211 122345678999999988889999999999999999998 99999888776655
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 738 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 738 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+ ........+ ...+.+++.+||+ +|++||++.++++.|+++..
T Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 543 333333333 3478999999999 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=316.45 Aligned_cols=252 Identities=36% Similarity=0.579 Sum_probs=209.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC--C---eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~--G---~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..++|+..+.||+|+||.||+|... + ..+|+|.+.... .....+.|.+|+++++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4567889999999999999999762 3 368999875432 334457899999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ....+++.++..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 82 MIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999863 335789999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC---CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 681 SPMRD---SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 681 ~~~~~---~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
..... .....++.|+|||.+.+..++.++|||||||++|||++ |+.||...........+... ...+.+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC-CCCCCCCCCCHH
Confidence 22111 11223457999999998889999999999999999997 99999887776666665443 222222 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+.+++.+||+ +|++||++.+|++.|.++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 8899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=317.48 Aligned_cols=244 Identities=27% Similarity=0.536 Sum_probs=202.2
Q ss_pred EEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 535 RVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.||+|+||.||+|.+. +..||+|++.... .....+.|.+|+.++++++||||+++++++.. ..+++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999763 4569999986443 34445779999999999999999999998864 4689999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC---CC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD---SS 687 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~---~~ 687 (786)
+|.+++.. ....+++..++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++..+....... ..
T Consensus 80 ~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99998862 34578999999999999999999999999999999999999999999999999998654332111 12
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .+.....+ ...+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 233578999999988889999999999999999996 999999887766655443 33333333 3468999999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003919 764 -EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 764 -DP~kRPSa~EIL~~L~~i~~ 783 (786)
+|++||++.+|++.|+++.|
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CChhhCcCHHHHHHHHhhhcC
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.23 Aligned_cols=260 Identities=32% Similarity=0.573 Sum_probs=210.0
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 594 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~ 594 (786)
|.+..++|.+.+.||+|+||+||+|.+ .++.||||++..... ......+.+|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 566678999999999999999999974 367899999865433 33456788999999999 689999999988
Q ss_pred ccC-CceEEEEEeeccchhHHHHHhhcC----------------------------------------------------
Q 003919 595 TKP-PRLSMITEYMELGSLYHLIHLSGQ---------------------------------------------------- 621 (786)
Q Consensus 595 ~~~-~~l~LV~Ey~~gGSL~dlL~~~~~---------------------------------------------------- 621 (786)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 568899999999999998863210
Q ss_pred ------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--CCCC
Q 003919 622 ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSS 687 (786)
Q Consensus 622 ------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~ 687 (786)
...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12467888899999999999999999999999999999999999999999999987533211 1122
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...............+.....+ +..+.+++..||+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999997 899998765443333334444333333 3468899999999
Q ss_pred -CCCCCCCHHHHHHHHHhhhh
Q 003919 764 -EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 764 -DP~kRPSa~EIL~~L~~i~~ 783 (786)
||++||++.+|+++|+++..
T Consensus 321 ~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 321 GEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.27 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=211.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCceEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMIT 604 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~LV~ 604 (786)
+|.+.+.||.|+||.||++.+ +++.+|+|++..........+.+.+|+++++.++||||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 578899999999999999976 57889999987766666667889999999999999999999997753 45689999
Q ss_pred EeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhh-----hcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 605 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIH-----RMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLH-----s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
||+++++|.+++... .....+++..++.++.||+.||+||| +.+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999988643 23467899999999999999999999 899999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLG 755 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~ 755 (786)
...........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. +....++ ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHHHH
Confidence 6544333456789999999999988899999999999999999999999998876555554443 3323333 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+++.+|+. +|.+||++.+|+++
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhC
Confidence 99999999 99999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.69 Aligned_cols=239 Identities=25% Similarity=0.414 Sum_probs=199.1
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc---CCCceeEEecccccCCceEEEEEeecc
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL---RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
||+|+||+||+|.+ .++.||||++..... .......+..|..++..+ .||||+++++++.+...+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 588999999865433 223345566777777665 699999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99998886 345789999999999999999999999999999999999999999999999999976533333344567
Q ss_pred CCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CC
Q 003919 690 GTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EP 765 (786)
Q Consensus 690 GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP 765 (786)
||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+......... -...+.+++.+||. ||
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P 237 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCH
Confidence 99999999998764 4899999999999999999999999988877776666544433322 24578899999999 99
Q ss_pred CCCC----CHHHHHHH
Q 003919 766 QERP----SCEEILSR 777 (786)
Q Consensus 766 ~kRP----Sa~EIL~~ 777 (786)
.+|| ++.+++++
T Consensus 238 ~~R~~~~~~~~~ll~h 253 (330)
T cd05586 238 QHRLGAHRDAVELKEH 253 (330)
T ss_pred HHCCCCCCCHHHHhcC
Confidence 9998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.32 Aligned_cols=246 Identities=27% Similarity=0.471 Sum_probs=205.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++...+.+++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788889999999999999987 578999999865432 23456889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ..+.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999999999886 3457899999999999999999999999999999999999999999999999998776543333
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------CChHHH
Q 003919 685 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI------PEGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i------p~~~L~ 755 (786)
.....|++.|+|||.+. ...++.++|||||||++|+|++|+.||....+................ -+..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 34567899999999874 456889999999999999999999999776655544443333222211 123588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+++.+||. +|++||++.+|+++
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcC
Confidence 99999999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.99 Aligned_cols=240 Identities=24% Similarity=0.401 Sum_probs=197.2
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||+||+|.. +++.||+|++..... .....+.+.+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 577899999976543 234456788999999888 599999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99998876 345799999999999999999999999999999999999999999999999999976433323334567
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV------LPERVVYAVANEGSRLEIP---EGPLGRLIAD 760 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~------~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~ 760 (786)
||+.|+|||++.+..++.++|||||||+||+|++|+.||... ............. ...+| +..+.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999532 2222222222222 22223 3468899999
Q ss_pred hhh-CCCCCCC------HHHHHHH
Q 003919 761 CWA-EPQERPS------CEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPS------a~EIL~~ 777 (786)
||. ||.+|++ +.++++|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 999 9999998 4577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=321.53 Aligned_cols=253 Identities=32% Similarity=0.574 Sum_probs=210.0
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
++..+|.+.++||+|+||.||++.. ++..+|+|.+... .....+.|.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4567889999999999999999963 3557888987543 334457899999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcC------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
...++++||+++++|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999864321 13588999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003919 666 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 742 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~ 742 (786)
.+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999999976543221 1122345678999999999999999999999999999998 8999988777766665544
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 743 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 743 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
.. ....+ +..+.+|+.+||+ ||.+||++.+|++.|+.
T Consensus 240 ~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 GR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred Cc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 32 22222 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.38 Aligned_cols=248 Identities=31% Similarity=0.626 Sum_probs=208.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+..+|++.+.||.|+||.||++.+ +++.+|+|++...... ...|.+|+++++.++||||+++++++......++++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 456899999999999999999977 4788999998654443 356889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999998863 2346889999999999999999999999999999999999999999999999998765433221
Q ss_pred -CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC--CCCCChHHHHHHHH
Q 003919 685 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR--LEIPEGPLGRLIAD 760 (786)
Q Consensus 685 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~--~~ip~~~L~~LI~~ 760 (786)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...........+...... +......+.+|+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 112335578999999998889999999999999999998 89999887776666655432211 22234579999999
Q ss_pred hhh-CCCCCCCHHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L 778 (786)
||. +|++||++.+++++|
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HcccChhhCCCHHHHHHhh
Confidence 999 999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.14 Aligned_cols=258 Identities=29% Similarity=0.558 Sum_probs=214.6
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 593 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~ 593 (786)
.|.+..++|.+.+.||+|+||.||++.+ .+..+|||++..... ....+.|.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4556678899999999999999999964 234799998765432 33457899999999999 79999999999
Q ss_pred cccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 594 ~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
+...+..+++|||+++++|.++++.. ....+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999999998632 23348999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 674 LSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 674 LA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
++..+..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...............+.....+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence 9986643221 1122345678999999999889999999999999999998 999998877665555555444333322
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+..+.+|+.+||. +|++||++.++++.|.+.
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 3578999999999 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=315.18 Aligned_cols=243 Identities=26% Similarity=0.550 Sum_probs=202.5
Q ss_pred eEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 534 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
++||+|+||.||+|.+. +..+|+|.+...... ...+.+.+|+++++.+.|||||++++++.. +.++++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46999999999999762 257999998765543 445789999999999999999999998764 46899999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC--
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-- 686 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-- 686 (786)
+++|.+++. ....+++..+..++.|++.||+|||..+++|+||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLK---KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999997 334789999999999999999999999999999999999999999999999999987644322211
Q ss_pred -CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003919 687 -SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 761 (786)
Q Consensus 687 -~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~C 761 (786)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-GERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHH
Confidence 1223467999999998899999999999999999998 9999988777666555443 3333333 24688999999
Q ss_pred hh-CCCCCCCHHHHHHHHHhhh
Q 003919 762 WA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~L~~i~ 782 (786)
|. +|++||++.++++.|+++.
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhcc
Confidence 99 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.41 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=206.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.++||+|+||+||++.+ .++.+|+|++.+... .......|..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999987 467899999864332 2233456888999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999999999963 235689999999999999999999999999999999999999999999999999876533222
Q ss_pred CCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003919 684 RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 752 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip------~~ 752 (786)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.........| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3468899999999999999999999999988888777776554433333 34
Q ss_pred HHHHHHHHhhh-C--CCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-E--PQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-D--P~kRPSa~EIL~~ 777 (786)
.+.+|+.+|+. + +..|+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 68899999886 3 3447899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=320.62 Aligned_cols=253 Identities=32% Similarity=0.561 Sum_probs=210.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+..+|.+.+.||+|+||.||++.+ .+..+|+|++.... .......|.+|+.+++.+.||||+++++++.++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 457899999999999999999976 35689999986433 3344577999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhc-------------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccE
Q 003919 599 RLSMITEYMELGSLYHLIHLSG-------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANC 659 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~-------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNI 659 (786)
.+++++||+++++|.+++.... ....+++..++.++.|++.||+|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986321 113478889999999999999999999999999999999
Q ss_pred EEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 003919 660 LVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERV 736 (786)
Q Consensus 660 LLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~ 736 (786)
+++.++.++|+|||++..+...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999998765432211 122345667999999998899999999999999999997 8889988877776
Q ss_pred HHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 737 VYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 737 l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
...+.... ....+ ...+.+|+.+||+ +|.+||++.|+++.|++
T Consensus 242 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 IYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 66554332 22222 3468999999999 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.40 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=204.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeEEecccccC--Cce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l 600 (786)
.+|.+.+.||+|+||.||++.+ +++.||||.+..... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999987 578999998754322 233457888999999999999999999988663 468
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 899999999999998862 34578888999999999999999999999999999999999999999999999876542
Q ss_pred CCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....................| ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence 211 1223468889999999988889999999999999999999999998876665555544333333344 2357
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003919 755 GRLIADCWAEPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~DP~kRPSa~EIL~~ 777 (786)
.+++.+|+.+|+.||++++|+++
T Consensus 239 ~~~i~~~l~~p~~Rp~~~~il~~ 261 (265)
T cd06652 239 RDFLKRIFVEAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHhcChhhCCCHHHHhcC
Confidence 88999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.08 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=206.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||++.+ .++.||+|++..... .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 577899999865322 2333456888999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999732 35688999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC------Ch
Q 003919 684 RDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP------EG 752 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip------~~ 752 (786)
......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||...........+.....+...| ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2223579999999999875 467899999999999999999999999888777776666544433333 24
Q ss_pred HHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQE--RPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~k--RPSa~EIL~~ 777 (786)
.+.+|+.+|+. ++.+ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 68899999988 4433 5689988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=319.22 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=209.0
Q ss_pred cccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccc
Q 003919 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 594 (786)
Q Consensus 518 ~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~ 594 (786)
..++.+....++|.+.+.||+|+||+||++.+ .++.+|+|++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34566677789999999999999999999977 578899998754322 235678899999999 699999999987
Q ss_pred c-----cCCceEEEEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEE
Q 003919 595 T-----KPPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 595 ~-----~~~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VK 668 (786)
. ..+.++++|||+++++|.+++... .....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEE
Confidence 3 445689999999999999887532 2345788999999999999999999999999999999999999999999
Q ss_pred EEecCccccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003919 669 ICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~ 743 (786)
|+|||++..+...........|++.|+|||++.. ..++.++|||||||++|+|++|+.||...............
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9999999876544333345578999999998853 45788999999999999999999999877655444333222
Q ss_pred CC-CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 744 GS-RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 744 ~~-~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
.. ....+ ...+.+|+.+||+ ||++||++.+|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 11112 3468999999999 999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=313.83 Aligned_cols=249 Identities=28% Similarity=0.475 Sum_probs=210.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|++.+.||.|+||+||+|.. ++..+++|++....... ..+.+.+|+.+++.++|+||+++++.+.....+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999976 57789999986554443 56789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR- 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~- 684 (786)
|+++++|.+++........+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++..+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999999974433357899999999999999999999999999999999999999999999999999877543222
Q ss_pred ---CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC------CChH
Q 003919 685 ---DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI------PEGP 753 (786)
Q Consensus 685 ---~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i------p~~~ 753 (786)
.....++..|+|||.+... .++.++|+|||||++|+|++|+.||...+............... .. -...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 1334688999999998776 78999999999999999999999998877666555554432211 11 1235
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+++.+||. ||++||++.+|+++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999 99999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.90 Aligned_cols=243 Identities=23% Similarity=0.329 Sum_probs=196.4
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||+|+||+||++.. .|+.||+|.+....... .....+..|++++++++||||+++++++.++..++++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999976 58899999986544322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
.+++... ....+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....... ......|++
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN 158 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence 8887532 33458899999999999999999999999999999999999999999999999998765432 223457899
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCCC--CCCChHHHHHHHHhhh-CC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE----RVVYAVANEGSRL--EIPEGPLGRLIADCWA-EP 765 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~----~~l~~i~~~~~~~--~ip~~~L~~LI~~CL~-DP 765 (786)
.|+|||++.+..++.++|||||||++|+|++|+.||...... ............. ......+.+|+.+||+ ||
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 999999999888999999999999999999999999765332 2222222211111 1124568999999999 99
Q ss_pred CCCCCHHHHHHHHHh
Q 003919 766 QERPSCEEILSRLLD 780 (786)
Q Consensus 766 ~kRPSa~EIL~~L~~ 780 (786)
.+||++.++++.+..
T Consensus 239 ~~R~~~~~~~~~~~~ 253 (277)
T cd05607 239 EDRLGSREKNDDPRK 253 (277)
T ss_pred hhCCCCccchhhhhc
Confidence 999999776655444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.21 Aligned_cols=256 Identities=31% Similarity=0.568 Sum_probs=207.9
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCee--EEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~--VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
+.+++|.+.+.||+|+||.||+|.+ ++.. +|+|.+... ........|.+|+.++.++ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 3467899999999999999999986 3443 566665432 2334457889999999999 89999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 600 LSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
+|+++||+++++|.+++.... ....+++.+++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999986432 1236889999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003919 667 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~ 745 (786)
+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...........+.. ..
T Consensus 163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GY 240 (303)
T ss_pred EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CC
Confidence 999999998643211 11112234567999999988889999999999999999998 9999988777665554432 22
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
....+ ...+.+|+.+||+ +|++||++.++++.|.++..
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 22222 3468899999999 99999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.83 Aligned_cols=260 Identities=28% Similarity=0.573 Sum_probs=215.6
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
.+|++...+|++++.||+|+||.||++.+. +..+|+|++... ......+.+.+|+++++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 356777788999999999999999999752 236899987643 3344567899999999999 79999999
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+++|...+.+++++||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999986422 1235788999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999876443221 122334567999999999899999999999999999998 88999888777
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 735 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.....+.. ......+ ...+.+|+.+||+ +|.+||++.++++.|.++.
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 66655543 3333333 3468899999999 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=345.15 Aligned_cols=243 Identities=25% Similarity=0.357 Sum_probs=194.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------- 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------- 597 (786)
..+|.+++.||+|+||.||+|.+ .++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 46799999999999999999987 57899999875432 2234799999999999999998876321
Q ss_pred -CceEEEEEeeccchhHHHHHh-hcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCc
Q 003919 598 -PRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGL 674 (786)
Q Consensus 598 -~~l~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGL 674 (786)
..+++||||+++ +|.+++.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 246789999985 56655542 23456789999999999999999999999999999999999999664 799999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------ 747 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------ 747 (786)
++.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.+......+..+......+
T Consensus 218 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 218 AKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred chhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 98764432 22356789999999998664 68999999999999999999999999877665554443211000
Q ss_pred ------------C---------CC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------E---------IP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------~---------ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. +| +..+.+||.+||. ||.+|||+.++++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 11 2357899999999 99999999999976
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.66 Aligned_cols=246 Identities=27% Similarity=0.474 Sum_probs=205.3
Q ss_pred CeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEecccc----ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL----TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~----~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+|++++.||+|+||+||+|.. +++.+|+|.+..... .....+.+.+|+++++.++|+||+++++++.+.+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 688899998865432 123346788999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 682 (786)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999863 3468899999999999999999999999999999999999999999999999987653211
Q ss_pred -----CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCC---ChH
Q 003919 683 -----MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE-GSRLEIP---EGP 753 (786)
Q Consensus 683 -----~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~-~~~~~ip---~~~ 753 (786)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ......+ +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1122456889999999999888999999999999999999999999877655544443332 2222232 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 8999999998 99999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.89 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=211.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
|++..++|.+.+.||+|+||.||++.+ .+..+|+|.+.... ...+.|.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 567788999999999999999999976 45679999876432 234678999999999999999999999887 6789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999998642 3456788999999999999999999999999999999999999999999999999776443
Q ss_pred CCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHH
Q 003919 682 PMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGR 756 (786)
Q Consensus 682 ~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~ 756 (786)
... .....++..|+|||++....++.++|+|||||++|++++ |+.||...........+.. ....+.+ ...+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYN 234 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHH
Confidence 221 122345677999999998889999999999999999999 8999998777666554433 3232222 346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
++.+||. +|++||++.++++.|.++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhcC
Confidence 9999999 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.51 Aligned_cols=245 Identities=28% Similarity=0.534 Sum_probs=205.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-------HHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-------~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
+|.+++.||+|+||.||+|.+ .++.+|+|.+....... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 57889999886543321 234678899999999999999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.++++||+++++|.+++. ....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 999999999999999996 33578899999999999999999999999999999999999999999999999998775
Q ss_pred CCCC------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 680 DSPM------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 680 ~~~~------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
.... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCccc
Confidence 3211 11234578899999999988899999999999999999999999988766555544433 2222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+++.+||+ ||.+||++.+|+++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 3468899999999 99999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=316.95 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=202.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccC------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP------ 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~------ 597 (786)
...|.+.+.||+|+||+||+|.+ .++.+|+|++..... ....+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45688889999999999999977 577899999865432 235788999999998 699999999998643
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4589999999999999998632 345688999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 749 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i--- 749 (786)
............|++.|+|||++. +..++.++|||||||++|||++|+.||.....................
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 644333334567899999999986 345888999999999999999999999877665555444332222211
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+|+.+||. +|.+|||+.+++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 23468999999999 99999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.33 Aligned_cols=243 Identities=31% Similarity=0.570 Sum_probs=206.3
Q ss_pred eEEeecCcEEEEEEEEC---C--eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 534 TRVGIGFFGEVFRGIWN---G--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~---G--~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
+.||+|+||.||+|.+. + ..+|||.+...... ...+.|.+|+.++++++||||+++++++.. ..+++++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 36899999999999762 2 26899998765543 556889999999999999999999999988 88999999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC---C
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---D 685 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~ 685 (786)
+++|.+.+..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999874322 57899999999999999999999999999999999999999999999999999876442211 1
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~C 761 (786)
....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+.........+ +..+.+++.+|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence 13456788999999999899999999999999999998 999998888777766666544444333 35789999999
Q ss_pred hh-CCCCCCCHHHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~L~ 779 (786)
|+ +|.+||++.++++.|.
T Consensus 238 l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 238 WAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCcccCCCHHHHHHHhc
Confidence 99 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=322.53 Aligned_cols=254 Identities=33% Similarity=0.575 Sum_probs=206.1
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEECC----------------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWNG----------------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~G----------------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVk 589 (786)
+..+|.+.+.||+|+||.||++.+.+ ..||+|++... ........|.+|++++++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35689999999999999999987532 24899998643 33444578999999999999999999
Q ss_pred EecccccCCceEEEEEeeccchhHHHHHhhc---------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSG---------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 590 L~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~---------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
+++++...+..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886321 1124688999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 003919 661 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPERV 736 (786)
Q Consensus 661 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT--G~~PF~~~~~~~~ 736 (786)
++.++.+||+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++ +..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 999999999999999765432211 122345678999999998889999999999999999998 6678988776665
Q ss_pred HHHHHh----cCCC-----CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 737 VYAVAN----EGSR-----LEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 737 l~~i~~----~~~~-----~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
...+.. .... ...-+..+.+|+.+||. ||++||++.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 544322 1111 11123569999999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.54 Aligned_cols=244 Identities=30% Similarity=0.572 Sum_probs=207.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||.||+|.+. ++.+++|.+..... .+.|.+|+.+++.++||||+++++++.....+|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 57888999999999999999874 68899999864321 5789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 79 YCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred cCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 9999999999863 34578999999999999999999999999999999999999999999999999998775543233
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip---~~~L~~LI~~C 761 (786)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..... ....+ ...+.+++.+|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 345688899999999988999999999999999999999999987766554444322111 11111 24688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|+ ||++||++.+++++
T Consensus 237 l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 237 LVKDPEERPSAIQLLQH 253 (256)
T ss_pred HhcChhhCcCHHHHhcC
Confidence 99 99999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.41 Aligned_cols=251 Identities=35% Similarity=0.586 Sum_probs=208.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--C---eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G---~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
..+|++.+.||+|+||.||+|.+. + ..||||++... ......+.|..|+.+++.++||||+++++++.+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 467899999999999999999763 3 35999998643 23445678999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++.. ..+.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999998863 2356899999999999999999999999999999999999999999999999998766432
Q ss_pred CCC--CC-CCC--CCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003919 682 PMR--DS-SSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 752 (786)
Q Consensus 682 ~~~--~~-~~~--GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~ 752 (786)
... .. ... .+..|+|||.+.+..++.++|||||||++|||++ |..||...........+... ...+.+ +.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~ 238 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPPPMDCPT 238 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCcccCCH
Confidence 211 11 111 2357999999998899999999999999999886 99999888777666655432 222222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+.+++.+||. +|.+||++.+|+..|+++
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 239 ALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 68899999999 999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.16 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=207.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||.||+|.+ +++.+|+|.+...... ..+.+.+|+.+++.+.|+||+++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999986 5789999998765443 2467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ...+++.++..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 97 EYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred cccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999999999885 235788999999999999999999999999999999999999999999999998776443323
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip---~~~L~~LI~~ 760 (786)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+..... ....+ ...+.+|+.+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 3345788999999999988899999999999999999999999988776554444333221 11122 2358899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. +|++||++.+|+++
T Consensus 253 ~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 253 CLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HCcCCcccCcCHHHHhhC
Confidence 999 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.51 Aligned_cols=249 Identities=29% Similarity=0.490 Sum_probs=206.9
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
...+.|++.++||.|+||.||+|.+ .++.+++|++... .....+.+.+|+.+++.++||||+++++++..++.+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3457799999999999999999987 4788999998643 34456789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++++|..++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 87 MIEFCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEecCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999999887753 23568999999999999999999999999999999999999999999999999987654333
Q ss_pred CCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChH
Q 003919 683 MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGP 753 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip---~~~ 753 (786)
.......+++.|+|||.+. ...++.++|||||||++|+|++|+.||...........+...... ...+ ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 3334456888999999984 345788999999999999999999999887765555444332221 1112 236
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+++.+||. ||++||++.+++++
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcC
Confidence 8899999999 99999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.48 Aligned_cols=246 Identities=23% Similarity=0.301 Sum_probs=197.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|+||.||+|.+ +|+.+|+|.+............+.+|+.++++++||||+++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999987 588999999875544333346788899999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 985 67766642 245689999999999999999999999999999999999999999999999999986644322333
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcC---------------C---C
Q 003919 687 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVANEG---------------S---R 746 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF-~~~~~~~~l~~i~~~~---------------~---~ 746 (786)
...+++.|+|||.+.+. .++.++|||||||++|+|++|..|| .+.+.......+.... . .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 45678899999998764 4789999999999999999999885 4433333322221100 0 0
Q ss_pred C------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 L------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ~------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ......+.+|+.+||. ||.+|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0112357789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.51 Aligned_cols=244 Identities=34% Similarity=0.556 Sum_probs=209.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||.|+||.||+|.+ +++.+|+|++.... .......+.+|+++++.++|+||+++++++.++..+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3678889999999999999987 57899999986543 23345678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..+.......
T Consensus 80 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 80 YCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred eeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999999999862 278999999999999999999999999999999999999999999999999998876543333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip----~~~L~~LI~~C 761 (786)
....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+.... ....+ +..+.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-PPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-CCCCcccccCHHHHHHHHHH
Confidence 45678889999999998889999999999999999999999998877666555444332 22222 23688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. +|++||++++++++
T Consensus 235 l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 235 LNKDPKERPSAKELLKH 251 (274)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 98 99999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.14 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=198.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------C
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~ 598 (786)
.++|.+.+.||+|+||+||+|.+ .++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999976 577899999865544444456788999999999999999999987543 3
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|++++++ +++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 678887774 346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----------- 746 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~----------- 746 (786)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+......
T Consensus 169 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred CCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 442 235678999999999876 56899999999999999999999999876655444333211100
Q ss_pred ----------CCCC-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ----------LEIP-----------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ----------~~ip-----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+ ...+.+|+.+|+. ||.+|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011 1236789999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.74 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=203.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|++.+.||+|+||.||++.+ ++..+|+|.+... .......++.+|++++++++||||++++++|.+++.+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 4778899987643 234445778999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++...... .
T Consensus 80 y~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 154 (308)
T cd06615 80 HMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 154 (308)
T ss_pred ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--c
Confidence 9999999999873 3578899999999999999999997 69999999999999999999999999998765432 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------------------
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--------------------- 743 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~--------------------- 743 (786)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 23567889999999998888999999999999999999999999765433322211110
Q ss_pred --------------CCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 744 --------------GSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 744 --------------~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
...+..| +..+.+|+.+||. +|++||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0111111 2358899999999 999999999999873
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.57 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=210.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~L 602 (786)
.++|..+++|++|.||.||+|++ +++.||+|.++.........-.-++||.+|.+++|||||.+-.+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 36788899999999999999988 57789999997665444444567899999999999999999887643 356999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
|||||+. +|..++.. -..++...+++.++.|+++|++|||.+.|+|||||++|+|++..|.+||+|||||+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999986 78887763 23689999999999999999999999999999999999999999999999999999998887
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-------------
Q 003919 683 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------------- 748 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~------------- 748 (786)
...+..+-|.+|.|||++.+. .|+...|+||+|||+.||+++++-|.+......++.+...-..+.
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 777888999999999999874 699999999999999999999999999888777777654322211
Q ss_pred -------CCC-------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -------IPE-------------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -------ip~-------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.|. +.-.+|+..++. ||.+|.|+++.|++
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 010 123468999999 99999999999976
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.16 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=207.0
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||+|+||.||+|.. +++.+++|++..........+.+..|+.+++.++|+||+++++++...+.+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999976 578999999987766555678999999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC-
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD- 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~- 685 (786)
+++++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999999986 33468899999999999999999999999999999999999999999999999998775433221
Q ss_pred ---CCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHH
Q 003919 686 ---SSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPL 754 (786)
Q Consensus 686 ---~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L 754 (786)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....................+| ...+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHH
Confidence 1356788999999998766 8899999999999999999999997664333222222223333333 3358
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+++.+||+ +|.+||++.+++.+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 899999998 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.61 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=201.8
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..++|.+.+.||.|+||.||+|.+ .++.||+|.+...... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 357899999999999999999977 4788999998644322 2235677899999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+||+. ++|..++.. ....+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred Eeccc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99998 478777753 244688999999999999999999999999999999999999999999999999976544333
Q ss_pred CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------------
Q 003919 684 RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------------- 745 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~----------------- 745 (786)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 33345678999999988654 578899999999999999999999988766544433221100
Q ss_pred CCC--------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RLE--------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~~--------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... .-+..+.+||.+|+. ||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 012357899999999 99999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=318.67 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=203.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|++.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+++++.++||||+++++++..+..+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999987 47899999986554444445678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|..+.. ....+++.+++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++..+.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999998887765 33458999999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------
Q 003919 686 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------------ 746 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~------------------ 746 (786)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44568889999999875 45788999999999999999999999766544333222211000
Q ss_pred --CC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 --LE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 --~~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. -....+.+|+.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 012358899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.99 Aligned_cols=254 Identities=30% Similarity=0.545 Sum_probs=210.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECC-----eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G-----~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
+...+|.+.+.||+|+||.||+|.+.. ..+|||...... .....+.|.+|+.+++.+.||||+++++++.+. .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence 445779999999999999999997632 368899875432 344567899999999999999999999998764 5
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++|||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 7899999999999999863 23468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 680 DSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 680 ~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
..... .....++..|+|||.+....++.++|||||||++|||++ |..||...........+... .....+ +..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTL 237 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHH
Confidence 43222 122334568999999988889999999999999999986 99999888776666554433 233332 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+++.+|+. +|.+|||+.++++.|.++..
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.31 Aligned_cols=245 Identities=31% Similarity=0.513 Sum_probs=207.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+|+..+.||+|+||+||+|.. +++.|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999987 588999999865432 234567899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+||+++++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999986 33468899999999999999999999999999999999999999999999999988764432
Q ss_pred CCCCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
......+++.|++||.+.... ++.++|+|||||++|+|++|+.||...........+........++ +..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence 234566889999999987766 8999999999999999999999998776555555444423333333 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||. +|.+||++.+++.+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhhcCcccCcCHHHHhcC
Confidence 9999 99999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.67 Aligned_cols=245 Identities=30% Similarity=0.503 Sum_probs=209.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|++.+.||.|+||.||++.+ +++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+.+++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46799999999999999999976 6889999998654433 2467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|..++. ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 96 EYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999999885 235899999999999999999999999999999999999999999999999998876544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip---~~~L~~LI~~ 760 (786)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+..... ....+ ...+.++|.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3345788999999999988899999999999999999999999988877655554443222 11122 3468899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+||++.+|+++
T Consensus 252 ~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 252 CLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HhhcChhhCCCHHHHhhC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.90 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=220.6
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEECC--eeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G--~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+.++.|++++.||+|.-|+||++...+ ..+|+|++.+..+. .....+...|-+||+.+.||.+..||..|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 344567889999999999999999998865 68999999776653 445677888999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
..+++||||+||+|..++++. ..+.+++..++.|+.+|+-||+|||.+|||+|||||+||||.++|+|-|+||.|+...
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred eeEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999999988744 5778999999999999999999999999999999999999999999999999987543
Q ss_pred cCC----------------------------------C----------------------CCCCCCCCCCcccCcccccc
Q 003919 679 TDS----------------------------------P----------------------MRDSSSAGTPEWMAPELIRN 702 (786)
Q Consensus 679 ~~~----------------------------------~----------------------~~~~~~~GT~~Y~APEvl~~ 702 (786)
.-. . ......+||-+|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 110 0 01123469999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCC----HHHH
Q 003919 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPS----CEEI 774 (786)
Q Consensus 703 ~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPS----a~EI 774 (786)
.-.+.++|+|+|||+||||+.|..||.+.+..+.+..++......+-.. ...++||+++|. ||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 9999999999999999999999999999999999999987665544333 468999999998 9999987 7777
Q ss_pred HHH
Q 003919 775 LSR 777 (786)
Q Consensus 775 L~~ 777 (786)
.+|
T Consensus 390 K~H 392 (459)
T KOG0610|consen 390 KRH 392 (459)
T ss_pred hcC
Confidence 765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=339.80 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=194.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+....|.+.+.||+|+||.||++.+ .++.||+|... ...+.+|++++++++|||||++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4457899999999999999999987 57889999743 2456789999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC-
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~- 681 (786)
++|++. ++|..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999996 57877775 3456889999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHh------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-------PERVVYAVAN------------ 742 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-------~~~~l~~i~~------------ 742 (786)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112235679999999999999999999999999999999999998764321 1111111110
Q ss_pred --------------cCCCC--CCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 743 --------------EGSRL--EIP--------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 743 --------------~~~~~--~ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..... ..+ +..+.+|+.+||. ||.+|||+.|+|++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000 1257789999999 99999999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.21 Aligned_cols=246 Identities=30% Similarity=0.563 Sum_probs=207.4
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+...+|++.+.||+|+||.||++...++.+|+|.+.... ..+.|.+|+.+++.++||||+++++++... ..+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 456789999999999999999999999999999985432 236789999999999999999999998765 479999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+++|.+++... ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred ECCCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999998643 3346889999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~ 760 (786)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...........+.. +..+..+ +..+.+++.+
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHH
Confidence 122334568999999988889999999999999999997 9999988877666554433 3333322 3468899999
Q ss_pred hhh-CCCCCCCHHHHHHHHHh
Q 003919 761 CWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L~~ 780 (786)
||+ +|++||++.+|++.|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.95 Aligned_cols=247 Identities=29% Similarity=0.524 Sum_probs=209.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||.|+||.||++.+ ++..+|+|++... .....+.|.+|+.++++++||||+++++++..+..++++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 46788999999999999999987 4788999998643 3344578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|..++.. ....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998863 2356899999999999999999999999999999999999999999999999998766443333
Q ss_pred CCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHH
Q 003919 685 DSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip---~~~L~ 755 (786)
.....+++.|+|||.+. ...++.++|||||||++|+|++|+.||...........+...... ...+ ...+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999975 345778999999999999999999999988776666555443221 1122 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+++.+||+ +|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999 99999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.58 Aligned_cols=244 Identities=29% Similarity=0.495 Sum_probs=194.7
Q ss_pred EEeecCcEEEEEEEE-C---CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 535 RVGIGFFGEVFRGIW-N---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~-~---G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.||+|+||.||+|.. + ...+++|.+... ........|.+|+.+++.++||||+++++++.+...++++|||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 689999999999964 2 346788876533 23444567899999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcC--CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC--CC
Q 003919 611 SLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR--DS 686 (786)
Q Consensus 611 SL~dlL~~~~~--~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~--~~ 686 (786)
+|.+++..... ....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99999864322 234567888999999999999999999999999999999999999999999998764332211 12
Q ss_pred CCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC-CCC------CC
Q 003919 687 SSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR-LEI------PE 751 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~-~~i------p~ 751 (786)
...+++.|+|||++.. ..++.++|||||||++|||++ |..||.................. ... ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3345678999998743 456889999999999999999 78899887776665555443321 111 12
Q ss_pred hHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003919 752 GPLGRLIADCWAEPQERPSCEEILSRLL 779 (786)
Q Consensus 752 ~~L~~LI~~CL~DP~kRPSa~EIL~~L~ 779 (786)
..+..++..||.||.+||++++|++.|.
T Consensus 241 ~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 241 DRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 3577899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.23 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=209.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|++.+.||+|+||.||++.+ .++.+|+|++..... .....+.+.+|+++++++.||||+++++++.+...++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 578999999865433 2334577899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ....+++..+..++.||+.||+|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999986 3457899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA 763 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~ 763 (786)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+........ ..+..+.+++.+||.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 2345788999999999888899999999999999999999999988776665555553322221 124578999999999
Q ss_pred -CCCCCC-----CHHHHHHH
Q 003919 764 -EPQERP-----SCEEILSR 777 (786)
Q Consensus 764 -DP~kRP-----Sa~EIL~~ 777 (786)
||.+|+ ++++++++
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHccCcccCCHHHHHcC
Confidence 999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.22 Aligned_cols=244 Identities=28% Similarity=0.478 Sum_probs=204.5
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|++.+.||+|+||.||++.+ .+..+++|.+... .....+.|.+|+++++.++||||+++++++...+..++++||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 56778999999999999988 4677888887543 2345678999999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
++++|..++.. ....+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 99999887753 3457899999999999999999999999999999999999999999999999998766443333345
Q ss_pred CCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHH
Q 003919 688 SAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLI 758 (786)
Q Consensus 688 ~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip---~~~L~~LI 758 (786)
..+++.|+|||++. +..++.++|||||||++|+|++|+.||...........+..... ....+ +..+.+|+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 57899999999984 44578899999999999999999999988877666555543322 11122 34799999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+||. ||.+||++.+++++
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.97 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=199.3
Q ss_pred eeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 601 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~ 601 (786)
|++.+.||+|+||+||++.+ .++.||+|++..... ......|.+|+++++.++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 38889999999999988753 466899999865432 33457789999999999999999999987653 4589
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++.. ..+++.+++.++.|++.||+|||++||+|+||||+|||+++++.++|+|||++..+...
T Consensus 85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999862 35899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHhcC
Q 003919 682 PMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVANEG 744 (786)
Q Consensus 682 ~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~--------------~l~~i~~~~ 744 (786)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 221 122345667999999988889999999999999999999999986533210 011111112
Q ss_pred CCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 745 SRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 745 ~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.....+ ...+.+++.+||+ +|++|||+.+|++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222 3478999999999 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.52 Aligned_cols=246 Identities=30% Similarity=0.462 Sum_probs=210.3
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|+||.||++.. +++.+|+|.+............+.+|+++++.++||||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999876 678899999977666556678899999999999999999999999988999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCccccccCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~~~~~~~ 685 (786)
+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||+|+||+++++ +.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~ 158 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA 158 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence 9999999998632 24468999999999999999999999999999999999999855 468999999998775432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... ..++ ...+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHc
Confidence 345688899999999988899999999999999999999999988777666655544332 2232 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. +|.+|||+.+++++
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.23 Aligned_cols=246 Identities=30% Similarity=0.480 Sum_probs=202.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l 600 (786)
-+|.+.+.||+|+||.||++.+ .++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999976 578999998864432 22345678899999999999999999998765 3568
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++++|.+++. ....+++...+.++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999886 334688999999999999999999999999999999999999999999999999876532
Q ss_pred CCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..................+.++ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 111 1123457889999999998889999999999999999999999998876666555554444334333 3457
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..++ +||. +|++||++++|++|
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcC
Confidence 7788 5666 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.44 Aligned_cols=241 Identities=29% Similarity=0.561 Sum_probs=202.0
Q ss_pred EEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhH
Q 003919 535 RVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~ 613 (786)
.||+|+||.||+|.. +++.+|+|++.... .......|.+|+++++.++||||+++++++......+++|||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 689999999999976 57789999876443 3344467899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC-CCCCCC
Q 003919 614 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTP 692 (786)
Q Consensus 614 dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~-~~~GT~ 692 (786)
+++.. ....+++..++.++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++........... ...+++
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 98863 234688999999999999999999999999999999999999999999999999876543322211 223456
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~k 767 (786)
.|+|||++.+..++.++||||||+++|++++ |..||...........+.. ......+ ...+.+++.+||. +|++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 7999999998889999999999999999998 9999988877766555543 3333322 2468999999999 9999
Q ss_pred CCCHHHHHHHHH
Q 003919 768 RPSCEEILSRLL 779 (786)
Q Consensus 768 RPSa~EIL~~L~ 779 (786)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.05 Aligned_cols=247 Identities=23% Similarity=0.264 Sum_probs=203.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|+..+.||+|+||+||++.+ +++.+|+|.+....... .....+.+|+++++.++|+||+.+++++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999999987 57899999986554332 234567889999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SI 158 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cc
Confidence 99999999887633 23469999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC---CChHHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEI---PEGPLGRLIAD 760 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~--~~~i---p~~~L~~LI~~ 760 (786)
....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+..... .... ....+.+|+..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 345789999999999988899999999999999999999999987765443333322111 1111 23468899999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003919 761 CWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPS-----a~EIL~~ 777 (786)
||+ ||.+||+ +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 999 9999999 7787765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=336.51 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=194.3
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC------CceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH------PNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H------PNIVkL~g 592 (786)
+++.....+|.+.+.||+|+||+||+|.+ .++.||||++.... .....+..|+++++.++| .+|+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 44455568899999999999999999977 57789999985421 223455667777777654 46889998
Q ss_pred ccccC-CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCC-----
Q 003919 593 ACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW----- 665 (786)
Q Consensus 593 ~~~~~-~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g----- 665 (786)
++... ..+++||+++ +++|.+++. ....+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 88764 4688899888 567877775 34578999999999999999999997 6999999999999998765
Q ss_pred -----------eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 003919 666 -----------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE 734 (786)
Q Consensus 666 -----------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~ 734 (786)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 234568999999999999999999999999999999999999999887665
Q ss_pred HHHHHHHhcCCCC-------------------------------------------CCCChHHHHHHHHhhh-CCCCCCC
Q 003919 735 RVVYAVANEGSRL-------------------------------------------EIPEGPLGRLIADCWA-EPQERPS 770 (786)
Q Consensus 735 ~~l~~i~~~~~~~-------------------------------------------~ip~~~L~~LI~~CL~-DP~kRPS 770 (786)
..+..+......+ .+.+..+.+||.+||+ ||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 4443322111000 0012246689999999 9999999
Q ss_pred HHHHHHH
Q 003919 771 CEEILSR 777 (786)
Q Consensus 771 a~EIL~~ 777 (786)
+.|+|+|
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.30 Aligned_cols=248 Identities=31% Similarity=0.532 Sum_probs=209.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|+||.||+|.. .|..+|+|.+..........+.+.+|+++++.++|+||+++++.+.....+++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999987 578899999876554444557788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~~~~~ 685 (786)
+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||++++++ .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9999999988632 234679999999999999999999999999999999999999875 57999999998775443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA 763 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip--~~~L~~LI~~CL~ 763 (786)
....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.........+ ...+.+++.+||.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 34568899999999988889999999999999999999999998877766665554433222111 3469999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|++|||+.+++++
T Consensus 240 ~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 240 VSPRDRPSITSILKR 254 (257)
T ss_pred cChhhCcCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.01 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=221.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.-|.+.+.||+|.|++|.++.+ .|..||||++.+..++.-.-..+.+|+..|+.++|||||+||++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477788999999999999965 89999999999888877767789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEEEecCccccccCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
+-++|+|++++-. +...+.+..+++|+.||+.||.|||+.++|||||||+||.+. .-|-|||.|||++..+..+ ..
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KK 174 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-ch
Confidence 9999999999973 456799999999999999999999999999999999999875 5689999999999887654 34
Q ss_pred CCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 762 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~CL 762 (786)
..+.||+..|-|||++.+..|+ ++.||||||||||-|++|+.||+..+..+.+-.+....+..+- ...+.++||..||
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHH
Confidence 5688999999999999999887 6789999999999999999999999998888888877765542 3457899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||.+|.+.++|...
T Consensus 255 vRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVST 270 (864)
T ss_pred hcCchhhccHHHHhcc
Confidence 9 99999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.18 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=211.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+|++.+.||+|+||.||++.. .++.+|+|.+....... ...+.+..|+++++.++||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999987 47899999997665442 35678899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999999999988632 346789999999999999999999999999999999999999999999999999876532110
Q ss_pred ----------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003919 684 ----------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 735 (786)
Q Consensus 684 ----------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~ 735 (786)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123467889999999999889999999999999999999999999887777
Q ss_pred HHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCC----HHHHHHH
Q 003919 736 VVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPS----CEEILSR 777 (786)
Q Consensus 736 ~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPS----a~EIL~~ 777 (786)
....+.......... +..+.+++.+||. ||++||+ +++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 666655444333222 4569999999999 9999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.60 Aligned_cols=245 Identities=28% Similarity=0.460 Sum_probs=195.4
Q ss_pred eEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||.||+|.+. +..+|+|.+..... ......|.+|+.++++++||||+++++++.+...+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999763 34689998765443 23345789999999999999999999999998899999999999
Q ss_pred chhHHHHHhhc--CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC--C
Q 003919 610 GSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR--D 685 (786)
Q Consensus 610 GSL~dlL~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~--~ 685 (786)
|+|.+++.... .....++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++......... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999986432 1235677788899999999999999999999999999999999999999999999765432211 1
Q ss_pred CCCCCCCcccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcC-CCCCC------C
Q 003919 686 SSSAGTPEWMAPELIRNE-------PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEG-SRLEI------P 750 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~-------~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~-~~~~i------p 750 (786)
....+++.|+|||++.+. .++.++|||||||++|||++ |+.||......+......... ..... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence 234577889999998642 35789999999999999996 999998776665544333221 11111 1
Q ss_pred ChHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003919 751 EGPLGRLIADCWAEPQERPSCEEILSRLL 779 (786)
Q Consensus 751 ~~~L~~LI~~CL~DP~kRPSa~EIL~~L~ 779 (786)
...+.+++.+||.+|++|||+.+|+..|.
T Consensus 240 ~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 240 SDRWYEVMQFCWLQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence 23578899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.63 Aligned_cols=253 Identities=34% Similarity=0.565 Sum_probs=204.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC------------------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~------------------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV 588 (786)
.++|++.+.||+|+||.||++.+. +..+|+|++.... .......|.+|+++++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 467999999999999999998542 3368999986442 334457899999999999999999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhcC--------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~--------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
++++++...+..+++|||+++++|.+++..... ...+++.++..++.|++.||+|||+.||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999998864321 134778899999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 003919 661 VNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT--LNRPWEGVLPERV 736 (786)
Q Consensus 661 Ld~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT--G~~PF~~~~~~~~ 736 (786)
++.++.++|+|||++..+...... .....+++.|++||...+..++.++|||||||++|||++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 999999999999999865432211 112334678999999888889999999999999999998 7789987766554
Q ss_pred HHHHHh---c---CCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 737 VYAVAN---E---GSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 737 l~~i~~---~---~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
...... . ....+. ....+.+|+.+||+ ||.+||++.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 433211 0 111111 13568999999999 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.50 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=202.3
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||.|+||.||+|.+ +|+.||||++............+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 578999999865544444456788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+. ++|..++... ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 96 5788877532 345789999999999999999999999999999999999999999999999999876644322233
Q ss_pred CCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003919 687 SSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 747 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------ 747 (786)
...+++.|+|||.+.+.. ++.++|||||||++|+|+||+.||...........+.......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 445788999999887644 6889999999999999999999998776554443332211100
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..-+..+.++|.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0112357789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.30 Aligned_cols=249 Identities=30% Similarity=0.489 Sum_probs=205.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCC----
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPP---- 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~---- 598 (786)
..++|.+.+.||+|+||.||+|.+ +++.+++|++..... ..+.|.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 357899999999999999999987 467899999865432 346789999999999 6999999999986544
Q ss_pred --ceEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 599 --RLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 599 --~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
.++++|||+++++|.+++.... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4899999999999999886432 2467899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 749 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i- 749 (786)
..............+++.|+|||.+.. ..++.++|||||||+||+|++|+.||...........+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 776543333345668899999998753 34778999999999999999999999877666655555433221111
Q ss_pred C---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 P---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 p---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ ...+.+|+.+||. ||++|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 2368899999999 99999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.52 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=202.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|++.+.||+|+||.||++.+ .++.||+|.+...... ......+.+|+.++++++|+||+.+++.+.+.+.++++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999987 5789999998655432 2234567889999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI 158 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence 99999999888532 23468999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCC--CCCCCChHHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGS--RLEIPEGPLGRLIAD 760 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---~~l~~i~~~~~--~~~ip~~~L~~LI~~ 760 (786)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+..... ........+.+|+..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999865432 12222211111 111224468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003919 761 CWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPS-----a~EIL~~ 777 (786)
||+ ||.+||| +.+++++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcC
Confidence 999 9999999 8999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.40 Aligned_cols=239 Identities=29% Similarity=0.455 Sum_probs=199.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||.||+|.+ +++.||+|++.... .......|.+|+.++++++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999986 67889999986543 33445779999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+... ..
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~ 150 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IA 150 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cc
Confidence 99999886542 4678888999999999999999999999999999999999999999999999876433 23
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC----CChHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI----PEGPL 754 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-------~~~l~~i~~~~~~~~i----p~~~L 754 (786)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+.... .... ....+
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCCCCCcCCHHH
Confidence 356789999999999998899999999999999999999999965322 12222222211 1111 23468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+++.+||+ +|.+||++.+++++
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcC
Confidence 899999999 99999999999977
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=313.64 Aligned_cols=251 Identities=30% Similarity=0.573 Sum_probs=209.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..+|++.+.||+|+||.||+|.+ +|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 46789999999999999999976 233 588998764433 4456789999999999999999999999887 679
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999863 234689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
..... ....++..|+|||.+....++.++|||||||++||+++ |+.||.+.........+.. +.....+ ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-GERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-CCCCCCCCCCCHHH
Confidence 32111 12224568999999988889999999999999999998 9999998887776665543 3333332 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+++.+||. ||+.||++.++++.|.++.
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 899999999 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.10 Aligned_cols=245 Identities=31% Similarity=0.564 Sum_probs=198.0
Q ss_pred eEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc-cCCceEEEEEee
Q 003919 534 TRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT-KPPRLSMITEYM 607 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~-~~~~l~LV~Ey~ 607 (786)
+.||+|+||.||+|.+. +..+|+|.+... ......+.|.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999752 357999987532 23344678999999999999999999999775 455689999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC----
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 683 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~---- 683 (786)
.+++|.+++... ...+++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998632 33467778889999999999999999999999999999999999999999999976543221
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
......++..|+|||.+.+..++.++|||||||++|||++| ..||...........+.. +.....+ +..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHHHH
Confidence 11233456789999999888899999999999999999995 567777666655554433 2222222 346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 760 DCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+||. +|++||++.+|++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 9999 9999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.67 Aligned_cols=245 Identities=29% Similarity=0.475 Sum_probs=207.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 37899999999999999999986 6889999998654433 2467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ...+++.++..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999999885 235788999999999999999999999999999999999999999999999999876544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip---~~~L~~LI~~ 760 (786)
.....+++.|+|||.+.+..++.++|||||||++|+|++|..||...........+...+... ..+ ...+.+|+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 345578899999999999889999999999999999999999998766544433333222111 112 3458899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. +|++||++.+++++
T Consensus 252 ~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 252 CLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999 99999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.26 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=204.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.+|.+.+.||+|+||.||+|.+ +++.||+|++..........+.+.+|++++++++|+||+++++++...+.+++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 47789999987655444556789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 684 (786)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999877766654 345689999999999999999999999999999999999999999999999999987755432 2
Q ss_pred CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003919 685 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 745 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------------ 745 (786)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345678899999999887 789999999999999999999999987655443332221000
Q ss_pred ---------------CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 ---------------RLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ---------------~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....-+..+.+||.+||. +|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000113458899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.15 Aligned_cols=254 Identities=32% Similarity=0.551 Sum_probs=210.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+.++|.+.+.||.|+||+||+|... .+.+++|.+..... ....+.|.+|+.++++++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4578999999999999999999752 35689998754332 234578999999999999999999999999988
Q ss_pred ceEEEEEeeccchhHHHHHhhcCC------ccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQK------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~------~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
..+++|||+++++|.+++...... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999998743322 26899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 673 GLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 673 GLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........+............+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 99875533221 2233456778999999988888999999999999999998 788998877766666554333222222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
+..+.+++.+||. +|.+||++.++++.|.+
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 3468999999999 99999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.99 Aligned_cols=245 Identities=33% Similarity=0.582 Sum_probs=199.6
Q ss_pred EEeecCcEEEEEEEEC--Ce--eEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeecc
Q 003919 535 RVGIGFFGEVFRGIWN--GT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~--G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
.||+|+||.||+|.+. +. .+++|.+... ......+.|.+|++++.++ +||||+++++++...+.++++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999873 33 4678876532 2334457889999999999 799999999999999999999999999
Q ss_pred chhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 610 GSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 610 GSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
++|.+++.... ....+++.+++.++.|++.||+|||+.|++|+||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986422 12357899999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EG 752 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~ 752 (786)
..... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.. ......+ +.
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDD 238 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-CCCCCCCCcCCH
Confidence 43211 11112234567999999988889999999999999999997 9999988777665555433 2222222 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+.+|+.+||. ||.+|||+.++++.|.++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 68899999999 9999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.36 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=205.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||.|+||.||+|.+ +|+.+|+|++..........+.+.+|+.++++++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999987 588999999977665455567899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-CC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~ 685 (786)
+ +++|.+++... ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 99999988632 36789999999999999999999999999999999999999999999999999987654321 12
Q ss_pred CCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 003919 686 SSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------- 747 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------------- 747 (786)
....++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 46899999999999999999988887766554443333211000
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+++.+|+. +|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0112467889999999 99999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.88 Aligned_cols=247 Identities=26% Similarity=0.461 Sum_probs=204.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|++.+.||+|+||.||++.+ .++.||+|.+... ........+.+|+.++++++||||+++++++...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688899999999999999988 4889999988643 334445789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|+++++|..++........+++..+..++.|++.||.|||+ .||+|+||||+||+++.++.++|+|||++..+... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--L 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--c
Confidence 99999999888643234478999999999999999999996 69999999999999999999999999999766432 2
Q ss_pred CCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCCCC---ChH
Q 003919 685 DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLEIP---EGP 753 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~--~~~~~~ip---~~~ 753 (786)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.. ......++ +..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 2345688899999998554 357899999999999999999999976655443332221 22222233 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+|+.+||. +|.+||++.+++.+
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcC
Confidence 8899999999 99999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.66 Aligned_cols=251 Identities=29% Similarity=0.531 Sum_probs=199.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~ 598 (786)
..+|++.+.||+|+||.||++.+ ++..||+|.+... .....+.|.+|+++++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 35788999999999999999864 4678999997643 33446789999999999999999999998643 34
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++++||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 68999999999999999863 2346899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHHH
Q 003919 679 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VVYAV 740 (786)
Q Consensus 679 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~---------------~l~~i 740 (786)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..|+....... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 433211 112233456999999998889999999999999999999877654322110 11112
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 741 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 741 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.........+ ...+.+|+.+||. +|++|||+.+|++.|.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2222222222 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=314.47 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=208.1
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACT 595 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~ 595 (786)
....+....++|.+.+.||+|+||.||++.. .++.+|+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3445555678899999999999999999987 578899999854322 235677899999999 7999999999986
Q ss_pred cC-----CceEEEEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEE
Q 003919 596 KP-----PRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669 (786)
Q Consensus 596 ~~-----~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL 669 (786)
.. ..+++|+||+++++|.++++.. .....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 43 3589999999999999988632 23457899999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003919 670 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 670 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~ 744 (786)
+|||++..............++..|+|||.+... .++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999998765433333455788999999998643 36889999999999999999999998877666555544332
Q ss_pred CC-CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 SR-LEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ~~-~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ...+ ...+.+||.+||+ +|++||++.+|+++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 21 1112 2358899999999 99999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.03 Aligned_cols=245 Identities=20% Similarity=0.317 Sum_probs=196.7
Q ss_pred EeeEEeec--CcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 532 VGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 532 i~k~LG~G--~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
++++||+| +|++||++.. +|+.||+|++............+.+|+.+++.++||||++++++|..++.+++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999976 6889999998766555555667888999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC----
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM---- 683 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~---- 683 (786)
++|+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998632 234589999999999999999999999999999999999999999999999987544322111
Q ss_pred ---CCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003919 684 ---RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 748 (786)
Q Consensus 684 ---~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------- 748 (786)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1122356778999999976 4689999999999999999999999987655443333222110000
Q ss_pred -------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -------------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.-+..+.+|+.+||+ ||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 001257789999999 99999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.82 Aligned_cols=244 Identities=34% Similarity=0.582 Sum_probs=207.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
..|+..+.||.|+||.||+|.+ .++.+|+|++..... ....+.+.+|+.+++.+.||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3567788999999999999987 578999999865433 3446789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++. ...+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 83 YLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 999999999885 2358889999999999999999999999999999999999999999999999998765443333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....++..|+|||.+.+..++.++|+|||||++|||++|..||....+......+.. .....++ +..+.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-CCCCCCchhhhHHHHHHHHHHc
Confidence 345688899999999988899999999999999999999999988777665554432 2222222 236889999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. +|++||++.+++++
T Consensus 238 ~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 238 NKDPSFRPTAKELLKH 253 (277)
T ss_pred ccCcccCcCHHHHHhC
Confidence 9 99999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=310.92 Aligned_cols=251 Identities=28% Similarity=0.435 Sum_probs=201.5
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
++.+++++.....||+|+||.||+|.+ +++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++.+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 344556666667899999999999976 46789999876443 33457899999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccc--hHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCcccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 677 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~L--s~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 677 (786)
++++||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.||+|+||||+||+++. ++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999986322 334 78888999999999999999999999999999999976 67999999999877
Q ss_pred ccCCCCCCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC---C
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP---E 751 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~ip---~ 751 (786)
............+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... .............++ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 64433333345688999999998664 37899999999999999999999997654322 222221112222233 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+.+++.+||. +|.+||++.+++.+
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 468899999999 99999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.55 Aligned_cols=243 Identities=33% Similarity=0.580 Sum_probs=205.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
.|+..+.||+|+||.||+|.+ .++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++.+++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466678899999999999987 577899999864433 23457899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++..+........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99999998875 24688999999999999999999999999999999999999999999999999987654333333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...++..|+|||.+.+..++.++|||||||++|||++|+.||....+......+.. ......+ ...+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-NSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45688899999999998899999999999999999999999987766555444332 2222222 3468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 99999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=361.94 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=211.0
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK- 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~- 596 (786)
+........+|.+.+.||+|+||+||++.+ .+..+|+|++............|..|+.+++.|+|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 344555678999999999999999999987 46789999987766666667889999999999999999999998854
Q ss_pred -CCceEEEEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhc-------ceeeccCCcccEEEcC----
Q 003919 597 -PPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-------KIVHRDLKSANCLVNK---- 663 (786)
Q Consensus 597 -~~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-------gIIHrDLKpsNILLd~---- 663 (786)
...+|+||||+++++|.+++... .....+++..++.|+.||+.||+|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 45689999999999999988642 2235799999999999999999999985 4999999999999964
Q ss_pred -------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 003919 664 -------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPW 728 (786)
Q Consensus 664 -------------~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF 728 (786)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||+|+||+.||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2358999999998764432 2235579999999999864 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 729 EGVLPERVVYAVANEGSRLEIP--EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 729 ~~~~~~~~l~~i~~~~~~~~ip--~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
........+...........++ ...+.+||..||. +|.+||++.++|.+
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 8766554444444444333332 4579999999999 99999999999954
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.14 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=209.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.+|.+.+.||.|++|.||++.+ .++.++||++...... .....|.+|+..+.+++|+||+++++++...+.+++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3688899999999999999987 4889999998665432 446789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999873 3678999999999999999999999 99999999999999999999999999999877554333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLEIP----EGPLGRL 757 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~---~~~~l~~i~~~~~~~~ip----~~~L~~L 757 (786)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....+. .......+ +..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHH
Confidence 335568889999999999889999999999999999999999998774 333333333 22223332 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. +|++||++.+++++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHccCChhhCCCHHHHHhC
Confidence 999999 99999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.44 Aligned_cols=247 Identities=35% Similarity=0.660 Sum_probs=206.1
Q ss_pred eeEeeEEeecCcEEEEEEEECC------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~G------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+++.+.||.|+||.||++.+.. ..+|+|++..... ....+.+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998753 7799999854433 22467899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.... ...+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EeccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999986322 12289999999999999999999999999999999999999999999999999987754422
Q ss_pred CCC-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHH
Q 003919 684 RDS-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIA 759 (786)
Q Consensus 684 ~~~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~i--p~~~L~~LI~ 759 (786)
... ...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......... .+..+.+++.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML 238 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 221 2346789999999988889999999999999999998 78899887777766665543322211 2346889999
Q ss_pred Hhhh-CCCCCCCHHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L 778 (786)
+||. ||.+|||+.++++.|
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 239 QCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHCcCChhhCcCHHHHHhhC
Confidence 9999 999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.01 Aligned_cols=234 Identities=27% Similarity=0.511 Sum_probs=191.5
Q ss_pred eEEeecCcEEEEEEEECCe------------eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 534 TRVGIGFFGEVFRGIWNGT------------DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~------------~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+.||+|+||.||+|.+.+. .+++|++...... ...|.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3689999999999987432 3777876533221 5789999999999999999999999888 7789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-------eEEEEecCc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-------TVKICDFGL 674 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-------~VKL~DFGL 674 (786)
+|+||+++++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998732 22788999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
+..... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||............. .......+
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 229 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPD 229 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCC
Confidence 987543 2234567789999999876 78999999999999999999 577887765443333222 22222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
...+.+++.+||. +|.+||++.++++.|
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 3578999999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.25 Aligned_cols=236 Identities=22% Similarity=0.435 Sum_probs=190.5
Q ss_pred eEEeecCcEEEEEEEEC--------------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 534 TRVGIGFFGEVFRGIWN--------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~--------------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
+.||+|+||.||+|... ...+++|++.... ....+.|..|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 36899999999999742 2258888865432 2334678899999999999999999999999889
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe-------EEEEec
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-------VKICDF 672 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~-------VKL~DF 672 (786)
.+++|||+++++|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999888763 3356899999999999999999999999999999999999987654 899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 673 GLSRIITDSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 673 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELl-TG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
|++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......... ..........+
T Consensus 157 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~ 231 (262)
T cd05077 157 GIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTP 231 (262)
T ss_pred CCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCC
Confidence 998765322 2446788999999886 467899999999999999998 5888887765443322 22222222222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
...+.+|+.+||+ ||.+||++.+|+++|
T Consensus 232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 232 SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3468899999999 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=353.74 Aligned_cols=259 Identities=27% Similarity=0.484 Sum_probs=213.3
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE-CC-eeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecc-ccc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA-CTK 596 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G-~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~-~~~ 596 (786)
..+.+...+++|.+.|.+|||+.||+|+. .+ ..||+|++... ++...+...+||++|++|+ |+|||.|++. ...
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 45566778899999999999999999987 34 89999998765 5667889999999999997 9999999993 211
Q ss_pred ---C---CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeEE
Q 003919 597 ---P---PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVK 668 (786)
Q Consensus 597 ---~---~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~VK 668 (786)
+ -.++|.||||.||.|-+++...... .|++.++++|++++++|+++||... |||||||.+||||..+++.|
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 2478999999999999999754333 4999999999999999999999987 99999999999999999999
Q ss_pred EEecCccccccCCCCCC---------CCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 003919 669 ICDFGLSRIITDSPMRD---------SSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 736 (786)
Q Consensus 669 L~DFGLA~~l~~~~~~~---------~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~ 736 (786)
|||||.+.-........ -...-|+.|+|||++ .+.+.++|+|||+|||+||-||....||++.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la- 265 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA- 265 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-
Confidence 99999987543322111 123478999999987 56789999999999999999999999998764432
Q ss_pred HHHHHhcCCCCCC-C--ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhcC
Q 003919 737 VYAVANEGSRLEI-P--EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSLC 786 (786)
Q Consensus 737 l~~i~~~~~~~~i-p--~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sLc 786 (786)
|++..+.++. | ...+.+||..||+ ||.+||++.+++.++-.+...-|
T Consensus 266 ---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 ---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 3444444433 2 3469999999999 99999999999999988776443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=326.50 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=212.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc-eeEEecccccCC-----
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPP----- 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN-IVkL~g~~~~~~----- 598 (786)
+..|...++||+|+||+||+|+. +|+.||+|++......+.......+|+.+++.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677778899999999999976 6889999998765443333456789999999999999 999999998776
Q ss_pred -ceEEEEEeeccchhHHHHHhhcCC-ccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 599 -RLSMITEYMELGSLYHLIHLSGQK-KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 599 -~l~LV~Ey~~gGSL~dlL~~~~~~-~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+++|+||++. +|..++...... ..++...++.++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 79999999974 888888744322 467778999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---C---
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---I--- 749 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---i--- 749 (786)
.+.-+....+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+......+..+...-..+. .
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776554445677899999999999886 799999999999999999999999999988777776654332221 0
Q ss_pred ----------C---------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003919 750 ----------P---------------EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 782 (786)
Q Consensus 750 ----------p---------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i~ 782 (786)
+ +....+++..|++ +|.+|.|+...+.| +..+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0 0135578999999 99999999999988 55543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=305.85 Aligned_cols=242 Identities=29% Similarity=0.591 Sum_probs=202.8
Q ss_pred eEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 534 TRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
++||.|+||.||++.++ ++.||+|.+...... ...+.|.+|++++++++|+||+++++++.+....++++||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999874 889999988655443 4567899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAG 690 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~G 690 (786)
.+++.. ....+++..+..++.+++.||+|||+++++|+||+|+|||++.++.++|+|||++.......... .....
T Consensus 80 ~~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 998863 23468899999999999999999999999999999999999999999999999998664322211 12233
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CC
Q 003919 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EP 765 (786)
Q Consensus 691 T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP 765 (786)
+..|+|||.+.+..++.++|||||||++|+|+| |..||...........+.. ......+ +..+.+++.+||. +|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999988889999999999999999999 7889988776665555433 2222222 3478999999999 99
Q ss_pred CCCCCHHHHHHHHH
Q 003919 766 QERPSCEEILSRLL 779 (786)
Q Consensus 766 ~kRPSa~EIL~~L~ 779 (786)
.+||++.++++.|.
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.55 Aligned_cols=246 Identities=23% Similarity=0.274 Sum_probs=202.0
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC---hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~---~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+|.+.+.||+|+||.||+|.+ +++.||||.+...... ......+..|+++++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 5789999998765543 33345677899999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+ +++|.+++... ...+++..++.++.||++||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 88999998632 23789999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------
Q 003919 684 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------------- 747 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~--------------- 747 (786)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334457788999998855 467899999999999999999988887766544443332211000
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..-...+.++|.+||. ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0012357789999999 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.69 Aligned_cols=251 Identities=28% Similarity=0.527 Sum_probs=205.2
Q ss_pred eeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------
Q 003919 530 LTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 598 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------ 598 (786)
|.+.+.||+|+||.||+|.+ .+..+|||++..+.......+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 3678999999766555666788999999999999999999999875432
Q ss_pred ceEEEEEeeccchhHHHHHhhc---CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..+++++|+.+|+|.+++.... ....+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478899999999988775321 1235788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 676 RIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 676 ~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
+....... ......+++.|++||.+.+..++.++|||||||++|+|++ |+.||.+.........+.... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCC
Confidence 87643321 1123345678999999998889999999999999999999 889998877766555444332 22222
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
...+.+++.+||+ +|++||++.++++.|+++
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.08 Aligned_cols=246 Identities=28% Similarity=0.372 Sum_probs=205.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-----CCce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-----~~~l 600 (786)
..|...+.||+|+||.|..+.+ +|+.||||++..........++..+|+.+|+.++|+||+.+++++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555678999999999999977 68899999987655566677899999999999999999999998865 3459
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+|+|+|+ .+|..+++ .++.|+...+..+++|++.||.|+|+.||+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elMe-tDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EEehhHHh-hHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999994 68888886 556699999999999999999999999999999999999999999999999999998853
Q ss_pred C--CCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003919 681 S--PMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 748 (786)
Q Consensus 681 ~--~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--------- 748 (786)
. ....+..+-|.+|.|||++. ...|+...||||.|||+.||++|++-|.+.+....+..+..--..+.
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 22346788999999999875 46799999999999999999999999988766555544433222111
Q ss_pred ------------CC-----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ------------IP-----------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ------------ip-----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.| .....+|+.+||. ||.+|+|++|.|+|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 1134578999999 99999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.89 Aligned_cols=240 Identities=26% Similarity=0.405 Sum_probs=185.0
Q ss_pred eeEEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCceEEEEEe
Q 003919 533 GTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEY 606 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~LV~Ey 606 (786)
+++||+|+||+||+|.+ .++.+|+|.+...... ..+.+|+.++++++||||+++++++.. ...+++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999975 3568999998654332 457789999999999999999998854 4568999999
Q ss_pred eccchhHHHHHhhc------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----cCCCeEEEEecCccc
Q 003919 607 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 676 (786)
Q Consensus 607 ~~gGSL~dlL~~~~------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~ 676 (786)
+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 874 7777764321 12358999999999999999999999999999999999999 456789999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003919 677 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 743 (786)
Q Consensus 677 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---------~~l~~i~~~ 743 (786)
.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 7643321 1234678999999999876 45899999999999999999999999643221 111111100
Q ss_pred CC---------------------------C------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 GS---------------------------R------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 ~~---------------------------~------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. . ...++..+.+|+.+||+ ||.+|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 00112346789999999 99999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=312.85 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=202.7
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccccc------
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK------ 596 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~------ 596 (786)
....|++.+.||.|+||.||+|.+ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 457788899999999999999987 57889999975432 3346788999999998 69999999999853
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...++++|||+++|+|.+++... ....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45689999999999999988632 34468888999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 749 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-- 749 (786)
.............|++.|+|||.+. +..++.++|||||||++|+|++|..||....+......+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence 6643322334567899999999885 346888999999999999999999999877665555443332221111
Q ss_pred -CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 -PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 -p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+..+.+||.+||. ||.+||++.+|+++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 23468999999999 99999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.79 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=202.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC--------hHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~--------~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+|.+.+.||.|+||.||+|.. +|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 5889999987543211 112457889999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++|+||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999863 357899999999999999999999999999999999999999999999999999765
Q ss_pred cCCC--CCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----
Q 003919 679 TDSP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---- 750 (786)
Q Consensus 679 ~~~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---- 750 (786)
.... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||...........+.........+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 4321 1123456888999999987654 7899999999999999999999997666554444433332222222
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+.+++.+||. +|.+||++.+|+++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 2468899999999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.61 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=204.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+|.+.+.||.|+||.||+|.+ .++.+|+|++...... ....+.+.+|++++++++||||+++++++.....+++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 588999999999999999987 4889999999765442 2456789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+++|..++.. ...+++..+..++.|+++||.|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 156 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LT 156 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cc
Confidence 9999999998863 3578999999999999999999999999999999999999999999999999988765432 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......... .....+ +..+.+++.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAIN 234 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence 345688899999999988899999999999999999999999987763 333322221 222222 347889999
Q ss_pred Hhhh-CCCCCCCH--HHHHH
Q 003919 760 DCWA-EPQERPSC--EEILS 776 (786)
Q Consensus 760 ~CL~-DP~kRPSa--~EIL~ 776 (786)
+||. ||.+||++ .++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999 99999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.36 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=206.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccc---cChHHHHHHHHHHHHHhhcCCCceeEEecccccC--Cce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD---LTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~---~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l 600 (786)
.+|.+.+.||+|+||.||++.+ +++.+|+|++.... ........|.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999976 58899999875432 2234467899999999999999999999998654 458
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999886 234588999999999999999999999999999999999999999999999999986532
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003919 681 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 754 (786)
Q Consensus 681 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L 754 (786)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+........+|. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 11 112235688999999999988899999999999999999999999988776666655554444444443 468
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 003919 755 GRLIADCWAEPQERPSCEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~DP~kRPSa~EIL~~ 777 (786)
.+++.+||++|.+||++.+++.|
T Consensus 239 ~~~i~~~l~~~~~r~~~~~~~~~ 261 (264)
T cd06653 239 RDFLKQIFVEEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHhcCcccCccHHHHhcC
Confidence 99999999988999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=312.86 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=199.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCc-----
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPR----- 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~----- 599 (786)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999987 5889999997654433333467889999999995 6999999999877655
Q ss_pred eEEEEEeeccchhHHHHHhhcC--CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSR 676 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~--~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~ 676 (786)
.|++|||+++ +|.+++..... ...+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 78777753322 356899999999999999999999999999999999999998 8899999999998
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------- 747 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-------- 747 (786)
.+...........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 66433222234467889999998865 457999999999999999999999998876655544433211000
Q ss_pred ---------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ---------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ---------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.....+.++|.+||. ||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0113358889999999 99999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.95 Aligned_cols=251 Identities=24% Similarity=0.440 Sum_probs=209.0
Q ss_pred CeeEeeEEeecCcEEEEEEEEC---CeeEEEEEEeccc--------cChHHHHHHHHHHHHHhh-cCCCceeEEeccccc
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQD--------LTAENMEDFCNEISILSR-LRHPNVILFLGACTK 596 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~---G~~VAVKvl~~~~--------~~~~~~~~f~~EI~iL~~-L~HPNIVkL~g~~~~ 596 (786)
.|++.+.||+|+||.||+|.+. ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999874 4789999875432 223345678889998865 789999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGL 674 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGL 674 (786)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||. .+++|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887532 234578999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCC
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPE 751 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---ip~ 751 (786)
+....... ......++..|++||.+.+..++.++||||||+++|+|++|+.||...........+......+. ...
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 98765443 33456688999999999988899999999999999999999999988777666555544333221 123
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
..+.+++.+||+ ||++||++.++..++.+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 579999999999 99999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.51 Aligned_cols=246 Identities=35% Similarity=0.578 Sum_probs=209.9
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMIT 604 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~LV~ 604 (786)
+|++.+.||+|++|.||+|.+. ++.+++|++..........+.+.+|+.++++++||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999884 88999999876655455678899999999999999999999999888 8899999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999873 33889999999999999999999999999999999999999999999999999988765432
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+........++ ...+.+++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1345678889999999988889999999999999999999999998765 333333333222333333 34699999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+|+. ||++||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=309.70 Aligned_cols=245 Identities=33% Similarity=0.603 Sum_probs=201.6
Q ss_pred eEEeecCcEEEEEEEECC--------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 534 TRVGIGFFGEVFRGIWNG--------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G--------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.||+|+||.||+|.+.. ..+|+|.+.... .......|.+|+++++.++||||+++++++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997632 568999875432 23345789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhc----CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-----eEEEEecCccc
Q 003919 606 YMELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-----TVKICDFGLSR 676 (786)
Q Consensus 606 y~~gGSL~dlL~~~~----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-----~VKL~DFGLA~ 676 (786)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 999999999986432 223578899999999999999999999999999999999999887 89999999997
Q ss_pred cccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 677 IITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 677 ~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
........ .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+... .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKPENC 238 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCcccc
Confidence 66433211 122345678999999999999999999999999999998 99999887776665554332 222222
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
+..+.+++.+||. +|.+||++.+|++.|++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3468899999999 99999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.68 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=205.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~ 598 (786)
...|++.+.||+|+||.||++.++ +..+|||++...... ...+.|.+|+++++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 456788899999999999999763 678999998755443 346789999999999999999999999877 55
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
..+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999998632 336899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHH
Q 003919 679 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--------------VVYAVA 741 (786)
Q Consensus 679 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~--------------~l~~i~ 741 (786)
...... .....++..|++||.+.+..++.++|||||||++|||++|..||....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 112344567999999988889999999999999999999999986543221 112222
Q ss_pred hcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 742 NEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 742 ~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
........+ +..+.+|+.+||. +|.+||++.+|++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 222222222 2468899999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.52 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=205.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
++.++|++.+.||+|+||+||++.+ .|+.+|+|++..... ....+.|.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3457899999999999999999987 488999998865432 3345789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||||+++++|.+++. ..+.+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999998886 34578999999999999999999997 68999999999999999999999999998765332
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCC
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-----------RVVYAVANEGSRLEIP 750 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-----------~~l~~i~~~~~~~~ip 750 (786)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+... ....++
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLP 234 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 123457899999999998888999999999999999999999999865442 122222221 112222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
...+.+|+.+||+ ||.+||++.+++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2358899999999 999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=313.58 Aligned_cols=237 Identities=22% Similarity=0.372 Sum_probs=190.2
Q ss_pred EEeecCcEEEEEEEEC--------------------------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003919 535 RVGIGFFGEVFRGIWN--------------------------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~--------------------------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV 588 (786)
.||+|+||.||+|... ...|++|++.... ......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999998641 1348888875432 23346788999999999999999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--- 665 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g--- 665 (786)
+++++|.+....++||||+++|+|..++.. ....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999988863 345688899999999999999999999999999999999997643
Q ss_pred ----eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHH
Q 003919 666 ----TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYA 739 (786)
Q Consensus 666 ----~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELl-TG~~PF~~~~~~~~l~~ 739 (786)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999998654321 23457788999998865 56899999999999999995 78999987766554332
Q ss_pred HHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 740 VANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 740 i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.......+......+.+++.+||+ +|.+||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 222111111122468999999999 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.41 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=204.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||.||++.+ .++.|++|.+...... ....+.+.+|+++++.++||||+++++.+..++.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 4678999998755432 233567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++++|.+++. ....+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999986 33568999999999999999999999999999999999999999999999999986421100
Q ss_pred -------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003919 683 -------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 749 (786)
Q Consensus 683 -------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i 749 (786)
.......++..|+|||.+.+..++.++|+|||||++|||++|..||.+....+..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0111245788999999998888999999999999999999999999988777766665544322211
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 750 ----PEGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 750 ----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
.+..+.+|+.+||. ||++||++.++++.|
T Consensus 238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 23468999999999 999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.70 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=194.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..+|.+.+.||.|+||.||++... +..||+|.+... ..+.+|+.+++.++|||||++++++.....+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999753 467899987532 234689999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+||++. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999996 57777774 44678999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhc--------------
Q 003919 683 MR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANE-------------- 743 (786)
Q Consensus 683 ~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---~~l~~i~~~-------------- 743 (786)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 21 22457999999999999999999999999999999999999999764321 111111110
Q ss_pred -----------CCCC--CCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -----------GSRL--EIP--------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -----------~~~~--~ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+. ..+ ...+.++|.+||. ||++||++.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 011 1246789999999 99999999999976
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.44 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=201.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--Cc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~ 599 (786)
.-|++.+.||+|+||.||++.+ .+..||+|.+.... .......|.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3477889999999999999974 36789999986443 334457899999999999999999999998765 56
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..+.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 89999999999999998632 3468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHh
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------------PERVVYAVAN 742 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--------------~~~~l~~i~~ 742 (786)
.... ......++..|+|||.+.+..++.++|||||||++|+|++++.|+.... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3321 1123456778999999988889999999999999999999876643211 1111111222
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 743 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 743 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+.....+ ...+.+|+.+||+ ||++||++.++++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 22233222 3468999999999 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.07 Aligned_cols=245 Identities=31% Similarity=0.567 Sum_probs=211.4
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|++|.||++.+ .++.+++|.+..........+.+.+|++++++++|||++++++++.+.+.+++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478899999999999999977 577899999987766556678899999999999999999999999998999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999863 36789999999999999999999999999999999999999999999999999988765433334
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...++..|+|||.+.+..++.++|||+||+++|+|++|+.||................. ...+ ...+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH-PPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHHh
Confidence 45688999999999888889999999999999999999999987776555554443222 2222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|++||++.+++.+
T Consensus 237 ~~p~~R~~~~~~l~~ 251 (254)
T cd06627 237 KDPNLRPTAKQLLKH 251 (254)
T ss_pred CChhhCcCHHHHhcC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.09 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=202.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||.|++|.||+|.+ +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 5889999998654432 2346778899999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++ +|.+++........+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||++...........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 7887776444445789999999999999999999999999999999999999999999999999976644322333
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------C-
Q 003919 687 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------E- 748 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------------~- 748 (786)
...+++.|++||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+ .
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence 45678899999988654 57899999999999999999999998776655544433211000 0
Q ss_pred -------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+++.+|++ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 012357789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.46 Aligned_cols=251 Identities=31% Similarity=0.593 Sum_probs=205.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
..+|+..+.||+|+||.||+|.+ +|. .+|+|.+..... ......|.+|+.+++.++||||++++++|... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 46788889999999999999976 343 578888754332 33345789999999999999999999998764 47
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 799999999999998863 234688999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+......... ...+.....+ ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHH
Confidence 221 1223345678999999999899999999999999999997 8999988765554443 3333333322 3468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+++..||. +|++||++.++++.|.++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 899999998 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.38 Aligned_cols=243 Identities=34% Similarity=0.599 Sum_probs=206.4
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
-|.+.+.||.|+||.||+|.+ +++.+|||++..... ....+.|.+|+.+++.++||||+++++++..+..+++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366788999999999999976 578999999764433 23457889999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|..++. ...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++..+........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 99999998885 24688999999999999999999999999999999999999999999999999877654332333
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA 763 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~ 763 (786)
...++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.. .....++ +..+.+++.+||+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHcc
Confidence 45688899999999888899999999999999999999999987776655554433 2222222 3468999999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|.+||++.+++++
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 239 KEPSFRPTAKELLKH 253 (277)
T ss_pred CChhhCcCHHHHHhC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=314.43 Aligned_cols=248 Identities=26% Similarity=0.329 Sum_probs=203.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~L 602 (786)
.++|.+.+.||.|+||.||+|.+ +++.+|+|.+............+.+|+.++++++||||+++++++... ..+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45788999999999999999988 478899999876554444445678899999999999999999998776 78999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
++||+.+ +|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 84 v~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999985 888887632 3468999999999999999999999999999999999999999999999999998775543
Q ss_pred CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------------
Q 003919 683 MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS---------------- 745 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~---------------- 745 (786)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+...-.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 233345678899999998764 468999999999999999999999987766554433321100
Q ss_pred -------------CCCC----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 -------------RLEI----PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 -------------~~~i----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.... -...+.++|.+||+ ||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001 13457899999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.35 Aligned_cols=248 Identities=30% Similarity=0.547 Sum_probs=215.0
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||.|+||.||++.+. +..+++|++..........+.+.+|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999884 88999999977666556678899999999999999999999999998999999999
Q ss_pred eccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 607 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
+++++|.+++.... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999999886431 24679999999999999999999999999999999999999999999999999998775543333
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....|++.|+|||.+.+..++.++|+||||+++++|++|+.||................ ...++ ...+.+++.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHc
Confidence 45578899999999998889999999999999999999999998877766666554432 22333 357999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. +|.+||++.+++++
T Consensus 240 ~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 240 QKDPEERPSIAQILQS 255 (258)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.91 Aligned_cols=243 Identities=32% Similarity=0.603 Sum_probs=207.9
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||+|++|.||++.+. +..+++|++..... ...+.+.+|+++++.++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788899999999999999884 88899999865443 3457899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++... ...+++..+..++.|++.||+|||.+|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 9999999998632 25789999999999999999999999999999999999999999999999999987754322 34
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADC 761 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~C 761 (786)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||................. ...+ ...+.+++.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC-CCcCcccccCHHHHHHHHHH
Confidence 55688899999999888899999999999999999999999988765555544443222 1121 34689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|+ ||++|||+.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99 99999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=309.90 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=195.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||.||+|.. +|+.||+|++...... .....+.+|+.+++.++|+||+++++++......++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 47899999999999999999976 5889999998654322 22346778999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+. ++|...+.. ....+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++.........
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9997 566655542 2346788889999999999999999999999999999999999999999999999765443323
Q ss_pred CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc-C---------------C-
Q 003919 685 DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANE-G---------------S- 745 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-~~l~~i~~~-~---------------~- 745 (786)
.....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... +.+..+... + .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 3345678999999998764 5788999999999999999999999765432 111111100 0 0
Q ss_pred ----CCC------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 ----RLE------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ----~~~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... .....+.+++.+|+. ||.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000 012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.60 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=197.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||.|+||.||+|.. +++.||||.+...... .....+.+|++++++++|+||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57899999999999999999987 5789999998654322 12345778999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+ +|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.........
T Consensus 83 e~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99985 888877632 347889999999999999999999999999999999999999999999999998765432222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCC----------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSR---------------- 746 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~l~~i~~~~~~---------------- 746 (786)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.. .......+...-..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233456889999999865 458899999999999999999999997655 22222211110000
Q ss_pred ----------------CCCC-ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ----------------LEIP-EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ----------------~~ip-~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+. ...+.+++.+|+. +|.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 1346789999999 99999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=307.72 Aligned_cols=246 Identities=28% Similarity=0.532 Sum_probs=202.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC----hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT----AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~----~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+|+.++.||+|+||.||++.. +++.+|+|++...... ....+.+.+|+.++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999976 6889999998644321 2245789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~ 681 (786)
++||+.+++|.+++.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999863 35788999999999999999999999999999999999998775 6999999999876543
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCCCCC---C
Q 003919 682 PMR----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 682 ~~~----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---~~l~~i~~~~~~~~ip---~ 751 (786)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+.........+ +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 211 12346788999999998888999999999999999999999999754432 2222222223333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 468899999998 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.71 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=204.1
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.+.+.||.|+||.||++.+. ++.+|+|.+..... ....+.+.+|+++++.++||||+++++++...+.+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999884 78899999876543 34567899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
+++++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999998733 2678899999999999999999999 9999999999999999999999999999877643321
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcCCCCCCC----ChHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL-----PERVVYAVANEGSRLEIP----EGPLGR 756 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-----~~~~l~~i~~~~~~~~ip----~~~L~~ 756 (786)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.. ...+..+ +..+.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChhhcCHHHHH
Confidence 12678889999999999899999999999999999999999997542 2222222222 2222222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|.+||. ||.+||++.+++.+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhC
Confidence 9999999 99999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.14 Aligned_cols=246 Identities=31% Similarity=0.547 Sum_probs=211.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|++.+.||.|+||.||++++ +++.+++|.+............+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478899999999999999977 577899999876665555667889999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 607 MELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 607 ~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
+++++|..++.... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 99999998886422 2457899999999999999999999999999999999999999999999999999877554 22
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...........+.... ....+ ...+.+++.+|+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchhhCHHHHHHHHHHc
Confidence 34568899999999999999999999999999999999999999887766655544322 22232 346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. +|++||++.+++++
T Consensus 238 ~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 238 QVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCcccCCCHHHHhcC
Confidence 8 99999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.40 Aligned_cols=235 Identities=25% Similarity=0.447 Sum_probs=190.2
Q ss_pred EEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 535 RVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.||+|+||.||+|.+. ...+++|.+.... ....+.|..|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 6899999999999763 2347888864332 2335678899999999999999999999999889999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe--------EEEEecCcccc
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRI 677 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~--------VKL~DFGLA~~ 677 (786)
|+++|+|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 80 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999863 2346889999999999999999999999999999999999987764 69999999866
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCCCCC-CCChHH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGSRLE-IPEGPL 754 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~-~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L 754 (786)
.... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||........... .......+ .....+
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPAPKWTEL 232 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCCCCcHHH
Confidence 5332 23567889999999976 45799999999999999999995 66666655444332 22222211 223468
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
.+|+.+||+ ||++|||+.+|++.|
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.10 Aligned_cols=249 Identities=25% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 601 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~ 601 (786)
..++|.+.+.||.|+||.||+|.+ +|+.||+|++............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 357899999999999999999987 588999999865544333334567899999999999999999998654 5689
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+.+ +|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 77777753 2357899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-------------- 746 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-------------- 746 (786)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222333456788999999865 45789999999999999999999999988777666555431110
Q ss_pred ---CC--------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ---LE--------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ---~~--------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. .....+.++|.+|+. ||++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 012356789999999 99999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.55 Aligned_cols=240 Identities=26% Similarity=0.416 Sum_probs=184.1
Q ss_pred eeEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc--cCCceEEEEEe
Q 003919 533 GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--KPPRLSMITEY 606 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~--~~~~l~LV~Ey 606 (786)
+.+||+|+||+||+|... +..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+++++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 46799998864432 245778999999999999999999884 35578999999
Q ss_pred eccchhHHHHHhhc------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----cCCCeEEEEecCccc
Q 003919 607 MELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSR 676 (786)
Q Consensus 607 ~~gGSL~dlL~~~~------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~ 676 (786)
+.+ +|.+++.... ....+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 975 6766664221 22358899999999999999999999999999999999999 466799999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHhc
Q 003919 677 IITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVYAVANE 743 (786)
Q Consensus 677 ~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---------~~l~~i~~~ 743 (786)
....... ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 7644321 1234568999999999876 45899999999999999999999999643211 000000000
Q ss_pred -C--------------------------------------CCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -G--------------------------------------SRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -~--------------------------------------~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ .....++..+.+|+.+|+. ||.+|||+.|+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000123347789999999 99999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.06 Aligned_cols=245 Identities=27% Similarity=0.493 Sum_probs=212.3
Q ss_pred CeeEeeEEeecCcEEEEEEEECCe--eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
-|.|+..||.|+||.||+++...+ ..|-|++..+ ..+.+++|+-||+||..+.||+||+|++.|...+.++|+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345667899999999999987533 4567887544 345678999999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
|.||.+..++-. -...|++.++..+++|++.||.|||+++|||||||+.|||++.+|.++|+|||.+...........
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 999999887753 346899999999999999999999999999999999999999999999999999876554444456
Q ss_pred CCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHHHH
Q 003919 687 SSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLGRL 757 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p---~~~L~~L 757 (786)
.+.|||+|||||++. ..+|+.++||||||++|.||.-+.+|-...++..++..+......... | ...+.++
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 789999999999874 578999999999999999999999999999999999888765543332 3 2358999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||..||++.+|++|
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhC
Confidence 999998 99999999999986
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.85 Aligned_cols=238 Identities=24% Similarity=0.406 Sum_probs=203.2
Q ss_pred EeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||.|+||.||++.+. ++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999885 88999999876543 234457899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
.+++. ....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 156 (262)
T cd05572 81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTP 156 (262)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCc
Confidence 99986 33468999999999999999999999999999999999999999999999999998775432 223456889
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQ 766 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~ 766 (786)
.|++||.+.+..++.++|+||||+++|+|++|..||.... .......+.........| +..+.+++.+||. +|.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999999988889999999999999999999999998776 555555554323333333 3579999999999 999
Q ss_pred CCCC-----HHHHHHH
Q 003919 767 ERPS-----CEEILSR 777 (786)
Q Consensus 767 kRPS-----a~EIL~~ 777 (786)
+||+ +.+++++
T Consensus 237 ~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 237 ERLGNLKGGIKDIKKH 252 (262)
T ss_pred hCcCCcccCHHHHhcC
Confidence 9999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.89 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=200.5
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|++.+.||.|++|.||+|.+ +|+.||+|++............+.+|+++++.++||||+++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999977 6889999998765544444467889999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
+ ++|.+++... ....+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+.........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 6 6888888632 2246899999999999999999999999999999999999999999999999999765433222233
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003919 688 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 747 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------- 747 (786)
..+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......+
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4568899999988664 57899999999999999999999998776654443332211000
Q ss_pred -----------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -----------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -----------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+++.+||+ ||.+||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0012357889999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.69 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=203.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.....||+|+||.||++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3344456799999999999976 57889999985433 2345678999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+||++++++.++|+|||++..........
T Consensus 100 ~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999999998874 2358899999999999999999999999999999999999999999999999987654333233
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-C---CCChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-E---IPEGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~---ip~~~L~~LI~~C 761 (786)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+....... . .....+.+++.+|
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 34568899999999988889999999999999999999999998877665554443221111 1 1234688999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||.+|||+++++++
T Consensus 256 l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 256 LVREPSQRATAQELLQH 272 (292)
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.23 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=200.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|++|+||+|.+ +|+.||+|.+............+.+|++++++++||||+++++++.....+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 57889999986554443445678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCccccccCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|+++ +|...+... ....+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.........
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9974 677666422 2334688889999999999999999999999999999999985 567999999999766443222
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 747 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------------- 747 (786)
.....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||...........+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 334567889999998866 457899999999999999999999998876655554433210000
Q ss_pred --------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+++.+|++ +|++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012357889999999 99999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.54 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=196.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHH-HhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~i-L~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||.||++.+ +|+.||+|++........ ...+..|+.+ ++.+.||||+++++++..++.++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4788999999999999999987 588999999865543332 3456667665 56678999999999999999999999
Q ss_pred EeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||++ ++|.+++... .....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 5777776532 2345789999999999999999999997 99999999999999999999999999998764321
Q ss_pred CCCCCCCCCCcccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC----ChH
Q 003919 683 MRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP----EGP 753 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~l~~i~~~~~~~~ip----~~~ 753 (786)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ....+..... .....++ +..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPE 236 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHH
Confidence 2233568889999998865 456889999999999999999999997532 2233333322 2222222 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+++.+||. +|.+||++.+++++
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999 99999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.33 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=203.1
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.....||.|+||.||++.. .++.||+|++...... ..+.+.+|+.+++.+.||||+++++++...+..++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33445799999999999976 5889999998654332 2467889999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
++++|..++. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+.........
T Consensus 101 ~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 101 QGGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999998774 246889999999999999999999999999999999999999999999999998766443333345
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-C---CCChHHHHHHHHhhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-E---IPEGPLGRLIADCWA 763 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~---ip~~~L~~LI~~CL~ 763 (786)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||...........+....... . .....+.+++.+||+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~ 256 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence 678899999999998889999999999999999999999998777666555443222111 1 113468899999999
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|.+||++.+++++
T Consensus 257 ~~P~~Rps~~~ll~~ 271 (297)
T cd06659 257 REPQERATAQELLDH 271 (297)
T ss_pred CCcccCcCHHHHhhC
Confidence 99999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=352.98 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=205.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+|.+.++||+|+||.||+|.+ .|+.||||++..... .....+.|.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 578999999865433 2334567999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcC--------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 605 EYMELGSLYHLIHLSGQ--------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~--------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
||++|++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999998864211 2345677889999999999999999999999999999999999999999999998
Q ss_pred cccCCC------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003919 677 IITDSP------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 738 (786)
Q Consensus 677 ~l~~~~------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~ 738 (786)
...... ......+||+.|+|||.+.+..++.++|||||||++|||+||+.||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 762110 01123469999999999999999999999999999999999999998765544333
Q ss_pred HHHhcCCCCC----CCChHHHHHHHHhhh-CCCCCC-CHHHHHHHHHhh
Q 003919 739 AVANEGSRLE----IPEGPLGRLIADCWA-EPQERP-SCEEILSRLLDC 781 (786)
Q Consensus 739 ~i~~~~~~~~----ip~~~L~~LI~~CL~-DP~kRP-Sa~EIL~~L~~i 781 (786)
.......... ..+..+.+++.+|+. ||++|| +++++++.|+.+
T Consensus 242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2111111000 113458899999999 999996 667777777665
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.12 Aligned_cols=245 Identities=24% Similarity=0.470 Sum_probs=193.3
Q ss_pred eEEeecCcEEEEEEEE-CCe---eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW-NGT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~---~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||+|+||.||++.. ++. .+++|.+..... ....+.|.+|+.+++.++||||+++++.|.+....+++|||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999965 332 355666543322 33457899999999999999999999999999999999999999
Q ss_pred chhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--CCC
Q 003919 610 GSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDS 686 (786)
Q Consensus 610 GSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~ 686 (786)
|+|.+++.... ....+++..++.++.||+.||+|||+.+++|+||||+|||++.++.++|+|||++........ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 99999987432 234567778889999999999999999999999999999999999999999999865322211 123
Q ss_pred CCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC----CCC---CC
Q 003919 687 SSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR----LEI---PE 751 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~----~~i---p~ 751 (786)
...++..|+|||++.. ..++.++|||||||++|||++ |..||...........+...... +.+ ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS 239 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence 4567889999998753 245789999999999999997 46788877776666555433221 111 13
Q ss_pred hHHHHHHHHhhhCCCCCCCHHHHHHHHH
Q 003919 752 GPLGRLIADCWAEPQERPSCEEILSRLL 779 (786)
Q Consensus 752 ~~L~~LI~~CL~DP~kRPSa~EIL~~L~ 779 (786)
..+.+++.+||.+|++||++.+|++.|.
T Consensus 240 ~~~~~l~~~c~~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 240 ERWYEVLQFCWLSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence 4578899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.62 Aligned_cols=243 Identities=33% Similarity=0.587 Sum_probs=204.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC---CCceeEEecccccCCceEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~~l~LV 603 (786)
.|++.+.||.|+||.||+|.+ +++.+|+|.+..... ....+.+.+|+.+++.++ ||||+++++++.....++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999987 578999999865432 334577889999999997 99999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998852 3789999999999999999999999999999999999999999999999999987755433
Q ss_pred CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRLI 758 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip----~~~L~~LI 758 (786)
......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+... ....++ ...+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCcccCCHHHHHHH
Confidence 3345578899999998865 45789999999999999999999999887665544333222 222222 24689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+||. ||++||++.+++.+
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999 99999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=336.82 Aligned_cols=249 Identities=25% Similarity=0.452 Sum_probs=226.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
.....|.+.+.||+|.|++|.++.+ .++.||||++.+...+....+.+.+|+++|+.|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3467899999999999999999987 69999999999888888877889999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+.+|.+++++. +.+.+.+..++.++.|+..|++|||+++|||||||++||||+.+..+||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EEEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-
Confidence 999999999999997 4556777999999999999999999999999999999999999999999999999998743
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 760 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~~ 760 (786)
....+.+|++.|.|||++.+..| .+.+|+||+|++||.|++|..||.+.+-.......+....+++.. .....+||++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 45578999999999999999877 478999999999999999999999988887777777777777765 4468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
++- +|.+|+++++|.++
T Consensus 289 ~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hhccCccccCCHHHhhhh
Confidence 998 99999999999876
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.27 Aligned_cols=245 Identities=29% Similarity=0.489 Sum_probs=206.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||.||++.. +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 46889999999999999999976 578899999854332 23467899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999998852 35788899999999999999999999999999999999999999999999998766544333
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip---~~~L~~LI~~ 760 (786)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..... ....+ ...+.+++.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 3445688899999999888899999999999999999999999987765544333322221 11111 2358899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. +|++||++.+++.+
T Consensus 252 ~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 252 CLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999 99999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.77 Aligned_cols=247 Identities=30% Similarity=0.497 Sum_probs=209.8
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
....|.+.+.||+|+||.||+|.+. ++.+++|++..... ..+.+.+|+++++.++|+||+++++++......+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3566888899999999999999884 88999999865433 457789999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 99999999999997322 4789999999999999999999999999999999999999999999999999876544322
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-C---CChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-I---PEGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-i---p~~~L~~LI~ 759 (786)
......+++.|++||.+.+..++.++|||||||++|+|++|+.||....+......+........ . .+..+.+++.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 22344578899999999988899999999999999999999999988777665555443332211 1 2346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||+ +|.+||++.+++.+
T Consensus 252 ~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHhccChhhCcCHHHHhhC
Confidence 9999 99999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.27 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=197.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-----
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----- 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~----- 598 (786)
..++|.+.+.||+|+||.||++.. +++.||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 356899999999999999999987 5889999998654433333345678999999999999999999876543
Q ss_pred ---ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 599 ---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 599 ---~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..+++|||+.+ +|.+.+.. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 35999999975 67776652 3346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC----CCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----
Q 003919 676 RIITDSPMR----DSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---- 746 (786)
Q Consensus 676 ~~l~~~~~~----~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~---- 746 (786)
..+...... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876432211 1234577889999988664 4788999999999999999999999877655443322221100
Q ss_pred -----------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -----------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -----------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+....+.+||.+||. ||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00112346789999999 99999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=306.06 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=201.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~LV 603 (786)
++|...+.||.|++|.||++.+ .++.+|+|.+..... ......+.+|++++++++||||++++++|.. .+.++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688899999999999999987 578999999865433 2445789999999999999999999998854 3468999
Q ss_pred EEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 604 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
|||+++++|.+++... .....+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999999999887532 234568899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcCCCCCCC-------
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-----LPERVVYAVANEGSRLEIP------- 750 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~-----~~~~~l~~i~~~~~~~~ip------- 750 (786)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||... ...+....+.. .....++
T Consensus 160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGNGI 236 (287)
T ss_pred --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCCCC
Confidence 12446788999999999889999999999999999999999999765 22233322222 1111111
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 --EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+.+++.+||. +|.+|||+.|++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2358899999999 99999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.11 Aligned_cols=255 Identities=33% Similarity=0.541 Sum_probs=215.4
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECC-eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G-~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+..+...++++||+|-||+|.++..++ ..||||+++.... .....+|.+|+.+|.+|+|||||.++|+|..++.++++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 456788899999999999999998865 9999999876554 33458999999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+|||.+|+|.+++..+. ...+......+|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++-+....+
T Consensus 614 ~EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999997442 23356667788999999999999999999999999999999999999999999997765554
Q ss_pred CCC--CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHh---cCC------CCCCC
Q 003919 684 RDS--SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC--TLNRPWEGVLPERVVYAVAN---EGS------RLEIP 750 (786)
Q Consensus 684 ~~~--~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELl--TG~~PF~~~~~~~~l~~i~~---~~~------~~~ip 750 (786)
... ..+-+++|||+|.+..++++.++|||+||++|||++ +...||.....++++..... ... ++.+-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 432 345667999999999999999999999999999986 56889999888877765432 111 11112
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+..+.++|.+||. |-.+||+++++..+|++.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3468899999999 999999999999998864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.34 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=213.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc------ChHHHHHHHHHHHHHhhc-CCCceeEEecccccC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL------TAENMEDFCNEISILSRL-RHPNVILFLGACTKP 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~------~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~ 597 (786)
+..|...+.||.|..++|-++.+ .|..+|+|++..... ..+..+.-.+|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677778899999999999866 588899999853321 123345667899999999 599999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+++|+|.|+.|.|+|+|. ..-.++++..++|+.|+++|++|||.++||||||||+|||++++.++||+|||+++.
T Consensus 96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999997 556899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
+..+. .....||||+|+|||.+.. ..|+...|+|++|||||.|+.|-+||....+.-++..+..+.+...-|
T Consensus 173 l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 173 LEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred cCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 86653 4467899999999999854 347888999999999999999999999877777777777666665544
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....++||.+|++ ||.+|.|++|+|.|
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2358899999999 99999999999986
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.26 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=208.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV 603 (786)
++|.+.+.||+|+||.||++.. +++.+|+|++..... .....+.+..|+.++++++ ||||+++++++...+.++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 688999999876433 2334567889999999998 99999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+.+++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999987 344799999999999999999999999999999999999999999999999999887644321
Q ss_pred --------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003919 684 --------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 684 --------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~ 743 (786)
......++..|+|||.+....++.++||||||++++++++|+.||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112345788999999998888999999999999999999999999987765555554433
Q ss_pred CCCCC-CCChHHHHHHHHhhh-CCCCCCCH----HHHHHH
Q 003919 744 GSRLE-IPEGPLGRLIADCWA-EPQERPSC----EEILSR 777 (786)
Q Consensus 744 ~~~~~-ip~~~L~~LI~~CL~-DP~kRPSa----~EIL~~ 777 (786)
..... ..+..+.+++.+||+ +|.+||++ .+++++
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 22221 123468999999999 99999999 777764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.51 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=199.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------C
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~ 598 (786)
..+|++.+.||+|+||.||++.+ +|+.||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999987 688999999865544445567788999999999999999999987543 3
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
..|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 57999999974 77777641 2888999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...-..+
T Consensus 169 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 4432 2334568899999999999999999999999999999999999998766443333222100000
Q ss_pred ---------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ---------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ---------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+++.+||+ ||++|||+.++|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0012246789999999 99999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=344.33 Aligned_cols=255 Identities=36% Similarity=0.612 Sum_probs=222.4
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEEC--C---eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWN--G---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~--G---~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+++.+..+|.++||.|.||+||+|..+ | ..||||.++.. .......+|+.|+.||.++.||||++|.|+.....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 456678899999999999999999763 3 46999998654 34556789999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
...||+|||++|+|..+|+.. .+.+++-++..+++.|+.||+||-++|+|||||.+.|||++.+..+|++||||++.+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999743 467999999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCC-CCCCC--CCcccCccccccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcCCCCCCCCh--
Q 003919 679 TDSPMRD-SSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELC-TLNRPWEGVLPERVVYAVANEGSRLEIPEG-- 752 (786)
Q Consensus 679 ~~~~~~~-~~~~G--T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELl-TG~~PF~~~~~~~~l~~i~~~~~~~~ip~~-- 752 (786)
.+..... ++.-| ..+|+|||.+...+++.++||||||++|||.+ .|.+||-+.++++++..+. .+++++.|-+
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP 860 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCP 860 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCc
Confidence 6654222 22222 35899999999999999999999999999987 5899999999999888765 4666665543
Q ss_pred -HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 753 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 753 -~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.|.+|+..||+ |-.+||.+.||+..|.++.
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 59999999999 9999999999999998864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.60 Aligned_cols=238 Identities=28% Similarity=0.419 Sum_probs=201.3
Q ss_pred EeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||.|+||.||++.+. |+.+++|++..... .....+.+.+|++++++++||||+++++.+.....+|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999884 88999999865443 234467889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--------C
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--------R 684 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--------~ 684 (786)
.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999873 23789999999999999999999999999999999999999999999999999876543311 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 761 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~C 761 (786)
.....++..|++||.+....++.++||||||+++|+|++|..||...........+.......... ...+.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 234567889999999988889999999999999999999999999888777766655433332222 45789999999
Q ss_pred hh-CCCCCCCH---HHHHH
Q 003919 762 WA-EPQERPSC---EEILS 776 (786)
Q Consensus 762 L~-DP~kRPSa---~EIL~ 776 (786)
|+ +|.+||++ .++++
T Consensus 238 l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred hcCCHhhcCCCccHHHHhc
Confidence 99 99999999 65554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.69 Aligned_cols=243 Identities=30% Similarity=0.453 Sum_probs=202.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccc-cChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~-~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..|.+.+.||+|+||+||+|.. .++.||+|++.... ......+.+.+|+.+++.++||||++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588889999999999999987 58899999986443 23445578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+ ++.+++.. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 99984 66666542 2346899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLI 758 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~L~~LI 758 (786)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||...........+......... ....+.+++
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 2456788999999874 456889999999999999999999999887776666555433221111 134689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+||. +|++||++.+|+.+
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999 99999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.64 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=204.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
.|...+.||.|++|.||++.. .++.+++|++.... ....+.+.+|+.+++.+.||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344457999999999999976 57889999875433 23346788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++...........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999998863 4688999999999999999999999999999999999999999999999998876544322233
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHHHHHhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRLIADCW 762 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i---p~~~L~~LI~~CL 762 (786)
...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+....... .. .+..+.+++.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 4568899999999998889999999999999999999999998877766655554332111 11 1346999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. +|++||++.+++++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9 99999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.34 Aligned_cols=204 Identities=27% Similarity=0.368 Sum_probs=179.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CC-----ceeEEecccccCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HP-----NVILFLGACTKPPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HP-----NIVkL~g~~~~~~~l 600 (786)
+|.+.+.||+|+||.|.+|.+ +++.||||+++++ +....+-..|+.+|..|+ |. |||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999987 5889999999754 334566778999999997 43 899999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC--eEEEEecCccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW--TVKICDFGLSRII 678 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g--~VKL~DFGLA~~l 678 (786)
|||+|.+. .+|+++++.. +...++...++.|+.||+.||.+||++||||+||||+||||.+.+ .|||+|||.++..
T Consensus 264 ciVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999996 5999999743 556799999999999999999999999999999999999997543 6999999999987
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i 740 (786)
....+ .++-+..|.|||++.+.+|+.++||||||||++||++|.+.|.+.+..+.+..+
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 65433 677889999999999999999999999999999999999889887776655444
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=302.90 Aligned_cols=245 Identities=26% Similarity=0.351 Sum_probs=203.3
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.+.+.||.|++|.||++.. +++.+++|.+............+.+|++++++++|+||+++++++.....+++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999987 5888999998766555445678889999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
++ +|.+++.. ....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 85 77777753 2357899999999999999999999999999999999999999999999999999877554322334
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------------
Q 003919 688 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------- 747 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------- 747 (786)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678899999998776 78999999999999999999999998776655443332211100
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.++|.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0012458899999999 99999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.09 Aligned_cols=239 Identities=25% Similarity=0.317 Sum_probs=188.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||.||+|.+ .++.||+|+.... .+..|+.++++++||||+++++++......++|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 45799999999999999999988 4568999974322 2356999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+. ++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~ 212 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-A 212 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-c
Confidence 9996 577777752 34578999999999999999999999999999999999999999999999999997543321 2
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChH---------HHHHHHHhc-CC-CCCCC--
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE---------RVVYAVANE-GS-RLEIP-- 750 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF-~~~~~~---------~~l~~i~~~-~~-~~~ip-- 750 (786)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+ ...... ..+..+... +. ....+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 23567999999999999999999999999999999999876554 322110 111111110 00 00000
Q ss_pred -------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 -------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 -------------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+.+||.+||+ ||.+|||+.|+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1235569999999 99999999999976
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.75 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=200.5
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceEEEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLSMITE 605 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~LV~E 605 (786)
|.+.+.||.|+||.||+|.+ +++.+|+|++............+.+|+++++.++|+||+++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 468999999976643344456788999999999999999999999887 78999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-C
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-R 684 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~ 684 (786)
|+++ +|..++.. ....+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9985 78877752 225789999999999999999999999999999999999999999999999999987754321 1
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------------- 747 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------------- 747 (786)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223456788999998765 457899999999999999999999998877655544433211100
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0013357789999999 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.53 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=196.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----CceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~l~ 601 (786)
.|...+++|.|+||.||+|+. .+..||||.......-. -+|+++|+.+.|||||++..+|... -++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 366778999999999999977 57799999875443211 2699999999999999999887432 2456
Q ss_pred EEEEeeccchhHHHHHh-hcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCcccccc
Q 003919 602 MITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 679 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~ 679 (786)
+||||++. +|...++. ...+..++...++-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999995 88877752 2345678888899999999999999999999999999999999976 999999999999886
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 748 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------- 748 (786)
... ....+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+....+..+.+--..+.
T Consensus 178 ~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 178 KGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred cCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 542 33567789999999999774 799999999999999999999999999887777666654222221
Q ss_pred --------C------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 --------I------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 --------i------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ .+.+..+|+.++++ +|.+|.++.|++.+
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 01246789999999 99999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=307.30 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=210.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
....++-++|.+.++||+|+|+-||+++. +++.||+|++.... .+..+..++|++..++++|||+++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 45567789999999999999999999975 78899999987654 455788999999999999999999999875543
Q ss_pred c-----eEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeEEEE
Q 003919 599 R-----LSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC 670 (786)
Q Consensus 599 ~-----l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~ 670 (786)
. .|+++.|...|+|.+.+.... ++..+++.+++.|+.+|++||++||... ++||||||.|||+.+.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 3 899999999999999887554 3448999999999999999999999998 9999999999999999999999
Q ss_pred ecCccccccCCCCC---------CCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HH
Q 003919 671 DFGLSRIITDSPMR---------DSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--RV 736 (786)
Q Consensus 671 DFGLA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~--~~ 736 (786)
|||.+....-.... ......|..|+|||.+.- ...++++|||||||+||+|+.|..||...-.. .+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998765321100 012357899999999864 46789999999999999999999999632211 11
Q ss_pred HHHHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 737 VYAVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 737 l~~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
...+. .....+| ++.+.+||+.|++ ||.+||++.+++.++.++.
T Consensus 252 aLAv~--n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ALAVQ--NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEeee--ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 1122222 4468999999999 9999999999999998764
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.11 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=193.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE----CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccC--CceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l~ 601 (786)
.|.+.+.||+|+||.||+|.+ .++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478889999999999999987 468999999876431 122236678899999999999999999999888 7899
Q ss_pred EEEEeeccchhHHHHHhhc--CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC----CCeEEEEecCcc
Q 003919 602 MITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 675 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~----~g~VKL~DFGLA 675 (786)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999985 5655554222 2237899999999999999999999999999999999999999 999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHh
Q 003919 676 RIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------VVYAVAN 742 (786)
Q Consensus 676 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~---------~l~~i~~ 742 (786)
..+..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..... .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87644321 1234567889999998876 458899999999999999999999997554321 0000000
Q ss_pred ------------------------cCCCCCC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 743 ------------------------EGSRLEI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 743 ------------------------~~~~~~i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....... ....+.+++.+|+. ||++|||+.+++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000111 12357789999999 99999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.20 Aligned_cols=241 Identities=31% Similarity=0.478 Sum_probs=212.1
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
|.-++.||.|+||-||.+.+ +...||||.+..... ..+..+++++|+..|++++|||++.+.|+|....+.|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44567899999999999977 677899999865443 456678999999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
|- |+-.|++.. ..+++-+..+..|+.+.+.||+|||+++.||||||+.||||++.|.|||+|||.+..... .+
T Consensus 108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 97 578888864 457899999999999999999999999999999999999999999999999999977653 35
Q ss_pred CCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHH
Q 003919 687 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIAD 760 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~ 760 (786)
.++|||.|||||++. .+.|+-|+||||||+++.||...++|+...+....++.|..+....... .+.+.+++..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 789999999999984 4689999999999999999999999999999999999998765543322 3468899999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||+ -|.+|||.++++.|
T Consensus 261 CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHhhCcccCCcHHHHhhc
Confidence 999 89999999999876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.32 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=194.1
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccC--CceEEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRLSMIT 604 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~--~~l~LV~ 604 (786)
|++.+.||+|+||.||+|.. +++.+|+|++........ .....+|+.++.++. |+||+++++++.+. +.+++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999987 578999999865433322 234567899999885 99999999999887 8899999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+ +|.+.+.. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.+||+|||++....... .
T Consensus 80 e~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~ 154 (282)
T cd07831 80 ELMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-P 154 (282)
T ss_pred ecCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-C
Confidence 99985 77766652 2357899999999999999999999999999999999999999 999999999998764432 2
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------------CCC
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG----------------SRL 747 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~----------------~~~ 747 (786)
.....+++.|+|||.+.. ..++.++|||||||++|||++|..||.+.+....+..+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 234567889999997644 557889999999999999999999998776554433332110 000
Q ss_pred CC--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 EI--------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. -+..+.+||.+||. +|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 12468899999999 99999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.80 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=195.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|...+.||+|+||.||++.+ +++.+|+|.+...... .....+.+|+.++.++. |+||+++++++..++..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4566778999999999999987 5789999998654433 44577899999999996 999999999999988999999
Q ss_pred EeeccchhHHHHHh--hcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 605 EYMELGSLYHLIHL--SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~--~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||+.. ++.++... ......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++..+...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 99874 44433221 1134578999999999999999999997 59999999999999999999999999999776443
Q ss_pred CCCCCCCCCCCcccCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCCC-------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEIP------- 750 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-~~l~~i~~~~~~~~ip------- 750 (786)
. ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... .....+.. ...+..+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (288)
T cd06616 162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEEREF 239 (288)
T ss_pred C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCCcc
Confidence 2 22344688999999998766 6899999999999999999999999765421 12222211 1111111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+.+|+.+||. ||++|||+.+|+++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2358899999999 99999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=330.86 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=192.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
...|.+.+.||+|+||.||++.+ .++.||||... ...+.+|++++++++|+|||++++++...+..+++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999988 46789999632 234678999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~- 683 (786)
|++. ++|..++.. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 240 e~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9996 677777752 234799999999999999999999999999999999999999999999999999987643211
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCCC--------
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--------PERVVYAVANEGSR-------- 746 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--------~~~~l~~i~~~~~~-------- 746 (786)
......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ...+...+......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1224579999999999999999999999999999999999876543211 11222211111100
Q ss_pred -----------------CC----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -----------------LE----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -----------------~~----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ..+..+.+||.+||+ ||.+|||+.|+|++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 011247789999999 99999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.80 Aligned_cols=244 Identities=29% Similarity=0.455 Sum_probs=204.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|...+.||+|+||.||++.+ ++..+|+|++..... ..+..+.+.+|+++++.++|||++++++++.+....+++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 466788999999999999987 578999999865432 33445789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+ +|.+++.. ....+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9975 67776642 2456899999999999999999999999999999999999999999999999998755332
Q ss_pred CCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIA 759 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~L~~LI~ 759 (786)
....+++.|+|||.+. .+.++.++|||||||++|+|++|+.||...........+......... ....+.+|+.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 3456888999999973 456899999999999999999999999887776666666554432222 2346899999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L~ 779 (786)
+||+ +|.+||++.++++++.
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred HHccCCcccCcCHHHHHhChh
Confidence 9999 9999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.53 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=200.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-----
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----- 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~----- 598 (786)
..++|.+.+.||+|+||.||+|.+ +|+.||+|++............+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 457899999999999999999987 5789999998755443334467788999999999999999999987654
Q ss_pred -----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 599 -----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 599 -----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.+++++||+++ ++...+.. ....+++..++.++.||+.||+|||+.||+|+||||+||++++++.+||+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999986 66666542 24478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 003919 674 LSRIITDSPM-RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----- 746 (786)
Q Consensus 674 LA~~l~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~----- 746 (786)
++..+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 9987654321 1123356788999998865 45789999999999999999999999876655444333221000
Q ss_pred --------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 --------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 --------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...-+..+.+++.+||. ||.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00113468899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.01 Aligned_cols=245 Identities=28% Similarity=0.368 Sum_probs=204.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-----ceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-----~l~ 601 (786)
+|.+.+.||.|+||.||+|.. .++.+|||++..........+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 488999999999999999987 4789999998765433445678999999999999999999999988775 789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+. ++|.+++. ....+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999998 47888776 3448999999999999999999999999999999999999999999999999999887554
Q ss_pred C---CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------
Q 003919 682 P---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------- 748 (786)
Q Consensus 682 ~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--------- 748 (786)
. .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.........+......+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 3 123345678899999999887 789999999999999999999999988776555444433211100
Q ss_pred -----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -----------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.-...+.+++.+||. +|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 012357789999999 99999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=303.95 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=195.0
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||+|+||+||++.+ +|+.+|+|++...... ......+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 5889999998754432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++...... .......++.
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP 158 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence 9988633 2246899999999999999999999999999999999999999999999999998776432 2223456788
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---CChHHHHHHHHhhh-CCC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI---PEGPLGRLIADCWA-EPQ 766 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~--~~~~~i---p~~~L~~LI~~CL~-DP~ 766 (786)
.|+|||.+.+..++.++|||||||++|+|++|+.||...........+... ...... .+..+.+++.+||+ ||.
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 999999998888999999999999999999999999765432111111111 111112 24568999999999 999
Q ss_pred CCC-----CHHHHHHH
Q 003919 767 ERP-----SCEEILSR 777 (786)
Q Consensus 767 kRP-----Sa~EIL~~ 777 (786)
+|| ++.+++.+
T Consensus 239 ~R~~~~~~~~~~ll~h 254 (277)
T cd05577 239 KRLGCRGGSADEVREH 254 (277)
T ss_pred HccCCCcccHHHHHhC
Confidence 999 67777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=313.76 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=199.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~l~ 601 (786)
++|.+.+.||.|+||.||+|.. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999976 58899999987554434446778899999999999999999998753 34689
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+|+||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999996 58888875 3456899999999999999999999999999999999999999999999999999876432
Q ss_pred CCC----CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q 003919 682 PMR----DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------- 743 (786)
Q Consensus 682 ~~~----~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~------------- 743 (786)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 124578889999999865 46899999999999999999999999776543332222111
Q ss_pred -----------CCCCCC--------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 -----------GSRLEI--------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 -----------~~~~~i--------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...... .+..+.++|.+||+ +|.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111 13468899999999 99999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.81 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=196.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------- 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------- 597 (786)
.++|.+.+.||.|+||.||+|.+ +++.+|||++............+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999987 578899999865544333335678899999999999999999987443
Q ss_pred -CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 598 -PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 598 -~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
..+++++||+.+ +|...+.. ....+++..+..++.|+++||+|||++||+|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999975 56555542 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-----------CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003919 677 IITDSPMR-----------DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 677 ~l~~~~~~-----------~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~ 744 (786)
........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 66432211 122356788999998765 458899999999999999999999998777655444433211
Q ss_pred CCC---------------------CCC----------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 SRL---------------------EIP----------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ~~~---------------------~ip----------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ..+ ...+.+++.+|+. ||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 100 000 1246789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.93 Aligned_cols=250 Identities=16% Similarity=0.187 Sum_probs=184.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECC-----eeEEEEEEeccccChHH---------HHHHHHHHHHHhhcCCCceeEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVILF 590 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G-----~~VAVKvl~~~~~~~~~---------~~~f~~EI~iL~~L~HPNIVkL 590 (786)
+...+|.+.+.||+|+||+||+|.+.+ ..+|+|+.......... ......+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 344789999999999999999998743 35667764322211100 0122334445666789999999
Q ss_pred ecccccCC----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 591 LGACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 591 ~g~~~~~~----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
++++.... ..+++++++.. ++.+.+.. ....++..++.++.|++.||+|||+.+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 98765443 23566776643 55555542 234567888999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHH--
Q 003919 667 VKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERV-- 736 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-~~~-- 736 (786)
++|+|||+++.+..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987632211 11234699999999999999999999999999999999999999987632 211
Q ss_pred ------HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 737 ------VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 737 ------l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
...+..........+..+.+++..||. +|++||++.+|++.|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 122222222222334578999999999 999999999999876
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.91 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=202.5
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP 597 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~ 597 (786)
.++.+..++|.+.+.||+|+||+||+|.++ ++.||||.+...... .....+..|+.++.++. ||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 456677889999999999999999999885 889999998755433 23466777888777775 99999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
..+|++|||+.+ +|.+++... ...+++..+..++.|++.||+|||+ .||+|+||+|+||++++++.+||+|||++.
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 999999999864 666666532 3478999999999999999999997 699999999999999999999999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCCCCCC--
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGSRLEI-- 749 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-~~l~~i~~~~~~~~i-- 749 (786)
.+..... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... +....+.... ....
T Consensus 164 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 164 RLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPP 241 (296)
T ss_pred hccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCC
Confidence 7644322 22345788999999987553 788999999999999999999999764332 2333333222 1111
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
....+.+|+.+||. ||.+||++.+++++-
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 13468999999999 999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.87 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=198.2
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.+++.+|.|+++.||++..+++.||||++..........+.+.+|+.+++.++|+||+++++++.+....+++|||++++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 44556667777777777778999999999776555666788999999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-------
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM------- 683 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~------- 683 (786)
+|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999998743 234688999999999999999999999999999999999999999999999999876533211
Q ss_pred CCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Q 003919 684 RDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------------- 747 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-------------- 747 (786)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||...................
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457778999999876 358899999999999999999999998766544333222111000
Q ss_pred C----------------CC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 E----------------IP-----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~----------------ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. .+ ...+.+|+..||. ||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00 1246789999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.03 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=209.1
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 598 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~ 598 (786)
.-+.++...|.++++||+||.+.||++.. +.+.||+|.+.....+...+..|.+|+..|.+|+ |.+||+||+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 44566788999999999999999999987 5678888887766677788899999999999996 999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+||||||=+ .+|.++|.... ..++.-.++.|..|++.++.++|.+||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9999999875 58999997432 2333337889999999999999999999999999999985 469999999999988
Q ss_pred cCCC--CCCCCCCCCCcccCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcC
Q 003919 679 TDSP--MRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEG 744 (786)
Q Consensus 679 ~~~~--~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-~~l~~i~~~~ 744 (786)
.... ......+||+.||+||.+... +.+.++||||||||||+|+.|+.||...... ..+..+...+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 6543 234567899999999998542 3567899999999999999999999877643 3334444443
Q ss_pred CCCC---CCCh-HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 SRLE---IPEG-PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ~~~~---ip~~-~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..++ ++.. ++.++++.||. ||++||++.++|++
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 4333 3333 49999999999 99999999999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=354.32 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=223.6
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
..++....++|.+++.||+|+||+|.++++ .++.||+|++.+-.+- .....-|..|-.+|..-..+-||.++.+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456667789999999999999999999987 5778999998764332 2334678889999998899999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
+.++|+||||++||+|..++. +...+++..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999999999999999997 33489999999999999999999999999999999999999999999999999988
Q ss_pred ccc-CCCCCCCCCCCCCcccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 677 IIT-DSPMRDSSSAGTPEWMAPELIR----N-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 677 ~l~-~~~~~~~~~~GT~~Y~APEvl~----~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
.+. ++.......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||+..+...++-.|.+-...+.+|
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 886 4444556778999999999994 2 578999999999999999999999999999999998888776666666
Q ss_pred C-----hHHHHHHHHhhhCCCCCCC---HHHHHHH
Q 003919 751 E-----GPLGRLIADCWAEPQERPS---CEEILSR 777 (786)
Q Consensus 751 ~-----~~L~~LI~~CL~DP~kRPS---a~EIL~~ 777 (786)
+ ...++||.+++.+|..|.. +++|..|
T Consensus 304 ~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cccccCHHHHHHHHHHhcChhhhcccccHHHHHhC
Confidence 2 3588999999999999987 8888766
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.88 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=199.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----Cce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~l 600 (786)
.+|.+.+.||+|+||+||++.+ +++.||||.+............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5799999999999999999987 588999999865443344456788999999999999999999987644 348
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+++||+. ++|.+++. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 57887775 345799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC---------------
Q 003919 681 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------------- 744 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~--------------- 744 (786)
.........++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3333345568889999998865 468899999999999999999999997765433222111100
Q ss_pred ---------CC--C------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 ---------SR--L------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ---------~~--~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. . ......+.+++.+||+ +|++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 0 0112357899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.51 Aligned_cols=248 Identities=31% Similarity=0.578 Sum_probs=215.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC---Ce--eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~---G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
-+++.+.++||+|.||.|++|.|+ |+ .||||.+....... ...+|++|+.+|.+|+|||+++|||+..+ ....
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 456777899999999999999884 43 69999987666554 57899999999999999999999999987 4588
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||+|+++.|+|.+.|+. .....|.......|+.||+.||.||..+++|||||.+.|+||-....|||+||||.+.+...
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999999986 56778889999999999999999999999999999999999999999999999999988654
Q ss_pred CCCC--C-CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCh---HH
Q 003919 682 PMRD--S-SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PL 754 (786)
Q Consensus 682 ~~~~--~-~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~L 754 (786)
.... . ...-...|+|||.++..+|+.++|||+|||+||||+|+ ..||.+....+++..+- .+.++..|.. .+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHH
Confidence 3221 1 22344579999999999999999999999999999974 67999999999888876 6777776644 59
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
+++++.||. +|++||+|..|.+.+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhH
Confidence 999999999 999999999998554
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.37 Aligned_cols=245 Identities=29% Similarity=0.390 Sum_probs=194.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----Cc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~ 599 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||||++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 36899999999999999999977 58899999985322 223456788999999999999999999876543 35
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.++++||+.+ +|..++. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 7999999975 7776664 3468999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-----------
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG----------- 744 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~----------- 744 (786)
.... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+...-
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 1123568899999998754 568999999999999999999999997654433222111100
Q ss_pred -------------CCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 -------------SRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 -------------~~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.... -....+.+++.+||. +|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 012357899999999 99999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.44 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=198.9
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc---CCCceeEEecccccCCc-----
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACTKPPR----- 599 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~~~~~----- 599 (786)
|++.+.||+|+||.||+|++ +++.+|+|++............+.+|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999988 478999999875544333345677888887766 59999999999987776
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999985 788877632 23368999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 747 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------ 747 (786)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.+....+....+.......
T Consensus 159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 432 2234457889999999999889999999999999999999999998877666555443311100
Q ss_pred -----C---C------C--ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -----E---I------P--EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -----~---i------p--~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. . + ...+.+++.+||+ ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0 0 1246789999999 99999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.30 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=194.3
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHH-hhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISIL-SRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL-~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.||.|+||.||+|.+ .|+.||+|++...... ......+..|..++ ...+|+||+++++++...+.+|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999987 5789999998654432 22234455565554 445899999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
++|.+++. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCC
Confidence 99999986 335789999999999999999999999999999999999999999999999999876533 23456
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--C---CChHHHHHHHHhhh-
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--I---PEGPLGRLIADCWA- 763 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--i---p~~~L~~LI~~CL~- 763 (786)
+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+........ . -+..+.+++.+||.
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 88899999999888899999999999999999999999988877766655543332211 1 24568999999999
Q ss_pred CCCCCCCH---HHHHHH
Q 003919 764 EPQERPSC---EEILSR 777 (786)
Q Consensus 764 DP~kRPSa---~EIL~~ 777 (786)
+|++||++ +|++.+
T Consensus 235 ~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 235 DPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHccCCCcHHHHHcC
Confidence 99999965 566544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.19 Aligned_cols=239 Identities=30% Similarity=0.468 Sum_probs=205.4
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccch
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGS 611 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGS 611 (786)
-+||+|.||+||.|.+ +...+|||.+..++. ...+-+..||.+.+.|+|.|||+++|.|.+++.+-|+||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 3799999999999977 456789998865543 345678899999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCccc--hHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEEEecCccccccCCCCCCCCC
Q 003919 612 LYHLIHLSGQKKKL--SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSS 688 (786)
Q Consensus 612 L~dlL~~~~~~~~L--s~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~~~~~ 688 (786)
|..++... =+++ .+..+-.+..||++||.|||.+.|||||||-+|||++ -.|.+||+|||-++.+..-+....++
T Consensus 659 LSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999743 3455 7888999999999999999999999999999999996 57899999999999886544455678
Q ss_pred CCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCh---HHHHHHHHhh
Q 003919 689 AGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG---PLGRLIADCW 762 (786)
Q Consensus 689 ~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~l~~i~~~~~~~~ip~~---~L~~LI~~CL 762 (786)
.||..|||||++..+ .|+.++|||||||++.||.||++||.... +....+++-.-...+++|+. ..+.+|.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999765 48899999999999999999999998664 44455555555566777765 5788999999
Q ss_pred h-CCCCCCCHHHHHH
Q 003919 763 A-EPQERPSCEEILS 776 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~ 776 (786)
. ||..||++.++|.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 9 9999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.49 Aligned_cols=238 Identities=27% Similarity=0.435 Sum_probs=201.9
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
||.|+||.||++.+ +++.+|+|++...... ......+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999987 4789999998765442 23567889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
.+++. ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++.
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99986 334689999999999999999999999999999999999999999999999999987655433344567888
Q ss_pred cccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhhh-CCCCCCC
Q 003919 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCWA-EPQERPS 770 (786)
Q Consensus 693 ~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL~-DP~kRPS 770 (786)
.|++||.+.+..++.++|+||||+++|+|++|+.||...........+.......+ .-+..+.+++.+||. ||++||+
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 99999999888889999999999999999999999987776665555544222221 114578999999999 9999999
Q ss_pred H---HHHHH
Q 003919 771 C---EEILS 776 (786)
Q Consensus 771 a---~EIL~ 776 (786)
+ .++++
T Consensus 238 ~~~~~~l~~ 246 (250)
T cd05123 238 SGGAEEIKA 246 (250)
T ss_pred cccHHHHHh
Confidence 9 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=295.87 Aligned_cols=247 Identities=30% Similarity=0.479 Sum_probs=202.6
Q ss_pred CeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecc---ccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQ---DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~---~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+|.+.+.||+|+||.||++.+. +..+++|++..- .........+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788999999999999999774 445666665432 22333345677899999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 604 TEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999999999888642 23467899999999999999999999999999999999999975 569999999998765443
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. +.....+ +..+.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-CCCCCCcchhcHHHHHHHH
Confidence 334456688999999999888889999999999999999999999987766555554433 2222222 346889999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||. +|++||++.+++++
T Consensus 239 ~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHhcCChhhCcCHHHHhhC
Confidence 9999 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.03 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=202.3
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.+.+.||+|.||.||+|+. +++.+|+|++..........+.+.+|+.+++.++|+||+++++++.....+++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56678899999999999987 4789999998766544444577889999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
. ++|.+++... ...+++..++.++.|++.||+|||++||+|+||+|+||++++++.++|+|||++............
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 8 5899888733 247899999999999999999999999999999999999999999999999999876544333334
Q ss_pred CCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------------CC
Q 003919 688 SAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-------------------RL 747 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-------------------~~ 747 (786)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||........+..+..... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 5567889999998766 789999999999999999999999987765544433321100 00
Q ss_pred ---------CC--CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ---------EI--PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ---------~i--p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. .+..+.+++.+||. ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 13358899999999 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.48 Aligned_cols=242 Identities=29% Similarity=0.540 Sum_probs=216.3
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.++.+||+|+||.||++.+ .|+.+|||.+.. ..+.+++.+|+.+|++++.|++|++||.|..+..+|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 56778999999999999977 689999998753 345789999999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
..|++.++++. .+++|++..+..++...++||+|||...-||||||+.||||+.+|+.||+|||.+-.+.+.-...++
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 99999999973 5689999999999999999999999999999999999999999999999999999988776555678
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHHhhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIADCWA 763 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip---~~~L~~LI~~CL~ 763 (786)
..|||.|||||++..-.|+.++||||||++..||..|++||.+..+...++.+..+.... ..| .+.+.++++.||.
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 899999999999998889999999999999999999999999999888777665443322 122 3468899999998
Q ss_pred -CCCCCCCHHHHHHH
Q 003919 764 -EPQERPSCEEILSR 777 (786)
Q Consensus 764 -DP~kRPSa~EIL~~ 777 (786)
+|++|-|+.++++|
T Consensus 269 K~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 269 KKPEERKTALRLCEH 283 (502)
T ss_pred CCHHHHHHHHHHhhh
Confidence 99999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.46 Aligned_cols=237 Identities=26% Similarity=0.357 Sum_probs=188.3
Q ss_pred EEeecCcEEEEEEEE--CCeeEEEEEEeccccChH-HHHHHHHHHHHHhh---cCCCceeEEecccccCCceEEEEEeec
Q 003919 535 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE-NMEDFCNEISILSR---LRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~-~~~~f~~EI~iL~~---L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
.||+|+||.||++.+ +++.+|+|.+........ ....+.+|..+++. ..||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999977 578999999865543222 12334455544443 479999999999998889999999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 688 (786)
+++|.+++. ....+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS 155 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCc
Confidence 999998886 34579999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred CCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 689 AGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER--VVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 689 ~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~--~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
.|++.|+|||.+. +..++.++|||||||++|+|++|+.||....... ...... ......++ ...+.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHh
Confidence 6899999999986 4568999999999999999999999997543221 111111 11122222 346899999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003919 763 A-EPQERP-----SCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRP-----Sa~EIL~~ 777 (786)
. ||.+|| ++.++++|
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhC
Confidence 9 999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=331.62 Aligned_cols=240 Identities=30% Similarity=0.529 Sum_probs=201.9
Q ss_pred EeeEEeecCcEEEEEEEEC--CeeEEEEEEeccc--cChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc--eEEEEE
Q 003919 532 VGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITE 605 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~--~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~--l~LV~E 605 (786)
...+||+|+|-+||+|.++ |-.||--.++..+ ..+...+.|..|+.+|+.|+|||||+||.++.+..+ +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999874 5555543322222 245556899999999999999999999999977655 889999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEc-CCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~ 682 (786)
.+..|+|..+++ +.+.++.+.++.|++||++||.|||++. |||||||-+||+|+ ..|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999997 4567888999999999999999999985 99999999999997 5689999999999998765
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRLI 758 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----ip~~~L~~LI 758 (786)
+.....|||.|||||++. ..|++.+||||||+.|+||+|+.+||........++.-+..+..+. +.+.++++||
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 444589999999999998 5699999999999999999999999987766555555555554442 3456799999
Q ss_pred HHhhhCCCCCCCHHHHHHH
Q 003919 759 ADCWAEPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~DP~kRPSa~EIL~~ 777 (786)
.+|+.-...|||+.|+|++
T Consensus 278 ekCl~~~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLATKSERLSAKELLKD 296 (632)
T ss_pred HHHhcCchhccCHHHHhhC
Confidence 9999988999999999975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=307.70 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=194.5
Q ss_pred eEEeec--CcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G--~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
..||+| +||+||++.+ .|+.||+|++..........+.+.+|+.+++.++||||++++++|...+.+++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999987 689999999876655555668899999999999999999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-----
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR----- 684 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~----- 684 (786)
++|.+++... ....+++..+..++.|++.||+|||+.||+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999988643 2346889999999999999999999999999999999999999999999999865433221110
Q ss_pred --CCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003919 685 --DSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 747 (786)
Q Consensus 685 --~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------- 747 (786)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112345679999999763 47899999999999999999999998776554443332211100
Q ss_pred ------------------------------CC-----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------------------------EI-----PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------------------------~i-----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. -...+.+|+.+||. ||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 01247889999999 99999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.43 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=217.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|..+++||+|.||.|-+++. .++.||+|++++... ....++.-+.|-.+|+..+||.+..+...|+..++++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 3467888999999999999999965 688999999977654 4445667778999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||..||.|+-+|. ....+++...+.+..+|+.||.|||+++||+||||.+|+|||.+|++||+||||++.--..
T Consensus 245 FVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999998886 4568999999999999999999999999999999999999999999999999999875444
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~~ 760 (786)
.....+.||||.|+|||++....|+...|.|.+||++|||++|+.||+..+...+...+.....+.+-. ..+.+.|+..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence 455678999999999999999999999999999999999999999999988888877777665554432 3467889999
Q ss_pred hhh-CCCCCC-----CHHHHHHH
Q 003919 761 CWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRP-----Sa~EIL~~ 777 (786)
++. ||.+|. .+.+|.++
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhh
Confidence 998 999994 45555543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.70 Aligned_cols=239 Identities=25% Similarity=0.419 Sum_probs=200.6
Q ss_pred eeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
...||+|+||.||++.. ++..+|||++.... ......+.+|+.+++.++|+||+++++++...+..+++|||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999977 68899999875332 234567899999999999999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~G 690 (786)
+|.+++. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..............+
T Consensus 103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9998774 235789999999999999999999999999999999999999999999999998766443323334568
Q ss_pred CCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC---CCCChHHHHHHHHhhh-CC
Q 003919 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RL---EIPEGPLGRLIADCWA-EP 765 (786)
Q Consensus 691 T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~---~ip~~~L~~LI~~CL~-DP 765 (786)
++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+..... .. ...+..+.+++.+||. +|
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 8999999999888899999999999999999999999988776655544432221 11 1123468899999999 99
Q ss_pred CCCCCHHHHHHH
Q 003919 766 QERPSCEEILSR 777 (786)
Q Consensus 766 ~kRPSa~EIL~~ 777 (786)
.+||++.+++.+
T Consensus 259 ~~R~~~~~ll~~ 270 (292)
T cd06657 259 AQRATAAELLKH 270 (292)
T ss_pred ccCcCHHHHhcC
Confidence 999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.73 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=197.3
Q ss_pred CeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+|++.+.||.|+||.||++.. +|+.||+|++..... .....+.+.+|+.+++++ +|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 578899999865432 122346788899999999 599999999999999899
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+++++|.+++. ....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999886 345688999999999999999999999999999999999999999999999999977643
Q ss_pred CCC-CCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCC-CCCCh
Q 003919 681 SPM-RDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRL-EIPEG 752 (786)
Q Consensus 681 ~~~-~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~----~~~l~~i~~~~~~~-~ip~~ 752 (786)
... ......|+..|+|||.+... .++.++||||||+++|+|++|..||..... ......+....... ...+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 221 12245688999999998753 467899999999999999999999964322 22222222222111 11134
Q ss_pred HHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
.+.+++.+||. ||.+|| ++.+++.+
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 68899999999 999997 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.33 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=198.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccC--CceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKP--PRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~--~~l~ 601 (786)
..+|.+.+.||+|+||.||+|.+ .|+.+|+|++............+.+|+.+++++ +||||++++++|... ..++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 36788899999999999999987 578899998865443444456788999999999 999999999988643 3589
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+. ++|..++. . ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++..+...
T Consensus 86 lv~e~~~-~~L~~~~~---~-~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIR---A-NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHh---c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999998 48888775 2 27888999999999999999999999999999999999999999999999999876433
Q ss_pred CC-----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------
Q 003919 682 PM-----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR--------- 746 (786)
Q Consensus 682 ~~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~--------- 746 (786)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 1223468889999998755 45788999999999999999999999876554443332221110
Q ss_pred -----------------C------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 -----------------L------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 -----------------~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ......+.+++.+||+ ||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0013458899999999 99999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.54 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------ 598 (786)
..+|++.+.||+|+||.||++.. +|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 5889999998654434444567889999999999999999999987654
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+ +++|..++. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 678887774 246899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------- 747 (786)
... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.......
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 224467889999999876 458899999999999999999999998766544433322211100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+++.+|+. ||.+|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0112347789999999 99999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=306.14 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=197.1
Q ss_pred CCee-EeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChH------------HHHHHHHHHHHHhhcCCCceeEEec
Q 003919 528 SELT-VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE------------NMEDFCNEISILSRLRHPNVILFLG 592 (786)
Q Consensus 528 s~y~-i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~------------~~~~f~~EI~iL~~L~HPNIVkL~g 592 (786)
.+|. +.+.||.|+||+||+|.+ .++.||||++........ ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 457799999999999986 588999999865433221 0125778999999999999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
++...+..+++|||+. ++|.+++. ....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 58888875 3456899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 003919 673 GLSRIITDSP--------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 737 (786)
Q Consensus 673 GLA~~l~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l 737 (786)
|++....... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9998765211 111233467889999998764 4789999999999999999999999888766554
Q ss_pred HHHHhcCCCC-----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 738 YAVANEGSRL-----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 738 ~~i~~~~~~~-----------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+......+ ......+.+++.+||. +|.+||++++++.+
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 4433211000 0012357799999999 99999999999976
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.58 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=200.3
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
|...+.||+|+||+||+|.+ .++.+++|++..... .....+.+.+|+++++.++||||+++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999987 688999999865433 334456788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+. +++.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 97 467776652 345689999999999999999999999999999999999999999999999999864322 23
Q ss_pred CCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHHHH
Q 003919 687 SSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLIAD 760 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~L~~LI~~ 760 (786)
...|+..|+|||.+. ...++.++|||||||++|+|++|..||...........+......... ....+.+|+.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 457889999999984 456889999999999999999999999887766666655443322211 23468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||+ +|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999 99999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=330.14 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=185.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC---CeeEEEEE--------------E-eccccChHHHHHHHHHHHHHhhcCCCcee
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKV--------------F-LEQDLTAENMEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~---G~~VAVKv--------------l-~~~~~~~~~~~~f~~EI~iL~~L~HPNIV 588 (786)
..+|.+.+.||+|+||+||++... +...++|. + +...........|.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998652 11222221 1 00111223346788999999999999999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhc--CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
++++++...+..|++++++.+ +|..++.... .........++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999964 6666554221 1223345677889999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCC--ChHHHHHHHHh
Q 003919 667 VKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGV--LPERVVYAVAN 742 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~P-F~~~--~~~~~l~~i~~ 742 (786)
+||+|||++..+..... ......||+.|+|||++.+..++.++|||||||+||||++|..+ |... .....+..+..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999987754322 22346799999999999999999999999999999999999864 4322 22222222111
Q ss_pred cCC--CCCC-------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 743 EGS--RLEI-------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 743 ~~~--~~~i-------------------------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ...+ .+..+.+++.+||+ ||.+|||+.|+|.+
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0000 01235667889999 99999999999976
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.87 Aligned_cols=244 Identities=30% Similarity=0.410 Sum_probs=197.8
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEe
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
|++.+.||+|+||+||+|.. .++.++||.+....... ......+|+..+++++ ||||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 47789999986543322 2334567999999999 99999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+ +++|.+.+... ....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~-~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~ 156 (283)
T cd07830 80 M-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYT 156 (283)
T ss_pred C-CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcC
Confidence 9 77888887632 23478999999999999999999999999999999999999999999999999998765432 223
Q ss_pred CCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003919 687 SSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 747 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------ 747 (786)
...++..|+|||.+. ...++.++|+||||+++++|++|+.||...........+......+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 456788999999875 4557899999999999999999999998776554443332111000
Q ss_pred -------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+++.+||+ ||++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0012458899999999 99999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=308.37 Aligned_cols=243 Identities=28% Similarity=0.348 Sum_probs=201.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc-----
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR----- 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~----- 599 (786)
.++|.+.+.||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 47899999999999999999988 47889999986554444455778899999999999999999998866554
Q ss_pred -eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 600 -LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 600 -l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
+++++||+ +++|.+++. ...+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 568988875 246899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------- 747 (786)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......+..+......+
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 169 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred ccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 432 234567889999999865 367899999999999999999999998777665544433211100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+++.+||. ||.+|||+.+|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0013457899999999 99999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.94 Aligned_cols=236 Identities=26% Similarity=0.356 Sum_probs=189.1
Q ss_pred EEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHH---HhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 535 RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISI---LSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~i---L~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
.||+|+||.||++.+ .++.||+|.+....... .....+..|..+ ++...||||+.+++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 57899999987654332 112234445444 444579999999999999999999999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 688 (786)
+++|..++. ....+++..++.++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++..+... .....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 155 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHAS 155 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCc
Confidence 999998886 3457999999999999999999999999999999999999999999999999998766432 22345
Q ss_pred CCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003919 689 AGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLEIP---EGPLGRLIADC 761 (786)
Q Consensus 689 ~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~~ip---~~~L~~LI~~C 761 (786)
.|+..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ........ .....++ +..+.+++.+|
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--ccCCCCCCcCCHHHHHHHHHH
Confidence 789999999998754 689999999999999999999999987632 22221111 1222222 45789999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003919 762 WA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRP-----Sa~EIL~~ 777 (786)
+. +|.+|| ++.+++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhC
Confidence 99 999999 99999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=355.90 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=213.0
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+++-+..||.|.||.||-+.. +|...|+|.+..+.........+.+|..++..++|||+|++||+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 355578899999999999976 688999999987777666677888999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC---
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--- 683 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--- 683 (786)
|.+|+|.+++. .++..++.....+..|++.|++|||+.|||||||||.||+|+.+|.+|++|||.|..+.+...
T Consensus 1316 C~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999997 456788888899999999999999999999999999999999999999999999988765421
Q ss_pred -CCCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~L~~ 756 (786)
......||+.|||||++.+.. ...+.|||||||++.||+||++||...+..-.+.-.+..+..+++|.. .-++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 123568999999999997653 456899999999999999999999877665544444556777888864 5678
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
++..|+. ||.+|.++.||+++
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHh
Confidence 9999999 99999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.52 Aligned_cols=245 Identities=29% Similarity=0.453 Sum_probs=202.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..|...+.||+|+||.||+|.+ ++..+|+|.+..... ......++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3466778999999999999987 577899998864322 3344567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9997 577766642 2346889999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLI 758 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---ip~~~L~~LI 758 (786)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+........ ..+..+.+||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 2456788999999974 35688899999999999999999999988776665555544332221 2234689999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.+||. +|.+||++.+++++-.
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 99999 9999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.04 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=188.0
Q ss_pred CCeeEeeEE--eecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEE
Q 003919 528 SELTVGTRV--GIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 528 s~y~i~k~L--G~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~L 602 (786)
++|.+.+.+ |.|+||.||++.. ++..+|+|++....... .|+.....+ +||||+++++++...+.+++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 445555555 9999999999976 57889999986543321 122222222 69999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~ 681 (786)
||||+++++|.+++.. ...+++..++.++.|+++||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999863 34889999999999999999999999999999999999999998 9999999998776432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-CCCCC---CCChHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVV-YAVANE-GSRLE---IPEGPLGR 756 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l-~~i~~~-~~~~~---ip~~~L~~ 756 (786)
....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..+... ..... ..+..+.+
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND 239 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence 2346889999999999988999999999999999999999999865433221 111111 11111 22456899
Q ss_pred HHHHhhh-CCCCCCC-HHHHHHH
Q 003919 757 LIADCWA-EPQERPS-CEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPS-a~EIL~~ 777 (786)
++.+||+ +|.+||+ +++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 9999999 9999995 6999864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.08 Aligned_cols=241 Identities=27% Similarity=0.330 Sum_probs=194.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------c
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------~ 599 (786)
.+|.+.+.||+|+||.||+|++ +|+.||||++............+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999986 5889999998654433334467889999999999999999999886543 4
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+++++||+.. +|..+. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999974 565543 2358889999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 745 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------- 745 (786)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+..+.....
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 2 2234567889999999876 4689999999999999999999999988765444433322100
Q ss_pred --------CC-----------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 --------RL-----------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 --------~~-----------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ...+..+.+|+.+||+ ||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0112347799999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.35 Aligned_cols=244 Identities=27% Similarity=0.365 Sum_probs=197.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~l~L 602 (786)
...+|.+.+.||.|+||.||++.. +++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 357899999999999999999976 57889999886544444445778899999999999999999998865 557899
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
++||+. ++|..++. ...+++..+..++.|++.||+|||+.||+|+||+|+|||++.++.++|+|||++.....
T Consensus 88 v~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 88 VTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred Eeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999984 58887775 24578888899999999999999999999999999999999999999999999976532
Q ss_pred CCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------------
Q 003919 683 MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------------------ 743 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~------------------ 743 (786)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234567889999998766 56899999999999999999999999876543322211110
Q ss_pred ------CCCCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 ------GSRLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 ------~~~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..... ..+..+.++|.+||+ +|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 113468899999999 99999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.58 Aligned_cols=244 Identities=26% Similarity=0.319 Sum_probs=197.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 597 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------ 597 (786)
..++|.+.+.||+|+||.||++.+ +++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 358899999999999999999976 588999999865443344456788999999999999999999987533
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
...+++++++ +++|.+++. ...+++..++.++.|++.||+|||++||+||||||+||++++++.+||+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3467788876 678888775 23588999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------- 745 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~----------- 745 (786)
.... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 170 TDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5332 234567889999999866 5688999999999999999999999987655443332221110
Q ss_pred -------------CCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 -------------RLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 -------------~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+. ..+..+.++|.+|++ ||.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 113357899999999 99999999999976
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.17 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=193.7
Q ss_pred CeeEeeEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccccc----CCc
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PPR 599 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~----~~~ 599 (786)
+|.+.+.||+|+||.||++.+. +..||+|++..........+.+.+|+.+++++ .||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999874 56899999864433333456788999999999 59999999987532 245
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++++++|+. ++|...+. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788888886 57888775 45578999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Q 003919 680 DSPM----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG---------- 744 (786)
Q Consensus 680 ~~~~----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~---------- 744 (786)
.... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...-
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3211 1223568999999998765 568999999999999999999999998765433322211100
Q ss_pred ----------------CCC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 ----------------SRL------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ----------------~~~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ......+.+++.+|++ ||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 0113468899999999 99999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.41 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=197.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+|++.+.||+|+||.||++.. +++.+|||++..... .....+.+.+|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999864 467899999865432 122346788999999999 599999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+.+++|.+.+. ....+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998886 335688999999999999999999999999999999999999999999999999877543
Q ss_pred CCC-CCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCC-CCCCh
Q 003919 681 SPM-RDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRL-EIPEG 752 (786)
Q Consensus 681 ~~~-~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvIL~ELlTG~~PF~~~~~----~~~l~~i~~~~~~~-~ip~~ 752 (786)
... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||..... ......+....... ..-+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 321 122346889999999987654 78899999999999999999999964322 22222222221111 11234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.+.+++.+||+ ||++|||+.++...|.
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 68999999999 9999999776655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.14 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=194.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-------- 597 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-------- 597 (786)
.+|.+.+.||.|+||.||+|.. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6899999999999999999987 578999999865543 3357788999999999999999999876543
Q ss_pred ------CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEEE
Q 003919 598 ------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKIC 670 (786)
Q Consensus 598 ------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~ 670 (786)
..+++++||+. ++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+||+++ .++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 58877774 23688999999999999999999999999999999999997 45678999
Q ss_pred ecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-
Q 003919 671 DFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS- 745 (786)
Q Consensus 671 DFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~- 745 (786)
|||++..+..... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999976543211 1123457889999998754 5688899999999999999999999987765544443322110
Q ss_pred ----------------------CCC--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 ----------------------RLE--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ----------------------~~~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... .....+.+|+.+||+ ||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 112357789999999 99999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=329.29 Aligned_cols=259 Identities=33% Similarity=0.629 Sum_probs=222.1
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
.|++..++..+.+.||.|.||.|++|... ...||||.++..... ...+.+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 68888888888999999999999999642 347999998766555 5678999999999999 599999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhc-----------CC--ccchHHHHHHHHHHHHHHHHhhhhcceeeccCCccc
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSG-----------QK--KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSAN 658 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~-----------~~--~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsN 658 (786)
|+|...+.+++|+||+..|+|.+++.... .. ..++....+.+++||+.||+||++.++|||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997443 00 248999999999999999999999999999999999
Q ss_pred EEEcCCCeEEEEecCccccccCCCCCC-CCCCC--CCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 659 CLVNKHWTVKICDFGLSRIITDSPMRD-SSSAG--TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 659 ILLd~~g~VKL~DFGLA~~l~~~~~~~-~~~~G--T~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
||+..+..+||+|||+++......+.. ....+ ...|||||.+....|+.++||||||++|||++| |..||.+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999999765543332 33333 446999999999999999999999999999998 57799987634
Q ss_pred HHHHHHHhcCCCCCCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 735 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
..+...+..+.+...|.. .+++||+.||. +|++||++.++.+.+.+.
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 444667888888888854 68899999999 999999999999998874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=320.68 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=225.9
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEECCee--EEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~--VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+.-++.++++..+..||-|+||.|-++..+++. +|+|++++... +..+.+.+..|-++|..++.|.||++|..|.+.
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 334566788888999999999999999887665 89999876654 445567888999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.++|+.||-|-||.|+.++. .++.++....+.++..+++|++|||++|||+|||||+|++|+.+|.+||.|||+|+.
T Consensus 493 kyvYmLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhhhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999999997 667899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---HH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 754 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~L 754 (786)
+.... ...++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...+..++.....+.+|.. ..
T Consensus 570 i~~g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a 648 (732)
T KOG0614|consen 570 IGSGR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTA 648 (732)
T ss_pred hccCC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhH
Confidence 87653 446899999999999999999999999999999999999999999999999999999988888887743 46
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHHH
Q 003919 755 GRLIADCWA-EPQERPS-----CEEILSRL 778 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPS-----a~EIL~~L 778 (786)
.+||+++.. +|.+|.. +.+|.+|-
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 678888776 9999964 67777663
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=327.07 Aligned_cols=147 Identities=24% Similarity=0.409 Sum_probs=133.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+++|.+.++||+|+||+||+|.+. ++.||||++..... .....+.+..|+.++..++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999885 88999999875443 344457888999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
|||+.+++|.+++.. ...+++..++.|+.||+.||+|||.++||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 3468889999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=287.73 Aligned_cols=250 Identities=24% Similarity=0.428 Sum_probs=206.3
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCC
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP 598 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~ 598 (786)
....+.++++.+..||.|.-|+|+++.+ .|..+|||.+.... +.+..++++..+.++...+ +|+||+.+|||..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3445566777788999999999999987 46899999987554 4555688899998887775 999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++.||.|. ..+..++.+ -.+++++..+-++...+++||.||.. ++|||||+||+|||+|+.|++||||||++-.
T Consensus 165 dV~IcMelMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 165 DVFICMELMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred hHHHHHHHHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 9999999986 355556553 34579999999999999999999986 6899999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCCCC--
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRLEIPE-- 751 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-~~~l~~i~~~~~~~~ip~-- 751 (786)
+.+.. ..+...|.+.|||||.+.- .+|+-++||||||+.|+||.||+.||.+... -+++-.+++ ...+-++.
T Consensus 242 lvdSk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 242 LVDSK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred eeccc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCccc
Confidence 87653 3456789999999999953 4789999999999999999999999998544 344455555 33344443
Q ss_pred ---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 ---GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ---~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+.+++..||+ |+.+||...++|+|
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 258899999999 99999999999976
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=312.75 Aligned_cols=363 Identities=18% Similarity=0.213 Sum_probs=247.9
Q ss_pred hhHHHhhhccccccCCccchhHHHHHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccc
Q 003919 378 SEARRIRRRSISITPEIGDDIVRAVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSAL 457 (786)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~ 457 (786)
-..++|-+-...++.|+.-++-+-+++|+.+.-+|||.. +.||.--|...+-+.-..++.- ...+.++..
T Consensus 194 ~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~--~~~~~~eik~h~f~~~i~~~~l--------~~r~~~~~f 263 (612)
T KOG0603|consen 194 DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA--GPDGVDEIKQHEFFQSIDWNEL--------EARSRPPPF 263 (612)
T ss_pred HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc--CcchhHHHhccchheeeeHhhH--------hhcCCCCCC
Confidence 347888888999999999999999999999999999865 3444444444331111111100 001111111
Q ss_pred cc-ccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCchhhhhhhhhccCCccCCCCccccc-cccccCCCeeEeeE
Q 003919 458 YN-LSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYE-EWNIDFSELTVGTR 535 (786)
Q Consensus 458 ~~-l~R~~~~sq~~~slPSsp~~~~s~sS~~~~ss~~~~~s~~~s~~~~il~sp~~~~~~~~~~~-e~~i~~s~y~i~k~ 535 (786)
-+ +.++..+.+....+++.........+.. ........ -+.+..... -++ .-...+++|.+...
T Consensus 264 kp~~~~e~~~~~fd~eft~~~P~dsp~~~~~------~s~~~if~-------g~sfva~~i-l~~~~~~~~~~~y~~~~~ 329 (612)
T KOG0603|consen 264 KPGSITERDVAQFDPEFTSQVPADSPLLSAS------GSDHTIFS-------GPSFVAPGV-LEDAVTAPFTESYEFREE 329 (612)
T ss_pred CCcccchhhhhhcCchhccCCcccCCCCCCC------ccccchhc-------CCCccChHH-hhccccCCcchhhccccc
Confidence 11 0011111111111212111111000000 00000000 001100000 000 00013577888888
Q ss_pred EeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeeccchh
Q 003919 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 536 LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
+|.|+|+.|..+.+ +++..++|++.+...+ -.+|+.++... +||||+++++.+.++.+.|+|||++.|+.+
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred cCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 99999999999977 6788999998765222 23577666655 699999999999999999999999999988
Q ss_pred HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE-cCCCeEEEEecCccccccCCCCCCCCCCCC
Q 003919 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPMRDSSSAGT 691 (786)
Q Consensus 613 ~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL-d~~g~VKL~DFGLA~~l~~~~~~~~~~~GT 691 (786)
.+.+. ..+.+. ..+..|+.+|+.|+.|||.+|+|||||||+|||+ ++.++++|+|||.++..... ..+.+-|
T Consensus 404 l~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t 476 (612)
T KOG0603|consen 404 LRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALT 476 (612)
T ss_pred HHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchh
Confidence 87775 233344 7778899999999999999999999999999999 69999999999999887654 3345778
Q ss_pred CcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCC
Q 003919 692 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 770 (786)
Q Consensus 692 ~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS 770 (786)
..|.|||++....|++++|+||||++||+|++|+.||........+...+..+......+...++|+.+||+ ||.+|++
T Consensus 477 ~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~ 556 (612)
T KOG0603|consen 477 LQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLG 556 (612)
T ss_pred hcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcC
Confidence 899999999999999999999999999999999999987766633333333333334456679999999999 9999999
Q ss_pred HHHHHHH
Q 003919 771 CEEILSR 777 (786)
Q Consensus 771 a~EIL~~ 777 (786)
+.+++.+
T Consensus 557 ~~~i~~h 563 (612)
T KOG0603|consen 557 ADEIGAH 563 (612)
T ss_pred hhhhccC
Confidence 9999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.51 Aligned_cols=245 Identities=26% Similarity=0.322 Sum_probs=202.9
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHH-HHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~-~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
.+..+.|..-++||+|+||+||-++. +|+-||.|.+.++...... ..-.++|-.+|.+++.+.||.+-.+|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34557788889999999999998754 7889999998766654332 34567899999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++|+..|.||+|.-++... .++.+++..++.++.+|+-||++||+.+||+|||||+|||||+.|+|.|+|+|||..+..
T Consensus 261 ClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998777533 347899999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcCCCCCCC---ChHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---VVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~---~l~~i~~~~~~~~ip---~~~L 754 (786)
.. .....+||.+|||||++.+..|+...|.|+|||+||||+.|+.||....... .+..... ......+ ....
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSEEA 417 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCHHH
Confidence 53 3345699999999999999999999999999999999999999997543221 2222221 1112223 3368
Q ss_pred HHHHHHhhh-CCCCCCCH
Q 003919 755 GRLIADCWA-EPQERPSC 771 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa 771 (786)
++|.+.+|+ ||.+|...
T Consensus 418 kslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHccCHHHhccC
Confidence 889999998 99999643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.15 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=207.1
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECCe--eEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G~--~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+...+|..+.+||+|+||.|-++..+|+ .||||++++... ...+++--+.|-.+|... +-|.+++++.+|++-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4467899999999999999999987655 699999876654 334455556777787766 478999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||+.||+|...++ +-+.+.+..+..++.+|+-||=+||++|||+||||.+||||+.+|++||+|||+++.---
T Consensus 426 yFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999998887 445788889999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-ChHHHHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-EGPLGRLIA 759 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-~~~L~~LI~ 759 (786)
......+.+|||.|+|||++..++|+..+|.|||||+||||+.|+.||.+.+..++.+.+.......+.. +.+...+.+
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICK 582 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHH
Confidence 4455678999999999999999999999999999999999999999999999999988887655443332 345667888
Q ss_pred Hhhh-CCCCCC
Q 003919 760 DCWA-EPQERP 769 (786)
Q Consensus 760 ~CL~-DP~kRP 769 (786)
..+. +|.+|.
T Consensus 583 g~ltK~P~kRL 593 (683)
T KOG0696|consen 583 GLLTKHPGKRL 593 (683)
T ss_pred HHhhcCCcccc
Confidence 8887 999994
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=318.09 Aligned_cols=198 Identities=31% Similarity=0.512 Sum_probs=174.5
Q ss_pred EeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------ceEEE
Q 003919 532 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RLSMI 603 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------~l~LV 603 (786)
....||+|+||.||+|.+ .|+.||||.+.... .....+...+|+++|++|+|+|||+++++-++.. ...++
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 446899999999999986 69999999987644 3345688899999999999999999999865544 36899
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc--CCC--eEEEEecCcccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHW--TVKICDFGLSRIIT 679 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd--~~g--~VKL~DFGLA~~l~ 679 (786)
||||.||+|...+....+...|++.+.+.++..++.||.|||++||+||||||.||++- .+| ..||+|||.|+.+.
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 99999999999998777778999999999999999999999999999999999999984 333 47999999999997
Q ss_pred CCCCCCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003919 680 DSPMRDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGV 731 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~ 731 (786)
+.. .....+||..|++||++. .+.|+..+|.|||||++|+++||..||...
T Consensus 176 d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 176 DNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 764 567889999999999998 488999999999999999999999999644
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.92 Aligned_cols=242 Identities=25% Similarity=0.413 Sum_probs=199.8
Q ss_pred CCCeeEe-eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccccc----CC
Q 003919 527 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PP 598 (786)
Q Consensus 527 ~s~y~i~-k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~----~~ 598 (786)
+++|++- ++||-|-.|.|-.+.+ .|+++|+|++.. .....+|+++.-.. .|||||.++++|+. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 4677765 4789999999999976 688999999742 14456899887666 59999999999864 35
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 675 (786)
.+.+|||.|+||.|++.++.. ....+++.++-.|+.||+.|+.|||+.+|.||||||+|+|+.. +..+||+|||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 688999999999999999744 4567999999999999999999999999999999999999974 457999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCCCCC-
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~----~~~~l~~i~~~~~~~~ip- 750 (786)
+.-.. .....+.+.||.|.|||++...+|+..+|+||+||++|-|++|.+||+... .......+....+.++-|
T Consensus 212 K~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 212 KETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred cccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 87653 234457889999999999999999999999999999999999999998653 233444455444444333
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+...+++|+.+|. +|.+|.|+++++++
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2347789999999 99999999999876
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=325.82 Aligned_cols=242 Identities=28% Similarity=0.459 Sum_probs=189.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc----------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT---------- 595 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~---------- 595 (786)
.+|..+..||+|+||.||++++ +|+.||||++.... .......+.+|+..|.+|+|||||++|..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5677788999999999999976 79999999997765 5555678899999999999999999873210
Q ss_pred --------------------------------------------------------------------cC----------
Q 003919 596 --------------------------------------------------------------------KP---------- 597 (786)
Q Consensus 596 --------------------------------------------------------------------~~---------- 597 (786)
+.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 00
Q ss_pred -------------------------------CceEEEEEeeccchhHHHHHhhcCCccc-hHHHHHHHHHHHHHHHHhhh
Q 003919 598 -------------------------------PRLSMITEYMELGSLYHLIHLSGQKKKL-SWRRKLKMLRDICRGLMCIH 645 (786)
Q Consensus 598 -------------------------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~L-s~~~i~~Ia~QIa~gL~yLH 645 (786)
-.+||-||||+..++.+++.... .. .....++++.||++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHH
Confidence 12688899999988888887332 22 46778999999999999999
Q ss_pred hcceeeccCCcccEEEcCCCeEEEEecCcccccc------C------------CCCCCCCCCCCCcccCccccccC---C
Q 003919 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT------D------------SPMRDSSSAGTPEWMAPELIRNE---P 704 (786)
Q Consensus 646 s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~------~------------~~~~~~~~~GT~~Y~APEvl~~~---~ 704 (786)
++|||||||||.||+|++++.|||+|||+++... + .....+..+||.-|+|||++.+. +
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 0 01123456899999999999764 4
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh-------HHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG-------PLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 705 ~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~-------~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
|+.|+|+||||+||+||+. ||........+..-++.+ .++.+.+ .-..+|..|++ ||.+|||+.|+|+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g-~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG-SIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC-CCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986 676544333222222222 2222211 24578999999 9999999999996
Q ss_pred H
Q 003919 777 R 777 (786)
Q Consensus 777 ~ 777 (786)
.
T Consensus 871 s 871 (1351)
T KOG1035|consen 871 S 871 (1351)
T ss_pred c
Confidence 4
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=278.30 Aligned_cols=219 Identities=23% Similarity=0.259 Sum_probs=178.7
Q ss_pred cCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHH
Q 003919 539 GFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLI 616 (786)
Q Consensus 539 G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL 616 (786)
|.||.||++.+ +++.||+|.+.... .+..|...+....||||+++++++.+....+++|||+++++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 68899999986432 2334555566667999999999999999999999999999999988
Q ss_pred HhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccC
Q 003919 617 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 696 (786)
Q Consensus 617 ~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~A 696 (786)
.. ...+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 77 ~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~a 150 (237)
T cd05576 77 SK---FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCA 150 (237)
T ss_pred HH---hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccC
Confidence 63 346899999999999999999999999999999999999999999999999988665432 223456778999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCH-
Q 003919 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSC- 771 (786)
Q Consensus 697 PEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa- 771 (786)
||.+.+..++.++||||+||++|||++|+.||....... .......+| ...+.+++.+|++ ||++||++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 999988889999999999999999999998876432210 111111222 3468999999999 99999986
Q ss_pred ----HHHHH
Q 003919 772 ----EEILS 776 (786)
Q Consensus 772 ----~EIL~ 776 (786)
+++++
T Consensus 225 ~~~~~~~~~ 233 (237)
T cd05576 225 VAGVEDIKS 233 (237)
T ss_pred ccchHHHHc
Confidence 55554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=313.26 Aligned_cols=248 Identities=30% Similarity=0.596 Sum_probs=211.6
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.+..++||+|+||+||+|.| +|+ +||+|++...... +.-.+|+.|+-+|.+|.|||+++|+++|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34467899999999999987 433 6999998755443 33578999999999999999999999998776 8899
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 682 (786)
++|+++|+|.++++. ++..+-.+..+.|.+||++||.|||.++++||||.++|||+..-.++||.|||+++.+....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999985 45678888999999999999999999999999999999999999999999999999885443
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCCh---HHHHH
Q 003919 683 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757 (786)
Q Consensus 683 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~L~~L 757 (786)
+......-.+.|||-|.+...+|+.++|||||||++|||+| |..||.+....++-. ++..+.++..|+. .+..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhccccCCCCCCccHHHHHH
Confidence 33334445678999999999999999999999999999986 788999988877655 4455666766654 58889
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+||. |+..||+++++...+..+.
T Consensus 933 mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HHHHhccCcccCccHHHHHHHHHHHh
Confidence 999999 9999999999998887653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=330.77 Aligned_cols=238 Identities=23% Similarity=0.410 Sum_probs=188.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
.|...+.||+|+||.||+|++ ++..||||++...... ...|++++++++|||||+++++|.+....++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456677899999999999986 6889999988543221 12468899999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh---hcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH---s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
+++|+|.++++ .++|..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999985 3789999999999999999999 6699999999999999999888875 665543321
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhc---------CCC--C
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANE---------GSR--L 747 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-----~~~l~~i~~~---------~~~--~ 747 (786)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||..... .......... ... .
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 1234688999999999999999999999999999999999999853211 0111000000 000 0
Q ss_pred CCCCh---HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 EIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ~ip~~---~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+.. .+.+++.+||+ ||++||++.++++.|+++..
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 11111 35678899999 99999999999999998754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=266.05 Aligned_cols=233 Identities=31% Similarity=0.484 Sum_probs=195.1
Q ss_pred CcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHH
Q 003919 540 FFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 617 (786)
Q Consensus 540 ~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~ 617 (786)
+||.||+|.+. |+.+++|++........ .+.|.+|++.+++++|+||+++++++......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999884 68999999876544322 5789999999999999999999999999899999999999999999886
Q ss_pred hhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCc
Q 003919 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 697 (786)
Q Consensus 618 ~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~AP 697 (786)
.. ..+++..++.++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 80 ~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KR---GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hc---cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 32 238899999999999999999999999999999999999999999999999998875532 23456688899999
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCC----CChHHHHHHHHhhh-CCCCCCCH
Q 003919 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGSRLEI----PEGPLGRLIADCWA-EPQERPSC 771 (786)
Q Consensus 698 Evl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~-~~~~~~l~~i~~~~~~~~i----p~~~L~~LI~~CL~-DP~kRPSa 771 (786)
|.+.+..++.++|||+||+++++|++|..||.. .........+......... -...+.+++.+||. +|++||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988899999999999999999999999987 4444443333322222211 23468899999999 99999999
Q ss_pred HHHHHH
Q 003919 772 EEILSR 777 (786)
Q Consensus 772 ~EIL~~ 777 (786)
.+++++
T Consensus 236 ~~~~~~ 241 (244)
T smart00220 236 EEALQH 241 (244)
T ss_pred HHHhhC
Confidence 999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=305.70 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=205.2
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+-+-|..++.||-|+||+|.++.. +...||+|.+.+.+. ....+...+.|-.||.....+-||+||..|.+.+++|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 456788899999999999999854 456799999976654 45556778899999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC-
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~- 681 (786)
||+|++||++..+|. ..+.+.+..++.|+.++.-|+++.|+.|+|||||||+|||||.+|++||+||||+.-+...
T Consensus 707 VMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999887 4568999999999999999999999999999999999999999999999999998644210
Q ss_pred --CC---------------------------------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHH
Q 003919 682 --PM---------------------------------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWE 720 (786)
Q Consensus 682 --~~---------------------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~E 720 (786)
.+ .....+||+.|+|||++....|+..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 0023469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCCCCCC-----hHHHHHHHHhhhCCCCCC
Q 003919 721 LCTLNRPWEGVLPERVVYAVANEGSRLEIPE-----GPLGRLIADCWAEPQERP 769 (786)
Q Consensus 721 LlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~-----~~L~~LI~~CL~DP~kRP 769 (786)
|+.|+.||...++.+..+.+.+....+.++. .+..++|.+++.+++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhh
Confidence 9999999999998888888887777776653 245667777666666664
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=288.30 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=172.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~ 599 (786)
...|.+...||+|.||.||+++.. ...+|||.++........-....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999542 2269999987664333334567899999999999999999999987 778
Q ss_pred eEEEEEeeccchhHHHHHhhc--CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC----CeEEEEecC
Q 003919 600 LSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFG 673 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~----g~VKL~DFG 673 (786)
+++++||.+. +|+++++... ..+.++...+++|++||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999986 7888886442 34679999999999999999999999999999999999999877 899999999
Q ss_pred ccccccCCCC---CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003919 674 LSRIITDSPM---RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEG 730 (786)
Q Consensus 674 LA~~l~~~~~---~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~ 730 (786)
+++.+.++-. .....+-|.+|.|||++.+. .|+.+.|||+.|||+.||+|-.+-|.+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999876532 23456788999999999875 699999999999999999998887754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=286.19 Aligned_cols=238 Identities=26% Similarity=0.462 Sum_probs=193.7
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+|+.|--++. +|..||||++.++. .....++.+|++++.+++ |+||++|+++|+++.++|+|||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 5799999999998754 89999999997763 344678999999999996 999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEecCccccccCCC-----
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSP----- 682 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l~~~~----- 682 (786)
.|...++ +.+.+++..+.++..+|+.||.+||.+||.||||||+|||-.... -||||||.|..-+....
T Consensus 162 plLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9998887 567899999999999999999999999999999999999997655 48999998875432110
Q ss_pred --CCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHHHHH
Q 003919 683 --MRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------------LPERVVYAVA 741 (786)
Q Consensus 683 --~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~--------------~~~~~l~~i~ 741 (786)
....+.+|+..|||||+.. ...|+.++|.||||||||-|++|.+||.+. ...+.++.-+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1123557889999999873 246899999999999999999999999743 1223333333
Q ss_pred hcCCCCCCCCh-------HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 742 NEGSRLEIPEG-------PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 742 ~~~~~~~ip~~-------~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.++ ..++|+. ..++|+..++. |+..|.++.+++++
T Consensus 319 QEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 319 QEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred hcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 333 2344543 45678999988 99999999998874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=301.98 Aligned_cols=241 Identities=29% Similarity=0.445 Sum_probs=203.6
Q ss_pred eeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccc
Q 003919 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.+.||+|.||+||-|++ +|+.||||++.+-.+......++.+|+.||+++.||.||.+--.|++.+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46899999999999977 6999999999888887777789999999999999999999999999999999999999875
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC---CeEEEEecCccccccCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
-|.-+|. ...+.|++.....++.||+.||+|||-+||+|+||||+||||.+. -++||||||+|+.+....+ ...
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-Rrs 725 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRS 725 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhh
Confidence 5655554 356789999999999999999999999999999999999999754 3799999999999977543 357
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C----ChHHHHHHHHhh
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P----EGPLGRLIADCW 762 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p----~~~L~~LI~~CL 762 (786)
.+|||.|+|||++.++.|...-|+||.|||+|--++|..||..... +-.++.+.....+. | +....+||..+|
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999975432 22333332222211 1 224568999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003919 763 A-EPQERPSCEEILSRL 778 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L 778 (786)
+ .-.+|-|....+.|-
T Consensus 804 qVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHP 820 (888)
T ss_pred HHHHHHhcchHhhccch
Confidence 9 999999999888763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=290.75 Aligned_cols=247 Identities=33% Similarity=0.591 Sum_probs=201.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhh--cCCCceeEEecccccCC----ceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~--L~HPNIVkL~g~~~~~~----~l~ 601 (786)
.+..+.+.||+|.||+||+|.|.|..||||+|...+ ...+.+|.+|.+- |+|+||+.|++.-..+. .+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 578889999999999999999999999999986432 3567888888765 49999999998865443 489
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc--------ceeeccCCcccEEEcCCCeEEEEecC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
+|++|.+.|+|+|+|. ..+++.+..++++..++.||++||.. .|.|||||..|||+.+++...|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999996 36899999999999999999999953 49999999999999999999999999
Q ss_pred ccccccCCC----CCCCCCCCCCcccCccccccC----CCC--chhhHHHHHHHHHHHHhC----------CCCCCCC--
Q 003919 674 LSRIITDSP----MRDSSSAGTPEWMAPELIRNE----PFT--EKCDIFSLGVIMWELCTL----------NRPWEGV-- 731 (786)
Q Consensus 674 LA~~l~~~~----~~~~~~~GT~~Y~APEvl~~~----~~s--~ksDVWSLGvIL~ELlTG----------~~PF~~~-- 731 (786)
||....... ...+..+||.+|||||++... .|. ..+||||||.++||++.. +.||++.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 998765432 234567899999999999653 121 368999999999998752 5688754
Q ss_pred ---ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 732 ---LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 732 ---~~~~~l~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+-+++..-+.....++.+|.. .+.+||+.||. ||.-|.|+--|.+.|.++.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 233344434445566666632 36788999999 99999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=294.11 Aligned_cols=246 Identities=28% Similarity=0.530 Sum_probs=204.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc--CCCceeEEecccccCC----ceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKPP----RLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L--~HPNIVkL~g~~~~~~----~l~ 601 (786)
....+.+.||+|.||.||+|+.+++.||||++. .+..+.|.+|-+|.+.. +|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345566889999999999999999999999985 34568899999998765 7999999999865544 799
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc---------ceeeccCCcccEEEcCCCeEEEEec
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---------gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
+|++|.+.|+|.++|+ ...++|....+++..+++||+|||+. .|+|||||..||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999996 45899999999999999999999963 4999999999999999999999999
Q ss_pred CccccccCCCCC--CCCCCCCCcccCccccccCC-CC-----chhhHHHHHHHHHHHHhCC------------CCCC---
Q 003919 673 GLSRIITDSPMR--DSSSAGTPEWMAPELIRNEP-FT-----EKCDIFSLGVIMWELCTLN------------RPWE--- 729 (786)
Q Consensus 673 GLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~-~s-----~ksDVWSLGvIL~ELlTG~------------~PF~--- 729 (786)
|||..+...... ....+||.+|||||++.+.. +. .+.||||+|.+||||++.- .||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988643211 22468999999999997642 22 4689999999999999842 2443
Q ss_pred --CCChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 730 --GVLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 730 --~~~~~~~l~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+-+++...++.+..++.+|+. .+.+.+..||. ||+-|.|+.=+-+++.++.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 23455666777788888888864 47889999999 9999999998888887664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=263.75 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=203.6
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|.-.++||+|.||+||+++. .++.||+|.....+.+.......++|+.+++.++|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999976 577899999877766655567889999999999999999999999888999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
|.. .|..+... -++.++.+.++.++.|+++||.+||++++.||||||.|+||+.+|.+||+|||+++.+.-+..-..
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 974 77766652 457899999999999999999999999999999999999999999999999999998866543445
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC---------CCC----
Q 003919 687 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE---------IPE---- 751 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~---------ip~---- 751 (786)
..+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|++.+....+..+...-..+. +|+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 56778999999999875 58899999999999999985 5666888877777666643221111 111
Q ss_pred -----------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 -----------------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 -----------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..-++|+..++. +|..|++++..+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 013468888888 99999999998876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=279.68 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=203.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEeccccc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTK 596 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~ 596 (786)
..|.+...+|.++++||+|+|++|.++.+ +.+.||+|++++.-. +.+++.-...|-.+..+. +||.+|.++.+|++
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45667789999999999999999999976 567899999876654 334456666788887766 69999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+++|.||++||+|.-.++ ....++++.++.+..+|+.||.|||++|||+||||.+|||++..|++||+|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999999987776 45689999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCChHHHHHHH-HhcCCCCC
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWE-------GVLPERVVYAV-ANEGSRLE 748 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~-------~~~~~~~l~~i-~~~~~~~~ 748 (786)
.--.+.....+.+|||.|.|||++++..|....|.|+|||+++||+.|+.||. ..+.+..+.++ +.+..+++
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip 479 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP 479 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence 76555556678999999999999999999999999999999999999999995 22233333333 33333332
Q ss_pred CCCh-HHHHHHHHhhh-CCCCCC
Q 003919 749 IPEG-PLGRLIADCWA-EPQERP 769 (786)
Q Consensus 749 ip~~-~L~~LI~~CL~-DP~kRP 769 (786)
..-. ....+++..++ ||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 2211 24457777787 999884
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=303.79 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=214.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccccc---
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK--- 596 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~--- 596 (786)
+......|.+...||.|.+|.||+++. +|+.+|+|++...... -+++..|.++++.+ .|||++.+||+|..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 334456788899999999999999854 7999999997544322 35677889999888 49999999999843
Q ss_pred --CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCc
Q 003919 597 --PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 674 (786)
Q Consensus 597 --~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 674 (786)
++.+|+|||||.+|+..|+++... ...+.|..+..|++.++.|+.+||++.+||||||-.|||++.++.|||+|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 467999999999999999998654 77899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 749 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i 749 (786)
+..+...-....+..|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..+...++.+..+......
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 9998776666678899999999999954 35788999999999999999999999999998888877655443333
Q ss_pred -CC---hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 -PE---GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 -p~---~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
|. ..+.++|..|+. |-.+||++.++|+|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 32 257789999998 99999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=281.39 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=201.3
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCC
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPP 598 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~ 598 (786)
-+.+..++.+-+..||.|+||+|++-.+ .|+..|||.+...... ...++|+.|.+...+- ++||||++||++..++
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 3445556777778999999999999987 5889999999766653 4468899998876554 7999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHh--hcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHL--SGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~--~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..|+.||+|+ .+|..+-+. ..+...++++-+-.|....+.||.||.. .+|||||+||+||||+..|.|||||||++
T Consensus 137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 9999999997 355433321 2245678899999999999999999985 68999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CC-
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PE- 751 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~- 751 (786)
-.+.+. ...+..+|...|||||.+.. ..|+-++||||||++|||+.||+.||.+.+..-....+...+..+.+ .+
T Consensus 216 GqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 216 GQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK 294 (361)
T ss_pred HhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence 877553 23345678889999999964 34899999999999999999999999988664333333333333322 21
Q ss_pred ------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 ------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+|.-|+. |-..||.+.+++++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 257889999998 99999999998864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.15 Aligned_cols=263 Identities=23% Similarity=0.444 Sum_probs=221.4
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEec
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g 592 (786)
..++.+...+++....+-+|.||+||+|.|. .+.|.+|.++.+.. .-++..|+.|...+..+.|||+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3556666778888889999999999999663 23467777654433 445678999999999999999999999
Q ss_pred ccccC-CceEEEEEeeccchhHHHHH-----hhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 593 ACTKP-PRLSMITEYMELGSLYHLIH-----LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 593 ~~~~~-~~l~LV~Ey~~gGSL~dlL~-----~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
++.+. ...+++|.++.-|+|..++. .....+.++..+...++.|++.|++|||++||||.||.+.|++|++..+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 98654 56788999999999999997 3334567888999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003919 667 VKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~ 743 (786)
|||+|=.+++.+....++. .....+..||+||.+.+..|+..+|||||||+||||+| |+.||...++.++.. .+..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-YLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-HHhc
Confidence 9999999999886655543 23345678999999999999999999999999999997 788999998877654 4566
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 744 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 744 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
++++..| ++++..++..||. +|++||+++|+...|.++...
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 7777766 4579999999999 999999999999999988654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=297.09 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=170.2
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--C----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecc---
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--N----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA--- 593 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~--- 593 (786)
.....++|.+.+.||+|+||.||+|.+ + +..||||++..... .+.+..| .+....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 344678999999999999999999987 3 67899998753221 1111221 1222223333332222
Q ss_pred ---cccCCceEEEEEeeccchhHHHHHhhcC-----------------CccchHHHHHHHHHHHHHHHHhhhhcceeecc
Q 003919 594 ---CTKPPRLSMITEYMELGSLYHLIHLSGQ-----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653 (786)
Q Consensus 594 ---~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-----------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrD 653 (786)
+.....+++++||+.+++|.+++..... ........+..++.||+.||+|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2455679999999999999998863211 01122345678999999999999999999999
Q ss_pred CCcccEEEcC-CCeEEEEecCccccccCC-CCCCCCCCCCCcccCccccccC----------------------CCCchh
Q 003919 654 LKSANCLVNK-HWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPELIRNE----------------------PFTEKC 709 (786)
Q Consensus 654 LKpsNILLd~-~g~VKL~DFGLA~~l~~~-~~~~~~~~GT~~Y~APEvl~~~----------------------~~s~ks 709 (786)
|||+|||++. ++.+||+|||+++.+... .+......+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 579999999999865432 2334567889999999965322 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------CCC---------CCChHHHHHHHHhhh-CCC
Q 003919 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-------------RLE---------IPEGPLGRLIADCWA-EPQ 766 (786)
Q Consensus 710 DVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-------------~~~---------ip~~~L~~LI~~CL~-DP~ 766 (786)
|||||||+||||+++..|+..... .....+...+. ... .......+|+.+|++ ||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999999998766543211 11111111010 000 011124589999999 999
Q ss_pred CCCCHHHHHHH
Q 003919 767 ERPSCEEILSR 777 (786)
Q Consensus 767 kRPSa~EIL~~ 777 (786)
+|||+.++|+|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=275.91 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=199.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------ 597 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------ 597 (786)
..+.|.-..+||+|.||+||++.. .|+.||+|++...+.........++|+.+|..|+|+|++.+++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 346677778999999999999865 577899987654443333445678999999999999999999998532
Q ss_pred --CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 598 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 598 --~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..+|+||.+|.. +|.-++. +....++...+.+++.+++.||.|+|+..|+|||+|+.|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 348999999985 7777774 34467899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cCCCCC
Q 003919 676 RIITDSP----MRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN--EGSRLE 748 (786)
Q Consensus 676 ~~l~~~~----~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~--~~~~~~ 748 (786)
+.+.... ...+..+-|..|.+||.+.+ ..|+++.|||..|||+.||+|+.+-|.+.+..+.+..+.. +....+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 8764321 12345567999999999876 5799999999999999999999999998887776665532 111111
Q ss_pred ------------------CC----------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ------------------IP----------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ------------------ip----------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
++ ++...+|+..++. ||.+|+.+.+++.|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11 1134468999999 99999999999976
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-31 Score=283.43 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=196.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccc-cCh----HHHHHHHHHHHHHhhcCCCceeEEeccccc-CC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTA----ENMEDFCNEISILSRLRHPNVILFLGACTK-PP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~-~~~----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~ 598 (786)
-++|-+++.||+|+|++||++.+ ..+.||||+-..+. +.. ...+...+|..|.+.|.||.||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 36788889999999999999965 68889999864332 211 224567789999999999999999999864 45
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc--ceeeccCCcccEEEcC---CCeEEEEecC
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--KIVHRDLKSANCLVNK---HWTVKICDFG 673 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--gIIHrDLKpsNILLd~---~g~VKL~DFG 673 (786)
.++-|+|||+|.+|.-+|+ ..+.++++.++.|+.||+.||.||... .|||-||||.||||-+ -|.+||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6899999999999999997 567899999999999999999999976 5999999999999954 4789999999
Q ss_pred ccccccCCCCC-------CCCCCCCCcccCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HH
Q 003919 674 LSRIITDSPMR-------DSSSAGTPEWMAPELIRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVY-AV 740 (786)
Q Consensus 674 LA~~l~~~~~~-------~~~~~GT~~Y~APEvl~~~----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~-~i 740 (786)
|++.+.+..+. .....||.+|++||.+.-. +.+.|+||||.|||+|.++.|+.||......+ ++. ..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99999765443 2346799999999988543 46789999999999999999999998654333 222 11
Q ss_pred HhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 741 ANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 741 ~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
+.+.....+| ....+.+|++||+ .-+.|....++..
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1222222233 3468899999998 7788888777654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=239.89 Aligned_cols=210 Identities=40% Similarity=0.641 Sum_probs=184.1
Q ss_pred EeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhH
Q 003919 536 VGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY 613 (786)
Q Consensus 536 LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~ 613 (786)
||+|.+|.||++... ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999886 8899999987554432 3478999999999999999999999999989999999999999999
Q ss_pred HHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCccccccCCCCCCCCCCCCC
Q 003919 614 HLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIITDSPMRDSSSAGTP 692 (786)
Q Consensus 614 dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~~~~~~~~~~GT~ 692 (786)
+++... ...+++..++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKEN--EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 998632 146889999999999999999999999999999999999999 89999999999987755432233456788
Q ss_pred cccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCC
Q 003919 693 EWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPS 770 (786)
Q Consensus 693 ~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPS 770 (786)
.|++||.+... .++.+.|+|++|+++++| ..+.+++..|+. ||.+||+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999999877 788999999999999999 568889999998 9999999
Q ss_pred HHHHHHHH
Q 003919 771 CEEILSRL 778 (786)
Q Consensus 771 a~EIL~~L 778 (786)
+.++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=276.74 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=198.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcC--CC----ceeEEeccccc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HP----NVILFLGACTK 596 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~--HP----NIVkL~g~~~~ 596 (786)
.-..+|.+...+|+|.||.|-.+.++ +..||||+++.- ....+..+-|+++|+++. .| -+|++.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 33678999999999999999999874 678999998532 223456677999999994 23 38899999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-------------
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK------------- 663 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~------------- 663 (786)
.++.++|+|.+ |-++++++.. ++..+++...++.|++|+++++++||+++++|.||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 99999999988 4699999963 35568999999999999999999999999999999999999942
Q ss_pred -------CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 003919 664 -------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 736 (786)
Q Consensus 664 -------~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~ 736 (786)
+..|+|+|||.|..-.. .....+.|..|.|||++.+-.++.++||||+||||+||+||...|++..+.+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 33589999999987543 33577889999999999999999999999999999999999999988776553
Q ss_pred HHHHHhcCC-------------------CCCC-----------------C-----------ChHHHHHHHHhhh-CCCCC
Q 003919 737 VYAVANEGS-------------------RLEI-----------------P-----------EGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 737 l~~i~~~~~-------------------~~~i-----------------p-----------~~~L~~LI~~CL~-DP~kR 768 (786)
+..+...-. +++. | ...|.+|+++||. ||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 322211000 1110 0 0147789999999 99999
Q ss_pred CCHHHHHHH
Q 003919 769 PSCEEILSR 777 (786)
Q Consensus 769 PSa~EIL~~ 777 (786)
+|+.|+|+|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999976
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=282.49 Aligned_cols=254 Identities=19% Similarity=0.244 Sum_probs=180.0
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE------------------CCeeEEEEEEeccccCh------------HHHHHHH
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW------------------NGTDVAIKVFLEQDLTA------------ENMEDFC 573 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~------------------~G~~VAVKvl~~~~~~~------------~~~~~f~ 573 (786)
....++|.+.++||+|+||+||+|.+ .++.||||.+....... ...+.+.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34578999999999999999999863 34679999985432110 0112334
Q ss_pred HHHHHHhhcCCCce-----eEEeccccc--------CCceEEEEEeeccchhHHHHHhhcC-------------------
Q 003919 574 NEISILSRLRHPNV-----ILFLGACTK--------PPRLSMITEYMELGSLYHLIHLSGQ------------------- 621 (786)
Q Consensus 574 ~EI~iL~~L~HPNI-----VkL~g~~~~--------~~~l~LV~Ey~~gGSL~dlL~~~~~------------------- 621 (786)
.|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46777777766554 677777653 3468999999999999998863210
Q ss_pred --CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCcc
Q 003919 622 --KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPE 698 (786)
Q Consensus 622 --~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APE 698 (786)
...+++..++.++.|++.+|+|||+.+|+||||||+|||++.++.+||+|||++..+...... .....+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 123467788999999999999999999999999999999999999999999999765432211 12234578999999
Q ss_pred ccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCChHHHH--------HHHH-hcCCC
Q 003919 699 LIRNEP--------------------F--TEKCDIFSLGVIMWELCTLNR-PWEGVLPERVV--------YAVA-NEGSR 746 (786)
Q Consensus 699 vl~~~~--------------------~--s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~l--------~~i~-~~~~~ 746 (786)
.+.... | ..+.||||+||++|+|++|.. ||.+....... ..+. .....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875422 1 134799999999999999986 77543211111 1000 01111
Q ss_pred CCC-----CChHHHHHHHHhhh-CC---CCCCCHHHHHHH
Q 003919 747 LEI-----PEGPLGRLIADCWA-EP---QERPSCEEILSR 777 (786)
Q Consensus 747 ~~i-----p~~~L~~LI~~CL~-DP---~kRPSa~EIL~~ 777 (786)
..+ ......+|+.+|+. +| .+|+|+.|+|+|
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 13457889999997 54 689999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=250.48 Aligned_cols=224 Identities=27% Similarity=0.416 Sum_probs=179.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEE--EECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg--~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
+++.-+++..+..||+|+||.|-+. ..+|+..|+|.+...- +.+..++.++|+.+..+. .+|.+|.|||.+.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 4455566677789999999987655 4589999999986543 445568889999887665 69999999999999999
Q ss_pred eEEEEEeeccchhHHHHH-hhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 600 LSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~-~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.++.||.|+ .+|..+-. ...+++.+++..+-+|+..+.+||+|||+ ..+||||+||+|||++.+|+||+||||.+-.
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 999999997 46665543 22467789999999999999999999997 5899999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCC
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN----EPFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIP 750 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~l~~i~~~~~~~~ip 750 (786)
+.+.- ..+-..|...|||||.+.. ..|+-++||||||++++||.+++.||.... +-+.+.++.. ...+.+|
T Consensus 199 L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe-ep~P~Lp 274 (282)
T KOG0984|consen 199 LVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE-EPSPQLP 274 (282)
T ss_pred ehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc-CCCCCCc
Confidence 76642 2223567889999998853 468999999999999999999999998764 4444444443 3344444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=253.77 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=192.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccC--Cce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKP--PRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~--~~l 600 (786)
..++|++.+++|+|.|++||.|.. ++++++||+++. -..+.+.+|+.+|+.|. ||||++++++..++ ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 468899999999999999999974 788999999863 23467899999999997 99999999998775 457
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCcccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIIT 679 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~ 679 (786)
.+++||+.+.+...+.. .++...++.++.++++||.|||++||+|||+||.|+++|. ...++|+|+|||.++.
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 89999999877666543 7888899999999999999999999999999999999985 4579999999999886
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHh-----------cCCC
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPERVVYAVAN-----------EGSR 746 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF-~~~~~~~~l~~i~~-----------~~~~ 746 (786)
... ..+-.+.+..|--||.+.. +.|+..-|+|||||+|..|+..+.|| .+.++...+..+.. ..+.
T Consensus 185 p~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 185 PGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred CCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 542 2334566778899999876 46889999999999999999999987 44444333322221 0111
Q ss_pred CCCC---------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 LEIP---------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ~~ip---------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.++ ..+.-+|+..++. |-++|+|+.|.+.|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111 1245678999999 99999999998865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=238.53 Aligned_cols=213 Identities=35% Similarity=0.554 Sum_probs=179.1
Q ss_pred eeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.+.+.||.|++|.||++... ++.+++|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999884 689999998755433 24678999999999999999999999999889999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC-CCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDS 686 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-~~~~ 686 (786)
++++|.+++.... ..+++..+..++.+++.++.+||+.+++|+||++.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999987322 128899999999999999999999999999999999999999999999999998775432 1223
Q ss_pred CCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCC
Q 003919 687 SSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEG-VLPERVVYAVANEGS 745 (786)
Q Consensus 687 ~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~-~~~~~~l~~i~~~~~ 745 (786)
...++..|++||.+ ....++.++|||+||+++++|++|+.||.. ..+...+......+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 45677889999998 667788899999999999999999999987 455544444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=291.15 Aligned_cols=236 Identities=34% Similarity=0.516 Sum_probs=188.2
Q ss_pred eEEeecCcEE-EEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEEEeeccch
Q 003919 534 TRVGIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGS 611 (786)
Q Consensus 534 k~LG~G~fG~-VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~Ey~~gGS 611 (786)
+.+|.|+-|+ ||+|.+.|+.||||.+... ...-..+||..|+.. .|||||++|+.-.+....|+..|.|. .+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 5689999974 7999999999999997533 234556899999988 49999999999888999999999997 59
Q ss_pred hHHHHHhhcC-CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---C--CeEEEEecCccccccCCCCC-
Q 003919 612 LYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---H--WTVKICDFGLSRIITDSPMR- 684 (786)
Q Consensus 612 L~dlL~~~~~-~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~--g~VKL~DFGLA~~l~~~~~~- 684 (786)
|.+++..... .........+.++.|+++||++||+.+||||||||.||||+. + ..++|+|||+++.+......
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 9999974311 111111445788999999999999999999999999999976 3 47899999999988654322
Q ss_pred --CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCC----CCChHHHHH
Q 003919 685 --DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE----IPEGPLGRL 757 (786)
Q Consensus 685 --~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~~~~~~~----ip~~~L~~L 757 (786)
.....||-+|+|||.+....-+.++|||||||++|+.++| ..||.+....+ ..+........ .++....+|
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dL 746 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDL 746 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHH
Confidence 3456799999999999988888899999999999999987 78998754432 23333333222 222267899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+|+. +|..||++.+||.|
T Consensus 747 I~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCC
Confidence 999999 99999999999965
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=275.74 Aligned_cols=244 Identities=21% Similarity=0.355 Sum_probs=203.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC------CCceeEEecccccCCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR------HPNVILFLGACTKPPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~------HPNIVkL~g~~~~~~~ 599 (786)
..|.+....|+|-|++|.+|.+ .|..||||+|..+... .+.=+.|+++|++|+ --|+++|+..|...++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 5788888999999999999977 4779999999765432 245568999999996 3489999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRII 678 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l 678 (786)
+|||+|-+. -+|.++|+..+.+-.|....++.|+.|++.||..|...||+|.||||+|||+++. ..+||||||.|...
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 999999886 5899999988888899999999999999999999999999999999999999865 57899999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 748 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------- 748 (786)
..... +.+.-+..|.|||++.+.+|+...|+||.||+||||+||+..|++.++..++.....-...++
T Consensus 588 ~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 588 SENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 65422 334455679999999999999999999999999999999999999887776654432111110
Q ss_pred ------------------------------CC---------------Ch------HHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 749 ------------------------------IP---------------EG------PLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 749 ------------------------------ip---------------~~------~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
.| ++ .|.+|+..|+. ||++|.|..+.|+
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01 11 36678999999 9999999999997
Q ss_pred H
Q 003919 777 R 777 (786)
Q Consensus 777 ~ 777 (786)
|
T Consensus 746 H 746 (752)
T KOG0670|consen 746 H 746 (752)
T ss_pred C
Confidence 6
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=279.05 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=175.2
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC------hHHHHHHHHHHHHHhhcC---CCceeEEeccc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLR---HPNVILFLGAC 594 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~------~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~ 594 (786)
++++|...+.+|.|+||.|+++++ +...|+||.+.+.+.- ....-.+-.||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 578899999999999999999988 4567999998766531 111224557999999997 99999999999
Q ss_pred ccCCceEEEEEeec-cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 595 TKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 595 ~~~~~l~LV~Ey~~-gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
++++++|++||--. +.+|++++. -.+.+++..+..|+.||+-|+++||+.||||||||-+||.++.+|.+||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 99999999999764 458999997 55689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 003919 674 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEG 730 (786)
Q Consensus 674 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~ 730 (786)
.+.....++ ....+||..|.|||++.+.+|- ..-|||++|++||.++....||+.
T Consensus 716 saa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998776553 3578999999999999999884 567999999999999999999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=283.94 Aligned_cols=246 Identities=30% Similarity=0.504 Sum_probs=217.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+..++|.|.||.||++++ .+...|+|+++....+ +.+-+.+|+-+++.++|||||.++|.+.....++++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 46888999999999999999976 6889999998755432 3566778999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|||.+|+|.++-+ -.+++++.++..++++.+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..++.....
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999887 4568999999999999999999999999999999999999999999999999999888765555
Q ss_pred CCCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC------hHHH
Q 003919 685 DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE------GPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~------~~L~ 755 (786)
...+.||+.|||||+. +.+-|..++|||++|+...|+-.-+.|..+..+.+.++...+.++.+..-. ..+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 5678999999999986 345689999999999999999999999988899999988888777665432 2588
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|++.|+. +|++||+++.+|+|
T Consensus 249 ~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHhcCCCccCCChhhheec
Confidence 99999998 99999999988864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=259.96 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=191.9
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-----ceE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-----RLS 601 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-----~l~ 601 (786)
++...+.||-|+||.||-+.+ +|+.||+|++..-..+-...+.+.+|+.+|.-++|.|++..++...-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344457899999999999987 7999999988654444445688999999999999999999888764432 267
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+++|.|. .+|..++- ....++...++.+++||++||.|||+.||.||||||.|+|++.+..+||||||+++.-...
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 7788775 46666664 4567889999999999999999999999999999999999999999999999999875432
Q ss_pred -CCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----------
Q 003919 682 -PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---------- 749 (786)
Q Consensus 682 -~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---------- 749 (786)
....+..+-|..|.|||++.+. .|+...||||.|||+.||+-.+..|..-++.+.+..+..--..+..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 2233445678899999999875 6899999999999999999999999887777766655432222211
Q ss_pred -----------CC-----------h---HHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 750 -----------PE-----------G---PLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 750 -----------p~-----------~---~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
|+ . +--.++..++. ||.+|.+.++.+.++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 10 0 12234445566 999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=250.10 Aligned_cols=130 Identities=28% Similarity=0.385 Sum_probs=109.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----C---CceeEEeccccc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H---PNVILFLGACTK 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----H---PNIVkL~g~~~~ 596 (786)
..+|.+.++||-|.|++||++.+ ..+.||+|+.+.. ....+..+.||.+|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 46899999999999999999987 5778999997643 233466788999999984 2 379999999964
Q ss_pred ----CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEE
Q 003919 597 ----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLV 661 (786)
Q Consensus 597 ----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILL 661 (786)
+.+++||+|++. .+|..++... ..+.++...+++|++||+.||.|||. .||||.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvLG-dnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLG-DNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhhh-hHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 346999999994 5777777644 45679999999999999999999997 699999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=248.77 Aligned_cols=242 Identities=25% Similarity=0.320 Sum_probs=193.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------c
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------R 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------~ 599 (786)
.+|.-++.+|.|.- .|..+.+ .+++||+|.......+....++..+|..++..++|+||++++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 5655544 6899999988666544555678889999999999999999999986543 4
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+|||||. .+|...+. ..++-..+..+++|++-|++|||+.||+||||||+||++..+..+||.|||+++...
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 799999997 47776665 357778889999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------ 747 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------ 747 (786)
.. ...+.++.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.+.-....++...-..+
T Consensus 170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 43 56677889999999999998889999999999999999999999887654333222221100000
Q ss_pred -----------------CCCC--------------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -----------------EIPE--------------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -----------------~ip~--------------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+|+ +..++++.+||. ||++|.|+.++|+|
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0111 136788999998 99999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=274.29 Aligned_cols=193 Identities=19% Similarity=0.179 Sum_probs=140.7
Q ss_pred hhcCC-CceeEEeccc-------ccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceee
Q 003919 580 SRLRH-PNVILFLGAC-------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651 (786)
Q Consensus 580 ~~L~H-PNIVkL~g~~-------~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIH 651 (786)
+.+.| +||++++++| .+...+++++||+. ++|.+++.. ....+++..++.++.||++||+|||++||+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~gIvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQGIVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 34555 5888888877 33346788889874 699999862 3456999999999999999999999999999
Q ss_pred ccCCcccEEEcCCC-------------------eEEEEecCccccccCCC----------------CCCCCCCCCCcccC
Q 003919 652 RDLKSANCLVNKHW-------------------TVKICDFGLSRIITDSP----------------MRDSSSAGTPEWMA 696 (786)
Q Consensus 652 rDLKpsNILLd~~g-------------------~VKL~DFGLA~~l~~~~----------------~~~~~~~GT~~Y~A 696 (786)
|||||+||||+..+ .+||+|||+++...... .......||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 45566666665321100 00112458889999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CChHHHHHHHHhhh-CCCCCCCHHH
Q 003919 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--PEGPLGRLIADCWA-EPQERPSCEE 773 (786)
Q Consensus 697 PEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i--p~~~L~~LI~~CL~-DP~kRPSa~E 773 (786)
||++.+..|+.++|||||||+||||++|..|+..... ....+......... .......++..||. +|.+||++.+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 9999999999999999999999999999888764321 11112111111111 12245678889999 9999999999
Q ss_pred HHHH
Q 003919 774 ILSR 777 (786)
Q Consensus 774 IL~~ 777 (786)
++++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=214.40 Aligned_cols=160 Identities=23% Similarity=0.298 Sum_probs=128.4
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|+|.+++.. .+..+++.+++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 688888863 2456999999999999999999999998 999999999999999 9999876442 236
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCC-----CC---Ch--HHHHHH
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLE-----IP---EG--PLGRLI 758 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~-----ip---~~--~L~~LI 758 (786)
||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+........ .+ .. .+.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8899999999999999999999999999999999999997654322 2222222111110 00 11 488999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 759 ADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
.+||. +|.+||++.++++++......
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 99999 999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-23 Score=210.83 Aligned_cols=247 Identities=31% Similarity=0.470 Sum_probs=202.0
Q ss_pred eeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH-HHHHHHHHHHHHhhcCCC-ceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMEDFCNEISILSRLRHP-NVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~-~~~~f~~EI~iL~~L~HP-NIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....|.+|+.++..+.|+ +|+++++.+......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678899999999999999888 7889999876655443 568899999999999988 7999999997777789999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccCCCC---
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPM--- 683 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~~~~--- 683 (786)
.++++.+++........+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999996665211113788999999999999999999999999999999999999988 799999999986654332
Q ss_pred ---CCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCC---CCCC
Q 003919 684 ---RDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSR---LEIP 750 (786)
Q Consensus 684 ---~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~----~~~l~~i~~~~~~---~~ip 750 (786)
......|+..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... ....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC
Confidence 2356789999999999987 5788999999999999999999999887763 3444444433322 1222
Q ss_pred C-------hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 E-------GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ~-------~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ..+.+++..|+. +|..|.+..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2 257889999998 99999998887764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=228.13 Aligned_cols=231 Identities=21% Similarity=0.332 Sum_probs=176.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecc-cccCCceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA-CTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~-~~~~~~l~LV 603 (786)
+.|.|.+.||+|.||.+-++.+. ++.+++|.+.... ...++|.+|..---.| .|.||+.-|++ |+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 67999999999999999999884 6689999886543 3357899998776556 49999988875 6777788899
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc--CCCeEEEEecCccccccCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd--~~g~VKL~DFGLA~~l~~~ 681 (786)
+||++.|+|...+. ...+.+.....++.|++.||.|+|+.++||||||.+||||- +..+|||||||+.+..+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999998774 34677888899999999999999999999999999999994 3348999999998765432
Q ss_pred CCCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCCCCCCh-
Q 003919 682 PMRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRLEIPEG- 752 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~---~~~~~l~~i~~~~~~~~ip~~- 752 (786)
......+..|.+||.... -...+.+|||.||+++|.++||..||+.. .+...-+.....+..+..|..
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 122334567899997643 23577899999999999999999999743 222222333333444444432
Q ss_pred -----HHHHHHHHhhh-CCCCC
Q 003919 753 -----PLGRLIADCWA-EPQER 768 (786)
Q Consensus 753 -----~L~~LI~~CL~-DP~kR 768 (786)
.+..+.++-+. ++++|
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccCHHHHHHHHHhcCCccccc
Confidence 24455566666 78777
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=237.71 Aligned_cols=193 Identities=28% Similarity=0.427 Sum_probs=162.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l 600 (786)
...|.+.++||.|.|++||++.+ ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+++..++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 35688899999999999999854 356899999865443 356889999999995 99999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCcccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRIIT 679 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~ 679 (786)
.+|+||++.....++.. .++...++.+++.++.||+++|.+|||||||||+|+|++. .+.-.|+||||+....
T Consensus 111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 99999999988888875 5668899999999999999999999999999999999974 4677899999997321
Q ss_pred CC---------------C-------------------C----------CCCCCCCCCcccCccccccC-CCCchhhHHHH
Q 003919 680 DS---------------P-------------------M----------RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSL 714 (786)
Q Consensus 680 ~~---------------~-------------------~----------~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSL 714 (786)
.. . + ......||++|.|||++... .-+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 0 0 00134699999999998764 46889999999
Q ss_pred HHHHHHHHhCCCCCC
Q 003919 715 GVIMWELCTLNRPWE 729 (786)
Q Consensus 715 GvIL~ELlTG~~PF~ 729 (786)
|||++.+++++.||.
T Consensus 265 GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFF 279 (418)
T ss_pred cceeehhhccccccc
Confidence 999999999999984
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=220.79 Aligned_cols=251 Identities=19% Similarity=0.235 Sum_probs=195.4
Q ss_pred CeeEeeEEeecCcEEEEEEEECC---eeEEEEEEeccccChHHHHHHHHHHHHHhhcCC----CceeEEeccc-ccCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWNG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----PNVILFLGAC-TKPPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~G---~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H----PNIVkL~g~~-~~~~~l 600 (786)
+|.+.+.||+|+||.||.|.... ..+|+|+......... ..+..|+.++..+.. .++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688888754432221 257788999888863 6888888888 477778
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-----CeEEEEecCcc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLS 675 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-----g~VKL~DFGLA 675 (786)
|+||+.+ |.+|.++..... .+.++...+..++.|++.+|++||+.|++||||||.|++++.. ..++|.|||++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9999877 679999886443 6789999999999999999999999999999999999999865 46999999999
Q ss_pred c--cccCCCC------C--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003919 676 R--IITDSPM------R--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 676 ~--~l~~~~~------~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~ 745 (786)
+ .+..... . .....||..|+++....+...+.+.|+||++.++.+++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3321111 0 1235599999999999999999999999999999999999999977654333332222221
Q ss_pred CC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 746 RL------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 746 ~~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.. ..+...+..+...+-. +...+|....+...|++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 11 1233456777777766 89999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=215.71 Aligned_cols=251 Identities=31% Similarity=0.610 Sum_probs=214.3
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++++++.+..+|.....|+.|+|+|+|..+++|++.........-.+|..|.-.|+.+.||||+.+++.|..+.++.++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 35567778888999999999999999999999999988777777678899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeEEEE--ecCcccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKIC--DFGLSRIIT 679 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~--DFGLA~~l~ 679 (786)
..||+.|+|+..++.. .+-..+..++.+++.++++|++|||+.. |----|....|++|++.+.+|. |--++..
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 9999999999999843 3446788899999999999999999974 3344688889999998876653 4333321
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCh---H
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 753 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s---~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~---~ 753 (786)
.....-.|.|++||.+..++-+ ..+|+|||.++||||.|...||.+..+.+.-..+.-++.+..+|++ .
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1234456899999999877544 5799999999999999999999999999998899999999999876 5
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+|+.-|+. ||.+||.+..|+-.|+++.
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 8899999999 9999999999998888753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=219.51 Aligned_cols=163 Identities=20% Similarity=0.201 Sum_probs=128.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeE-EecccccCC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVIL-FLGACTKPP 598 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVk-L~g~~~~~~ 598 (786)
-..+|.+.+.||+|+||+||+|.+ +++.+|||++..... .....+.|.+|+++|++++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 357899999999999999999976 467789998753311 2334567999999999999999985 5442 4
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccC-CcccEEEcCCCeEEEEecCcccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDL-KpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..|+||||++|++|... . ... ...++.|++++|+|||++||+|||| ||+|||++.++.+||+|||+++.
T Consensus 92 ~~~LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 57999999999999632 1 111 1467889999999999999999999 99999999999999999999987
Q ss_pred ccCCCCCC--------CCCCCCCcccCcccccc
Q 003919 678 ITDSPMRD--------SSSAGTPEWMAPELIRN 702 (786)
Q Consensus 678 l~~~~~~~--------~~~~GT~~Y~APEvl~~ 702 (786)
+....... ....+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 65432111 24567888999998853
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-22 Score=231.49 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=185.8
Q ss_pred EeeEEeecCcEEEEEEEE--CCeeEEEEEEec---cccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 532 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLE---QDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~---~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
....+|.|++|.|+.... .....+.|.+.. .... ......+..|..+-..++||||+..+..+.+....+..||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456899999997777654 233344443321 1111 2222336678888888999999999888888777777799
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC---
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--- 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--- 682 (786)
||++ +|+.++. ....++...+..++.|++.|++|+|..||.|||||++|++++.+|.+||+|||.+..+..+.
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999986 33578888899999999999999999999999999999999999999999999988764432
Q ss_pred -CCCCCCCCCCcccCccccccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHH-hcCCCCCCC--------
Q 003919 683 -MRDSSSAGTPEWMAPELIRNEPFTE-KCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVA-NEGSRLEIP-------- 750 (786)
Q Consensus 683 -~~~~~~~GT~~Y~APEvl~~~~~s~-ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~-~i~-~~~~~~~ip-------- 750 (786)
......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+..+ ... .........
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2235678999999999999999986 5799999999999999999997654443321 111 111111111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 782 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i~ 782 (786)
+..-+.+|.++|+ ||.+|.|+++|++. ++.+.
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 1134568889999 99999999999964 44443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-22 Score=233.32 Aligned_cols=242 Identities=23% Similarity=0.289 Sum_probs=187.7
Q ss_pred CeeEeeEEeecCcEEEEEEEECCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+|...+.||++.|=+|.+++++...|+||++.+++. .-....+-+.|++ ...++|||.+.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 788889999999999999998655699999977663 2222333444445 5556899999999988888889999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC-----
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS----- 681 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~----- 681 (786)
+.+ +|+|.+. .++.+...+.+.|+.||+.||..||+.||+|+|||.+||||+.-..+.|+||..-+...-+
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 975 8888886 6678889999999999999999999999999999999999999999999999876653211
Q ss_pred --CCCCCCCCCCCcccCccccccC----------C-CCchhhHHHHHHHHHHHHhC-CCCCCC-----------CChHHH
Q 003919 682 --PMRDSSSAGTPEWMAPELIRNE----------P-FTEKCDIFSLGVIMWELCTL-NRPWEG-----------VLPERV 736 (786)
Q Consensus 682 --~~~~~~~~GT~~Y~APEvl~~~----------~-~s~ksDVWSLGvIL~ELlTG-~~PF~~-----------~~~~~~ 736 (786)
.+...+...-..|+|||.+... . .+++.||||+||+++||++- ++||.- ..++.+
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 1112233444579999987431 2 57789999999999999874 667741 111111
Q ss_pred HHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 737 VYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 737 l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+. .+++..+++++..|++ ||.+|.++++.|+.-+-..|.
T Consensus 259 Le---------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 259 LE---------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred HH---------hCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 11 2455579999999999 999999999999986655543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=190.40 Aligned_cols=248 Identities=17% Similarity=0.263 Sum_probs=189.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC-CceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H-PNIVkL~g~~~~~~~l~L 602 (786)
....|.++++||.|+||.+|.|.. .|..||||+-..+... -++.-|..+.+.|++ ..|-.+..+..+..+-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 457899999999999999999976 7999999996544332 346678999998974 567777777888888899
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC---CeEEEEecCcccccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIIT 679 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~ 679 (786)
||+.+ |.+|.++.... ...++..+++.++-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+||||++.+.
T Consensus 89 VMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99988 57999988754 3578999999999999999999999999999999999999744 468999999999875
Q ss_pred CCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCCC
Q 003919 680 DSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV---VYAVANEGSRLEI 749 (786)
Q Consensus 680 ~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~---l~~i~~~~~~~~i 749 (786)
+... ......||.+|.+-....+..-+.+.|+=|+|.+|.++.-|..||++...... ...+........+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 5321 12456799999988777777778899999999999999999999998755433 3333333322221
Q ss_pred C------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 750 P------EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 750 p------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
. +.++...+.-|-. .-++-|...-+.+.++-
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 1 2245555666665 55556666655555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=196.23 Aligned_cols=208 Identities=20% Similarity=0.296 Sum_probs=173.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV 603 (786)
.-.|.++++||+|+||+.+.|+. +++.||||.-..+.. .-++..|....+.|. .++|-..|.+-.++.+-.||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 34689999999999999999965 899999998544332 235667888888884 78999999888888888899
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-----CeEEEEecCccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-----WTVKICDFGLSRII 678 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-----g~VKL~DFGLA~~l 678 (786)
+|++ |.+|.|+.... ...++.+.+..++.|++.-++|+|++.+|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 103 idLL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 9988 57999888754 4689999999999999999999999999999999999999743 46899999999998
Q ss_pred cCCCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHH
Q 003919 679 TDSPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVA 741 (786)
Q Consensus 679 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~---~~~~l~~i~ 741 (786)
.++... .....||.+||+=....+..-+.+-|+=|||-++++.+-|..||.+.. ..+.+..|-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 765321 235679999999988888889999999999999999999999998764 334444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=187.52 Aligned_cols=141 Identities=17% Similarity=0.132 Sum_probs=107.5
Q ss_pred eeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHH-------H-----------------HHHHHHHHHHhhcCCCce
Q 003919 533 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAEN-------M-----------------EDFCNEISILSRLRHPNV 587 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~-------~-----------------~~f~~EI~iL~~L~HPNI 587 (786)
...||+|+||.||+|.. +|+.||||++......... . .....|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 6999999998754321111 1 122359999999987766
Q ss_pred eEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhh-hhcceeeccCCcccEEEcCCCe
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yL-Hs~gIIHrDLKpsNILLd~~g~ 666 (786)
.....+.. ...++||||++++++..... ....+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 33222211 12389999999877764432 235688999999999999999999 799999999999999998 478
Q ss_pred EEEEecCcccccc
Q 003919 667 VKICDFGLSRIIT 679 (786)
Q Consensus 667 VKL~DFGLA~~l~ 679 (786)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-21 Score=217.94 Aligned_cols=221 Identities=25% Similarity=0.379 Sum_probs=182.8
Q ss_pred EeecCcEEEEEEE-----ECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEeecc
Q 003919 536 VGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 536 LG~G~fG~VYkg~-----~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+|+|.||.|+++. +.|..||+|++.+.............|..++..++ ||.+|++...++.+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999999762 35778999998766553333335667888888887 99999999999999999999999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~ 689 (786)
|.|...+. +...+++.....+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .|
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~c 154 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----AC 154 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cc
Confidence 99988775 566788888889999999999999999999999999999999999999999999988755422 29
Q ss_pred CCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CC
Q 003919 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EP 765 (786)
Q Consensus 690 GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP 765 (786)
||..|||||+++ ......|.||||++++||+||..||.+ ++...+.... +.+|. ...+.++..++. +|
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCH
Confidence 999999999998 467889999999999999999999998 4444444322 22332 356778888888 99
Q ss_pred CCCCCH
Q 003919 766 QERPSC 771 (786)
Q Consensus 766 ~kRPSa 771 (786)
.+|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 988644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-20 Score=190.15 Aligned_cols=172 Identities=17% Similarity=0.102 Sum_probs=134.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH-HHHH------HHHHHHHHhhcCCCceeEEecccccC--
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMED------FCNEISILSRLRHPNVILFLGACTKP-- 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~-~~~~------f~~EI~iL~~L~HPNIVkL~g~~~~~-- 597 (786)
..+|++.+.||.|+||.||+...++..+|||++.......+ ..+. |.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 37899999999999999999877788999999975544332 2233 57899999999999999988875533
Q ss_pred ------CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEe
Q 003919 598 ------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 671 (786)
Q Consensus 598 ------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~D 671 (786)
+..+++|||++|.+|.++.. +++ ....+++.+|..||..|++|+|++|+||+++.+| ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999987642 222 2456899999999999999999999999999988 99999
Q ss_pred cCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHH
Q 003919 672 FGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELC 722 (786)
Q Consensus 672 FGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELl 722 (786)
||........... ..++....|+.++|+|+||+++.-+.
T Consensus 178 fg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988655321110 11334455778999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=178.92 Aligned_cols=142 Identities=15% Similarity=0.136 Sum_probs=110.1
Q ss_pred eeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChH------------------------HHHHHHHHHHHHhhcCCCce
Q 003919 533 GTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAE------------------------NMEDFCNEISILSRLRHPNV 587 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~------------------------~~~~f~~EI~iL~~L~HPNI 587 (786)
...||+|+||.||+|.+ +|+.||||++........ ....+..|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 599999999876532100 01234578999999999887
Q ss_pred eEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCe
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~ 666 (786)
.....+.... .++||||++|+++..... ....++......++.|++.++.+||. .||+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 4433332222 489999999875543321 22457788899999999999999999 9999999999999999 889
Q ss_pred EEEEecCccccccC
Q 003919 667 VKICDFGLSRIITD 680 (786)
Q Consensus 667 VKL~DFGLA~~l~~ 680 (786)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=188.29 Aligned_cols=234 Identities=23% Similarity=0.309 Sum_probs=151.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCC---C-------c------ee
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH---P-------N------VI 588 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~H---P-------N------IV 588 (786)
..+..+..||.|+++.||.+.+ +|+.+|||++..... .....+++.+|.-....+.+ | . ++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3566788999999999999999 479999999865543 23346777777766555322 1 1 22
Q ss_pred EEec---ccccC---C-----ceEEEEEeeccchhHHHHHh---hc-CCccchHHHHHHHHHHHHHHHHhhhhcceeecc
Q 003919 589 LFLG---ACTKP---P-----RLSMITEYMELGSLYHLIHL---SG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653 (786)
Q Consensus 589 kL~g---~~~~~---~-----~l~LV~Ey~~gGSL~dlL~~---~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrD 653 (786)
++-+ ++... . +.+++|+-+. ++|.+++.. .. ....+.......+..|+++.+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 2211 01111 1 2456676664 577766542 11 123455666678889999999999999999999
Q ss_pred CCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCC
Q 003919 654 LKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLN 725 (786)
Q Consensus 654 LKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvIL~ELlTG~ 725 (786)
|+|+|++++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++|.|++++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988766543211 1234477999997743 25788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCC
Q 003919 726 RPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 726 ~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kR 768 (786)
.||........... ...... .+ ++.++.||..+|+ ||.+|
T Consensus 248 lPf~~~~~~~~~~~-~f~~C~-~~-Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW-DFSRCR-DM-PEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG-GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc-cchhcC-Cc-CHHHHHHHHHHccCCcccC
Confidence 99986544322211 111222 22 3569999999999 99887
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=178.94 Aligned_cols=187 Identities=18% Similarity=0.107 Sum_probs=140.9
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccC--hHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEee
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~--~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
.+...|++|+||+||.+...+.+++.+.+.....- .-....|.+|+++|++|. |++|.+++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 35678999999999988778888888877544331 111235789999999995 5889898886 3479999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccC-CcccEEEcCCCeEEEEecCccccccCCCCC--
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL-KSANCLVNKHWTVKICDFGLSRIITDSPMR-- 684 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDL-KpsNILLd~~g~VKL~DFGLA~~l~~~~~~-- 684 (786)
.|.+|..... .. ...++.|++.+|+++|++||+|||| ||.|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 81 AGAAMYQRPP----RG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred cCccHHhhhh----hh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 9988875432 11 1347789999999999999999999 799999999999999999999855432210
Q ss_pred --C---------CCCCCCCcccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 003919 685 --D---------SSSAGTPEWMAPELIRNE-PFT-EKCDIFSLGVIMWELCTLNRPWEGV 731 (786)
Q Consensus 685 --~---------~~~~GT~~Y~APEvl~~~-~~s-~ksDVWSLGvIL~ELlTG~~PF~~~ 731 (786)
. .....++.|+.|+...-- ..+ ...+.++.|+-+|.++|++.|+.+.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 011256777777754321 233 5678899999999999999987544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.3e-19 Score=210.66 Aligned_cols=243 Identities=20% Similarity=0.271 Sum_probs=188.0
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC---CCceeEEeccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGAC 594 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~ 594 (786)
+..+.++....|.|.+.||+|+||.||+|.. +|+.+|||+=..... -+|+-=.+++.+|+ -+.|..+..++
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHH
Confidence 3455666678899999999999999999976 789999999543332 23444455666666 34566677777
Q ss_pred ccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-------CCeE
Q 003919 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------HWTV 667 (786)
Q Consensus 595 ~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-------~g~V 667 (786)
.-.+.-++|+||.+.|+|.+++. ..+.+++..+..++.|++..++.||..+|||+||||+|+||.. .--+
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 77778899999999999999997 7788999999999999999999999999999999999999953 2358
Q ss_pred EEEecCcccccc--CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003919 668 KICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 668 KL~DFGLA~~l~--~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~ 745 (786)
+|+|||.+..+. .........++|-.+-.+|...|.+++..+|.|.|..+++-|+.|++-- ..++.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~ 908 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGS 908 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCc
Confidence 999999987663 2223445677889999999999999999999999999999999997521 12222
Q ss_pred CCCCC--------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 746 RLEIP--------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 746 ~~~ip--------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
...+. .+.+.+++..+|. |-..=|...+|...|+..
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 22211 1235667777777 555557777777766654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=189.46 Aligned_cols=202 Identities=37% Similarity=0.652 Sum_probs=161.0
Q ss_pred HhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcce-eeccCCcc
Q 003919 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-VHRDLKSA 657 (786)
Q Consensus 579 L~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gI-IHrDLKps 657 (786)
|+.+.|.|+.+|+|.+.+++..++|.+||..|+|.+.+.. ....+++.....++.+|++||+|||.-.| +|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678899999999999999999999999999999999973 45689999999999999999999998654 99999999
Q ss_pred cEEEcCCCeEEEEecCccccccCC--CCCCCCCCCCCcccCccccccCC-------CCchhhHHHHHHHHHHHHhCCCCC
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDS--PMRDSSSAGTPEWMAPELIRNEP-------FTEKCDIFSLGVIMWELCTLNRPW 728 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~--~~~~~~~~GT~~Y~APEvl~~~~-------~s~ksDVWSLGvIL~ELlTG~~PF 728 (786)
|++++..+.+||+|||+....... ........-...|.|||.+.+.. .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776431 11111222345699999997641 466799999999999999999999
Q ss_pred CCC----ChHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 729 EGV----LPERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 729 ~~~----~~~~~l~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
... .+.+++..+...+.....|. ..+..++..||. +|.+||++.+|-..++.+.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 742 33445555444233222221 147788999999 9999999999998887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-18 Score=200.22 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=149.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|..++.|..|+||-||.+.++ .+++|+|+ +++.+-.. + ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR------n---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR------N---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh------c---cccccCCccee-----------------
Confidence 67788899999999999999875 77888855 33222110 0 22222333333
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC----
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---- 681 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~---- 681 (786)
|+-..+++ ..+.++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+++.....
T Consensus 136 ----gDc~tllk---~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ----chhhhhcc---cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444443 333444433 77899999999999999999999999999999999998754211
Q ss_pred -----------CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003919 682 -----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 749 (786)
Q Consensus 682 -----------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i- 749 (786)
.......+|||.|.|||++..+.|...+|+|++|+|+||.+.|..||.+.++++++..++......+-
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 11224568999999999999999999999999999999999999999999999988877654433221
Q ss_pred ---CChHHHHHHHHhhh-CCCCCC
Q 003919 750 ---PEGPLGRLIADCWA-EPQERP 769 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRP 769 (786)
...+.++++.++|. +|..|-
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhc
Confidence 12368899999998 999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=170.73 Aligned_cols=134 Identities=15% Similarity=0.206 Sum_probs=104.1
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-----CCCceeEEecccccCC---c-eEEE
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-----RHPNVILFLGACTKPP---R-LSMI 603 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-----~HPNIVkL~g~~~~~~---~-l~LV 603 (786)
.+.||+|+||.||....++.. +||++...... ..+.+.+|+.+++.+ .||||++++|+++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 468999999999963334444 68987654322 346789999999999 5799999999998873 3 3378
Q ss_pred EEe--eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHH-HhhhhcceeeccCCcccEEEcC----CCeEEEEecCcc
Q 003919 604 TEY--MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL-MCIHRMKIVHRDLKSANCLVNK----HWTVKICDFGLS 675 (786)
Q Consensus 604 ~Ey--~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL-~yLHs~gIIHrDLKpsNILLd~----~g~VKL~DFGLA 675 (786)
+|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 557999999963 235555 35678888887 9999999999999999999974 348999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=165.64 Aligned_cols=136 Identities=25% Similarity=0.342 Sum_probs=114.4
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChH------HHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~------~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
+.||+|++|.||+|.+.|..+++|+......... ....+.+|+.++..+.|++|.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998754332211 1246788999999999999877666666677789999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+|++|.+++... . . ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN---G---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988621 1 1 7788999999999999999999999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=163.59 Aligned_cols=133 Identities=26% Similarity=0.335 Sum_probs=108.2
Q ss_pred EEeecCcEEEEEEEECCeeEEEEEEeccccCh------HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 535 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~------~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
.||+|+||.||+|.+.|..+++|+........ .....+.+|++++..++|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 37999999999999999999999975433211 123567889999999998876544444455666799999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
|++|.+++... .. .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887521 11 7899999999999999999999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.6e-17 Score=169.86 Aligned_cols=145 Identities=19% Similarity=0.187 Sum_probs=111.9
Q ss_pred CCeeEeeEEeecCcEEEEEEE-E--CCeeEEEEEEeccccCh----------------------HHHHHHHHHHHHHhhc
Q 003919 528 SELTVGTRVGIGFFGEVFRGI-W--NGTDVAIKVFLEQDLTA----------------------ENMEDFCNEISILSRL 582 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~-~--~G~~VAVKvl~~~~~~~----------------------~~~~~f~~EI~iL~~L 582 (786)
.-|.+.+.||+|+||.||+|. + +|+.||||++....... .....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999998 3 68999999986543210 0113456899999999
Q ss_pred CCCc--eeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc-eeeccCCcccE
Q 003919 583 RHPN--VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK-IVHRDLKSANC 659 (786)
Q Consensus 583 ~HPN--IVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-IIHrDLKpsNI 659 (786)
.+.+ +.+++++ ...++||||+++++|..... ....+....+..++.|++.+|++||..| |+|+||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 7533 3344432 23589999999988876542 2334566677899999999999999999 99999999999
Q ss_pred EEcCCCeEEEEecCccccccC
Q 003919 660 LVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 660 LLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++ ++.++|+|||++.....
T Consensus 181 li~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEE-CCCEEEEEChhhhccCC
Confidence 999 88999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=171.07 Aligned_cols=191 Identities=23% Similarity=0.349 Sum_probs=137.2
Q ss_pred CCCceeEEeccccc---------------------------CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHH
Q 003919 583 RHPNVILFLGACTK---------------------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635 (786)
Q Consensus 583 ~HPNIVkL~g~~~~---------------------------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~ 635 (786)
+|||||++.++|.+ +..+|+||.-.+ .+|..++- ....+....+-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 69999998877632 235788888776 48888885 23456666778999
Q ss_pred HHHHHHHhhhhcceeeccCCcccEEEc--CCC--eEEEEecCccccccCC----CC--CCCCCCCCCcccCccccccCCC
Q 003919 636 DICRGLMCIHRMKIVHRDLKSANCLVN--KHW--TVKICDFGLSRIITDS----PM--RDSSSAGTPEWMAPELIRNEPF 705 (786)
Q Consensus 636 QIa~gL~yLHs~gIIHrDLKpsNILLd--~~g--~VKL~DFGLA~~l~~~----~~--~~~~~~GT~~Y~APEvl~~~~~ 705 (786)
|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||++---... ++ ......|....||||+....+-
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999994 333 5789999987432221 11 1123457788999999865321
Q ss_pred ------CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHH
Q 003919 706 ------TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEIL 775 (786)
Q Consensus 706 ------s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL 775 (786)
-.|+|.|+.|.+.||+++...||++.-....-..-..+...+.+|+ ..+++|+..+++ ||.+|++..-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 2589999999999999999999987322221111122333444443 358899999999 999999876555
Q ss_pred HHH
Q 003919 776 SRL 778 (786)
Q Consensus 776 ~~L 778 (786)
+.|
T Consensus 509 Nvl 511 (598)
T KOG4158|consen 509 NVL 511 (598)
T ss_pred hHH
Confidence 444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=184.30 Aligned_cols=138 Identities=22% Similarity=0.300 Sum_probs=114.5
Q ss_pred CeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccCh------HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~------~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
.|...+.||+|+||+||++.+.+..+++|+........ ...+.+.+|+++++.++|++|+..+.++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34567899999999999999987777777653322111 123568899999999999999887777777777899
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
||||+++++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999998874 246789999999999999999999999999999 6779999999999653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-16 Score=157.68 Aligned_cols=139 Identities=21% Similarity=0.246 Sum_probs=108.3
Q ss_pred CeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccCh--------------------HHHHHHHHHHHHHhhcCCCc-
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA--------------------ENMEDFCNEISILSRLRHPN- 586 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~--------------------~~~~~f~~EI~iL~~L~HPN- 586 (786)
.|.+.+.||+|+||.||++.. +|+.+|||++....... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377788999999999999987 68999999876432110 01123677899999888774
Q ss_pred -eeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 587 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 587 -IVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
+...++. ...+++|||++|++|..+... .....++.+++.++.++|..||+|+||||+||+++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4444432 345899999999988765420 23457889999999999999999999999999999999
Q ss_pred eEEEEecCccccccC
Q 003919 666 TVKICDFGLSRIITD 680 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~ 680 (786)
.++|+|||++.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.7e-15 Score=137.17 Aligned_cols=132 Identities=20% Similarity=0.185 Sum_probs=112.0
Q ss_pred EeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC--CceeEEecccccCCceEEEEEeecc
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H--PNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
+.+.||.|.++.||++..++..+++|....... ...+.+|+.+++.++| .++.+++.++...+..++++||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357899999999999999888999999754432 3578899999999976 5889999888887889999999998
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc---ceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.+..+ +......++.+++.+|++||.. +++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766543 3445567889999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=146.88 Aligned_cols=138 Identities=21% Similarity=0.251 Sum_probs=97.7
Q ss_pred eeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHH----------------------HHHHHHHhhcCCCc--e
Q 003919 533 GTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDF----------------------CNEISILSRLRHPN--V 587 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f----------------------~~EI~iL~~L~HPN--I 587 (786)
++.||+|+||+||+|.+. |+.||||++............+ ..|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 8999999986543322111111 24555555554332 3
Q ss_pred eEEecccccCCceEEEEEeeccchhHH-HHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCC
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYH-LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~d-lL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g 665 (786)
.+.+++ ...+++|||++++.+.. .+... ... ..+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 333332 23589999999854321 12100 011 5678899999999999999 9999999999999999 88
Q ss_pred eEEEEecCccccccC
Q 003919 666 TVKICDFGLSRIITD 680 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~ 680 (786)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-16 Score=174.37 Aligned_cols=168 Identities=27% Similarity=0.413 Sum_probs=130.5
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
++|+.|++|...+|.+.+.........++...+.++.|++.|++| ++.+|+|+||.||++..+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 588999999999999999755566678888899999999999999 99999999999999999999999999998877
Q ss_pred cCCC------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC-C-C
Q 003919 679 TDSP------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL-E-I 749 (786)
Q Consensus 679 ~~~~------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~-~-i 749 (786)
.... ...+...||..||+||.+.+..|+.|+|||+||+||+||+. -..+|... ....-...+..+ . +
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----ATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----HhhhhhhcCCCChHHh
Confidence 5543 12356789999999999999999999999999999999998 33333221 111111112111 1 1
Q ss_pred CChH-HHHHHHHhhh-CCCCCCCHHH
Q 003919 750 PEGP-LGRLIADCWA-EPQERPSCEE 773 (786)
Q Consensus 750 p~~~-L~~LI~~CL~-DP~kRPSa~E 773 (786)
-+.+ -..|+..++. .|.+||++.+
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1222 3478888888 9999994443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=151.07 Aligned_cols=136 Identities=18% Similarity=0.171 Sum_probs=105.8
Q ss_pred eEEe-ecCcEEEEEEEECCeeEEEEEEecccc-----------ChHHHHHHHHHHHHHhhcCCCce--eEEecccccCC-
Q 003919 534 TRVG-IGFFGEVFRGIWNGTDVAIKVFLEQDL-----------TAENMEDFCNEISILSRLRHPNV--ILFLGACTKPP- 598 (786)
Q Consensus 534 k~LG-~G~fG~VYkg~~~G~~VAVKvl~~~~~-----------~~~~~~~f~~EI~iL~~L~HPNI--VkL~g~~~~~~- 598 (786)
..|| .|+.|+||.+...+..++||.+..... .......+.+|++++.+|.|++| ...+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999988899999998854321 11223568889999999998875 56666543322
Q ss_pred c---eEEEEEeecc-chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCc
Q 003919 599 R---LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 674 (786)
Q Consensus 599 ~---l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 674 (786)
. .++|+||++| .+|.+++.. ..++.. .+.||+.+|.+||.+||+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 3599999997 688888752 234443 357899999999999999999999999999989999999998
Q ss_pred ccc
Q 003919 675 SRI 677 (786)
Q Consensus 675 A~~ 677 (786)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.2e-16 Score=179.99 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=188.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~L 602 (786)
...|.+.+.||+|+|+.|-.... ....+|+|.+..........+....|..+-+.+. |.|++.+++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34566677799999999987754 2345666666544433344456667888888887 9999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh-hcceeeccCCcccEEEcCCC-eEEEEecCccccccC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 680 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-s~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 680 (786)
+++|..+++++..+. .......+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999998772 112225666677789999999999999 99999999999999999999 999999999988765
Q ss_pred -CC--CCCCCCCC-CCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCC-CCCC---
Q 003919 681 -SP--MRDSSSAG-TPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-AVANEGSR-LEIP--- 750 (786)
Q Consensus 681 -~~--~~~~~~~G-T~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~-~i~~~~~~-~~ip--- 750 (786)
.. ......+| ++.|+|||...+. ...+..|+||.|+++..+++|..||.........+ .+...... ...+
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 22 12234578 9999999999884 45678999999999999999999997654443222 22221111 1111
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
.....+++.+++. +|..|.+.+++-.
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred CChhhhhcccccccCCchhccccccccc
Confidence 2246677888887 9999999887753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=149.25 Aligned_cols=245 Identities=22% Similarity=0.168 Sum_probs=178.3
Q ss_pred CeeEeeEEee--cCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceE
Q 003919 529 ELTVGTRVGI--GFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLS 601 (786)
Q Consensus 529 ~y~i~k~LG~--G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~ 601 (786)
.+.+.+.+|. |.+|.||.+.. .+..+|+|.-+........-..=++|+...+.++ |+|.|+.+..++..+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556678999 99999998754 5778999874332222222233346677777774 999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHH----HHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR----GLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSR 676 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~----gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~ 676 (786)
+-+|++. .+|..+.+ .....++...++.++.+... |+.++|+.+++|-|+||.||+...+ ...+++|||+..
T Consensus 195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 9999997 57766665 23445788888888888888 9999999999999999999999999 889999999999
Q ss_pred cccCCCCCCCCC-----CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHHHhcCCCCCC
Q 003919 677 IITDSPMRDSSS-----AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPERVVYAVANEGSRLEI 749 (786)
Q Consensus 677 ~l~~~~~~~~~~-----~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~--~~~~~l~~i~~~~~~~~i 749 (786)
.+.+........ .|...|++||.+.+. ++...|+|++|.+..+..++..+.... ..-..............-
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 987765443333 688899999998776 889999999999999999886644322 110000000000000001
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+...+..+++ +|-.|++++.++.+
T Consensus 351 ~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 351 GSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 12245567777787 89899988877653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.2e-11 Score=137.23 Aligned_cols=141 Identities=20% Similarity=0.229 Sum_probs=97.5
Q ss_pred eEEeecCcEEEEEEEE-CCeeEEEEEEeccccCh----------------------------HH----------HHHHHH
Q 003919 534 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------------------EN----------MEDFCN 574 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~----------------------------~~----------~~~f~~ 574 (786)
+.||.|++|.||+|+. +|+.||||+........ .. .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999977 79999999975431100 00 013556
Q ss_pred HHHHHhhcC----CCceeEEeccc-ccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHH-HHHhhhhcc
Q 003919 575 EISILSRLR----HPNVILFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR-GLMCIHRMK 648 (786)
Q Consensus 575 EI~iL~~L~----HPNIVkL~g~~-~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~-gL~yLHs~g 648 (786)
|+..+.+++ |.+-+.+-.++ ......+++|||++|++|.++...... ..+ ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhCC
Confidence 666666653 22223322222 223346899999999999887653211 111 2345556655 478899999
Q ss_pred eeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 649 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++|+|++|.||+++.++.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-11 Score=140.22 Aligned_cols=145 Identities=19% Similarity=0.224 Sum_probs=95.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE-C-CeeEEEEEEecccc---------------------------C-h----HHHH--
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW-N-GTDVAIKVFLEQDL---------------------------T-A----ENME-- 570 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~-~-G~~VAVKvl~~~~~---------------------------~-~----~~~~-- 570 (786)
|.+|.. +.||.|++|.||+|+. + |+.||||+...... + . +..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455655 7899999999999987 4 89999999864310 0 0 0111
Q ss_pred ----HHHHHHHHHhhcC----CCceeEEeccccc-CCceEEEEEeeccchhHHHHHhhcC---CccchHHHHHHHHHHHH
Q 003919 571 ----DFCNEISILSRLR----HPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHLSGQ---KKKLSWRRKLKMLRDIC 638 (786)
Q Consensus 571 ----~f~~EI~iL~~L~----HPNIVkL~g~~~~-~~~l~LV~Ey~~gGSL~dlL~~~~~---~~~Ls~~~i~~Ia~QIa 638 (786)
+|.+|+..+.+++ +.+.+.+-.++.+ ....++||||+.|+.+.++...... ...+....+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 2444554444442 3333332222211 2345799999999999875321111 12455555666666664
Q ss_pred HHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccccc
Q 003919 639 RGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRIIT 679 (786)
Q Consensus 639 ~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~l~ 679 (786)
..|++|+|+||.||+++.++ +++++|||++..+.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999888 99999999997664
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-11 Score=120.26 Aligned_cols=128 Identities=15% Similarity=0.082 Sum_probs=96.5
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCceEEEEEeeccch
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMITEYMELGS 611 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l~LV~Ey~~gGS 611 (786)
.+.|+.|.++.||++...+..+++|+...... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35788999999999999999999999754321 123467899999988655544 4444433 23589999999987
Q ss_pred hHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcce-----eeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 612 LYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI-----VHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 612 L~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gI-----IHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.... .....++.+++++|+.||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75431 0112456789999999999875 9999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.1e-10 Score=129.48 Aligned_cols=163 Identities=21% Similarity=0.240 Sum_probs=123.7
Q ss_pred CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHH
Q 003919 550 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRR 629 (786)
Q Consensus 550 ~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~ 629 (786)
.+.+|.|.++..... .......+-+..|+.++||||++++..++..+.+|+|+|-+. .|...++ .+....
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------~l~~~~ 105 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------ELGKEE 105 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------HhHHHH
Confidence 566777777654443 334556677888999999999999999999999999999886 5666665 233566
Q ss_pred HHHHHHHHHHHHHhhh-hcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003919 630 KLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708 (786)
Q Consensus 630 i~~Ia~QIa~gL~yLH-s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 708 (786)
+..-+.||+.||.+|| ..+++|++|...-|+++..|+.||++|.++...............--.|..|+.+.... -.
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cc
Confidence 6778899999999997 57899999999999999999999999998865543221111112223466666544332 34
Q ss_pred hhHHHHHHHHHHHHhC
Q 003919 709 CDIFSLGVIMWELCTL 724 (786)
Q Consensus 709 sDVWSLGvIL~ELlTG 724 (786)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-10 Score=118.35 Aligned_cols=137 Identities=17% Similarity=0.098 Sum_probs=96.7
Q ss_pred eEEeecCcEEEEEEEEC--------CeeEEEEEEecccc-----------C---------hHHHHHHH----HHHHHHhh
Q 003919 534 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-----------T---------AENMEDFC----NEISILSR 581 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~--------G~~VAVKvl~~~~~-----------~---------~~~~~~f~----~EI~iL~~ 581 (786)
..||.|.-+.||.|... +..+|||++..... + ....+.+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999753 37899999753211 0 01122333 79999988
Q ss_pred cCC--CceeEEecccccCCceEEEEEeeccchhH-HHHHhhcCCccchHHHHHHHHHHHHHHHHhh-hhcceeeccCCcc
Q 003919 582 LRH--PNVILFLGACTKPPRLSMITEYMELGSLY-HLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSA 657 (786)
Q Consensus 582 L~H--PNIVkL~g~~~~~~~l~LV~Ey~~gGSL~-dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yL-Hs~gIIHrDLKps 657 (786)
+.. -++-..+++ ..-++||||+.++.+. ..+. ...++..+...+..+++.+|.+| |..||||+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 852 223333332 3458999999865442 2222 12344556677889999999999 8999999999999
Q ss_pred cEEEcCCCeEEEEecCcccccc
Q 003919 658 NCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~ 679 (786)
|||++ ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-11 Score=128.00 Aligned_cols=200 Identities=26% Similarity=0.339 Sum_probs=140.4
Q ss_pred HhhcCCCceeEEecccccC-----CceEEEEEeeccchhHHHHHhhcC-CccchHHHHHHHHHHHHHHHHhhhhcc--ee
Q 003919 579 LSRLRHPNVILFLGACTKP-----PRLSMITEYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMK--IV 650 (786)
Q Consensus 579 L~~L~HPNIVkL~g~~~~~-----~~l~LV~Ey~~gGSL~dlL~~~~~-~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--II 650 (786)
|-++-|.|||+++.|+.+. ....++.||+.-|+|..+|++..+ ...+......+|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4456799999999998554 457899999999999999975543 356788888999999999999999874 99
Q ss_pred eccCCcccEEEcCCCeEEEEecCccccc--cCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003919 651 HRDLKSANCLVNKHWTVKICDFGLSRII--TDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR 726 (786)
Q Consensus 651 HrDLKpsNILLd~~g~VKL~DFGLA~~l--~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~ 726 (786)
|+++..+.|++..+|-+|+.----...- .... .......+-++|.+||.=.....+-.+|||+||...++|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999988887522111000 0000 00112235688999998766667789999999999999988865
Q ss_pred C-CCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 727 P-WEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 727 P-F~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
- -.+.........+.+ .......+.-+.++..|++ .|+.||++..++-|...
T Consensus 281 q~tnseS~~~~ee~ia~--~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIAN--VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred ccCCCcceeehhhhhhh--heeeccCccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 3 222222111111111 1111222233468899999 99999999999977543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.1e-11 Score=144.23 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=185.3
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
+....+.+.+.+-+-+|.++.++...- .|...+.|+...... ...+.+....+-+++-..++|-++.....+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 345567788888899999999997754 243445554322221 11223344445555555567888877776666677
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++++|+.+++|...++ ..+..+.+..+.++..+..+++|||...+.|+|++|.|+|...+++.++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~---~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLH---NSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhh---cCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999999987 34467777888889999999999999999999999999999999999999998433221
Q ss_pred C------C--C-----------------------CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003919 680 D------S--P-----------------------MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728 (786)
Q Consensus 680 ~------~--~-----------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF 728 (786)
. . . .......+|+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0012346899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHH
Q 003919 729 EGVLPERVVYAVANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCE 772 (786)
Q Consensus 729 ~~~~~~~~l~~i~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~ 772 (786)
....+.+....+.+.......- ....++++...+. +|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999998887776555443321 2347788888888 888887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.3e-11 Score=136.04 Aligned_cols=245 Identities=22% Similarity=0.194 Sum_probs=174.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
....+|..+..||.|.|+.|+.+.. .+..|++|.+.+.......-..-..|+-+...+ .|.+++.++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457888999999999999998754 467899998765544332222234566666666 489999988888888888
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCcccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT 679 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~ 679 (786)
|+-.|||.++++..... -...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+...+.
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 89999999988876553 33567888889999999999999999999999999999999886 788999999986532
Q ss_pred CCCCCCCCCCCCCcc-cCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC--hHHH
Q 003919 680 DSPMRDSSSAGTPEW-MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE--GPLG 755 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y-~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~l~~i~~~~~~~~ip~--~~L~ 755 (786)
-. .......+..| .+++......+..+.|+|+||..+.+.+++.. +..+..... +..+..+..+. ..+.
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-----i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-----IRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred ee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee-----eecccccCCCchHHhhh
Confidence 21 11112223334 35666677788899999999999999999875 333221111 12222233332 2344
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
.+.+.+.. ++..||.+.++..+..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccch
Confidence 45555655 8888999888776644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-09 Score=110.69 Aligned_cols=132 Identities=21% Similarity=0.279 Sum_probs=100.5
Q ss_pred EEeecCcEEEEEEEECCeeEEEEEEeccccChHH------HHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 535 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAEN------MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~------~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
.+++|+-+.+|.+.+.|.++.+|.-..+...... ...-.+|+.++.+++--.|---+=+..+.+...++|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5789999999999888888888876544432221 2456679999988864444333333456667789999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
|..|.+.+... ...++..|-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888632 134667777778889999999999999999998775 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.7e-09 Score=109.07 Aligned_cols=139 Identities=19% Similarity=0.236 Sum_probs=101.7
Q ss_pred eEEeecCcEEEEEEEECC-eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCC--ceeEEecccccC---CceEEEEEee
Q 003919 534 TRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP--NVILFLGACTKP---PRLSMITEYM 607 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G-~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HP--NIVkL~g~~~~~---~~l~LV~Ey~ 607 (786)
+.|+.|.++.||++...+ +.+++|+....... .....+.+|+++++.+.+. ++.+++.+.... +..+++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999997754 89999997543321 1235688999999999753 345666666553 3678999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-----------------------------------------
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 646 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs----------------------------------------- 646 (786)
+|.++.+.+. ...++..+...++.+++++|.+||+
T Consensus 83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876542 0235555566666666666666663
Q ss_pred ---------------cceeeccCCcccEEEcC--CCeEEEEecCcccc
Q 003919 647 ---------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRI 677 (786)
Q Consensus 647 ---------------~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~ 677 (786)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24799999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.8e-09 Score=105.73 Aligned_cols=145 Identities=19% Similarity=0.174 Sum_probs=105.6
Q ss_pred EeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH------HHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~------~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
....|-+|+-+.|+++.+.|+.+.||.-..+..... ..++-.+|+.+|.++.--.|.--.-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 456788999999999999999999987654443222 13567789999988863333322223344455678999
Q ss_pred eecc-chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEecCcccc
Q 003919 606 YMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRI 677 (786)
Q Consensus 606 y~~g-GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~ 677 (786)
|++| .++.+++...... .........++.+|-+.+.-||.++|||+||.++||+|..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 4777777643322 223333377889999999999999999999999999997554 468999999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-08 Score=107.47 Aligned_cols=142 Identities=16% Similarity=0.053 Sum_probs=100.2
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChHHH----------HHHHHHHHHHhhcC-----CCceeEEeccccc--
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM----------EDFCNEISILSRLR-----HPNVILFLGACTK-- 596 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~----------~~f~~EI~iL~~L~-----HPNIVkL~g~~~~-- 596 (786)
+.+-......|+++..+|+.|.||........ +.. ..+.+|...+.+|. .|.+|-+...-..
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444455557788889999999976433311 111 14778998888874 3444433211111
Q ss_pred CCceEEEEEeeccc-hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-------CCeEE
Q 003919 597 PPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------HWTVK 668 (786)
Q Consensus 597 ~~~l~LV~Ey~~gG-SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-------~g~VK 668 (786)
...-++|+|++++. +|.+++.... ....+......++.+++..+..||..||+|+|+++.|||++. ++.+.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 23468999999986 7888875221 234556677889999999999999999999999999999975 46899
Q ss_pred EEecCcccc
Q 003919 669 ICDFGLSRI 677 (786)
Q Consensus 669 L~DFGLA~~ 677 (786)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.8e-08 Score=108.27 Aligned_cols=247 Identities=16% Similarity=0.217 Sum_probs=160.2
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeE--------EecccccCCceE
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL--------FLGACTKPPRLS 601 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVk--------L~g~~~~~~~l~ 601 (786)
..+..||+|+-+.+|-.-.- ...+-|++........ . +-+..|... .||-+-. ++|-- .....-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh-hchhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeE
Confidence 35678999999999954221 2234577765433211 1 223334333 3553322 22211 122256
Q ss_pred EEEEeeccch-hHHHHH---hhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 602 MITEYMELGS-LYHLIH---LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGS-L~dlL~---~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.|..+.+.. ...+.. +...-....|..+++.+..++.+.+.||..|.+-+|++++|+|+.+++.|.|.|-..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 6777776542 222221 222345688999999999999999999999999999999999999999999998665443
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------hHH-HHHH----
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL-------PER-VVYA---- 739 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~-------~~~-~l~~---- 739 (786)
.. ........+|.+.|++||.-. +-.-+...|.|.||+++++|+.| +.||.+.. +-+ .+..
T Consensus 167 ~~-ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NA-NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred cc-CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 32 233445678999999999765 23346789999999999999887 88997542 111 1100
Q ss_pred --HHhcCCCCCCC--------ChHHHHHHHHhhh---CCCCCCCHHHHHHHHHhhhhhc
Q 003919 740 --VANEGSRLEIP--------EGPLGRLIADCWA---EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 740 --i~~~~~~~~ip--------~~~L~~LI~~CL~---DP~kRPSa~EIL~~L~~i~~sL 785 (786)
-.......+-| ...+..|..+|+. ++.-|||++..+..|..+..+|
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00001111111 2357889999997 4668999999999888777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=9.8e-08 Score=97.24 Aligned_cols=127 Identities=28% Similarity=0.310 Sum_probs=82.5
Q ss_pred EEEEEEE-CCeeEEEEEEeccccC------------------------hHHHHHHHHHHHHHhhcCCCc--eeEEecccc
Q 003919 543 EVFRGIW-NGTDVAIKVFLEQDLT------------------------AENMEDFCNEISILSRLRHPN--VILFLGACT 595 (786)
Q Consensus 543 ~VYkg~~-~G~~VAVKvl~~~~~~------------------------~~~~~~f~~EI~iL~~L~HPN--IVkL~g~~~ 595 (786)
.||.|.. +|..+|||+....... ........+|.+.|.++..-+ +-+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 7889999997542110 011245678999999997553 33444332
Q ss_pred cCCceEEEEEeec--cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHh-hhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 596 KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC-IHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 596 ~~~~l~LV~Ey~~--gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~y-LHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
.-++||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2479999999 6666554431 12233445677788885555 579999999999999999988 9999999
Q ss_pred Ccccccc
Q 003919 673 GLSRIIT 679 (786)
Q Consensus 673 GLA~~l~ 679 (786)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=5e-07 Score=102.57 Aligned_cols=221 Identities=15% Similarity=0.205 Sum_probs=152.5
Q ss_pred eeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCceEEEEEe
Q 003919 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMITEY 606 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~l~LV~Ey 606 (786)
.+..+.-.-.+.|++.. +|..|++|+++-...... .....-+++++++.|+|||+|.+++.. +..+++||+|
T Consensus 281 l~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY 358 (655)
T KOG3741|consen 281 LELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY 358 (655)
T ss_pred cccccccccceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence 33444324467899865 799999999843322111 122345788999999999999998863 4458999999
Q ss_pred ecc-chhHHHHHhh------------cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 607 MEL-GSLYHLIHLS------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 607 ~~g-GSL~dlL~~~------------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.++ ++|.++.-.. ..+...++..+|.|+.|+..||.++|+.|+..+-|.+.+||++.+.+++|...|
T Consensus 359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~ 438 (655)
T KOG3741|consen 359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCG 438 (655)
T ss_pred CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEeccc
Confidence 986 4666544211 123457889999999999999999999999999999999999999899998888
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHHHhcCCCCCCCC
Q 003919 674 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERV-VYAVANEGSRLEIPE 751 (786)
Q Consensus 674 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~-l~~i~~~~~~~~ip~ 751 (786)
....+.... . |.+.. -.+-|.=.||.+++.|.||.. -+........ +..+. ....
T Consensus 439 i~Dvl~~d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------~~yS 495 (655)
T KOG3741|consen 439 IMDVLQEDP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------TTYS 495 (655)
T ss_pred ceeeecCCC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------hhhh
Confidence 776654432 0 11111 235688899999999999954 3443333332 22221 1223
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
..+++++.-+.. ++++ -++.+++.++-
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 457777777776 6665 67777776643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=95.82 Aligned_cols=128 Identities=22% Similarity=0.191 Sum_probs=88.9
Q ss_pred EECCeeEEEEEEeccccCh-----HHHHHHHHHHHHHhhcC-----CCceeEEeccccc-CCceEEEEEeeccc-hhHHH
Q 003919 548 IWNGTDVAIKVFLEQDLTA-----ENMEDFCNEISILSRLR-----HPNVILFLGACTK-PPRLSMITEYMELG-SLYHL 615 (786)
Q Consensus 548 ~~~G~~VAVKvl~~~~~~~-----~~~~~f~~EI~iL~~L~-----HPNIVkL~g~~~~-~~~l~LV~Ey~~gG-SL~dl 615 (786)
...++.+.+|.+....... .....+.+|...+..|. -|..|-+...-.. ....++|+|++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 3456666666543221111 12345778888877774 3444443222111 12358999999974 78888
Q ss_pred HHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEecCccccc
Q 003919 616 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRII 678 (786)
Q Consensus 616 L~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l 678 (786)
+... ..++......++.+++..++-||.+||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 109 ~~~~---~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 109 LQQW---EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHhh---cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 8632 2266677788999999999999999999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-06 Score=90.40 Aligned_cols=140 Identities=16% Similarity=0.075 Sum_probs=101.3
Q ss_pred eecCcEEEEEEEECCeeEEEEEEecccc---C-hHHHHHHHHHHHHHhhcCCCc--eeEEe--cccccC--CceEEEEEe
Q 003919 537 GIGFFGEVFRGIWNGTDVAIKVFLEQDL---T-AENMEDFCNEISILSRLRHPN--VILFL--GACTKP--PRLSMITEY 606 (786)
Q Consensus 537 G~G~fG~VYkg~~~G~~VAVKvl~~~~~---~-~~~~~~f~~EI~iL~~L~HPN--IVkL~--g~~~~~--~~l~LV~Ey 606 (786)
|+||.+-|++...+|..+-+|.-..... . +.-...|.+|...|.+|..-+ +.+.. +.-..+ -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 5789999999998888888997531111 1 223468999999999885222 22333 111111 236789997
Q ss_pred ecc-chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe--EEEEecCcccc
Q 003919 607 MEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 677 (786)
Q Consensus 607 ~~g-GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~ 677 (786)
++| .+|.+++... .-.+.+..+...++.+|+..++-||..|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 764 4788777522 2335677778899999999999999999999999999999986666 99999986654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.4e-06 Score=92.94 Aligned_cols=137 Identities=26% Similarity=0.288 Sum_probs=97.7
Q ss_pred eEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccC--------------------hHHHHHHHHHHHHHhhcCCC--ce
Q 003919 531 TVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT--------------------AENMEDFCNEISILSRLRHP--NV 587 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~--------------------~~~~~~f~~EI~iL~~L~HP--NI 587 (786)
.++++||-|.-+.||.|.. +|.++|||.-...... .-......+|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999988 6999999975322110 11134566788999888643 34
Q ss_pred eEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeE
Q 003919 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 588 VkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~V 667 (786)
-+.++ .+.-.+||||++|-.|...- ++......++..|+.-+.-+-..||||+|+.+=||+++++|.+
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 34333 34568999999986665432 1233344455566666666668999999999999999999999
Q ss_pred EEEecCcccccc
Q 003919 668 KICDFGLSRIIT 679 (786)
Q Consensus 668 KL~DFGLA~~l~ 679 (786)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999998775543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.5e-06 Score=86.44 Aligned_cols=139 Identities=16% Similarity=0.137 Sum_probs=94.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH-HHHH------HHHHHHHHhhcC---CCceeEEecccc-
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE-NMED------FCNEISILSRLR---HPNVILFLGACT- 595 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~-~~~~------f~~EI~iL~~L~---HPNIVkL~g~~~- 595 (786)
-.+|.+.+++-.....-|.+-..+|+.+.+|.........+ .... ..+++..+.+++ ...+..++.+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 36788888888888888888888999999999765443221 1111 223444444443 223333222221
Q ss_pred ----cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEe
Q 003919 596 ----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 671 (786)
Q Consensus 596 ----~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~D 671 (786)
-....+++|||++|..|.++.. +++ .+...+..+|..||..|++|+|..|.|++++++ .++++|
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 1234578999999988877643 222 244567788999999999999999999999865 499999
Q ss_pred cCcccc
Q 003919 672 FGLSRI 677 (786)
Q Consensus 672 FGLA~~ 677 (786)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.5e-07 Score=107.96 Aligned_cols=139 Identities=22% Similarity=0.353 Sum_probs=96.5
Q ss_pred HHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccCCC-CCCC--------CCCCCCcccCccccccCCC
Q 003919 636 DICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-MRDS--------SSAGTPEWMAPELIRNEPF 705 (786)
Q Consensus 636 QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-~~~~--------~~~GT~~Y~APEvl~~~~~ 705 (786)
+++.|+.|+|+ .++||++|.|++|.++.++..||+.|+++.....+. +... .......|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 44599999997 589999999999999999999999999876554311 1111 1124457999999999888
Q ss_pred CchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhc-------CCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 706 TEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANE-------GSRLEIPEGPLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 706 s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~l~~i~~~-------~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
+.++|+||+||++|.++.|.. -+...... ..+..... +..-.+| .++.+-+.+++. ++..||++..++.
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p-~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLP-SELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCc-HHHHHHHHHHhcCCcccCcchhhhhc
Confidence 999999999999999995544 44333221 11111111 1112233 346666777777 9999997777653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.1e-05 Score=79.37 Aligned_cols=141 Identities=18% Similarity=0.199 Sum_probs=83.0
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeEEeccc---ccCCceEEEEEee
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC---TKPPRLSMITEYM 607 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVkL~g~~---~~~~~l~LV~Ey~ 607 (786)
++.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+.... +.+++.++ ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999997789999996533 33467778888888885322 33444432 2333478999999
Q ss_pred ccchhHH----------------HHH---hh-cCCccch-HH--------HHHHH------------HHHHHH-HHHhhh
Q 003919 608 ELGSLYH----------------LIH---LS-GQKKKLS-WR--------RKLKM------------LRDICR-GLMCIH 645 (786)
Q Consensus 608 ~gGSL~d----------------lL~---~~-~~~~~Ls-~~--------~i~~I------------a~QIa~-gL~yLH 645 (786)
+|..+.. .+. .. .....+. .. ..... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887766 111 11 0000000 00 00000 111222 233333
Q ss_pred -------hcceeeccCCcccEEEc-CCCeEEEEecCcccc
Q 003919 646 -------RMKIVHRDLKSANCLVN-KHWTVKICDFGLSRI 677 (786)
Q Consensus 646 -------s~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~ 677 (786)
...++|+|+.+.|||++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 34699999999999999 667778999988744
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.6e-06 Score=95.61 Aligned_cols=140 Identities=21% Similarity=0.252 Sum_probs=88.7
Q ss_pred eEEeecCcEEEEEEEE-CCeeEEEEEEeccccC---------------------------h-HHH----------HHHHH
Q 003919 534 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT---------------------------A-ENM----------EDFCN 574 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~---------------------------~-~~~----------~~f~~ 574 (786)
+.|+.++-|.||+|+. +|+.||||+....-.. . ..+ -+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999988 4999999996532110 0 001 12444
Q ss_pred HHHHHhhcC-----CCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCC---ccchHHHHHHHHHHHHHHHHhhhh
Q 003919 575 EISILSRLR-----HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK---KKLSWRRKLKMLRDICRGLMCIHR 646 (786)
Q Consensus 575 EI~iL~~L~-----HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~---~~Ls~~~i~~Ia~QIa~gL~yLHs 646 (786)
|...+.+++ .+++.=-.=|.+-...-.++|||++|..+.++......+ +.+...-...++.|+ =.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~-------~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL-------LR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh
Confidence 555555442 233221111112223458999999999998885322111 122233333333333 23
Q ss_pred cceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 647 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
.|++|.|.+|.||+++.+|++.+.|||+...+..
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 7999999999999999999999999999877653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.1e-05 Score=82.18 Aligned_cols=135 Identities=16% Similarity=0.121 Sum_probs=81.1
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce--eEEecccccCCceEEEEEeeccch
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV--ILFLGACTKPPRLSMITEYMELGS 611 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI--VkL~g~~~~~~~l~LV~Ey~~gGS 611 (786)
..||+|..+.||+. .|..+++|...... . .....+|.++++.+..-++ .+.+++....+...++||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 47899999999984 35578888875422 2 2456789999988853332 455666666777889999999863
Q ss_pred -hHHH---------------------HHhhc-CCccchHHHHHHHHHH----------HHH-HHHhhh----hcceeecc
Q 003919 612 -LYHL---------------------IHLSG-QKKKLSWRRKLKMLRD----------ICR-GLMCIH----RMKIVHRD 653 (786)
Q Consensus 612 -L~dl---------------------L~~~~-~~~~Ls~~~i~~Ia~Q----------Ia~-gL~yLH----s~gIIHrD 653 (786)
+... +|... ....+.. ....+..+ +.. ..++|. ...++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1111 11000 0001110 00001000 001 112222 12478999
Q ss_pred CCcccEEEcCCCeEEEEecCccc
Q 003919 654 LKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 654 LKpsNILLd~~g~VKL~DFGLA~ 676 (786)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.6e-05 Score=78.25 Aligned_cols=137 Identities=18% Similarity=0.103 Sum_probs=83.0
Q ss_pred EEeecCc-EEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEeeccchh
Q 003919 535 RVGIGFF-GEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSL 612 (786)
Q Consensus 535 ~LG~G~f-G~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL 612 (786)
.|-.|.+ +.||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++....+..++||++++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 7899997777788889864332 235667888888874 33344666666666678999999998776
Q ss_pred HHHH-------------------HhhcC-CccchHH--HHHHH-----------------------HHHHHHHHHhh---
Q 003919 613 YHLI-------------------HLSGQ-KKKLSWR--RKLKM-----------------------LRDICRGLMCI--- 644 (786)
Q Consensus 613 ~dlL-------------------~~~~~-~~~Ls~~--~i~~I-----------------------a~QIa~gL~yL--- 644 (786)
.... +.... ...+... ..... ..++...|...
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5331 10000 0011000 00000 11111111111
Q ss_pred -hhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 645 -HRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 645 -Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22459999999999999998888899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=74.40 Aligned_cols=127 Identities=23% Similarity=0.338 Sum_probs=92.4
Q ss_pred CCeeEeeEEeecCc-EEEEEEEECCeeEEEEEEec---ccc-------Ch---------HHHHHHHHHHHHHhhcC---C
Q 003919 528 SELTVGTRVGIGFF-GEVFRGIWNGTDVAIKVFLE---QDL-------TA---------ENMEDFCNEISILSRLR---H 584 (786)
Q Consensus 528 s~y~i~k~LG~G~f-G~VYkg~~~G~~VAVKvl~~---~~~-------~~---------~~~~~f~~EI~iL~~L~---H 584 (786)
.+++.++.||.|.- |.||++..+|+.||||++.. ... .. ....-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78889999999999 99999999999999999321 110 00 12346888998888775 5
Q ss_pred Cce--eEEecccccC------------------CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhh
Q 003919 585 PNV--ILFLGACTKP------------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644 (786)
Q Consensus 585 PNI--VkL~g~~~~~------------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yL 644 (786)
.++ |+.+||..-. ....||.||++... .+.. .-+.++.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence 566 8999886211 12467888776432 2222 2345667778889
Q ss_pred hhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 645 Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
|..||+-+|+++.|.. .=+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 3478999865
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=5.3e-05 Score=80.23 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=89.4
Q ss_pred EEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHH----------------------HHHHHHHHHHhhcCCCc--eeE
Q 003919 535 RVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENM----------------------EDFCNEISILSRLRHPN--VIL 589 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~----------------------~~f~~EI~iL~~L~HPN--IVk 589 (786)
.|..|.-+.||+|.. ++..+|||++.........+ .-..+|...|+++..-+ +-+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 677888889999875 68999999986544322211 11234555566553221 111
Q ss_pred EecccccCCceEEEEEeeccchh-HHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeE
Q 003919 590 FLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 590 L~g~~~~~~~l~LV~Ey~~gGSL-~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~V 667 (786)
-+.+. .-.++|||+..... .-.|. .-++.......+..++++.+.-|=. .++||+||..=|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 12211 23689999975311 11111 1122333567788888888888866 8999999999999999 7899
Q ss_pred EEEecCccccccC
Q 003919 668 KICDFGLSRIITD 680 (786)
Q Consensus 668 KL~DFGLA~~l~~ 680 (786)
.|+|||.+.....
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999999876653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00021 Score=88.06 Aligned_cols=78 Identities=19% Similarity=0.166 Sum_probs=56.3
Q ss_pred eeEEeecCcEEEEEEEECC----eeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCce--eEEecccccC---CceEE
Q 003919 533 GTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNV--ILFLGACTKP---PRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G----~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNI--VkL~g~~~~~---~~l~L 602 (786)
.+.|+.|.++.+|+....+ ..+++|+....... .....+.+|+.+++.+. |.++ .+++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678999999999987643 46788875433221 12356789999999995 6664 6777777664 46789
Q ss_pred EEEeeccch
Q 003919 603 ITEYMELGS 611 (786)
Q Consensus 603 V~Ey~~gGS 611 (786)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=4.1e-06 Score=97.26 Aligned_cols=181 Identities=22% Similarity=0.186 Sum_probs=132.6
Q ss_pred EeeEEeecCcEEEEEEEECCee-EEEEEEeccccChHHHHHHHHHHHHHhhcCCCc-eeEEecccccCCceEEEEEeecc
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-VILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~-VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN-IVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
..+.+++|+++.+|+.+...++ ...+.+... ....-++++|.+++||| .+..++-+..+...++.++++.+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3455789999999987553322 223333211 34556899999999999 77777777778889999999987
Q ss_pred c-hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCC
Q 003919 610 G-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS 688 (786)
Q Consensus 610 G-SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~ 688 (786)
+ +...... ...-.+...+...+...-+++++|||+.-=+|+| ||+..+ +..+..||+....+.... .....
T Consensus 319 ~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~ 390 (829)
T KOG0576|consen 319 GRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTA 390 (829)
T ss_pred CccccccCC--hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccC
Confidence 6 2222111 1122344555566777788899999988778998 777665 689999999988776542 44567
Q ss_pred CCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003919 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727 (786)
Q Consensus 689 ~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~P 727 (786)
.+++.++|||+.....+..+.|+|++|+--.++.-|-.|
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 899999999999999999999999999877777777655
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00022 Score=72.23 Aligned_cols=130 Identities=22% Similarity=0.210 Sum_probs=91.6
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeE-EecccccCCceEEEEEeecc
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL-FLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVk-L~g~~~~~~~l~LV~Ey~~g 609 (786)
.+.+.|++|.+|.||+|.+.|..+|+|+-..+.. ...+..|+++|..++-.++-. +|.|-.+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 3456899999999999999999999999654332 467889999999998666543 3333222 345999998
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCC-cccEEEcCCCeEEEEecCccccc
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLK-SANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLK-psNILLd~~g~VKL~DFGLA~~l 678 (786)
-.|...-.. .+. +-+..+++.---|-..||-|..|. |...+|.+++.+.|+||.-|...
T Consensus 97 ~~L~~~~~~------~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG------GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc------ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 787765531 122 233455666666778899998885 44444445559999999988743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00015 Score=74.03 Aligned_cols=102 Identities=23% Similarity=0.268 Sum_probs=81.3
Q ss_pred HHHHHHHhhcCC-CceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh---cc
Q 003919 573 CNEISILSRLRH-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MK 648 (786)
Q Consensus 573 ~~EI~iL~~L~H-PNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---~g 648 (786)
..|.-+++.+++ +++.+++|+|-. +++.||...+++.........-...+|..+.+|+.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 699999999953 6799999977665321100122356899999999999999999987 45
Q ss_pred eeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 649 IVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 649 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
+.-.|++++|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00025 Score=82.71 Aligned_cols=141 Identities=23% Similarity=0.228 Sum_probs=89.0
Q ss_pred eEEeecCcEEEEEEEE-CCeeEEEEEEeccccCh-----------------------------HH------HHHHHHHHH
Q 003919 534 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA-----------------------------EN------MEDFCNEIS 577 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~-----------------------------~~------~~~f~~EI~ 577 (786)
+.||.-+.|.||+++. +|+.||||+-+..-... +. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999976 78999999954321100 00 114566665
Q ss_pred HHhhc----CCCc------eeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc
Q 003919 578 ILSRL----RHPN------VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647 (786)
Q Consensus 578 iL~~L----~HPN------IVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 647 (786)
...++ +|-+ |-++|..+. ....++||||+|..+.|+.... ...++...+...+.+... +.+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 55444 3444 333333222 2468999999999887664322 223444433333332211 112235
Q ss_pred ceeeccCCcccEEEcC----CCeEEEEecCccccccC
Q 003919 648 KIVHRDLKSANCLVNK----HWTVKICDFGLSRIITD 680 (786)
Q Consensus 648 gIIHrDLKpsNILLd~----~g~VKL~DFGLA~~l~~ 680 (786)
|++|.|=.|.||+++. ++.+.+-|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 67899999999877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00021 Score=88.10 Aligned_cols=196 Identities=19% Similarity=0.224 Sum_probs=136.6
Q ss_pred HHHHHHHHHHhhcCCCceeEEecccccCCc----eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh
Q 003919 570 EDFCNEISILSRLRHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645 (786)
Q Consensus 570 ~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~----l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH 645 (786)
....-|...+.++.|+|++.++.|-.+... ..+..+++..-++...+. .-...+....+.+..++.+||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence 344456677888899999999988655432 334557788778887776 4567888999999999999999999
Q ss_pred hcceeeccCCcc---cEEEcCCCeEEEE--ecCccccccCCCCCCCCCCCCCcccCccccccCCCCc--hhhHHHHHHHH
Q 003919 646 RMKIVHRDLKSA---NCLVNKHWTVKIC--DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTE--KCDIFSLGVIM 718 (786)
Q Consensus 646 s~gIIHrDLKps---NILLd~~g~VKL~--DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~--ksDVWSLGvIL 718 (786)
+....|.-|..+ +...+..+.+.+. ||+.+..+.+.... .....+..+.++|......++. ..|+|++|..+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 986665555554 4444566677777 99988887654332 2334456677888887765554 47999999999
Q ss_pred HHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 719 WELCTLNRPWE-GVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 719 ~ELlTG~~PF~-~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
..+..|..+-. .......+.. . . .....+....|+. ++++|+++.+++.+.
T Consensus 383 ~~~~~~~~i~~~~~~~~~~l~~----~----~-~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPVSLLDV----L----S-TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccchhhhhcc----c----c-chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99998876422 1111111110 0 0 1145667788988 999999999999764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00083 Score=69.94 Aligned_cols=72 Identities=21% Similarity=0.164 Sum_probs=43.6
Q ss_pred eEEeecCcE-EEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCC---ceeEEecccccC---CceEEEEEe
Q 003919 534 TRVGIGFFG-EVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKP---PRLSMITEY 606 (786)
Q Consensus 534 k~LG~G~fG-~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HP---NIVkL~g~~~~~---~~l~LV~Ey 606 (786)
+.|+.|+.. .||+. +..+++|+..... ....+.+|.+++..+... .+-++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467767766 58975 3467788754321 234688899998877521 122333333222 235889999
Q ss_pred eccchh
Q 003919 607 MELGSL 612 (786)
Q Consensus 607 ~~gGSL 612 (786)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0018 Score=66.79 Aligned_cols=133 Identities=16% Similarity=0.179 Sum_probs=93.1
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccc--------------cChHHHHHHHHHHHHHhhcC------CCceeEEecc
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--------------LTAENMEDFCNEISILSRLR------HPNVILFLGA 593 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~--------------~~~~~~~~f~~EI~iL~~L~------HPNIVkL~g~ 593 (786)
..||+|+.=.||.--. .....||+..... .......++.+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5799999999996433 3345788876554 11122456777777766665 7899999999
Q ss_pred cccCCceEEEEEeecc------chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC--
Q 003919 594 CTKPPRLSMITEYMEL------GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-- 665 (786)
Q Consensus 594 ~~~~~~l~LV~Ey~~g------GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-- 665 (786)
.+++-...+|+|.+.+ -+|.+++. ...++. . +...+-+-.+||-.++|+.+||+|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999889999998753 35667764 234554 2 333444556788889999999999999996432
Q ss_pred --eEEEEe-cCcc
Q 003919 666 --TVKICD-FGLS 675 (786)
Q Consensus 666 --~VKL~D-FGLA 675 (786)
.+.|+| ||..
T Consensus 158 ~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 158 EFRLVLIDGLGEK 170 (199)
T ss_pred ceEEEEEeCCCCc
Confidence 577776 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00043 Score=57.95 Aligned_cols=60 Identities=23% Similarity=0.225 Sum_probs=47.3
Q ss_pred ccccccchhhHHHHHHhhhcCCccccccccCCCCcccc---ccccccceEEEeeCCeeeeeee
Q 003919 187 IRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMEC---VDSYKHMSVIVVLNSVELLVDL 246 (786)
Q Consensus 187 ~~~g~~r~ra~lfk~lad~~~l~~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (786)
-+.|.|.+.|.||+.|...+|+|||+|.|........- .....|.|+.|-++.+=+.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLEGGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEECCCeEEEeC
Confidence 46899999999999999999999999999763222111 2457799999999876666663
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0042 Score=67.66 Aligned_cols=78 Identities=13% Similarity=-0.067 Sum_probs=55.2
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC---CceeEEeccccc---CCceEEEE
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH---PNVILFLGACTK---PPRLSMIT 604 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H---PNIVkL~g~~~~---~~~l~LV~ 604 (786)
.-.+.||.|..+.||+....+..+++|..+. ... ...|..|...|+.|.- -.+.+++++|.. .+..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3456799999999999877555677887432 111 2468889999988852 245666766643 36689999
Q ss_pred Eeeccchh
Q 003919 605 EYMELGSL 612 (786)
Q Consensus 605 Ey~~gGSL 612 (786)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0013 Score=69.35 Aligned_cols=135 Identities=17% Similarity=0.100 Sum_probs=76.5
Q ss_pred EeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCceEEEEEeeccchhHH
Q 003919 536 VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMITEYMELGSLYH 614 (786)
Q Consensus 536 LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l~LV~Ey~~gGSL~d 614 (786)
+..|-.+.+|+...++..+++|+........ .-...+|..+++.+...+++ ++++.+. -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4568888999998888889999854321110 01346788888888533232 2233222 268999999866531
Q ss_pred --------------HH---Hhhc-CCccchHH-HHHHHHHHH---------HHHHHhhh--------hcceeeccCCccc
Q 003919 615 --------------LI---HLSG-QKKKLSWR-RKLKMLRDI---------CRGLMCIH--------RMKIVHRDLKSAN 658 (786)
Q Consensus 615 --------------lL---~~~~-~~~~Ls~~-~i~~Ia~QI---------a~gL~yLH--------s~gIIHrDLKpsN 658 (786)
.+ |... ....++.. .+..+..++ ...+..+- ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 1111 01111111 111221111 11111121 1258999999999
Q ss_pred EEEcCCCeEEEEecCcccc
Q 003919 659 CLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 659 ILLd~~g~VKL~DFGLA~~ 677 (786)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0067 Score=62.65 Aligned_cols=73 Identities=15% Similarity=0.139 Sum_probs=46.4
Q ss_pred eeEEeecCcEEEEEEEEC---CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEEEEEeec
Q 003919 533 GTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~---G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~LV~Ey~~ 608 (786)
.+.|..|-...+|++... +..|++|+....... .....+|+.+++.+...++ .++++.+. . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 356778888999998765 578999976532211 1123468888888853333 34443332 2 37999999
Q ss_pred cchh
Q 003919 609 LGSL 612 (786)
Q Consensus 609 gGSL 612 (786)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0045 Score=67.15 Aligned_cols=143 Identities=15% Similarity=0.165 Sum_probs=82.3
Q ss_pred eeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeEEeccc------ccCCceE
Q 003919 530 LTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGAC------TKPPRLS 601 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVkL~g~~------~~~~~l~ 601 (786)
....+.++.|....+|+...++..+++|+..... . .+....|++++..|...+ +.+++... ...+..+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 3345667888888999987766678899865421 1 133455667776664222 23333221 2235578
Q ss_pred EEEEeeccchhH-----------HH---HHhhcCC---------ccchHHHHH------------HHHHHHHHHHHhhh-
Q 003919 602 MITEYMELGSLY-----------HL---IHLSGQK---------KKLSWRRKL------------KMLRDICRGLMCIH- 645 (786)
Q Consensus 602 LV~Ey~~gGSL~-----------dl---L~~~~~~---------~~Ls~~~i~------------~Ia~QIa~gL~yLH- 645 (786)
++++|++|..+. .. +|..... ..-.|.... .....+...++++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999874421 11 1111110 001111100 01112333455553
Q ss_pred ------hcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 646 ------RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 646 ------s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2589999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00017 Score=90.43 Aligned_cols=160 Identities=16% Similarity=0.102 Sum_probs=120.4
Q ss_pred HHHHHHHHHHhhcCCCceeEEeccccc--CCceEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhh
Q 003919 570 EDFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHR 646 (786)
Q Consensus 570 ~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs 646 (786)
+-...|...++...|++++..+.-... ....|..++|+.+|.+++.+...- +...+....+.....+......-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334455666667789999877655432 334688999999999999886432 33455555555444554666677665
Q ss_pred c-----ceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHH
Q 003919 647 M-----KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWEL 721 (786)
Q Consensus 647 ~-----gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~EL 721 (786)
. -.+|+++|+.|.+|..+..+|++++|+.+.............+++.|+.|+....-.++.++|+|..|+.+|++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3 27999999999999999999999999998554433334456788899999999888899999999999999999
Q ss_pred HhCCCCCC
Q 003919 722 CTLNRPWE 729 (786)
Q Consensus 722 lTG~~PF~ 729 (786)
.-|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 99888764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.013 Score=63.53 Aligned_cols=139 Identities=20% Similarity=0.271 Sum_probs=76.0
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-----CCCceeEEe-c--ccccCCceEEEE
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-----RHPNVILFL-G--ACTKPPRLSMIT 604 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-----~HPNIVkL~-g--~~~~~~~l~LV~ 604 (786)
.+.|+.|....+|+...++..+++|++. .... +....|+.++..| ..|.++.-. | +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3457778888999987766689999875 2222 2233445555554 244444311 1 112245578999
Q ss_pred EeeccchhH-----------HHH---HhhcCC--------ccchH-HHHH------------HHHHH-HHHHHHhhh---
Q 003919 605 EYMELGSLY-----------HLI---HLSGQK--------KKLSW-RRKL------------KMLRD-ICRGLMCIH--- 645 (786)
Q Consensus 605 Ey~~gGSL~-----------dlL---~~~~~~--------~~Ls~-~~i~------------~Ia~Q-Ia~gL~yLH--- 645 (786)
+|++|..+. ..+ |..... ..+.+ .... ..+.+ +...++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999886431 111 111000 01111 1111 01111 111223332
Q ss_pred ----hcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 646 ----RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 646 ----s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
..++||+|+.+.|||++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999976556899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00055 Score=75.04 Aligned_cols=137 Identities=15% Similarity=0.163 Sum_probs=93.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChH--------------------HHHHHHHHHHHHhhcC-CCc
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAE--------------------NMEDFCNEISILSRLR-HPN 586 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~--------------------~~~~f~~EI~iL~~L~-HPN 586 (786)
-+.++++||-|.-+.||.+.+ +|++.++|.-......-. ..-...+|...|+.|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 466789999999999999987 599999986322111100 0123456777787774 221
Q ss_pred -eeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 587 -VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 587 -IVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
+-+. .+.+.-++|||++.|-.|....+. .+.. .+...+..-|--|..+|+||+|+.-=||++++++
T Consensus 173 pVPkp----iD~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKP----IDHNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCc----ccccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 1122 234567899999998777755431 1122 2334444556677889999999999999999999
Q ss_pred eEEEEecCccccc
Q 003919 666 TVKICDFGLSRII 678 (786)
Q Consensus 666 ~VKL~DFGLA~~l 678 (786)
.++++||-.....
T Consensus 240 ~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 KIVVIDFPQMVST 252 (465)
T ss_pred CEEEeechHhhcc
Confidence 9999999765443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0089 Score=64.05 Aligned_cols=139 Identities=17% Similarity=0.215 Sum_probs=83.1
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeEEecc------cccCCceEEEE
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGA------CTKPPRLSMIT 604 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVkL~g~------~~~~~~l~LV~ 604 (786)
.+.|..|....+|+....+..+++|+... .. ...+..|+.++..+.+.+ +.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45677788889999877777899998753 11 245666777777774322 3343332 12234578999
Q ss_pred EeeccchhHH-----------H---HHhhcCC--------ccchHHHHH----------HHHHHHHHHHHhhhh------
Q 003919 605 EYMELGSLYH-----------L---IHLSGQK--------KKLSWRRKL----------KMLRDICRGLMCIHR------ 646 (786)
Q Consensus 605 Ey~~gGSL~d-----------l---L~~~~~~--------~~Ls~~~i~----------~Ia~QIa~gL~yLHs------ 646 (786)
+|++|..+.. . +|..... ....|.... .....+..++.++..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998865421 0 1111000 001111100 011123334444443
Q ss_pred -cceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 647 -MKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 647 -~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0092 Score=64.29 Aligned_cols=73 Identities=18% Similarity=0.256 Sum_probs=45.8
Q ss_pred eEEeecCcEEEEEEEEC--------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCceEEEE
Q 003919 534 TRVGIGFFGEVFRGIWN--------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLSMIT 604 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~--------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l~LV~ 604 (786)
+.|..|-...||++... ++.+++|+...... ......+|..++..+...++. ++++++. + .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 45666777899998764 47899999654321 123456788888887533333 3444443 2 3578
Q ss_pred EeeccchhH
Q 003919 605 EYMELGSLY 613 (786)
Q Consensus 605 Ey~~gGSL~ 613 (786)
+|++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 998876653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.046 Score=62.27 Aligned_cols=76 Identities=17% Similarity=0.018 Sum_probs=51.2
Q ss_pred eeEEeecCcEEEEEEEEC-C-eeEEEEEEecccc---C--hHHHHHHHHHHHHHhhcC---CCceeEEecccccCCceEE
Q 003919 533 GTRVGIGFFGEVFRGIWN-G-TDVAIKVFLEQDL---T--AENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~-G-~~VAVKvl~~~~~---~--~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~~l~L 602 (786)
.+.||.|.+..||++... | +.++||.-..... . +-..+.+..|.+.|+.+. -.++.+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 357999999999999874 4 4899997431100 0 123466778888888763 23455666653 345789
Q ss_pred EEEeeccc
Q 003919 603 ITEYMELG 610 (786)
Q Consensus 603 V~Ey~~gG 610 (786)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.037 Score=59.52 Aligned_cols=29 Identities=24% Similarity=0.328 Sum_probs=25.5
Q ss_pred cceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 647 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999988 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0037 Score=57.11 Aligned_cols=100 Identities=22% Similarity=0.296 Sum_probs=57.2
Q ss_pred HHHHHHHHhcCCCCHHHHHHHHHHHHHhhhCCC-CCCChhhhhhHHHHHHHhhcceeeeccccccccchhhHHHHHHhhh
Q 003919 127 KQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLADT 205 (786)
Q Consensus 127 ~~l~~~~~~~~~~~~~~~~~~~a~lv~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~r~ra~lfk~lad~ 205 (786)
|+|+.+++.... ++.+.++.|..-|.+.+.-- ......... -...|+ -++|.|..-|.||..|+..
T Consensus 1 ~~la~~i~~~~~-~~~~~~~~i~~~v~~~~~y~~~~~~~~~~~---~~~~l~---------~~~G~C~~~a~l~~allr~ 67 (113)
T PF01841_consen 1 RALAREITANSK-TPLEKAKAIYDWVRSNIRYDDPNYSPGPRD---ASEVLR---------SGRGDCEDYASLFVALLRA 67 (113)
T ss_dssp --------TTSH-CHHCCCCCCCCCCCCCCCEC-TCCCCCCTT---HHHHHH---------CEEESHHHHHHHHHHHHHH
T ss_pred CCcccccCCCCC-CHHHHHHHHHHHHHhCcEEeCCCCCCCCCC---HHHHHH---------cCCCccHHHHHHHHHHHhh
Confidence 456666665555 55566666666666554433 001111100 112222 3459999999999999999
Q ss_pred cCCccccccccCCC----CccccccccccceEEEeeCC
Q 003919 206 VGLESRLMVGLPND----GTMECVDSYKHMSVIVVLNS 239 (786)
Q Consensus 206 ~~l~~~l~~g~~~~----~~~~~~~~~~~~~~~~~~~~ 239 (786)
+|+|||+|.|.... +...-.....|.|+-|.+++
T Consensus 68 ~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~ 105 (113)
T PF01841_consen 68 LGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPG 105 (113)
T ss_dssp HT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETT
T ss_pred CCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcC
Confidence 99999999998832 22344556679999999944
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.042 Score=60.81 Aligned_cols=146 Identities=14% Similarity=0.164 Sum_probs=83.7
Q ss_pred EeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC--CceeEEecccccCC--ceEEEEEee
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPP--RLSMITEYM 607 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H--PNIVkL~g~~~~~~--~l~LV~Ey~ 607 (786)
+.+.+-.|....+|.....++++++. ...............+|..+|+.+.- --.-..+++|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 44455455556677766668888888 33222233345566778888877742 12234466666655 779999999
Q ss_pred ccchhHH------------------HHHhhcC---------C--ccchHHHHHHHHHH--------------HHHHHHhh
Q 003919 608 ELGSLYH------------------LIHLSGQ---------K--KKLSWRRKLKMLRD--------------ICRGLMCI 644 (786)
Q Consensus 608 ~gGSL~d------------------lL~~~~~---------~--~~Ls~~~i~~Ia~Q--------------Ia~gL~yL 644 (786)
.|..+.. +|..... . ......++..+..+ ......||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 8833221 1110000 0 00001111111111 12223444
Q ss_pred hhc--------ceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 645 HRM--------KIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 645 Hs~--------gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
+.+ .++|+|+.+.|++++.++-+-|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 432 4899999999999999988999999998653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.059 Score=60.49 Aligned_cols=139 Identities=17% Similarity=0.202 Sum_probs=90.7
Q ss_pred eEEeecCcEEEEEEEE-CCeeEEEEEEeccccC----------------------hHH-H-HHHHHHHHHHhhcCCCcee
Q 003919 534 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----------------------AEN-M-EDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~----------------------~~~-~-~~f~~EI~iL~~L~HPNIV 588 (786)
..|..|.-+.||.+.. +|..+|||+++..-+. +.. + --...|+..|++|+...|-
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4577899999999976 7889999997543211 111 1 1233577778887643321
Q ss_pred EEecccccCCceEEEEEeeccchh-HHHHHhhcCCccchHHHHHHHHHHHHHHHHhh-hhcceeeccCCcccEEEcCCCe
Q 003919 589 LFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI-HRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL-~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yL-Hs~gIIHrDLKpsNILLd~~g~ 666 (786)
-- ....- ..-.|||+|+....- .-.| +...++...+..+-.|++.-|.-| |..++||.||.-=|+|+.+ |.
T Consensus 230 ~P-ePIlL-k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 230 CP-EPILL-KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred CC-Cceee-ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence 00 00000 124789999863211 1122 234566677788888888888777 5679999999999999965 59
Q ss_pred EEEEecCcccccc
Q 003919 667 VKICDFGLSRIIT 679 (786)
Q Consensus 667 VKL~DFGLA~~l~ 679 (786)
++|+|.+.+....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999999886543
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.012 Score=67.49 Aligned_cols=61 Identities=23% Similarity=0.273 Sum_probs=51.4
Q ss_pred cccccchhhHHHHHHhhhcCCccccccccC-CCCccccccccccceEEEeeCCeeeeeeecc
Q 003919 188 RHGSCRPRAILFKVLADTVGLESRLMVGLP-NDGTMECVDSYKHMSVIVVLNSVELLVDLMR 248 (786)
Q Consensus 188 ~~g~~r~ra~lfk~lad~~~l~~~l~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (786)
..+.|-.=|.|||.||-..||||-+|+|+- +.-...=--.++|-|++|.+++-=|+||-.-
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~~yy~VDtTw 269 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDNEYYLVDTTW 269 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECCeEEEEeeec
Confidence 568999999999999999999999999994 3333344457899999999999889999753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.09 Score=57.37 Aligned_cols=75 Identities=23% Similarity=0.160 Sum_probs=46.9
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC---CCceeEEecccccCCceEEEEEee
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
+-.+.|+-|....+|+...+++.+.||+-.... ...|..|.+-|+.|. --.+.+.+++....+.-++++||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999998889999999965221 245778888888884 234556677666566679999998
Q ss_pred ccc
Q 003919 608 ELG 610 (786)
Q Consensus 608 ~gG 610 (786)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.11 Score=56.18 Aligned_cols=30 Identities=20% Similarity=0.432 Sum_probs=25.2
Q ss_pred ceeeccCCcccEEEcCCCe-EEEEecCcccc
Q 003919 648 KIVHRDLKSANCLVNKHWT-VKICDFGLSRI 677 (786)
Q Consensus 648 gIIHrDLKpsNILLd~~g~-VKL~DFGLA~~ 677 (786)
.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.13 Score=56.95 Aligned_cols=142 Identities=18% Similarity=0.261 Sum_probs=78.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEECC-----eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G-----~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l~ 601 (786)
+++.+. .|..|-...+|++...+ ..|++|+...... ..-.-.+|..+++.+..-++- ++++++. .+
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 344444 44448888999986543 3788998754321 112234688888888644442 4454442 22
Q ss_pred EEEEeeccchhHH--------------HH---Hhhc-C--CccchHHHHHHHHHHH----------------------HH
Q 003919 602 MITEYMELGSLYH--------------LI---HLSG-Q--KKKLSWRRKLKMLRDI----------------------CR 639 (786)
Q Consensus 602 LV~Ey~~gGSL~d--------------lL---~~~~-~--~~~Ls~~~i~~Ia~QI----------------------a~ 639 (786)
+|.+|+++.+|.. .+ |... . ...-.+..+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4888887655421 11 1100 0 0111233333332222 11
Q ss_pred HHH----hhhhc----ceeeccCCcccEEEcC-CCeEEEEecCcccc
Q 003919 640 GLM----CIHRM----KIVHRDLKSANCLVNK-HWTVKICDFGLSRI 677 (786)
Q Consensus 640 gL~----yLHs~----gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 677 (786)
-+. .+... -++|+|+.+.|||+++ ++.++++||..|..
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 12111 3899999999999975 57899999998743
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.23 Score=54.02 Aligned_cols=30 Identities=17% Similarity=0.219 Sum_probs=27.3
Q ss_pred ceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 648 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.19 Score=57.52 Aligned_cols=75 Identities=17% Similarity=0.002 Sum_probs=50.3
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEecccc--C---hHHHHHHHHHHHHHhhcC---CCceeEEecccccCCceEEEE
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL--T---AENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~--~---~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+.||.|....||+....+..++||.-..... . +....+-..|...|+.+. -.++-+++.++.+. .+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEE
Confidence 56899999999999988777899997541111 0 012334445667776553 23667788877744 57889
Q ss_pred Eeecc
Q 003919 605 EYMEL 609 (786)
Q Consensus 605 Ey~~g 609 (786)
||+++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.14 Score=57.02 Aligned_cols=142 Identities=20% Similarity=0.283 Sum_probs=80.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l 600 (786)
+.+.+. .|-.|-...+|++... ++.+++|+..... ... -.-.+|..+++.+..-++. ++++.+.. +
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g-- 109 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G-- 109 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECC-c--
Confidence 344443 5545888999998652 3578999875432 111 1225688888888643333 34454432 2
Q ss_pred EEEEEeeccchhHHH-----------------HHhhc-C--CccchHHHHHHHHHHH-----------------HHHHHh
Q 003919 601 SMITEYMELGSLYHL-----------------IHLSG-Q--KKKLSWRRKLKMLRDI-----------------CRGLMC 643 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dl-----------------L~~~~-~--~~~Ls~~~i~~Ia~QI-----------------a~gL~y 643 (786)
.|++|+++.+|... +|... . .....+.++..++.++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57899887665311 11111 0 1112233333333221 111111
Q ss_pred --------hhhcceeeccCCcccEEEcC-CCeEEEEecCcccc
Q 003919 644 --------IHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 677 (786)
Q Consensus 644 --------LHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 677 (786)
.+...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12346999999999999986 46899999988753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.4 Score=53.42 Aligned_cols=137 Identities=19% Similarity=0.261 Sum_probs=80.3
Q ss_pred EEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc------eeEEecc----cccCCceEEEE
Q 003919 535 RVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGA----CTKPPRLSMIT 604 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN------IVkL~g~----~~~~~~l~LV~ 604 (786)
.|.+ .-..||+....+..+++|+.... ... .++.-|...+..|.-.+ +..+-|- .......+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 4544 56679999887667799998655 333 45666777777773111 2222221 22223678899
Q ss_pred EeeccchhHH------------H---HHhhcCC---------ccchHHH----H---------HHHHHHHHHHHHhhhh-
Q 003919 605 EYMELGSLYH------------L---IHLSGQK---------KKLSWRR----K---------LKMLRDICRGLMCIHR- 646 (786)
Q Consensus 605 Ey~~gGSL~d------------l---L~~~~~~---------~~Ls~~~----i---------~~Ia~QIa~gL~yLHs- 646 (786)
+|++|..+.. + ++..... ....|.. . .....++...++.+..
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999876662 1 1111100 1122220 0 0123334444444443
Q ss_pred -------cc--eeeccCCcccEEEcCCCe-EEEEecCccc
Q 003919 647 -------MK--IVHRDLKSANCLVNKHWT-VKICDFGLSR 676 (786)
Q Consensus 647 -------~g--IIHrDLKpsNILLd~~g~-VKL~DFGLA~ 676 (786)
.+ +||+|+.+.||+++.+.. +-++||+.+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 24 999999999999998875 8899999874
|
|
| >COG1305 Transglutaminase-like enzymes, putative cysteine proteases [Amino acid transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.22 Score=53.07 Aligned_cols=135 Identities=20% Similarity=0.173 Sum_probs=84.8
Q ss_pred HHHHHHHHHhcCCCCHHHHHHHHHHHHHhhhCCCCCCChhhhhhHHHHHHHhhcceeeeccccccccchhhHHHHHHhhh
Q 003919 126 LKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLADT 205 (786)
Q Consensus 126 l~~l~~~~~~~~~~~~~~~~~~~a~lv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~r~ra~lfk~lad~ 205 (786)
+.+|+..+..+.. +..+.+..|...|-+.+--..-..+.... ....|+. | .|.|+|-|.||=+|+-.
T Consensus 144 ~~~la~~~~~~~~-~~~~~~~~~~~~~~~~~~y~~~~~~~~~~---~~~~l~~------~---~G~C~d~a~l~val~Ra 210 (319)
T COG1305 144 VAELAARETGGAT-TPREKAAALFDYVNSKIRYSPGPTPVTGS---ASDALRL------G---RGVCRDFAHLLVALLRA 210 (319)
T ss_pred HHHHHHHhhcccC-CHHHHHHHHHHHHhhcceeecCCCCCCCC---HHHHHHh------C---CcccccHHHHHHHHHHH
Confidence 7777777666677 78888888888886332221011111100 0122222 2 99999999999999999
Q ss_pred cCCccccccccCCCCcc------ccccccccceEEEeeCCeeeeeeeccCCcccccCcchhhhhhc-ccccCCCCCcCCC
Q 003919 206 VGLESRLMVGLPNDGTM------ECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRSTKAIFMSH-ISAAGESDSAEND 278 (786)
Q Consensus 206 ~~l~~~l~~g~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 278 (786)
.|+|+|+|.|+...... .......|-|+-|-++.. -||.+=--+|.+. -..| +.+++..|..+-.
T Consensus 211 ~GIpAR~V~Gy~~~~~~~~~~~~~~~~~~~Haw~ev~~~~~-gW~~~Dpt~~~~~-------~~~~~~~~~~~~~~~~~~ 282 (319)
T COG1305 211 AGIPARYVSGYLGAEVEPLSGRPLVRNDDAHAWAEVYLPGR-GWVPLDPTNGLLA-------GGRYSILAAWGRDYVDVA 282 (319)
T ss_pred cCCcceeeeccccCCCCcccccccccCcccceeeeeecCCC-ccEeecCCCCCcc-------CcccccccccccCccccc
Confidence 99999999998743321 245566799999999986 4444433444444 2223 5666666665554
Q ss_pred CCC
Q 003919 279 SCD 281 (786)
Q Consensus 279 ~~~ 281 (786)
.+.
T Consensus 283 ~~~ 285 (319)
T COG1305 283 PVR 285 (319)
T ss_pred ceE
Confidence 443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.38 Score=53.02 Aligned_cols=70 Identities=13% Similarity=0.074 Sum_probs=40.9
Q ss_pred cCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeE---Eec--ccccCCceEEEEEeeccc
Q 003919 539 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VIL---FLG--ACTKPPRLSMITEYMELG 610 (786)
Q Consensus 539 G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVk---L~g--~~~~~~~l~LV~Ey~~gG 610 (786)
+.-..||+... +|..+++|+....... ..++..|++.+..|.... ++. .-| ....++..+.++++++|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 55677999876 5678999987543333 245556777776663111 121 111 112234577899998875
Q ss_pred h
Q 003919 611 S 611 (786)
Q Consensus 611 S 611 (786)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 3
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.3 Score=55.07 Aligned_cols=73 Identities=18% Similarity=0.114 Sum_probs=45.5
Q ss_pred EEeecCcEEEEEEEECC--eeEEEEEEec-----cccChHHHHHHHHHHHHHhhcC--CCcee-EEecccccCCceEEEE
Q 003919 535 RVGIGFFGEVFRGIWNG--TDVAIKVFLE-----QDLTAENMEDFCNEISILSRLR--HPNVI-LFLGACTKPPRLSMIT 604 (786)
Q Consensus 535 ~LG~G~fG~VYkg~~~G--~~VAVKvl~~-----~~~~~~~~~~f~~EI~iL~~L~--HPNIV-kL~g~~~~~~~l~LV~ 604 (786)
.||.|....||++...+ +.++||.-.. ...-+-...+..-|...|+... .|..| ++|.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 58999999999998753 5789986321 1001122345557778887663 45444 44443 344467899
Q ss_pred Eeecc
Q 003919 605 EYMEL 609 (786)
Q Consensus 605 Ey~~g 609 (786)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.3 Score=55.74 Aligned_cols=75 Identities=16% Similarity=0.069 Sum_probs=48.4
Q ss_pred eeEEeecCcEEEEEEEEC--CeeEEEEEEec----cccChHHHHHHHHHHHHHhhcC--CCcee-EEecccccCCceEEE
Q 003919 533 GTRVGIGFFGEVFRGIWN--GTDVAIKVFLE----QDLTAENMEDFCNEISILSRLR--HPNVI-LFLGACTKPPRLSMI 603 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~----~~~~~~~~~~f~~EI~iL~~L~--HPNIV-kL~g~~~~~~~l~LV 603 (786)
.+.||.|.-..||++... ++.++||.-.. ...-+-..++..-|.+.|+.+. .|..| ++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 568999999999999874 66788886321 1111122456677888888764 45444 45443 34446788
Q ss_pred EEeecc
Q 003919 604 TEYMEL 609 (786)
Q Consensus 604 ~Ey~~g 609 (786)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.29 E-value=1.2 Score=50.52 Aligned_cols=78 Identities=17% Similarity=0.146 Sum_probs=44.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEECC---ee-----EEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCC
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNG---TD-----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPP 598 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G---~~-----VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~ 598 (786)
+++.+ +.|..|-...+|++...+ .. |.+++.... . ...-.-.+|+.+++.+...++- ++++.+..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 33444 455558889999986532 22 334432111 1 1111224688999999765554 44555432
Q ss_pred ceEEEEEeeccchhH
Q 003919 599 RLSMITEYMELGSLY 613 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~ 613 (786)
++++||++|.+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 6999999987654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.86 E-value=1.5 Score=55.97 Aligned_cols=31 Identities=26% Similarity=0.420 Sum_probs=26.2
Q ss_pred cceeeccCCcccEEEcCCC--eEE-EEecCcccc
Q 003919 647 MKIVHRDLKSANCLVNKHW--TVK-ICDFGLSRI 677 (786)
Q Consensus 647 ~gIIHrDLKpsNILLd~~g--~VK-L~DFGLA~~ 677 (786)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4699999999999999775 565 999998743
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.13 E-value=0.73 Score=53.96 Aligned_cols=152 Identities=22% Similarity=0.238 Sum_probs=88.8
Q ss_pred HHHHHHHHHHhhcCCCceeEEecccccC-CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc
Q 003919 570 EDFCNEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648 (786)
Q Consensus 570 ~~f~~EI~iL~~L~HPNIVkL~g~~~~~-~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g 648 (786)
.+++-..++++.+.|+|...++++.... .+..+|+|++. .+|.|++.... ....+ ++ .+|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s-------------~~----~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDES-------------LL----AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhh-------------hc----ccc
Confidence 4566678889999999999998876543 45788999985 58888886322 11110 00 222
Q ss_pred eeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003919 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW 728 (786)
Q Consensus 649 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF 728 (786)
+.|- |+ ++.+| ...... .. +..+|+|||++|.++.+++-|..-+
T Consensus 88 ~~~~-----~~-------~~~td----~~~t~~----~~----------------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 88 VLHL-----NI-------IYITD----HFLTKY----PS----------------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ccee-----hh-------hhccc----cccccC----CC----------------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 3222 22 22333 011100 00 1114999999999999999998877
Q ss_pred CCCChHHHHHHHHhcCCCCCC-------------CChHHHHHHHHhhh-CCCCCCCHHHHHH
Q 003919 729 EGVLPERVVYAVANEGSRLEI-------------PEGPLGRLIADCWA-EPQERPSCEEILS 776 (786)
Q Consensus 729 ~~~~~~~~l~~i~~~~~~~~i-------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~ 776 (786)
......+....+..-.....- -+..+..+...|+. .|..||...++.+
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 766555544444322211110 01224456677877 8888886655543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 786 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-71 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-71 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-40 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-39 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-37 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-37 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-37 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-37 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-37 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-37 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-36 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-36 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-36 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-36 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-36 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-35 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-35 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-35 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-35 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-35 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-34 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-34 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-34 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-34 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-34 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-33 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-33 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-33 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-33 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-33 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-33 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-33 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-32 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-32 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-32 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-32 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-32 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-32 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-32 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-32 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-32 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-32 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-32 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-32 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-32 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-32 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-32 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-32 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-32 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-32 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-32 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-31 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-31 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-31 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-31 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-31 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-31 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-31 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-31 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-31 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-31 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-31 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-31 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-31 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-31 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-31 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-31 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-31 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-30 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-30 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-30 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-29 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-29 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-29 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-29 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-29 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-29 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-29 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-28 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-28 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-28 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-28 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-28 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-28 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-28 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-28 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-28 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-28 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-28 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-28 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-28 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-28 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-28 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-28 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-28 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-28 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-27 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-27 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-27 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-27 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-27 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-26 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-26 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-26 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-26 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-26 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-26 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-26 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-26 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-26 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-25 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-25 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-25 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-25 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-24 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-24 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-24 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-23 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-23 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-23 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-22 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-22 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-22 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-22 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-22 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-21 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-21 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-20 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-20 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-20 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-20 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-19 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-18 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-18 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-17 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-17 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-17 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-17 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-17 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-17 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-17 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-17 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-17 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-17 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-17 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-142
Identities = 125/289 (43%), Positives = 187/289 (64%), Gaps = 6/289 (2%)
Query: 496 NSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVA 555
+ + + + + + ++ +I + +L + ++G G FG V R W+G+DVA
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 64
Query: 556 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 615
+K+ +EQD AE + +F E++I+ RLRHPN++LF+GA T+PP LS++TEY+ GSLY L
Sbjct: 65 VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124
Query: 616 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFG 673
+H SG +++L RR+L M D+ +G+ +H IVHR+LKS N LV+K +TVK+CDFG
Sbjct: 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184
Query: 674 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733
LSR+ + + S+AGTPEWMAPE++R+EP EK D++S GVI+WEL TL +PW + P
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244
Query: 734 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+VV AV + RLEIP + +I CW EP +RPS I+ L
Sbjct: 245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-128
Identities = 94/273 (34%), Positives = 142/273 (52%), Gaps = 23/273 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLE--QDLTAENMEDFCNEISILS 580
IDF+ELT+ +GIG FG+V+R W G +VA+K + ++ +E+ E + +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
L+HPN+I G C K P L ++ E+ G L ++ K++ + I RG
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARG 117
Query: 641 LMCIHRMK---IVHRDLKSANCLVNK--------HWTVKICDFGLSRIITDSPMRDSSSA 689
+ +H I+HRDLKS+N L+ + + +KI DFGL+R + S+A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAA 175
Query: 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 749
G WMAPE+IR F++ D++S GV++WEL T P+ G+ V Y VA L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 750 PEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
P P +L+ DCW +P RPS IL +L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-127
Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 17/269 (6%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 580
+ IDF +L T++ GE+++G W G D+ +KV +D + DF E L
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 581 RLRHPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
HPNV+ LGAC PP ++IT +M GSLY+++H G + + +K D+
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMA 121
Query: 639 RGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 696
RG+ +H ++ I L S + ++++ T +I + + P W+A
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-----FQSPGRMYAPAWVA 176
Query: 697 PELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 752
PE ++ +P D++S V++WEL T P+ + + VA EG R IP G
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 753 --PLGRLIADCW-AEPQERPSCEEILSRL 778
+ +L+ C +P +RP + I+ L
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-124
Identities = 81/290 (27%), Positives = 145/290 (50%), Gaps = 24/290 (8%)
Query: 508 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE 567
P ++ + +EW+I F +L +G +G G FG+V+ G W+G +VAI++ + +
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED 71
Query: 568 NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSW 627
++ F E+ + RH NV+LF+GAC PP L++IT + +LY ++ K L
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDV 129
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD-- 685
+ ++ ++I +G+ +H I+H+DLKS N + + V I DFGL I
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188
Query: 686 ---SSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733
G +APE+IR PF++ D+F+LG I +EL P++
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 734 ERVVYAVANEGSRLEIPEG----PLGRLIADCWA-EPQERPSCEEILSRL 778
E +++ + G + + + + ++ CWA E +ERP+ +++ L
Sbjct: 249 EAIIWQMGT-GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 371 bits (955), Expect = e-123
Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
+ S+L G +G G FG+ + T + + E F E+ +
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+ L HPNV+ F+G K RL+ ITEY++ G+L +I + W +++ +DI
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIA 118
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS------------ 686
G+ +H M I+HRDL S NCLV ++ V + DFGL+R++ D +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 687 --SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NE 743
+ G P WMAPE+I + EK D+FS G+++ E+ LP + + +
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 744 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
P + C +P++RPS ++ L
Sbjct: 239 FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 370 bits (953), Expect = e-123
Identities = 87/273 (31%), Positives = 154/273 (56%), Gaps = 17/273 (6%)
Query: 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
A ++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L + RH N++LF+G T P L+++T++ E SLYH +H + K ++ + + R
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMA 696
RG+ +H I+HRDLKS N +++ TVKI DFGL+ + +G+ WMA
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 697 PELIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRLEIPEG 752
PE+IR + P++ + D+++ G++++EL T P+ + ++++ V ++ +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 753 P------LGRLIADCWA-EPQERPSCEEILSRL 778
+ RL+A+C + ERPS IL+ +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-119
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 29/287 (10%)
Query: 514 NKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-----TA 566
+ +E+ ++G G FG V +G + + VAIK + D
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626
E ++F E+ I+S L HPN++ G PP M+ E++ G LYH + + +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL--DKAHPIK 120
Query: 627 WRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLV-----NKHWTVKICDFGLSRIIT 679
W KL+++ DI G+ + IVHRDL+S N + N K+ DFGLS+
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 680 DSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--R 735
S G +WMAPE I E +TEK D +S +I++ + T P++ +
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 736 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ + EG R IPE L +I CW+ +P++RP I+ L
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-117
Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 18/270 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH 584
ID+ E+ V VG G FG V + W DVAIK + + F E+ LSR+ H
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----ERKAFIVELRQLSRVNH 60
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
PN++ GAC P + ++ EY E GSLY+++H + + + +G+ +
Sbjct: 61 PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 645 HRMK---IVHRDLKSANCLVNKHWTV-KICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
H M+ ++HRDLK N L+ TV KICDFG + I ++ G+ WMAPE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVF 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIPEG---PLGR 756
++EKCD+FS G+I+WE+ T +P++ + P + + G+R + + P+
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 757 LIADCWA-EPQERPSCEEILSRLLDCEYSL 785
L+ CW+ +P +RPS EEI+ +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-102
Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 529 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++T+ VG G +GEV+RG W G +VA+K+F +D + E E+ LRH N++
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENIL 65
Query: 589 LFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
F+ + +L +IT Y E+GSLY + L L+++ I GL +
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHL 121
Query: 645 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 692
H + I HRDLKS N LV K+ I D GL+ + + S + ++ GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 693 EWMAPELIRNEP------FTEKCDIFSLGVIMWELCT----------LNRPWEGVLP--- 733
+MAPE++ ++ DI++ G+++WE+ P+ V+P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 734 --ERVVYAVANEGSRLEIPE--------GPLGRLIADCW-AEPQERPSCEEILSRLLDCE 782
E + V + R IP L +L+ +CW P R + I L +
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 78/307 (25%), Positives = 124/307 (40%), Gaps = 53/307 (17%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 577
L ++ + ++G G +GEV+ G W G VA+KVF + + E EI
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---TEIY 83
Query: 578 ILSRLRHPNVILFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 633
+RH N++ F+ A K +L +IT+Y E GSLY + L + LK+
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKL 139
Query: 634 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685
GL +H + I HRDLKS N LV K+ T I D GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 686 ----SSSAGTPEWMAPELI------RNEPFTEKCDIFSLGVIMWELCT----------LN 725
++ GT +M PE++ + D++S G+I+WE+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 726 RPWEGVLP-----ERVVYAVANEGSRLEIPEGP--------LGRLIADCW-AEPQERPSC 771
P+ ++P E + V + R P +G+L+ +CW P R +
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 772 EEILSRL 778
+ L
Sbjct: 320 LRVKKTL 326
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 2e-96
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 577
L + + +G G FGEV+RG W G +VA+K+F ++ + E EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIY 88
Query: 578 ILSRLRHPNVILFLGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 633
LRH N++ F+ A K +L ++++Y E GSL+ ++ + ++ +K+
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKL 144
Query: 634 LRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685
GL +H + I HRDLKS N LV K+ T I D GL+ +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 686 ----SSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNR--------- 726
+ GT +MAPE++ + ++ DI+++G++ WE+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 727 -PWEGVLP-----ERVVYAVANEGSRLEIPEG--------PLGRLIADCW-AEPQERPSC 771
P+ ++P E + V + R IP + +++ +CW A R +
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 772 EEILSRL 778
I L
Sbjct: 325 LRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 8e-92
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 68/320 (21%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEIS 577
A E ++D L + +G G +G V++G + VA+KVF + ++F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKN 57
Query: 578 I--LSRLRHPNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
I + + H N+ F+ + ++ EY GSL + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSS 113
Query: 631 LKMLRDICRGLMCIH---------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681
++ + RGL +H + I HRDL S N LV T I DFGLS +T +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 682 PMRDSSS--------AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWEL---CT 723
+ GT +MAPE++ E ++ D+++LG+I WE+ CT
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 724 LNRPWEGVLPERVVYA---------------VANEGSRLEIPEG---------PLGRLIA 759
P E V ++ + V+ E R + PE L I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 760 DCW-AEPQERPSCEEILSRL 778
DCW + + R + + R+
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-87
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL 579
E L + G FG V++ VA+K+F QD + E+ L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSL 72
Query: 580 SRLRHPNVILFLGACTKPPRLSM----ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
++H N++ F+GA + + + IT + E GSL + +SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAE 128
Query: 636 DICRGLMCIH----------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685
+ RGL +H + I HRD+KS N L+ + T I DFGL+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 686 SSS--AGTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEGVLP----- 733
+ GT +MAPE++ + D++++G+++WEL + +G +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 734 -----------ERVVYAVANEGSRLEIPE--------GPLGRLIADCWAE-PQERPSCEE 773
E + V ++ R + + L I +CW + R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 774 ILSRL 778
+ R+
Sbjct: 309 VGERI 313
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-73
Identities = 80/274 (29%), Positives = 131/274 (47%), Gaps = 16/274 (5%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 572
+ ++ I ++ + +G GFFGEV+ G++ +VA+K ++D T +N E F
Sbjct: 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKF 60
Query: 573 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
+E I+ L HP+++ +G + P +I E G L +L K L +
Sbjct: 61 MSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGEL--GHYLERNKNSLKVLTLVL 117
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
IC+ + + + VHRD+ N LV VK+ DFGLSR I D +S P
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177
Query: 693 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 750
+WM+PE I FT D++ V MWE+ + +P+ + + V+ + +G RL P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKP 236
Query: 751 EG---PLGRLIADCWA-EPQERPSCEEILSRLLD 780
+ L L+ CW +P +RP E++ L D
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 6e-73
Identities = 90/270 (33%), Positives = 140/270 (51%), Gaps = 13/270 (4%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEI 576
L Y W ID +LT +G G FG V G W G DVAIK+ +++ +E ++F E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSE--DEFIEEA 70
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
++ L H ++ G CTK + +ITEYM G L L +L + + ++ L+M +D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKD 128
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 695
+C + + + +HRDL + NCLVN VK+ DFGLSR + D S + P W
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 752
PE++ F+ K DI++ GV+MWE+ +L P+E + +G RL P
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLAS 247
Query: 753 -PLGRLIADCW-AEPQERPSCEEILSRLLD 780
+ ++ CW + ERP+ + +LS +LD
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-72
Identities = 82/270 (30%), Positives = 134/270 (49%), Gaps = 13/270 (4%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNE 575
+ ++W ++ +L +G ++G G FGEVF G T VA+K + L + F E
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQE 162
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
IL + HPN++ +G CT+ + ++ E ++ G L L + +L + L+M+
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF--LTFLRTEGARLRVKTLLQMVG 220
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT-P-E 693
D G+ + +HRDL + NCLV + +KI DFG+SR D S P +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG 752
W APE + ++ + D++S G+++WE +L P+ + ++ V G RL PE
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPEL 339
Query: 753 ---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ RL+ CWA EP +RPS I L
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 4e-72
Identities = 81/265 (30%), Positives = 143/265 (53%), Gaps = 13/265 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILSR 581
+ E+T+ +G G FG V G W G DVA+K+ +++ +E ++F E + +
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSE--DEFFQEAQTMMK 59
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L HP ++ F G C+K + ++TEY+ G L L +L K L + L+M D+C G+
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPELI 700
+ + +HRDL + NCLV++ VK+ DFG++R + D S P +W APE+
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 701 RNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
++ K D+++ G++MWE+ +L P++ VV V ++G RL P + +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQ 236
Query: 757 LIADCW-AEPQERPSCEEILSRLLD 780
++ CW P++RP+ +++LS +
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 5e-72
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 16/275 (5%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDF 572
+ ++ I + +G +G G FG+V +GI+ VAIK + + E F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKF 63
Query: 573 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
E + + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKYSLDLASLIL 120
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 693 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 750
+WMAPE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMP 239
Query: 751 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
L L+ CWA +P RP E+ ++L
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-72
Identities = 84/267 (31%), Positives = 146/267 (54%), Gaps = 13/267 (4%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEIS 577
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D E+F E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEV--EEFLKEAA 61
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 120
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMA 696
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A P +W A
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 752
PE + F+ K D+++ GV++WE+ T P+ G+ +V + + R+E PEG
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPE 239
Query: 753 PLGRLIADCW-AEPQERPSCEEILSRL 778
+ L+ CW P +RPS EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 13/266 (4%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISILS 580
+W ID SELT +G G FG V G W VAIK + + +E EDF E ++
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSE--EDFIEEAEVMM 58
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+L HP ++ G C + + ++TE+ME G L +L Q+ + L M D+C G
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAPEL 699
+ + ++HRDL + NCLV ++ +K+ DFG++R + D S+ P +W +PE+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
++ K D++S GV+MWE+ + P+E VV + + G RL P +
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVY 235
Query: 756 RLIADCW-AEPQERPSCEEILSRLLD 780
+++ CW P++RP+ +L +L +
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 95/294 (32%), Positives = 141/294 (47%), Gaps = 20/294 (6%)
Query: 504 NKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVA 555
+ + P A + I S +T +G G FGEV++G+ VA
Sbjct: 18 ENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 556 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHL 615
IK L+ T + DF E I+ + H N+I G +K + +ITEYME G+L
Sbjct: 78 IKT-LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL--D 134
Query: 616 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675
L + + S + + MLR I G+ + M VHRDL + N LVN + K+ DFGLS
Sbjct: 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 676 RIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGV 731
R++ D P +++G P W APE I FT D++S G++MWE+ T RP+ +
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 732 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
V+ A+ N+G RL P + +L+ CW E RP +I+S L
Sbjct: 255 SNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-70
Identities = 81/279 (29%), Positives = 141/279 (50%), Gaps = 20/279 (7%)
Query: 517 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEI 576
W ++ EL + +G G FG+V G + G VA+K ++ D TA+ F E
Sbjct: 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDATAQ---AFLAEA 65
Query: 577 SILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
S++++LRH N++ LG + L ++TEYM GSL + S + L LK
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSL 124
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EW 694
D+C + + VHRDL + N LV++ K+ DFGL++ + + + P +W
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKW 180
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG- 752
APE +R + F+ K D++S G+++WE+ + R P+ + + VV V +G +++ P+G
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGC 239
Query: 753 --PLGRLIADCW-AEPQERPSCEEI---LSRLLDCEYSL 785
+ ++ +CW + RPS ++ L + E L
Sbjct: 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-70
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 17/275 (6%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLT-AENMEDFCN 574
I +L + ++G G FG V RG W+ VA+K L+ E M+DF
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E++ + L H N+I G PP + M+TE LGSL L L + +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYA 127
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P 692
+ G+ + + +HRDL + N L+ VKI DFGL R + + P
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 693 -EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP 750
W APE ++ F+ D + GV +WE+ T PW G+ ++++ + EG RL P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247
Query: 751 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
E + ++ CWA +P++RP+ + LL+
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 4e-70
Identities = 93/289 (32%), Positives = 138/289 (47%), Gaps = 19/289 (6%)
Query: 505 KVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIK 557
+ P +P A I+ S + + +G G GEV G VAIK
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 558 VFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH 617
L+ T DF +E SI+ + HPN+I G T+ ++TEYME GSL
Sbjct: 84 A-LKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL--DTF 140
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
L + + + + MLR + G+ + + VHRDL + N LV+ + K+ DFGLSR+
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 678 ITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 733
+ D P ++ G P W APE I F+ D++S GV+MWE+ RP+ +
Sbjct: 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260
Query: 734 ERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
V+ +V EG RL P G L +L+ DCW + +RP +I+S L
Sbjct: 261 RDVISSV-EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-70
Identities = 91/268 (33%), Positives = 143/268 (53%), Gaps = 15/268 (5%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAENMEDFCNEISIL 579
+EW + L + R+G G FGEV+ G +NG T VA+K L+Q + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSP--DAFLAEANLM 62
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDIC 638
+L+H ++ T+ P +ITEYME GSL + L + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWMAP 697
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ A P +W AP
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---P 753
E I FT K D++S G+++ E+ T R P+ G+ V+ + G R+ P+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEE 238
Query: 754 LGRLIADCW-AEPQERPSCEEILSRLLD 780
L +L+ CW P++RP+ + + S L D
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-70
Identities = 85/282 (30%), Positives = 149/282 (52%), Gaps = 15/282 (5%)
Query: 508 ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLT 565
+ Y++W ++ +++T+ ++G G +GEV+ G+W VA+K L++D
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTM 258
Query: 566 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKK 624
E+F E +++ ++HPN++ LG CT+ P +ITE+M G+L L +L +++
Sbjct: 259 EV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL--LDYLRECNRQE 314
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
+S L M I + + + +HR+L + NCLV ++ VK+ DFGLSR++T
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 685 DSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVAN 742
+ A P +W APE + F+ K D+++ GV++WE+ T P+ G+ +V +
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-E 433
Query: 743 EGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 780
+ R+E PEG + L+ CW P +RPS EI
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-70
Identities = 98/299 (32%), Positives = 147/299 (49%), Gaps = 21/299 (7%)
Query: 493 YMANSEFVSTWNKVLESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 549
Y +++ + L + +KP LA + W I L + ++G G FGEV+ G W
Sbjct: 149 YSKHADGLCH---RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 550 NG-TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608
NG T VAIK + E F E ++ +LRH ++ ++ P ++TEYM
Sbjct: 206 NGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMS 261
Query: 609 LGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667
GSL L L K L + + M I G+ + RM VHRDL++AN LV ++
Sbjct: 262 KGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 668 KICDFGLSRIITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-N 725
K+ DFGL+R+I D+ A P +W APE FT K D++S G+++ EL T
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 726 RPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 780
P+ G++ V+ V G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 380 VPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 6e-70
Identities = 96/304 (31%), Positives = 143/304 (47%), Gaps = 19/304 (6%)
Query: 493 YMANSEFVSTWNKVLESPMFQNKPLLAYEE--WNIDFSELTVGTRVGIGFFGEVFRGIWN 550
+ N + P P E +D + +++ VG G FGEV G
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 551 G-----TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605
VAIK L+ T + DF E SI+ + HPN+I G TK + ++TE
Sbjct: 68 LPSKKEISVAIKT-LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665
YME GSL L + + + + MLR I G+ + M VHRDL + N L+N +
Sbjct: 127 YMENGSL--DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184
Query: 666 TVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPELIRNEPFTEKCDIFSLGVIMWELC 722
K+ DFGL R++ D P ++ G P W +PE I FT D++S G+++WE+
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
Query: 723 TL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 777
+ RP+ + + V+ AV +EG RL P L +L+ DCW + RP E+I+S
Sbjct: 245 SYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 778 LLDC 781
L
Sbjct: 304 LDKL 307
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 7e-70
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 578
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 696
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 752
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 753 PLGRLIADCWA-EPQERPSCEEILSRL 778
+ ++ CW + RP E++
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 1e-69
Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 18/278 (6%)
Query: 521 EEWNIDFSELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNE 575
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 60
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
I+ +L +P ++ +G C L ++ E G L L G+++++ ++L
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLH 117
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P- 692
+ G+ + VHRDL + N L+ KI DFGLS+ + ++ + P
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPE 751
+W APE I F+ + D++S GV MWE + +P++ + V+ + +G R+E P
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 236
Query: 752 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785
L L++DCW + ++RP + R+ C YSL
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 7e-69
Identities = 88/279 (31%), Positives = 137/279 (49%), Gaps = 15/279 (5%)
Query: 510 PMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQDLTAEN 568
+ + + W I L + ++G G FGEV+ +N T VA+K + +
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMS 226
Query: 569 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHL-SGQKKKLSW 627
+E F E +++ L+H ++ TK P + +ITE+M GSL L L S + K
Sbjct: 227 VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSL--LDFLKSDEGSKQPL 283
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
+ + I G+ I + +HRDL++AN LV+ KI DFGL+R+I D+
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 688 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 745
A P +W APE I FT K D++S G+++ E+ T P+ G+ V+ A+ G
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGY 402
Query: 746 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 780
R+ PE L ++ CW P+ERP+ E I S L D
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-68
Identities = 85/331 (25%), Positives = 137/331 (41%), Gaps = 24/331 (7%)
Query: 462 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYE 521
+ + S+P + S + + P +
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP--------STR 383
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNEI 576
++ I + +G +G G FG+V +GI+ VAIK + + E F E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEA 442
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
+ + HP+++ +G T+ P +I E LG L L +K L +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQ 499
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP-EWM 695
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S P +WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG-- 752
APE I FT D++ GV MWE+ +P++GV V+ + G RL +P
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCP 618
Query: 753 -PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
L L+ CWA +P RP E+ ++L
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-68
Identities = 79/281 (28%), Positives = 143/281 (50%), Gaps = 19/281 (6%)
Query: 506 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT 565
+ + W ++ EL + +G G FG+V G + G VA+K ++ D T
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-IKNDAT 229
Query: 566 AENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITEYMELGSLYHLIHL-SGQKK 623
A+ F E S++++LRH N++ LG + L ++TEYM GSL + +L S +
Sbjct: 230 AQ---AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL--VDYLRSRGRS 284
Query: 624 KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
L LK D+C + + VHRDL + N LV++ K+ DFGL++ + +
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342
Query: 684 RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVA 741
+ P +W APE +R + F+ K D++S G+++WE+ + R P+ + + VV V
Sbjct: 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV- 399
Query: 742 NEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+G +++ P+G + ++ +CW + RP+ ++ +L
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-68
Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 16/284 (5%)
Query: 507 LESPMFQNKP---LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-TDVAIKVFLEQ 562
L + +KP LA + W I L + ++G G FGEV+ G WNG T VAIK
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP- 301
Query: 563 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 622
+ E F E ++ +LRH ++ ++ P ++TEYM GSL +
Sbjct: 302 --GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLK-GETG 357
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
K L + + M I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 683 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 740
A P +W APE FT K D++S G+++ EL T P+ G++ V+ V
Sbjct: 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
Query: 741 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 780
G R+ P L L+ CW EP+ERP+ E + + L D
Sbjct: 478 -ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 5e-68
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 18/281 (6%)
Query: 518 LAYEEWNIDFSELTVGTRV-GIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDF 572
+ +E +D LT+ + G G FG V +G + VA+K+ + ++
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 573 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
E +++ +L +P ++ +G C ++ E ELG L + Q + + + ++
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 121
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT- 691
++ + G+ + VHRDL + N L+ KI DFGLS+ + +
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 692 -P-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLE 748
P +W APE I F+ K D++S GV+MWE + +P+ G+ V + +G R+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMG 240
Query: 749 IPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785
P G + L+ CW + + RP + RL + Y +
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 7e-68
Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMEDFC 573
I +L +G G F ++F+G+ T+V +KV E F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFF 60
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKM 633
S++S+L H +++L G C ++ E+++ GSL +L K ++ KL++
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL--DTYLKKNKNCINILWKLEV 118
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------VKICDFGLSRIITDS---- 681
+ + + + ++H ++ + N L+ + +K+ D G+S +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 682 -PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVY 738
+ W+ PE I N + D +S G +WE+C+ ++P + +R +
Sbjct: 179 ERIP---------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 739 AVANEGSRLEIPEG-PLGRLIADCWA-EPQERPSCEEILSRLLD 780
+ +L P+ L LI +C EP RPS I+ L
Sbjct: 230 FY-EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-67
Identities = 83/290 (28%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMED 571
+I ++ + +G G FG+VF VA+K + L A D
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--D 63
Query: 572 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHL 618
F E +L+ L+H +++ F G C L M+ EYM+ G L
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 619 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678
K +L + L + I G++ + VHRDL + NCLV + VKI DFG+SR +
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 679 TDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPER 735
+ R P WM PE I FT + D++S GVI+WE+ T +PW +
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 736 VVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
V+ + +G LE P + ++ CW EPQ+R + +EI L
Sbjct: 244 VIECI-TQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-67
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDF 572
+ + L ++G G FG V ++ VA+K L+ T E++ DF
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDF 58
Query: 573 CNEISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRK 630
EI IL L+H N++ + G C R + +I EY+ GSL +L K+++ +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL--RDYLQKHKERIDHIKL 116
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSS 688
L+ IC+G+ + + +HRDL + N LV VKI DFGL++++ +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 689 AGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----------------PWEGV 731
+P W APE + F+ D++S GV+++EL T +
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 732 LPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ ++ + RL P+G + ++ +CW +RPS ++ R+
Sbjct: 237 IVFHLIELL-KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 18/269 (6%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEI 576
+EL +G G FG V +G+W V IKV +E ++ + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
+ L H +++ LG C L ++T+Y+ LGSL L H+ + L + L
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQ 123
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EW 694
I +G+ + +VHR+L + N L+ V++ DFG++ ++ D S A TP +W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG- 752
MA E I +T + D++S GV +WEL T P+ G+ V + +G RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQIC 242
Query: 753 --PLGRLIADCWA-EPQERPSCEEILSRL 778
+ ++ CW + RP+ +E+ +
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEF 271
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 2e-66
Identities = 78/307 (25%), Positives = 135/307 (43%), Gaps = 39/307 (12%)
Query: 506 VLESPMFQNKPLLAY---EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAI 556
E+ FQ A+ + + L ++G G FG V ++ VA+
Sbjct: 16 TTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 557 KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYH 614
K L+ T E++ DF EI IL L+H N++ + G C R L +I EY+ GSL
Sbjct: 76 KK-LQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL-- 131
Query: 615 LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 674
+L K+++ + L+ IC+G+ + + +HRDL + N LV VKI DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 675 SRIITDSPM--RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR----- 726
++++ + +P W APE + F+ D++S GV+++EL T
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251
Query: 727 -----------PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSC 771
++ ++ + RL P+G + ++ +CW +RPS
Sbjct: 252 PAEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 772 EEILSRL 778
++ R+
Sbjct: 311 RDLALRV 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 86/292 (29%), Positives = 145/292 (49%), Gaps = 23/292 (7%)
Query: 511 MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQD 563
F + +EW + ++T+ +G G FG V+ G+ G T VAIK + +
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEA 66
Query: 564 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY-------HLI 616
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 67 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126
Query: 617 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676
+ S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 677 IITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLP 733
I ++ R P WM+PE +++ FT D++S GV++WE+ TL +P++G+
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
Query: 734 ERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
E+V+ V EG L+ P+ L L+ CW P+ RPS EI+S + +
Sbjct: 247 EQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-66
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 513 QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTA 566
+ KP + + + L +G G FG+V + G VA+K L+ +
Sbjct: 6 EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGG 64
Query: 567 ENMEDFCNEISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKK 624
++ D EI IL L H N++ + G CT+ + +I E++ GSL +L K K
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL--KEYLPKNKNK 122
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM- 683
++ +++LK IC+G+ + + VHRDL + N LV VKI DFGL++ I
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 684 -RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NR 726
+P W APE + F D++S GV + EL T
Sbjct: 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 727 PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ R+V + EG RL P + +L+ CW +P R S + ++
Sbjct: 243 THGQMTVTRLVNTL-KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-66
Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNE 575
I S + +G FG+V++G G VAIK L+ E+F +E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHE 62
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 622
+ +RL+HPNV+ LG TK LSMI Y G L K
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS- 681
L + ++ I G+ + +VH+DL + N LV VKI D GL R + +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 682 ----------PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEG 730
P+R WMAPE I F+ DI+S GV++WE+ + +P+ G
Sbjct: 183 YYKLLGNSLLPIR---------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 731 VLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+ VV + L P+ + L+ +CW P RP ++I SRL
Sbjct: 234 YSNQDVVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 85/333 (25%), Positives = 143/333 (42%), Gaps = 51/333 (15%)
Query: 484 GSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGE 543
G+ GSS + ++E+P + + +I ++ + +G G FG+
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGK 56
Query: 544 VFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596
VF + VA+K ++ + +DF E +L+ L+H +++ F G CT+
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114
Query: 597 PPRLSMITEYMELGSL------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
L M+ EYM G L L + L + + G++ +
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPE 693
+ VHRDL + NCLV + VKI DFG+SR I + P+R
Sbjct: 175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR--------- 225
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG 752
WM PE I FT + D++S GV++WE+ T +PW + + + +G LE P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-TQGRELERPRA 284
Query: 753 ---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
+ ++ CW EPQ+R S +++ +RL
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-66
Identities = 70/267 (26%), Positives = 128/267 (47%), Gaps = 18/267 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISI 578
+ +E +G G FG V++G+W VAIK L + + + ++ +E +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYV 70
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
++ + +P+V LG C + +IT+ M G L L ++ K + + L I
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIA 127
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII-TDSPMRDSSSAGTP-EWMA 696
+G+ + ++VHRDL + N LV VKI DFGL++++ + + P +WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG--- 752
E I + +T + D++S GV +WEL T ++P++G+ + + +G RL P
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTI 246
Query: 753 PLGRLIADCWA-EPQERPSCEEILSRL 778
+ ++ CW + RP E++
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEF 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 21/275 (7%)
Query: 521 EEWNI--DFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFC 573
++ I + +G G FG V+ G + AIK L + + +E F
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEAFL 70
Query: 574 NEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
E ++ L HPNV+ +G P ++ YM G L L + ++ + + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL--LQFIRSPQRNPTVKDLIS 128
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSA 689
+ RG+ + K VHRDL + NC++++ +TVK+ DFGL+R I D ++ A
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 690 GTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRL 747
P +W A E ++ FT K D++S GV++WEL T P+ + P + + + +G RL
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRL 247
Query: 748 EIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
PE L +++ CW A+P RP+ ++ +
Sbjct: 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-65
Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 21/281 (7%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMEDFCNE 575
E+ ID + L +G +G G FG V G VA+K + + +E+F +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 576 ISILSRLRHPNVILFLGACTK-----PPRLSMITEYMELGSLYHLI---HLSGQKKKLSW 627
+ + HPNVI LG C + P+ +I +M+ G L+ + L K +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDS 686
+ LK + DI G+ + +HRDL + NC++ TV + DFGLS+ I R
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 687 SSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEG 744
A P +W+A E + + +T K D+++ GV MWE+ T P+ GV + + G
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHG 265
Query: 745 SRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
RL+ PE L ++ CW +P +RP+ + +L
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-65
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 81
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 629
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 685
L + RDI G + +HRD+ + NCL+ KI DFG++R I S R
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 686 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 743
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 260
Query: 744 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-65
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 21/277 (7%)
Query: 519 AYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENMED 571
A + I S + +G G FG V+ G A+K L + +
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 72
Query: 572 FCNEISILSRLRHPNVILFLGACTKP-PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
F E I+ HPNV+ LG C + ++ YM+ G L + + + + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDL 130
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSS 687
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + + +
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 688 SAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGS 745
A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +G
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 249
Query: 746 RLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
RL PE PL ++ CW + + RPS E++SR+
Sbjct: 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 9e-65
Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 22/294 (7%)
Query: 506 VLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFL 560
+L+S ++ E+ I + T+G +G G FG V VA+K+
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 561 EQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRLSMITEYMELGSLYH 614
+ + ++E+F E + + HP+V +G + P +I +M+ G L+
Sbjct: 61 ADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA 120
Query: 615 LI---HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 671
+ + L + ++ + DI G+ + +HRDL + NC++ + TV + D
Sbjct: 121 FLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 672 FGLSRIITDSPM-RDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPW 728
FGLSR I R ++ P +W+A E + + +T D+++ GV MWE+ T P+
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 729 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
G+ + + G+RL+ P + L+ CW A+P++RPS + L
Sbjct: 241 AGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-64
Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 27/287 (9%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
E+W + L G +G G FG+V G VA+K+ L+ A+ E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALM 97
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-----------YHLIHLSGQ 621
+E+ I+S L +H N++ LGACT + +ITEY G L +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 622 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR-IITD 680
S R L + +G+ + +HRD+ + N L+ KI DFGL+R I+ D
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 681 SPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVY 738
S +A P +WMAPE I + +T + D++S G+++WE+ +L P+ G+L Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 739 AVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
+ +G ++ P + ++ CW EP RP+ ++I S L +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 31/290 (10%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
+W + L+ G +G G FG+V G VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL---------------YHLIH 617
+E+ +LS L H N++ LGACT +ITEY G L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 676
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 677 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 734
I DS +A P +WMAPE I N +T + D++S G+ +WEL +L P+ G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLD 780
Y + EG R+ PE + ++ CW A+P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 36/288 (12%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 574
+ L +G G FG+V ++ VA+K L+ D ++ +
Sbjct: 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQ 82
Query: 575 EISILSRLRHPNVILFLGACTKPPR--LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
EI IL L H ++I + G C L ++ EY+ LGSL + + + + L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLL 138
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 690
+ IC G+ +H +HRDL + N L++ VKI DFGL++ + + R
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 691 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL---------------NRPWEGVLPE 734
+P W APE ++ F D++S GV ++EL T +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
R+ + G RL P+ + L+ +CW E RP+ E ++ L
Sbjct: 259 RLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-64
Identities = 90/305 (29%), Positives = 146/305 (47%), Gaps = 32/305 (10%)
Query: 508 ESPMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKV 558
E P+ ++ L Y+ +W L +G +G G FG+V G VA+K+
Sbjct: 5 ELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 559 FLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR-LSMITEYMELGSL---- 612
L++ T +E+ IL + H NV+ LGACTKP L +I E+ + G+L
Sbjct: 65 -LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 613 ---------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK 663
Y + K L+ + + +G+ + K +HRDL + N L+++
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 664 HWTVKICDFGLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWEL 721
VKICDFGL+R I D A P +WMAPE I + +T + D++S GV++WE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 722 CTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILS 776
+L P+ GV + EG+R+ P+ + + + DCW EP +RP+ E++
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 777 RLLDC 781
L +
Sbjct: 304 HLGNL 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-64
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 23/282 (8%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
+ + +T+ +G G FGEV+ G +G VA+K L + + ++ DF
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFL 122
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLY----HLIHLSGQKKKLSWRR 629
E I+S+ H N++ +G + ++ E M G L Q L+
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSR-IITDSPMRD 685
L + RDI G + +HRD+ + NCL+ KI DFG++R I R
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 686 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 743
A P +WM PE FT K D +S GV++WE+ +L P+ + V+ V
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TS 301
Query: 744 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
G R++ P+ P+ R++ CW +P++RP+ IL R+ C
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-64
Identities = 88/339 (25%), Positives = 149/339 (43%), Gaps = 27/339 (7%)
Query: 462 RDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMA----NSEFVSTWNKVLESPMFQNKPL 517
R + + SP G E +S Y N F ++ + +
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 518 LAYEEWNIDFSE--LTVGTRVGIGFFGEVFRGIWNG-----TDVAIKVFLEQDLTAENME 570
A + I S + +G G FG V+ G A+K L + +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVS 135
Query: 571 DFCNEISILSRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 628
F E I+ HPNV+ LG C + L ++ YM+ G L + + + + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN--FIRNETHNPTVK 192
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRD 685
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D + +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 686 SSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANE 743
+ A P +WMA E ++ + FT K D++S GV++WEL T P+ V + + +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQ 311
Query: 744 GSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
G RL PE PL ++ CW + + RPS E++SR+
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-63
Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 37/293 (12%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
+W L +G +G G FG+V + T VA+K+ L+++ + + D
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLL 74
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL--------------------- 612
+E ++L ++ HP+VI GAC++ L +I EY + GSL
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672
++ L+ + I +G+ + MK+VHRDL + N LV + +KI DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 673 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 729
GLSR + + S P +WMA E + + +T + D++S GV++WE+ TL P+
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 730 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
G+ PER+ + G R+E P+ + RL+ CW EP +RP +I L
Sbjct: 255 GIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 91/325 (28%), Positives = 144/325 (44%), Gaps = 58/325 (17%)
Query: 504 NKVLESPMFQNKPLLA---YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TD 553
+++ +PM+Q PLL + + +G G FG VF+ G T
Sbjct: 20 DRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM 79
Query: 554 VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSL- 612
VA+K+ L+++ +A+ DF E ++++ +PN++ LG C + ++ EYM G L
Sbjct: 80 VAVKM-LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 613 --------------------YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652
S LS +L + R + G+ + K VHR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 653 DLKSANCLVNKHWTVKICDFGLSRIITDS-----------PMRDSSSAGTPEWMAPELIR 701
DL + NCLV ++ VKI DFGLSR I + P+R WM PE I
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR---------WMPPESIF 249
Query: 702 NEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
+T + D+++ GV++WE+ + +P+ G+ E V+Y V +G+ L PE L L
Sbjct: 250 YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNL 308
Query: 758 IADCW-AEPQERPSCEEILSRLLDC 781
+ CW P +RPS I L
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 7e-63
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 571
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 86
Query: 572 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 617
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 676
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 677 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 734
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 267 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 36/296 (12%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFC 573
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 96
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------------- 612
+E+ ++++L H N++ LGACT + +I EY G L
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 613 YHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672
+ L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 673 GLSR-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWE 729
GL+R I++DS +A P +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 730 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
G+ + Y + G +++ P + ++ CW + ++RPS + S L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-62
Identities = 90/391 (23%), Positives = 165/391 (42%), Gaps = 28/391 (7%)
Query: 418 RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSP 477
+ + + L + L I + A N S + A +LP+ P
Sbjct: 215 QDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHP 274
Query: 478 HE--YGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAY--------EEWNIDF 527
+ + S GY +++ +K PM + + ++ +
Sbjct: 275 STLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR 334
Query: 528 SELTVG-TRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
L + +G G FG V +G++ DVAIKV L+Q + E+ E I+ +L
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQL 393
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+P ++ +G C + ++ E G L L G+++++ ++L + G+
Sbjct: 394 DNPYIVRLIGVCQAEALM-LVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT--P-EWMAPEL 699
+ VHR+L + N L+ KI DFGLS+ + ++ + P +W APE
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
I F+ + D++S GV MWE + +P++ + V+ + +G R+E P L
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELY 569
Query: 756 RLIADCWA-EPQERPSCEEILSRLLDCEYSL 785
L++DCW + ++RP + R+ C YSL
Sbjct: 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-62
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG----TDVAIKVFLEQDLTAENMEDFCNEI 576
+D++++ +G G FG+V + D AIK +++ + ++ DF E+
Sbjct: 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGEL 76
Query: 577 SILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIHLSGQK 622
+L +L HPN+I LGAC L + EY G+L +
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
LS ++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV 194
Query: 683 MRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAV 740
+ P WMA E + +T D++S GV++WE+ +L P+ G+ + +
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 741 ANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+G RLE P + L+ CW +P ERPS +IL L
Sbjct: 255 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-62
Identities = 85/291 (29%), Positives = 145/291 (49%), Gaps = 32/291 (10%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 571
W + L +G +G G FG+V G T VA+K+ L+ D T +++ D
Sbjct: 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSD 120
Query: 572 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 617
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 678 I-TDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 734
I + +++ P +WMAPE + + +T + D++S GV++WE+ TL P+ GV E
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRLLDC 781
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 301 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-62
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 33/287 (11%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCN 574
+ + L +++G G FG V ++ VA+K L+ + DF
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ-LQHSGP-DQQRDFQR 73
Query: 575 EISILSRLRHPNVILFLGACTKPPRLS--MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
EI IL L ++ + G P R S ++ EY+ G L L + +L R L
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLL 131
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAG 690
IC+G+ + + VHRDL + N LV VKI DFGL++++
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 691 TP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERV------------ 736
+P W APE + + F+ + D++S GV+++EL T ++
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 737 -VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+ + EG RL P + L+ CWA PQ+RPS + +L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 83/288 (28%), Positives = 148/288 (51%), Gaps = 32/288 (11%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG---------TDVAIKVFLEQDLTAENMED 571
+W +LT+G +G G FG+V G VA+K+ L+ D T +++ D
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSD 132
Query: 572 FCNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSL-------------YHLIH 617
+E+ ++ + +H N+I LGACT+ L +I EY G+L Y
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR- 676
+++++++ + + RG+ + K +HRDL + N LV ++ +KI DFGL+R
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 677 IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPE 734
I + +++ P +WMAPE + + +T + D++S GV+MWE+ TL P+ G+ E
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCW-AEPQERPSCEEILSRL 778
+ + EG R++ P L ++ DCW A P +RP+ ++++ L
Sbjct: 313 ELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-59
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 14/280 (5%)
Query: 509 SPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLT 565
P FQ + L + + + ++G G F EV+R + +G VA+K V + +
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 566 AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK- 624
A+ D EI +L +L HPNVI + + + L+++ E + G L +I ++K+
Sbjct: 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL 132
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
+ R K +C L +H +++HRD+K AN + VK+ D GL R +
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744
S GTP +M+PE I + K DI+SLG +++E+ L P+ G +Y++ +
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI 250
Query: 745 SRLEIPEGPLGR-------LIADCWA-EPQERPSCEEILS 776
+ + P P L+ C +P++RP +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-59
Identities = 66/257 (25%), Positives = 114/257 (44%), Gaps = 20/257 (7%)
Query: 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G F V++G+ +VA ++ LT + F E +L L+HPN++ F
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 591 LGA----CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
+ + ++TE M G+L + + K + + R I +GL +H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 647 MK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
I+HRDLK N + +VKI D GL+ + S + + GTPE+MAPE+ +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEMYEEK 205
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR-LIA 759
+ E D+++ G+ M E+ T P+ +Y G + + P + +I
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 760 DCWA-EPQERPSCEEIL 775
C ER S +++L
Sbjct: 265 GCIRQNKDERYSIKDLL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-59
Identities = 70/263 (26%), Positives = 133/263 (50%), Gaps = 11/263 (4%)
Query: 524 NIDFSEL---TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
N+ F + ++G G FG+ +G IK ++++ E+ E+++
Sbjct: 17 NLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV 76
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L+ ++HPN++ + + + L ++ +Y E G L+ I+ + + L IC
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQIC 135
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
L +H KI+HRD+KS N + K TV++ DFG++R++ + + GTP +++PE
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
+ N+P+ K DI++LG +++ELCTL +E + +V + GS + L
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-ISGSFPPVSLHYSYDLR 254
Query: 756 RLIADCWA-EPQERPSCEEILSR 777
L++ + P++RPS IL +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEK 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-56
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
V +G G +G R +G + K +T + +E+++L L+HPN++
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 589 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIH 645
+ L ++ EY E G L +I ++++ L L+++ + L H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 646 RMK-----IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
R ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
+ EK DI+SLG +++ELC L P+ + + + EG IP L +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEI 247
Query: 758 IADCWA-EPQERPSCEEILSR 777
I + RPS EEIL
Sbjct: 248 ITRMLNLKDYHRPSVEEILEN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-53
Identities = 65/268 (24%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG+VF+ +G IK E E E+ L++L H N++
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAE---REVKALAKLDHVNIV 67
Query: 589 LFLGA----------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
+ G +K L + E+ + G+L I + +KL L+
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALE 126
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTP 692
+ I +G+ IH K+++RDLK +N + VKI DFGL + + R + S GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTL 185
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG 752
+M+PE I ++ + ++ D+++LG+I+ EL + + I +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGIISDI 239
Query: 753 ---PLGRLIADCWA-EPQERPSCEEILS 776
L+ + +P++RP+ EIL
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILR 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 66/329 (20%), Positives = 118/329 (35%), Gaps = 46/329 (13%)
Query: 466 NSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQ-NKPLLAYEEWN 524
+ + + + F ++ L+SP + ++P +++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRR----VSFRGEASETLQSPGYDPSRPESFFQQ-- 57
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
F L+ +G G +GEVF+ +G A+K + ++ E+ ++
Sbjct: 58 -SFQRLSR---LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 583 -RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+HP + A + L + TE SL H L + LRD L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQ--HCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+H +VH D+K AN + K+ DFGL + + G P +MAPEL+
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELL- 228
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPW----------EGVLPERVVYAVANEGSRLEIPE 751
+ D+FSLG+ + E+ +G LP E
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-------------EFTA 275
Query: 752 G---PLGRLIADCWA-EPQERPSCEEILS 776
G L ++ +P+ R + E +L+
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 28/273 (10%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++G G F V G+ +G A+K L + ++ E+ E + HPN++
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNIL 89
Query: 589 LFLGACTKPP----RLSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 643
+ C + ++ + + G+L++ I L + L+ + L +L ICRGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---------GTPEW 694
IH HRDLK N L+ + D G + T +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 695 MAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE 751
APEL + E+ D++SLG +++ + P++ V + A+A + +L IP+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQ 268
Query: 752 GP-----LGRLIADCWAE-PQERPSCEEILSRL 778
P L +L+ P +RP +LS+L
Sbjct: 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 89/271 (32%), Positives = 145/271 (53%), Gaps = 17/271 (6%)
Query: 514 NKPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENME 570
L + D EL T ++G G FGEVF+GI N T VAIK+ ++ + + +E
Sbjct: 7 QSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIE 65
Query: 571 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
D EI++LS+ P V + G+ K +L +I EY+ GS L+ + L +
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQI 121
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690
+LR+I +GL +H K +HRD+K+AN L+++H VK+ DFG++ +TD+ ++ ++ G
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 691 TPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEI 749
TP WMAPE+I+ + K DI+SLG+ EL P + P +V++ + L
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL-- 239
Query: 750 PEGPLGRLIADCWA-----EPQERPSCEEIL 775
EG + + + EP RP+ +E+L
Sbjct: 240 -EGNYSKPLKEFVEACLNKEPSFRPTAKELL 269
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 531 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 587
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I + M+ E L + +KK + + +++ + IH+
Sbjct: 91 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 704
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 204
Query: 705 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 752
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 753 P---LGRLIADCWA-EPQERPSCEEILS 776
P L ++ C +P++R S E+L+
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 61/268 (22%), Positives = 125/268 (46%), Gaps = 28/268 (10%)
Query: 531 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 587
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I + M+ E L + +KK + + +++ + IH+
Sbjct: 72 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 704
IVH DLK AN L+ +K+ DFG++ + T S ++D S GT +M PE I++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMS 185
Query: 705 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 752
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 753 P---LGRLIADCWA-EPQERPSCEEILS 776
P L ++ C +P++R S E+L+
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 82/317 (25%), Positives = 125/317 (39%), Gaps = 25/317 (7%)
Query: 472 SLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELT 531
S+ S + S S A + + + E + K E+ + +T
Sbjct: 4 SVSSGQAHSLA--SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 532 VGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
RVG G FGEV R G A+K + L +E E+ + L P ++
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE----ELVACAGLSSPRIVP 114
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
GA + P +++ E +E GSL LI G L R L L GL +H +I
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 650 VHRDLKSANCLVNKH-WTVKICDFGLSRIITD-----SPMRDSSSAGTPEWMAPELIRNE 703
+H D+K+ N L++ +CDFG + + S + GT MAPE++ +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRLEIPEG--PLGR-LIA 759
P K DI+S +M + PW + +A+E EIP PL I
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 760 DCWA-EPQERPSCEEIL 775
+ EP R S E+
Sbjct: 292 EGLRKEPVHRASAMELR 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-49
Identities = 60/268 (22%), Positives = 124/268 (46%), Gaps = 28/268 (10%)
Query: 531 TVGTRVGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--V 587
++ ++G G +VF+ + AIK ++ + ++ + NEI+ L++L+ + +
Sbjct: 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I + M+ E L + +KK + + +++ + IH+
Sbjct: 119 IRLYDYEITDQYIYMVMECGN-IDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRII---TDSPMRDSSSAGTPEWMAPELIRNEP 704
IVH DLK AN L+ +K+ DFG++ + T S ++D S G +M PE I++
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPPEAIKDMS 232
Query: 705 -----------FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG 752
+ K D++SLG I++ + P++ ++ ++A+ + +E P+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 753 P---LGRLIADCWA-EPQERPSCEEILS 776
P L ++ C +P++R S E+L+
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISIL 579
W+I+ + + +G G V VAIK LE+ +M++ EI +
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAM 67
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------M 633
S+ HPN++ + + L ++ + + GS+ +I K L +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATI 126
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS----- 688
LR++ GL +H+ +HRD+K+ N L+ + +V+I DFG+S + +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 689 AGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-R 746
GTP WMAPE++ + + K DI+S G+ EL T P+ P +V+
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 747 LEIPEGPLGR----------LIADCWA-EPQERPSCEEIL 775
LE +I+ C +P++RP+ E+L
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 71/251 (28%), Positives = 124/251 (49%), Gaps = 15/251 (5%)
Query: 534 TRVGIGFFGEVFRG--IWNGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILF 590
++G G +G V++ G VAIK +E DL ++ EISI+ + P+V+ +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKY 89
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
G+ K L ++ EY GS+ +I L K L+ +L+ +GL +H M+ +
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
HRD+K+ N L+N K+ DFG++ +TD+ + ++ GTP WMAPE+I+ + D
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 711 IFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EP 765
I+SLG+ E+ P+ + P R ++ + PE + C P
Sbjct: 208 IWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267
Query: 766 QERPSCEEILS 776
++R + ++L
Sbjct: 268 EQRATATQLLQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 34/277 (12%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG VF + + + AIK + E E+ L++L HP ++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 589 LFLGAC------------TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
+ A + L + + +L ++ ++ L +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS------------PMR 684
I + +H ++HRDLK +N VK+ DFGL + R
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744
+ GT +M+PE I ++ K DIFSLG+I++EL P+ +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL 243
Query: 745 SRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSR 777
+ ++ D + P ERP I+
Sbjct: 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 55/273 (20%), Positives = 101/273 (36%), Gaps = 36/273 (13%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 587
++G G FG VF+ + +G AIK + + + ++ E+ + L +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMCIHR 646
+ + A + + + EY GSL I + + +L + RGL IH
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 647 MKIVHRDLKSANCLVNKH-------------------WTVKICDFGLSRIITDSPMRDSS 687
M +VH D+K +N +++ KI D G I+
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QV 189
Query: 688 SAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
G ++A E+++ N K DIF+L + + + +G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRL 245
Query: 747 LEIPEG---PLGRLIADCWA-EPQERPSCEEIL 775
IP+ L+ +P+ RPS ++
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 72/264 (27%), Positives = 127/264 (48%), Gaps = 12/264 (4%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISIL 579
E++ ++ E +G G +G V+ G N +AIK E+D + + EI++
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALH 73
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
L+H N++ +LG+ ++ + + E + GSL L+ K + + + I
Sbjct: 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
GL +H +IVHRD+K N L+N + +KI DFG S+ + + GT ++MAPE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
Query: 699 LIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEG--P 753
+I P + + DI+SLG + E+ T P+ + P+ ++ V EIPE
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 754 LGR-LIADCWA-EPQERPSCEEIL 775
+ I C+ +P +R ++L
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLL 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 19/276 (6%)
Query: 515 KPLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENME 570
+ ++D +E+ + +G G FG+V++ T A KV + + E +E
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELE 61
Query: 571 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
D+ EI IL+ HP ++ LGA +L ++ E+ G++ ++ + L+ +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQI 119
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAG 690
+ R + L +H +I+HRDLK+ N L+ +++ DFG+S + + S G
Sbjct: 120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 691 TPEWMAPELIRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745
TP WMAPE++ E + K DI+SLG+ + E+ + P + P RV+ +A
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239
Query: 746 -RLEIPEG---PLGRLIADCWA-EPQERPSCEEILS 776
L P + P+ RPS ++L
Sbjct: 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 15/249 (6%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
++G G G V+ + T VAI+ L+Q E NEI ++ ++PN++ +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYL 83
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
+ L ++ EY+ GSL ++ + + + + R+ + L +H +++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K DI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 766
+SLG++ E+ P+ P R +Y +A G+ L+ PE + C + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259
Query: 767 ERPSCEEIL 775
+R S +E+L
Sbjct: 260 KRGSAKELL 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 34/266 (12%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591
VG G +G+V++G G AIKV D+T + E+ EI++L + H N+ +
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKV---MDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 592 GA------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK------MLRDICR 639
GA +L ++ E+ GS+ LI K + LK + R+I R
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------KNTKGNTLKEEWIAYICREILR 140
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
GL +H+ K++HRD+K N L+ ++ VK+ DFG+S + + R ++ GTP WMAPE+
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 700 IRNEPFTE-----KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE-- 751
I + + K D++SLG+ E+ P + P R ++ + + RL+ +
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 260
Query: 752 GPLGRLIADCWA-EPQERPSCEEILS 776
I C +RP+ E+++
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 60/249 (24%), Positives = 116/249 (46%), Gaps = 15/249 (6%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
++G G G V + VA+K+ L + + E NE+ I+ +H NV+
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
+ L ++ E+++ G+L ++ + +L+ + + + + L +H ++H
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDI 711
RD+KS + L+ VK+ DFG I+ + S GTP WMAPE+I + + DI
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA-EPQ 766
+SLG+++ E+ P+ P + + + + +L+ L + +PQ
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
Query: 767 ERPSCEEIL 775
ER + +E+L
Sbjct: 285 ERATAQELL 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-46
Identities = 72/252 (28%), Positives = 111/252 (44%), Gaps = 17/252 (6%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPNVILFL 591
+G G FG V+ VAIK + E +D E+ L +LRHPN I +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVH 651
G + ++ EY GS L+ + KK L + +GL +H ++H
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 652 RDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE---PFTEK 708
RD+K+ N L+++ VK+ DFG + I+ +S GTP WMAPE+I + K
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPE--GPLGRLIADCWA-E 764
D++SLG+ EL P + +Y +A S L+ + C
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI 293
Query: 765 PQERPSCEEILS 776
PQ+RP+ E +L
Sbjct: 294 PQDRPTSEVLLK 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-46
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 528 SELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP 585
S+ +G G FG+V R + AIK T E + +E+ +L+ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 586 NVILFLGA-------------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
V+ + A K L + EY E G+LY LIH + +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWR 120
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD------- 685
+ R I L IH I+HRDLK N +++ VKI DFGL++ + S
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 686 -------SSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV 737
+S+ GT ++A E++ EK D++SLG+I +E+ G+ ++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNIL 238
Query: 738 YAVANEGSRLEIPEG-------PLGRLIADC-WAEPQERPSCEEILS 776
+ + +E P ++I +P +RP +L+
Sbjct: 239 KKLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 41/282 (14%)
Query: 530 LTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN 586
L V + G F V+ + + +G + A+K L + E+ + +L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPN 87
Query: 587 VILFLGACTKPPRLSMITEY-----MEL--GSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
++ F A + S + EL G L + + LS LK+ CR
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 640 GLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-------- 689
+ +HR K I+HRDLK N L++ T+K+CDFG + I+ P S+
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 690 ----GTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN 742
TP + PE+I N P EK DI++LG I++ LC P+E R+V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--- 264
Query: 743 EGSRLEIPEGP-----LGRLIADCWAE-PQERPSCEEILSRL 778
+ IP LI P+ER S E++ +L
Sbjct: 265 ---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 589 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 647 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 701
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 702 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-44
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 13/231 (5%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ R+G G FG V R I G VAIK Q+L+ +N E +C EI I+ +L HPNV+
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 589 -LF-----LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
L + EY E G L ++ L +L DI L
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H +I+HRDLK N ++ + KI D G ++ + + GT +++APEL
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-VGTLQYLAPEL 194
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750
+ + +T D +S G + +E T RP+ + E S I
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G VFRG G AIKVF ++ E +L +L H N++
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 589 LFLGA--CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
T +I E+ GSLY ++ L L +LRD+ G+ +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 647 MKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR- 701
IVHR++K N + + K+ DFG +R + D S GT E++ P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-VSLYGTEEYLHPDMYER 189
Query: 702 -------NEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ + D++S+GV + T + P+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 15/281 (5%)
Query: 508 ESPMFQNKPLLAYEEWNIDFS--ELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQD 563
E + + L ++ + + + +G G G VF+ +G +A K+ + +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLE 69
Query: 564 LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-- 621
+ E+ +L P ++ F GA +S+ E+M+ GSL ++ +G+
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 622 KKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680
++ L K+ + +GL + + KI+HRD+K +N LVN +K+CDFG+S + D
Sbjct: 130 EQILG-----KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
Query: 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740
S M + S GT +M+PE ++ ++ + DI+S+G+ + E+ P + +
Sbjct: 185 S-MAN-SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 741 ANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLDC 781
+ P R + + LLD
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 48/277 (17%), Positives = 101/277 (36%), Gaps = 35/277 (12%)
Query: 513 QNKPLLAYEEWNIDFSELTVGTRVGIGF--FGEVFRGI--WNGTDVAIKVFLEQDLTAEN 568
+N + + + T +G GF V G V ++ + + E
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 569 MEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWR 628
+ E+ + HPN++ + L ++T +M GS LI +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFM 122
Query: 629 RKLK------MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682
+ +L+ + + L IH M VHR +K+++ L++ V + + +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182
Query: 683 MR-------DSSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733
R S W++PE+++ + + K DI+S+G+ EL + P++ +
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 734 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPS 770
+++ E G + L+ +E
Sbjct: 243 TQMLL---------EKLNGTVPCLLDTSTIPAEELTM 270
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 17/227 (7%)
Query: 527 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
+L T +G G FG+V++G + +G VA+K + E+F EI
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETEIET 88
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG---QKKKLSWRRKLKMLR 635
LS RHP+++ +G C + + +I +YME G+L HL G +SW ++L++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR--HLYGSDLPTMSMSWEQRLEICI 146
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPE 693
RGL +H I+HRD+KS N L+++++ KI DFG+S+ T+ S+ GT
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV 740
++ PE TEK D++S GV+++E+ LP +V
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-41
Identities = 68/261 (26%), Positives = 106/261 (40%), Gaps = 31/261 (11%)
Query: 537 GIGFFGE-VFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGAC 594
G G G V+RG+++ DVA+K L + + + E+ +L HPNVI +
Sbjct: 33 GHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTE 87
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
+ E +L + + +L+ GL +H + IVHRDL
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 655 KSANCLV-----NKHWTVKICDFGLSRIITD---SPMRDSSSAGTPEWMAPELIR---NE 703
K N L+ + I DFGL + + S R S GT W+APE++ E
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 704 PFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------ 756
T DIFS G + + + + P+ L +R + S L+
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQANILLGACS-LDCLHPEKHEDVIARE 262
Query: 757 LIADCWA-EPQERPSCEEILS 776
LI A +PQ+RPS + +L
Sbjct: 263 LIEKMIAMDPQKRPSAKHVLK 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 582
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 119
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 698
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 177
Query: 699 LIRNEPFTEKCDIFSLGVIM 718
+++ +P+++ DI++ GVI+
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 21/273 (7%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
+ W+ +L +G G +G V + + +G +A+K + + + + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDV 73
Query: 579 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL--KMLR 635
+ R P ++ F GA + + E M S ++ K+
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 636 DICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 694
+ L + +KI+HRD+K +N L+++ +K+CDFG+S + DS + + AG +
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPY 191
Query: 695 MAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLE 748
MAPE I + + + D++SLG+ ++EL T P+ + V +L
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 749 IPEG-----PLGRLIADC-WAEPQERPSCEEIL 775
E + C + +RP +E+L
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 25/250 (10%)
Query: 545 FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604
++ + + + + M+ +I + N + L + L +
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH 664
+ +L ++ + L + I + +H ++HRDLK +N
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 665 WTVKICDFGLSRIITDSPMRDSSSA------------GTPEWMAPELIRNEPFTEKCDIF 712
VK+ DFGL + + GT +M+PE I ++ K DIF
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 713 SLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------LGRLIADCWA-EP 765
SLG+I++EL ERV + + L+ P ++ D + P
Sbjct: 261 SLGLILFELLYSFSTQM----ERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314
Query: 766 QERPSCEEIL 775
ERP +I+
Sbjct: 315 TERPEATDII 324
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 14/210 (6%)
Query: 527 FSELTVGTR-------VGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
EL V + +G G FG+V++G + +GT VA+K E+ ++ F E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTEVEM 80
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDI 637
+S H N++ G C P ++ YM GS+ L + L W ++ ++
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 638 CRGLMCIH---RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPE 693
RGL +H KI+HRD+K+AN L+++ + + DFGL++++ +++ GT
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
+APE + +EK D+F GV++ EL T
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 76/353 (21%), Positives = 134/353 (37%), Gaps = 82/353 (23%)
Query: 510 PMFQNKPLLAYE--EWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFL 560
P+ ++ L Y+ +W L +G +G G FG+V G VA+K+ L
Sbjct: 2 PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-L 60
Query: 561 EQDLTAENMEDFCNEIS---------------------------ILSRLRHPNVILFLGA 593
++ T +E+ I+ + N+ +L +
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 594 CTK--PPRLSMITEYMELGSLYHLIHLS-------------------------------- 619
P + + + I +
Sbjct: 121 KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180
Query: 620 ----GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 676 R-IITDSPMRDSSSAGTP-EWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVL 732
R I D A P +WMAPE I + +T + D++S GV++WE+ +L P+ GV
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 733 PERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
+ EG+R+ P+ + + + DCW EP +RP+ E++ L +
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 522 EWNI-DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEIS 577
+W + DF +G +G G FG V+ R + +A+KV + L +E E+
Sbjct: 5 QWALEDF---EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
I S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITEL 118
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAP 697
L H +++HRD+K N L+ +KI DFG S S R + GT +++ P
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTDLCGTLDYLPP 176
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733
E+I EK D++SLGV+ +E G P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLV------GKPP 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 527 FSELTVGTR-------------VGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENM---E 570
F EL T +G G FG V++G N T VA+K L + +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK-LAAMVDITTEELKQ 75
Query: 571 DFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
F EI ++++ +H N++ LG + L ++ YM GSL + LSW +
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-- 688
K+ + G+ +H +HRD+KSAN L+++ +T KI DFGL+R S +
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMT 192
Query: 689 ---AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
GT +MAPE +R E T K DI+S GV++ E+ T
Sbjct: 193 SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 582
FS+ V +G G F V R + T + A K+ + L+A + + E I +L
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+HPN++ + + ++ + + G L+ I ++ S ++ I +
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIA 142
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 698
H IVHR+LK N L+ K VK+ DFGL+ + D AGTP +++PE
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPE 200
Query: 699 LIRNEPFTEKCDIFSLGVIM 718
+++ +P+++ DI++ GVI+
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISI 578
++ ID ++ G +G G FG V+ R N +A+KV + L E +E EI I
Sbjct: 10 KFTIDDFDI--GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
S LRHPN++ R+ ++ E+ G LY + + + +R + ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDEQRSATFMEELA 124
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
L H K++HRD+K N L+ +KI DFG S + S R + GT +++ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRR-TMCGTLDYLPPE 182
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733
+I + EK D++ GV+ +E G+ P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLV------GMPP 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 578
+ +G +G G F V + G + A K L + E+ E++I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L +RHPN+I + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQIL 118
Query: 639 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRII-TDSPMRDSSSAGTPE 693
G+ +H +I H DLK N + ++K+ +K+ DFG++ I + ++ GTPE
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPE 176
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIM 718
++APE++ EP + D++S+GVI
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-38
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 521 EEWNIDFSELTVGTRV-GIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
+ L V ++ G G G V F+G + G VA+K L + + EI +
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEIKL 61
Query: 579 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLI----HLSGQKKKLSWRRKLKM 633
L+ HPNVI + + T L + E +L L+ K + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 634 LRDICRGLMCIHRMKIVHRDLKSANCLV-------------NKHWTVKICDFGLSRIITD 680
LR I G+ +H +KI+HRDLK N LV ++ + I DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 681 SPMRDSSS----AGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRP-- 727
++ +GT W APEL+ T DIFS+G + + + + +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 728 WEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSCEEILS 776
+ E + ++ + ++I +P +RP+ ++L
Sbjct: 241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID---HDPLKRPTAMKVLR 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 63/270 (23%), Positives = 119/270 (44%), Gaps = 23/270 (8%)
Query: 524 NIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI-LS 580
+ +L +G G +G V + +G +A+K + + ++ + ++ I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+ P + F GA + + + E M+ + + + + K+ I +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 641 LMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
L +H ++ ++HRD+K +N L+N VK+CDFG+S + D + AG +MAPE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPER 180
Query: 700 IRNE----PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERVVYAVANEGSRLEIPEGPL 754
I E ++ K DI+SLG+ M EL L P++ P + + V E P+ P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE----PSPQLPA 236
Query: 755 GR-------LIADC-WAEPQERPSCEEILS 776
+ + C +ERP+ E++
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 582
F+E + +G G FGEV + T + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPE 698
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 699 LIRNEPFTEKCDIFSLGVIM 718
++R + EKCD++S GVI+
Sbjct: 194 VLR-GTYDEKCDVWSAGVIL 212
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G F EVF T A+K + + NEI++L +++H N++
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIV 69
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
++ + + G L+ I ++ + + +++ + + +H
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 649 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 705
IVHRDLK N L ++ + I DFGLS++ + M + GTP ++APE++ +P+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA--CGTPGYVAPEVLAQKPY 184
Query: 706 TEKCDIFSLGVIM 718
++ D +S+GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 578
+ +G +G G F V + G + A K + E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L ++ H NVI + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 639 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 693
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIM 718
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-38
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 582
F+E + +G G F V R + + A + + L+A + + E I L
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+HPN++ + ++ +I + + G L+ I ++ S ++ I ++
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVL 124
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
H+M +VHR+LK N L+ K VK+ DFGL+ + AGTP +++PE+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 700 IRNEPFTEKCDIFSLGVIM 718
+R +P+ + D+++ GVI+
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 578
+ + G +G G F V + G A K + + ED E+SI
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L ++HPNVI + +I E + G L+ + +K+ L+ + L+ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 124
Query: 639 RGLMCIHRMKIVHRDLKSANCL-VNKHW---TVKICDFGLSRIIT-DSPMRDSSSAGTPE 693
G+ +H ++I H DLK N + ++++ +KI DFGL+ I + ++ GTPE
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPE 182
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIM 718
++APE++ EP + D++S+GVI
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 20/270 (7%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISI 578
+ + + ++L +G G G+V++ G +A+K + + E + ++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRILMDLDV 76
Query: 579 LSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
+ + P ++ G + + E M + + G + R KM I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133
Query: 638 CRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 696
+ L + + ++HRD+K +N L+++ +K+CDFG+S + D SAG +MA
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMA 192
Query: 697 PELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS-RLEI 749
PE I + + D++SLG+ + EL T P++ + V+ V E L
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 750 PEG---PLGRLIADC-WAEPQERPSCEEIL 775
G + DC + ++RP ++L
Sbjct: 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 68/262 (25%), Positives = 107/262 (40%), Gaps = 32/262 (12%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 588
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLP----------ERVVYAVANEGSRLEIPE---GPLG 755
D++S+G IM+ L G P R+ IP+
Sbjct: 196 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN------EYSIPKHINPVAA 243
Query: 756 RLIADC-WAEPQERPSCEEILS 776
LI +P RP+ E+L+
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 31/272 (11%)
Query: 537 GIGFFGEVFRGIWNGTDVAIKVF---------------LEQDLTAENMEDFCNEISILSR 581
G F ++ + A+K + ++ +DF NE+ I++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSG-----QKKKLSWRRKLKMLRD 636
+++ + G T + +I EYME S+ + + +++
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159
Query: 637 ICRGLMCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 695
+ IH K I HRD+K +N L++K+ VK+ DFG S + D ++ S GT E+M
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GSRGTYEFM 217
Query: 696 APELIRNEPFT--EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 753
PE NE K DI+SLG+ ++ + P+ + ++ +E P
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYPLDR 276
Query: 754 LGRLIADCWAEPQER-----PSCEEILSRLLD 780
L + + L L
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 10/189 (5%)
Query: 537 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGA 593
G G F V + I G + A K ++ + + +EI++L + P VI
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
+ +I EY G ++ L L + +S +++++ I G+ +H+ IVH D
Sbjct: 98 YENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLD 156
Query: 654 LKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEPFTEKC 709
LK N L+ +KI DFG+SR I +R+ GTPE++APE++ +P T
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI--MGTPEYLAPEILNYDPITTAT 214
Query: 710 DIFSLGVIM 718
D++++G+I
Sbjct: 215 DMWNIGIIA 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 65/266 (24%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 582
SE+ ++G G +GEV T AIK+ + ++ + E+++L L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HPN++ ++ E + G L+ I + K + +++ + G+
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVT 150
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
+H+ IVHRDLK N L+ K +KI DFGLS + + + GT ++APE+
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEV 209
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP------ 753
+R + + EKCD++S+GVI++ L P+ G + ++ V + PE
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 754 ---LGRLIADCWAEPQERPSCEEILS 776
+ +++ + Q R S ++ L
Sbjct: 269 KDLIKQMLQ---FDSQRRISAQQALE 291
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF----LEQDLTAENMEDFCNEISI 578
+ +G +G G F V + G + A K E+ E+SI
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
L ++ HPN+I + +I E + G L+ + QK+ LS ++ I
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQIL 125
Query: 639 RGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 693
G+ +H KI H DLK N ++ +K+ DFGL+ I D ++ GTPE
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPE 183
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIM 718
++APE++ EP + D++S+GVI
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
F+E + +G G FGEV + + A+KV + ++ E+ +L +L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HPN++ ++ E G L+ I ++K+ S ++++ + G+
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGIT 135
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPEWMAPE 698
+H+ IVHRDLK N L+ K +KI DFGLS ++ M+D GT ++APE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 699 LIRNEPFTEKCDIFSLGVIMWE-LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 757
++R + EKCD++S GVI++ L G P Y + G
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLS-------GTPP---FYGKNEYDILKRVETGKY-AF 241
Query: 758 IADCWAE----------------PQERPSCEEILS 776
W P R + + L
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
T+ +G G +GEV + A K + + E+++ F EI I+ L HPN+I
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNII 69
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ ++ E G L+ + K+ ++++D+ + H++
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 649 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 704
+ HRDLK N L + +K+ DFGL+ MR GTP +++P+++
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEG-L 183
Query: 705 FTEKCDIFSLGVIM 718
+ +CD +S GV+M
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 22/257 (8%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 588
G +G G F + F A K+ + L + + EISI L H +V+
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
F G + ++ E SL L ++K L+ LR I G +HR +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
++HRDLK N +N+ VKI DFGL+ + R GTP ++APE++ + + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLP-----ERVVYAVANEGSRLEIPE---GPLGRLIAD 760
D++S+G IM+ L G P + Y + IP+ LI
Sbjct: 222 VDVWSIGCIMYTLLV------GKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQK 274
Query: 761 C-WAEPQERPSCEEILS 776
+P RP+ E+L+
Sbjct: 275 MLQTDPTARPTINELLN 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 59/269 (21%), Positives = 113/269 (42%), Gaps = 29/269 (10%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 587
+ ++G G V+ VAIK + + ++ F E+ S+L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKA-IFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 588 --ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
++ + L M EY+E +L I LS + I G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVM--EYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH 128
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPELIRNEP 704
M+IVHRD+K N L++ + T+KI DFG+++ ++++ + ++ GT ++ +PE + E
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP----------L 754
E DI+S+G++++E+ P+ G + + +P L
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD----SVPNVTTDVRKDIPQSL 244
Query: 755 GRLIADCWA-EPQERP-SCEEILSRLLDC 781
+I + R + +E+ L
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKDDLSSV 273
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 59/194 (30%), Positives = 90/194 (46%), Gaps = 15/194 (7%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
V + +G G V+R GT A+KV + + EI +L RL HPN+I
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
P +S++ E + G L+ I +K S R ++ I + +H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 649 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPELIRNEP 704
IVHRDLK N L +KI DFGLS+I+ M+ GTP + APE++R
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILRGCA 226
Query: 705 FTEKCDIFSLGVIM 718
+ + D++S+G+I
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++G G FG+V +G + IK + +D + ME EI +L L HPN+I
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 589 LFLGACTKPPRLSMITEYMELGSLYH-LIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ ++ E E G L ++ + K LS ++++ + L H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 648 KIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNE 703
+VH+DLK N L + H +KI DFGL+ + D + +AGT +MAPE+ +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-R 200
Query: 704 PFTEKCDIFSLGVIM 718
T KCDI+S GV+M
Sbjct: 201 DVTFKCDIWSAGVVM 215
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 5/193 (2%)
Query: 532 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMED-FCNEISILSRLRHPNVI 588
VG +G G F V+ I G +VAIK+ ++ + M NE+ I +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ ++ E G + + + K S + I G++ +H
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
I+HRDL +N L+ ++ +KI DFGL+ + + + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 709 CDIFSLGVIMWEL 721
D++SLG + + L
Sbjct: 193 SDVWSLGCMFYTL 205
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 64/305 (20%), Positives = 108/305 (35%), Gaps = 62/305 (20%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHP 585
+ +G G +G V I AIK+ + + +++E E+ ++ +L HP
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL-------------- 631
N+ + ++ E G L +++ +
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 632 -----------------------KMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWT 666
++R I L +H I HRD+K N L NK +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE 208
Query: 667 VKICDFGLSRIITDSPMRD----SSSAGTPEWMAPELIR--NEPFTEKCDIFSLGVIMWE 720
+K+ DFGLS+ + ++ AGTP ++APE++ NE + KCD +S GV++
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 721 LCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---------LGRLIADCWAEPQERPSC 771
L P+ GV + V N+ E P L L+ ER
Sbjct: 269 LLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN---RNVDERFDA 325
Query: 772 EEILS 776
L
Sbjct: 326 MRALQ 330
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 13/279 (4%)
Query: 447 HDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKV 506
H SG NL M + S +E S + S+ S
Sbjct: 6 HHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD 65
Query: 507 LESP--MFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQ 562
+ +P F ++ + A + F ++ +G G FG+V + T +A K+ +
Sbjct: 66 IPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 563 DLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK 622
+ ++ E+ NEIS++++L H N+I A + ++ EY++ G L+ I +
Sbjct: 126 GM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDES 181
Query: 623 KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIIT- 679
L+ + ++ IC G+ +H+M I+H DLK N L +KI DFGL+R
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 718
++ + GTPE++APE++ + + D++S+GVI
Sbjct: 242 REKLKVN--FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL 582
+ E + +G G FG V R + + K + + EISIL+
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIA 58
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
RH N++ + L MI E++ ++ I+ S + L+ R + + +C L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQ 116
Query: 643 CIHRMKIVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPEL 699
+H I H D++ N + T+KI +FG +R + R PE+ APE+
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV 174
Query: 700 IRNEPFTEKCDIFSLGVIM 718
+++ + D++SLG ++
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 582
+ +G G GEV VAI++ + A+ + EI IL +L
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HP +I ++ E ME G L+ + K+L + +
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKV---VGNKRLKEATCKLYFYQMLLAVQ 253
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 698
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 311
Query: 699 LIRN---EPFTEKCDIFSLGVIM 718
++ + + D +SLGVI+
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDL-TAENMEDFCNEISILSR 581
FS+ +G G FGEV G + A+KV ++ + + E E+ +L +
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
L HPN++ ++ E G L+ I +K+ S +++R + G+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGI 139
Query: 642 MCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAP 697
+H+ KIVHRDLK N L+ +K ++I DFGLS S M+D GT ++AP
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---- 753
E++ + EKCD++S GVI++ L + P+ G ++ V E+P+
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 754 -----LGRLIADCWAEPQERPSCEEILS 776
+ +++ P R S + L
Sbjct: 257 SAKDLIRKMLT---YVPSMRISARDALD 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEI 576
+F + +G G V R + G + A+K+ L + E E E
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 577 SILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
IL ++ HP++I + + + ++ + M G L+ + +K LS + ++R
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMR 207
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEW 694
+ + +H IVHRDLK N L++ + +++ DFG S + +R+ GTP +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGY 265
Query: 695 MAPELIR------NEPFTEKCDIFSLGVIM 718
+APE+++ + + ++ D+++ GVI+
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 526 DFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF-------LEQDLTAENMEDFCNE 575
F E +G G V R I + A+K+ + E E E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 576 ISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
+ IL ++ HPN+I ++ + M+ G L+ + +K LS + K++
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIM 130
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD-SPMRDSSSAGTPE 693
R + + +H++ IVHRDLK N L++ +K+ DFG S + +R+ GTP
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPS 188
Query: 694 WMAPELIR------NEPFTEKCDIFSLGVIM 718
++APE+I + + ++ D++S GVIM
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVF------LEQDLTAENMEDFCNEISILSRL 582
+ +G G GEV VAIK+ + A+ + EI IL +L
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
HP +I ++ E ME G L+ + K+L + +
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQ 128
Query: 643 CIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD-SPMRDSSSAGTPEWMAPE 698
+H I+HRDLK N L+ + +KI DFG S+I+ + S MR GTP ++APE
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 699 LIRN---EPFTEKCDIFSLGVIM 718
++ + + D +SLGVI+
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 56/193 (29%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G FG V R + T K + NEISI+++L HP +I
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLI 111
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
A + +I E++ G L+ I + + K+S + +R C GL +H
Sbjct: 112 NLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 649 IVHRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPF 705
IVH D+K N C K +VKI DFGL+ + D ++ + T E+ APE++ EP
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 227
Query: 706 TEKCDIFSLGVIM 718
D++++GV+
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 15/251 (5%)
Query: 474 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSEL-TV 532
G E+G + +P+ + + +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD---HVLDHYDI 161
Query: 533 GTRVGIGFFGEVFRGIWNGT--DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
+G G FG V R T + A K + + E EI +S LRHP ++
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
A + MI E+M G L+ + + + K+S ++ +R +C+GL +H V
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 651 HRDLKSAN--CLVNKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRNEPFTE 707
H DLK N + +K+ DFGL+ + ++ + GT E+ APE+ +P
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 335
Query: 708 KCDIFSLGVIM 718
D++S+GV+
Sbjct: 336 YTDMWSVGVLS 346
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 516 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAE---NM 569
+L + ++ F ++ + +G G F V R I G A+K+ T+ +
Sbjct: 11 GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 570 EDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-KKLSWR 628
ED E SI L+HP+++ L + L M+ E+M+ L I S
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRD 685
+R I L H I+HRD+K L+ VK+ FG++ + +S +
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIM 718
GTP +MAPE+++ EP+ + D++ GVI+
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 43/291 (14%), Positives = 92/291 (31%), Gaps = 44/291 (15%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 573
E+ + + V +G G F +V+ + +KV + +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT-- 115
Query: 574 NEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ--KKKLSWRRKL 631
+ L + F A ++ E G+L + I+L +K + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----------VKICDFGLSRIITD 680
+ + +H +I+H D+K N ++ + + + D G S +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 681 SP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 738
P ++ T + E++ N+P+ + D F + ++ + G +
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF------GTYMK---- 285
Query: 739 AVANEGSRLEIPEGPLGRLIADCWAE---------PQERPSCEEILSRLLD 780
V NEG + D W E ++L + L
Sbjct: 286 -VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 537 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 593
G G F + + + A+K+ ++ + EI+ L HPN++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEV 74
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
++ E + G L+ I +KK S ++R + + +H + +VHRD
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 654 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCD 710
LK N L N + +KI DFG +R+ + T + APEL+ + E CD
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 711 IFSLGVIM 718
++SLGVI+
Sbjct: 192 LWSLGVIL 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD--VAIKV-----------FLEQDLTAENMEDFCNEIS 577
++G G +GEV AIKV + + E+ NEIS
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
+L L HPN+I ++TE+ E G L+ I + K +++ I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQI 155
Query: 638 CRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRII-TDSPMRDSSSAGTPE 693
G+ +H+ IVHRD+K N L+ N +KI DFGLS D +RD GT
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAY 213
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 753
++APE+++ + + EKCD++S GVIM+ L G P ++ ++ +G
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLC------GYPP---FGGQNDQDIIKKVEKGK 263
Query: 754 LGRLIADCWAE----------------PQERPSCEEILS 776
+ W +R + EE L+
Sbjct: 264 Y-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 6e-33
Identities = 35/292 (11%), Positives = 71/292 (24%), Gaps = 48/292 (16%)
Query: 530 LTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSRLRHPN 586
L + + +G VF A+KVF + + + +E +RL +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 587 V-----------------------ILFLGACTKPPRLSMITEYMEL--GSLYHLIHL--- 618
L ++ M L L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 619 -SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
+ + + R + +VH N + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 678 ITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-- 733
+ R +S+ + E + FT + + LG+ ++ + L P+ V P
Sbjct: 244 VGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 734 -ERVVYAVANEGSRLEIPEGPLGRLIADCWA--------EPQERPSCEEILS 776
+ G L + + R E +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 41/288 (14%), Positives = 82/288 (28%), Gaps = 43/288 (14%)
Query: 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR--- 583
L GT +G G + V + + ++ E+ L LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 584 ----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HLI 616
+I LS L + L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 617 HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676
S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 677 IITDSPMRDSSSA-GTPEWMAPELIRNEP-----FTEKCDIFSLGVIMWELCTLNRPWEG 730
S + PE A ++ T D ++LG+ ++ + + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 731 VLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777
+ IP+ P+ L+ ++R + +
Sbjct: 320 DAALGGSEWIFRS--CKNIPQ-PVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAEN--MEDFCNEISILSRLRHPNV 587
+G +G G EV + + DVA+KV L DL + F E + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKV-LRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 588 I------LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ P + M EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 75 VAVYDTGEAETPAGPLPYIVM--EYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQAL 129
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--PMRDSSSA-GTPEWMAPE 698
H+ I+HRD+K AN +++ VK+ DFG++R I DS + +++ GT ++++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEG 752
R + + D++SLG +++E+ T P+ G P V Y E +
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA- 248
Query: 753 PLGRLIADCWA-EPQERP-SCEEILSRLLDC 781
L ++ A P+ R + E+ + L+
Sbjct: 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRV 279
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 537 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGA 593
G G V I + A+K+ +Q E+ +L + + H NV+ +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRD 653
+ R ++ E M GS+ IH +++ + +++D+ L +H I HRD
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 654 LKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSS-------AGTPEWMAPELIR-- 701
LK N L N+ VKICDF L I + S G+ E+MAPE++
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 702 ---NEPFTEKCDIFSLGVIM 718
+ ++CD++SLGVI+
Sbjct: 197 SEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 27/260 (10%)
Query: 532 VGTRVGIGFFGEVFRG---IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
V + G G ++ NG V +K L AE E L+ + HP+++
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKG-LVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 589 LFLGACTKPPRLSMITEY--MEL---GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
R Y ME SL +KL + L +I L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+H + +V+ DLK N ++ + +K+ D G I GTP + APE++R
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG 252
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA 763
P T DI+++G + L G + + + L+ + GRL+
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPTRNGRYVD----GLPEDDPVLKTYD-SYGRLLRRAID 306
Query: 764 -EPQERP-SCEEILSRLLDC 781
+P++R + EE+ ++L
Sbjct: 307 PDPRQRFTTAEEMSAQLTGV 326
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 587
V +G+G + R I + A+K+ ++ D EI IL R +HPN+
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQHPNI 78
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I + ++TE M+ G L I ++K S R +L I + + +H
Sbjct: 79 ITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 648 KIVHRDLKSANCLVNKH----WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE 703
+VHRDLK +N L +++ICDFG ++ + + T ++APE++ +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 704 PFTEKCDIFSLGVIM 718
+ CDI+SLGV++
Sbjct: 196 GYDAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 537 GIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGA 593
G+G G+V G A+K+ + E+ + P+++ L
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 594 C----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
L +I E ME G L+ I G + + R +++RDI + +H I
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 650 VHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
HRD+K N L K +K+ DFG ++ T + ++ TP ++APE++ E +
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP--CYTPYYVAPEVLGPEKYD 207
Query: 707 EKCDIFSLGVIM 718
+ CD++SLGVIM
Sbjct: 208 KSCDMWSLGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 29/255 (11%)
Query: 537 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
G G F +V I G +VAIK+ + L +++ E+ I+ L HPN++
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
L +I EY G ++ + ++ + R I + H+ +IVHRDL
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDL 140
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFS 713
K+ N L++ +KI DFG S T + G P + APEL + + + + D++S
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGGKL-DAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 714 LGVIMWELCTLNRPWEG----VLPERVVYAVANEGSRLEIPEGPLGRLIADCW------- 762
LGVI++ L + + P++G L ERV+ + IP + DC
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVLRG------KYRIPFY----MSTDCENLLKRFL 249
Query: 763 -AEPQERPSCEEILS 776
P +R + E+I+
Sbjct: 250 VLNPIKRGTLEQIMK 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 31/270 (11%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENM--EDFCNEISILSRL 582
+ VG G G+V+ D VA+K+ + + L+++ + E RL
Sbjct: 37 RLRRLVGRGGMGDVYEA----EDTVRERIVALKL-MSETLSSDPVFRTRMQREARTAGRL 91
Query: 583 RHPNV--ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+ P+V I G + M + L ++ G L+ R + ++R I
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDM--RLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSA 146
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMAPEL 699
L H HRD+K N LV+ + DFG++ TD + + GT +MAPE
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE------GSRLEIPEGP 753
T + DI++L +++E T + P++G V+ A N+ R IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVA- 264
Query: 754 LGRLIADCWA-EPQER-PSCEEILSRLLDC 781
+IA A P++R +C ++ +
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVF-----------------------LEQDLT 565
T+ +G G +G V + T A+KV +
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 566 AENMEDFC-NEISILSRLRHPNVI-LF--LGACTKPPRLSMITEYMELGSLYHLIHLSGQ 621
+ EI+IL +L HPNV+ L L + L M+ E + G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVP----T 130
Query: 622 KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681
K LS + +D+ +G+ +H KI+HRD+K +N LV + +KI DFG+S S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 682 PMRDSSSAGTPEWMAPELIRNEPFT---EKCDIFSLGVIMWELCTLNRPWEGVLP----- 733
S++ GTP +MAPE + + D++++GV ++ G P
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF------GQCPFMDER 244
Query: 734 ERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSCEEILSRLLD 780
+++ LE P+ +P +++++R+LD
Sbjct: 245 IMCLHSKIKSQ-ALEFPD------------QPDIAEDLKDLITRMLD 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 537 GIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 711
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 771
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 772 EEILSRLLD 780
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 48/256 (18%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 474 PSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVG 533
P+ P + + + + ++ + +N + Y+
Sbjct: 17 PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK---------VTS 67
Query: 534 TRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590
+G+G G+V + A+K+ ++ E+ + R + P+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRI 120
Query: 591 LGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
+ L ++ E ++ G L+ I G + + R ++++ I + +H
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 179
Query: 647 MKIVHRDLKSANCLV---NKHWTVKICDFGLSRIIT-DSPMRDSSSAGTPEWMAPELIRN 702
+ I HRD+K N L + +K+ DFG ++ T + + TP ++APE++
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGP 237
Query: 703 EPFTEKCDIFSLGVIM 718
E + + CD++SLGVIM
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 43/293 (14%), Positives = 85/293 (29%), Gaps = 52/293 (17%)
Query: 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMEDFCNEISILSRLR-- 583
L GT +G G + V + + ++ E+ L LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 584 -----------------------HPNVILFLGACTKPPRLS----MITEYMELGSLY-HL 615
+I LS L + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 616 IHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675
+ S K L +L++ + R L +H +VH L+ + ++++ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 676 RIITDSPMRDSSSAGTPEWMAPELI-----------RNEPFTEKCDIFSLGVIMWELCTL 724
S+ + + PEL R T D ++LG++++ +
Sbjct: 254 VRDG----ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 725 NRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILS 776
+ P + S IP+ P+ L+ ++R + +
Sbjct: 310 DLPITKDAALGGSEWIFR--SCKNIPQ-PVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 22/249 (8%)
Query: 537 GIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594
G G +GEV VA+K+ ++ + E+ EI I L H NV+ F G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDL 654
+ + EY G L+ I + + + G++ +H + I HRD+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 655 KSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFT-EKCDI 711
K N L+++ +KI DFGL+ + + + GT ++APEL++ F E D+
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 712 FSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAEPQERPSC 771
+S G+++ + PW+ Y+ E P + +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID-------------SAP 238
Query: 772 EEILSRLLD 780
+L ++L
Sbjct: 239 LALLHKILV 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNV 587
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++
Sbjct: 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I + P M+ EY+ G L+ I + ++ ++ + I + HR
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT- 706
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAG 189
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLP 733
+ DI+S GVI++ L G LP
Sbjct: 190 PEVDIWSCGVILYALLC------GTLP 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDF-CNEISILSRL 582
DF + +G G F V R + + AIK+ ++ + EN + E ++SRL
Sbjct: 31 DFKFGKI---LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 636
HP + +L Y + G L ++ RK+ +
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK--YI----------RKIGSFDETCTRFY 135
Query: 637 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD--SPMRDSSSAGT 691
I L +H I+HRDLK N L+N+ ++I DFG +++++ R +S GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 692 PEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
++++PEL+ + + D+++LG I+++L
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN------EISILSRL 582
+ + +G G FG V+ +V +K ++ + + + EI+ILSR+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
H N+I L ++ E G L+ I + +L + R + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAV 143
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+ I+HRD+K N ++ + +T+K+ DFG + + + + GT E+ APE++
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-TFCGTIEYCAPEVLM 202
Query: 702 NEPFT-EKCDIFSLGVIMWEL 721
P+ + +++SLGV ++ L
Sbjct: 203 GNPYRGPELEMWSLGVTLYTL 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 28/261 (10%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH 584
VG +G G FG V+ G + + VAIK + ++ E+ +L ++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 585 --PNVILFLGACTKPPRLSMITEYME-LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
VI L +P +I E E + L+ I ++ L + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAV 162
Query: 642 MCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
H ++HRD+K N L++ +K+ DFG ++ D+ D GT + PE I
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--FDGTRVYSPPEWI 220
Query: 701 RNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---LGR 756
R + ++SLG++++++ + P+E E ++ ++ +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQH 272
Query: 757 LIADC-WAEPQERPSCEEILS 776
LI C P +RP+ EEI +
Sbjct: 273 LIRWCLALRPSDRPTFEEIQN 293
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 531 TVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G FG R VA+K EN++ EI LRHPN++
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIV 79
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
F P L++I EY G LY I + S + + G+ H M+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 649 IVHRDLKSANCLVNKHWT--VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
I HRDLK N L++ +KICDFG S+ S+ GTP ++APE++ + +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQEYD 195
Query: 707 -EKCDIFSLGVIMWELCTLNRPWEGVLP 733
+ D++S GV ++ + G P
Sbjct: 196 GKIADVWSCGVTLYVMLV------GAYP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 9/210 (4%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 581
F + V +G G FGEVF T A K L + + E IL++
Sbjct: 186 WFLDFRV---LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAK 241
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+ ++ A L ++ M G + YH+ ++ R + I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H+ I++RDLK N L++ V+I D GL+ + + AGTP +MAPEL+
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
E + D F+LGV ++E+ P+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 588
+ +G G FG+V VA+K Q L +M EIS L LRHP++I
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
T P + M+ EY G L+ I +KK+++ + + I + HR K
Sbjct: 73 KLYDVITTPTDIVMVIEYAG-GELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 707
IVHRDLK N L++ + VKI DFGLS I+TD +S G+P + APE+I + +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TSCGSPNYAAPEVINGKLYAGP 187
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLP 733
+ D++S G++++ + G LP
Sbjct: 188 EVDVWSCGIVLYVMLV------GRLP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 30/263 (11%)
Query: 531 TVGTRVGIGFFGEVFRG--IWNGTDVAIKVFL-EQDLTAENMEDFCN---EISILSRLR- 583
+G +G G FG VF G + + VAIKV + L + D E+++L ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 584 ---HPNVILFLGACTKPPRLSMITEYMELGS-LYHLIHLSGQKKKLSWRRKLKMLRDICR 639
HP VI L ++ E L+ I +K L +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVA 150
Query: 640 GLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
+ H +VHRD+K N L++ + K+ DFG ++ D P D GT + PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD--FDGTRVYSPPE 208
Query: 699 LIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP---L 754
I + ++SLG++++++ + P+E + ++ + L P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEIL------EAELHFPAHVSPDC 260
Query: 755 GRLIADC-WAEPQERPSCEEILS 776
LI C +P RPS EEIL
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILL 283
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCN-EISILSRLRHPNVI 588
+G +G+G FG+V G G VA+K+ Q + + ++ EI L RHP++I
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ P + M+ EY+ G L+ I + +L + ++ + I G+ HR
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-E 707
+VHRDLK N L++ H KI DFGLS +++D +S G+P + APE+I +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TSCGSPNYAAPEVISGRLYAGP 195
Query: 708 KCDIFSLGVIMWEL 721
+ DI+S GVI++ L
Sbjct: 196 EVDIWSSGVILYAL 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +G VF+ VA+K V L+ D +A EI +L L+H N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKN 62
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ +L+++ E+ + L + L + +GL H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHS 119
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 700
++HRDLK N L+N++ +K+ +FGL+R P+R + E W P+ L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVR----CYSAEVVTLWYRPPDVLF 174
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRP 727
+ ++ D++S G I EL RP
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-27
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISILSR 581
F + V +G G FGEV T A K LE+ + + NE IL +
Sbjct: 185 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEK 240
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
+ V+ A L ++ M G L I+ G + R + +IC GL
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGL 299
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+HR +IV+RDLK N L++ H ++I D GL+ + + GT +MAPE+++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVK 358
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
NE +T D ++LG +++E+ P++
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLT-AENMEDFCN-EISILSRLRHPNV 587
+G +G G +G+V A+K+ ++ L N E EI +L RLRH NV
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 588 I-LF--LGACTKPPRLSMITEYMELGS--LYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
I L L K ++ M+ EY G + + +K+ + + GL
Sbjct: 69 IQLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV----PEKRFPVCQAHGYFCQLIDGLE 123
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELI 700
+H IVH+D+K N L+ T+KI G++ + D +S G+P + PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 701 RN-EPFT-EKCDIFSLGVIMWELCTLNRPWEGVLP 733
+ F+ K DI+S GV ++ + T G+ P
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITT------GLYP 212
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 25/263 (9%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
DF L V +G G FGEV + A+K+ + ++ F E +L
Sbjct: 75 DFEILKV---IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
+ A L ++ +Y G L LS + +L L ++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT--LLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 701
+H++ VHRD+K N L++ + +++ DFG +++ D ++ S + GTP++++PE+++
Sbjct: 190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 702 NEPFTEK-----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR 756
+ CD +SLGV M+E+ P+ + N R + P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV--- 306
Query: 757 LIADCWAEPQERPSCEEILSRLL 779
+ ++++ RL+
Sbjct: 307 --------TDVSENAKDLIRRLI 321
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +G VF+ T VAIK F +D A EI +L +L+HPN
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA------LREIRMLKQLKHPN 63
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ L + RL ++ EY + ++ H + + + + + + H+
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHK 120
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 700
+HRD+K N L+ KH +K+CDFG +R++T P E W +PE L+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSD----YYDDEVATRWYRSPELLV 175
Query: 701 RNEPFTEKCDIFSLGVIMWELCT 723
+ + D++++G + EL +
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLS 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G FGEVF+ G VA+K V +E + +TA EI IL L+H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHEN 77
Query: 587 VILFLGACT--------KPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
V+ + C + ++ ++ E L L LS K + ++++
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVMQM 132
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE--- 693
+ GL IHR KI+HRD+K+AN L+ + +K+ DFGL+R + T
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVVT 191
Query: 694 -WM-APELIRNEP-FTEKCDIFSLGVIMWELCT 723
W PEL+ E + D++ G IM E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
D+ + V +G G FGEV R A+K+ + ++ + F E I++
Sbjct: 70 DYEVVKV---IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
P V+ A L M+ EYM G L +L+ + + ++ L
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLALD 182
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAPELIR 701
IH M +HRD+K N L++K +K+ DFG ++ + +R ++ GTP++++PE+++
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 702 NEPFTEK----CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP 753
++ CD +S+GV ++E+ + P+ + N + L P+
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 55/243 (22%), Positives = 102/243 (41%), Gaps = 24/243 (9%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
DF L V +G G F EV + G A+K+ + D+ + F E +L
Sbjct: 62 DFEILKV---IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR----DIC 638
+ A L ++ EY G L LS +++ +M R +I
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLT--LLSKFGERIP----AEMARFYLAEIV 172
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEWMAP 697
+ +HR+ VHRD+K N L+++ +++ DFG ++ D +R + GTP++++P
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 698 ELIRNE-------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750
E+++ + +CD ++LGV +E+ P+ + + L +P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 751 EGP 753
Sbjct: 293 LVD 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIKVF-LEQD-----LTAENMEDFCNEISILSRLRHPN 586
VG G +G V + T VAIK F D A EI +L +LRH N
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA------MREIKLLKQLRHEN 85
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ L C K R ++ E+++ ++ + L L ++ K L I G+ H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHS 142
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 700
I+HRD+K N LV++ VK+CDFG +R + +P E W APE L+
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGE----VYDDEVATRWYRAPELLV 197
Query: 701 RNEPFTEKCDIFSLGVIMWELCT 723
+ + + D++++G ++ E+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFM 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 587
++G G + V++G G VA+K V L+ + TA EIS++ L+H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENI 65
Query: 588 ILFLGACTKPPRLSMITEYME--LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
+ +L+++ E+M+ L + + L + +GL H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELI 700
KI+HRDLK N L+NK +K+ DFGL+R P+ + E W AP+++
Sbjct: 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVN----TFSSEVVTLWYRAPDVL 180
Query: 701 RNEPF-TEKCDIFSLGVIMWELCTLNRP 727
+ DI+S G I+ E+ T +P
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMIT-GKP 207
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK---VFLEQDLTAENMEDFCN-- 574
+NI S+ + + +G G +G V G VAIK F F
Sbjct: 6 VYNIS-SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPL------FALRT 56
Query: 575 --EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMELGSLYHLIHLSGQKKKLSW 627
EI IL +H N+I + I E M+ L+ +I S Q LS
Sbjct: 57 LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQM--LSD 111
Query: 628 RRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687
+ R + +H ++HRDLK +N L+N + +K+CDFGL+RII +S +S
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 688 SAGTPEWM----------APELIRN-EPFTEKCDIFSLGVIMWEL 721
G M APE++ ++ D++S G I+ EL
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +G V++ N A+K + LE++ T EISIL L+H N
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTT------IREISILKELKHSN 61
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ RL ++ E+++ L L+ + + + L + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCHD 118
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIR 701
+++HRDLK N L+N+ +KI DFGL+R P+R T E W AP+++
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVR----KYTHEIVTLWYRAPDVLM 173
Query: 702 NEPF-TEKCDIFSLGVIMWELCTLNRP 727
+ DI+S+G I E+ P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTP 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 73/303 (24%), Positives = 114/303 (37%), Gaps = 56/303 (18%)
Query: 476 SPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTR 535
S HE + G+ ++ S+ K S + +W I +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRHL 60
Query: 536 VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRHP 585
+G G +G V VAIK VF +DL C EI+IL+RL H
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLI------DCKRILREIAILNRLNHD 112
Query: 586 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+V+ L ++ E + L + L+ +L ++ G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR-TPVY--LTELHIKTLLYNLLVG 168
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM----- 695
+ +H I+HRDLK ANCLVN+ +VK+CDFGL+R + +S +P
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 696 ----------------------APELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVL 732
APELI + +TE D++S+G I EL + +
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 733 PER 735
+R
Sbjct: 289 ADR 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 29/203 (14%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
+VG G +G V++ + VA+K + L+ + TA EIS+L L HPN
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
++ + L+++ E+ME L ++ + + S + L + RG+ H+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCHQ 137
Query: 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APE-LI 700
+I+HRDLK N L+N +K+ DFGL+R P+R T E W AP+ L+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSY----THEVVTLWYRAPDVLM 192
Query: 701 RNEPFTEKCDIFSLGVIMWELCT 723
++ ++ DI+S+G I E+ T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMIT 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 41/208 (19%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 584
+G G G V +VAIK F Q+ T E+ ++ + H
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQT------HAKRAYRELVLMKCVNH 83
Query: 585 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
N+I L T L ++ E M+ +L +I + +L R +L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI-----QMELDHERMSYLLYQML 137
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM--- 695
G+ +H I+HRDLK +N +V T+KI DFGL+R +S TP +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVVTRY 191
Query: 696 --APELIRNEPFTEKCDIFSLGVIMWEL 721
APE+I + E DI+S+G IM E+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFCNEISILS 580
F L V +G G FG+VF + + A+KV + L + E IL
Sbjct: 25 QFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 581 RLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+ HP I+ L T +L +I +++ G L+ LS ++ + L ++
Sbjct: 82 EVNHP-FIVKLHYAFQT-EGKLYLILDFLRGGDLFT--RLS-KEVMFTEEDVKFYLAELA 136
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
L +H + I++RDLK N L+++ +K+ DFGLS+ D + S GT E+MAPE
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
++ T+ D +S GV+M+E+ T P++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 508 ESPMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK-- 557
M ++K + + S TV R +G G G V +VAIK
Sbjct: 36 HYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL 95
Query: 558 --VFLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITE 605
F Q+ T E+ ++ + H N+I L T L ++ E
Sbjct: 96 SRPF--QNQT------HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665
M+ +L +I + +L R +L + G+ +H I+HRDLK +N +V
Sbjct: 148 LMD-ANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 666 TVKICDFGLSRIITDSPMRDSSSAGTPEWM-----APELIRNEPFTEKCDIFSLGVIMWE 720
T+KI DFGL+R S M TP + APE+I + E DI+S+G IM E
Sbjct: 202 TLKILDFGLARTAGTSFMM------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 721 L 721
+
Sbjct: 256 M 256
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD----LTAENMEDFCNEISILSRLRHPNV 587
++G G + V++G TD VA+K + LE + TA E+S+L L+H N+
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDLKHANI 62
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ L+++ EY++ L + G + + L + RGL HR
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ 119
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 702
K++HRDLK N L+N+ +K+ DFGL+R + P + E W P+++
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTY----DNEVVTLWYRPPDILLG 174
Query: 703 EP-FTEKCDIFSLGVIMWELCTLNRP 727
++ + D++ +G I +E+ T RP
Sbjct: 175 STDYSTQIDMWGVGCIFYEMAT-GRP 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 36/210 (17%)
Query: 536 VGIGFFGEVFRGI-WNGTDVAIKVFLEQDLTAENMEDFCN---------EISILSRLRHP 585
+ G +G V G+ G VAIK + + EI +L+ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 586 NVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
N++ + ++TE M L +IH Q+ +S + + I G
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIVISPQHIQYFMYHILLG 146
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-------RDSSSAGTPE 693
L +H +VHRDL N L+ + + ICDF L+R T R
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--------- 197
Query: 694 WM-APELIRN-EPFTEKCDIFSLGVIMWEL 721
W APEL+ + FT+ D++S G +M E+
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFL 591
+G G FG V++ +G VAIK V ++ F N E+ I+ +L H N++ L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIV-RL 112
Query: 592 GACTKPPR-------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICRGLMC 643
L+++ +Y+ ++Y + H S K+ L + + R L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 644 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIIT-DSPMRD--SSSAGTPEWM-APE 698
IH I HRD+K N L++ +K+CDFG ++ + P S + APE
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS-----RYYRAPE 226
Query: 699 LI-RNEPFTEKCDIFSLGVIMWELCTLNRP 727
LI +T D++S G ++ EL L +P
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELL-LGQP 255
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 51/220 (23%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
F L +G G FG+V + A+K +Q N + + E+ I+ L
Sbjct: 16 HFEILRA---IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSL-YHLIHLSGQKKKLSWRRKLKMLRDICR-- 639
HP ++ + + M+ + + G L YHL ++ + + +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL------------QQNVHFKEETVKLF 120
Query: 640 ------GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
L + +I+HRD+K N L+++H V I DF ++ ++ + ++ AGT
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKP 179
Query: 694 WMAPELIRNEPF---TEKCDIFSLGVIMWELCTLNRPWEG 730
+MAPE+ + + D +SLGV +EL RP+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
F + +G G FG V + +G A+K+ +Q + +E NE IL +
Sbjct: 42 QFDRIKT---LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR--- 639
P ++ + L M+ EY+ G ++ HL RR + R
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS--HL---------RRIGRFSEPHARFYA 147
Query: 640 -----GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 694
+H + +++RDLK N L+++ +++ DFG ++ + R + GTPE
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEA 204
Query: 695 MAPELIRNEPFTEKCDIFSLGVIMWELCT 723
+APE+I ++ + + D ++LGV+++E+
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC--NEISI 578
F L V +G G +G+VF + T A+KV + + + E +I
Sbjct: 18 CFELLRV---LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI 74
Query: 579 LSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
L ++HP I+ L T +L +I EY+ G L+ L ++ L +
Sbjct: 75 LEEVKHP-FIVDLIYAFQT-GGKLYLILEYLSGGELFM--QLE-REGIFMEDTACFYLAE 129
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 696
I L +H+ I++RDLK N ++N VK+ DFGL + + GT E+MA
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
PE++ D +SLG +M+++ T P+ G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DFS + +G G FGEV+ R G A+K L++ + NE +LS
Sbjct: 190 DFSVHRI---IGRGGFGEVYGCRKADTGKMYAMKC-LDKKRIKMKQGETLALNERIMLSL 245
Query: 582 L---RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+ P ++ A P +LS I + M G L++ HLS Q S +I
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLS-QHGVFSEADMRFYAAEII 302
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
GL +H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPE 360
Query: 699 LI-RNEPFTEKCDIFSLGVIMWELCT 723
++ + + D FSLG ++++L
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 532 VGTRVGIGFFGEVFRG----IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV 587
G +VG G +G V++ + D A+K ++ C EI++L L+HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNV 80
Query: 588 ILFLGACT--KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL------KMLRDICR 639
I ++ ++ +Y E L+H+I K +L +L I
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 640 GLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE-- 693
G+ +H ++HRDLK AN LV + VKI D G +R+ SP++ + P
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLK-PLADLDPVVV 197
Query: 694 --WM-APELIRNEPF-TEKCDIFSLGVIMWELCTLNRP 727
W APEL+ T+ DI+++G I EL T P
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EP 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 536 VGIGFFGEVFRGIWNGTD-VAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVILFLG 592
+G G FG VF+ +D VAIK V + + F N E+ I+ ++HPNV+ L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVD-LK 98
Query: 593 ACTKPP-------RLSMITEYMELGSLYHLI-HLSGQKKKLSWRR-KLKMLRDICRGLMC 643
A L+++ EY+ ++Y H + K+ + KL M + + R L
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 644 IHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM-APELI- 700
IH + I HRD+K N L++ +K+ DFG ++I+ + S + APELI
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIF 214
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRP 727
+T DI+S G +M EL +P
Sbjct: 215 GATNYTTNIDIWSTGCVMAELM-QGQP 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 62/254 (24%), Positives = 98/254 (38%), Gaps = 51/254 (20%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFC 573
+ ++ + +G G +G V+ +VAIK +F +DL C
Sbjct: 19 IKNVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLI------DC 69
Query: 574 N----EISILSRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKK 624
EI+IL+RL+ +I L ++ E + L L +
Sbjct: 70 KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIF-- 125
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
L+ +L ++ G IH I+HRDLK ANCL+N+ +VK+CDFGL+R I
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 685 DSSSAGTPEWM----------------------APELIRNEP-FTEKCDIFSLGVIMWEL 721
+ + APELI + +T+ DI+S G I EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 722 CTLNRPWEGVLPER 735
+ + R
Sbjct: 246 LNMLQSHINDPTNR 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 73/238 (30%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 510 PMFQNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK---V 558
M F VG R +G G +G V N VAIK
Sbjct: 6 HMAAAAAAGPEMVRGQVF---DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62
Query: 559 FLEQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLSM-----ITEYMEL 609
F + T +C EI IL R RH N+I P M + + ME
Sbjct: 63 F--EHQT------YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669
LY L+ + LS L I RGL IH ++HRDLK +N L+N +KI
Sbjct: 115 -DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKI 169
Query: 670 CDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 721
CDFGL+R+ P D + T W APE++ N + +T+ DI+S+G I+ E+
Sbjct: 170 CDFGLARVA--DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 50/230 (21%)
Query: 520 YEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAE 567
+ + +++ + + VG G +G V I +G VAIK F Q
Sbjct: 10 FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEI-- 65
Query: 568 NMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELGSLYHLIH 617
F E+ +L ++H NVI L T L ++ +M+ L ++
Sbjct: 66 ----FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM- 119
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
K S + ++ + +GL IH +VHRDLK N VN+ +KI DFGL+R
Sbjct: 120 ----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 678 ITDSPMRDSSSAGTPEWM-----APELIRN-EPFTEKCDIFSLGVIMWEL 721
D+ M T + APE+I + + + DI+S+G IM E+
Sbjct: 175 HADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRL 582
DF L +G G FG V R NG A+KV ++ + +E +E +LS +
Sbjct: 7 DFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 583 RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD------ 636
HP +I G ++ MI +Y+E G L+ L RK + +
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS--LL----------RKSQRFPNPVAKFY 111
Query: 637 ---ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
+C L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPD 168
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
++APE++ +P+ + D +S G++++E+
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 535 RVGIGFFGEVFRG--IWNGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLR---H 584
+G+G +G V++ +G VA+K V + E+++L RL H
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLRRLEAFEH 73
Query: 585 PNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
PNV + + +++++ E+++ L + + + K ++R R
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 131
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM 695
GL +H IVHRDLK N LV TVK+ DFGL+RI M TP W
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMA-----LTPVVVTLWY 185
Query: 696 -APELIRNEPFTEKCDIFSLGVIMWELCT 723
APE++ + D++S+G I E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 535 RVGIGFFGEVFRGI---WNGTDVAIK-VFLEQD-----LTAENMEDFCNEISILSRLR-- 583
+G G +G+VF+ G VA+K V ++ L+ E+++L L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLRHLETF 71
Query: 584 -HPNV-----ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
HPNV + + + +L+++ E+++ L + + + K M+ +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE---- 693
RGL +H ++VHRDLK N LV +K+ DFGL+RI M T
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMA-----LTSVVVTL 183
Query: 694 WM-APELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727
W APE++ + D++S+G I E+ +P
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 39/198 (19%), Positives = 76/198 (38%), Gaps = 40/198 (20%)
Query: 531 TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNV 587
+G+G G+V + A+K+ ++ E+ + R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73
Query: 588 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
+ + L ++ E ++ G L+ I + + R ++++ I +
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 644 IHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
+H + I HRD+K N L + +K+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKETT 171
Query: 701 RNEPFTEKCDIFSLGVIM 718
E + + CD++SLGVIM
Sbjct: 172 G-EKYDKSCDMWSLGVIM 188
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN----EISILSRLRH 584
VG G +G V + G VAIK F Q F E+ +L +RH
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSEL------FAKRAYRELRLLKHMRH 83
Query: 585 PNVILFLGACTKPPRLS------MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
NVI L T L ++ +M L L+ +KL R ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK----HEKLGEDRIQFLVYQML 138
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
+GL IH I+HRDLK N VN+ +KI DFGL+R DS M T + APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGYVV--TRWYRAPE 195
Query: 699 LIRN-EPFTEKCDIFSLGVIMWEL 721
+I N +T+ DI+S+G IM E+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEM 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNV 587
+G G F V++ T+ VAIK + L +E + EI +L L HPN+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHR--SEAKDGINRTALREIKLLQELSHPNI 74
Query: 588 ILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
I L A +S++ ++ME L +I + S + + +GL +H+
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQH 131
Query: 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPE----WM-APELIRN 702
I+HRDLK N L++++ +K+ DFGL++ P R T + W APEL+
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAY----THQVVTRWYRAPELLFG 186
Query: 703 EPF-TEKCDIFSLGVIMWELCTLNRP 727
D++++G I+ EL P
Sbjct: 187 ARMYGVGVDMWAVGCILAELLL-RVP 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF L + +G G FG+V R G A+K+ L +++ E E +L
Sbjct: 6 DFDYLKL---LGKGTFGKVILVREKATGRYYAMKI-LRKEVIIAKDEVAHTVTESRVLQN 61
Query: 582 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
RHP + L T RL + EY G L+ HLS +++ + R +I
Sbjct: 62 TRHP-FLTALKYAFQT-HDRLCFVMEYANGGELFF--HLS-RERVFTEERARFYGAEIVS 116
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
L +H +V+RD+K N +++K +KI DFGL + + GTPE++APE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ + + D + LGV+M+E+ P+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/220 (22%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 520 YEEWNIDFSEL---TVGTRVGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN 574
YE +++ + ++G G + EVF I N V +K+ L +
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPVKKKKIKR 79
Query: 575 EISILSRLR-HPNVILFLGACTKPP---RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
EI IL LR PN+I K P +++ E++ L + L+
Sbjct: 80 EIKILENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 132
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRD-SSS 688
+ +I + L H M I+HRD+K N +++ +H +++ D+GL+ P ++ +
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVR 190
Query: 689 AGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 727
+ + PEL+ + + + D++SLG ++ + P
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIK-VFLEQDLTAENMEDFCN----EISILSRLRHPNVI 588
G G FG V G G VAIK V QD F N + L+ L HPN++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPR------FRNRELQIMQDLAVLHHPNIV 82
Query: 589 LFLGACTKPPR--------LSMITEYMELGSLYHLI-HLSGQKKKLSWRRKLKMLRDICR 639
L + L+++ EY+ +L+ + ++ L + R
Sbjct: 83 Q-LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 640 GLMCIHR--MKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM- 695
+ C+H + + HRD+K N LVN+ T+K+CDFG ++ + SP + + +
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRYYR 198
Query: 696 APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 727
APELI + +T DI+S+G I E+ L P
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMM-LGEP 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 513 QNKPLLAYEEWNIDFSELTVGTR------VGIGFFGEVFRGI--WNGTDVAIK----VFL 560
++ + ++ + V R VG G +G V G VA+K F
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF- 66
Query: 561 EQDLTAENMEDFCN----EISILSRLRHPNVILFLGACTKPPRLS------MITEYMELG 610
Q + E+ +L ++H NVI L T L ++T M
Sbjct: 67 -QSII------HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-A 118
Query: 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 670
L +++ +KL+ ++ I RGL IH I+HRDLK +N VN+ +KI
Sbjct: 119 DLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWEL 721
DFGL+R T M + T + APE++ N + + DI+S+G IM EL
Sbjct: 175 DFGLAR-HTADEMTGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
+F L + +G G FG+V + G A+K+ L++++ E E +L
Sbjct: 149 EFEYLKL---LGKGTFGKVILVKEKATGRYYAMKI-LKKEVIVAKDEVAHTLTENRVLQN 204
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
RHP + + RL + EY G L+ HLS +++ S R +I L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFF--HLS-RERVFSEDRARFYGAEIVSAL 261
Query: 642 MCIHRMK-IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
+H K +V+RDLK N +++K +KI DFGL + + GTPE++APE++
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ + D + LGV+M+E+ P+
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 535 RVGIGFFGEVFRGIWNGTD--VAIK-VFLEQD-----LTAENMEDFCNEISILSRLRHPN 586
++G G +GEV++ I T+ VAIK + LE + TA E+S+L L+H N
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHRN 94
Query: 587 VILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR 646
+I RL +I EY E L + + +S R L + G+ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 647 MKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSPMRDSSSAGTPE----WM-A 696
+ +HRDLK N L++ +KI DFGL+R P+R T E W
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQF----THEIITLWYRP 205
Query: 697 PELIRNEP-FTEKCDIFSLGVIMWELCT 723
PE++ ++ DI+S+ I E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF + +G G FG+VF AIK L++D+ + + C E +LS
Sbjct: 18 DFILHKM---LGKGSFGKVFLAEFKKTNQFFAIKA-LKKDVVLMDDDVECTMVEKRVLSL 73
Query: 582 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
HP + + T L + EY+ G L + I K R +I
Sbjct: 74 AWEHP-FLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEII 128
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
GL +H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
++ + + D +S GV+++E+ P+ G
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-21
Identities = 75/341 (21%), Positives = 140/341 (41%), Gaps = 22/341 (6%)
Query: 405 MNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQ 464
++ L E E F +D L ++ L + ++ G S + +
Sbjct: 211 QKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKA 270
Query: 465 MNSQKAISLPSSPHEYGSHGSERGGSSGYMANSEFVSTWNKVLESPMFQNKPLLAYEEWN 524
L EY + GS G + + + K +++
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330
Query: 525 I----------DFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDF 572
DF+ L V +G G FG+V GTD A+K+ L++D+ ++ +
Sbjct: 331 NNGNRDRMKLTDFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVE 386
Query: 573 C--NEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRR 629
C E +L+ P + L +C + RL + EY+ G L + H+ Q +
Sbjct: 387 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPH 443
Query: 630 KLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA 689
+ +I GL + I++RDLK N +++ +KI DFG+ + + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC 503
Query: 690 GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
GTP+++APE+I +P+ + D ++ GV+++E+ P+EG
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 526 DFSELTVGTRVGIGFFGEVF---RGIWNGTDV--AIKVFLEQDLTAENMEDFC---NEIS 577
+F L V +G G +G+VF + + T A+KV L++ + + E
Sbjct: 55 NFELLKV---LGTGAYGKVFLVRKISGHDTGKLYAMKV-LKKATIVQKAKTTEHTRTERQ 110
Query: 578 ILSRLRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
+L +R ++ L T +L +I +Y+ G L+ HLS Q+++ + +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFT--HLS-QRERFTEHEVQIYVG 166
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS-RIITDSPMRDSSSAGTPEW 694
+I L +H++ I++RD+K N L++ + V + DFGLS + D R GT E+
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 695 MAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEG 730
MAP+++R + D +SLGV+M+EL T P+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 44/216 (20%)
Query: 535 RVGIGFFGEVFRGI--WNGTDVAIK--VFLEQDLTAENMEDFCN----EISILSRLRHPN 586
+G G G VF + VAIK V D EI I+ RL H N
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQ------SVKHALREIKIIRRLDHDN 69
Query: 587 VILFLGACTKPPRLS--------------MITEYMELGSLYHLIHLSGQKKKLSWRRKLK 632
++ ++ EYME L +++ + L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE----QGPLLEEHARL 124
Query: 633 MLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITDSPMRDSSSAGT 691
+ + RGL IH ++HRDLK AN +N +KI DFGL+RI+ P +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHYSHKGHLS 182
Query: 692 PE----WM-APELIRN-EPFTEKCDIFSLGVIMWEL 721
W +P L+ + +T+ D+++ G I E+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
+F + V +G G FG+V R G A+KV L++D+ ++ + C E ILS
Sbjct: 24 NFEFIRV---LGKGSFGKVMLARVKETGDLYAVKV-LKKDVILQDDDVECTMTEKRILSL 79
Query: 582 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
R+ + L C T P RL + E++ G L H+ + ++ R +I
Sbjct: 80 ARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDLMF--HIQ-KSRRFDEARARFYAAEIIS 135
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
LM +H I++RDLK N L++ K+ DFG+ + + + ++ GTP+++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
++ + D +++GV+++E+ + P+E
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF L V +G G + +V R A+KV ++++L ++ + E + +
Sbjct: 10 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMKV-VKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 582 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 66 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 121
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 739
+R E + D ++LGV+M+E+ P++ V
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 14/211 (6%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF+ L V +G G FG+V A+K+ L++D+ ++ + C E +L+
Sbjct: 21 DFNFLMV---LGKGSFGKVMLSERKGTDELYAVKI-LKKDVVIQDDDVECTMVEKRVLAL 76
Query: 582 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
P + L +C T RL + EY+ G L + H+ Q + + +I
Sbjct: 77 PGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMY--HIQ-QVGRFKEPHAVFYAAEIAI 132
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
GL + I++RDLK N +++ +KI DFG+ + + + GTP+++APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
I +P+ + D ++ GV+++E+ P+EG
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF L V +G G + +V R A++V ++++L ++ + E + +
Sbjct: 53 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMRV-VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 582 LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ ++ L +C T RL + EY+ G L H+ +++KL +I
Sbjct: 109 ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMF--HMQ-RQRKLPEEHARFYSAEISL 164
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
L +H I++RDLK N L++ +K+ D+G+ + S+ GTP ++APE+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 739
+R E + D ++LGV+M+E+ P++ V
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 58/238 (24%)
Query: 536 VGIGFFGEVFRGIWN--GTDVAIK-VFLEQDLTAENMEDFCN-EISILSRLRHPNVI--- 588
+G G FG V G A+K V + + N E+ I+ L H N+I
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLV 66
Query: 589 -----------------------------LFLGACTKPPR------LSMITEYMELGSLY 613
+ + L++I EY+ +L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 614 HLI-HLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICD 671
++ + + + + R + IH + I HRD+K N LVN K T+K+CD
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 672 FGLSRIITDSPMRDSSSAGTPEWM-APELIRN-EPFTEKCDIFSLGVIMWELCTLNRP 727
FG ++ + P S + + APEL+ +T D++S+G + EL L +P
Sbjct: 186 FGSAKKL--IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI-LGKP 240
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 53/239 (22%), Positives = 99/239 (41%), Gaps = 57/239 (23%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGI--WNGTDVAIK----VFLEQDLTAENMEDFCN- 574
+ ++ + + ++G G +G V++ I G VA+K F Q+ T
Sbjct: 4 DRHVL-RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNST------DAQR 54
Query: 575 ---EISILSRLR-HPNVILFLGACTKPPRLS---MITEYMELGSLYHLIH---LSGQKKK 624
EI IL+ L H N++ L + ++ +YME L+ +I L K+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ 112
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684
++ + + + +H ++HRD+K +N L+N VK+ DFGLSR +
Sbjct: 113 Y-------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 685 DSSSAGTPEWM---------------------APELIRN-EPFTEKCDIFSLGVIMWEL 721
++ + APE++ +T+ D++SLG I+ E+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 16/212 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFC--NEISILSR 581
DF L V +G G FG+V R A+KV L++ + E+ +E ++L +
Sbjct: 39 DFHFLKV---IGKGSFGKVLLARHKAEEVFYAVKV-LQKKAILKKKEEKHIMSERNVLLK 94
Query: 582 -LRHPNVILFLGAC--TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
++HP ++ L T +L + +Y+ G L++ HL +++ R +I
Sbjct: 95 NVKHP-FLVGLHFSFQT-ADKLYFVLDYINGGELFY--HLQ-RERCFLEPRARFYAAEIA 149
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
L +H + IV+RDLK N L++ + + DFGL + + S+ GTPE++APE
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
++ +P+ D + LG +++E+ P+
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 30/261 (11%), Positives = 70/261 (26%), Gaps = 46/261 (17%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNVI 588
+ G + ++ VA+ Q + +++ ++ + LSR+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L ++ E++ GSL + S ++ ++ + HR
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
+ + V+ V + M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT--------------------MPDA-------NPQ 182
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------RLEIPEGP--LGRLIAD 760
DI +G ++ L P + + + + P + + A
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 761 CWA-EPQERPSCEEILSRLLD 780
+ R + L L+
Sbjct: 243 SVQGDGGIRSAST--LLNLMQ 261
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 57/202 (28%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 536 VGIGFFGEVFRGI--WNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRH----- 584
+G G FG+V + VA+K+ N + F EI IL LR
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKM-------VRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 585 -PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
NVI L T + M E + + +LY LI + + S K I + L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 644 IHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+H+ +I+H DLK N L+ +K+ DFG S S + APE+I
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR---FYRAPEVIL 272
Query: 702 NEPFTEKCDIFSLGVIMWELCT 723
+ D++SLG I+ EL T
Sbjct: 273 GARYGMPIDMWSLGCILAELLT 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 2e-14
Identities = 38/198 (19%), Positives = 58/198 (29%), Gaps = 50/198 (25%)
Query: 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENME------DFCNEISILSR 581
+L ++G G FGEVF+ I + T VAIK+ + N + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 582 L---------RHPNVILFLGAC------------------------------TKPPRLSM 602
L R I K +L +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLV 661
+ E+ G + K S +L + L ++ HRDL N L+
Sbjct: 140 VLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 662 NKHWTVKICDFGLSRIIT 679
K K+ + T
Sbjct: 196 KKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 47/219 (21%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 537 GIGFFGEVFRG--IWNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR----- 583
G G F V+ + N T VA+K+ + E EI +L R+
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---------EIKLLQRVNDADNT 78
Query: 584 ------HPNVILFL------GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 631
+++ L G + M+ E + +L LI + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVH--VVMVFEVLGE-NLLALIKKYEHRG-IPLIYVK 134
Query: 632 KMLRDICRGLMCIHRM-KIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMR 684
++ + + GL +HR I+H D+K N L+ +KI D G + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---H 191
Query: 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
++S T E+ +PE++ P+ DI+S +++EL T
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 32/210 (15%)
Query: 532 VGTRVGIGFFGEVFRGIW--NGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLR 583
+ + +G G FG+V + VAIK+ FL Q E+ +L +
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---------EVRLLELMN 108
Query: 584 HP------NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
++ L ++ E + +LY L+ + + +S K + +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQM 166
Query: 638 CRGLMCIH--RMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPE 693
C L+ + + I+H DLK N L+ K +KI DFG S + +
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRF 223
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
+ +PE++ P+ D++SLG I+ E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 46/227 (20%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH----P 585
VG ++G G FGE+ G ++ VAIK LE + E +L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQ--LHLEYRFYKQLGSGDGIP 68
Query: 586 NVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD--ICR 639
V F G C K +M+ E LG SL L L + S LK M+ I R
Sbjct: 69 QVYYF-GPCGK--YNAMVLEL--LGPSLEDLFDLCD--RTFS----LKTVLMIAIQLISR 117
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMRDSSS 688
+ +H +++RD+K N L+ + + I DF L++ D P R+ S
Sbjct: 118 -MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 689 -AGTPEWMAPELIRNEPFTE---KCDIFSLGVIMWELCTLNRPWEGV 731
GT +M+ I E + D+ +LG + + PW+G+
Sbjct: 177 LTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 78/236 (33%)
Query: 537 GIGFFGEVFRGI---WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRHP-- 585
G G FG+V I G VA+K+ + E + EI +L L
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---------EIQVLEHLNTTDP 73
Query: 586 ----NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
+ L C ++ E + L S Y I +G KM
Sbjct: 74 NSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENG-FLPFRLDHIRKMA 124
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG-- 673
IC+ + +H K+ H DLK N L + +K+ DFG
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 674 ------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
S +++ R APE+I +++ CD++S+G I+ E
Sbjct: 185 TYDDEHHSTLVSTRHYR-----------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 40/235 (17%), Positives = 78/235 (33%), Gaps = 74/235 (31%)
Query: 536 VGIGFFGEVFR---GIWNGTDVAIKVFLEQDLTAENMEDFCN----EISILSRLRHP--- 585
+G G FG+V + VA+K+ N+ + EI++L +++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII-------RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 586 ---NVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
+L C + E + + + + + M
Sbjct: 80 NKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLK-ENNFQPYPLPHVRHMAY 130
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVN-------------------KHWTVKICDFG--- 673
+C L +H ++ H DLK N L K+ ++++ DFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 674 -----LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
+ I+ R PE+I + + CD++S+G I++E
Sbjct: 191 FDHEHHTTIVATRHYR-----------PPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 49/240 (20%), Positives = 77/240 (32%), Gaps = 82/240 (34%)
Query: 537 GIGFFGEVFRGI--WNGTDVAIKV------FLEQDLTAENMEDFCNEISILSRLRH---- 584
G G FG V N A+KV + E IL ++++
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---------EADILKKIQNDDIN 94
Query: 585 -PNVILFLGA-------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
N++ + G C +I E + SLY +I + +
Sbjct: 95 NNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNN-YNGFHIEDIKLYCIE 145
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVN-------------------------KHWTVKICD 671
I + L + +M + H DLK N L++ K +K+ D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 672 FG--------LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT 723
FG II R APE+I N + D++S G ++ EL T
Sbjct: 206 FGCATFKSDYHGSIINTRQYR-----------APEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 54/231 (23%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 584
VG R+G G FG +F G + N VAIK E +E L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 585 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLK---MLRD- 636
PNV F G ++ + LG SL L+ L G +K S +K M
Sbjct: 66 TGIPNVYYF-GQEGL--HNVLVIDL--LGPSLEDLLDLCG--RKFS----VKTVAMAAKQ 114
Query: 637 -ICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDS------PMR 684
+ R + IH +V+RD+K N L+ + + + + DFG+ + D P R
Sbjct: 115 MLAR-VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 685 DSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 731
+ + +GT +M+ I E+ D+ +LG + + PW+G+
Sbjct: 174 EKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 584
+G ++G G FG+++ G I G +VAIK+ E ++ E I ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 585 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
P + GA M+ E LG SL L + +K S + L + +
Sbjct: 65 VGIPTIRWC-GAEGD--YNVMVMEL--LGPSLEDLFNFCS--RKFSLKTVLLLADQMISR 117
Query: 641 LMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS------PMRDSSS-AG 690
+ IH +HRD+K N L+ K V I DFGL++ D+ P R++ + G
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 691 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 731
T + + I E+ D+ SLG ++ + PW+G+
Sbjct: 178 TARYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 48/239 (20%), Positives = 76/239 (31%), Gaps = 46/239 (19%)
Query: 532 VGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILF 590
VG +G G FG ++ + + V + + E+ R P I
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 591 LGACTKPPRLSM------------ITEY----ME-LG-SLYHLIHLSGQKKKLSWRRKLK 632
K L + Y M+ G L + + K+ S K
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--KRFS----RK 152
Query: 633 ---MLRD--ICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDS---- 681
L + L IH + VH D+K++N L+N V + D+GL+
Sbjct: 153 TVLQLSLRILDI-LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 682 --PMRDSSS-AGTPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGVLPE 734
GT E+ + I D+ LG M + T + PWE L +
Sbjct: 212 AYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMED----FCNEISILSRLRH- 584
+G ++G G FGE++ G I +VAIK+ EN++ E I L+
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGG 62
Query: 585 ---PNVILFLGACTKPPRLSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
PNV F G ++ + LG SL L + +KLS + L + +
Sbjct: 63 TGIPNVRWF-GVEGD--YNVLVMDL--LGPSLEDLFNF--CSRKLSLKTVLMLADQMINR 115
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS------PMRDSSS-AG 690
+ +H +HRD+K N L+ V I DFGL++ D+ P R++ + G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 691 TPEWMAPELIRNEPFTEKC---DIFSLGVIMWELCTLNRPWEGV 731
T + + + E+ D+ SLG ++ + PW+G+
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 50/263 (19%), Positives = 84/263 (31%), Gaps = 86/263 (32%)
Query: 532 VGTRVGIGFFGEVF--RGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----H 584
V ++G G F V+ I VA+KV E +EI +L +R
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK---SAEHYTETALDEIRLLKSVRNSDPND 97
Query: 585 PN---VILFLGA-----------CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
PN V+ L C M+ E + L I S + L
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLKWIIKSNYQG-LPLPCV 148
Query: 631 LKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN--------------------------- 662
K+++ + +GL +H +I+H D+K N L++
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 663 ----------------------KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
+ VKI D G + + D T ++ + E++
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ---TRQYRSLEVL 265
Query: 701 RNEPFTEKCDIFSLGVIMWELCT 723
+ DI+S + +EL T
Sbjct: 266 IGSGYNTPADIWSTACMAFELAT 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/244 (16%), Positives = 76/244 (31%), Gaps = 56/244 (22%)
Query: 532 VGTRVGIGFFGEVFRGI----------WNGTDVAIKVFLEQDLTAENME-DFCNEISILS 580
+ + G ++ ++K+ + + NE +
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL--------DAKDGRLFNEQNFFQ 97
Query: 581 RLRHPNVILFLGACTKPPRLSMITEY-------------ME-LG-SLYHLIHLSGQKKKL 625
R P + P L++ T + LG SL + +S K L
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-KHVL 156
Query: 626 SWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDS-- 681
S R L++ + L +H + VH ++ + N V V + +G + S
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 682 --PMRDSSSA---GTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
+ S + G E+++ R + D+ SLG M + PW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFLPWTN 270
Query: 731 VLPE 734
LP
Sbjct: 271 CLPN 274
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 51/245 (20%), Positives = 78/245 (31%), Gaps = 57/245 (23%)
Query: 532 VGTRVGIGFFGEVFRG--IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
+G ++G G FG ++ A V + EN F +E+ R+ + I
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHV--VKVEYQENGPLF-SELKFYQRVAKKDCIK 97
Query: 590 FLGACTKPPRLSMITEY----------------ME-LG-SLYHLIHLSGQKKKLSWRRKL 631
+ L + Y ME LG L + +G
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG---TFK----K 150
Query: 632 K---MLRD--ICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDS--- 681
L + L IH + VH D+K+AN L+ V + D+GLS +
Sbjct: 151 STVLQLGIRMLDV-LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 682 ---PMRDSSS-AGTPEWMA------PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV 731
GT E+ + L R + D+ LG M PWE
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLCGKLPWEQN 263
Query: 732 LPERV 736
L + V
Sbjct: 264 LKDPV 268
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 786 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.02 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 96.92 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.73 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.07 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 95.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 94.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.23 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 94.18 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 93.05 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 92.92 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 92.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.96 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 90.77 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 89.72 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 88.79 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 88.03 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 87.95 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 86.31 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 85.66 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 82.86 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 82.71 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 81.29 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 81.28 | |
| 2dx0_A | 138 | Phospholipase C, gamma 2; phosphoric diester hydro | 80.72 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 80.69 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 80.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=457.58 Aligned_cols=262 Identities=35% Similarity=0.620 Sum_probs=222.6
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
...|+++.++|.++++||+|+||+||+|++++ .||||+++.........+.|.+|+.+|++++|||||+++++|.+ +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 35689999999999999999999999998876 59999997776677778899999999999999999999999865 46
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+++|||||++|+|.++++. ....+++.+++.|+.||+.||+|||+++||||||||+||||++++++||+|||+|+...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 8999999999999999963 34579999999999999999999999999999999999999999999999999998764
Q ss_pred CCC--CCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC
Q 003919 680 DSP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP 750 (786)
Q Consensus 680 ~~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----ip 750 (786)
... ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+....+..+...+...+ .+
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 263 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY 263 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence 322 22345689999999999964 4699999999999999999999999998877666665555443322 22
Q ss_pred ---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 751 ---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 751 ---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+..+.+|+.+||+ ||++|||+.+|+++|+.++.++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 2468999999999 9999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=462.88 Aligned_cols=249 Identities=27% Similarity=0.513 Sum_probs=217.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.++++||+|+||+||+|++ +|+.||||++..........+.|.+|+.+|++|+|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 57899999999999999999988 5899999999887777777889999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
|||+||+|.+++... ....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+......
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 999999999999632 3456899999999999999999999999999999999999999999999999999876543222
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADC 761 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~C 761 (786)
....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+...++..+...... ..+ +..+.+||.+|
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~ 260 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQL 260 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHH
Confidence 33567999999999999999999999999999999999999999999998888888765543 222 35799999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|+ ||++|||+.|+|+|
T Consensus 261 L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 261 FKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=447.04 Aligned_cols=257 Identities=30% Similarity=0.557 Sum_probs=222.0
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.+..++|.+.++||+|+||+||+|.+ +++.||||++... .....++|.+|+++|++++|||||+++|+|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45668999999999999999999986 3678999998643 34556889999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhc----------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSG----------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~----------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
.+.+|+|||||++|+|.++++... ....+++.+++.|+.||+.||+|||+++||||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 999999999999999999997432 2357999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003919 667 VKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~ 743 (786)
+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999876443222 223468999999999999999999999999999999998 89999999988887776653
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 744 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 744 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+..| +..+.+|+.+||+ ||++|||+.+|++.|+++..
T Consensus 247 -~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 -RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 344444 3469999999999 99999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=447.50 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=222.0
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
++..+++++.++||+|+||+||+|.+ +++.||||++..... ....++|.+|+.++++++|||||+++|+|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45678899999999999999999986 357899999865432 3345789999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK 663 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~ 663 (786)
++.+++|||||++|+|.+++..... ...+++..++.|+.||+.||+|||+++||||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999964321 246899999999999999999999999999999999999999
Q ss_pred CCeEEEEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 003919 664 HWTVKICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAV 740 (786)
Q Consensus 664 ~g~VKL~DFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i 740 (786)
++++||+|||+++.+.... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999998764332 22345689999999999999999999999999999999998 89999999988877766
Q ss_pred HhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 741 ANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 741 ~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.. +..++.|+ ..+.+|+.+||+ ||.+|||+.+|+++|+.+.
T Consensus 261 ~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 RN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred Hc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 54 44455553 368999999999 9999999999999998763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=447.71 Aligned_cols=258 Identities=31% Similarity=0.566 Sum_probs=218.0
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
+.+..++|.+.++||+|+||+||+|.+. ++.||||++... .....++|.+|+++|++++|||||+++|+|.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4456789999999999999999999863 678999998643 4455688999999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcC------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQ------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK 663 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~ 663 (786)
+.+.+|+|||||++|+|.++++.... ...+++.+++.|+.||+.||+|||+++||||||||+||||++
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 99999999999999999999974321 246899999999999999999999999999999999999999
Q ss_pred CCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 003919 664 HWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAV 740 (786)
Q Consensus 664 ~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i 740 (786)
++++||+|||+++.+..... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987644322 2235679999999999999999999999999999999999 89999999988887776
Q ss_pred HhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 741 ANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 741 ~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.. +.+++.|. ..+.+|+.+||+ ||++|||+.||+++|+.+..
T Consensus 274 ~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 TQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred Hc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 54 44455553 469999999999 99999999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=450.75 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=217.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.+.++||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999998 58899999997654432 3568899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 152 y~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 152 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999862 469999999999999999999999999999999999999999999999999999886655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCC---CChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEI---PEGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~i---p~~~L~~LI~~C 761 (786)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+....+...... ... -+..+.+||.+|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999888887777654321 111 134689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||++|||+.|+++|
T Consensus 308 L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 308 LVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99 99999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=446.17 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=218.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999988 588999999976543 223457899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 682 (786)
|||++||+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999997 34579999999999999999999999999999999999999999999999999999875332
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003919 683 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 760 (786)
Q Consensus 683 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~ 760 (786)
....+.+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+...+...+.......+ .-...+.+||.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 234567999999999999999999999999999999999999999999999888888877554332 124468999999
Q ss_pred hhh-CCCCCCCHHHHHH
Q 003919 761 CWA-EPQERPSCEEILS 776 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~ 776 (786)
||. ||.+|||++|++.
T Consensus 268 lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HSCSSGGGSTTSGGGTC
T ss_pred HccCCHhHCcChHHHcC
Confidence 999 9999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=450.08 Aligned_cols=263 Identities=31% Similarity=0.569 Sum_probs=226.4
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEECC-------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCC-CceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H-PNIVkL~ 591 (786)
..+|+++.++|++++.||+|+||+||+|.+.+ +.||||++..... ....+.|.+|+.+|.++.| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35799999999999999999999999998743 5799999875443 4446789999999999965 9999999
Q ss_pred cccccC-CceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 592 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 592 g~~~~~-~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
|+|.+. +.+++|||||++|+|.++++.... ...+++..++.|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998764 568999999999999999974321 345899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
||||++++.+||+|||+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987754322 2234578999999999999999999999999999999998 89999987766
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 735 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+......+.++..|+ ..+.+||.+||+ ||.+|||+.+|+++|.++..
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 66666666677766664 469999999999 99999999999999988753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=435.28 Aligned_cols=242 Identities=27% Similarity=0.471 Sum_probs=208.8
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCceEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 603 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~l~LV 603 (786)
|++.++||+|+||+||+|.+ +++.||+|++..........+.|.+|+.+|++++|||||+++++|.+ ...+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 46788999999999999998 47889999998777777777899999999999999999999999864 3568999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcC-CCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNK-HWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~-~g~VKL~DFGLA~~l~~ 680 (786)
||||+||+|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999973 457999999999999999999999998 999999999999984 78999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGR 756 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i---p~~~L~~ 756 (786)
. .....+||+.|||||++.+ +|+.++|||||||+||||+||+.||.+......+......+..+ .. ....+.+
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 2 3456789999999999875 59999999999999999999999998776655555555444332 22 2346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
||.+||. ||++|||+.|+++|
T Consensus 262 li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=445.69 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=211.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
+.++|++++.||+|+||+||+|++ .++.||||++............+.+|+++|++++|||||++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 457899999999999999999976 367899999976654433345788999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999999973 45799999999999999999999999999999999999999999999999999987755
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
......+.+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+..++...+.......+ .-+..+.+||.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 54455678999999999999999999999999999999999999999999999888888876544332 12457999999
Q ss_pred Hhhh-CCCCCCC-----HHHHHHH
Q 003919 760 DCWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPS-----a~EIL~~ 777 (786)
+||+ ||++||| ++|+++|
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHcccCHHHCCCCCcCCHHHHHcC
Confidence 9999 9999998 5788865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=442.84 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=214.7
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
....+.|.+.++||+|+||+||+|++ +|+.||||++...... .+|+.+++.++|||||++++++.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567899999999999999999998 4889999999765432 46999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 680 (786)
+|||||+||+|.++++. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+..
T Consensus 127 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999999999973 45799999999999999999999999999999999999999987 699999999988754
Q ss_pred CCC-----CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---C
Q 003919 681 SPM-----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---E 751 (786)
Q Consensus 681 ~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip---~ 751 (786)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+...+...+....... .++ +
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 321 1234689999999999999999999999999999999999999999887777777776654332 233 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+.+||.+||. ||.+|||+.||+++|....
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 468999999999 9999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=452.81 Aligned_cols=244 Identities=25% Similarity=0.397 Sum_probs=218.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.+.++||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5699999999999999999998 58899999997654432 3568899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 229 y~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 229 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred CCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999862 359999999999999999999999999999999999999999999999999999886655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCC---CChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEI---PEGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~i---p~~~L~~LI~~C 761 (786)
...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+....+..+...... ... -+..+.+||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 6789999999999999999999999999999999999999999999988888777654321 111 134799999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||++|||+.|+|+|
T Consensus 385 L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 385 LVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99 99999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=428.90 Aligned_cols=246 Identities=30% Similarity=0.460 Sum_probs=200.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+|++.+.||+|+||+||+|.+ +|+.||||++.+.... ....+.|.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999987 5899999999766543 33356799999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+ +|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 578988886 34679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 761 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~C 761 (786)
...+.+||+.|+|||++.+..| +.++|||||||+||+|+||+.||.+.+.......+.......+ ..+..+.+||.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3346789999999999998876 5899999999999999999999999888888777766554332 2245799999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|+ ||++|||++|+++|
T Consensus 247 L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SCSSGGGSCCHHHHHHC
T ss_pred ccCChhHCcCHHHHHcC
Confidence 99 99999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=421.74 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=200.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC----ceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~----~l~LV 603 (786)
.+|.+.++||+|+||+||+|+++|+.||||++.... .....+..|+..+.+++|||||+++++|.+++ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999986432 11122334566667889999999999997654 57999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc--------ceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
|||+++|+|.++++. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999963 3689999999999999999999987 9999999999999999999999999999
Q ss_pred ccccCCCC----CCCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCC----------CC----
Q 003919 676 RIITDSPM----RDSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWE----------GV---- 731 (786)
Q Consensus 676 ~~l~~~~~----~~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvIL~ELlTG~~PF~----------~~---- 731 (786)
+....... .....+||+.|+|||++.+. .|+.++|||||||+||||+||..||. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87754322 12345799999999999764 46789999999999999999976543 22
Q ss_pred -ChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 732 -LPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 732 -~~~~~l~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
........+.....++.+|.. .+.+|+.+||. ||++|||+.||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 223344444455556666532 47789999999 99999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=419.87 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=192.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 598 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------- 598 (786)
++|.+.+.||+|+||+||+|++ +|+.||||++.... .....+.|.+|+.+|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999988 58899999987554 3444578999999999999999999999986544
Q ss_pred -----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 599 -----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 599 -----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.+|+|||||++|+|.+++.........++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 379999999999999999754444456677889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC------------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH
Q 003919 674 LSRIITDSPM------------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAV 740 (786)
Q Consensus 674 LA~~l~~~~~------------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i 740 (786)
+|+.+..... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.+..... .+..+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 9988754321 1234579999999999999999999999999999999996 886543222 22222
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 741 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 741 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ....++.. ...+.+||.+||+ ||.+|||+.|++++
T Consensus 241 ~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 241 R-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2 22221111 1246789999999 99999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=425.72 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=211.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc------cCCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT------KPPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~------~~~~ 599 (786)
++|.+++.||+|+||+||+|.+ +|+.||||++..........+.+.+|+++|+.++|||||++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6799999999999999999988 5899999999776666667788999999999999999999999865 3467
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+|||||. |+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 999999996 57888886 45689999999999999999999999999999999999999999999999999998764
Q ss_pred CC----CCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003919 680 DS----PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 748 (786)
Q Consensus 680 ~~----~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~------ 748 (786)
.. .....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+....+..+......+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 2233567999999999998875 569999999999999999999999999988887776654322111
Q ss_pred --------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 --------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 --------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+||.+||. ||.+|||+.|+|+|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 012357889999999 99999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=421.67 Aligned_cols=356 Identities=27% Similarity=0.462 Sum_probs=276.1
Q ss_pred HHHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCC
Q 003919 401 AVRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEY 480 (786)
Q Consensus 401 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~ 480 (786)
-.+.|+|.++++.|+..++.+|+|++|.++ +.++.+.+++...++..++..+||.+.+..... ..+. +.. .+
T Consensus 73 ~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~-~~i~-~~~--~F 144 (454)
T 1qcf_A 73 FFKGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGG-FYIS-PRS--TF 144 (454)
T ss_dssp EETTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEECTTSC-EESS-SSS--CB
T ss_pred cccccchhhhhhhhhcCCCCCceEEEEECc----CCCCeEEEEEEecccCCCCceEEEEEEEcCCCc-EEEe-Ccc--cc
Confidence 356789999999999999999999999998 667888888877666556778888876631110 0000 000 00
Q ss_pred CCCCCCCCCCCCCCCCchhhhhhhh-------hccCCccCCC--CccccccccccCCCeeEeeEEeecCcEEEEEEEEC-
Q 003919 481 GSHGSERGGSSGYMANSEFVSTWNK-------VLESPMFQNK--PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 550 (786)
Q Consensus 481 ~s~sS~~~~ss~~~~~s~~~s~~~~-------il~sp~~~~~--~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~- 550 (786)
..-...+..+.. .+..+..... .....+.|.+..++|.+.+.||+|+||+||+|.++
T Consensus 145 -------------~sl~eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~ 211 (454)
T 1qcf_A 145 -------------STLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK 211 (454)
T ss_dssp -------------SSHHHHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT
T ss_pred -------------CCHHHHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECC
Confidence 000000000000 0001111111 12335778999999999999999999999999984
Q ss_pred CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHH
Q 003919 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630 (786)
Q Consensus 551 G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i 630 (786)
+..||||++..... ..+.|.+|+.+|++++|||||++++++. ...+++||||+.+|+|.+++... ....+++..+
T Consensus 212 ~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~ 286 (454)
T 1qcf_A 212 HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKL 286 (454)
T ss_dssp TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHHHH
T ss_pred ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHHHH
Confidence 78899999875443 2578999999999999999999999987 55689999999999999999732 2236788999
Q ss_pred HHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchh
Q 003919 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKC 709 (786)
Q Consensus 631 ~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ks 709 (786)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++....++.++
T Consensus 287 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 366 (454)
T 1qcf_A 287 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366 (454)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHH
Confidence 999999999999999999999999999999999999999999999876543211 2234567899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 710 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 710 DVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|||||||+||||+| |+.||.+....+....+.. +.+...+ +..+.+||.+||. ||.+|||+.+|++.|+++..
T Consensus 367 DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999 9999999988887776654 3444433 3469999999999 99999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=393.65 Aligned_cols=265 Identities=47% Similarity=0.898 Sum_probs=224.5
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
....+.+..++|.+.+.||+|+||+||+|.++|+.||||++..........+.|.+|+.++++++||||+++++++.+.+
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 45677788899999999999999999999999999999999877777777889999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+++||||+++|+|.+++........+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999974433345999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---hH
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---GP 753 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~ 753 (786)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........++. ..
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 765543344567899999999999999999999999999999999999999999998888777765665555553 46
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+.+||.+||. ||.+|||+.+|++.|+.+..
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999 99999999999999998764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=419.48 Aligned_cols=356 Identities=28% Similarity=0.487 Sum_probs=271.2
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 481 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~ 481 (786)
.+.|.|.++++.|+..++.+|+|++|.++ +.++.+.+++...+...+++.+||.+.+..... +-+.. ...+.
T Consensus 69 ~g~~~r~~ae~~L~~~~~~~G~FLvR~s~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~---~~~~~-~~~F~ 140 (452)
T 1fmk_A 69 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGG---FYITS-RTQFN 140 (452)
T ss_dssp EETCCHHHHHHHHTCTTSCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEECTTSC---EESST-TSEES
T ss_pred cCCccHHHHHHHhccCCCCCceEEEEeCC----CCCCceEEEEEeeccCCCCcEEEEEEEEcCCCC---EEEec-CcccC
Confidence 46789999999999999999999999998 567888888887665567788999887642110 11100 00000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhh-------ccCCcc---CCCCccccccccccCCCeeEeeEEeecCcEEEEEEEEC-
Q 003919 482 SHGSERGGSSGYMANSEFVSTWNKV-------LESPMF---QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 550 (786)
Q Consensus 482 s~sS~~~~ss~~~~~s~~~s~~~~i-------l~sp~~---~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~- 550 (786)
+-...+..+... +..+.. ........+.|++..++|.+.+.||+|+||+||+|.++
T Consensus 141 -------------Sl~~Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 207 (452)
T 1fmk_A 141 -------------SLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 207 (452)
T ss_dssp -------------SHHHHHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETT
T ss_pred -------------CHHHHHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECC
Confidence 000000000000 000000 01112235778899999999999999999999999985
Q ss_pred CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHH
Q 003919 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630 (786)
Q Consensus 551 G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i 630 (786)
+..||||++...... .+.|.+|+.+|++++||||+++++++.+ +.+++||||+++|+|.+++... ....+++..+
T Consensus 208 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~ 282 (452)
T 1fmk_A 208 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 282 (452)
T ss_dssp TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-CCCCCCHHHH
Confidence 467999998765433 3679999999999999999999999876 6689999999999999999632 2346899999
Q ss_pred HHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCCCchh
Q 003919 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKC 709 (786)
Q Consensus 631 ~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ks 709 (786)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++
T Consensus 283 ~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 362 (452)
T 1fmk_A 283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362 (452)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccc
Confidence 999999999999999999999999999999999999999999999876543222 2234577899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 710 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 710 DVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
|||||||+||||++ |+.||.+....+....+.. +.+...+ +..+.+||.+||. ||++|||+.+|++.|+++..+
T Consensus 363 DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999999 9999999888877766654 4444443 3468999999999 999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=403.47 Aligned_cols=345 Identities=24% Similarity=0.442 Sum_probs=259.9
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 481 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~ 481 (786)
.+.|.|.++++.|+ .+|+|++|.+++ .. .+.+++.. +++.+||.+.+... ...+.
T Consensus 17 hg~i~r~~a~~lL~----~~G~flvR~s~~----~~-~~~lsv~~-----~~~~~h~~i~~~~~----~~~~~------- 71 (377)
T 3cbl_A 17 HGAIPRAEVAELLV----HSGDFLVRESQG----KQ-EYVLSVLW-----DGLPRHFIIQSLDN----LYRLE------- 71 (377)
T ss_dssp CTTCCHHHHHHHCC----STTEEEEEECC------C-CEEEEC----------CCEEEC----C----CCCC--------
T ss_pred CCCCCHHHHHHHHh----cCCCEEEEEeCC----CC-cEEEEEEE-----CCCccchhhccccc----eEEec-------
Confidence 46789999999887 479999999973 22 56667765 24577887765310 01000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhccC----CccCCCCccccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEE
Q 003919 482 SHGSERGGSSGYMANSEFVSTWNKVLES----PMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVA 555 (786)
Q Consensus 482 s~sS~~~~ss~~~~~s~~~s~~~~il~s----p~~~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VA 555 (786)
...+.+-...+..+...... ...........+.|.++.++|.+.+.||+|+||+||+|.+ +++.||
T Consensus 72 --------~~~F~sl~~LI~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va 143 (377)
T 3cbl_A 72 --------GEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143 (377)
T ss_dssp -----------CCSHHHHHHHHHHHTCCC-----CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEE
T ss_pred --------ceeccchHHHHHHHhhccCCcccccCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEE
Confidence 00111111222221111000 0011112234567888899999999999999999999998 488999
Q ss_pred EEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHH
Q 003919 556 IKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635 (786)
Q Consensus 556 VKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~ 635 (786)
||++... ......+.|.+|+.++++++|||||++++++.+.+.+++||||+++|+|.+++.. ....+++..++.++.
T Consensus 144 vK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~ 220 (377)
T 3cbl_A 144 VKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVG 220 (377)
T ss_dssp EEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHH
T ss_pred EEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHH
Confidence 9998643 3444557899999999999999999999999999999999999999999999973 234689999999999
Q ss_pred HHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC--CCCCCCCcccCccccccCCCCchhhHHH
Q 003919 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD--SSSAGTPEWMAPELIRNEPFTEKCDIFS 713 (786)
Q Consensus 636 QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~--~~~~GT~~Y~APEvl~~~~~s~ksDVWS 713 (786)
||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....+++.|+|||.+.+..++.++||||
T Consensus 221 qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 300 (377)
T 3cbl_A 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300 (377)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHH
T ss_pred HHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHH
Confidence 99999999999999999999999999999999999999998754432211 1223567899999999889999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 714 LGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 714 LGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|||++|||++ |..||.+.........+.. +.+...| +..+.+||.+||. ||.+|||+.+|++.|+++..
T Consensus 301 lG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 301 FGILLWETFSLGASPYPNLSNQQTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 9999999998 9999999888776655543 4444444 3469999999999 99999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=427.30 Aligned_cols=246 Identities=25% Similarity=0.413 Sum_probs=217.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+++.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+...+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999988 58899999987543 334577899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC--CeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~--g~VKL~DFGLA~~l~~~~ 682 (786)
|||+||+|.+++. .....+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 234 E~~~gg~L~~~i~--~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHT--CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999885 234579999999999999999999999999999999999999854 899999999999875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+....+..+......+.. -+..+.+|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 334568999999999999999999999999999999999999999999998888888765544332 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.|+|+|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=401.64 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=196.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~ 601 (786)
+.|.+.++||+|+||+||+|++ .++.||||++..... ...+.+|+++|+.+ +|||||++++++.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 5799999999999999999976 267899999865432 35688999999998 6999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~l~~ 680 (786)
+||||+++|+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999999884 48899999999999999999999999999999999999876 8999999999986543
Q ss_pred CCC----------------------------CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003919 681 SPM----------------------------RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGV 731 (786)
Q Consensus 681 ~~~----------------------------~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~ 731 (786)
... .....+||+.|+|||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 12345899999999999875 4899999999999999999999999544
Q ss_pred -ChHHHHHHHHhcC-------------------------------------------------------CCCCCCChHHH
Q 003919 732 -LPERVVYAVANEG-------------------------------------------------------SRLEIPEGPLG 755 (786)
Q Consensus 732 -~~~~~l~~i~~~~-------------------------------------------------------~~~~ip~~~L~ 755 (786)
+....+..+.... ......+....
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 3333333222100 00001123577
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||.+|||++|+|+|
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHCcCChhHCcCHHHHhcC
Confidence 89999999 99999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=423.46 Aligned_cols=356 Identities=28% Similarity=0.475 Sum_probs=276.4
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 481 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~ 481 (786)
.+.|.|.++++.|+..++.+|+|++|.++ +.++.+.+++...+...++..+||.+.+.... ...+.. ...
T Consensus 152 ~g~i~r~~ae~~L~~~~~~~G~FLvR~S~----~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g-~~~i~~---~~~-- 221 (535)
T 2h8h_A 152 FGKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSG-GFYITS---RTQ-- 221 (535)
T ss_dssp CCSCCHHHHHHHHTCTTCCTTEEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEBC-CCS-CEEEET---TEE--
T ss_pred ccccCHHHHHHHhccCCCCCCeEEEEecC----CCCCcEEEEEEeeccCCCCceEEEEEEEcCCC-cEEeec---ccc--
Confidence 56789999999999999999999999998 55778888888766666778899988764211 000000 000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCcc---CCCCccccccccccCCCeeEeeEEeecCcEEEEEEEEC-
Q 003919 482 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMF---QNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN- 550 (786)
Q Consensus 482 s~sS~~~~ss~~~~~s~~~s~~~~il~-------sp~~---~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~- 550 (786)
+.+-...+..+..... .+.. ........+.|++..++|.+.+.||+|+||+||+|.++
T Consensus 222 -----------F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~ 290 (535)
T 2h8h_A 222 -----------FNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG 290 (535)
T ss_dssp -----------ESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETT
T ss_pred -----------ccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECC
Confidence 0001111111110000 0000 01112245778999999999999999999999999985
Q ss_pred CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHH
Q 003919 551 GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630 (786)
Q Consensus 551 G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i 630 (786)
+..||||++...... .+.|.+|+.+|++++|||||++++++.+ ..+++||||+.+|+|.+++... ....+++..+
T Consensus 291 ~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~ 365 (535)
T 2h8h_A 291 TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQL 365 (535)
T ss_dssp TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-HHTTCCHHHH
T ss_pred CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-CCCCCCHHHH
Confidence 467999999765443 3679999999999999999999999876 6689999999999999999632 2346889999
Q ss_pred HHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchh
Q 003919 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKC 709 (786)
Q Consensus 631 ~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ks 709 (786)
+.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..... ......++..|+|||++.+..++.++
T Consensus 366 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 445 (535)
T 2h8h_A 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445 (535)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchh
Confidence 99999999999999999999999999999999999999999999987643211 12234567899999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 710 DIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 710 DVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
|||||||+||||++ |+.||.+....+....+.. +.+...+ ...+.+||.+||. ||++|||+.+|++.|+++..+
T Consensus 446 DvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999 8999999888877766654 4444433 3469999999999 999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=404.50 Aligned_cols=344 Identities=23% Similarity=0.443 Sum_probs=261.6
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 481 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~ 481 (786)
.+.|.|.++++.|+. ..+|.|++|.++ ...+.+.+++.. ++..+||.+.... ....+... ..+.
T Consensus 84 hg~i~r~~ae~~L~~--~~~G~FlvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~~----~~~~i~~~-~~F~ 147 (450)
T 1k9a_A 84 HGKITREQAERLLYP--PETGLFLVREST----NYPGDYTLCVSC-----EGKVEHYRIMYHA----SKLSIDEE-VYFE 147 (450)
T ss_dssp CTTCCHHHHHHHTCS--CCTTEEEEEECS----SSTTSEEEEEEC-----SSSEEEEEEEEET----TEEESSSS-SCBS
T ss_pred ccCcCHHHhhhhhcc--CCCceEEEEecC----CCCCceEEEEEe-----CCeeeEEEEEecC----CceEeccc-cccc
Confidence 578999999999964 345999999998 445667777743 4567777763321 11111000 0000
Q ss_pred CCCCCCCCCCCCCCCchhhhhhhhhcc-------CCccCCCC-----ccccccccccCCCeeEeeEEeecCcEEEEEEEE
Q 003919 482 SHGSERGGSSGYMANSEFVSTWNKVLE-------SPMFQNKP-----LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW 549 (786)
Q Consensus 482 s~sS~~~~ss~~~~~s~~~s~~~~il~-------sp~~~~~~-----~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~ 549 (786)
+-...+..+..... .+.....+ .+....|.+..++|.+.+.||+|+||+||+|.+
T Consensus 148 -------------sl~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~ 214 (450)
T 1k9a_A 148 -------------NLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214 (450)
T ss_dssp -------------SHHHHHHHHHHCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEE
T ss_pred -------------cHHHHHhhhcccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEe
Confidence 00111111110000 00000000 112467888999999999999999999999999
Q ss_pred CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-ceEEEEEeeccchhHHHHHhhcCCccchHH
Q 003919 550 NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWR 628 (786)
Q Consensus 550 ~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~ 628 (786)
+|+.||||++.... ..+.|.+|+.+|++++|||||++++++.+.. .+++||||+++|+|.+++... ....+++.
T Consensus 215 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~ 289 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGD 289 (450)
T ss_dssp TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHH
T ss_pred cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHH
Confidence 99999999987543 2467999999999999999999999987654 799999999999999999743 23457899
Q ss_pred HHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCch
Q 003919 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708 (786)
Q Consensus 629 ~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k 708 (786)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||.+.+..++.+
T Consensus 290 ~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 290 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcH
Confidence 99999999999999999999999999999999999999999999999865332 223467889999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 709 CDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 709 sDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+|||||||+||||++ |+.||.+....+....+.. +.+...| +..+.+||.+||. ||.+|||+.+|++.|+++..
T Consensus 367 sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999999999998 9999998877776665543 4444444 3479999999999 99999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=422.56 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=205.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC----hHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT----AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~----~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
..++|.+++.||+|+||+||+|++ +|+.||||++.+.... .........++.+++.++|||||+++++|.+.+.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 457899999999999999999988 5889999999755432 1112223344667777899999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 267 lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999973 4579999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCC-CCChHH
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVL---PERVVYAVANEGSRLE-IPEGPL 754 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~---~~~~l~~i~~~~~~~~-ip~~~L 754 (786)
.. ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.. ...+...+.......+ .-+..+
T Consensus 344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a 421 (689)
T 3v5w_A 344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421 (689)
T ss_dssp SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence 54 3356799999999999964 579999999999999999999999997642 3333344433332221 124579
Q ss_pred HHHHHHhhh-CCCCCCC-----HHHHHHH
Q 003919 755 GRLIADCWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPS-----a~EIL~~ 777 (786)
.+||.+||. ||.+|++ +++|++|
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 999999999 9999998 7888875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=409.05 Aligned_cols=346 Identities=26% Similarity=0.536 Sum_probs=265.1
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCCC
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYGS 482 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~s 482 (786)
+.|.|.+++..|.. +.+|+|++|.++ ..++.+.+++.. +++.+||.+.+..... +-.... ..
T Consensus 110 g~i~r~~ae~ll~~--~~~G~fLvR~s~----~~~~~~~lsv~~-----~~~v~h~~I~~~~~g~---~~~~~~-~~--- 171 (495)
T 1opk_A 110 GPVSRNAAEYLLSS--GINGSFLVRESE----SSPGQRSISLRY-----EGRVYHYRINTASDGK---LYVSSE-SR--- 171 (495)
T ss_dssp EECCHHHHHHHGGG--CCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEECTTSC---EESSTT-SC---
T ss_pred cCCCHHHHHHHhhC--CCCceEEEEeCC----CCCCceEEEEee-----CCeEEEEEEEecCCCc---eEeccC-cc---
Confidence 57889999976643 678999999998 446677777765 3467888776531110 000000 00
Q ss_pred CCCCCCCCCCCCCCchhhhhhhhhc--------------cCCccCCCCccccccccccCCCeeEeeEEeecCcEEEEEEE
Q 003919 483 HGSERGGSSGYMANSEFVSTWNKVL--------------ESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGI 548 (786)
Q Consensus 483 ~sS~~~~ss~~~~~s~~~s~~~~il--------------~sp~~~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~ 548 (786)
+..-.+.+..+.... ..+... .....+..|++..++|.+.+.||+|+||+||+|.
T Consensus 172 ----------F~sl~eLv~~~~~~~~g~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~ 240 (495)
T 1opk_A 172 ----------FNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIY-GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240 (495)
T ss_dssp ----------BSSHHHHHHHHTTCCTTSSSCCCEECCCCSCCCCS-SSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEE
T ss_pred ----------chhHHHHhhhhcccccccchhcccccccccccccc-ccCccccccccCHHHceeeeEecCCCCeEEEEEE
Confidence 000000110000000 000000 0011357788999999999999999999999999
Q ss_pred EC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeeccchhHHHHHhhcCCccch
Q 003919 549 WN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLS 626 (786)
Q Consensus 549 ~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls 626 (786)
+. +..||||++...... .+.|.+|+.+|++++|||||+++++|.+...+++||||+++|+|.+++... ....++
T Consensus 241 ~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~ 316 (495)
T 1opk_A 241 WKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVS 316 (495)
T ss_dssp EGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSC
T ss_pred EcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCC
Confidence 84 789999998754433 478999999999999999999999999999999999999999999999743 345689
Q ss_pred HHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC-CCCCCCCCcccCccccccCCC
Q 003919 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR-DSSSAGTPEWMAPELIRNEPF 705 (786)
Q Consensus 627 ~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~ 705 (786)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..+
T Consensus 317 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 317 AVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 9999999999999999999999999999999999999999999999999877543222 233456789999999999999
Q ss_pred CchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 706 TEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 706 s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
+.++|||||||+||||++ |..||.+.........+ ....+...+ +..+.+||.+||+ ||.+|||+.+|++.|++
T Consensus 397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 999999999999999999 99999988876665544 334444444 3469999999999 99999999999999988
Q ss_pred hh
Q 003919 781 CE 782 (786)
Q Consensus 781 i~ 782 (786)
+.
T Consensus 476 ~~ 477 (495)
T 1opk_A 476 MF 477 (495)
T ss_dssp SC
T ss_pred HH
Confidence 64
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=384.53 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=222.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
...+|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999987 688999999987777777778899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp ECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999999873 3568999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADC 761 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~C 761 (786)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......+. .+..+.+|+.+|
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 248 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF 248 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 34567899999999999988775 8999999999999999999999999988888877766554432 245789999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||.+|||+.++++|
T Consensus 249 L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 249 LVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCSSTTTSCCHHHHTTC
T ss_pred CCCChhHCcCHHHHhcC
Confidence 99 99999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=386.30 Aligned_cols=261 Identities=29% Similarity=0.576 Sum_probs=222.9
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++... ......+.|.+|+.+++.+ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 346667789999999999999999999762 356999998654 3445568899999999999 89999999
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+++|.+.+.+|+||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 9999999999999999999999999975321 235889999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||+++.+...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999999876543322 234567889999999999999999999999999999999 99999988877
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 735 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.....+.. +.....+ ...+.+||.+||. ||.+||++.+++++|+++..
T Consensus 313 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 313 ELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp GHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 66655543 3344443 3479999999999 99999999999999998764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=362.86 Aligned_cols=254 Identities=29% Similarity=0.562 Sum_probs=225.1
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--Cce
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PRL 600 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~l 600 (786)
+.+..++|.+.+.||+|+||+||+|.++++.+|||++..........+.|.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456678999999999999999999999999999999987776777778899999999999999999999999877 788
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
+++|||+++|+|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999999732 2336899999999999999999999999 999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---Ch
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTE---KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EG 752 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~---ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~ 752 (786)
.. ....||+.|+|||.+.+..++. ++|||||||++|+|++|+.||.+.........+.........+ +.
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 22 3457899999999998765444 8999999999999999999999998888887777776666555 34
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 79999999999 9999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=413.25 Aligned_cols=260 Identities=26% Similarity=0.514 Sum_probs=217.8
Q ss_pred ccccccCCCeeEe-eEEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 521 EEWNIDFSELTVG-TRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~-k~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
.++.+....+.+. +.||+|+||+||+|.+ .++.||||++..........+.|.+|+.+|++++|||||+++++|.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3455555566654 4899999999999966 3578999999776655566788999999999999999999999996
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
. +.+++||||+.+|+|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred c-CCEEEEEEccCCCCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 5 45899999999999999996 3457899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 676 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 676 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
+.+..... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.........+.. +.....+
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 87754321 1223456789999999999999999999999999999998 9999999988877766654 3344444
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 751 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+..+.+||..||. ||++||++.+|++.|+++.+.+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 3479999999999 9999999999999999988765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=363.41 Aligned_cols=257 Identities=30% Similarity=0.614 Sum_probs=223.2
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
.|.+..++|.+.+.||+|+||.||+|.+ +++.||+|++....... +.|.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 5677789999999999999999999988 78889999997655443 5789999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEEeCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999863 345689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChHHHH
Q 003919 681 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGPLGR 756 (786)
Q Consensus 681 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~--~ip~~~L~~ 756 (786)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....... ...+..+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence 221 2234567789999999999999999999999999999999 999999988888777765542221 122457999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|+.+||. ||.+||++.+++++|+++..
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999 99999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=410.55 Aligned_cols=260 Identities=27% Similarity=0.529 Sum_probs=216.8
Q ss_pred ccccccCCCeeEee-EEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 521 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
..+.+..+++.+.. .||+|+||+||+|.+ ++..||||++.... .....+.|.+|+.+|++++|||||+++++|.
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 34556677788777 899999999999976 35579999987543 2334688999999999999999999999997
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
. +.+++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 6 569999999999999999862 3457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC
Q 003919 676 RIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE 751 (786)
Q Consensus 676 ~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~ 751 (786)
+.+...... .....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+.. +.+...+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~ 562 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPP 562 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCCCCCT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876433211 122345689999999999999999999999999999998 9999999888877766554 44444443
Q ss_pred ---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 752 ---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 752 ---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
..+.+||.+||. ||.+||++.+|++.|+++..++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 479999999999 9999999999999999886653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.23 Aligned_cols=252 Identities=37% Similarity=0.688 Sum_probs=210.0
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccC--hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~--~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
++..++|.+.+.||+|+||.||+|.+.++.+|||++...... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 456789999999999999999999999999999998654322 233578899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc---eeeccCCcccEEEcC--------CCeEEEE
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK---IVHRDLKSANCLVNK--------HWTVKIC 670 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g---IIHrDLKpsNILLd~--------~g~VKL~ 670 (786)
+||||+++++|.+++. ...+++..++.++.|++.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999884 457899999999999999999999999 999999999999986 7789999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 671 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+.........+
T Consensus 159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 999998765432 235679999999999999999999999999999999999999999998888877777666555554
Q ss_pred C---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 751 E---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 751 ~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
. ..+.+|+.+||. ||.+|||+.+++++|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 3 469999999999 999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=372.25 Aligned_cols=245 Identities=28% Similarity=0.466 Sum_probs=215.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..+|.+.+.||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46799999999999999999986 68899999987554433 467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred ECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999863 35899999999999999999999999999999999999999999999999999887665555
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCC---ChHHHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIP---EGPLGRLIAD 760 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip---~~~L~~LI~~ 760 (786)
.....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+....... ..+ +..+.+|+.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 566789999999999999999999999999999999999999999988877776665544322 222 3468999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+|||+.+++++
T Consensus 253 ~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 253 CLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HSCSSTTTSCCHHHHTTC
T ss_pred HccCChhHCcCHHHHhhC
Confidence 999 99999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=381.29 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=218.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 457899999999999999999988 588999999975432 22335678999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus 83 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999998873 4578999999999999999999999999999999999999999999999999998754444
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 761 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~C 761 (786)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ ..+..+.+||.+|
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 445567899999999999999999999999999999999999999999888887777766544332 2245799999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003919 762 WA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRP-----Sa~EIL~~ 777 (786)
|. ||.+|| ++.+|++|
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhcCHHHhcCCCCCCHHHHHcC
Confidence 99 999999 89999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=377.45 Aligned_cols=266 Identities=31% Similarity=0.560 Sum_probs=223.7
Q ss_pred cccccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeE
Q 003919 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL 589 (786)
Q Consensus 518 ~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVk 589 (786)
.....|++..++|.+++.||+|+||.||+|.+ +++.||||++.... .....+.|.+|+.+++++ +|||||+
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34567888899999999999999999999984 34789999986543 344567899999999999 7999999
Q ss_pred EecccccCCc-eEEEEEeeccchhHHHHHhhcC-----------------------------------------------
Q 003919 590 FLGACTKPPR-LSMITEYMELGSLYHLIHLSGQ----------------------------------------------- 621 (786)
Q Consensus 590 L~g~~~~~~~-l~LV~Ey~~gGSL~dlL~~~~~----------------------------------------------- 621 (786)
+++++.+.+. +++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999887654 8999999999999999974322
Q ss_pred ----------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--
Q 003919 622 ----------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-- 683 (786)
Q Consensus 622 ----------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-- 683 (786)
...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 11289999999999999999999999999999999999999999999999999987643321
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...................+ ...+.+|+.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 2234568889999999999999999999999999999998 999998877655555555555544444 347999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 760 DCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+||. ||.+|||+.+++++|+++..+
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999 999999999999999988654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=362.73 Aligned_cols=260 Identities=31% Similarity=0.602 Sum_probs=221.5
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
.+..|.+..++|.+.+.||+|+||+||++.+. +..||||++....... ++|.+|+.++++++||||+++++++.+.
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 34677788899999999999999999999884 6689999997655443 5789999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred CCeEEEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 999999999999999999963 245699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChH
Q 003919 678 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGP 753 (786)
Q Consensus 678 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~--~ip~~~ 753 (786)
...... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....... ...+..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence 643211 1234457788999999999999999999999999999998 999999988887777666543221 223457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 9999999999 99999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=358.77 Aligned_cols=257 Identities=28% Similarity=0.581 Sum_probs=221.7
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
.+++..++|.+.+.||+|+||.||++.+. +..||+|++....... +.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 45667789999999999999999999884 5689999997655443 5789999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999999998743 34689999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChHHHH
Q 003919 681 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGPLGR 756 (786)
Q Consensus 681 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~--~ip~~~L~~ 756 (786)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....... ...+..+.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 322 2234456778999999999889999999999999999999 999999988887776665443222 222457999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|+..||. ||.+|||+.+++++|+.+..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 9999999 99999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.38 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=209.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 36899999999999999999988 5889999999877666666788999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9998755444443 3467999999999999999999999999999999999999999999999999999887655444
Q ss_pred CCCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCC--------------
Q 003919 685 DSSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLE-------------- 748 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvIL~ELlTG~~P-F~~~~~~~~l~~i~~~~~~~~-------------- 748 (786)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.........+......+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 55678999999999998765 89999999999999999998887 556565555555443111100
Q ss_pred ----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ----------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+|+.+||+ ||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 012357899999999 99999999999985
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.65 Aligned_cols=263 Identities=32% Similarity=0.585 Sum_probs=224.5
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEe
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFL 591 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~ 591 (786)
....|.+..++|.+.+.||+|+||.||++.+ .++.||||++... ......+.+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 4456777889999999999999999999976 2478999998644 3455568899999999999999999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC---------------------CccchHHHHHHHHHHHHHHHHhhhhccee
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIV 650 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~---------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gII 650 (786)
+++.+.+.+++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999975432 23589999999999999999999999999
Q ss_pred eccCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 003919 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRP 727 (786)
Q Consensus 651 HrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~P 727 (786)
||||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654322 2234567889999999999999999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 728 WEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 728 F~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|.+.........+... .....+ +..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 253 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp STTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9988877666555443 333333 3479999999999 99999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=371.48 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=223.3
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEECC-------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~ 593 (786)
..+.+..++|.+.+.||+|+||.||+|.+.+ +.||||++.... .....+.|.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4566778899999999999999999998753 789999986543 34556789999999999999999999999
Q ss_pred cccCCceEEEEEeeccchhHHHHHhhcC---------------------CccchHHHHHHHHHHHHHHHHhhhhcceeec
Q 003919 594 CTKPPRLSMITEYMELGSLYHLIHLSGQ---------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652 (786)
Q Consensus 594 ~~~~~~l~LV~Ey~~gGSL~dlL~~~~~---------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHr 652 (786)
+.+.+.+++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999999999999999999999975321 2578999999999999999999999999999
Q ss_pred cCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003919 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 729 (786)
Q Consensus 653 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~ 729 (786)
||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643221 2234568899999999999999999999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 730 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+.........+..... ...+ +..+.+|+.+||. ||.+||++.+++++|+++...
T Consensus 279 ~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCChHHHHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9888877776654432 2333 3479999999999 999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.67 Aligned_cols=255 Identities=30% Similarity=0.564 Sum_probs=213.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+..++|.+++.||+|+||+||++.+ +++.||+|++.. ......+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4568999999999999999999998 488999998854 345567889999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999999973 24578999999999999999999999999999999999999999999999999998764432
Q ss_pred CCC--------------CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhc
Q 003919 683 MRD--------------SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-----VVYAVANE 743 (786)
Q Consensus 683 ~~~--------------~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-----~l~~i~~~ 743 (786)
... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||....... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 14579999999999999999999999999999999999999986532211 11111111
Q ss_pred CCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 744 GSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 744 ~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
...... +..+.+|+.+||. ||.+|||+.++++.|+++...
T Consensus 243 ~~~~~~-~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 YCPPNC-PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp TCCTTC-CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCC-CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112222 3469999999999 999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=378.13 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=218.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||.||+|.+ +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999988 48899999998777777777889999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC---CeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~~~~ 682 (786)
|+.+|+|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 109 LVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp CCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred cCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999886 44678999999999999999999999999999999999999865 459999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 264 (362)
T 2bdw_A 186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264 (362)
T ss_dssp -SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred -ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 3345789999999999999999999999999999999999999999988888877776655444332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+||++.+++++
T Consensus 265 i~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 265 IDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=382.93 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=212.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+..++|.+.+.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3468999999999999999999988 478999999975432 233456788999999988 699999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999873 35799999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIA 759 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~ 759 (786)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+. ....+.+||.
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 444455678999999999999989999999999999999999999999999998888888765543332 2457899999
Q ss_pred Hhhh-CCCCCCCH------HHHHHH
Q 003919 760 DCWA-EPQERPSC------EEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa------~EIL~~ 777 (786)
+||. ||.+||++ .+|++|
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999 99999998 788765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=390.37 Aligned_cols=247 Identities=24% Similarity=0.381 Sum_probs=220.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||+|.+ +|+.+|+|++..........+.+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 6799999999999999999987 68999999998777666667889999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 682 (786)
|+.+|+|.+.+. ....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999887 345799999999999999999999999999999999999998 46789999999998876655
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.........+ +..+.+|
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 45556789999999999999999999999999999999999999999999888888877665544332 3469999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.++|+|
T Consensus 248 i~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhHCCCHHHHhcC
Confidence 999999 99999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.07 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=207.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh------------------------HHHHHHHHHHHHH
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA------------------------ENMEDFCNEISIL 579 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~------------------------~~~~~f~~EI~iL 579 (786)
..++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.|.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 357899999999999999999987 58899999987654211 1245789999999
Q ss_pred hhcCCCceeEEeccccc--CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 580 SRLRHPNVILFLGACTK--PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 580 ~~L~HPNIVkL~g~~~~--~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
++++||||+++++++.+ ...+++||||+++++|.+++ ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 99999999999999876 56799999999999998765 3457999999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~ 734 (786)
|||++.++.+||+|||++..+...........||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999988765444445678999999999998765 378999999999999999999999988877
Q ss_pred HHHHHHHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 735 RVVYAVANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 735 ~~l~~i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.....+......... .+..+.+|+.+||. ||.+|||+.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 766666554433322 23569999999999 99999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=377.10 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=216.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+.|.+++.||+|+||+||+|.+ +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 6799999999999999999988 48899999997654422 13467899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 677 (786)
+||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999986 456799999999999999999999999999999999999998877 799999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 752 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~ 752 (786)
+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+........ ..+.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 75532 33467899999999999999999999999999999999999999999988888877765544332 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||.+|||+.++++|
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.01 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 58899999999999999999998 68899999997655555556789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++ +|.+.+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 9985 67776652 34568999999999999999999999999999999999999999999999999998876544444
Q ss_pred CCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------
Q 003919 686 SSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------------- 748 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------------- 748 (786)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 56689999999999876 5689999999999999999999999987766655554432111100
Q ss_pred ---------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ---------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ---------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.-...+.+||.+||. ||.+|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 012357789999999 99999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=361.63 Aligned_cols=264 Identities=28% Similarity=0.520 Sum_probs=224.7
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
...|++..++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++++ +||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 456788889999999999999999999985 35789999987543 334467899999999999 899999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC---------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCc
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ---------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~---------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKp 656 (786)
+++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999999974322 12589999999999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003919 657 ANCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 733 (786)
Q Consensus 657 sNILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~ 733 (786)
+|||++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999877543221 223457789999999999999999999999999999999 9999988776
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 734 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
................+ +..+.+|+.+||. ||.+|||+.+++++|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55555555555444333 3479999999999 999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=372.45 Aligned_cols=263 Identities=28% Similarity=0.514 Sum_probs=220.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g 592 (786)
.+|++..++|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35778889999999999999999999986 35579999986443 233457899999999999 8999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcC--------------------CccchHHHHHHHHHHHHHHHHhhhhcceeec
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHr 652 (786)
++...+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999974322 1347999999999999999999999999999
Q ss_pred cCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003919 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 729 (786)
Q Consensus 653 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~ 729 (786)
||||+|||++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987644322 1223457789999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 730 GVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+...................+ +..+.+|+.+||. ||.+|||+.+|+++|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 887666666666655554444 4579999999999 999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.84 Aligned_cols=257 Identities=33% Similarity=0.545 Sum_probs=218.6
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
++..++|.+.+.||+|+||+||+|.+ .+..||||++... ......+.|.+|+.+++.++||||+++++++.+..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567899999999999999999987 2446999998644 34455678999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ccEEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999863 3457999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003919 679 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 679 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~ 751 (786)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... .....+ +
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcC
Confidence 54322 1223456778999999999999999999999999999999 99999999888877766554 333333 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
..+.+|+..||. ||.+|||+.+|++.|+.+...
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 469999999999 999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.86 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.++|.+.+.||+|+||+||+|.+ .|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 36899999999999999999988 48899999987655444344678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 9985 88888763 34578999999999999999999999999999999999999999999999999998775443334
Q ss_pred CCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Q 003919 686 SSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------------- 747 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------------- 747 (786)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 456789999999999764 58999999999999999999999999888776666554311000
Q ss_pred -------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..-+..+.+|+.+||. ||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0013457899999999 99999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.20 Aligned_cols=260 Identities=33% Similarity=0.652 Sum_probs=208.9
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..+.+++...+|++.+.||+|+||+||+|.+.+ .+|||++..........+.|.+|+.++++++||||+++++++ ...
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 455677888999999999999999999998766 499999987776777778999999999999999999999965 455
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+.+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred ccEEEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 68999999999999999852 3467899999999999999999999999999999999999999999999999999865
Q ss_pred cCC--CCCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-C---
Q 003919 679 TDS--PMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-I--- 749 (786)
Q Consensus 679 ~~~--~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-i--- 749 (786)
... ........||+.|+|||.+. +..++.++|||||||++|+|++|+.||.+.................. .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 432 12223457999999999986 66789999999999999999999999988766655555544333222 1
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+..+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 12469999999999 9999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.80 Aligned_cols=257 Identities=30% Similarity=0.621 Sum_probs=222.1
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
+|.++.++|.+.+.||+|+||.||++.+ +++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4677889999999999999999999988 67889999997655433 6789999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EEEECCCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEEeCCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999863 335689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC--CCCChHHHH
Q 003919 681 SPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL--EIPEGPLGR 756 (786)
Q Consensus 681 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~--~ip~~~L~~ 756 (786)
... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+....... ...+..+.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHH
Confidence 211 1234567889999999998899999999999999999999 899999988887777665432211 122457999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|+.+||. ||.+||++.+++++|+++..
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999 99999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.16 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=211.4
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC--
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-- 598 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-- 598 (786)
.++.+...+|++.+.||+|+||+||+|.+.++.||||++.... .....+..|+.++++++|||||++++++....
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 4566778899999999999999999999999999999986432 23355667999999999999999999997754
Q ss_pred --ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc----------ceeeccCCcccEEEcCCCe
Q 003919 599 --RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM----------KIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 599 --~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~----------gIIHrDLKpsNILLd~~g~ 666 (786)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 37999999999999999963 3589999999999999999999999 9999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------
Q 003919 667 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNE-----PFTEKCDIFSLGVIMWELCTLNRPWEGVL------- 732 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~-----~~s~ksDVWSLGvIL~ELlTG~~PF~~~~------- 732 (786)
+||+|||+++.+..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999987754322 22346799999999999863 45678999999999999999999997532
Q ss_pred ---------hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 733 ---------PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 733 ---------~~~~l~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.......+......+..+. ..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2222333333333333332 138899999999 99999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=367.16 Aligned_cols=264 Identities=25% Similarity=0.438 Sum_probs=206.8
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC--Ce---eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~---~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~ 594 (786)
.+++.+..++|.+.+.||+|+||+||+|.+. +. .||||++..........+.|.+|+.++++++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4556677889999999999999999999763 22 799999976655556678999999999999999999999999
Q ss_pred ccCCce------EEEEEeeccchhHHHHHhhcC---CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 595 TKPPRL------SMITEYMELGSLYHLIHLSGQ---KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 595 ~~~~~l------~LV~Ey~~gGSL~dlL~~~~~---~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
...... +++|||+.+|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876654 999999999999999864322 22589999999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 003919 666 TVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVAN 742 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~ 742 (786)
.+||+|||++......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 9999999999876543221 223456789999999999999999999999999999999 8999999888777776655
Q ss_pred cCCCCCC--CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 743 EGSRLEI--PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 743 ~~~~~~i--p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
....... ....+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 4432222 23479999999999 99999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.58 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=206.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999988 4889999998776666666778999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999999886 4567999999999999999999999999999999999999999999999999999887654444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------------ 745 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------------ 745 (786)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 456689999999999976 6789999999999999999999999998887766554432110
Q ss_pred -CCC-------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 -RLE-------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 -~~~-------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
... ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 112357899999999 99999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=372.94 Aligned_cols=262 Identities=29% Similarity=0.543 Sum_probs=224.8
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeE
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVIL 589 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVk 589 (786)
...|++..++|.+++.||+|+||+||+|.+. +..||||++... ......+.+.+|+++++++ +|||||+
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 3456777899999999999999999999862 257999998654 3455568899999999999 8999999
Q ss_pred EecccccCCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCc
Q 003919 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656 (786)
Q Consensus 590 L~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKp 656 (786)
+++++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 99999999999999999999999999975431 24699999999999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003919 657 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 733 (786)
Q Consensus 657 sNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~ 733 (786)
+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322 2234567889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 734 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
......+... .....+ ...+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 300 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 EELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 7776655543 333333 3479999999999 99999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.63 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=205.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+..++|.+.+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4467899999999999999999986 578999999976543 223346788999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.+|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999999873 35688999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGR 756 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~ 756 (786)
...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+ .....+.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 250 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD 250 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 54443344567899999999999999999999999999999999999999999888887777766443322 22457999
Q ss_pred HHHHhhh-CCCCCC-----CHHHHHHH
Q 003919 757 LIADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
||.+||. ||.+|| ++.++++|
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 9999999 999999 88898875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=354.10 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=219.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999988 4889999999877777777788999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe---EEEEecCccccccCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITDS 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l~~~ 681 (786)
||+.+++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999988863 356899999999999999999999999999999999999986655 999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGR 756 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~ 756 (786)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+.........+ +..+.+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 162 E-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred c-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 2 3345679999999999999999999999999999999999999999988888877776655444332 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
|+.+||. ||.+|||+.+++++
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHcccChhhCCCHHHHhcC
Confidence 9999999 99999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=360.00 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=213.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+.+.||+|+||.||++.+ .++.||+|++..... .....+.|.+|+.++++++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 36899999999999999999987 588999999865443 445567899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999973 34789999999999999999999999999999999999999999999999999987654322
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------CCChHHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------IPEGPLGR 756 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~------ip~~~L~~ 756 (786)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.................. .-+..+.+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 22345799999999999999999999999999999999999999999888776665554432211 11346899
Q ss_pred HHHHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003919 757 LIADCWA-EPQERP-SCEEILSRLLDCE 782 (786)
Q Consensus 757 LI~~CL~-DP~kRP-Sa~EIL~~L~~i~ 782 (786)
++.+||. ||.+|| +++++++.|..+.
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 9999999 999998 9999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=365.07 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=215.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+.|.+.+.||+|+||.||++.+ +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999988 48899999997654321 13578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 677 (786)
+||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999986 456799999999999999999999999999999999999999887 899999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 752 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~ 752 (786)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+........ ..+.
T Consensus 168 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 75432 23456799999999999999999999999999999999999999999888877777665443332 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||.+|||+.++++|
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 68899999999 99999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=363.21 Aligned_cols=265 Identities=30% Similarity=0.523 Sum_probs=224.5
Q ss_pred CccccccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee
Q 003919 516 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 516 ~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV 588 (786)
..+..++|++..++|.+.+.||+|+||.||+|.+. ++.||||++.... .......|.+|+.+++.++||||+
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34456788888899999999999999999999764 5789999986443 344557899999999999999999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhcC-------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV 661 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL 661 (786)
++++++.+....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 999999999999999999999999999874321 1456899999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 003919 662 NKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVY 738 (786)
Q Consensus 662 d~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~ 738 (786)
+.++.+||+|||++......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 99999999999999876433211 223456889999999999999999999999999999999 899999988877777
Q ss_pred HHHhcCCCCC--CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 739 AVANEGSRLE--IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 739 ~i~~~~~~~~--ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+........ ..+..+.+|+.+||. ||.+|||+.+++++|++.
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 6655433221 123469999999999 999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=369.14 Aligned_cols=246 Identities=24% Similarity=0.439 Sum_probs=216.2
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||+||++.+ +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 357899999999999999999988 588999999875432 11235678899999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999997 3457899999999999999999999999999999999999999999999999999876542
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 761 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~C 761 (786)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+|+.+|
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 3457899999999999999999999999999999999999999999888888877776543322 2245799999999
Q ss_pred hh-CCCCCC-----CHHHHHHH
Q 003919 762 WA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRP-----Sa~EIL~~ 777 (786)
|. ||.+|| ++++|++|
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hccCHHHcCCCcCCCHHHHhcC
Confidence 99 999999 89999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.71 Aligned_cols=258 Identities=30% Similarity=0.532 Sum_probs=207.6
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
.++++..++|.+.+.||+|+||.||+|.+. +..||+|++... ......+.|.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 456677889999999999999999999873 456999997643 23455678999999999999999999999985
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCccEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 4568999999999999999863 2346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 676 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 676 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+.... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 242 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 242 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCC
Confidence 87754322 2233457789999999999999999999999999999997 999999888777766665433 22233
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+..+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 243 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3469999999999 99999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=370.97 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=211.2
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~ 601 (786)
..++|.+.+.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+.+++++ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 457899999999999999999988 488999999976654 344567788999999988 8999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 87 lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999873 357999999999999999999999999999999999999999999999999999875444
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-CCC
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-IPE 751 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~---------~~~~~l~~i~~~~~~~~-ip~ 751 (786)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ ..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 34455678999999999999999999999999999999999999999752 22333344443332221 124
Q ss_pred hHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSC------EEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa------~EIL~~ 777 (786)
..+.+||.+||. ||.+||++ .++++|
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 468999999999 99999995 677765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=377.46 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=216.0
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
.+..++|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999988 588999999975432 122346788899999887 89999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999873 3578999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHH
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLI 758 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI 758 (786)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ ..+..+.+||
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 443445577899999999999999999999999999999999999999999988888777766543322 2245799999
Q ss_pred HHhhh-CCCCCCCHH-HHHHH
Q 003919 759 ADCWA-EPQERPSCE-EILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~-EIL~~ 777 (786)
.+||. ||.+||++. +|++|
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHhcCCHhHcCCChHHHHcC
Confidence 99999 999999997 77654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=371.48 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=210.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+.|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999988 588999999864322 11135779999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe---EEEEecCccccc
Q 003919 603 ITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRII 678 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l 678 (786)
||||+++++|.+.+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998777533 23346899999999999999999999999999999999999986654 999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCChH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEGP 753 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~~ 753 (786)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ......+........ ..+..
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHH
Confidence 665444556789999999999999999999999999999999999999998853 344444444333222 12456
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||.+||. ||.+|||+.++++|
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 8999999999 99999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=364.17 Aligned_cols=263 Identities=29% Similarity=0.556 Sum_probs=223.4
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEECC-------eeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
.+.|++..++|.+.+.||+|+||.||+|.+.+ ..||+|++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 34678889999999999999999999998742 379999986543 344567899999999999 899999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcC-----------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQ-----------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-----------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
+++.+.+.+++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 999999999999999999999999874321 345799999999999999999999999999999999999
Q ss_pred EcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 003919 661 VNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVV 737 (786)
Q Consensus 661 Ld~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l 737 (786)
++.++.+||+|||++........ ......+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999987643322 1234456789999999999999999999999999999998 89999887766666
Q ss_pred HHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 738 YAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 738 ~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+.........+ +..+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 6665555444333 4579999999999 99999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=356.96 Aligned_cols=260 Identities=25% Similarity=0.510 Sum_probs=217.2
Q ss_pred ccccccCCCeeEee-EEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 521 EEWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
.++.++.++|.+.+ .||+|+||+||+|.+ .++.||||++..........+.|.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 45666778999998 999999999999965 367899999976655555578899999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..+.+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 55678999999999999999973 456899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 676 RIITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 676 ~~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.. +.....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 243 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPA 243 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCC
Confidence 876543221 123456789999999998889999999999999999999 9999999888776665544 3333333
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 751 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+..+.+|+.+||. ||.+||++.++++.|+++..+.
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 3479999999999 9999999999999999886643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=358.18 Aligned_cols=257 Identities=28% Similarity=0.507 Sum_probs=208.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-- 596 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-- 596 (786)
+..++|++.+.||+|+||+||+|.+ +++.||||++... .....+.|.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4457899999999999999999985 5789999998643 34556789999999999999999999998854
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+++||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 35689999999999999999732 3468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------HHH
Q 003919 677 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER---------------VVY 738 (786)
Q Consensus 677 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~---------------~l~ 738 (786)
....... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654321 1223457778999999999999999999999999999999999986532211 112
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 739 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 739 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
...........+ +..+.+|+.+||. ||.+|||+.++++.|+++...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 222333333333 3469999999999 9999999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=374.74 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=216.1
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+..++|.+.+.||+|+||+||+|.+. |+.||||++..... .....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34689999999999999999999984 67899999875432 123356788999999988 799999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999873 34699999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+||.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 44445577899999999999999999999999999999999999999999988888887776544332 12457899999
Q ss_pred Hhhh-CCCCCCC-----HHHHHHH
Q 003919 760 DCWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPS-----a~EIL~~ 777 (786)
+||. ||.+||+ +.+|++|
T Consensus 254 ~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 254 GLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999 9999995 5788765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=357.62 Aligned_cols=247 Identities=32% Similarity=0.590 Sum_probs=203.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhh--cCCCceeEEeccccc----CCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTK----PPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~--L~HPNIVkL~g~~~~----~~~l 600 (786)
.++|.+.+.||+|+||+||+|.++++.||||++... ....+..|.+++.. ++||||+++++++.. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999999999999998543 23566677777766 789999999998644 3458
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh--------hcceeeccCCcccEEEcCCCeEEEEec
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--------s~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
++||||+++|+|.++++ ...+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999999995 347999999999999999999999 999999999999999999999999999
Q ss_pred CccccccCCCCC----CCCCCCCCcccCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 003919 673 GLSRIITDSPMR----DSSSAGTPEWMAPELIRNE------PFTEKCDIFSLGVIMWELCTL----------NRPWEGVL 732 (786)
Q Consensus 673 GLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~------~~s~ksDVWSLGvIL~ELlTG----------~~PF~~~~ 732 (786)
|++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999876543222 2345799999999999876 455799999999999999999 88886432
Q ss_pred -----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 733 -----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 733 -----~~~~l~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.......+.........+. ..+.+|+.+||. ||.+|||+.+|++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 2223333333334444443 248899999999 9999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=367.64 Aligned_cols=245 Identities=21% Similarity=0.313 Sum_probs=215.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +++.+|+|++... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 47899999999999999999988 5889999998643 234567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC--CCeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~ 682 (786)
||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999862 3357999999999999999999999999999999999999987 7899999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~~L~~L 757 (786)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+........ ..+..+.+|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 22345789999999999998899999999999999999999999999988888887776554432 124468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.++++|
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.99 Aligned_cols=253 Identities=23% Similarity=0.430 Sum_probs=209.1
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC--C-------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN--G-------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~--G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
+..++|.+.+.||+|+||+||+|.+. + ..||+|++.... ....+.|.+|+.++++++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 44678999999999999999999763 3 569999986443 334578999999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe--------E
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--------V 667 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~--------V 667 (786)
+.+..++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999973 2345899999999999999999999999999999999999998887 9
Q ss_pred EEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003919 668 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 668 KL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~-~PF~~~~~~~~l~~i~~~~~ 745 (786)
||+|||++...... ....||+.|+|||.+.+ ..++.++|||||||++|+|++|. .||.................
T Consensus 161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 99999998765332 23457889999999987 67999999999999999999965 45555555544443333222
Q ss_pred CCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 746 RLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 746 ~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
........+.+|+.+||. ||.+|||+.+++++|+++..+-
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 222234579999999999 9999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.19 Aligned_cols=258 Identities=27% Similarity=0.523 Sum_probs=220.1
Q ss_pred cccccCCCeeEee-EEeecCcEEEEEEEE----CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 522 EWNIDFSELTVGT-RVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 522 e~~i~~s~y~i~k-~LG~G~fG~VYkg~~----~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
++.+..++|.+.. .||+|+||.||+|.+ ++..||||++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4556678888887 999999999999975 47789999987543 445578899999999999999999999999 4
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 5569999999999999999862 34579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 677 IITDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 677 ~l~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
........ .....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...........+... .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~ 237 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPE 237 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCCCC
Confidence 77543221 223456889999999998889999999999999999998 99999988887776665543 333333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+..+.+|+.+||. ||.+||++.+++++|+++..+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3479999999999 999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.18 Aligned_cols=259 Identities=32% Similarity=0.559 Sum_probs=221.1
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
.++|++..++|.+.+.||+|+||.||+|.++ ++.||||++...... .+.|.+|+++++.++||||+++++++.. +
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 4678888999999999999999999999884 568999998755433 4678999999999999999999999874 4
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
..++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CcEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 589999999999999998632 1236899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 679 TDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 679 ~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+... .....+ +..
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHH
Confidence 543222 234457789999999998889999999999999999999 89999998887776665543 222222 347
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
+.+|+.+||. ||.+|||+.++++.|+++...
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999 999999999999999987653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=356.90 Aligned_cols=260 Identities=30% Similarity=0.650 Sum_probs=224.0
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.++.|++..++|.+.+.||+|+||+||+|.+. +..||+|++.... ...+.|.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 35678888999999999999999999999984 8899999986433 335789999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+++||||+.+++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 99999999999999999999643 34568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~ 751 (786)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+... .....+ +
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCCCCCC
Confidence 7654322 1223456788999999999999999999999999999999 99999988777666555443 233332 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 469999999999 99999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.40 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=212.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
.|...+.||+|+||.||+|.+ +|+.||||++...... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 377778999999999999987 5899999998754432 346789999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+++++|.+++. ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 124 ~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999885 34689999999999999999999999999999999999999999999999999988765443445
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHHHHHhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRLIADCW 762 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i----p~~~L~~LI~~CL 762 (786)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......... .+..+.+|+.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 678999999999999999999999999999999999999999988887776666543322111 1346899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||.+|||+.+++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9 99999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=385.03 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=208.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+.+.||+|+||.||+|.+ +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3457899999999999999999987 588999999975432 2334567889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999998863 4578999999999999999999998 9999999999999999999999999999987554
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.........+.......+ ..+..+.+||.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 44445567899999999999999999999999999999999999999999988888777776554432 22457999999
Q ss_pred Hhhh-CCCCCC-----CHHHHHHH
Q 003919 760 DCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
+||. ||.+|| ++.++++|
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999 999999 99999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=354.38 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=211.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
...++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 3568999999999999999999988 4668999998654322 122467889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999873 356899999999999999999999999999999999999999999999999998665433
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~ 760 (786)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.......+ .....+.+|+.+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 23456799999999999999999999999999999999999999999888877776665443322 234579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+|||+.++++|
T Consensus 241 ~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HCCSSGGGSCCHHHHHHC
T ss_pred HhccChhhCCCHHHHhhC
Confidence 999 99999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=372.43 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=216.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||.||++.+ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457899999999999999999988 588999999865432 22335778999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 119 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999973 346899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHh
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADC 761 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~C 761 (786)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+ .-+..+.+||.+|
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 2456899999999999999999999999999999999999999999988888877776543322 1245799999999
Q ss_pred hh-CCCCCCC-----HHHHHHH
Q 003919 762 WA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPS-----a~EIL~~ 777 (786)
|. ||.+||+ +++|++|
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhcCHHhccCCccCCHHHHHhC
Confidence 99 9999998 8888865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=377.55 Aligned_cols=250 Identities=21% Similarity=0.364 Sum_probs=209.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+..++|.+.+.||+|+||+||+|++ +++.||||++.+.... ....+.+.+|..++.++ +|||||++++++.+...+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4567899999999999999999988 4789999999765443 23345688999999887 899999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999873 35799999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcCCCCC-CC
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---------LPERVVYAVANEGSRLE-IP 750 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~---------~~~~~l~~i~~~~~~~~-ip 750 (786)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+.......+ .-
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 444556789999999999999999999999999999999999999999643 12223334443332221 12
Q ss_pred ChHHHHHHHHhhh-CCCCCCCH------HHHHHH
Q 003919 751 EGPLGRLIADCWA-EPQERPSC------EEILSR 777 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa------~EIL~~ 777 (786)
+..+.+||.+||+ ||.+||++ .+|++|
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 4468999999999 99999985 677765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=372.30 Aligned_cols=259 Identities=29% Similarity=0.511 Sum_probs=219.0
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
.++..++|.+.+.||+|+||+||+|.+ .++.||||++... ........+.+|+.++++++|||||++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345568899999999999999999984 3568999998643 34455678999999999999999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcC----CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEE
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVK 668 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VK 668 (786)
+....++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999975432 24689999999999999999999999999999999999999554 599
Q ss_pred EEecCccccccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCC
Q 003919 669 ICDFGLSRIITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 669 L~DFGLA~~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~ 745 (786)
|+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~- 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG- 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999998653221 12234567899999999999999999999999999999998 999999988887777666543
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
....+ +..+.+|+.+||+ ||.+|||+.+|+++|+.+..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 22222 3469999999999 99999999999999987754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=364.40 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC-------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------- 598 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------- 598 (786)
++|.+.+.||+|+||.||+|.+ +|+.||||++.... .....+.+.+|+.++++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999988 58899999997544 2334578999999999999999999999885543
Q ss_pred --------------------------------------------------ceEEEEEeeccchhHHHHHhhcCCccchHH
Q 003919 599 --------------------------------------------------RLSMITEYMELGSLYHLIHLSGQKKKLSWR 628 (786)
Q Consensus 599 --------------------------------------------------~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~ 628 (786)
.++++|||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999999999999865555667778
Q ss_pred HHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC------------CCCCCCCCCCcccC
Q 003919 629 RKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP------------MRDSSSAGTPEWMA 696 (786)
Q Consensus 629 ~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~------------~~~~~~~GT~~Y~A 696 (786)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 899999999999999999999999999999999999999999999998875432 12234579999999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003919 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCE 772 (786)
Q Consensus 697 PEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~ 772 (786)
||.+.+..++.++|||||||++|+|++|..|+... ......+.. ...+... ...+.+|+.+||. ||.+|||+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 321 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN-LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc-cCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence 99999999999999999999999999987765321 111222211 1111111 2357889999999 999999999
Q ss_pred HHHHH
Q 003919 773 EILSR 777 (786)
Q Consensus 773 EIL~~ 777 (786)
+++++
T Consensus 322 ~~l~~ 326 (332)
T 3qd2_B 322 DIIEN 326 (332)
T ss_dssp HHHHS
T ss_pred HHhhc
Confidence 99975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.90 Aligned_cols=264 Identities=31% Similarity=0.563 Sum_probs=220.4
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
....|.+..++|.+.+.||+|+||+||+|.+ +++.||||++.... .....+.+.+|+.+++++ +||||+++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3456777889999999999999999999975 35789999986543 344567899999999999 69999999
Q ss_pred ecccccCC-ceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCc
Q 003919 591 LGACTKPP-RLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656 (786)
Q Consensus 591 ~g~~~~~~-~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKp 656 (786)
++++...+ .++++|||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 49999999999999999974322 12389999999999999999999999999999999
Q ss_pred ccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 003919 657 ANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLP 733 (786)
Q Consensus 657 sNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~ 733 (786)
+|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999987644322 1224457889999999999999999999999999999998 9999988765
Q ss_pred HHHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 734 ERVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..........+.....+ ...+.+++.+||. ||.+|||+.+++++|+++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 54444444444444433 3479999999999 99999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.43 Aligned_cols=261 Identities=28% Similarity=0.570 Sum_probs=221.8
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 456777899999999999999999999863 5679999986543 445568899999999999 89999999
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
++++.+.+.+++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 9999999999999999999999999974321 234899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654322 1234567889999999998889999999999999999999 99999998887
Q ss_pred HHHHHHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 735 RVVYAVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.....+.... ....+ ...+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 267 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7666555433 33333 3469999999999 99999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.56 Aligned_cols=252 Identities=19% Similarity=0.294 Sum_probs=211.2
Q ss_pred ccCCCeeEeeEEeec--CcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 525 IDFSELTVGTRVGIG--FFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 525 i~~s~y~i~k~LG~G--~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
....+|.+.+.||+| +||+||++.+ +|+.||||++..........+.+.+|+.+++.++|||||++++++.+.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 346789999999999 9999999998 488999999987776677778899999999999999999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999998743 335699999999999999999999999999999999999999999999999999865432
Q ss_pred CC-------CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----
Q 003919 681 SP-------MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR----- 746 (786)
Q Consensus 681 ~~-------~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~----- 746 (786)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 11 11233578999999999987 67999999999999999999999999876554444332211110
Q ss_pred ------------------------------------------CCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ------------------------------------------LEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ------------------------------------------~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+..+.+||.+||+ ||.+|||+.++++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00112358889999999 99999999999976
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=366.47 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=205.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999988 5889999998654432 22467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC--C
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS--P 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~--~ 682 (786)
||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+... .
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999999886 4567999999999999999999999999999999999999999999999999999876422 1
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCC---CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVV-YAVANEGSRLEI---PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l-~~i~~~~~~~~i---p~~~L~~L 757 (786)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+......... .+..+.+|
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 22345689999999999988765 78999999999999999999999876554222 222222222211 23468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.|++++
T Consensus 242 i~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 242 LHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999 99999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.73 Aligned_cols=265 Identities=29% Similarity=0.515 Sum_probs=214.5
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~ 594 (786)
...+.+..++|.+.+.||+|+||.||+|.+. +..||||++..........+.|.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4566677889999999999999999999762 34799999977666666778899999999999999999999998
Q ss_pred ccCC-----ceEEEEEeeccchhHHHHHhh---cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 595 TKPP-----RLSMITEYMELGSLYHLIHLS---GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 595 ~~~~-----~l~LV~Ey~~gGSL~dlL~~~---~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
.+.. ..+++|||+.+++|.+++... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 359999999999999998532 23457999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 003919 667 VKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~ 743 (786)
+||+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999999987644321 1233457889999999999999999999999999999999 88999988877766665543
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 744 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 744 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
. ....+ ...+.+|+.+||. ||.+|||+.+++++|+++...+
T Consensus 266 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 H-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp C-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 3 22222 3469999999999 9999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.88 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=196.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46899999999999999999987 588999999875442 223467889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhc---CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 605 EYMELGSLYHLIHLSG---QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~---~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||++ ++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 9998 58888876432 1245899999999999999999999999999999999999999999999999999887554
Q ss_pred CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 747 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------- 747 (786)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 444456689999999999976 468999999999999999999999999988877666654321100
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+|+.+||+ ||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0113468899999999 99999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.05 Aligned_cols=256 Identities=28% Similarity=0.558 Sum_probs=211.0
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-C
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-P 598 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-~ 598 (786)
...|.+..++|.+.+.||+|+||+||++.++|+.||||++.... ..+.|.+|+.++++++||||+++++++.+. +
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 34577788999999999999999999999999999999986432 346799999999999999999999986544 5
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 799999999999999998633 2234889999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+.. +.....+ +..+
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 243 (278)
T 1byg_A 168 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHH
T ss_pred ccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHH
Confidence 432 224467889999999999999999999999999999998 9999998877666655433 3333333 3479
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
.+++.+||. ||.+||++.++++.|+++...
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 999999999 999999999999999988653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.62 Aligned_cols=250 Identities=33% Similarity=0.605 Sum_probs=209.6
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHH-----HHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-----MEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~-----~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+..++|.+.+.||+|+||+||+|.+ +++.||||++......... .+.|.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 3458899999999999999999988 5889999998655432221 16889999999999999999999999776
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCe-----EEEE
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWT-----VKIC 670 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~-----VKL~ 670 (786)
. ++||||+++++|.+.+.. ....+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred C--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 5 799999999999988862 4457999999999999999999999999 999999999999988776 9999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCcccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCC
Q 003919 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELI--RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSR 746 (786)
Q Consensus 671 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl--~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~--l~~i~~~~~~ 746 (786)
|||+++.... ......||+.|+|||.+ ....++.++|||||||++|+|++|+.||........ ...+......
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 9999976543 23456799999999998 445678999999999999999999999986654333 4444444544
Q ss_pred CCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 747 LEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 747 ~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
...+. ..+.+|+.+||. ||.+|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 44443 469999999999 999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=374.26 Aligned_cols=255 Identities=34% Similarity=0.587 Sum_probs=206.6
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
++..++|.+.+.||+|+||+||+|.+. +..||||++.... .....+.|.+|+.++++++||||+++++++.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999763 6679999986543 4455678999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+++|+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999973 3457899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC---CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003919 679 TDSPMR---DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 679 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~ 751 (786)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. +.....+ .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccc
Confidence 543221 122345678999999999999999999999999999998 9999999888777666544 3333322 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+.+|+.+||. ||.+||++.+|++.|+++.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=374.76 Aligned_cols=251 Identities=20% Similarity=0.342 Sum_probs=207.4
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHH-HhhcCCCceeEEecccccCCceE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISI-LSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~i-L~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
..++|.+.+.||+|+||+||+|++ +++.||||++.+.... ......+.+|..+ ++.++|||||++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 457899999999999999999988 4778999999766542 3334567778777 57789999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999873 357889999999999999999999999999999999999999999999999999875544
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~ 760 (786)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+........ .-...+.+||.+
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG 272 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 4445577899999999999999999999999999999999999999999988888887776543322 124578999999
Q ss_pred hhh-CCCCCCCHHHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~L~ 779 (786)
||+ ||.+||++.+.+..+.
T Consensus 273 lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHH
T ss_pred HcccCHHhCCCCCCCHHHHh
Confidence 999 9999999854443333
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.81 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=210.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC--ceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~--~l~L 602 (786)
..+|.+.+.||+|+||+||+|.+. |+.||||++...... ...+.+.+|++++++++||||+++++++.... .+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999984 889999998754432 23577889999999999999999999987654 7899
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----cCCCeEEEEecCccccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 678 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~~l 678 (786)
||||+++++|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999999854444459999999999999999999999999999999999999 78889999999999887
Q ss_pred cCCCCCCCCCCCCCcccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCC
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIR--------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSR 746 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~--------~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~----~~~~l~~i~~~~~~ 746 (786)
.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .......+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 5543 234567999999999986 5778999999999999999999999996432 33444444433221
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 747 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 747 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
. ..+ ...+.+|+.+||+ ||++|||+.|++++..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0 111 1247889999999 999999999999998864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=349.86 Aligned_cols=253 Identities=18% Similarity=0.233 Sum_probs=211.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||+||+|.+ +|+.||||++...... +.+.+|+.+++.+ +|+||+++++++.+....++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 357899999999999999999986 6899999998654332 4578899999999 79999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe-----EEEEecCcccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRI 677 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~-----VKL~DFGLA~~ 677 (786)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99999 89999999742 346999999999999999999999999999999999999987766 99999999987
Q ss_pred ccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC
Q 003919 678 ITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL 747 (786)
Q Consensus 678 l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~---~~~~~l~~i~~~~~~~ 747 (786)
...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+. ........+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 754322 124567999999999999999999999999999999999999999874 3333333332222111
Q ss_pred C------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 748 E------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 748 ~------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
. .-+..+.+|+.+||. ||.+||++.+|++.|+++...+
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1 123579999999999 9999999999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=363.98 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=208.0
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC--CceeEEecccccCCc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH--PNVILFLGACTKPPR 599 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H--PNIVkL~g~~~~~~~ 599 (786)
+.+...+|.+.+.||+|+||.||++.+ +++.||||++..........+.|.+|+.+++.++| |||+++++++.+...
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345678899999999999999999987 57889999998777777777899999999999986 999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+++||| +.+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++..+.
T Consensus 84 ~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999999 56789999987 345789999999999999999999999999999999999997 6789999999998775
Q ss_pred CCCC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC
Q 003919 680 DSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE-RVVYAVANEGS 745 (786)
Q Consensus 680 ~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~-~~l~~i~~~~~ 745 (786)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4322 2235679999999999865 67899999999999999999999999875443 34444444444
Q ss_pred CCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHH
Q 003919 746 RLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 746 ~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L 778 (786)
....+ +..+.+|+.+||. ||.+|||+.+++++-
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 33333 4579999999999 999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.82 Aligned_cols=248 Identities=19% Similarity=0.256 Sum_probs=209.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++...... +.+.+|+.+++.+ +||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 47899999999999999999986 6899999998754332 3578999999999 899999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe-----EEEEecCccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT-----VKICDFGLSRII 678 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~-----VKL~DFGLA~~l 678 (786)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.+
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 89999999743 457999999999999999999999999999999999999998887 999999999876
Q ss_pred cCCCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC
Q 003919 679 TDSPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRLE 748 (786)
Q Consensus 679 ~~~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~~ 748 (786)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 543221 2456899999999999999999999999999999999999999987433 333333322111111
Q ss_pred -------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 749 -------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 749 -------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.| .+.+|+..||. ||.+||++.+|++.|+++..
T Consensus 241 ~~~~~~~~p--~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 241 IEVLCENFP--EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHTTTCH--HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhccCh--HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 22 79999999999 99999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=361.35 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=206.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc----
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR---- 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~---- 599 (786)
.++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.|.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999987 688999999976543 34456789999999999999999999999876543
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 4999999999999999973 3478999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCC
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPE 751 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~ 751 (786)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.................. ..+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 4321 22345689999999999999999999999999999999999999999988887776665544332 123
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH-HHh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSR-LLD 780 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~-L~~ 780 (786)
..+.+|+.+||. ||.+||+..+++.+ +.+
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 468999999999 99999976666644 443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.30 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=213.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
++|.+.+.||+|+||+||+|.+ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6799999999999999999988 577899999865432 33456789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhh-------------------------------------cCCccchHHHHHHHHHHHHHHHHhhh
Q 003919 603 ITEYMELGSLYHLIHLS-------------------------------------GQKKKLSWRRKLKMLRDICRGLMCIH 645 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~-------------------------------------~~~~~Ls~~~i~~Ia~QIa~gL~yLH 645 (786)
||||+++|+|.+++... .....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988411 01234678889999999999999999
Q ss_pred hcceeeccCCcccEEEcCCC--eEEEEecCccccccCCC----CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHH
Q 003919 646 RMKIVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSP----MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVI 717 (786)
Q Consensus 646 s~gIIHrDLKpsNILLd~~g--~VKL~DFGLA~~l~~~~----~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvI 717 (786)
++||+||||||+|||++.++ .+||+|||++..+.... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 89999999998764321 12345679999999999975 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhh
Q 003919 718 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDCE 782 (786)
Q Consensus 718 L~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i~ 782 (786)
+|+|++|+.||.+.........+.........+ +..+.+||.+||. ||.+||++.+++++ +.++.
T Consensus 266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999888888877766554433 3468999999999 99999999999986 44443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=365.76 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=199.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++..........+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 56899999999999999999987 6889999999766555555677889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-----CCCeEEEEecCcccccc
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-----KHWTVKICDFGLSRIIT 679 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-----~~g~VKL~DFGLA~~l~ 679 (786)
||+.+ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 113 e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99985 8988886 345699999999999999999999999999999999999994 55569999999998876
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------- 748 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------- 748 (786)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 544444566789999999999874 589999999999999999999999999888777766654211110
Q ss_pred ------C---------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ------I---------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ------i---------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. .+..+.+||.+||. ||.+|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 13457899999999 99999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.74 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=210.4
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
.+....|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34456799999999999999999984 588999999865432 23457899999999999999999999999876
Q ss_pred --CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 598 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 598 --~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
..+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 668999999999999999963 2356899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------ChHHHHH
Q 003919 676 RIITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--------------LPERVVY 738 (786)
Q Consensus 676 ~~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~--------------~~~~~l~ 738 (786)
........ ......||+.|+|||.+.+..++.++|||||||++|+|++|..|+... .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 88754431 233556888999999999999999999999999999999999875322 2222333
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 739 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 739 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
...........+ +..+.+|+.+||. ||.+|||+.++++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 333344444443 3469999999999 9999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=356.75 Aligned_cols=249 Identities=35% Similarity=0.665 Sum_probs=203.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++.++|.+.+.||+|+||+||++.+.++.||||++... ...+.|.+|+.++++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 45678999999999999999999999999999998532 335789999999999999999999999874 479999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh---cceeeccCCcccEEEcCCCe-EEEEecCccccccC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---MKIVHRDLKSANCLVNKHWT-VKICDFGLSRIITD 680 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---~gIIHrDLKpsNILLd~~g~-VKL~DFGLA~~l~~ 680 (786)
||+++++|.+++........+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999999744434457899999999999999999999 89999999999999998876 89999999976643
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcCCCCCCC---ChHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYAVANEGSRLEIP---EGPLG 755 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~--~~~l~~i~~~~~~~~ip---~~~L~ 755 (786)
. .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+. .......+ +..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHHHH
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHHHH
Confidence 2 2345699999999999999999999999999999999999999986432 22222222 23333222 34799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 756 RLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+|+.+||. ||.+|||+.++++.|+++..
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 99999999 99999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=353.25 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=215.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc--ccCCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~--~~~~~l~L 602 (786)
.++|.+.+.||+|+||.||++.+ +|+.||+|++..........+.|.+|+.++++++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999988 588999999987776667778899999999999999999999987 44677999
Q ss_pred EEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcc-----eeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 603 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-----IIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.| |+|+||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987432 2345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+..... ..++ +..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCCcccCHH
Confidence 765432222234689999999999999999999999999999999999999999887776666554432 2333 457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLD 780 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~ 780 (786)
+.+|+.+||. ||.+||++.+|++++..
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 9999999999 99999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=350.54 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=214.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.+.+..++|.+.+.||+|+||+||+|.+. +..||+|++.... .....+.|.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45667789999999999999999999762 2359999986543 34556889999999999999999999999875
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
+ ..+++|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred C-CCEEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 4 57899999999999999964 23568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~ 751 (786)
....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.... ....+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 240 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-RLPKPDLCP 240 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-CCCCCTTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-CCCCCCCCC
Confidence 7654322 2234567889999999999999999999999999999998 999998877766665554433 22222 4
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+.+|+.+||. ||.+||++.+++++|+++..
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 569999999999 99999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.38 Aligned_cols=252 Identities=27% Similarity=0.548 Sum_probs=206.7
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCe----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
..++|.+.+.||+|+||+||+|.+ +++ +||+|.+.... .....+.|.+|+.++++++||||++++++|.+..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 347899999999999999999987 344 35777765332 2334578999999999999999999999998764
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++++|+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 91 ~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 8899999999999999873 34578999999999999999999999999999999999999999999999999998775
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 680 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 680 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+.. ......+ ...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-CCCCCCCccCCHH
Confidence 4322 2234456889999999999999999999999999999999 9999998877666555443 3333333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+|+.+||+ ||.+||++.+++++|+.+.
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8999999999 9999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=358.18 Aligned_cols=257 Identities=34% Similarity=0.552 Sum_probs=213.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEEC------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWN------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.++..++|.+.+.||+|+||+||+|.+. +..||||++.... .......|.+|+.+++.++||||+++++++.+
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3566789999999999999999999763 2359999986543 44556789999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999863 34578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 677 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 677 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+... .....+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCccc
Confidence 7654321 1223456788999999999999999999999999999999 99999998887777666543 233333
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...+.+|+.+||. ||.+||++.++++.|+++..
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3469999999999 99999999999999988754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.79 Aligned_cols=248 Identities=27% Similarity=0.362 Sum_probs=217.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+|.+.+.||+|+||.||++.+. ++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 478999999999999999999884 77899999876543 345567899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999999998863 35789999999999999999999999999999999999999999999999999988754444
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+........ ..+..+.+|+.+||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHc
Confidence 44567799999999999998899999999999999999999999999887777666654433221 22457899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||.+|||+.+++++
T Consensus 251 ~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 251 QTDPTARPTINELLND 266 (294)
T ss_dssp CSSGGGSCCGGGGGGS
T ss_pred ccChhhCcCHHHHhhC
Confidence 9 99999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=383.29 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=217.4
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
...+.+..++|.+.+.||+|+||+||+|.+ +++.||+|++.+... .....+.+.+|+.+++.++|||||+++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345666788999999999999999999988 478899999865322 11122457899999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999862 358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIRNEP----FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~----~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip- 750 (786)
.+..... .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+.......+.........|
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 7754322 234678999999999998765 7899999999999999999999999999888888776543222222
Q ss_pred ----ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQE--RPSCEEILSR 777 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 777 (786)
+..+.+||.+||. +|.+ ||++++|++|
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 3569999999999 8888 9999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=348.55 Aligned_cols=254 Identities=29% Similarity=0.540 Sum_probs=211.2
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CC---eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce-EE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NG---TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL-SM 602 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G---~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l-~L 602 (786)
.|.+.+.||+|+||+||+|.+ ++ ..+|+|++... ......+.|.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 466789999999999999976 22 26999998643 3445568899999999999999999999999876655 99
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
++||+.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999863 35678999999999999999999999999999999999999999999999999998664321
Q ss_pred ----CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCC---ChHH
Q 003919 683 ----MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIP---EGPL 754 (786)
Q Consensus 683 ----~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~l~~i~~~~~~~~ip---~~~L 754 (786)
.......+++.|+|||.+.+..++.++|||||||++|+|++|.. ||...........+.. ......+ +..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-TCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-CCCCCCCccchHHH
Confidence 22234568889999999999999999999999999999999555 5666565555554443 3333333 3469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhcC
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCEYSLC 786 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sLc 786 (786)
.+|+.+||. ||.+|||+.++++.|+++...++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 999999999 99999999999999999877654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=355.18 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=215.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
++|.+.+.||+|+||.||++.+ +|+.||||++....... ...+.|.+|+.+++.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5799999999999999999988 58899999997654322 13578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 677 (786)
+||||+++++|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999997 456799999999999999999999999999999999999999888 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 752 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~ 752 (786)
..... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.........+........ ..+.
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (321)
T 2a2a_A 169 IEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247 (321)
T ss_dssp CCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred cCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence 75532 23456799999999999999999999999999999999999999999888877777665443321 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 248 ~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 248 LAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 68999999999 99999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=370.46 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=198.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCC--ceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~--~l~ 601 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.+. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999987 5889999998766556666788999999999997 999999999986543 689
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+. ++|..++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9999998 588888862 46889999999999999999999999999999999999999999999999999875321
Q ss_pred ---------------------CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 003919 682 ---------------------PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA 739 (786)
Q Consensus 682 ---------------------~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~ 739 (786)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 112234689999999999976 6799999999999999999999999999887776665
Q ss_pred HHhcCCCCC------------------------------------------------CCChHHHHHHHHhhh-CCCCCCC
Q 003919 740 VANEGSRLE------------------------------------------------IPEGPLGRLIADCWA-EPQERPS 770 (786)
Q Consensus 740 i~~~~~~~~------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPS 770 (786)
+......+. .....+.+|+.+||. ||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 542211110 113458899999999 9999999
Q ss_pred HHHHHHH
Q 003919 771 CEEILSR 777 (786)
Q Consensus 771 a~EIL~~ 777 (786)
+.|+++|
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=351.86 Aligned_cols=258 Identities=27% Similarity=0.468 Sum_probs=203.9
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccc-cChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~-~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
...+|.+.+.||+|+||.||+|.+ +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 356899999999999999999987 68899999987543 345556789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||||+.+++|.+++... .....+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999999988643 23456899999999999999999999999999999999999999999999999999877554
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCCC---CCChHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL--PERVVYAVANEGSRLE---IPEGPLGR 756 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~--~~~~l~~i~~~~~~~~---ip~~~L~~ 756 (786)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.. .......+........ ..+..+.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 269 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHH
Confidence 333445678999999999999999999999999999999999999997543 3333333333322221 12346999
Q ss_pred HHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 757 LIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
|+.+||. ||.+|||+.+|++.|+++..
T Consensus 270 li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 270 LVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 9999999 99999999999999998864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=372.60 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=211.3
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+.+++|.+.+.||+|+||.||++.+ +++.||+|++..... .....+.+.+|+.+++.++|||||+++++|.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4456678999999999999999999988 477899999865432 2233578899999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEEECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999997 4567999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcCCCC-CCCC
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGV---LPERVVYAVANEGSRL-EIPE 751 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~---~~~~~l~~i~~~~~~~-~ip~ 751 (786)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ........+....... ...+
T Consensus 166 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 166 PRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp CTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred cCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 543 23456789999999999964 45899999999999999999999999743 3333333333322222 1224
Q ss_pred hHHHHHHHHhhh-CCCCCCC-HHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPS-CEEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPS-a~EIL~~ 777 (786)
..+.+||.+||. ||.+||+ +++|+++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 579999999999 9999998 7777753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=345.65 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=212.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||+|.+. +..+|+|++...... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 56999999999999999999884 668999998765433 24789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~~ 682 (786)
|+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998863 4568999999999999999999999999999999999999 788999999999998775432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...........+......... .+..+.+|
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 33466799999999998765 899999999999999999999999998888877777665443321 24468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.+++++
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=361.69 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=208.8
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..++|.+.+.||+|+||.||+|.+. |+.||||++..........+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4678999999999999999999884 88999999977766666667889999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 103 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999998875 445799999999999999999999999999999999999999999999999999987765444
Q ss_pred CCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Q 003919 684 RDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR---------------- 746 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~---------------- 746 (786)
......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 44567899999999999875 7899999999999999999999999988877666554421110
Q ss_pred ---C-C------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ---L-E------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ---~-~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. . .-+..+.+|+.+||. ||.+|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0 113468899999999 99999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=361.12 Aligned_cols=252 Identities=27% Similarity=0.514 Sum_probs=209.1
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCee----EEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~----VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
..++|.+.+.||+|+||+||+|.+ +++. ||+|++..... ....+.+.+|+.++++++||||+++++++.+ ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 457899999999999999999987 3443 77787754322 2223567789999999999999999999864 56
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred cEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 8999999999999999862 34578999999999999999999999999999999999999999999999999998875
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 680 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 680 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
.... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.. ......+ ...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-GERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-TCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCCCcCcHH
Confidence 4322 2234567889999999999999999999999999999999 9999998877766665544 3333332 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+|+.+||. ||.+||++.+++++|+++.
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 8899999999 9999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.00 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=187.6
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 356899999999999999999987 6889999998654321 1224678999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
+|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999862 34678999999999999999999999999999999999999999999999999998775443
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHHHHHHHh
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLGRLIADC 761 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip~~~L~~LI~~C 761 (786)
.......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+...... +...+..+.+|+.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 3334567999999999999988999999999999999999999999876654444333222211 112245789999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||.+|||+.+++++
T Consensus 247 l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCSSGGGSCCHHHHTTS
T ss_pred cccCHhhCCCHHHHhcC
Confidence 99 99999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=363.53 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=214.6
Q ss_pred CccccccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc
Q 003919 516 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594 (786)
Q Consensus 516 ~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~ 594 (786)
..++..++....++|.+.+.||+|+||.||+|.+ +|+.||||++....... ....|.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3456778888899999999999999999999976 58899999986543321 123688999999999999999999999
Q ss_pred ccCCceEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhc---ceeeccCCcccEEEcCCCeEEEE
Q 003919 595 TKPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRM---KIVHRDLKSANCLVNKHWTVKIC 670 (786)
Q Consensus 595 ~~~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---gIIHrDLKpsNILLd~~g~VKL~ 670 (786)
.+....++||||+.+|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997432 234599999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHh---
Q 003919 671 DFGLSRIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVAN--- 742 (786)
Q Consensus 671 DFGLA~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~----~~~~~l~~i~~--- 742 (786)
|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...........
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999987653322 233456999999999999888999999999999999999999999521 11011111111
Q ss_pred -cCCCC---------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 743 -EGSRL---------EIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 743 -~~~~~---------~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..... ..+. ..+.+++.+||+ ||.+|||+.+|+++|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 11000 1111 257889999999 9999999999999998643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.19 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=207.7
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccc--cChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeec
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQD--LTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~--~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
..++.||+|+||.||+|.++++.||||++.... ......+.|.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 345899999999999999999999999986543 233446789999999999999999999999999999999999999
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--CCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDS 686 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~ 686 (786)
+++|.+++........+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 999999997555556799999999999999999999999999999999999999999999999999987643221 123
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCC---------CCCCC---
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER----VVYAVANEGS---------RLEIP--- 750 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~----~l~~i~~~~~---------~~~ip--- 750 (786)
...||+.|+|||.+.+. ++.++|||||||++|+|++|+.||....... ....+..... ....+
T Consensus 194 ~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T 2nru_A 194 RIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272 (307)
T ss_dssp SCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHH
T ss_pred ccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHH
Confidence 45799999999988764 8999999999999999999999997654322 1111111110 01111
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...+.+++.+||. ||.+|||+.+++++|+++.-
T Consensus 273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1247889999999 99999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=349.31 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=211.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc-ccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~-~~~~~l 600 (786)
..+|.+.+.||+|+||+||+|.+. +..+|+|.+... ......+.|.+|+.++++++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356889999999999999999863 225888987643 3445568899999999999999999999985 455678
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+++|||+++++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999963 345688999999999999999999999999999999999999999999999999987644
Q ss_pred CCC----CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCC--CCChH
Q 003919 681 SPM----RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLE--IPEGP 753 (786)
Q Consensus 681 ~~~----~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~--ip~~~ 753 (786)
... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...........+........ ..+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 321 1234567889999999999999999999999999999999 5667777766665555544332221 12457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+.+++.+||. ||.+|||+.++++.|+++...+
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999 9999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.99 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=217.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+|.+.+.||+|+||.||++.+ +++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57899999999999999999988 477899999876543 345567899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+.+++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999998863 35789999999999999999999999999999999999999999999999999988754444
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........ .....+.+||.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence 44567899999999999999999999999999999999999999998887777666655443322 22457899999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||.+|||+.+++++
T Consensus 277 ~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 277 QTDPTARPTINELLND 292 (335)
T ss_dssp CSSGGGSCCGGGGGGS
T ss_pred cCChhHCcCHHHHhcC
Confidence 9 99999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=376.07 Aligned_cols=247 Identities=28% Similarity=0.389 Sum_probs=188.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-----CCc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-----PPR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-----~~~ 599 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 37899999999999999999987 58899999997665666677899999999999999999999999843 356
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 999999985 68888886 45679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---------------------------CCCCCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHh--------
Q 003919 680 DSPM---------------------------RDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCT-------- 723 (786)
Q Consensus 680 ~~~~---------------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvIL~ELlT-------- 723 (786)
.... .....+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3211 12345789999999976 56679999999999999999999
Q ss_pred ---CCCCCCCCCh--------------------HHHHHHHHhc-CC-------------------------------CCC
Q 003919 724 ---LNRPWEGVLP--------------------ERVVYAVANE-GS-------------------------------RLE 748 (786)
Q Consensus 724 ---G~~PF~~~~~--------------------~~~l~~i~~~-~~-------------------------------~~~ 748 (786)
|+.+|.+... ...+..+... +. ...
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6667765431 1111111100 00 001
Q ss_pred CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.....+.+||.+||. ||.+|||++|+|+|
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 113468899999999 99999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.05 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=211.7
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----CCceeEEe
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL 591 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----HPNIVkL~ 591 (786)
.+.+..+-.++|.+.++||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3455555568999999999999999999998 6889999998632 334567888999999996 99999999
Q ss_pred cccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC--------
Q 003919 592 GACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------- 663 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-------- 663 (786)
+++...+.+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 9999999999999999 88999998743 3346899999999999999999999999999999999999975
Q ss_pred -----------------CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 003919 664 -----------------HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR 726 (786)
Q Consensus 664 -----------------~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~ 726 (786)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999875432 245689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCC------------------------C-----------------------CChHHHHHHH
Q 003919 727 PWEGVLPERVVYAVANEGSRLE------------------------I-----------------------PEGPLGRLIA 759 (786)
Q Consensus 727 PF~~~~~~~~l~~i~~~~~~~~------------------------i-----------------------p~~~L~~LI~ 759 (786)
||...........+.......+ . ....+.+|+.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9998877766655543221111 0 0134668999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||+ ||.+|||+.++|+|
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999 99999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=368.00 Aligned_cols=258 Identities=20% Similarity=0.219 Sum_probs=204.1
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHH---------HHHHHHHHHHHhhcCCCcee
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAEN---------MEDFCNEISILSRLRHPNVI 588 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~---------~~~f~~EI~iL~~L~HPNIV 588 (786)
+...+|.+.+.||+|+||+||+|.+. ++.||||++......... ...+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34678999999999999999999873 468999998654321110 12344566677888999999
Q ss_pred EEecccccC----CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc--
Q 003919 589 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-- 662 (786)
Q Consensus 589 kL~g~~~~~----~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-- 662 (786)
++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 999998764 4589999999 9999999973 346799999999999999999999999999999999999999
Q ss_pred CCCeEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 003919 663 KHWTVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER 735 (786)
Q Consensus 663 ~~g~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~ 735 (786)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||+||||+||+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999987643211 1134569999999999999999999999999999999999999998543222
Q ss_pred HHHHHHhcC------------CCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 736 VVYAVANEG------------SRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 736 ~l~~i~~~~------------~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
......... ......+..+.+|+..||. ||.+||++.+|++.|+++...+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 211111111 0011224579999999999 9999999999999999876543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.04 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=214.0
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+..++....++|.+.+.||+|+||.||+|.+ +|+.||||++..... ...+.|.+|+.+++.++||||+++++++.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3445566778999999999999999999987 488999999765433 3457899999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
+.+++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999999886322 12368999999999999999999999999999999999999999999999999998
Q ss_pred cccCCC--CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCCC-
Q 003919 677 IITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV------VYAVANEGSRL- 747 (786)
Q Consensus 677 ~l~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~------l~~i~~~~~~~- 747 (786)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ...........
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 754321 122345689999999999988999999999999999999999999976433211 11111111100
Q ss_pred --------CCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 748 --------EIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 748 --------~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.++. ..+.+++.+||. ||++|||+.+++++|+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111 247889999999 9999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=383.25 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=217.5
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
...+.+..++|.+.++||+|+||+||+|.+ .++.||||++.+.... ....+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345566778999999999999999999988 4788999998653221 1112348899999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 9999999999999999999973 24679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.......+.........|
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 7654332 234568999999999997 5678999999999999999999999999999888887776543222222
Q ss_pred ------ChHHHHHHHHhhh-CCCC--CCCHHHHHHH
Q 003919 751 ------EGPLGRLIADCWA-EPQE--RPSCEEILSR 777 (786)
Q Consensus 751 ------~~~L~~LI~~CL~-DP~k--RPSa~EIL~~ 777 (786)
+..+.+||.+||. +|++ ||+++++++|
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 3468999999998 7777 9999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=348.73 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=214.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 3457899999999999999999988 4778999998654321 122467889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999873 346899999999999999999999999999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCCChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EIPEGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~ip~~~L~~LI~~ 760 (786)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+....... ...+..+.+|+.+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 2345679999999999999999999999999999999999999999888777776665543322 1224579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+||++.+++++
T Consensus 246 ~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HSCSSGGGSCCHHHHHTC
T ss_pred HhhcCHhhCCCHHHHhhC
Confidence 999 99999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=380.20 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=217.8
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
..++.+..++|.+.+.||+|+||+||++.+ +|+.||||++.+... .....+.+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 455667789999999999999999999988 588999999965432 12233568899999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 99999999999999999999732 3478999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIR-------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 748 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~-------~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ 748 (786)
.+..... .....+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+.......+........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 7754332 233568999999999997 35689999999999999999999999999988888777765332222
Q ss_pred C------CChHHHHHHHHhhhCCCCC---CCHHHHHHH
Q 003919 749 I------PEGPLGRLIADCWAEPQER---PSCEEILSR 777 (786)
Q Consensus 749 i------p~~~L~~LI~~CL~DP~kR---PSa~EIL~~ 777 (786)
. -+..+.+||.+||.+|.+| |++++|++|
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred CCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence 2 2347899999999988887 699999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.86 Aligned_cols=246 Identities=27% Similarity=0.461 Sum_probs=209.6
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~ 599 (786)
....|.+.+.||+|+||.||+|.+ ++..||+|++..........+.|.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 345689999999999999999988 47789999998777777778899999999999999999999998764 456
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEc-CCCeEEEEecCccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSR 676 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~ 676 (786)
+++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.| |+|+||||+|||++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 8999999999999999973 357899999999999999999999999 99999999999998 78999999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CCCh
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IPEG 752 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----ip~~ 752 (786)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.................... ....
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 65433 2335679999999998875 499999999999999999999999988666555554444333221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 69999999999 99999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.44 Aligned_cols=245 Identities=34% Similarity=0.593 Sum_probs=215.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.+.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999987 5889999999765433 335789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++++|.+++. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999985 3568999999999999999999999999999999999999999999999999998876554444
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHHHhh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIADCW 762 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~~CL 762 (786)
....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+..... ...+ +..+.+|+.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHc
Confidence 567899999999999999999999999999999999999999998887776665554332 2222 346999999999
Q ss_pred h-CCCCCCCHHHHHHHH
Q 003919 763 A-EPQERPSCEEILSRL 778 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L 778 (786)
. ||.+|||+.+++++.
T Consensus 256 ~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSGGGSCCHHHHTTCH
T ss_pred CCChhhCcCHHHHhhCh
Confidence 9 999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.28 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=207.6
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACT 595 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~ 595 (786)
...++....++|.+.+.||+|+||.||+|.+ +|+.||||++...... .+.+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3445555678999999999999999999998 6889999998654332 36788999999999 7999999999987
Q ss_pred c------CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEE
Q 003919 596 K------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669 (786)
Q Consensus 596 ~------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL 669 (786)
. ...+++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 6 46799999999999999999743 3457899999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003919 670 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 670 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~ 744 (786)
+|||++..............||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 99999987654333334567999999999987 5678999999999999999999999999888777766655443
Q ss_pred CCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 745 SRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 745 ~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..... .+..+.+||.+||. ||.+||++.+++++
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 32221 24579999999999 99999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.92 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=207.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC--CCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~--HPNIVkL~g~~~~~~~l~ 601 (786)
+...+|.+.+.||+|+||+||++.+ +++.||||++..........+.|.+|+.++++++ ||||+++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3456799999999999999999987 5788999999877666777789999999999996 599999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 133 lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999 567899999873 34788899999999999999999999999999999999995 579999999999876543
Q ss_pred CC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcCCCC
Q 003919 682 PM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYAVANEGSRL 747 (786)
Q Consensus 682 ~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-~~~l~~i~~~~~~~ 747 (786)
.. .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ...+..+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 21 2345689999999999865 4689999999999999999999999987643 34445555444443
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 EIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+ +..+.+||.+||. ||.+|||+.+++++
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 333 4579999999999 99999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.25 Aligned_cols=244 Identities=30% Similarity=0.455 Sum_probs=210.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
..|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999987 688999999976543 3344578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+. |+|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9998 577777653 3457899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---CChHHHHHH
Q 003919 685 DSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---PEGPLGRLI 758 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---p~~~L~~LI 758 (786)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+.........+......... .+..+.+||
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3567999999999984 567899999999999999999999999988887777766655433322 245699999
Q ss_pred HHhhh-CCCCCCCHHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSRL 778 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L 778 (786)
.+||. ||.+|||+.+++++.
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHcccChhhCcCHHHHhhCh
Confidence 99999 999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.93 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=210.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChH----HHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE----NMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~----~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
++|.+.+.||+|+||.||++.+ +|+.||+|++........ ..+.|.+|+.++++++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4699999999999999999988 488999999876543221 3578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 677 (786)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+||+++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999863 35789999999999999999999999999999999999998877 899999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----CCCh
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-----IPEG 752 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-----ip~~ 752 (786)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+........ ..+.
T Consensus 162 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 65432 23456799999999999999999999999999999999999999999888777766654433221 1234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+|+.+||. ||.+|||+.+++++
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 68999999999 99999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=378.65 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------C
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------P 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~ 598 (786)
.++|.+++.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999987 588999999987665666678899999999999999999999998654 3
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 579999999875 555543 24889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+....+..+......+
T Consensus 215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 543 23456789999999999999999999999999999999999999999988776666554321110
Q ss_pred ------------C------CC--------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------E------IP--------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------~------ip--------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. .+ ...+.+||.+||. ||.+|||+.|+|+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 1247889999999 99999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=357.36 Aligned_cols=242 Identities=23% Similarity=0.267 Sum_probs=198.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.++||+|+||+||+|.+ +|+.||||++............+..|+..+.++ +||||++++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999988 588999999876655555566777777777666 8999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....... .
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A 212 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence 999 56888777633 4579999999999999999999999999999999999999999999999999998765432 3
Q ss_pred CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---CCChHHHHHHHHh
Q 003919 685 DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---IPEGPLGRLIADC 761 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---ip~~~L~~LI~~C 761 (786)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ...+........ ..+..+.+|+.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence 345679999999999886 699999999999999999999776654322 222222111111 1235689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||++|||+.+++++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 289 LEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred cCCChhhCcCHHHHHhC
Confidence 99 99999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=378.41 Aligned_cols=245 Identities=26% Similarity=0.474 Sum_probs=214.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+.++++++|||||++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 6799999999999999999988 58899999997554433345789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 682 (786)
|+.+++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 102 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999988863 35789999999999999999999999999999999999995 45679999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
......||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 179 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred -ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 33456899999999999864 9999999999999999999999999999888888887766555443 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.++|+|
T Consensus 257 i~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999 99999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=346.94 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=195.6
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
+++..++|.+.+.||+|+||+||++.+ +|+.||||++..........+.+..+...++.++||||+++++++.+.+..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 456678999999999999999999998 789999999876544444444455556668888999999999999999999
Q ss_pred EEEEEeeccchhHHHHHh-hcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 601 SMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
++||||+++ +|.+++.. ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 77766643 23456899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCC---C
Q 003919 679 TDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEI---P 750 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~-~~~~~l~~i~~~~~~~~i---p 750 (786)
.... ......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||... .................. .
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence 5432 23345799999999996 5667899999999999999999999999864 344444444433322221 2
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+|+.+||. ||.+|||+.+++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 3469999999999 99999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=353.86 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=194.4
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEeccc---
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGAC--- 594 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~--- 594 (786)
..+++...+|.+.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+++++. ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 45566677899999999999999999998 6889999998544 3445678999999999996 99999999988
Q ss_pred -----ccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEcCCCeE
Q 003919 595 -----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 595 -----~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd~~g~V 667 (786)
.....++++|||+. |+|.+++........+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 33445899999997 688888875445667999999999999999999999999 9999999999999999999
Q ss_pred EEEecCccccccCCCCC------------CCCCCCCCcccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 003919 668 KICDFGLSRIITDSPMR------------DSSSAGTPEWMAPELI---RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL 732 (786)
Q Consensus 668 KL~DFGLA~~l~~~~~~------------~~~~~GT~~Y~APEvl---~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~ 732 (786)
||+|||++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543211 1144689999999998 56678999999999999999999999998765
Q ss_pred hHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 733 PERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 733 ~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.......... ..........+.+|+.+||+ ||.+|||+.+++++|+++..
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 258 KLRIVNGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhcCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5433322111 11111223468999999999 99999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=364.13 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=197.7
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
...++|.+.+.||+|+||+||++.+ +++.||||++....... +.+.+|+.+++.++||||+++++++.+...+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 3468899999999999999999988 58899999997654332 567899999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe--EEEEecCccccccC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSRIITD 680 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~l~~ 680 (786)
||||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999999863 346999999999999999999999999999999999999987765 99999999975433
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCCCCCC---CCh
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEK-CDIFSLGVIMWELCTLNRPWEGVLP----ERVVYAVANEGSRLEI---PEG 752 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~k-sDVWSLGvIL~ELlTG~~PF~~~~~----~~~l~~i~~~~~~~~i---p~~ 752 (786)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+. ...
T Consensus 171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 249 (361)
T 3uc3_A 171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence 2 22345679999999999988887665 8999999999999999999986533 3444444433333222 134
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||.+|||+.++++|
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 68999999999 99999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.27 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=199.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+++|.+.+.||+|+||+||+|.+ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999988 5889999998644321 11234567999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+.+ +|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 80 EYLDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp ECCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 99984 78877763 3456899999999999999999999999999999999999999999999999999876554444
Q ss_pred CCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Q 003919 685 DSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--------------- 748 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--------------- 748 (786)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 455678999999999876 5689999999999999999999999999888776666544211110
Q ss_pred ----------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ----------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ----------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+|+.+||. ||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 012357899999999 99999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=348.34 Aligned_cols=256 Identities=30% Similarity=0.561 Sum_probs=209.0
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC---Ce--eEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN---GT--DVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~---G~--~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+..++|.+.+.||+|+||+||+|.+. ++ .||||++..... .....+.|.+|+.++++++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34578999999999999999999862 23 589999865543 3345688999999999999999999999998765
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.++++||+++++|.+++... ...+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999998742 356899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---C
Q 003919 679 TDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---E 751 (786)
Q Consensus 679 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~ 751 (786)
..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.........+.........+ +
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 54322 1224467889999999998889999999999999999999 999999998888888777665554443 3
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+.+++.+||. ||.+|||+.+++++|++...
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 469999999999 99999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.00 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=206.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||++.+ ++..+|+|++...... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 6799999999999999999987 4789999998765432 235788999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhh-cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccCC
Q 003919 606 YMELGSLYHLIHLS-GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 606 y~~gGSL~dlL~~~-~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~ 681 (786)
|+++++|.+.+... .....+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999888533 234679999999999999999999999999999999999999 45678999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPLGRL 757 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i----p~~~L~~L 757 (786)
. ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+................... ....+.+|
T Consensus 181 ~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 181 E-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred c-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 2 2345679999999999864 5899999999999999999999999998887777666554433322 14468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.|++++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=357.99 Aligned_cols=253 Identities=27% Similarity=0.533 Sum_probs=206.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCee----EEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTD----VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~----VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
...+|.+.+.||+|+||+||+|.+ +++. ||+|.+.... .....+.|.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 457899999999999999999987 4544 5677664332 2334578999999999999999999999998765
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++++|+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 91 ~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 8899999999999999873 34578999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 680 DSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 680 ~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
.... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.... ....+ ...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCccCCHH
Confidence 4322 2234457789999999999999999999999999999999 999999888777666554433 33333 346
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+.+|+.+||. ||.+||++.++++.|.++..
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999 99999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=370.24 Aligned_cols=246 Identities=29% Similarity=0.434 Sum_probs=205.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+|.+.+.||+|+||+||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++.+...+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999998 68899999986543211 1235788999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999 6788888763 3579999999999999999999999999999999999999999999999999998775543
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHHHHHHHh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLGRLIADC 761 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip~~~L~~LI~~C 761 (786)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+...... +...+..+.+|+.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence 3346789999999999988776 78999999999999999999999876543322221111111 111245689999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||.+|||+.|++++
T Consensus 243 L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCSSGGGSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHHhC
Confidence 99 99999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=379.00 Aligned_cols=248 Identities=27% Similarity=0.480 Sum_probs=216.7
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
...+|.+++.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999988 5889999999754321 1235678999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~ 682 (786)
||||+++|+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 v~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999986 45679999999999999999999999999999999999999999999999999998875533
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 760 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~ 760 (786)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......+ .-+..+.+||.+
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 3346789999999999988765 6899999999999999999999999888777777665443322 124579999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+|||+.+|++|
T Consensus 250 ~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 250 MLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HTCSSTTTSCCHHHHHTC
T ss_pred HcCCCchhCcCHHHHHhC
Confidence 999 99999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.65 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=213.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+.|.+.+.||+|+||+||+|.+ +|+.+|+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999988 58899999986543 233467899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC--CCeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~ 682 (786)
||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 128 E~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp ECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999998862 3347999999999999999999999999999999999999974 4789999999998875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......... .+..+.+|
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 223457999999999999999999999999999999999999999998888777777665433221 23468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.+++++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhhC
Confidence 999999 99999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.54 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=199.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHH--hhcCCCceeEEeccc-----
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISIL--SRLRHPNVILFLGAC----- 594 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL--~~L~HPNIVkL~g~~----- 594 (786)
+..+..++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.+++ ..++||||+++++++
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 345668999999999999999999999999999999986432 24455555554 458999999999743
Q ss_pred ccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc---------ceeeccCCcccEEEcCCC
Q 003919 595 TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM---------KIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 595 ~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~---------gIIHrDLKpsNILLd~~g 665 (786)
.....+++||||+++|+|.+++.. ...++..++.++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred CCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 334467999999999999999963 2458888999999999999999999 999999999999999999
Q ss_pred eEEEEecCccccccCCC--------CCCCCCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003919 666 TVKICDFGLSRIITDSP--------MRDSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCTLNRPWEG 730 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~--------~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvIL~ELlTG~~PF~~ 730 (786)
.+||+|||++..+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998765321 11234579999999999987 3566789999999999999999776532
Q ss_pred C-C-----------------hHHHHHHHHhcCCCCCCCCh---------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 731 V-L-----------------PERVVYAVANEGSRLEIPEG---------PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 731 ~-~-----------------~~~~l~~i~~~~~~~~ip~~---------~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
. . .......+........++.. .+.+||.+||. ||++|||+.++++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1 1 11222222233334444432 58999999999 9999999999999999875
Q ss_pred h
Q 003919 783 Y 783 (786)
Q Consensus 783 ~ 783 (786)
.
T Consensus 318 ~ 318 (336)
T 3g2f_A 318 M 318 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=363.05 Aligned_cols=242 Identities=25% Similarity=0.418 Sum_probs=206.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++...... +.+|++++.++ +||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 36799999999999999999988 4889999999765432 34688888888 799999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC----CeEEEEecCcccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH----WTVKICDFGLSRIIT 679 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~l~ 679 (786)
|||+.+|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999886 44579999999999999999999999999999999999998543 359999999998876
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC---CChHHHHHHHHhcCCCCC-----CCC
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG---VLPERVVYAVANEGSRLE-----IPE 751 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~---~~~~~~l~~i~~~~~~~~-----ip~ 751 (786)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+ .........+........ ..+
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 554445567899999999999888899999999999999999999999975 345556666555443332 124
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+.+||.+||. ||.+||++.++++|
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 578999999999 99999999999976
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=362.27 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=193.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.+.|.+.+.||+|+||+||+|.+ .++.||||++.... ..+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 46799999999999999999998 46789999987542 2356889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCccccccCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDS 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~ 681 (786)
||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999886 4457899999999999999999999999999999999999975 889999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC-----CChHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEI-----PEGPLG 755 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~i-----p~~~L~ 755 (786)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+......... .+..+.
T Consensus 205 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 V-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred c-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 2 2345679999999999999999999999999999999999999998776655 44444443332221 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||++|||+.+++++
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999 99999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.29 Aligned_cols=249 Identities=26% Similarity=0.470 Sum_probs=205.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+++.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 3467899999999999999999988 488999999865432 1223567899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999973 346899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIA 759 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~ 759 (786)
. ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+.......+ .-+..+.+++.
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence 2 2235678999999999988765 6899999999999999999999998887777666654433222 22457999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||. ||.+|||+.+++++
T Consensus 244 ~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCCCHHHHHhC
Confidence 9999 99999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=364.54 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=206.4
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEee
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYM 607 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~ 607 (786)
|...+.||+|+||.||+|.+ +|+.||+|++..... ...+.|.+|+.++++++||||+++++++.+.+.+++||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34467899999999999987 588999999875432 34578999999999999999999999999999999999999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE--cCCCeEEEEecCccccccCCCCCC
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL--d~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+.... ..
T Consensus 169 ~~~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 99999988863 34578999999999999999999999999999999999999 567899999999998875432 33
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRLIAD 760 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~LI~~ 760 (786)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......... .+..+.+||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 4567999999999999999999999999999999999999999999888888777765543321 23568999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||. ||.+|||+.+++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999 99999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=359.74 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=206.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-------- 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-------- 596 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 57899999999999999999988 58899999987665544445678899999999999999999999876
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.+++||||+.+ +|.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCC-CHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 3468999999986 6666554 234569999999999999999999999999999999999999999999999999998
Q ss_pred cccCC----CCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--C
Q 003919 677 IITDS----PMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--I 749 (786)
Q Consensus 677 ~l~~~----~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--i 749 (786)
.+... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+........ .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 76422 122345678999999999876 4589999999999999999999999999887776666543221111 0
Q ss_pred -C------------------------------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 -P------------------------------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 -p------------------------------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+ +..+.+||.+||. ||.+|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 2347789999999 99999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.54 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=211.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc--cC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--KP 597 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~--~~ 597 (786)
+.++|++.+.||+|+||.||++.+ .++.||||++... .....+.|.+|++++++++||||+++++++. +.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 457899999999999999999984 5788999998654 3445678999999999999999999999876 45
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred ceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 6689999999999999999742 34699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHH
Q 003919 678 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYAV 740 (786)
Q Consensus 678 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~--------------~~l~~i 740 (786)
...... ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 754322 223456888999999999999999999999999999999999998653322 222233
Q ss_pred HhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 741 ANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 741 ~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.........+ +..+.+|+.+||. ||.+|||+.+++++|+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3334333333 3469999999999 99999999999999997753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=344.45 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=204.5
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
++|.+.+.||+|+||+||+|.+ +++.||||++............+.+|+..+..+ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999988 588999999987666556678899999999999 8999999999999999999999
Q ss_pred EeeccchhHHHHHhhcC-CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-------------------
Q 003919 605 EYMELGSLYHLIHLSGQ-KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------------------- 664 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~-~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~------------------- 664 (786)
||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99999999999974321 2568999999999999999999999999999999999999844
Q ss_pred CeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 003919 665 WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE 743 (786)
Q Consensus 665 g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~ 743 (786)
..+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||++|+|++|..|+..... ...+. .
T Consensus 171 ~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~-~ 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR-Q 242 (289)
T ss_dssp CCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH-T
T ss_pred eEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH-c
Confidence 47999999999877543 244699999999999876 567899999999999999999987755432 22222 2
Q ss_pred CCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 744 GSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 744 ~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+....++ +..+.+|+.+||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 3333333 4579999999999 99999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=376.20 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=209.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.+.+.||+|+||+||+|.+ ++..||||++............+.+|+.+++.++|||||+++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999998 57899999997665544445788999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~~ 682 (786)
|+.+|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999999988863 356899999999999999999999999999999999999976 4559999999998876542
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 194 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 194 -KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHH
T ss_pred -cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHH
Confidence 3346789999999999874 59999999999999999999999999999988888877665544332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.++|+|
T Consensus 272 i~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHCCCChhhCccHHHHhcC
Confidence 999999 99999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=363.68 Aligned_cols=257 Identities=19% Similarity=0.214 Sum_probs=201.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEeccccChH---------HHHHHHHHHHHHhhcCCCceeEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDLTAE---------NMEDFCNEISILSRLRHPNVILF 590 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~~~~---------~~~~f~~EI~iL~~L~HPNIVkL 590 (786)
+..++|.+.+.||+|+||+||+|.+ .+..+|||++........ ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999988 457899999875532111 11346788899999999999999
Q ss_pred eccccc----CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-
Q 003919 591 LGACTK----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW- 665 (786)
Q Consensus 591 ~g~~~~----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g- 665 (786)
++++.. ...+++||||+ +++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 999877 67899999999 999999986 334899999999999999999999999999999999999999887
Q ss_pred -eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHH
Q 003919 666 -TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV--LPER 735 (786)
Q Consensus 666 -~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~--~~~~ 735 (786)
.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ....
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643211 113557999999999999999999999999999999999999999653 2222
Q ss_pred HHHHHHh--cCCCC--------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 736 VVYAVAN--EGSRL--------EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 736 ~l~~i~~--~~~~~--------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
....... ..... ...+..+.+|+.+||. ||.+||++.+|++.|++....+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 1111111 11100 0223479999999999 9999999999999999876544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.07 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=207.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
++....++|.....||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3444556666677999999999999988 578999999875532 335789999999999999999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRII 678 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~l 678 (786)
+++||||+++++|.+++........+++..++.++.||+.||+|||++||+|+||||+|||++. ++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999975444456778999999999999999999999999999999999987 899999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCC---Ch
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEIP---EG 752 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~ip---~~ 752 (786)
...........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .............++ +.
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 54433344667999999999997653 8899999999999999999999997654332 222222223333333 45
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+|+.+||. ||++||++.+++++
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 78999999999 99999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.19 Aligned_cols=253 Identities=22% Similarity=0.278 Sum_probs=204.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
+++|.+.+.||+|+||.||++.+ +++.||||++..... .....+.|.+|+.++++++||||+++++++...+.++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 68899999999999999999987 588999999865543 334457899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999999973 35689999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHHH
Q 003919 684 -RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRLI 758 (786)
Q Consensus 684 -~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i---p~~~L~~LI 758 (786)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.........+....... .. -+..+.+|+
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 2235578999999999999999999999999999999999999999876654443333222211 11 234699999
Q ss_pred HHhhh-CCCCCC-CHHHHHHHHHhhh
Q 003919 759 ADCWA-EPQERP-SCEEILSRLLDCE 782 (786)
Q Consensus 759 ~~CL~-DP~kRP-Sa~EIL~~L~~i~ 782 (786)
.+||. ||.+|| +++++++.|++..
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred HHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 99999 999999 9999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.44 Aligned_cols=246 Identities=28% Similarity=0.511 Sum_probs=208.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..++|.+.+.||+|+||.||+|.+. |+.||||++..... .+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3578999999999999999999884 88999999875432 36788999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999999863 345789999999999999999999999999999999999999999999999999987765443
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGRLIA 759 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i---p~~~L~~LI~ 759 (786)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+....... .. .+..+.+|+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 4456679999999999999999999999999999999999999999888776665554433211 11 2456899999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||. ||.+|||+.+++++
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTS
T ss_pred HHccCChhhCcCHHHHHhC
Confidence 9999 99999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.82 Aligned_cols=257 Identities=29% Similarity=0.521 Sum_probs=213.4
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+..++|.+.+.||+|+||.||+|.+ .++.||||++... ........|.+|+.++++++||||+++++++.+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999973 4668999998643 3345567899999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcC----CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEE
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQ----KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKIC 670 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~----~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~ 670 (786)
...++||||+++++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++. +..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999999975432 145899999999999999999999999999999999999984 4569999
Q ss_pred ecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003919 671 DFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 747 (786)
Q Consensus 671 DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~ 747 (786)
|||++......... .....+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...........+.... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CC
Confidence 99999866433221 223457889999999999999999999999999999998 999999888877766655433 22
Q ss_pred CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 EIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+ +..+.+|+.+||. ||.+||++.+|+++|+.+..
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 222 3469999999999 99999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=352.56 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=204.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC---hHHHHHHHHHHHHHhhcC---CCceeEEecccccCC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT---AENMEDFCNEISILSRLR---HPNVILFLGACTKPP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~---~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~ 598 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++...... ......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999986 6889999998644321 111245667777777664 999999999987655
Q ss_pred -----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 599 -----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 599 -----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.++++|||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4899999998 5999888632 23449999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 003919 674 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----- 748 (786)
Q Consensus 674 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----- 748 (786)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 166 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 166 LARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp CTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 998765432 33456789999999999999999999999999999999999999999888877766654211110
Q ss_pred -----------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -----------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -----------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.....+.+||.+||. ||.+|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 012457899999999 99999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=376.67 Aligned_cols=246 Identities=28% Similarity=0.466 Sum_probs=216.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999988 5889999999765432 33457899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 680 (786)
|||+.+++|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999886 45679999999999999999999999999999999999999 5678999999999987754
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLG 755 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~ 755 (786)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.........+ +..+.
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 182 SK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred cc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 32 2234579999999999977 59999999999999999999999999999988888887766555443 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||.+|||+.++++|
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHCCCChhHCcCHHHHhhC
Confidence 99999999 99999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.87 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=203.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh---HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA---ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~---~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
..+|.+.+.||+|+||.||+|.+ +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 57899999999999999999987 48899999986543221 11246889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+.+ +|.+++.. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 89 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999986 78777752 3457889999999999999999999999999999999999999999999999999887655
Q ss_pred CCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------- 747 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------- 747 (786)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+..+......+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 4445567899999999999764 58999999999999999999999999988877766665421111
Q ss_pred ----------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+||.+||. ||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0012468899999999 99999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=358.35 Aligned_cols=236 Identities=22% Similarity=0.367 Sum_probs=180.9
Q ss_pred eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEeeccc
Q 003919 534 TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
+.||+|+||+||+|.+ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 7899999999999988 4889999998643 2467789999999997 999999999999999999999999999
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEecCccccccCCCCCCCC
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++............
T Consensus 92 ~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 168 (325)
T 3kn6_A 92 ELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168 (325)
T ss_dssp BHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence 9999997 346799999999999999999999999999999999999998766 8999999999877655444456
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC-----CChHHH
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-------ERVVYAVANEGSRLEI-----PEGPLG 755 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-------~~~l~~i~~~~~~~~i-----p~~~L~ 755 (786)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+......... .+..+.
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 248 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAK 248 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHH
Confidence 7889999999999999999999999999999999999999986433 3344444333322221 234689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||.+|||+.+++++
T Consensus 249 ~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 249 DLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999 99999999999865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.49 Aligned_cols=261 Identities=30% Similarity=0.558 Sum_probs=216.7
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
...+|.+..++|.+.+.||+|+||.||+|.+.+ .+|+|++..........+.|.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 457788889999999999999999999999876 4999998765544444466888999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.++++|||+++++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999999862 334789999999999999999999999999999999999998 679999999998765
Q ss_pred cCC-----CCCCCCCCCCCcccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Q 003919 679 TDS-----PMRDSSSAGTPEWMAPELIRN---------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG 744 (786)
Q Consensus 679 ~~~-----~~~~~~~~GT~~Y~APEvl~~---------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~ 744 (786)
... ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 321 112234568899999999864 457899999999999999999999999988887776665443
Q ss_pred CCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 745 SRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 745 ~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..... .+..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 32222 13469999999999 99999999999999988764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.30 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||++.+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...++++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999988 588999999875432 223678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~~~ 682 (786)
|+++++|.+++.. ...+++..++.++.|++.||+|||++||+|+||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999998863 3468999999999999999999999999999999999999 78889999999999765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+......... .+..+.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 241 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHH
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 122346899999999999999999999999999999999999999998888777776665443322 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.+++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 242 ICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.82 Aligned_cols=255 Identities=31% Similarity=0.572 Sum_probs=211.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeE--EEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDV--AIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~V--AVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
.+++|.+.+.||+|+||.||+|.+ ++..+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 357899999999999999999976 56654 899886432 233456799999999999 899999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeE
Q 003919 601 SMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTV 667 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~V 667 (786)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999997431 23478999999999999999999999999999999999999999999
Q ss_pred EEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCC
Q 003919 668 KICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSR 746 (786)
Q Consensus 668 KL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~ 746 (786)
||+|||++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.........+.. +..
T Consensus 182 kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~ 259 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYR 259 (327)
T ss_dssp EECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCC
T ss_pred EEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CCC
Confidence 99999999754321 12234467889999999999889999999999999999998 9999999888776665543 333
Q ss_pred CCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 747 LEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 747 ~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...+ +..+.+|+.+||. ||.+|||+.+++++|.++..
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 3333 3479999999999 99999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.45 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=207.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999988 4889999998755432 345789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--C
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP--M 683 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~--~ 683 (786)
|+++++|.+++. ....+++..++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..+.... .
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999999885 44679999999999999999999999999999999999999999999999999998764321 1
Q ss_pred CCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCC---CChHHHHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVANEGSRLEI---PEGPLGRLI 758 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~~~~~~~i---p~~~L~~LI 758 (786)
......|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||....... ....+......... .+..+.+|+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345679999999999987765 789999999999999999999998765432 22223322222211 244689999
Q ss_pred HHhhh-CCCCCCCHHHHHHH
Q 003919 759 ADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+||. ||.+|||+.+++++
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHCCCCchhCCCHHHHhcC
Confidence 99999 99999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=348.42 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=201.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc--CCCceeEEecccccC----Cce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL--RHPNVILFLGACTKP----PRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L--~HPNIVkL~g~~~~~----~~l 600 (786)
.++|.+.+.||+|+||.||+|.++++.||||++.... ...+..|.+++..+ +||||+++++++... ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3689999999999999999999999999999985432 24556666666655 899999999998876 679
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc--------ceeeccCCcccEEEcCCCeEEEEec
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM--------KIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~--------gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999963 3689999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCC----CCCCCCCCcccCccccccCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCC
Q 003919 673 GLSRIITDSPMR----DSSSAGTPEWMAPELIRNEPFTEK------CDIFSLGVIMWELCTL----------NRPWEGVL 732 (786)
Q Consensus 673 GLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~~~~s~k------sDVWSLGvIL~ELlTG----------~~PF~~~~ 732 (786)
|++..+...... .....||+.|+|||++.+..+..+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 999876443221 224579999999999988766654 9999999999999999 77776432
Q ss_pred -----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 733 -----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 733 -----~~~~l~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
.......+.........+. ..+.+|+.+||. ||.+|||+.+|+++|+++..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2222222223333333432 248899999999 999999999999999988654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.32 Aligned_cols=243 Identities=27% Similarity=0.327 Sum_probs=202.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------ 598 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 37899999999999999999988 5889999998766555666788999999999999999999999987653
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899998863 46899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------- 747 (786)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 DSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 432 345688999999999887 679999999999999999999999999888766665554321110
Q ss_pred ----------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+|+.+||. ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0113468899999999 99999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.19 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=207.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc---------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 596 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--------- 596 (786)
.+|.+.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5799999999999999999998 48899999986543 346789999999999999999998754
Q ss_pred -------CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEE
Q 003919 597 -------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKI 669 (786)
Q Consensus 597 -------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL 669 (786)
...+++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 34589999999999999999643 3457899999999999999999999999999999999999999999999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003919 670 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 749 (786)
Q Consensus 670 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i 749 (786)
+|||++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||... ......+ ........
T Consensus 164 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~-~~~~~~~~ 239 (284)
T 2a19_B 164 GDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL-RDGIISDI 239 (284)
T ss_dssp CCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH-HTTCCCTT
T ss_pred Ccchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh-hccccccc
Confidence 9999998875532 234567999999999999999999999999999999999999987532 1222222 22333334
Q ss_pred CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 750 PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 750 p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
.+..+.+|+.+||. ||.+|||+.+++++|..+..+.
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 45679999999999 9999999999999999887653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=375.13 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=211.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-----------HHHHHHHHHHHHHhhcCCCceeEEecc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-----------ENMEDFCNEISILSRLRHPNVILFLGA 593 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-----------~~~~~f~~EI~iL~~L~HPNIVkL~g~ 593 (786)
.++|.++++||+|+||+||+|.+ .++.||||++....... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999988 47889999997654321 235689999999999999999999999
Q ss_pred cccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEE
Q 003919 594 CTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKIC 670 (786)
Q Consensus 594 ~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~ 670 (786)
+.+...+++||||+++|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999998863 35799999999999999999999999999999999999998776 69999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 003919 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI- 749 (786)
Q Consensus 671 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i- 749 (786)
|||++..+... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999877543 23356789999999999875 5999999999999999999999999999998888887766544332
Q ss_pred ----CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 ----PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 ----p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+..+.+||.+||. ||.+|||+.++|++
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 24568999999999 99999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.23 Aligned_cols=247 Identities=29% Similarity=0.539 Sum_probs=208.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhh--cCCCceeEEecccccCC----ceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSR--LRHPNVILFLGACTKPP----RLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~--L~HPNIVkL~g~~~~~~----~l~ 601 (786)
++|.+.+.||+|+||.||+|.++|+.||||++... ....+.+|++++.. ++||||+++++++.... .++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 67999999999999999999999999999998532 24678889999887 78999999999998775 799
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh--------hcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--------RMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--------s~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
+||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||
T Consensus 117 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 99999999999999963 36899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCC-
Q 003919 674 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTL----------NRPWEGVL- 732 (786)
Q Consensus 674 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvIL~ELlTG----------~~PF~~~~- 732 (786)
++........ ......||+.|+|||++.+.. ++.++|||||||++|||++| +.||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987754432 224567999999999997752 34789999999999999999 78987642
Q ss_pred ----hHHHHHHHHhcCCCCCCCC--------hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 733 ----PERVVYAVANEGSRLEIPE--------GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 733 ----~~~~l~~i~~~~~~~~ip~--------~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.......+........++. ..+.+|+.+||. ||.+|||+.+|+++|+++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 2333444434444444443 258899999999 99999999999999998864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=342.56 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=214.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc---C----hHHHHHHHHHHHHHhhcC-CCceeEEeccccc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL---T----AENMEDFCNEISILSRLR-HPNVILFLGACTK 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~---~----~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~ 596 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||||++..... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 57899999999999999999988 578999999975532 1 223467889999999996 9999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
....++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999973 3578999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIR------NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
...... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...........+.........+
T Consensus 173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 765432 334567999999999985 4568899999999999999999999999888877777766655444332
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 -----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 -----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+|+.+||. ||.+|||+.+++++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 3468999999999 99999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=358.83 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=199.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------ 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------ 598 (786)
.++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999987 5889999999876656666788999999999999999999999987654
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999985 6777764 35889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 543 22345689999999999999999999999999999999999999999988776666554322110
Q ss_pred ---------C--------------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ---------E--------------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ---------~--------------ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. .+ ...+.+|+.+||. ||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 01 1247899999999 99999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.58 Aligned_cols=247 Identities=28% Similarity=0.482 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+.+.||+|+||.||+|.+. ++.+|+|++..... ...+.|.+|+.+++.++||||+++++++...+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 478999999999999999999984 88999999865432 33578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 999999999988632 356899999999999999999999999999999999999999999999999997654222112
Q ss_pred CCCCCCCCcccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-C---ChHHH
Q 003919 685 DSSSAGTPEWMAPELI-----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-P---EGPLG 755 (786)
Q Consensus 685 ~~~~~GT~~Y~APEvl-----~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p---~~~L~ 755 (786)
.....||+.|+|||++ .+..++.++|||||||++|+|++|+.||...........+......... + +..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 2345789999999998 4667899999999999999999999999998887777666554432221 1 34689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|+.+||. ||.+|||+.+++++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999 99999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=340.82 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=205.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc-ccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~-~~~~~l~LV 603 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||||++...... +.+.+|+.+++.++|++++..+.++ ......+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 47899999999999999999986 6899999998655432 3588999999999988876666555 566778999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 680 (786)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 84 MELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 9999 8999999863 24579999999999999999999999999999999999999 4889999999999987755
Q ss_pred CCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003919 681 SPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 747 (786)
Q Consensus 681 ~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~--- 747 (786)
... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 422 12456799999999999999999999999999999999999999986432 12222222111111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ---~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...+..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 1124569999999999 99999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=350.32 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=208.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC--Cc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--PR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--~~ 599 (786)
..|++++.||+|+||+||++.+ +++.||||++... ......+.|.+|+.+++.++||||+++++++.+. ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 3359999999999999998865 5788999998754 3445567899999999999999999999999774 56
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+++||||+++++|.+++.. ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 8999999999999999862 348999999999999999999999999999999999999999999999999998875
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------------HHHHHHHh
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE--------------RVVYAVAN 742 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~--------------~~l~~i~~ 742 (786)
.... ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 4321 123456888999999999989999999999999999999999999754221 11222333
Q ss_pred cCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 743 EGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 743 ~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.......+ +..+.+|+.+||. ||.+|||+.++++.|+++..
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 33333333 3469999999999 99999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.63 Aligned_cols=250 Identities=20% Similarity=0.283 Sum_probs=201.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc-ccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC-TKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~-~~~~~l~LV 603 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ..+.+|+.+++.++|++++..++++ ......+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 36899999999999999999986 6889999987654332 3578899999999988877666655 566778999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 680 (786)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 84 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9999 8999999863 24569999999999999999999999999999999999999 7899999999999987754
Q ss_pred CCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC---
Q 003919 681 SPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---RVVYAVANEGSRL--- 747 (786)
Q Consensus 681 ~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---~~l~~i~~~~~~~--- 747 (786)
... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 322 223567999999999999999999999999999999999999999764321 1222221111111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ---~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...+..+.+|+.+||. ||.+|||+.+|++.|+++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 1114579999999999 99999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.30 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=208.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSM 602 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~L 602 (786)
+..++|.+.+.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 44578999999999999999999984 8899999987543 44556789999999999999999999999999999999
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999973 34689999999999999999999996 9999999999999999999999999999766432
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------------------
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------------- 740 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i--------------------- 740 (786)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 223567999999999999999999999999999999999999999876654432211
Q ss_pred --------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 741 --------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 741 --------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.........+ +..+.+||.+||. ||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111111222 3368899999999 99999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=390.83 Aligned_cols=251 Identities=20% Similarity=0.353 Sum_probs=217.3
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
.+..++|.+.+.||+|+||+||+|.+ +++.||||++.+... .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34578999999999999999999988 477899999975432 223346788999999988 69999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||+++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...
T Consensus 417 ~~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999973 3579999999999999999999999999999999999999999999999999998755
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHH
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLI 758 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI 758 (786)
.........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...+...+.......+. -+..+.+||
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 4444556788999999999999999999999999999999999999999999998888888765543322 245799999
Q ss_pred HHhhh-CCCCCCCH-----HHHHHH
Q 003919 759 ADCWA-EPQERPSC-----EEILSR 777 (786)
Q Consensus 759 ~~CL~-DP~kRPSa-----~EIL~~ 777 (786)
.+||. ||.+||++ ++|++|
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999 99999997 777754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.46 Aligned_cols=254 Identities=28% Similarity=0.533 Sum_probs=202.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE---CC--eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW---NG--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~---~G--~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~l~ 601 (786)
..|.+.+.||+|+||+||+|.+ ++ ..||||.+... ......+.|.+|+.++++++||||+++++++.+ .+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4578899999999999999976 22 35889987643 234456889999999999999999999998654 56789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 168 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999962 3456889999999999999999999999999999999999999999999999999876443
Q ss_pred CCC----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 682 PMR----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 682 ~~~----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+.........+... .....+ +..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence 211 133457789999999999999999999999999999999 67788877665555554443 233222 457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+.+|+.+||. ||.+|||+.+++++|+++..++
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999 9999999999999999886554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=352.00 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=210.3
Q ss_pred CCeeEe-eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEE
Q 003919 528 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~-k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV 603 (786)
..|.+. +.||+|+||+||+|.+ +++.||||++............+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 457776 8899999999999988 4889999999766555555678999999999995 69999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~ 680 (786)
|||+.+|+|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999998852 23467999999999999999999999999999999999999987 78999999999987754
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLG 755 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~ 755 (786)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......... ....+.
T Consensus 187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 265 (327)
T 3lm5_A 187 AC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLAT 265 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHH
Confidence 32 234567999999999999999999999999999999999999999998888777766654433322 134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||.+|||+.+++++
T Consensus 266 ~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 266 DFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999 99999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.68 Aligned_cols=247 Identities=27% Similarity=0.348 Sum_probs=198.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----Cc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~ 599 (786)
.++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999988 578999999976655666678999999999999999999999998766 56
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||+. ++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 999999987 59998886 45679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----------------------CCCCCCCCCcccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCC----------
Q 003919 680 DSPM----------------------RDSSSAGTPEWMAPELI-RNEPFTEKCDIFSLGVIMWELCTLNR---------- 726 (786)
Q Consensus 680 ~~~~----------------------~~~~~~GT~~Y~APEvl-~~~~~s~ksDVWSLGvIL~ELlTG~~---------- 726 (786)
.... .....+||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 4321 12567899999999986 56679999999999999999998543
Q ss_pred -CCCCCCh-----------------HHHHHHHHh------------------------cCCCCC--------CCChHHHH
Q 003919 727 -PWEGVLP-----------------ERVVYAVAN------------------------EGSRLE--------IPEGPLGR 756 (786)
Q Consensus 727 -PF~~~~~-----------------~~~l~~i~~------------------------~~~~~~--------ip~~~L~~ 756 (786)
+|.+... ...+..+.. ...... ..+..+.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 3433320 111111110 001111 12346889
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
||.+||. ||.+|||+.|+|+|
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999 99999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.35 Aligned_cols=257 Identities=15% Similarity=0.151 Sum_probs=209.7
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEE-------ECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC---CCcee
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGI-------WNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVI 588 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~-------~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~---HPNIV 588 (786)
...++++..++|.+.+.||+|+||+||+|. ..++.||||++.... ..++..|+++++.++ |+||+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence 446677788999999999999999999993 268899999986432 356788888888887 99999
Q ss_pred EEecccccCCceEEEEEeeccchhHHHHHhhc--CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---
Q 003919 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSG--QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--- 663 (786)
Q Consensus 589 kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~--~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~--- 663 (786)
++++++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence 99999999999999999999999999997432 3457999999999999999999999999999999999999998
Q ss_pred --------CCeEEEEecCccccccC--CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 003919 664 --------HWTVKICDFGLSRIITD--SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP 733 (786)
Q Consensus 664 --------~g~VKL~DFGLA~~l~~--~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~ 733 (786)
++.+||+|||+++.+.. ........+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976532 22233567899999999999999999999999999999999999999964322
Q ss_pred HHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCC-CCHHHHHHHHHhhhh
Q 003919 734 ERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQER-PSCEEILSRLLDCEY 783 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kR-PSa~EIL~~L~~i~~ 783 (786)
.... .............+.+++..|+. +|.+| |++.++.+.|+++..
T Consensus 291 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 GECK---PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp TEEE---ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred Ccee---echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1100 00001111123468899999999 88887 688888888877644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.93 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=198.1
Q ss_pred CCeeEe-eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEE
Q 003919 528 SELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~-k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV 603 (786)
+.|.+. +.||+|+||+||+|.+ +++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568884 7899999999999987 688999999975533 2346789999999985 799999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe---EEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~~l~~ 680 (786)
|||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999973 357899999999999999999999999999999999999998776 99999999976532
Q ss_pred CC-------CCCCCCCCCCcccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------
Q 003919 681 SP-------MRDSSSAGTPEWMAPELIRN-----EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP--------------- 733 (786)
Q Consensus 681 ~~-------~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~--------------- 733 (786)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 11124569999999999975 4588999999999999999999999986542
Q ss_pred HHHHHHHHhcCCCCC-----CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 734 ERVVYAVANEGSRLE-----IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 734 ~~~l~~i~~~~~~~~-----ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.......+ ..+..+.+|+.+||. ||.+|||+.+++++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 223333333332221 123468999999999 99999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.86 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=206.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC--hHHHHHHHHHHHHHhhcCCCceeEEeccc--ccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~--~~~~~~f~~EI~iL~~L~HPNIVkL~g~~--~~~~~l 600 (786)
..+|.+.+.||+|+||.||++.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999988 5789999998654321 23457899999999999999999999998 455679
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+.++ |.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999999987 66666532 356789999999999999999999999999999999999999999999999999987643
Q ss_pred CC--CCCCCCCCCCcccCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHH
Q 003919 681 SP--MRDSSSAGTPEWMAPELIRNEP--FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLG 755 (786)
Q Consensus 681 ~~--~~~~~~~GT~~Y~APEvl~~~~--~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~ 755 (786)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+........ .....+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 21 1223567999999999997654 37899999999999999999999999888777776665443222 1245699
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|+.+||. ||.+|||+.+++++
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCCCHHHHhcC
Confidence 99999999 99999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=348.42 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=192.7
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
.|.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4667789999999999999999999976 688999999864432 2335678899999999999999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhh-----cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCc
Q 003919 600 LSMITEYMELGSLYHLIHLS-----GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 674 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~-----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 674 (786)
.++||||+++++|.+++... .....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999999988632 1245689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Q 003919 675 SRIITDSPM-----RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 748 (786)
Q Consensus 675 A~~l~~~~~-----~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ 748 (786)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 977643211 1234579999999999876 5689999999999999999999999988776665554443322110
Q ss_pred -----------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 -----------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 -----------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+|+.+||. ||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 113468899999999 99999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=368.53 Aligned_cols=248 Identities=15% Similarity=0.141 Sum_probs=195.4
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHH---HHHhhcCCCceeEEe----
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEI---SILSRLRHPNVILFL---- 591 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI---~iL~~L~HPNIVkL~---- 591 (786)
++....++|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.|.+|+ .+++.++|||||+++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 3444567899999999999999999986 589999999975432 344567899999 455556799999998
Q ss_pred ---cccccCC-----------------ceEEEEEeeccchhHHHHHhhc----CCccchHHHHHHHHHHHHHHHHhhhhc
Q 003919 592 ---GACTKPP-----------------RLSMITEYMELGSLYHLIHLSG----QKKKLSWRRKLKMLRDICRGLMCIHRM 647 (786)
Q Consensus 592 ---g~~~~~~-----------------~l~LV~Ey~~gGSL~dlL~~~~----~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 647 (786)
+++.+.+ ..|++|||+ +|+|.+++.... ....+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 4444332 388999999 579999987432 123466788999999999999999999
Q ss_pred ceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-----------CCCchhhHHHHHH
Q 003919 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-----------PFTEKCDIFSLGV 716 (786)
Q Consensus 648 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDVWSLGv 716 (786)
||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999999986433 2345677 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 717 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 717 IL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||||++|+.||.+.........+... ....+..+.+||.+||. ||.+|||+.+++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999999776543332222111 12224579999999999 99999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=359.55 Aligned_cols=241 Identities=22% Similarity=0.384 Sum_probs=204.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh------HHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA------ENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~------~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
++|.+.+.||+|+||+||+|.+ +++.||||++....... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999987 68899999997654322 133467789999999999999999999999999
Q ss_pred eEEEEEeeccc-hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 600 LSMITEYMELG-SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 600 l~LV~Ey~~gG-SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
+++||||+.+| +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999887 4557999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRL 757 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~L 757 (786)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .......+...+..+.+|
T Consensus 181 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~l~~l 254 (335)
T 3dls_A 181 ERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VEAAIHPPYLVSKELMSL 254 (335)
T ss_dssp CTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----TTTCCCCSSCCCHHHHHH
T ss_pred CCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----HhhccCCCcccCHHHHHH
Confidence 5442 2335679999999999988876 88999999999999999999999763321 001111122234579999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.+++++
T Consensus 255 i~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 255 VSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999 99999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=378.33 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=214.0
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+.+.||+|+||+||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999988 5889999999754432 123567899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+||||++||+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999999886432 245799999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCCC-CCChHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRLE-IPEGPLG 755 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~----~~~~~l~~i~~~~~~~~-ip~~~L~ 755 (786)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ........+.......+ ..+..+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 421 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence 544445568999999999999999999999999999999999999999875 33445555544332221 2245799
Q ss_pred HHHHHhhh-CCCCCCCH-----HHHHHH
Q 003919 756 RLIADCWA-EPQERPSC-----EEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa-----~EIL~~ 777 (786)
+||.+||. ||.+||++ .+|++|
T Consensus 422 ~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 422 DFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 99999999 99999965 677754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.54 Aligned_cols=247 Identities=22% Similarity=0.396 Sum_probs=212.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc--C----hHHHHHHHHHHHHHhhc-CCCceeEEecccccC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--T----AENMEDFCNEISILSRL-RHPNVILFLGACTKP 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~--~----~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~ 597 (786)
..+|.+.+.||+|+||.||+|.+ +|+.||||++..... . ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 35799999999999999999988 488999999865432 1 12246788999999999 799999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
...++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999999873 35789999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 749 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-- 749 (786)
+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 250 LEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred cCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 75432 3346789999999999863 35889999999999999999999999988887777766655443322
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+..+.+|+.+||. ||.+|||+.+++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 13458999999999 99999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=362.27 Aligned_cols=242 Identities=21% Similarity=0.365 Sum_probs=193.4
Q ss_pred CCCeeEe-eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhh-cCCCceeEEeccccc----CC
Q 003919 527 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSR-LRHPNVILFLGACTK----PP 598 (786)
Q Consensus 527 ~s~y~i~-k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~-L~HPNIVkL~g~~~~----~~ 598 (786)
.++|.+. +.||+|+||+||++.+ +|+.||||++... ..+.+|+.++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678776 7899999999999988 4889999998532 356788888744 589999999998865 56
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 675 (786)
.+|+||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 789999999999999999732 2346999999999999999999999999999999999999997 789999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcCCCCCC--
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPER----VVYAVANEGSRLEI-- 749 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~----~l~~i~~~~~~~~i-- 749 (786)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+.........
T Consensus 212 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 8765432 2346789999999999999999999999999999999999999997654321 23333333333222
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+||.+||. ||.+|||+.++++|
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23468999999999 99999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=362.39 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=204.8
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhc-CCCceeEEecccc
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRL-RHPNVILFLGACT 595 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~ 595 (786)
.+..++|.+.+.||+|+||+||++.+ +++.||||++..... .....+.+.+|+++++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34567999999999999999999987 688999999864332 112235677899999999 6999999999999
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
....+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999973 346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHhcCCCC-
Q 003919 676 RIITDSP-MRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWEGV----LPERVVYAVANEGSRL- 747 (786)
Q Consensus 676 ~~l~~~~-~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~~~----~~~~~l~~i~~~~~~~- 747 (786)
+.+.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||... ........+.......
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 8754321 12234579999999999986 35789999999999999999999999743 2333333333322211
Q ss_pred CCCChHHHHHHHHhhh-CCCCCC-----CHHHHHHHH
Q 003919 748 EIPEGPLGRLIADCWA-EPQERP-----SCEEILSRL 778 (786)
Q Consensus 748 ~ip~~~L~~LI~~CL~-DP~kRP-----Sa~EIL~~L 778 (786)
......+.+||.+||. ||.+|| ++.+++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123468999999999 999999 999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.36 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=209.2
Q ss_pred CccccccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC--CCceeEEec
Q 003919 516 PLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--HPNVILFLG 592 (786)
Q Consensus 516 ~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~--HPNIVkL~g 592 (786)
..+.+..+.+...+|.+.+.||+|+||.||++.+ +++.||||++..........+.+.+|+.++++++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3345566777788999999999999999999987 5788999999877666777789999999999997 599999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
++.+.+.++++|| +.+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||+++ +.+||+||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCC
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeec
Confidence 9999999999999 56789999987 3457899999999999999999999999999999999999965 89999999
Q ss_pred CccccccCCCC--CCCCCCCCCcccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Q 003919 673 GLSRIITDSPM--RDSSSAGTPEWMAPELIRN-----------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP-ERVVY 738 (786)
Q Consensus 673 GLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~-~~~l~ 738 (786)
|++..+..... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .....
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 99987644321 1234578999999999875 4688999999999999999999999987643 33444
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 739 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 739 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.........+ +..+.+|+.+||. ||.+||++.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 444444433333 4579999999999 99999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.18 Aligned_cols=249 Identities=17% Similarity=0.197 Sum_probs=203.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC----------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeE-------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN----------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL------- 589 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~----------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVk------- 589 (786)
.++|.+.+.||+|+||.||+|.+. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 578999999999999999999873 678999998643 35789999999999999998
Q ss_pred --------Eeccccc-CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEE
Q 003919 590 --------FLGACTK-PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCL 660 (786)
Q Consensus 590 --------L~g~~~~-~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNIL 660 (786)
+++++.. ...+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4455544 67789999999 99999999732 2467999999999999999999999999999999999999
Q ss_pred EcCCC--eEEEEecCccccccCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003919 661 VNKHW--TVKICDFGLSRIITDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGV 731 (786)
Q Consensus 661 Ld~~g--~VKL~DFGLA~~l~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~ 731 (786)
++.++ .+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999987643211 123457999999999999999999999999999999999999999875
Q ss_pred C--hHHHHHHHH---hcCCCCC-------CCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 732 L--PERVVYAVA---NEGSRLE-------IPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 732 ~--~~~~l~~i~---~~~~~~~-------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
. ......... ....... ..+..+.+|+.+||. ||.+||++.+|++.|+++...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 3 222222221 1111110 124579999999999 999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.15 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=200.7
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-----
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----- 596 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----- 596 (786)
+....+|.+++.||+|+||+||+|.+ +|+.||||++...... +.+|+.+++.++|||||++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 44568899999999999999999987 6889999998654322 2379999999999999999999843
Q ss_pred ---------------------------------CCceEEEEEeeccchhHHHHHh-hcCCccchHHHHHHHHHHHHHHHH
Q 003919 597 ---------------------------------PPRLSMITEYMELGSLYHLIHL-SGQKKKLSWRRKLKMLRDICRGLM 642 (786)
Q Consensus 597 ---------------------------------~~~l~LV~Ey~~gGSL~dlL~~-~~~~~~Ls~~~i~~Ia~QIa~gL~ 642 (786)
...+++||||+++ +|.+.+.. ......+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999985 77666642 234567999999999999999999
Q ss_pred hhhhcceeeccCCcccEEEc-CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHH
Q 003919 643 CIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWE 720 (786)
Q Consensus 643 yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~E 720 (786)
|||++||+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999999998 68999999999998765432 33456789999999998775 48999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCC------------------------------CCCChHHHHHHHHhhh-CCCCCC
Q 003919 721 LCTLNRPWEGVLPERVVYAVANEGSRL------------------------------EIPEGPLGRLIADCWA-EPQERP 769 (786)
Q Consensus 721 LlTG~~PF~~~~~~~~l~~i~~~~~~~------------------------------~ip~~~L~~LI~~CL~-DP~kRP 769 (786)
|++|+.||.+......+..+......+ ...+..+.+|+.+||. ||.+||
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999999999988877766665321110 0113358899999999 999999
Q ss_pred CHHHHHHH
Q 003919 770 SCEEILSR 777 (786)
Q Consensus 770 Sa~EIL~~ 777 (786)
|+.|+++|
T Consensus 315 t~~e~l~h 322 (383)
T 3eb0_A 315 NPYEAMAH 322 (383)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999965
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.99 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=206.3
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..|++. ++|.+.+.||+|+||+||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 344443 7899999999999999999987 5899999999876666666788999999999999999999999998776
Q ss_pred ce------EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 599 RL------SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 599 ~l------~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
.. ++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred CcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 54 99999998 57777663 34899999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----
Q 003919 673 GLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---- 747 (786)
Q Consensus 673 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---- 747 (786)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 189 g~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 189 GLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999876432 345678999999999987 679999999999999999999999999888776665554311111
Q ss_pred ----------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ----------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ----------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
......+.+||.+||+ ||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0113468899999999 99999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=341.23 Aligned_cols=245 Identities=26% Similarity=0.470 Sum_probs=212.6
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||.||+|.+ +++.||||++..........+.+.+|+.++++++||||+++++++.+...+++++|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 6799999999999999999988 58899999997665544556789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC---CeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH---WTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~---g~VKL~DFGLA~~l~~~~ 682 (786)
|+.+++|.+.+.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 102 LYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred ccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999999988863 3468999999999999999999999999999999999999754 479999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
......|++.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.........+.........+ +..+.+|
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred -ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 22344588899999998765 8999999999999999999999999988887777776655443332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||. ||.+|||+.+++++
T Consensus 257 i~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHcccChhhCcCHHHHhcC
Confidence 999999 99999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=365.14 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=195.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC------hHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~------~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++...... ......+.+|+.+|++++|||||++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999988 5789999999765432 1223358899999999999999999999865 4
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC---eEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW---TVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g---~VKL~DFGLA 675 (786)
.+++||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 5899999999999998875 456799999999999999999999999999999999999997544 5999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC---
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI--- 749 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i--- 749 (786)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...............+.....
T Consensus 290 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 290 KILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred eecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 8875432 3346789999999999853 56889999999999999999999999865443333333333322221
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+|+.+||. ||.+|||+.++++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 23468999999999 99999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.72 Aligned_cols=239 Identities=20% Similarity=0.308 Sum_probs=198.7
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEeccccc--CCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~--~~~l~ 601 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47899999999999999999987 68899999986332 367889999999997 9999999999987 56789
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 680 (786)
++|||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999998874 488899999999999999999999999999999999999776 899999999987654
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHh-------------cCC
Q 003919 681 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVAN-------------EGS 745 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~-~~~~~l~~i~~-------------~~~ 745 (786)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... .....+..+.. ...
T Consensus 184 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 2345679999999999977 67899999999999999999999999543 22222222111 000
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ..-+..+.+||.+||. ||.+|||+.++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0023468899999999 99999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=352.97 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=212.2
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH---------------HHHHHHHHHHHHhhcCCCceeE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE---------------NMEDFCNEISILSRLRHPNVIL 589 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~---------------~~~~f~~EI~iL~~L~HPNIVk 589 (786)
...++|.+.+.||+|+||.||+|.++|+.||||++........ ..+.|.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3457999999999999999999999999999999865433211 1278999999999999999999
Q ss_pred EecccccCCceEEEEEeeccchhHHH------HHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEc
Q 003919 590 FLGACTKPPRLSMITEYMELGSLYHL------IHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVN 662 (786)
Q Consensus 590 L~g~~~~~~~l~LV~Ey~~gGSL~dl------L~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd 662 (786)
+++++.+.+.+++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ .||+|+||||+|||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99999999999999999999999988 531 125689999999999999999999999 9999999999999999
Q ss_pred CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 003919 663 KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTE-KCDIFSLGVIMWELCTLNRPWEGVLP-ERVVYA 739 (786)
Q Consensus 663 ~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~-ksDVWSLGvIL~ELlTG~~PF~~~~~-~~~l~~ 739 (786)
.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++|||||||++|+|++|+.||..... ......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 9999999999999876543 33456799999999999887 6666 99999999999999999999988766 555555
Q ss_pred HHhcCCCCC--------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 740 VANEGSRLE--------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 740 i~~~~~~~~--------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.......+ ..+..+.+|+.+||. ||.+|||+.+++++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 543322222 123468999999999 99999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.30 Aligned_cols=256 Identities=28% Similarity=0.508 Sum_probs=210.5
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
+...+|.+.+.||+|+||.||++.+ +|+.||||++... .....+.|.+|+.++++++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 4457899999999999999999985 5789999998653 3345678999999999999999999999886654
Q ss_pred --ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 599 --RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 599 --~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+++||||+++++|.+++.. ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 78999999999999999973 23568999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------------H---HHH
Q 003919 677 IITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------------R---VVY 738 (786)
Q Consensus 677 ~l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~------------~---~l~ 738 (786)
....... ......++..|+|||.+.+..++.++|||||||++|+|+||..||...... . .+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 7754322 123445778899999999988999999999999999999999988643111 0 112
Q ss_pred HHHhcCCCCCCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 739 AVANEGSRLEIP---EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 739 ~i~~~~~~~~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
...........+ +..+.+||.+||. ||.+|||+.+|++.|+++...
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222333333333 3479999999999 999999999999999988654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=345.96 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=207.5
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc---
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--- 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~--- 595 (786)
+.+.+..++|.+.+.||+|+||.||++.+ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER 99 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence 44556678999999999999999999987 6889999998653 3445678999999999999999999999986
Q ss_pred -cCCceEEEEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecC
Q 003919 596 -KPPRLSMITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 596 -~~~~l~LV~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.....++||||+.+++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence 3446899999999999999887432 34679999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC---------CCCCCCCCcccCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH
Q 003919 674 LSRIITDSPMR---------DSSSAGTPEWMAPELIRNEP---FTEKCDIFSLGVIMWELCTLNRPWEGVLP--ERVVYA 739 (786)
Q Consensus 674 LA~~l~~~~~~---------~~~~~GT~~Y~APEvl~~~~---~s~ksDVWSLGvIL~ELlTG~~PF~~~~~--~~~l~~ 739 (786)
++......... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98765321000 01234689999999987654 68999999999999999999999953211 111111
Q ss_pred HHhcCCCCCC---CChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 740 VANEGSRLEI---PEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 740 i~~~~~~~~i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+ ........ .+..+.+|+.+||. ||.+|||+.+++++|+++..
T Consensus 260 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 V-QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H-HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 2 22222221 23479999999999 99999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=357.79 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=189.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC------Cc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP------PR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~------~~ 599 (786)
++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7899999999999999999987 588999999876555566678899999999999999999999998654 56
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+++||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred EEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 89999999 689998885 2569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 345689999999999977 678999999999999999999999999888766655544311110
Q ss_pred -------------C--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -------------E--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -------------~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. -.+..+.+|+.+||. ||.+|||+.++|+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 012357899999999 99999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=360.56 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=210.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC--ceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP--RLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~--~l~L 602 (786)
..+|.+.+.||+|+||+||+|.+. |+.||||++...... ...+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467999999999999999999984 889999998754332 23577889999999999999999999987654 6899
Q ss_pred EEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----cCCCeEEEEecCccccc
Q 003919 603 ITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICDFGLSRII 678 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~DFGLA~~l 678 (786)
||||+++|+|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999999754444459999999999999999999999999999999999999 78888999999999877
Q ss_pred cCCCCCCCCCCCCCcccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC----CChHHHHHHHHhcCCC
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRN--------EPFTEKCDIFSLGVIMWELCTLNRPWEG----VLPERVVYAVANEGSR 746 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDVWSLGvIL~ELlTG~~PF~~----~~~~~~l~~i~~~~~~ 746 (786)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .........+......
T Consensus 167 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 167 EDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred cCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 5432 2345679999999999865 5678899999999999999999999964 2334455555443321
Q ss_pred C-----------------CCC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 747 L-----------------EIP---------EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 747 ~-----------------~ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
. ..+ ...+.+++.+||. ||++||++.++++.+.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1 011 1247789999999 99999999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.31 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=206.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCC------ceeEEecccccC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP------NVILFLGACTKP 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HP------NIVkL~g~~~~~ 597 (786)
.++|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++|+ +|+++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 47899999999999999999987 5789999998643 34457788999999998765 499999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC--------------
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-------------- 663 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-------------- 663 (786)
+.+++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999999 78999888633 3346889999999999999999999999999999999999987
Q ss_pred -----CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003919 664 -----HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 738 (786)
Q Consensus 664 -----~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~ 738 (786)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 667999999999875432 245679999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC------------------------------------------CC---ChHHHHHHHHhhh-CCCCCCCHH
Q 003919 739 AVANEGSRLE------------------------------------------IP---EGPLGRLIADCWA-EPQERPSCE 772 (786)
Q Consensus 739 ~i~~~~~~~~------------------------------------------ip---~~~L~~LI~~CL~-DP~kRPSa~ 772 (786)
.+.......+ .+ ...+.+|+.+||. ||.+|||+.
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 4322111000 00 1247799999999 999999999
Q ss_pred HHHHH--HHhhhh
Q 003919 773 EILSR--LLDCEY 783 (786)
Q Consensus 773 EIL~~--L~~i~~ 783 (786)
|++++ ++.+..
T Consensus 325 ell~hp~f~~~~~ 337 (339)
T 1z57_A 325 EALKHPFFDLLKK 337 (339)
T ss_dssp HHTTSGGGGGGGC
T ss_pred HHhcCHHHHHHhc
Confidence 99976 555443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.29 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=205.8
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc---CCCceeEEecccc-----
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT----- 595 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~----- 595 (786)
.++|.+.+.||+|+||.||+|.+ +|+.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 47899999999999999999987 478899999875544332234566788877776 8999999999986
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
....+++||||+. |+|.+++... ....+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5567999999998 5999888643 3345899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------- 747 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-------- 747 (786)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 8764321 2345678999999999999999999999999999999999999999988777666655321100
Q ss_pred --------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+|+.+||. ||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0113357899999999 99999999999965
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=353.24 Aligned_cols=252 Identities=27% Similarity=0.348 Sum_probs=200.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEecccc---------ChHHHHHHHHHHHHHhhcCCCceeEEe
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDL---------TAENMEDFCNEISILSRLRHPNVILFL 591 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~---------~~~~~~~f~~EI~iL~~L~HPNIVkL~ 591 (786)
++....++|.+.+.||+|+||.||+|.+ +|+.||||++..... .....+.+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 4444568999999999999999999977 688999999855332 223357899999999999999999999
Q ss_pred cccc-----cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 592 GACT-----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 592 g~~~-----~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
+++. ....+++||||+. |+|.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9983 3346899999998 57777765 24457999999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003919 667 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~ 745 (786)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999997654332 2345678999999999877 6789999999999999999999999998887766665543211
Q ss_pred CCC---------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RLE---------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~~---------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+. ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 110 012358899999999 99999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=344.74 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=202.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----Cc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~ 599 (786)
.++|.+.+.||+|+||.||+|.+. |+.||||++... ........+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 478999999999999999999984 889999998543 2344567889999999999999999999987654 67
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
.+++|||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999999998 588888862 468999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC----------CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-
Q 003919 680 DSPM----------RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL- 747 (786)
Q Consensus 680 ~~~~----------~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~- 747 (786)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 3211 1123578999999998764 678999999999999999999999999887665554433211100
Q ss_pred --------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+|+.+||. ||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0113357899999999 99999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=356.68 Aligned_cols=243 Identities=25% Similarity=0.299 Sum_probs=200.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC------ce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP------RL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~------~l 600 (786)
.+|.+.+.||+|+||+||+|.+ .+..+|+|++...... ..+|+++++.++||||+++++++.... .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 5799999999999999999988 5666999987644322 236999999999999999999985433 38
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEEEecCcccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGLSRIIT 679 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~ 679 (786)
++||||++++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 89999999876655554444567899999999999999999999999999999999999999 79999999999998764
Q ss_pred CCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL----------- 747 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~----------- 747 (786)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 194 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 194 AGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp TTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred CCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 432 33456789999999998765 58999999999999999999999999988777666554321100
Q ss_pred -------C------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -------E------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -------~------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ..+..+.+|+.+||. ||.+|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 013468899999999 99999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.80 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=197.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc---------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT--------- 595 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~--------- 595 (786)
.++|.+.+.||+|+||.||+|.+. |+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 478999999999999999999884 889999998654 3455688999999999999999999998863
Q ss_pred -----cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEE
Q 003919 596 -----KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKI 669 (786)
Q Consensus 596 -----~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL 669 (786)
+...+++||||+. |+|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 58998885 35688999999999999999999999999999999999997 5679999
Q ss_pred EecCccccccCCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Q 003919 670 CDFGLSRIITDSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 670 ~DFGLA~~l~~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~ 745 (786)
+|||++........ ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987643211 1223457899999998865 6789999999999999999999999998887666655543221
Q ss_pred CC-------------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RL-------------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~-------------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ...+..+.+|+.+||. ||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 10 0123468899999999 99999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=349.25 Aligned_cols=245 Identities=28% Similarity=0.365 Sum_probs=203.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC-----Cc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP-----PR 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~-----~~ 599 (786)
..+|.+.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 36899999999999999999987 58899999986433 344567899999999999999999999998654 46
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++++|||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 899999998 488888852 358999999999999999999999999999999999999999999999999998764
Q ss_pred CCCC---CCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-------- 747 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-------- 747 (786)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 3221 1245689999999998754 558999999999999999999999998877665555443211100
Q ss_pred ------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+||.+||. ||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0113468899999999 99999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=348.57 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=197.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC------hHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT------AENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~------~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
++|.+.+.||+|+||.||+|.+ +++.||||++...... ......|.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999988 5789999998654321 122356889999999999999999999987655
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe---EEEEecCccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLSR 676 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA~ 676 (786)
+++||||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 899999999999999886 4567999999999999999999999999999999999999987664 9999999998
Q ss_pred cccCCCCCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI---- 749 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i---- 749 (786)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...............+.....
T Consensus 166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred eccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 764321 112346899999999974 467899999999999999999999999765443222222222222111
Q ss_pred --CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 --PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 --p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+|+.+||. ||.+||++.+++++
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 23468999999999 99999999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.78 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=205.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc------CCCceeEEecccccCC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL------RHPNVILFLGACTKPP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L------~HPNIVkL~g~~~~~~ 598 (786)
..+|.+.+.||+|+||+||+|.+ .++.||||++... ......+.+|+.+++.+ .|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 46799999999999999999988 4789999998643 33456788899888887 5779999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe--EEEEecCccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT--VKICDFGLSR 676 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~ 676 (786)
.+++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999997 5888888643 3346899999999999999999999999999999999999999887 9999999997
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-------- 748 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-------- 748 (786)
..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+......+.
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 251 YEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp ETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred ecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 65432 3356899999999999999999999999999999999999999999887776655543110000
Q ss_pred ----------------------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003919 749 ----------------------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEIL 775 (786)
Q Consensus 749 ----------------------------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL 775 (786)
..+..+.+||.+||. ||.+|||+.|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 012357899999999 999999999999
Q ss_pred HH
Q 003919 776 SR 777 (786)
Q Consensus 776 ~~ 777 (786)
+|
T Consensus 408 ~H 409 (429)
T 3kvw_A 408 RH 409 (429)
T ss_dssp TS
T ss_pred CC
Confidence 85
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=358.69 Aligned_cols=242 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc------CCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~------~~~ 599 (786)
.+|.+.+.||+|+||+||+|.+ +|+.||||++..... .+.+|+++++.++|||||+++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999998 588999999865422 23469999999999999999998743 223
Q ss_pred eEEEEEeeccchhHHHHH-hhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC-CeEEEEecCcccc
Q 003919 600 LSMITEYMELGSLYHLIH-LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRI 677 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~-~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~-g~VKL~DFGLA~~ 677 (786)
+++||||+++ +|.+.+. .......+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 7799999986 4544443 22345689999999999999999999999999999999999999954 6789999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS----------- 745 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~----------- 745 (786)
+.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+......+..+.....
T Consensus 207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 65432 23456889999999999764 799999999999999999999999999887666655543110
Q ss_pred ----CCCC---------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 ----RLEI---------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ----~~~i---------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+ .+..+.+||.+||. ||.+||++.|+++|
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0001 13468899999999 99999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.45 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=191.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
..+....++|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+..+..+++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45666788999999999999999999988 5889999999766544443444555556788889999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.+++||||+ ++.+..+... ....+++..++.++.||+.||+|||+. ||+|+||||+|||++.++.+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 4556555542 245789999999999999999999995 999999999999999999999999999977
Q ss_pred ccCCCCCCCCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcCCCCCCC-
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGV-LPERVVYAVANEGSRLEIP- 750 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~-~~~~~l~~i~~~~~~~~ip- 750 (786)
..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||... ........+.... ....+
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCc
Confidence 65432 233557999999999994 557889999999999999999999999874 3444444444332 22222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+|+.+||. ||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3569999999999 99999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.68 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=193.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc---
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR--- 599 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~--- 599 (786)
...++|.+.+.||+|+||+||+|.+ +|+.||||++...... ...+.+++..+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3468999999999999999999988 4889999998654322 2456778888999999999999999865333
Q ss_pred ----eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh--hcceeeccCCcccEEEcC-CCeEEEEec
Q 003919 600 ----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVNK-HWTVKICDF 672 (786)
Q Consensus 600 ----l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--s~gIIHrDLKpsNILLd~-~g~VKL~DF 672 (786)
+++||||++++.+..+.........+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 8899999997654444433345678899999999999999999999 999999999999999997 899999999
Q ss_pred CccccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---
Q 003919 673 GLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE--- 748 (786)
Q Consensus 673 GLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~--- 748 (786)
|++..+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+.
T Consensus 177 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 177 GSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9998775432 23456789999999998665 489999999999999999999999999888777666653211100
Q ss_pred ---------------------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ---------------------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ---------------------------i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ....+.+|+.+||+ ||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 12358899999999 99999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=376.60 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=211.6
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+.+.||+|+||.||+|.+ +|+.||||++...... ......+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999988 5889999999654321 223467889999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.+...
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999999988632 2345999999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcCCCC-CCCChHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVL----PERVVYAVANEGSRL-EIPEGPLGR 756 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~----~~~~l~~i~~~~~~~-~ip~~~L~~ 756 (786)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ...+...+....... ..-+..+.+
T Consensus 340 ~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d 418 (576)
T 2acx_A 340 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS 418 (576)
T ss_dssp C-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred c-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence 2 2345689999999999999899999999999999999999999998753 333433333322221 122457999
Q ss_pred HHHHhhh-CCCCCC-----CHHHHHHH
Q 003919 757 LIADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
||.+||. ||.+|| ++.+|++|
T Consensus 419 LI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 419 LCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 9999999 999999 78999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.22 Aligned_cols=241 Identities=26% Similarity=0.341 Sum_probs=202.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR------ 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~------ 599 (786)
.+|.+.+.||+|+||.||+|.+ +|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 7899999999999999999987 58999999997666566667889999999999999999999999987654
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
++++|||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999998 58877663 248999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS------------- 745 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~------------- 745 (786)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 178 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 32 235678999999999877 6789999999999999999999999998877665554432110
Q ss_pred -------------CC------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 -------------RL------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 -------------~~------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ...+..+.+|+.+||. ||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0113468999999999 99999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.74 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=186.1
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHHH-HHhhcCCCceeEEeccccc
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEIS-ILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI~-iL~~L~HPNIVkL~g~~~~ 596 (786)
...|.+..++|.+.+.||+|+||.||+|.+. |+.||||++..... ......+..|+. +++.++||||+++++++.+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4567788899999999999999999999984 89999999976543 334456667766 6777899999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhh--cCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCCeEEEEecC
Q 003919 597 PPRLSMITEYMELGSLYHLIHLS--GQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~--~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
.+..++||||+.+ +|.+++... .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 777666421 2356789999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Q 003919 674 LSRIITDSPMRDSSSAGTPEWMAPELI----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI 749 (786)
Q Consensus 674 LA~~l~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i 749 (786)
++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...............+....+
T Consensus 172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 998765432 22345799999999998 4567899999999999999999999999875432111111111111111
Q ss_pred -------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 -------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 -------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+|+.+||. ||.+|||+.+|+++
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 13468999999999 99999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.75 Aligned_cols=243 Identities=21% Similarity=0.286 Sum_probs=196.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC--------CCceeEEecccc-
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR--------HPNVILFLGACT- 595 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~--------HPNIVkL~g~~~- 595 (786)
..+|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999987 5889999998643 344578899999999985 788999999987
Q ss_pred ---cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEcCCC------
Q 003919 596 ---KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVNKHW------ 665 (786)
Q Consensus 596 ---~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd~~g------ 665 (786)
....+++||||+.++.+..++. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 5567999999996544444443 2335799999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------eEEEEecCccccccCCCCCCCCCCCCCcccCcccccc
Q 003919 666 -------------------------------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702 (786)
Q Consensus 666 -------------------------------------------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~ 702 (786)
.+||+|||++...... .....||+.|+|||++.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC
Confidence 7999999999876542 345679999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC-----------------------------
Q 003919 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLP------ERVVYAVANEGSRL----------------------------- 747 (786)
Q Consensus 703 ~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~------~~~l~~i~~~~~~~----------------------------- 747 (786)
..++.++|||||||+||+|++|+.||..... ......+.......
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999976542 22222221100000
Q ss_pred -----------CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 -----------EIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 -----------~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+ ...+.+||.+||. ||.+|||+.|+++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 011 1247789999999 99999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=332.42 Aligned_cols=242 Identities=27% Similarity=0.446 Sum_probs=192.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc---------
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--------- 596 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--------- 596 (786)
++|.+.+.||+|+||.||+|.+ +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5799999999999999999987 5889999998542 3456789999999999999999999998754
Q ss_pred ----CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 597 ----PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 597 ----~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
...+++||||+++++|.+++.. ....+++..++.++.|++.||+|||++||+|+||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 3568999999999999999973 3457888999999999999999999999999999999999999999999999
Q ss_pred CccccccCCC--------------CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 003919 673 GLSRIITDSP--------------MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVL-PERV 736 (786)
Q Consensus 673 GLA~~l~~~~--------------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~-~~~~ 736 (786)
|++....... .......||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998764321 112345689999999999864 78999999999999999998 665432 2233
Q ss_pred HHHHHhcCCCC--CCC---ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 737 VYAVANEGSRL--EIP---EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 737 l~~i~~~~~~~--~ip---~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+....... ..+ ...+.+|+.+||. ||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 33333222111 122 2358999999999 99999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=357.67 Aligned_cols=248 Identities=15% Similarity=0.110 Sum_probs=182.8
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhc--CCCceeEEeccc----
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRL--RHPNVILFLGAC---- 594 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L--~HPNIVkL~g~~---- 594 (786)
.....+|.+.+.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|+.+++.+ +||||++++..+
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 33345699999999999999999987 588999999987655 334456778886555555 699988865332
Q ss_pred ---ccC-----------------CceEEEEEeeccchhHHHHHhhcCCccchHHHH------HHHHHHHHHHHHhhhhcc
Q 003919 595 ---TKP-----------------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRK------LKMLRDICRGLMCIHRMK 648 (786)
Q Consensus 595 ---~~~-----------------~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i------~~Ia~QIa~gL~yLHs~g 648 (786)
... ..+|+||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||++|
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 221 33899999999 89999997432 23344444 677799999999999999
Q ss_pred eeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCC
Q 003919 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNR 726 (786)
Q Consensus 649 IIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~ 726 (786)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876432 114456799999999987 679999999999999999999999
Q ss_pred CCCCCChHHHHH--H---HHhcCCCCCCC-----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 727 PWEGVLPERVVY--A---VANEGSRLEIP-----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 727 PF~~~~~~~~l~--~---i~~~~~~~~ip-----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
||.+........ . ..........+ +..+.+||.+||. ||++|||+.++++|
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 998764321100 0 00001111111 3469999999999 99999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.75 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=181.3
Q ss_pred CeeE-eeEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc--ccCCceE
Q 003919 529 ELTV-GTRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC--TKPPRLS 601 (786)
Q Consensus 529 ~y~i-~k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~--~~~~~l~ 601 (786)
.|.+ +++||+|+||+||+|.+. ++.||||++...... ..+.+|+.+|+.++|||||++++++ .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3555 568999999999999863 678999998654433 4678999999999999999999999 4467899
Q ss_pred EEEEeeccchhHHHHHhhc------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----cCCCeEEEEe
Q 003919 602 MITEYMELGSLYHLIHLSG------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV----NKHWTVKICD 671 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL----d~~g~VKL~D 671 (786)
+||||+.+ +|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999985 6776664321 12258999999999999999999999999999999999999 6788999999
Q ss_pred cCccccccCCC---CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 003919 672 FGLSRIITDSP---MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPE---------RVVY 738 (786)
Q Consensus 672 FGLA~~l~~~~---~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~---------~~l~ 738 (786)
||+++.+.... ......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+.... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99998765421 122456799999999999874 5899999999999999999999999765432 2222
Q ss_pred HHHhcCCCCC---------------------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 739 AVANEGSRLE---------------------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 739 ~i~~~~~~~~---------------------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+......+. .++..+.+||.+||. ||.+|||+.|+|+|
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2221110000 013457889999999 99999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.53 Aligned_cols=243 Identities=18% Similarity=0.306 Sum_probs=200.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC---CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc------eeEEecccccC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN------VILFLGACTKP 597 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~---G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN------IVkL~g~~~~~ 597 (786)
.++|.+.+.||+|+||+||+|.+. ++.||||++... ....+.+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999873 378999998643 334577889999999997665 99999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE----------------
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---------------- 661 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---------------- 661 (786)
+.+++||||+. ++|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 GHMCIAFELLG-KNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TEEEEEEECCC-CBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CeEEEEEeccC-CChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999995 555555542 233578999999999999999999999999999999999999
Q ss_pred ---cCCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 003919 662 ---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY 738 (786)
Q Consensus 662 ---d~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~ 738 (786)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66789999999999875432 245679999999999999999999999999999999999999999887766554
Q ss_pred HHHhcCCCCC-----------------------------------------CC----ChHHHHHHHHhhh-CCCCCCCHH
Q 003919 739 AVANEGSRLE-----------------------------------------IP----EGPLGRLIADCWA-EPQERPSCE 772 (786)
Q Consensus 739 ~i~~~~~~~~-----------------------------------------ip----~~~L~~LI~~CL~-DP~kRPSa~ 772 (786)
.+.......+ .. ...+.+||.+||. ||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 4332111100 00 1257799999999 999999999
Q ss_pred HHHHH
Q 003919 773 EILSR 777 (786)
Q Consensus 773 EIL~~ 777 (786)
+++++
T Consensus 330 e~l~h 334 (355)
T 2eu9_A 330 EALLH 334 (355)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=371.21 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=215.9
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACT 595 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~ 595 (786)
..+.+..++|.+++.||+|+||+||+|.+. +..||||++... ......+.|.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 456677789999999999999999999873 456999987543 23445678999999999999999999999985
Q ss_pred cCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 596 KPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 596 ~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
+ +.+++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 4 568999999999999999973 3346899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---
Q 003919 676 RIITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP--- 750 (786)
Q Consensus 676 ~~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip--- 750 (786)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.... ....+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 617 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNC 617 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccc
Confidence 87754322 2233457789999999999999999999999999999997 999999988887777665543 33333
Q ss_pred ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 751 EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 751 ~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+..+.+|+.+||. ||.+|||+.+|++.|.++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3479999999999 9999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=343.09 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=203.3
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcC--CCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~--HPNIVkL~ 591 (786)
..+...-.++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.++++++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344445568899999999999999999987 68899999997654322 12245778999999996 59999999
Q ss_pred cccccCCceEEEEEeecc-chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEE
Q 003919 592 GACTKPPRLSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKI 669 (786)
Q Consensus 592 g~~~~~~~l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL 669 (786)
+++...+.+++++||+.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999999976 899999873 45789999999999999999999999999999999999999 7899999
Q ss_pred EecCccccccCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC
Q 003919 670 CDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG-SRL 747 (786)
Q Consensus 670 ~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~-~~~ 747 (786)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +.... ...
T Consensus 192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~ 263 (320)
T 3a99_A 192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR 263 (320)
T ss_dssp CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCCCCS
T ss_pred eeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhccccccc
Confidence 999999877543 2345679999999999987765 6889999999999999999999976421 11211 111
Q ss_pred CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+||.+||. ||.+|||+.+|+++
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234579999999999 99999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.11 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=194.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhc----CCCceeEEeccccc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRL----RHPNVILFLGACTK 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L----~HPNIVkL~g~~~~ 596 (786)
.++|.+.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.+++++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 47899999999999999999987 68899999986554322 1234566799999999 89999999999999
Q ss_pred CCceEEEEEe-eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc-CCCeEEEEecCc
Q 003919 597 PPRLSMITEY-MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN-KHWTVKICDFGL 674 (786)
Q Consensus 597 ~~~l~LV~Ey-~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd-~~g~VKL~DFGL 674 (786)
.+..++++|| +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred CCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999 789999999973 34689999999999999999999999999999999999999 889999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCCCh
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRNEPFT-EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG 752 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~-~~~ip~~ 752 (786)
+...... ......|++.|+|||++.+..+. .++|||||||++|+|++|+.||..... +..... .......
T Consensus 187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~ 258 (312)
T 2iwi_A 187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAHVSP 258 (312)
T ss_dssp CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCCCTTSCH
T ss_pred hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCCcccCCH
Confidence 9887553 23456799999999999877664 589999999999999999999976321 112111 1122245
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||++|||+.+++++
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 79999999999 99999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.70 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=203.8
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CC-----ceeEEecccccC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HP-----NVILFLGACTKP 597 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HP-----NIVkL~g~~~~~ 597 (786)
..++|.+.+.||+|+||+||+|.+ +++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 358999999999999999999988 5889999998643 334567888999988885 55 499999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh--hcceeeccCCcccEEEc--CCCeEEEEecC
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH--RMKIVHRDLKSANCLVN--KHWTVKICDFG 673 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH--s~gIIHrDLKpsNILLd--~~g~VKL~DFG 673 (786)
+.+++||||+.+ +|.+++... ....+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||
T Consensus 129 ~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999974 999888643 2356899999999999999999999 57999999999999995 47789999999
Q ss_pred ccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-----
Q 003919 674 LSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----- 748 (786)
Q Consensus 674 LA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----- 748 (786)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+.
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99887542 2456899999999999999999999999999999999999999999887776665543211000
Q ss_pred -----------CC-------------------------------------------------ChHHHHHHHHhhh-CCCC
Q 003919 749 -----------IP-------------------------------------------------EGPLGRLIADCWA-EPQE 767 (786)
Q Consensus 749 -----------ip-------------------------------------------------~~~L~~LI~~CL~-DP~k 767 (786)
++ ...+.+||.+||. ||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 00 0147899999999 9999
Q ss_pred CCCHHHHHHH
Q 003919 768 RPSCEEILSR 777 (786)
Q Consensus 768 RPSa~EIL~~ 777 (786)
|||+.|+|+|
T Consensus 364 Rpta~e~L~h 373 (382)
T 2vx3_A 364 RIQPYYALQH 373 (382)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.32 Aligned_cols=244 Identities=20% Similarity=0.330 Sum_probs=196.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----------CCceeEEec
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFLG 592 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----------HPNIVkL~g 592 (786)
...+|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+.+|+.++++++ ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 457899999999999999999987 6889999998643 334567889999999886 899999999
Q ss_pred ccccCC----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhc-ceeeccCCcccEEEc-----
Q 003919 593 ACTKPP----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM-KIVHRDLKSANCLVN----- 662 (786)
Q Consensus 593 ~~~~~~----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~-gIIHrDLKpsNILLd----- 662 (786)
++...+ .++++|||+ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 987644 689999999 88999998743 345689999999999999999999998 999999999999995
Q ss_pred -CCCeEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HH
Q 003919 663 -KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP------ER 735 (786)
Q Consensus 663 -~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~------~~ 735 (786)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876542 2356799999999999999999999999999999999999999986542 22
Q ss_pred HHHHHHhc-CC---------------------------------------CCCCC---ChHHHHHHHHhhh-CCCCCCCH
Q 003919 736 VVYAVANE-GS---------------------------------------RLEIP---EGPLGRLIADCWA-EPQERPSC 771 (786)
Q Consensus 736 ~l~~i~~~-~~---------------------------------------~~~ip---~~~L~~LI~~CL~-DP~kRPSa 771 (786)
....+... +. ....+ ...+.+||.+||. ||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 22222110 00 00111 1257789999999 99999999
Q ss_pred HHHHHH
Q 003919 772 EEILSR 777 (786)
Q Consensus 772 ~EIL~~ 777 (786)
.+++++
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=356.80 Aligned_cols=250 Identities=19% Similarity=0.272 Sum_probs=206.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC-CceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H-PNIVkL~g~~~~~~~l~LV 603 (786)
.++|.++++||+|+||.||+|.+ +++.||||++...... .++.+|+.+++.++| ++|..+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 47899999999999999999987 4889999998655433 357889999999986 5666666667778889999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEE---cCCCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV---NKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILL---d~~g~VKL~DFGLA~~l~~ 680 (786)
|||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 82 me~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 89999999732 4579999999999999999999999999999999999999 6889999999999988755
Q ss_pred CCCC-------CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC---
Q 003919 681 SPMR-------DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL--- 747 (786)
Q Consensus 681 ~~~~-------~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~--- 747 (786)
.... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 3221 2256799999999999999999999999999999999999999987543 22222222211111
Q ss_pred ---CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 748 ---EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 748 ---~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
......+.+|+..||. ||.+||++.+|++.|+++..
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1124569999999999 99999999999999988743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=335.71 Aligned_cols=241 Identities=23% Similarity=0.382 Sum_probs=171.0
Q ss_pred CCCeeEee-EEeecCcEEEEEEEEC--CeeEEEEEEeccccChHHHHHHHHHH-HHHhhcCCCceeEEeccccc----CC
Q 003919 527 FSELTVGT-RVGIGFFGEVFRGIWN--GTDVAIKVFLEQDLTAENMEDFCNEI-SILSRLRHPNVILFLGACTK----PP 598 (786)
Q Consensus 527 ~s~y~i~k-~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~~~~~~~~f~~EI-~iL~~L~HPNIVkL~g~~~~----~~ 598 (786)
.++|.+.+ .||+|+||+||+|.+. |+.||||++... . ...+|+ ..++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46799865 6999999999999884 889999998643 1 122333 34566789999999999865 44
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 675 (786)
.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 589999999999999999732 2357999999999999999999999999999999999999976 456999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCC---
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA----VANEGSRLE--- 748 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~----i~~~~~~~~--- 748 (786)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +........
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 179 KETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp EEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred eecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 876543 23456789999999999888899999999999999999999999987655433211 111111111
Q ss_pred --CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 --IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 --ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+..+.+|+.+||. ||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 123468999999999 99999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=342.90 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=186.6
Q ss_pred cccCCC-eeEeeEEeecCcEEEEEE-EECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCce
Q 003919 524 NIDFSE-LTVGTRVGIGFFGEVFRG-IWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRL 600 (786)
Q Consensus 524 ~i~~s~-y~i~k~LG~G~fG~VYkg-~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l 600 (786)
+....+ |.+.+.||+|+||+||.+ ..+|+.||||++... ..+.+.+|+.+++.+ +|||||++++++.+...+
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 333444 455788999999999754 558999999998643 235678999999887 899999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCc----cchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC------------
Q 003919 601 SMITEYMELGSLYHLIHLSGQKK----KLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH------------ 664 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~----~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~------------ 664 (786)
|+||||+. |+|.+++....... ..++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 69999997332111 11333467899999999999999999999999999999754
Q ss_pred -CeEEEEecCccccccCCCCC----CCCCCCCCcccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 003919 665 -WTVKICDFGLSRIITDSPMR----DSSSAGTPEWMAPELIRN-------EPFTEKCDIFSLGVIMWELCT-LNRPWEGV 731 (786)
Q Consensus 665 -g~VKL~DFGLA~~l~~~~~~----~~~~~GT~~Y~APEvl~~-------~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~ 731 (786)
+.+||+|||++..+...... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999887543221 234579999999999975 678999999999999999999 89999876
Q ss_pred ChHHHHHHHHhcCCCCCC----CC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 732 LPERVVYAVANEGSRLEI----PE----GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 732 ~~~~~l~~i~~~~~~~~i----p~----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.... ..+......... .. ..+.+||.+||. ||.+|||+.++++|
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 5443 223332222211 11 358899999999 99999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.00 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=190.6
Q ss_pred cccccCCCeeEeeEEeecCcEEE-EEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEV-FRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~V-Ykg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
.+.+...+|.+.+.||+|+||+| |++..+|+.||||++..... ..+.+|+.+++.+ +|||||++++++.+...
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 34455567999999999999985 55666899999999865433 2356899999999 79999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-----CCeEEEEecCc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGL 674 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-----~g~VKL~DFGL 674 (786)
+|+||||+. |+|.+++.. ....+.+..++.++.||+.||+|||++||+||||||+|||++. ...+||+|||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEECCC-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999997 599988863 2234455566789999999999999999999999999999953 23688999999
Q ss_pred cccccCCC---CCCCCCCCCCcccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Q 003919 675 SRIITDSP---MRDSSSAGTPEWMAPELIR---NEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRL 747 (786)
Q Consensus 675 A~~l~~~~---~~~~~~~GT~~Y~APEvl~---~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~ 747 (786)
++...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...................
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98775432 1234567999999999997 4567889999999999999999 899997665544333221111111
Q ss_pred CCCC----hHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 EIPE----GPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ~ip~----~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
..+. ..+.+||.+||. ||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 237789999999 99999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=317.63 Aligned_cols=224 Identities=13% Similarity=0.055 Sum_probs=184.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+|.+.+.||+|+||.||+|.+. |+.||||++..... .....+.|.+|+.++.+++||||+++++++.+.+.+|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999984 89999999976544 345568899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||++|++|.+++.. + .....+..++.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999852 2 2445678899999999999999999999999999999999999998443
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCC-----CCCChHHH
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY---AVANEGSRL-----EIPEGPLG 755 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~---~i~~~~~~~-----~ip~~~L~ 755 (786)
|++ +++.++|||||||++|+|+||+.||.+.+....+. ......... ..-+..+.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 333 37899999999999999999999998765432110 000110000 01134689
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 756 RLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+|+.+||. ||.+| |+.++++.|.+...
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 99999999 99999 99999999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.09 Aligned_cols=221 Identities=21% Similarity=0.374 Sum_probs=178.2
Q ss_pred CCCeeEe-eEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHH-hhcCCCceeEEeccccc----CC
Q 003919 527 FSELTVG-TRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL-SRLRHPNVILFLGACTK----PP 598 (786)
Q Consensus 527 ~s~y~i~-k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL-~~L~HPNIVkL~g~~~~----~~ 598 (786)
..+|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678887 7899999999999988 5889999998532 4567889888 55689999999999876 66
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 675 (786)
.+++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 799999999999999999743 3457999999999999999999999999999999999999998 789999999998
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCC----
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEI---- 749 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~--~~~i---- 749 (786)
..... ..++.++|||||||++|+|++|+.||.+.........+..... ....
T Consensus 168 ~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 65432 3467899999999999999999999987654432211111110 1111
Q ss_pred ---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 ---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 ---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+..+.+|+.+||. ||.+|||+.+++++
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 13468999999999 99999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.10 Aligned_cols=248 Identities=16% Similarity=0.127 Sum_probs=189.0
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC--CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCC-CceeEE-------
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN--GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRH-PNVILF------- 590 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~H-PNIVkL------- 590 (786)
++.....+|..++.||+|+||+||+|.+. |+.||||++..... .....+.|.+|+.+++.++| +|+..+
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 44455677999999999999999999984 99999999873332 22335789999999999987 322111
Q ss_pred --------------eccccc-----CCceEEEEEeeccchhHHHHHhh----cCCccchHHHHHHHHHHHHHHHHhhhhc
Q 003919 591 --------------LGACTK-----PPRLSMITEYMELGSLYHLIHLS----GQKKKLSWRRKLKMLRDICRGLMCIHRM 647 (786)
Q Consensus 591 --------------~g~~~~-----~~~l~LV~Ey~~gGSL~dlL~~~----~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~ 647 (786)
..++.. ...++++|+++ +++|.+++... .....+++..++.++.||+.||+|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 111111 12356666655 57888888422 2356789999999999999999999999
Q ss_pred ceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCCCCCcccCcccc----------ccCCCCchhhHHHHHHH
Q 003919 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI----------RNEPFTEKCDIFSLGVI 717 (786)
Q Consensus 648 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl----------~~~~~s~ksDVWSLGvI 717 (786)
|||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999999999876443 345677 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 718 MWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 718 L~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+|||++|+.||...........+.... ..+ +..+.+||.+||. ||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~~~~~--~~~-~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWIFRSC--KNI-PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGGGSSC--CCC-CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHHHHhhc--ccC-CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999998765543333222111 122 3579999999999 99999999888765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.09 Aligned_cols=237 Identities=22% Similarity=0.242 Sum_probs=187.0
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEecccc------ChHHHHHHHHHHHHHhhcC----------------
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDL------TAENMEDFCNEISILSRLR---------------- 583 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~------~~~~~~~f~~EI~iL~~L~---------------- 583 (786)
..++|.+.+.||+|+||+||+|.++|+.||||++..... .....+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 357899999999999999999999999999999976542 2233477889999998886
Q ss_pred ----------CCceeEEeccccc-------------CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHH
Q 003919 584 ----------HPNVILFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640 (786)
Q Consensus 584 ----------HPNIVkL~g~~~~-------------~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~g 640 (786)
||||+++++++.+ ...+|+||||+++|++.+.+. ...+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 5555555666554 678999999999997766653 2568999999999999999
Q ss_pred HHhhh-hcceeeccCCcccEEEcCCC--------------------eEEEEecCccccccCCCCCCCCCCCCCcccCccc
Q 003919 641 LMCIH-RMKIVHRDLKSANCLVNKHW--------------------TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699 (786)
Q Consensus 641 L~yLH-s~gIIHrDLKpsNILLd~~g--------------------~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEv 699 (786)
|+||| ++||+||||||+|||++.++ .+||+|||+++..... ..+||+.|+|||+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhh
Confidence 99999 99999999999999999887 9999999999887543 3479999999999
Q ss_pred cccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhcCCCCCC-C-------ChHHHHHHHHhhh-CCCCC
Q 003919 700 IRNEPFTEKCDIFSLGVI-MWELCTLNRPWEGVLP-ERVVYAVANEGSRLEI-P-------EGPLGRLIADCWA-EPQER 768 (786)
Q Consensus 700 l~~~~~s~ksDVWSLGvI-L~ELlTG~~PF~~~~~-~~~l~~i~~~~~~~~i-p-------~~~L~~LI~~CL~-DP~kR 768 (786)
+.+.. +.++||||||++ .+++++|..||.+... ......+......... + +..+.+||.+||. |
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98776 899999998777 7788999999854321 1122233322111111 1 1258899999999 5
Q ss_pred CCHHHHH-HH
Q 003919 769 PSCEEIL-SR 777 (786)
Q Consensus 769 PSa~EIL-~~ 777 (786)
|+.|+| +|
T Consensus 324 -sa~e~l~~H 332 (336)
T 2vuw_A 324 -SATDLLCQH 332 (336)
T ss_dssp -SHHHHHHHC
T ss_pred -CHHHHHhcC
Confidence 999998 64
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=353.93 Aligned_cols=234 Identities=23% Similarity=0.312 Sum_probs=193.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE---CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc----
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPR---- 599 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~---~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~---- 599 (786)
.++|.+.+.||+|+||+||++.+ +|+.||||++... ......+.|.+|+.++++++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 47899999999999999999987 4789999998643 334556789999999999999999999999987665
Q ss_pred -eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 600 -LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 600 -l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ .+||+|||+++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 799999999999998764 268999999999999999999999999999999999999985 9999999999877
Q ss_pred cCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----CChHH
Q 003919 679 TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI----PEGPL 754 (786)
Q Consensus 679 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i----p~~~L 754 (786)
... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+..... ..... ....+
T Consensus 232 ~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~~l 297 (681)
T 2pzi_A 232 NSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LPEDDPVLKTYDSY 297 (681)
T ss_dssp TCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CCTTCHHHHHCHHH
T ss_pred ccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------ccccccccccCHHH
Confidence 543 456799999999999776 4899999999999999999999886532110 00000 02458
Q ss_pred HHHHHHhhh-CCCCCCC-HHHHHHHHHhh
Q 003919 755 GRLIADCWA-EPQERPS-CEEILSRLLDC 781 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPS-a~EIL~~L~~i 781 (786)
.+||.+||. ||.+||+ ++++.+.|..+
T Consensus 298 ~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 298 GRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 899999999 9999995 66666666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=355.39 Aligned_cols=247 Identities=28% Similarity=0.366 Sum_probs=197.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc------CC
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PP 598 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~------~~ 598 (786)
..+|.+.+.||+|+||+||+|.+ +|+.||||++... ......+.|.+|+.++++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46899999999999999999987 5889999998654 345566889999999999999999999998765 66
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe---EEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT---VKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~---VKL~DFGLA 675 (786)
..++||||+++|+|.+++........+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999999999999975444457999999999999999999999999999999999999997664 999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---------HH-h---
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYA---------VA-N--- 742 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~---------i~-~--- 742 (786)
....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........... +. .
T Consensus 172 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 8875443 33456899999999999999999999999999999999999999976533221100 00 0
Q ss_pred -c----CCCCCCC-------ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003919 743 -E----GSRLEIP-------EGPLGRLIADCWA-EPQERPSCEEIL 775 (786)
Q Consensus 743 -~----~~~~~ip-------~~~L~~LI~~CL~-DP~kRPSa~EIL 775 (786)
. ....+.+ ...+.+|+.+||. ||.+|||+.+++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0000111 1358899999999 999999998854
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=296.91 Aligned_cols=186 Identities=16% Similarity=0.105 Sum_probs=134.0
Q ss_pred EEeecCcEEEEEE--EECCeeEEEEEEecccc--------ChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCceEEE
Q 003919 535 RVGIGFFGEVFRG--IWNGTDVAIKVFLEQDL--------TAENMEDFCNEISILSRL-RHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 535 ~LG~G~fG~VYkg--~~~G~~VAVKvl~~~~~--------~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~l~LV 603 (786)
..+.|+.|.+..+ .+-|+.+|+|++.+... .....++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667777766655 34689999999975532 123457899999999999 699999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||++|++|.+++. ..+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999997 34566654 4889999999999999999999999999999999999999999988765544
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP 727 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~P 727 (786)
...+.+||+.|+|||++.+. +..++|+|++|+++++|.++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 44566899999999999875 67789999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-27 Score=268.56 Aligned_cols=186 Identities=16% Similarity=0.166 Sum_probs=148.9
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChH------HHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAE------NMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~------~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
...+.||+|+||+||++...++.+++|+......... ..+.|.+|++++++++||||+++..++...+..|+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3456899999999999988999999998765443221 2456899999999999999996555555667789999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++++|.+++.. ++.++.|++.||+|||++||+||||||+|||++. .+||+|||+++........
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999999999862 5689999999999999999999999999999999 9999999999887543111
Q ss_pred -------CCCCCCCCcccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 003919 685 -------DSSSAGTPEWMAPELIRN--EPFTEKCDIFSLGVIMWELCTLNRPWE 729 (786)
Q Consensus 685 -------~~~~~GT~~Y~APEvl~~--~~~s~ksDVWSLGvIL~ELlTG~~PF~ 729 (786)
....+||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124579999999999987 568888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=214.68 Aligned_cols=146 Identities=20% Similarity=0.175 Sum_probs=117.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccCh----------------HHHHHHHHHHHHHhhcCCCceeEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTA----------------ENMEDFCNEISILSRLRHPNVILF 590 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~----------------~~~~~f~~EI~iL~~L~HPNIVkL 590 (786)
.-|.+++.||+|+||.||+|.+ +|+.||||++....... .....|.+|+.++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 4456679999999999999998 58899999986432211 13567999999999999 5 666
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEE
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKIC 670 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~ 670 (786)
.+++.. +..++||||++|++|.+ +. . .....++.||+.||+|||++||+||||||+|||++ ++.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 665543 55799999999999988 42 1 12346999999999999999999999999999999 9999999
Q ss_pred ecCccccccCCCCCCCCCCCCCcccCccccc
Q 003919 671 DFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701 (786)
Q Consensus 671 DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~ 701 (786)
|||++... ..+.|||++.
T Consensus 235 DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET-------------TSTTHHHHHH
T ss_pred ECCCCeEC-------------CCCCHHHHHH
Confidence 99999643 3467899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=182.94 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=106.7
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCee--EEEEEEeccccCh----------------------HHHHHHHHHHHHHhhc
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTD--VAIKVFLEQDLTA----------------------ENMEDFCNEISILSRL 582 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~--VAVKvl~~~~~~~----------------------~~~~~f~~EI~iL~~L 582 (786)
-|.+.+.||+|+||.||+|.+ +|+. ||||++....... .....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999987 8999 9999975432110 1124688999999999
Q ss_pred CCCce--eEEecccccCCceEEEEEeecc-c----hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh-hcceeeccC
Q 003919 583 RHPNV--ILFLGACTKPPRLSMITEYMEL-G----SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDL 654 (786)
Q Consensus 583 ~HPNI--VkL~g~~~~~~~l~LV~Ey~~g-G----SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-s~gIIHrDL 654 (786)
.|++| ..++++ ...++||||+.+ | +|.++.. ..++..+..++.|++.||.||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 87754 333332 356899999943 3 5655432 1335567889999999999999 999999999
Q ss_pred CcccEEEcCCCeEEEEecCccccc
Q 003919 655 KSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 655 KpsNILLd~~g~VKL~DFGLA~~l 678 (786)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=177.23 Aligned_cols=138 Identities=13% Similarity=0.228 Sum_probs=97.8
Q ss_pred CeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccC------------hHHHHHH--------HHHHHHHhhcCCCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT------------AENMEDF--------CNEISILSRLRHPNV 587 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~------------~~~~~~f--------~~EI~iL~~L~HPNI 587 (786)
=|.+++.||.|+||.||+|.. +|+.||||++...... ....... .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999987 6899999997532111 0001112 235555555543332
Q ss_pred e--EEecccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 588 I--LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 588 V--kL~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
. ..+++ ...++||||++|++|..+.. . .....++.||+.+|.|||++|||||||||.|||+++++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 1 11111 12369999999988865532 1 12356889999999999999999999999999998876
Q ss_pred ----------eEEEEecCcccccc
Q 003919 666 ----------TVKICDFGLSRIIT 679 (786)
Q Consensus 666 ----------~VKL~DFGLA~~l~ 679 (786)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 48999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.2e-11 Score=125.00 Aligned_cols=140 Identities=12% Similarity=0.016 Sum_probs=110.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEe
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
..|.+...++.|+++.||++...++.+++|+....... ....+.+|+.+++.+. +..+.++++++.+.+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46888888898999999999888889999998643211 1245788999999885 56677888888888889999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh----------------------------------------
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR---------------------------------------- 646 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs---------------------------------------- 646 (786)
++|.+|.+.+. +......++.+++++|+.||+
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876531 111224678889999999998
Q ss_pred -------------------cceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 647 -------------------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 647 -------------------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 5599999999999998766667999997743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=2.2e-10 Score=115.96 Aligned_cols=135 Identities=16% Similarity=0.109 Sum_probs=97.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce--eEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV--ILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI--VkL~g~~~~~~~l~LV 603 (786)
...|.+....+.|..+.||++.. +|+.+++|+..... ...+..|+.+++.+.+.++ .++++++...+..+++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 44565544444566699999976 46789999975431 2457789999998865454 4588887777789999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc-----------------------------------
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK----------------------------------- 648 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g----------------------------------- 648 (786)
|||++|.+|. .. . .. ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998884 21 0 11 1245666667777777532
Q ss_pred -----------------------eeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 649 -----------------------IVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 649 -----------------------IIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.6e-10 Score=119.89 Aligned_cols=140 Identities=16% Similarity=0.218 Sum_probs=105.6
Q ss_pred EeeEEeecCcEEEEEEEECCeeEEEEEEe--ccccChHHHHHHHHHHHHHhhcC--CCceeEEecccccC---CceEEEE
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTDVAIKVFL--EQDLTAENMEDFCNEISILSRLR--HPNVILFLGACTKP---PRLSMIT 604 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~VAVKvl~--~~~~~~~~~~~f~~EI~iL~~L~--HPNIVkL~g~~~~~---~~l~LV~ 604 (786)
..+.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998888889999865 32211 12356788999999997 34567788877766 4589999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh--------------------------------------
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-------------------------------------- 646 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-------------------------------------- 646 (786)
||++|..+.+.. ...++......++.++++.|+.||+
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998775421 1246677788899999999999996
Q ss_pred --------------------cceeeccCCcccEEEcCCCe--EEEEecCcccc
Q 003919 647 --------------------MKIVHRDLKSANCLVNKHWT--VKICDFGLSRI 677 (786)
Q Consensus 647 --------------------~gIIHrDLKpsNILLd~~g~--VKL~DFGLA~~ 677 (786)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=4.9e-09 Score=110.62 Aligned_cols=182 Identities=18% Similarity=0.116 Sum_probs=117.5
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCc--eeEEecccccCC---ceEEEEEee
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPN--VILFLGACTKPP---RLSMITEYM 607 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPN--IVkL~g~~~~~~---~l~LV~Ey~ 607 (786)
+.++.|.+..||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999863 57899985422 34567889999998883 322 223444433332 358899999
Q ss_pred ccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-----------------------------------------
Q 003919 608 ELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR----------------------------------------- 646 (786)
Q Consensus 608 ~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs----------------------------------------- 646 (786)
+|.+|..... ..++..+...++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988875332 235566666777777777777774
Q ss_pred -----------------cceeeccCCcccEEEcC--CCeEEEEecCccccccCCCCCCCCCCCCCcccCccccc----c-
Q 003919 647 -----------------MKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR----N- 702 (786)
Q Consensus 647 -----------------~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~----~- 702 (786)
..++|+|+++.||+++. +..+.|+||+.+............ .....-..|+... .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~-~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL-MEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT-CCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH-HhhccccCHHHHHHHHHHc
Confidence 24799999999999998 556889999998654221000000 0000001222211 1
Q ss_pred CCC---------CchhhHHHHHHHHHHHHhCCCCC
Q 003919 703 EPF---------TEKCDIFSLGVIMWELCTLNRPW 728 (786)
Q Consensus 703 ~~~---------s~ksDVWSLGvIL~ELlTG~~PF 728 (786)
... ....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.9e-06 Score=89.04 Aligned_cols=132 Identities=17% Similarity=0.117 Sum_probs=86.8
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCC---ceeEEecccc-cCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACT-KPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HP---NIVkL~g~~~-~~~~l~LV~Ey~~g 609 (786)
+.++.|....||+. |..+++|+.. .......+.+|+.+|+.|.+. .+-+.+.++. ..+..+++|+|++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 46888999999988 7789999842 223456788999999999642 2334444442 44567899999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh--------------------------------------------
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-------------------------------------------- 645 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-------------------------------------------- 645 (786)
..+....- ..++......++.++.+.|+.||
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88765211 01122222223333333333333
Q ss_pred ----------------hcceeeccCCcccEEEcC---CCe-EEEEecCcccc
Q 003919 646 ----------------RMKIVHRDLKSANCLVNK---HWT-VKICDFGLSRI 677 (786)
Q Consensus 646 ----------------s~gIIHrDLKpsNILLd~---~g~-VKL~DFGLA~~ 677 (786)
...++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 225799999999999987 355 58999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=8.2e-06 Score=83.65 Aligned_cols=131 Identities=15% Similarity=0.154 Sum_probs=88.5
Q ss_pred EEeecCcE-EEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEeeccc
Q 003919 535 RVGIGFFG-EVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 535 ~LG~G~fG-~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.+..|..+ .||+... .+..+++|+-.. .....+..|...|+.+. +--+-++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556555 6898765 466899998642 23467888999998885 222445677778888899999999998
Q ss_pred hhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh--------------------------------------------
Q 003919 611 SLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-------------------------------------------- 646 (786)
Q Consensus 611 SL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-------------------------------------------- 646 (786)
++.+...... .....+..+++..|..||.
T Consensus 106 ~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 8766543110 1112233344444444442
Q ss_pred --------------cceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 647 --------------MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 647 --------------~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999887778999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.9e-05 Score=80.69 Aligned_cols=137 Identities=13% Similarity=0.095 Sum_probs=78.7
Q ss_pred eEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----CCceeEEe-c--ccccCCceEEEEE
Q 003919 534 TRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSMITE 605 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----HPNIVkL~-g--~~~~~~~l~LV~E 605 (786)
+.|+.|..+.||++...+..+++|+.... . ..+..|+.+++.|. .|.++... | +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666788999999887777999998642 2 23334555555442 34444321 1 1123566899999
Q ss_pred eeccchhH--------------HHHHhhcCC---c--------cchHHH-------------------------------
Q 003919 606 YMELGSLY--------------HLIHLSGQK---K--------KLSWRR------------------------------- 629 (786)
Q Consensus 606 y~~gGSL~--------------dlL~~~~~~---~--------~Ls~~~------------------------------- 629 (786)
|++|..+. -.+|..... . ...|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986431 111211110 0 001110
Q ss_pred HHHHHHHHHHHHHhhh-------------hcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 630 KLKMLRDICRGLMCIH-------------RMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 630 i~~Ia~QIa~gL~yLH-------------s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+..++..++++|+ ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223444566665 2579999999999999888899999999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=8.4e-05 Score=79.54 Aligned_cols=83 Identities=12% Similarity=-0.031 Sum_probs=53.4
Q ss_pred eEeeEE-eecCcEEEEEEEEC--------CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcC-C--CceeEEecccccC
Q 003919 531 TVGTRV-GIGFFGEVFRGIWN--------GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLR-H--PNVILFLGACTKP 597 (786)
Q Consensus 531 ~i~k~L-G~G~fG~VYkg~~~--------G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~-H--PNIVkL~g~~~~~ 597 (786)
...+.| +.|....+|+.... ++.+++|+...... .......+.+|+.+++.|. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999998654 77899998643220 0000134667888887774 2 2345566665554
Q ss_pred ---CceEEEEEeeccchhH
Q 003919 598 ---PRLSMITEYMELGSLY 613 (786)
Q Consensus 598 ---~~l~LV~Ey~~gGSL~ 613 (786)
+..+++|||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3578999999986543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=5.1e-05 Score=82.76 Aligned_cols=76 Identities=16% Similarity=0.086 Sum_probs=48.3
Q ss_pred eeEEeecCcEEEEEEEE--CCeeEEEEEEecccc--C---hHHHHHHHHHHHHHhhcCC--Ccee-EEecccccCCceEE
Q 003919 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL--T---AENMEDFCNEISILSRLRH--PNVI-LFLGACTKPPRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~--~---~~~~~~f~~EI~iL~~L~H--PNIV-kL~g~~~~~~~l~L 602 (786)
.+.||.|.++.||++.. .++.++||....... . ......+..|.++++.+.. +.++ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 46799999999999954 567899998643211 0 0112456778888887742 3333 44443 2344689
Q ss_pred EEEeeccc
Q 003919 603 ITEYMELG 610 (786)
Q Consensus 603 V~Ey~~gG 610 (786)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00073 Score=74.54 Aligned_cols=78 Identities=14% Similarity=0.051 Sum_probs=47.1
Q ss_pred hhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCCCC--CCCcccCccccccC---CCCchhhHHHHHHHHH
Q 003919 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA--GTPEWMAPELIRNE---PFTEKCDIFSLGVIMW 719 (786)
Q Consensus 645 Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~~~--GT~~Y~APEvl~~~---~~s~ksDVWSLGvIL~ 719 (786)
+...++|+|+++.|||++.++ ++|+||+.+..-....... ... -...|.+|+..... .-....++......+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 456899999999999998876 9999999886532110000 000 01235555544311 1122345567777777
Q ss_pred HHHhC
Q 003919 720 ELCTL 724 (786)
Q Consensus 720 ELlTG 724 (786)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00084 Score=72.02 Aligned_cols=76 Identities=17% Similarity=0.063 Sum_probs=59.6
Q ss_pred EeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC---CCceeEEecccccCCceEEEEEeec
Q 003919 532 VGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR---HPNVILFLGACTKPPRLSMITEYME 608 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~---HPNIVkL~g~~~~~~~l~LV~Ey~~ 608 (786)
-.+.|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+++.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567999999999999878889999987532 2466888999988884 2456677777777778999999999
Q ss_pred cchh
Q 003919 609 LGSL 612 (786)
Q Consensus 609 gGSL 612 (786)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0022 Score=67.31 Aligned_cols=143 Identities=15% Similarity=0.143 Sum_probs=79.3
Q ss_pred eEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----CCceeEEe-c--ccccCCceEE
Q 003919 531 TVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----HPNVILFL-G--ACTKPPRLSM 602 (786)
Q Consensus 531 ~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----HPNIVkL~-g--~~~~~~~l~L 602 (786)
.-.+.|+.|....+|++...+..+++|+..... . .+.+..|+.+++.|. .|.++... | +....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 345678889899999998766689999976421 1 134556777776664 33333211 1 0112345789
Q ss_pred EEEeeccchhHH--------------HHHhhcC----C-----ccchHHHHHH------------HHHHHHHHHHhhh--
Q 003919 603 ITEYMELGSLYH--------------LIHLSGQ----K-----KKLSWRRKLK------------MLRDICRGLMCIH-- 645 (786)
Q Consensus 603 V~Ey~~gGSL~d--------------lL~~~~~----~-----~~Ls~~~i~~------------Ia~QIa~gL~yLH-- 645 (786)
+++|++|..+.. .++.... . ....|..... +...+...+++++
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998754310 1121100 0 0011221100 0011333444444
Q ss_pred -----hcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 646 -----RMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 646 -----s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 24799999999999999876668999997743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0035 Score=65.16 Aligned_cols=78 Identities=17% Similarity=0.117 Sum_probs=53.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCC---ceeEEecccccCCceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHP---NVILFLGACTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HP---NIVkL~g~~~~~~~l~LV 603 (786)
.++.-.+.+|.|..+.||+... +|+.+++|+........ ...|..|+..|+.|.-. -+.+++++. .-+++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4556678899999999999987 68999999865433221 23577899998887421 223344432 23789
Q ss_pred EEeeccch
Q 003919 604 TEYMELGS 611 (786)
Q Consensus 604 ~Ey~~gGS 611 (786)
|||+.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0012 Score=69.09 Aligned_cols=135 Identities=16% Similarity=0.112 Sum_probs=73.8
Q ss_pred eeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEEEEEee-ccc
Q 003919 533 GTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYM-ELG 610 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~LV~Ey~-~gG 610 (786)
.+.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++ -++++++.+ .-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence 578989999999998 67899987542111 1122457777776642222 244444332 346899999 665
Q ss_pred hhHH---------------HHHh-hcCCcc----c-hHHHHHHHHHH--------------HHHHHHhh--------hhc
Q 003919 611 SLYH---------------LIHL-SGQKKK----L-SWRRKLKMLRD--------------ICRGLMCI--------HRM 647 (786)
Q Consensus 611 SL~d---------------lL~~-~~~~~~----L-s~~~i~~Ia~Q--------------Ia~gL~yL--------Hs~ 647 (786)
++.. .+.. +..... . ....+..+..+ +...+..| ...
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 5431 0100 000000 0 11111111111 11111111 123
Q ss_pred ceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 648 KIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 648 gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5667889999998754
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0021 Score=73.45 Aligned_cols=116 Identities=11% Similarity=0.143 Sum_probs=84.0
Q ss_pred cchhHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHhhhCCCCCCChhh-hhhHHHHHHHhhcceeeeccccccccchhhH
Q 003919 119 KDKKLSMLKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRPSVESPAK-AALEETSHMFETRGVQLLGQIRHGSCRPRAI 197 (786)
Q Consensus 119 ~d~~~~~l~~l~~~~~~~~~~~~~~~~~~~a~lv~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~g~~~~g~~r~ra~ 197 (786)
.++. +++++.++..+.. ++.+.++.|-..|.+++.--.+..+.. ..-.....-|++ +.|-|+-.|+
T Consensus 226 ~~~~---i~~~a~~l~~~~~-~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~~vl~~---------~~G~C~d~a~ 292 (506)
T 3kd4_A 226 QGYE---SKTFAQFLTDKSG-NEQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDIDTVLRS---------AYGTPLEIAQ 292 (506)
T ss_dssp CCHH---HHHHHHHHHSSCS-SHHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHHHHHHH---------TEECHHHHHH
T ss_pred CCHH---HHHHHHHHHhcCC-CHHHHHHHHHHHHHhccEecceecccCCCCCCCHHHHHHh---------CCcchHHHHH
Confidence 3555 8999999998887 999999999999999885321111110 000001133333 3699999999
Q ss_pred HHHHHhhhcCCccccccccCC-CCcc-ccccccccceEEEeeCCeeeeeeec
Q 003919 198 LFKVLADTVGLESRLMVGLPN-DGTM-ECVDSYKHMSVIVVLNSVELLVDLM 247 (786)
Q Consensus 198 lfk~lad~~~l~~~l~~g~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (786)
||.+|+..+|+|||+|.+... .|.. .-+.+..|+++.|.++...|++|-=
T Consensus 293 Ll~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~g~~y~lDat 344 (506)
T 3kd4_A 293 LLNVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVDGKDQYLSAS 344 (506)
T ss_dssp HHHHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEETTEEEEESSS
T ss_pred HHHHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEECCEEEEEecC
Confidence 999999999999999999863 3322 2234458999999999999999983
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=96.86 E-value=3.1e-05 Score=87.58 Aligned_cols=146 Identities=8% Similarity=0.109 Sum_probs=62.0
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccccccccccccCCCCCCCCCC
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRDQMNSQKAISLPSSPHEYG 481 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~~~~sq~~~slPSsp~~~~ 481 (786)
.+.|+|.+++..|.. .+|+|++|.|+ ...|.+.+|+.. +++.+||.+.+. .. .-+
T Consensus 55 hg~i~r~~ae~lL~~---~~G~FLvR~S~----~~~g~~~Lsv~~-----~~~v~H~~I~~~---g~--~~~-------- 109 (463)
T 3cxl_A 55 HGMISREAADQLLIV---AEGSYLIRESQ----RQPGTYTLALRF-----GSQTRNFRLYYD---GK--HFV-------- 109 (463)
T ss_dssp CCSCCHHHHHHHHTT---STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEES---SS--EES--------
T ss_pred ccCCCHHHHHHHHcC---CCCeEEEeccC----CCCCCEEEEEEE-----CCEEEEEEEecC---Ce--EEE--------
Confidence 467899999998853 58999999998 456778888876 456788887651 11 111
Q ss_pred CCCCCCCCCCCCCCCchhhh-----hhhhhccCCccCCCCccccccccccCCCeeEeeEEeecCcEEEEEEEECC--eeE
Q 003919 482 SHGSERGGSSGYMANSEFVS-----TWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNG--TDV 554 (786)
Q Consensus 482 s~sS~~~~ss~~~~~s~~~s-----~~~~il~sp~~~~~~~~~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G--~~V 554 (786)
. ...+.+-.+.+. .+.....++.....+ +. .+.+.|| ||+||+|.+.+ .+|
T Consensus 110 ---~----~~~F~sl~~Lv~dGl~~~~~~~~~~~~~l~~~--------i~----~l~~~lG---fG~v~~g~~~~~~~~V 167 (463)
T 3cxl_A 110 ---G----EKRFESIHDLVTDGLITLYIETKAAEYIAKMT--------IN----PIYEHVG---YTTLNREPAYKKHMPV 167 (463)
T ss_dssp ---S----SCCBSCHHHHHHHHHHHHHHHHHTHHHHHHTT--------SS----CSTTTSS---BCCC---------CCB
T ss_pred ---C----CCccCCHHHHHHHHHHhhhccCCCcchhhccc--------cc----cccccCC---chhhhcccccccCCch
Confidence 0 011222233333 222211111000000 10 3445666 99999998854 578
Q ss_pred EE------EEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccc
Q 003919 555 AI------KVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGAC 594 (786)
Q Consensus 555 AV------Kvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~ 594 (786)
|+ |.........+....|.+|..+++.++|||+++.+++.
T Consensus 168 av~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 168 LKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp GGGC-----------------------------------CBCCCEE
T ss_pred hhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 88 77655555555567899999999999999999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0026 Score=67.36 Aligned_cols=33 Identities=30% Similarity=0.359 Sum_probs=28.1
Q ss_pred hcceeeccCCcccEEEcCC----CeEEEEecCccccc
Q 003919 646 RMKIVHRDLKSANCLVNKH----WTVKICDFGLSRII 678 (786)
Q Consensus 646 s~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~l 678 (786)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999874 68999999988653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.003 Score=70.33 Aligned_cols=72 Identities=18% Similarity=0.256 Sum_probs=48.8
Q ss_pred eeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEE
Q 003919 533 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~L 602 (786)
.+.|+.|....||++... +..+++|+.... .. .+.+..|..+++.|...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 467888999999999764 468999997432 11 1445679999888853333 455665542 38
Q ss_pred EEEeeccchh
Q 003919 603 ITEYMELGSL 612 (786)
Q Consensus 603 V~Ey~~gGSL 612 (786)
|+||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.014 Score=59.95 Aligned_cols=139 Identities=19% Similarity=0.156 Sum_probs=88.6
Q ss_pred cchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhh-hcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCCC
Q 003919 609 LGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSS 687 (786)
Q Consensus 609 gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLH-s~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~~ 687 (786)
.-+|.++|.. .+.+++++++|.++.|.+.+|.-+- +..-..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 3478899974 4579999999999999999987762 11111233456899999999987753 1110
Q ss_pred CCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCChHHHHHHHHhhhC---
Q 003919 688 SAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGRLIADCWAE--- 764 (786)
Q Consensus 688 ~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~~~L~~LI~~CL~D--- 764 (786)
.....+.|||... ...+.+.=|||||++||..+-...|=.. ...-...|.+||..|..+
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e----------------E~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE----------------ERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE----------------EECCCHHHHHHHHHHTTCCC-
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc----------------chhhCHHHHHHHHHHHhcccc
Confidence 1123567888764 3457889999999999999876654211 011123566777666542
Q ss_pred -----------------------CCCCCCHHHHHHHHH
Q 003919 765 -----------------------PQERPSCEEILSRLL 779 (786)
Q Consensus 765 -----------------------P~kRPSa~EIL~~L~ 779 (786)
+..|+++++|++.=.
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 367899999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0026 Score=68.63 Aligned_cols=73 Identities=12% Similarity=0.185 Sum_probs=42.8
Q ss_pred eeEEeecCcEEEEEEEECC----------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccCCceE
Q 003919 533 GTRVGIGFFGEVFRGIWNG----------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKPPRLS 601 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G----------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~~~l~ 601 (786)
.+.|+.|....+|++...+ +.+++|+..... ........|..+++.+...+++ ++++.+ . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 4567888889999998754 688889864321 1111235688888777533333 455443 2 26
Q ss_pred EEEEeeccchh
Q 003919 602 MITEYMELGSL 612 (786)
Q Consensus 602 LV~Ey~~gGSL 612 (786)
++|+|++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.02 Score=60.17 Aligned_cols=138 Identities=13% Similarity=0.135 Sum_probs=78.6
Q ss_pred eEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeEEecc-----cccCCceEEEEE
Q 003919 534 TRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGA-----CTKPPRLSMITE 605 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVkL~g~-----~~~~~~l~LV~E 605 (786)
..|+ |....||++.. +|+.+++|+........ ..+..|..+++.+.... +.+++.. ....+..+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3566 88889999866 46689999986433322 45666888777774212 3333332 112345678999
Q ss_pred eeccchhH-----------HH---HHhhcC------CccchHHHH----------------------HHHHHHHHHHHHh
Q 003919 606 YMELGSLY-----------HL---IHLSGQ------KKKLSWRRK----------------------LKMLRDICRGLMC 643 (786)
Q Consensus 606 y~~gGSL~-----------dl---L~~~~~------~~~Ls~~~i----------------------~~Ia~QIa~gL~y 643 (786)
|++|..+. .. +|.... ...++.... ...+.+++..++.
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 01 111100 111111110 1112222222222
Q ss_pred h----hhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 644 I----HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 644 L----Hs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+ +...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2 235689999999999999 4 899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.01 Score=65.38 Aligned_cols=137 Identities=15% Similarity=0.217 Sum_probs=81.0
Q ss_pred eEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEEE
Q 003919 534 TRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMI 603 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~LV 603 (786)
+.|..|....+|++... ++.+++|+..... .....+.+|..+++.|.--++ -++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56777888999998763 4689999853211 123556689999988852222 455665543 289
Q ss_pred EEeeccchhHH--------------HH---Hhhc---CCccc-hHHHHHHHHHHHHH-------------------HHHh
Q 003919 604 TEYMELGSLYH--------------LI---HLSG---QKKKL-SWRRKLKMLRDICR-------------------GLMC 643 (786)
Q Consensus 604 ~Ey~~gGSL~d--------------lL---~~~~---~~~~L-s~~~i~~Ia~QIa~-------------------gL~y 643 (786)
+||++|.+|.. .| |... ..... -+.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999865531 11 1110 01111 34556656554422 2233
Q ss_pred hh--------hcceeeccCCcccEEEcCC----CeEEEEecCcccc
Q 003919 644 IH--------RMKIVHRDLKSANCLVNKH----WTVKICDFGLSRI 677 (786)
Q Consensus 644 LH--------s~gIIHrDLKpsNILLd~~----g~VKL~DFGLA~~ 677 (786)
|. ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 1369999999999999876 7899999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.043 Score=61.84 Aligned_cols=73 Identities=15% Similarity=0.017 Sum_probs=47.4
Q ss_pred eeEEeecCcEEEEEEEECC--eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEEEEEeecc
Q 003919 533 GTRVGIGFFGEVFRGIWNG--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~G--~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~LV~Ey~~g 609 (786)
.+.|+.|-...+|++...+ ..+++|+........ -.-..|..+++.|...++ .++++++. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678889999999998865 889999874321110 111478888988875444 35666653 2 359999987
Q ss_pred chh
Q 003919 610 GSL 612 (786)
Q Consensus 610 GSL 612 (786)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.028 Score=60.28 Aligned_cols=32 Identities=22% Similarity=0.383 Sum_probs=28.1
Q ss_pred cceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 647 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999877653
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.017 Score=61.57 Aligned_cols=125 Identities=16% Similarity=0.135 Sum_probs=86.9
Q ss_pred HHHHHHHHHhcCCCCHHHHHHHHHHHHHhhhCCC-CCCChhhhhhHHHHHHHhhcceeeeccccccccchhhHHHHHHhh
Q 003919 126 LKQLIVALVKGLNSNPAAMIKKIAGLVADFYKRP-SVESPAKAALEETSHMFETRGVQLLGQIRHGSCRPRAILFKVLAD 204 (786)
Q Consensus 126 l~~l~~~~~~~~~~~~~~~~~~~a~lv~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~g~~r~ra~lfk~lad 204 (786)
+++++..+..+.. ++.+.++.|...|.+.+.=- ......... .+-|+ -+.|.|++-|.||-+|+-
T Consensus 128 i~~~A~~~~~~~~-~~~~~~~ai~~~v~~~~~Y~~~~~~~~~~a----~~~l~---------~~~G~C~d~A~l~val~R 193 (293)
T 3isr_A 128 LQKLAYKEFGKIE-NVYSKVLAITDWIYNNVEYISGSTNSQTSA----FDTIT---------ERAGVCRDFAHLGIALCR 193 (293)
T ss_dssp SHHHHHHHHTTCC-SHHHHHHHHHHHHHHHSEECTTSCCTTCCH----HHHHH---------HCEECHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCC-CHHHHHHHHHHHHHhhcEEeccCCCCCCCH----HHhhc---------CCcEehHHHHHHHHHHHH
Confidence 8888888887766 77889999999998876422 111111111 12222 368999999999999999
Q ss_pred hcCCccccccccCCCCccccccccccceEEEeeCCeeeeeeeccCCcccccCcchhhhhhcccccCCCCCcCCC
Q 003919 205 TVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQLIPRSTKAIFMSHISAAGESDSAEND 278 (786)
Q Consensus 205 ~~~l~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (786)
.+|||||+|.|+-.+.. ..-.|.|+-|-|+..=+.+|- -++. |. ..||--|.--|.++-.
T Consensus 194 a~GIPAR~VsGy~~~~~----~~~~HAW~Evyl~ggWv~~Dp--T~~~--~~------~~~I~vA~GRD~~Dva 253 (293)
T 3isr_A 194 ALSIPARYFTGYAFKLN----PPDFHACFEAYIGGNWIIFDA--TRLV--PL------NGLVKIATGRDAADAA 253 (293)
T ss_dssp HTTCCEEEEEEEETTCS----SCCEEEEEEEEETTEEEEECT--TCCS--CG------GGEEEEEEESSGGGCC
T ss_pred HCCCCEEEEEEECCCCC----CCCeEEEEEEEECCcEEEEEC--CCCC--CC------CCeEEEEECCCHHHCC
Confidence 99999999999874332 233599999999985444443 2332 22 4688888777777754
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.37 E-value=0.0033 Score=58.92 Aligned_cols=54 Identities=7% Similarity=0.033 Sum_probs=43.2
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
++.|+|++||..| ..++.+|+|++|++++ .+ .+.+|++.+++ ++..+||.+.+.
T Consensus 19 f~~isR~eAE~lL-~~~~~~GaFLVR~Se~----~~-~ySLSVR~~~~--~~~VKHYkI~~~ 72 (125)
T 3maz_A 19 FYTVSRKEATEML-QKNPSLGNMILRPGSD----SR-NYSITIRQEID--IPRIKHYKVMSV 72 (125)
T ss_dssp BCCCCHHHHHHHH-HHCGGGCSEEEEECTT----SS-SEEEEEEECSS--SCEEEEEEEEEE
T ss_pred cCCCCHHHHHHHH-hccCCCCcEEEEeCCC----CC-CEEEEEEecCC--CCCEeeeEEEEe
Confidence 4678999999644 5688899999999983 23 57888887644 789999999886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.19 Score=56.04 Aligned_cols=73 Identities=12% Similarity=0.136 Sum_probs=45.9
Q ss_pred eeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEE
Q 003919 533 GTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~L 602 (786)
.+.|..|-...+|++... +..+++++....... .-...+|..+++.+...+| .++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888999999875 678999986432111 1122468888877742222 23444332 278
Q ss_pred EEEeeccchh
Q 003919 603 ITEYMELGSL 612 (786)
Q Consensus 603 V~Ey~~gGSL 612 (786)
|++|++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=94.18 E-value=0.013 Score=52.54 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=47.3
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|+..++.+|+|++|.++ ...+.+.+++...++..+++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 66 (106)
T 1aot_F 10 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 66 (106)
T ss_dssp BSCCHHHHHHHHHTTTCCTTEECCBCBS----SSSSBBCCEEECCBTTTBCCEEECCBEEE
T ss_pred CCCCHHHHHHHHhhCCCCCcEEEEEeCC----CCCCCEEEEEEecccCCCCcEEEEEEEEe
Confidence 4689999999999999999999999998 34677888888766556778889988763
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=93.05 E-value=0.059 Score=57.36 Aligned_cols=55 Identities=20% Similarity=0.240 Sum_probs=44.1
Q ss_pred cccccccchhhHHHHHHhhhcCCccccccccCCCCccccccccccceEEEeeCCeeeeeeeccCCc
Q 003919 186 QIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPG 251 (786)
Q Consensus 186 ~~~~g~~r~ra~lfk~lad~~~l~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (786)
.-+.|.|++-|.||-+|+-.+|+|+|+|.|+ ..|.|+=|-++...-||.+=-.+|
T Consensus 137 ~~r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----------~~HaW~Evy~~g~~gWv~~Dpt~~ 191 (295)
T 2f4m_A 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDY-----------TDHVWTEVYSPSQQRWLHCDACED 191 (295)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEET-----------TTEEEEEEEETTTTEEEEEETTTT
T ss_pred HcCCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----------CCEEEEEEEECCCCeEEEEeCCcC
Confidence 4589999999999999999999999999998 469999999987333443333333
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=92.92 E-value=0.032 Score=50.61 Aligned_cols=57 Identities=14% Similarity=0.169 Sum_probs=45.8
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
.+.|+|.+++..|+..++.+|+|++|.++ ...+.+.+|+...+.. +++.+|+.+.+.
T Consensus 16 hg~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~~~~~-~~~v~H~~I~~~ 72 (114)
T 1blj_A 16 FRTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDITTQ-GEVVKHYKIRSL 72 (114)
T ss_dssp CCSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCCTT-TCBCCCEEEEEE
T ss_pred CCCCCHHHHHHHHhhCCCCCceEEEEeCC----CCCCCEEEEEEEecCC-CCcEEEEEEEEc
Confidence 35789999999999999999999999998 4467788888875433 677888887763
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=92.10 E-value=0.016 Score=51.73 Aligned_cols=57 Identities=11% Similarity=0.180 Sum_probs=45.8
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|+..+..+|+|++|.++ ...+.+.+++...++..+++.+|+.+.+.
T Consensus 9 g~isR~~Ae~lL~~~~~~~G~FLVR~S~----~~~g~~~LSv~~~~~~~~~~v~H~~I~~~ 65 (105)
T 1lkk_A 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 65 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEECC----CCCCcEEEEEEEcccCCCCcEEEEEEEEC
Confidence 5689999999999999999999999998 34567888887755445567888877653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.96 E-value=0.52 Score=51.59 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.2
Q ss_pred ceeeccCCcccEEE------cCCCeEEEEecCcccc
Q 003919 648 KIVHRDLKSANCLV------NKHWTVKICDFGLSRI 677 (786)
Q Consensus 648 gIIHrDLKpsNILL------d~~g~VKL~DFGLA~~ 677 (786)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 3466799999988754
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.77 E-value=0.068 Score=49.11 Aligned_cols=55 Identities=9% Similarity=-0.066 Sum_probs=44.7
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
.+.|+|.++++.|+..+ .+|+|++|.|+ ..++.+.+++...+ ..+++.+||.+.+
T Consensus 25 hG~isR~eAe~lL~~~~-~~G~FLVR~S~----~~~g~y~LSv~~~~-~~~~~v~H~~I~~ 79 (118)
T 2el8_A 25 FLKVSRLEAQLLLERYP-ECGNLLLRPSG----DGADGVSVTTRQMH-NGTHVVRHYKVKR 79 (118)
T ss_dssp CCCCCHHHHHHHHHHSS-TTCSBEEEECC----SSSSSEEEEECCCB-TTBCCCEEECBCC
T ss_pred ecCCCHHHHHHHHhhCC-CCcEEEEeeCC----CCCCceEEEEEEec-CCCCcEEEEEEEE
Confidence 46789999999998887 99999999998 45677888888744 2356788888776
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=89.72 E-value=0.077 Score=46.99 Aligned_cols=51 Identities=14% Similarity=0.168 Sum_probs=41.9
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.+++..|...|..+|+|++|.++ ...+.+.+++.. +++.+|+.+.+
T Consensus 7 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 57 (100)
T 1rja_A 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWR 57 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCCEEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEE
Confidence 5689999999999999999999999998 345667777776 45678887766
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=88.79 E-value=0.091 Score=46.88 Aligned_cols=51 Identities=10% Similarity=0.016 Sum_probs=41.6
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.+++..|...|+.+|+|++|.++ ...+.+.+|+.. +++.+|+.+.+
T Consensus 10 g~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 60 (105)
T 1nrv_A 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILP 60 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEeCC----CCCCCEEEEEEe-----CCEEEEEEEEE
Confidence 5689999999999999999999999998 345677777765 35678887765
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=88.03 E-value=0.088 Score=48.43 Aligned_cols=52 Identities=15% Similarity=0.225 Sum_probs=42.4
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
.+.|+|.+++..|+..++.+|+|++|.++ ...+.+.+++.. +++.+|+.+.+
T Consensus 20 hG~isR~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 71 (121)
T 2dly_A 20 FGAIKRADAEKQLLYSENQTGAFLIRESE----SQKGDFSLSVLD-----EGVVKHYRIRR 71 (121)
T ss_dssp CSSCCHHHHHHHHTSSSCCTTCEEEEECS----SSSSCEEEEEES-----SSCEEEEEEEE
T ss_pred ccCCCHHHHHHHHhcCCCCCCEEEEEcCC----CCCCceEEEEEE-----CCeEEEEEEEE
Confidence 35789999999999999999999999998 345667777766 35678887766
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=87.95 E-value=0.072 Score=51.88 Aligned_cols=58 Identities=10% Similarity=0.178 Sum_probs=47.9
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
.+.|+|.+++..|+..++.+|+|++|.++ ...+.+.+++...++..+++.+||.+.+.
T Consensus 78 ~g~isr~~ae~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~v~H~~I~~~ 135 (175)
T 4d8k_A 78 FKNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRNL 135 (175)
T ss_dssp CSSCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECTTSCEEEEEEEEEEC
T ss_pred cCcccHHHHHHHHhcCCCCCCEEEEEECC----CCCCeEEEEEEeCcccCCCceEEEEEEEC
Confidence 35789999999999999999999999997 55677888888766666778889987653
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=86.31 E-value=0.13 Score=46.65 Aligned_cols=52 Identities=12% Similarity=-0.028 Sum_probs=41.4
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
.+.|+|.++++.|...|..+|+|++|.++ ...+.+.+++.. +++.+|+.+.+
T Consensus 18 hg~isR~~Ae~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 69 (117)
T 3pqz_A 18 HGRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILP 69 (117)
T ss_dssp CCSCCHHHHHHHHHHTTCCTTEEEEEECC----C-CCCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhcCCCCCCEEEEEecC----CCCCcEEEEEEe-----CCeeEEEEEEE
Confidence 35789999999999989999999999998 345667777766 45678887765
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.66 E-value=0.12 Score=48.08 Aligned_cols=52 Identities=10% Similarity=0.115 Sum_probs=42.5
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
.+.|+|.++++.|...|..+|+|++|.++ ...+.+.+++.. +++.+++.+.+
T Consensus 30 hG~isR~eAe~lL~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 81 (126)
T 2aug_A 30 HHKISRDEAQRLIIQQGLVDGVFLVRDSQ----SNPKTFVLSMSH-----GQKIKHFQIIP 81 (126)
T ss_dssp ETTCCHHHHHHHHHTTTCCTTEEEEEECS----SSSCCEEEEEEE-----TTEEEEEEEEE
T ss_pred cCCCCHHHHHHHHhccCCCCCEEEEeecC----CCCCCEEEEEEc-----CCeEEEEEEEE
Confidence 46789999999999999999999999998 345677777776 34678887765
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=82.86 E-value=0.18 Score=46.20 Aligned_cols=50 Identities=10% Similarity=0.167 Sum_probs=39.4
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.++++.|.. ++.+|+|++|.++ ...+.+.+|+.. +++.+++.+.+
T Consensus 11 G~isR~eAe~lL~~-~~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 60 (117)
T 3ov1_A 11 GKIPRAKAEEMLSK-QRHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLR 60 (117)
T ss_dssp CSCCHHHHHHHHHT-CCSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEE
T ss_pred CCCCHHHHHHHHhC-CCCCCcEEEEeCC----CCCCCEEEEEec-----CCceEEEEEEE
Confidence 46889999998777 8899999999998 445667777765 45678887765
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=82.71 E-value=0.82 Score=49.34 Aligned_cols=57 Identities=19% Similarity=0.289 Sum_probs=44.2
Q ss_pred cccccccchhhHHHHHHhhhcCCccccccccCCCCccccccccccceEEEeeCCeeeeeeeccCCccc
Q 003919 186 QIRHGSCRPRAILFKVLADTVGLESRLMVGLPNDGTMECVDSYKHMSVIVVLNSVELLVDLMRFPGQL 253 (786)
Q Consensus 186 ~~~~g~~r~ra~lfk~lad~~~l~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (786)
.-+.|.|.|=|.||=+|+-.+|+|+|+|.|. ..|.|+=|-++...=||.+=.+=|++
T Consensus 178 ~tr~G~C~e~A~lF~~llRalGi~aR~V~~~-----------~~H~W~EV~~~~~~rWv~vDp~~~~i 234 (335)
T 1x3z_A 178 ETRKGRCGEWCNLFTLILKSFGLDVRYVWNR-----------EDHVWCEYFSNFLNRWVHVDSCEQSF 234 (335)
T ss_dssp HHCEECHHHHHHHHHHHHHTTTCCEEEEEET-----------TTEEEEEEEETTTTEEEEEETTTTEE
T ss_pred HhCCcChHHHHHHHHHHHHHCCCCeEEEecC-----------CCcEEEEEEECCCCCEEEECCCCCcc
Confidence 3468999999999999999999999999872 45999999987744455443333433
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=81.29 E-value=0.18 Score=44.78 Aligned_cols=51 Identities=12% Similarity=0.093 Sum_probs=39.4
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|...+ .+|+|++|.++ ...+.+.+|+.. +++.+|+.+.+.
T Consensus 9 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 59 (104)
T 1d4t_A 9 GKISRETGEKLLLATG-LDGSYLLRDSE----SVPGVYCLCVLY-----HGYIYTYRVSQT 59 (104)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred cCCCHHHHHHHHHhcC-CCCEEEEeeCC----CCCCCEEEEEEE-----CCeEEEEEEEEC
Confidence 4688999999887766 88999999998 345667777775 356788877653
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.28 E-value=0.36 Score=43.34 Aligned_cols=55 Identities=11% Similarity=0.158 Sum_probs=41.4
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCC-cccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHD-EISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~-~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|...+ .+|+|++|.++ ..+.+.+++...+ ...+++.+|+.+.+.
T Consensus 16 g~isR~~Ae~lL~~~~-~~G~FLVR~S~-----~~g~y~LSv~~~~~~~~~~~v~H~~I~~~ 71 (110)
T 2ekx_A 16 GNISRSQSEQLLRQKG-KEGAFMVRNSS-----QVGMYTVSLFSKAVNDKKGTVKHYHVHTN 71 (110)
T ss_dssp CSCCHHHHHHHHHHTC-CTTEEEEEECS-----STTCEEEEECCCCSSCSSCCCEEEECEEC
T ss_pred CCCCHHHHHHHHhccC-CCceEEEEecC-----CCCCEEEEEEeccccCCCCcEEEEEEEEC
Confidence 5688999999776665 88999999994 1677888887654 234567888887764
|
| >2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=80.72 E-value=0.29 Score=46.04 Aligned_cols=53 Identities=13% Similarity=0.150 Sum_probs=42.4
Q ss_pred HHHh-hHHHHHhhhhhh----cCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 402 VRAM-NETLKQNRLLQE----RGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 402 ~~~~-~~~~~~~~l~~~----~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
.+.| +|.++++.|... ++.+|+|++|.++ ...+.+.+++.. +++.+||.+.+.
T Consensus 26 hG~i~sR~eAe~lL~~~c~~~g~~~G~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 83 (138)
T 2dx0_A 26 HKKVESRTSAEKLLQEYCAETGAKDGTFLVRESE----TFPNDYTLSFWR-----SGRVQHCRIRST 83 (138)
T ss_dssp CTTCCCHHHHHHHHHHHHTTTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEE
T ss_pred cCCCCCHHHHHHHHHhhccccCCCCCEEEEEeCC----CCCCCeEEEEEE-----CCeEEEEEEEEe
Confidence 4678 899999999876 8999999999998 345667788765 456888887764
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=80.69 E-value=0.25 Score=43.82 Aligned_cols=50 Identities=14% Similarity=0.078 Sum_probs=38.0
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.+++..|...+ .+|+|++|.++ ...+.+.+++.. +++.+|+.+.+
T Consensus 8 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~ 57 (103)
T 1i3z_A 8 GCLTKRECEALLLKGG-VDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFR 57 (103)
T ss_dssp SSCCHHHHHHHHHTTC-STTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEE
T ss_pred CCCCHHHHHHHHhhcC-CCceEEEEeCC----CCCCCEEEEEEE-----CCEEEEEEEEE
Confidence 4688999999887655 89999999998 334567777765 45678887765
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=80.11 E-value=0.32 Score=43.20 Aligned_cols=49 Identities=8% Similarity=0.156 Sum_probs=37.7
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLS 461 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~ 461 (786)
+.|+|.+++..|++.+ .+|+|++|.++ ...+.+.+|+.. +++.+|+.+.
T Consensus 10 g~isR~~Ae~lL~~~~-~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~ 58 (102)
T 2cia_A 10 GNVTRHQAECALNERG-VEGDFLIRDSE----SSPSDFSVSLKA-----SGKNKHFKVQ 58 (102)
T ss_dssp CSCCHHHHHHHHHHHC-CTTEEEEEECS----SSTTCEEEEECC-----SSSCEEEEEE
T ss_pred CCCCHHHHHHHHhhCC-CCcEEEEEECC----CCCCCEEEEEEe-----CCeeEEEEEE
Confidence 4689999999876665 88999999998 345667778876 3467788766
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 786 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-78 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-71 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-62 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-53 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (641), Expect = 4e-78
Identities = 84/271 (30%), Positives = 148/271 (54%), Gaps = 17/271 (6%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILS 580
++W I ++TVG R+G G FG V++G W+G DVA+K+ T + ++ F NE+ +L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+ RH N++LF+G T P L+++T++ E SLYH +H + K + + + R +G
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQG 116
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS--AGTPEWMAPE 698
+ +H I+HRDLKS N +++ TVKI DFGL+ + + +G+ WMAPE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 699 LIRNE---PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 753
+IR + P++ + D+++ G++++EL T P+ + + + G
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 754 -----LGRLIADCWA-EPQERPSCEEILSRL 778
+ RL+A+C + ERP +IL+ +
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 3e-72
Identities = 73/261 (27%), Positives = 130/261 (49%), Gaps = 13/261 (4%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
W ++ EL + +G G FG+V G + G VA+K + F E S++++L
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQL 57
Query: 583 RHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
RH N++ LG + L ++TEYM GSL + G + L LK D+C +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAM 116
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+ VHRDL + N LV++ K+ DFGL++ + + + +W APE +R
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
+ F+ K D++S G+++WE+ + R +P + V +G +++ P+G + ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 759 ADCWA-EPQERPSCEEILSRL 778
+CW + RPS ++ +L
Sbjct: 234 KNCWHLDAAMRPSFLQLREQL 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-71
Identities = 82/264 (31%), Positives = 131/264 (49%), Gaps = 11/264 (4%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISIL 579
+EW + L + R+G G FGEV+ G +N T VA+K + + + F E +++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLM 62
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+L+H ++ T+ P +ITEYME GSL + KL+ + L M I
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 120
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS-PMRDSSSAGTPEWMAPE 698
G+ I +HRDL++AN LV+ + KI DFGL+R+I D+ + +W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
I FT K D++S G+++ E+ T R + V G R+ P+ L
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240
Query: 756 RLIADCWA-EPQERPSCEEILSRL 778
+L+ CW P++RP+ + + S L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-70
Identities = 84/263 (31%), Positives = 133/263 (50%), Gaps = 13/263 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
ID +LT +G G FG V G W DVAIK+ + + ++F E ++ L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLS 57
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
H ++ G CTK + +ITEYM G L + +L + + ++ L+M +D+C +
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 702
+ + +HRDL + NCLVN VK+ DFGLSR + D S W PE++
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 703 EPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
F+ K DI++ GV+MWE+ +L + P+E +A +G RL P + ++
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 759 ADCWA-EPQERPSCEEILSRLLD 780
CW + ERP+ + +LS +LD
Sbjct: 235 YSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-68
Identities = 87/267 (32%), Positives = 128/267 (47%), Gaps = 11/267 (4%)
Query: 518 LAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-VAIKVFLEQDLTAENMEDFCNEI 576
LA + W I L + ++G G FGEV+ G WNGT VAIK + E F E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEA 63
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
++ +LRH ++ ++ P ++TEYM GSL + K + + M
Sbjct: 64 QVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQ 121
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 695
I G+ + RM VHRDL++AN LV ++ K+ DFGL+R+I D+ +W
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 752
APE FT K D++S G+++ EL T R + R V G R+ P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 753 PLGRLIADCWA-EPQERPSCEEILSRL 778
L L+ CW EP+ERP+ E + + L
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (572), Expect = 4e-68
Identities = 80/266 (30%), Positives = 139/266 (52%), Gaps = 11/266 (4%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEIS 577
Y++W ++ +++T+ ++G G +GEV+ G+W VA+K +E+F E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAA 65
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
++ ++HPN++ LG CT+ P +ITE+M G+L + ++++S L M I
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQI 124
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-GTPEWMA 696
+ + + +HRDL + NCLV ++ VK+ DFGLSR++T + A +W A
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---P 753
PE + F+ K D+++ GV++WE+ T + VY + + R+E PEG
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 754 LGRLIADCWA-EPQERPSCEEILSRL 778
+ L+ CW P +RPS EI
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-68
Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 11/260 (4%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
ID SELT +G G FG V G W N VAIK A + EDF E ++ +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLS 58
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
HP ++ G C + + ++ E+ME G L + Q+ + L M D+C G+
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAY 116
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWMAPELIRN 702
+ ++HRDL + NCLV ++ +K+ DFG++R + D S+ +W +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIA 759
++ K D++S GV+MWE+ + + V + G RL P + +++
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236
Query: 760 DCWA-EPQERPSCEEILSRL 778
CW P++RP+ +L +L
Sbjct: 237 HCWKERPEDRPAFSRLLRQL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-66
Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 37/297 (12%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 573
+W L G +G G FG+V G VA+K+ L++ + E
Sbjct: 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALM 88
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK---------- 622
+E+ ++++L H N++ LGACT + +I EY G L + + +K
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 623 ----------KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672
L++ L + +G+ + VHRDL + N LV VKICDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 673 GLSRIIT--DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWE 729
GL+R I + + ++ +WMAPE + +T K D++S G+++WE+ +L P+
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 730 GVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782
G+ + Y + G +++ P + ++ CWA + ++RPS + S L C+
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF-LGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-66
Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 17/266 (6%)
Query: 524 NIDFSEL-TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILS 580
+++ + + +G G FG+V++ T A KV + E +ED+ EI IL+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILA 64
Query: 581 RLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
HPN++ L A L ++ E+ G++ ++ ++ L+ + + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQVVCKQTLDA 122
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
L +H KI+HRDLK+ N L +K+ DFG+S T + R S GTP WMAPE++
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 701 -----RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIPEG-- 752
++ P+ K D++SLG+ + E+ + P + P RV+ +A +E L P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 753 -PLGRLIADCWA-EPQERPSCEEILS 776
+ C R + ++L
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 8e-66
Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 15/261 (5%)
Query: 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN 586
+ V +G G +G + +G + K +T + +E+++L L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 587 VILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK-LSWRRKLKMLRDICRGLMC 643
++ + L ++ EY E G L +I ++++ L L+++ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 644 IHR-----MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
HR ++HRDLK AN ++ VK+ DFGL+RI+ + GTP +M+PE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
+ + EK DI+SLG +++ELC L P+ + + + G IP L
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDELN 243
Query: 756 RLIADCWA-EPQERPSCEEIL 775
+I + RPS EEIL
Sbjct: 244 EIITRMLNLKDYHRPSVEEIL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 16/262 (6%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISI 578
+W ++ + +G +G G FG V+ + +A+KV + L + E+ I
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
S LRHPN++ G R+ +I EY LG++Y + + K +R + ++
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELA 116
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
L H +++HRD+K N L+ +KI DFG S S + GT +++ PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPE 174
Query: 699 LIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLG 755
+I EK D++SLGV+ +E P+E + ++ P+
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGAR 232
Query: 756 RLIADCWA-EPQERPSCEEILS 776
LI+ P +RP E+L
Sbjct: 233 DLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 17/272 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLT-AENMEDFCNEISI 578
I +L + ++G G FG V RG W+ VA+K L+ E M+DF E++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 579 LSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+ L H N+I G PP + M+TE LGSL + + + +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVA 121
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWM 695
G+ + + +HRDL + N L+ VKI DFGL R + D + W
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG-- 752
APE ++ F+ D + GV +WE+ T + PW G+ ++++ + EG RL PE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 753 -PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782
+ ++ CWA +P++RP+ + LL+ +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 7e-65
Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 18/267 (6%)
Query: 525 IDFSELTVGTRV-GIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISIL 579
+D LT+ + G G FG V +G + VA+K+ + ++ E +++
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+L +P ++ +G C + ++ E ELG L + Q + + + ++++ +
Sbjct: 63 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSM 118
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS---AGTPEWMA 696
G+ + VHRDL + N L+ KI DFGLS+ + + +W A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPEG--- 752
PE I F+ K D++S GV+MWE + + P+ G+ V + G R+ P G
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPR 237
Query: 753 PLGRLIADCWA-EPQERPSCEEILSRL 778
+ L+ CW + + RP + RL
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 2e-64
Identities = 88/271 (32%), Positives = 132/271 (48%), Gaps = 19/271 (7%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEIS 577
ID S + + +G G FGEV G VAIK L+ T + DF +E S
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEAS 79
Query: 578 ILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDI 637
I+ + HPNVI G TK + +ITE+ME GSL + + + + + MLR I
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGI 137
Query: 638 CRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA-----GTP 692
G+ + M VHRDL + N LVN + K+ DFGLSR + D + ++
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 751
W APE I+ FT D++S G++MWE+ + P+ + + V+ A+ + RL P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPM 256
Query: 752 G---PLGRLIADCWA-EPQERPSCEEILSRL 778
L +L+ DCW + RP +I++ L
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-64
Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 18/278 (6%)
Query: 521 EEWNIDFSELTVG-TRVGIGFFGEVFRGIW----NGTDVAIKVFLEQDLTAENMEDFCNE 575
++ + L + +G G FG V +G++ DVAIKV L+Q + E+ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMRE 59
Query: 576 ISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
I+ +L +P ++ +G C + ++ E G L+ + G+++++ ++L
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLV--GKREEIPVSNVAELLH 116
Query: 636 DICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS---PMRDSSSAGTP 692
+ G+ + VHRDL + N L+ KI DFGLS+ + S+
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 693 EWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE 751
+W APE I F+ + D++S GV MWE + + P++ + V+ + +G R+E P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPP 235
Query: 752 G---PLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785
L L++DCW + ++RP + R+ C YSL
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-63
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 14/267 (5%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMEDFCNEI 576
++ I + +G +G G FG+V +GI+ + VAIK + + E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 59
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
+ + HP+++ +G T+ P +I E LG L + +K L +
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQ 116
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSS-AGTPEWM 695
+ L + + VHRD+ + N LV+ + VK+ DFGLSR + DS +S +WM
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG--- 752
APE I FT D++ GV MWE+ + V G RL +P
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 753 PLGRLIADCWA-EPQERPSCEEILSRL 778
L L+ CWA +P RP E+ ++L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 6e-63
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 18/272 (6%)
Query: 516 PLLAYEEWNIDFSEL-TVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-LEQDLTAENMED 571
P +A + D +L + +G G FG V+ N VAIK + E +D
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 572 FCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKL 631
E+ L +LRHPN I + G + ++ EY + L KK L
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIA 118
Query: 632 KMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGT 691
+ +GL +H ++HRD+K+ N L+++ VK+ DFG + I+ + +S GT
Sbjct: 119 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGT 174
Query: 692 PEWMAPELIR---NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE 748
P WMAPE+I + K D++SLG+ EL P + +Y +A S
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 749 IPEG---PLGRLIADCWA-EPQERPSCEEILS 776
+ C PQ+RP+ E +L
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-63
Identities = 88/269 (32%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEI 576
I S +T +G G FGEV++G+ + VAIK L+ T + DF E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEA 60
Query: 577 SILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
I+ + H N+I G +K + +ITEYME G+L + + + S + + MLR
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRG 118
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSA---GTPE 693
I G+ + M VHRDL + N LVN + K+ DFGLSR++ D P +++
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 694 WMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG- 752
W APE I FT D++S G++MWE+ T L V N+G RL P
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 753 --PLGRLIADCWA-EPQERPSCEEILSRL 778
+ +L+ CW E RP +I+S L
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-62
Identities = 70/253 (27%), Positives = 125/253 (49%), Gaps = 13/253 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
T ++G G G V+ + G +VAI+ Q + E NEI ++ ++PN++
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNIV 80
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+L + L ++ EY+ GSL ++ + + + + R+ + L +H +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
++HRD+KS N L+ +VK+ DFG IT + S+ GTP WMAPE++ + + K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIADCWA- 763
DI+SLG++ E+ P+ P R +Y +A G+ L+ PE + C
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 764 EPQERPSCEEILS 776
+ ++R S +E+L
Sbjct: 257 DVEKRGSAKELLQ 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-62
Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGT----DVAIKVFLEQDLTAENMEDFCNEISILS 580
+D++++ +G G FG+V + D AIK +++ + ++ DF E+ +L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVLC 65
Query: 581 RL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------LSGQKKKLS 626
+L HPN+I LGAC L + EY G+L + + LS
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 627 WRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686
++ L D+ RG+ + + + +HRDL + N LV +++ KI DFGLSR + ++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKT 184
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
WMA E + +T D++S GV++WE+ +L + +Y +G R
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 747 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
LE P + L+ CW +P ERPS +IL L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 7e-62
Identities = 85/294 (28%), Positives = 133/294 (45%), Gaps = 37/294 (12%)
Query: 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDF 572
+ + +G G FG VF+ T VA+K+ L+++ +A+ DF
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADF 63
Query: 573 CNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 617
E ++++ +PN++ LG C + ++ EYM G L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 618 ------LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICD 671
S LS +L + R + G+ + K VHRDL + NCLV ++ VKI D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 672 FGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PW 728
FGLSR I D D + A WM PE I +T + D+++ GV++WE+ + P+
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 729 EGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
G+ E V+Y V + G+ L PE L L+ CW+ P +RPS I L
Sbjct: 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-61
Identities = 83/288 (28%), Positives = 140/288 (48%), Gaps = 23/288 (7%)
Query: 512 FQNKPLLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDL 564
F + +EW + ++T+ +G G FG V+ G+ T VAIK + +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAA 62
Query: 565 TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQK-- 622
+ +F NE S++ +V+ LG ++ +I E M G L +
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 623 -----KKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
S + ++M +I G+ ++ K VHRDL + NC+V + +TVKI DFG++R
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 678 ITDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPE 734
I ++ + WM+PE +++ FT D++S GV++WE+ TL P++G+ E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
+V+ V EG L+ P+ L L+ CW P+ RPS EI+S +
Sbjct: 243 QVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-61
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 31/288 (10%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFC 573
+W + L+ G +G G FG+V VA+K+ L+ E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALM 74
Query: 574 NEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH--------------- 617
+E+ +LS L H N++ LGACT +ITEY G L + +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 618 LSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677
+ + L L + +G+ + +HRDL + N L+ KICDFGL+R
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 678 ITDSPMRDSSS--AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPW-EGVLPE 734
I + +WMAPE I N +T + D++S G+ +WEL +L G+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 735 RVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
Y + EG R+ PE + ++ CW +P +RP+ ++I+ +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRL 582
D L +G G F V++G+ T VA ++ LT + F E +L L
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 583 RHPNVILFLGACTKPPR----LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+HPN++ F + + + ++TE M G+L + + K + + R I
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQIL 122
Query: 639 RGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITDSPMRDSSSAGTPEWM 695
+GL +H I+HRDLK N + +VKI D GL+ + S + + GTPE+M
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFM 180
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-- 753
APE+ + E D+++ G+ M E+ T P+ +Y G + +
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 754 --LGRLIADCWA-EPQERPSCEEILS 776
+ +I C ER S +++L+
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 4e-61
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 22/276 (7%)
Query: 517 LLAYEEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-----VAIKVFLEQDLTAENMED 571
++ + F+E+ +G G FG V+ G D A+K L + +
Sbjct: 21 VIGPSSLIVHFNEV-----IGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 572 FCNEISILSRLRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQKKKLSWRRK 630
F E I+ HPNV+ LG C + ++ YM+ G L + I + + +
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDL 132
Query: 631 LKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM----RDS 686
+ + +G+ + K VHRDL + NC++++ +TVK+ DFGL+R + D +
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR 746
+ +WMA E ++ + FT K D++S GV++WEL T P + + +G R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 747 LEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
L PE PL ++ CW + + RPS E++SR+
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 79/286 (27%), Positives = 139/286 (48%), Gaps = 30/286 (10%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD---------VAIKVFLEQDLTAENMEDF 572
W + L +G +G G FG+V G D VA+K+ L+ D T +++ D
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDL 65
Query: 573 CNEISILSRL-RHPNVILFLGACTKPPRLSMITEYMELGSLYHLIH-------------L 618
+E+ ++ + +H N+I LGACT+ L +I EY G+L +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 619 SGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678
+++LS + + + RG+ + K +HRDL + N LV + +KI DFGL+R I
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 679 TDSPMRDSSSA--GTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV 736
++ +WMAPE + + +T + D++S GV++WE+ TL +P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 737 VYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
++ + EG R++ P L ++ DCW P +RP+ ++++ L
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 7e-60
Identities = 59/256 (23%), Positives = 106/256 (41%), Gaps = 14/256 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G +GEV + T+ VA+K+ ++ + E+ EI I L H NV+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
F G + + EY G L+ I + + + G++ +H +
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAPELIRNEPF- 705
I HRD+K N L+++ +KI DFGL+ + + + GT ++APEL++ F
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 706 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLG----RLIADC 761
E D++S G+++ + PW+ Y+ E P + L+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 762 WA-EPQERPSCEEILS 776
P R + +I
Sbjct: 244 LVENPSARITIPDIKK 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 62/250 (24%), Positives = 116/250 (46%), Gaps = 14/250 (5%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR 583
DF +++ +G G G VF+ +G +A K+ + ++ E+ +L
Sbjct: 7 DFEKISE---LGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECN 62
Query: 584 HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
P ++ F GA +S+ E+M+ GSL ++ + ++ + K+ + +GL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTY 119
Query: 644 IH-RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
+ + KI+HRD+K +N LVN +K+CDFG+S + DS +S GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG 177
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERV--VYAVANEGSRLEIPEGPLGRLIAD 760
++ + DI+S+G+ + E+ P + + ++ EG E P P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 761 CWAEPQERPS 770
RP
Sbjct: 238 SSYGMDSRPP 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-59
Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 14/257 (5%)
Query: 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHP 585
+ G +G G F V + AIK+ ++ + EN + E ++SRL HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 586 NVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIH 645
+ +L Y + G L I + +I L +H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 646 RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT--DSPMRDSSSAGTPEWMAPELIRNE 703
I+HRDLK N L+N+ ++I DFG +++++ R +S GT ++++PEL+ +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIAD 760
+ D+++LG I+++L P+ + + + PE L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEK 243
Query: 761 CWA-EPQERPSCEEILS 776
+ +R CEE+
Sbjct: 244 LLVLDATKRLGCEEMEG 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 200 bits (509), Expect = 3e-58
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 15/256 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G FG V R G + A K + + E EI +S LRHP ++
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLV 86
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
A + MI E+M G L+ + + K+S ++ +R +C+GL +H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 649 IVHRDLKSANCLVNKHW--TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
VH DLK N + +K+ DFGL+ + ++ GT E+ APE+ +P
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVG 203
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 761
D++S+GV+ + L + P+ G + + V + ++ I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 762 WA-EPQERPSCEEILS 776
+P R + + L
Sbjct: 264 LLADPNTRMTIHQALE 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-58
Identities = 68/265 (25%), Positives = 122/265 (46%), Gaps = 19/265 (7%)
Query: 526 DFSELTVGTRVGIGFFGEVFRGIWNGTD------VAIKVFLEQDLTAENMEDFCNEISIL 579
+F ++ V +G G FG V++G+W VAIK L + + + ++ +E ++
Sbjct: 10 EFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEAYVM 65
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
+ + +P+V LG C + +IT+ M G L + K + + L I +
Sbjct: 66 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAK 122
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII--TDSPMRDSSSAGTPEWMAP 697
G+ + ++VHRDL + N LV VKI DFGL++++ + +WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PL 754
E I + +T + D++S GV +WEL T +P + ++ +G RL P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 755 GRLIADCWA-EPQERPSCEEILSRL 778
++ CW + RP E++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 197 bits (502), Expect = 2e-57
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 15/256 (5%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ +G G FG V R + G K + NEISI+++L HP +I
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLI 89
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
A + +I E++ G L+ I + K+S + +R C GL +H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 649 IVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFT 706
IVH D+K N + K +VKI DFGL+ + + ++ T E+ APE++ EP
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREPVG 206
Query: 707 EKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIADC 761
D++++GV+ + L + P+ G + V + I +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 762 WA-EPQERPSCEEILS 776
EP++R + + L
Sbjct: 267 LQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 1e-56
Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 16/257 (6%)
Query: 531 TVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G F EV T VAIK ++ L + NEI++L +++HPN++
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIV 70
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L +I + + G L+ I +K + R +++ + + +H +
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 649 IVHRDLKSANCLV---NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 705
IVHRDLK N L ++ + I DFGLS++ + S++ GTP ++APE++ +P+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-STACGTPGYVAPEVLAQKPY 186
Query: 706 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRLIAD 760
++ D +S+GVI + L P+ ++ + + P I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 761 CWA-EPQERPSCEEILS 776
+P++R +CE+ L
Sbjct: 247 LMEKDPEKRFTCEQALQ 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 30/287 (10%)
Query: 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTD-------VAIKVFLEQDLTAENMEDFC 573
+W L +G +G G FG+V G D VA+K+ L++ T
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALM 64
Query: 574 NEISILSR-LRHPNVILFLGACTKPP-RLSMITEYMELGSLYHLIHLSGQ---------- 621
+E+ IL H NV+ LGACTKP L +I E+ + G+L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 622 ---KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678
K L+ + + +G+ + K +HRDL + N L+++ VKICDFGL+R I
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 679 TDSP--MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPER 735
P +R + +WMAPE I + +T + D++S GV++WE+ +L P+ GV +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 736 VVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQERPSCEEILSRL 778
EG+R+ P+ + + + DCW EP +RP+ E++ L
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-56
Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 53/296 (17%)
Query: 529 ELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ + +G G FGEV+RG W G +VA+K+F ++ + E EI LRH N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENIL 60
Query: 589 LFLGACTKP----PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
F+ A K +L ++++Y E GSL+ ++ + ++ +K+ GL +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHL 116
Query: 645 H--------RMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP----MRDSSSAGTP 692
H + I HRDLKS N LV K+ T I D GL+ + + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 693 EWMAPELIRNE------PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVY-------- 738
+MAPE++ + ++ DI+++G++ WE+ ++ Y
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 739 -------AVANEGSRLEIPEGP--------LGRLIADCWA-EPQERPSCEEILSRL 778
V + R IP + +++ +CW R + I L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 52/259 (20%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 527 FSELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAENMEDFCNEISILSRLRH 584
+ + + +G G FG V R + + K + + EISIL+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
N++ + L MI E++ ++ I+ S +L+ R + + +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFL 118
Query: 645 HRMKIVHRDLKSANCLV--NKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN 702
H I H D++ N + + T+KI +FG +R + PE+ APE+ ++
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-RLLFTAPEYYAPEVHQH 177
Query: 703 EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LGRL 757
+ + D++SLG +++ L + P+ ++++ + N +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 758 IADCWA-EPQERPSCEEIL 775
+ E + R + E L
Sbjct: 238 VDRLLVKERKSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (478), Expect = 7e-55
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVF-------LEQDLTAENMEDFCNEIS 577
+ +G G V R I + A+K+ + E E E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 578 ILSRLR-HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
IL ++ HPN+I ++ + M+ G L+ + +K LS + K++R
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRA 118
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMA 696
+ + +H++ IVHRDLK N L++ +K+ DFG S + GTP ++A
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLA 177
Query: 697 PELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750
PE+I + ++ D++S GVIM+ L + P+ ++ + + + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 751 EGP-----LGRLIADCWA-EPQERPSCEEILS 776
E + L++ +PQ+R + EE L+
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 13/255 (5%)
Query: 529 ELTVGTRVGIGFFGEVFRGIWNGTD--VAIKVF-LEQDLTAENMEDFCNEISILSR-LRH 584
+ + +G G FG+VF + T+ AIK + L +++E E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
P + L + EY+ G L + I K R +I GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL 119
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP 704
H IV+RDLK N L++K +KI DFG+ + + ++ GTP+++APE++ +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADC 761
+ D +S GV+++E+ P+ G E + +++ + P L+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLLVKL 237
Query: 762 WA-EPQERPSCEEIL 775
+ EP++R +
Sbjct: 238 FVREPEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (464), Expect = 7e-53
Identities = 64/266 (24%), Positives = 119/266 (44%), Gaps = 20/266 (7%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENM-EDFCNEISILSRLRHPNV 587
+G +G G EV DVA+KV + F E + L HP +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 588 ILFLGAC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMC 643
+ P ++ EY++ +L ++H + ++ +R ++++ D C+ L
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 126
Query: 644 IHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP---MRDSSSAGTPEWMAPELI 700
H+ I+HRD+K AN +++ VK+ DFG++R I DS + ++ GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 755
R + + D++SLG +++E+ T P+ G P V Y E L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 756 RLIADCWA-EPQERP-SCEEILSRLL 779
++ A P+ R + E+ + L+
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 20/262 (7%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN----MEDFCNEISILSRLRH 584
G +G G F V + G A K ++ + ED E+SIL ++H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
PNVI + +I E + G L+ + +K+ L+ + L+ I G+ +
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYL 129
Query: 645 HRMKIVHRDLKSANCLVNKHWT----VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELI 700
H ++I H DLK N ++ +KI DFGL+ I D + GTPE++APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIV 188
Query: 701 RNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----LG 755
EP + D++S+GVI + L + P+ G + + V+ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 756 RLIADCWA-EPQERPSCEEILS 776
I +P++R + ++ L
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (454), Expect = 4e-51
Identities = 60/266 (22%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISIL 579
+++ + + +G G FG V NG A+KV ++ + +E +E +L
Sbjct: 1 YSLQ--DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 580 SRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
S + HP +I G ++ MI +Y+E G L+ L+ + ++ ++C
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCL 115
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
L +H I++RDLK N L++K+ +KI DFG ++ + D + GTP+++APE+
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEV 172
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGR 756
+ +P+ + D +S G++++E+ P+ + + N L P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKD 230
Query: 757 LIADCWA-EPQER-----PSCEEILS 776
L++ + +R E++ +
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 7e-51
Identities = 60/264 (22%), Positives = 114/264 (43%), Gaps = 17/264 (6%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSR 581
+ ++ +G G FG+V G A+K+ ++ + A++ + E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 582 LRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGL 641
RHP + A RL + EY G L+ + +++ + R +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSAL 118
Query: 642 MCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
+H +V+RD+K N +++K +KI DFGL + + GTPE++APE++
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 702 NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLI 758
+ + D + LGV+M+E+ P+ ER+ + E + P L+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLL 236
Query: 759 ADCWA-EPQERPSC-----EEILS 776
A +P++R +E++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-48
Identities = 54/261 (20%), Positives = 108/261 (41%), Gaps = 29/261 (11%)
Query: 536 VGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592
+G+G G+V + A+K+ ++ E+ + R + P+++ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 593 AC----TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L ++ E ++ G L+ I G + + R ++++ I + +H +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 649 IVHRDLKSANCLVNKHW---TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPF 705
I HRD+K N L +K+ DFG ++ T ++ TP ++APE++ E +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKY 190
Query: 706 TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEIPEGPLGR------- 756
+ CD++SLGVIM+ L P+ + + + E P
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250
Query: 757 LIADCWA-EPQERPSCEEILS 776
LI + EP +R + E ++
Sbjct: 251 LIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 59/260 (22%), Positives = 107/260 (41%), Gaps = 26/260 (10%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR- 583
VG +G G FG V+ GI + VAIK + ++ N E+ +L ++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 584 -HPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
VI L +P +I E E L ++ L + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD--LFDFITERGALQEELARSFFWQVLEAVR 124
Query: 643 CIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIR 701
H ++HRD+K N L++ + +K+ DFG ++ D+ + GT + PE IR
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYSPPEWIR 182
Query: 702 NEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRL 757
+ ++SLG++++++ + P+E E ++ ++ + L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRG------QVFFRQRVSSECQHL 234
Query: 758 IADCWA-EPQERPSCEEILS 776
I C A P +RP+ EEI +
Sbjct: 235 IRWCLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (428), Expect = 6e-47
Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 22/263 (8%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFC----NEISILSRLRH 584
+V +G G FGEV+ G A+K ++ + + E +S++S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 585 PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCI 644
P ++ A P +LS I + M G L++ + Q S +I GL +
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHM 123
Query: 645 HRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE-LIRNE 703
H +V+RDLK AN L+++H V+I D GL+ + + +S GT +MAPE L +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGV 181
Query: 704 PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS-RLEIPEG---PLGRLIA 759
+ D FSLG ++++L + P+ + + +E+P+ L L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 760 DCWA-EPQERPSC-----EEILS 776
+ R C +E+
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 3e-45
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 36/279 (12%)
Query: 531 TVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVIL 589
++G G +G V++ N G A+K + EISIL L+H N++
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 590 FLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKI 649
RL ++ E+++ L + L L + G+ H ++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 650 VHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEK 708
+HRDLK N L+N+ +KI DFGL+R + + T + AP+++ ++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 709 CDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR------------ 756
DI+S+G I E+ + GV + + P
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 757 ------------------LIADCWA-EPQERPSCEEILS 776
L++ +P +R + ++ L
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-44
Identities = 49/274 (17%), Positives = 96/274 (35%), Gaps = 30/274 (10%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G ++G G FG+++ G G +VAIK+ + E I ++ I
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 589 LFLGAC-TKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRM 647
+ C + M+ E + +K S + L + + + IH
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 648 KIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP-------MRDSSSAGTPEWMAP 697
+HRD+K N L+ K V I DFGL++ D+ + + GT + +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 698 ELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN-EGSRLEIPEGPLGR 756
+ + D+ SLG ++ + PW+G+ ++ P L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 757 --------LIADCWA-EPQERPSCEEILSRLLDC 781
+ C + ++P + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-44
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 39/276 (14%)
Query: 536 VGIGFFGEVFRGIWNGTD--VAIKVFLEQDLTAEN---MEDFCNEISILSRLRHPNVILF 590
+G G F V++ T+ VAIK + EI +L L HPN+I
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 591 LGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIV 650
L A +S++ ++ME + L+ + +GL +H+ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 651 HRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKC 709
HRDLK N L++++ +K+ DFGL++ + T + APEL+ +
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 710 DIFSLGVIMWELCTLNRPWEGVLPERVVYAV------------------ANEGSRLEIPE 751
D++++G I+ EL G + + + + P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 752 GPLGR-----------LIADCWA-EPQERPSCEEIL 775
PL LI + P R + + L
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (402), Expect = 3e-44
Identities = 49/275 (17%), Positives = 93/275 (33%), Gaps = 30/275 (10%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
VG R+G G FG +F G N VAIK + + +E L I
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+ + +++ + SL L+ L G +K S + + + + IH
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 649 IVHRDLKSANCLVNKHWT-----VKICDFGLSRIITDSP-------MRDSSSAGTPEWMA 696
+V+RD+K N L+ + + + + DFG+ + D + +GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 697 PELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------SRLEIP 750
+ + D+ +LG + + PW+G+ G E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 751 EG---PLGRLIADCWA-EPQERPSCEEILSRLLDC 781
G + + P + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-44
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++G G FGEVF+ G VA+K L ++ EI IL L+H NV+
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 589 LFLGACTKPP--------RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRG 640
+ C + ++ ++ E L + K + ++++ + G
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNG 129
Query: 641 LMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS----PMRDSSSAGTPEWMA 696
L IHR KI+HRD+K+AN L+ + +K+ DFGL+R + + P R ++ T +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 697 PELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN------------- 742
PEL+ E + D++ G IM E+ T + +G + + ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 743 ----EGSRLEIPEGPLGR----------------LIADCWA-EPQERPSCEEILS 776
+LE+ +G + LI +P +R ++ L+
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 57/280 (20%), Positives = 101/280 (36%), Gaps = 36/280 (12%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++G G +G V++ G VA+K T EIS+L L HPN++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L +L ++ E++ + + L + +GL H +
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 707
++HRDLK N L+N +K+ DFGL+R + T + APE++ ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 708 KCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR----------- 756
DI+SLG I E+ T + G ++ + + P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 757 -------------------LIADCWA-EPQERPSCEEILS 776
L++ +P +R S + L+
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (399), Expect = 3e-43
Identities = 62/309 (20%), Positives = 129/309 (41%), Gaps = 36/309 (11%)
Query: 482 SHGSERGGSSGYMANS--EFVSTWNKVLESPMFQNKPLLAYEEWNIDFSELTVGTRVGIG 539
GSE+ ++A + +F+ W E+P L ++ +G G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKW----ETPSQNTAQLDQFD----------RIKTLGTG 52
Query: 540 FFGEVFRGIW--NGTDVAIKVFLEQDLTAEN-MEDFCNEISILSRLRHPNVILFLGACTK 596
FG V +G A+K+ +Q + +E NE IL + P ++ +
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKS 656
L M+ EY+ G ++ + + + S I +H + +++RDLK
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 657 ANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGV 716
N L+++ +++ DFG ++ + R + GTPE +APE+I ++ + + D ++LGV
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 717 IMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEG---PLGRLIADCWA-EPQER---- 768
+++E+ P+ P ++ + + ++ P L L+ + + +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNL 284
Query: 769 -PSCEEILS 776
+I +
Sbjct: 285 KNGVNDIKN 293
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 63/286 (22%), Positives = 108/286 (37%), Gaps = 43/286 (15%)
Query: 531 TVGTRVGIGFFGEVFRGIW---NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RH 584
+G G +G+VF+ G VA+K Q E+++L L H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 585 PNVILFLGACTKPP-----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICR 639
PNV+ CT +L+++ E+++ +L + + + M+ + R
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLR 127
Query: 640 GLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPEL 699
GL +H ++VHRDLK N LV +K+ DFGL+RI + M +S T + APE+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEV 186
Query: 700 IRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGPLGR--- 756
+ + D++S+G I E+ + G + + + + P
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 757 -------------------------LIADCWA-EPQERPSCEEILS 776
L+ C P +R S LS
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 69/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
T + +G G +G V N VAIK + + EI IL R RH N+I
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
P M Y+ + ++ + + LS L I RGL IH
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIIT---DSPMRDSSSAGTPEWMAPELIRNE-P 704
++HRDLK +N L+N +KICDFGL+R+ D + T + APE++ N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 705 FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN---------------------E 743
+T+ DI+S+G I+ E+ + + G + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 744 GSRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 776
S + P R L+ P +R E+ L+
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-42
Identities = 54/292 (18%), Positives = 99/292 (33%), Gaps = 49/292 (16%)
Query: 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL 582
+ +++ V +G G FG V++ +G VAIK L+ + E+ I+ +L
Sbjct: 20 VSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKL 70
Query: 583 RHPNVILFLGACTKP------PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRD 636
H N++ L+++ +Y+ H S K+ L +
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 637 ICRGLMCIHRMKIVHRDLKSANCLVNKH-WTVKICDFGLSRIITDSPMRDSSSAGTPEWM 695
+ R L IH I HRD+K N L++ +K+CDFG ++ + S
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 696 APELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV--------------- 740
+ +T D++S G ++ EL + G + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 741 ---ANEGSRLEIPEGPLGR------------LIADCWA-EPQERPSCEEILS 776
E +I P + L + P R + E +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 38/281 (13%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
++G G +G VF+ VA+K D EI +L L+H N++
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
+L+++ E+ + + +G L + +GL H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSRN 121
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEP-FTE 707
++HRDLK N L+N++ +K+ +FGL+R S+ T + P+++ ++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 708 KCDIFSLGVIMWELCTLNRPW----------------EGVLPERVVYAVANEGSRLEIPE 751
D++S G I EL RP G E ++ P
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 752 GPLGR---------------LIADCWA-EPQERPSCEEILS 776
P L+ + P +R S EE L
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 531 TVGTRVGIGFFGEVFRGI-----WNGTDVAIKVFLEQDLT--AENMEDFCNEISILSRLR 583
+ +G G +G+VF G A+KV + + A+ E E +L +R
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 584 H-PNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLM 642
P ++ A +L +I +Y+ G L+ + Q+++ + + +I L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALE 143
Query: 643 CIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS-SSAGTPEWMAPELIR 701
+H++ I++RD+K N L++ + V + DFGLS+ + GT E+MAP+++R
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 702 --NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPEGP-----L 754
+ + D +SLGV+M+EL T P+ + ++ + E P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263
Query: 755 GRLIADCWA-EPQERPSC-----EEILS 776
LI +P++R C +EI
Sbjct: 264 KDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-37
Identities = 66/292 (22%), Positives = 111/292 (38%), Gaps = 41/292 (14%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 579
W + + VG G +G V + G VAIK + + E+ +L
Sbjct: 13 AWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 580 SRLRHPNVILFLGACTKPPRLSMITE-YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDIC 638
+RH NVI L T L T+ Y+ + + + + +KL R ++ +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131
Query: 639 RGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPE 698
+GL IH I+HRDLK N VN+ +KI DFGL+R + T + APE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPE 188
Query: 699 LIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG------------- 744
+I N +T+ DI+S+G IM E+ T ++G + +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 745 --------SRLEIPEGPLGRLIADCWAE------------PQERPSCEEILS 776
E+ + ++ + ++R + E L+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 3/202 (1%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+G G G V +VAIK + + E+ ++ + H N+I
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 589 LFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK 648
L T L + + L + +L R +L + G+ +H
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 649 IVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEK 708
I+HRDLK +N +V T+KI DFGL+R S M + T + APE+I + E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRYYRAPEVILGMGYKEN 198
Query: 709 CDIFSLGVIMWELCTLNRPWEG 730
DI+S+G IM E+ + G
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPG 220
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 2e-36
Identities = 47/226 (20%), Positives = 95/226 (42%), Gaps = 22/226 (9%)
Query: 513 QNKPLLAYEEWNIDFS---ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAE 567
+ + YE +++ + + ++G G + EVF I N V +K+ L
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-----LKPV 71
Query: 568 NMEDFCNEISILSRLR-HPNVILFLGACTKPP--RLSMITEYMELGSLYHLIHLSGQKKK 624
+ EI IL LR PN+I P +++ E++ L +
Sbjct: 72 KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QT 125
Query: 625 LSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLV-NKHWTVKICDFGLSRIITDSPM 683
L+ + +I + L H M I+HRD+K N ++ ++H +++ D+GL+
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184
Query: 684 RDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPW 728
+ + + PEL+ + + + D++SLG ++ + P+
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 8e-36
Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 49/296 (16%)
Query: 522 EWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISIL 579
W + + VG G +G V G VA+K + + + E+ +L
Sbjct: 13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 580 SRLRHPNVILFLGACTKPPRLS-----MITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
++H NVI L T L + ++ L +++ +KL+ ++
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLI 127
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDSSSAGTPEW 694
I RGL IH I+HRDLK +N VN+ +KI DFGL+R + T +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWY 184
Query: 695 MAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEG--------- 744
APE++ N + + DI+S+G IM EL T + G + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 745 ------------SRLEIPEGPLGR-----------LIADCWA-EPQERPSCEEILS 776
S ++P+ L+ + +R + + L+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 5e-26
Identities = 45/222 (20%), Positives = 84/222 (37%), Gaps = 28/222 (12%)
Query: 531 TVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI 588
+ ++G G F V+ N T VA+K+ + E ED EI +L R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNT 72
Query: 589 LFLGACTK-------------PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLR 635
P + ++ + LG + + + + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 636 DICRGLM-CIHRMKIVHRDLKSANCLVN------KHWTVKICDFGLSRIITDSPMRDSSS 688
+ GL R I+H D+K N L+ +KI D G + + S
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---S 189
Query: 689 AGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEG 730
T E+ +PE++ P+ DI+S +++EL T + +E
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 3e-20
Identities = 26/169 (15%), Positives = 51/169 (30%), Gaps = 33/169 (19%)
Query: 532 VGTRVGIGFFGEVFRGI-WNGTDVAIKVF----------------LEQDLTAENMEDFCN 574
+G +G G VF + +K + + + N
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 575 EISILSRLRHPNVILFLGACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKML 634
E L +L+ V +++ E ++ + + ++ ++L
Sbjct: 64 EFRALQKLQGLAVPKVYAWE----GNAVLMELID----------AKELYRVRVENPDEVL 109
Query: 635 RDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683
I + + IVH DL N LV++ + I DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV-EVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 786 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.17 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.04 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 94.0 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 93.27 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 92.97 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 92.7 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 91.77 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 91.56 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 89.03 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 87.88 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 87.01 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 85.64 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 85.07 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 83.68 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 81.79 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 81.48 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=438.49 Aligned_cols=261 Identities=33% Similarity=0.640 Sum_probs=221.5
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
++|+++.++|.+++.||+|+||+||+|++++ .||||++..........+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4789999999999999999999999998766 59999998776666778899999999999999999999998765 568
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 999999999999999863 345799999999999999999999999999999999999999999999999999987653
Q ss_pred CC--CCCCCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----CC-
Q 003919 681 SP--MRDSSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE----IP- 750 (786)
Q Consensus 681 ~~--~~~~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~----ip- 750 (786)
.. .......||+.|+|||++.+ ..|+.++|||||||+||||+||+.||.+......+......+...+ ++
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence 22 22345689999999999864 3589999999999999999999999998877666655555443322 22
Q ss_pred --ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 751 --EGPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 751 --~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
+..+.+|+.+||. ||.+|||+.+|+++|+.+..++
T Consensus 237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 2469999999999 9999999999999999887653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-51 Score=432.80 Aligned_cols=260 Identities=30% Similarity=0.640 Sum_probs=224.8
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
.+++|+++.++|.+.+.||+|+||+||+|.+ +|+.||||++...... .++|.+|+.+|++++|||||+++++|.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 5678999999999999999999999999988 4889999998654433 4679999999999999999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
.+.++++|||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999999998643 45689999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCC-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003919 677 IITDSPMR-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIPE---G 752 (786)
Q Consensus 677 ~l~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip~---~ 752 (786)
........ .....|++.|+|||++.+..|+.++|||||||++|||++|..||........+......+..+..|. .
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 87544322 2334588999999999999999999999999999999998776554444444555555566665553 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+.+|+.+||. ||++|||+.+|++.|+.+.
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 69999999999 9999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=427.23 Aligned_cols=250 Identities=28% Similarity=0.474 Sum_probs=208.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--CCceEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK--PPRLSM 602 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~--~~~l~L 602 (786)
.++|.+.+.||+|+||+||+|++ +|+.||||++..........+.|.+|++++++++|||||++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999988 58899999998877777777889999999999999999999999864 456899
Q ss_pred EEEeeccchhHHHHHhhc-CCccchHHHHHHHHHHHHHHHHhhhhcc-----eeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 603 ITEYMELGSLYHLIHLSG-QKKKLSWRRKLKMLRDICRGLMCIHRMK-----IVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 603 V~Ey~~gGSL~dlL~~~~-~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g-----IIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
||||+++|+|.+++.... .+..+++..++.++.||+.||+|||+.| ||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986432 3467999999999999999999999976 9999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChH
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGP 753 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~ 753 (786)
.+..........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+..++...+...... .+| +..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~ 241 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDE 241 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHH
Confidence 8766544555678999999999999999999999999999999999999999999888877777654432 333 457
Q ss_pred HHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 754 LGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 754 L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||.+||+ ||.+|||+.||++|
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999 99999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=420.88 Aligned_cols=253 Identities=31% Similarity=0.633 Sum_probs=209.3
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
++.++|.+.+.||+|+||+||+|.+ +++.||||++...... .++|.+|++++++++|||||+++|+|.+++.+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3567899999999999999999988 5778999998755443 36799999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 ~E~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999998862 446789999999999999999999999999999999999999999999999999987754432
Q ss_pred C-CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 684 R-DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 684 ~-~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
. .....||+.|+|||++.+..|+.++|||||||++|||+|+ ++||...+..+....+.. +.+...| +..+.+|+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-TCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHH
Confidence 2 2346789999999999999999999999999999999995 566677677666665544 4444444 45799999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 759 ADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+||+ ||++|||+++|+++|+++..
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999 99999999999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=422.74 Aligned_cols=259 Identities=32% Similarity=0.579 Sum_probs=220.9
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
..++|+++.++|++.+.||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||++++++.+
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 35789999999999999999999999999985 678999999755443 3679999999999999999999998865
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.+++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||++++.+||+|||+++.
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 4579999999999999987532 234689999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003919 678 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNR-PWEGVLPERVVYAVANEGSRLEIPE---G 752 (786)
Q Consensus 678 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~-PF~~~~~~~~l~~i~~~~~~~~ip~---~ 752 (786)
+..... ......||+.|+|||++.+..++.++|||||||+||||+||.. ||...........+. .+.++..|. .
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChH
Confidence 754432 2345678999999999999999999999999999999999655 556666666555544 445555443 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+.+|+.+||+ ||++|||+.+|++.|+++..
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 69999999999 99999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=425.66 Aligned_cols=246 Identities=27% Similarity=0.468 Sum_probs=217.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|+||+||+|++ +|+.||+|++.+.... ....+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999988 4789999998754432 22356789999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 999999999999973 457999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+.......+ ..+..+.+|+.+||
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 23456899999999999999999999999999999999999999999988888877766543322 22457999999999
Q ss_pred h-CCCCCCCHHHHHHH
Q 003919 763 A-EPQERPSCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~ 777 (786)
. ||.+|||+.|+++|
T Consensus 240 ~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 240 KHNPSQRPMLREVLEH 255 (263)
T ss_dssp CSSGGGSCCHHHHHTC
T ss_pred cCCHhHCcCHHHHHcC
Confidence 9 99999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=426.30 Aligned_cols=244 Identities=28% Similarity=0.482 Sum_probs=217.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.+.+.||+|+||+||+|.+ +|+.||||++....... .+.+.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999987 58999999997654433 4679999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++|+|.+++.. ..+++.+++.++.||+.||+|||++|||||||||+|||++.++++||+|||+++.+.......
T Consensus 98 y~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999998752 369999999999999999999999999999999999999999999999999999886655555
Q ss_pred CCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHHHHHHh
Q 003919 686 SSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGRLIADC 761 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip---~~~L~~LI~~C 761 (786)
...+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.......+...... ...+ +..+.+||.+|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 253 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHH
Confidence 6778999999999999999999999999999999999999999998888777776655432 2232 34699999999
Q ss_pred hh-CCCCCCCHHHHHHH
Q 003919 762 WA-EPQERPSCEEILSR 777 (786)
Q Consensus 762 L~-DP~kRPSa~EIL~~ 777 (786)
|. ||.+|||+.|+|+|
T Consensus 254 L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 254 LDMDVEKRGSAKELLQH 270 (293)
T ss_dssp TCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99 99999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=423.08 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=207.0
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|++++.||+|+||+||+|++ +|+.||||++...... +..+.|.+|+.++++++|||||++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 36899999999999999999988 4889999999765432 23467899999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC--
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP-- 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~-- 682 (786)
||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 Ey~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 83 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred eccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999986 45689999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip----~~~L~~L 757 (786)
......+||+.|+|||++.+..+ +.++|||||||+||||+||+.||.....................+ +..+.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 23356789999999999988876 578999999999999999999997665443333333322222211 3468899
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
+.+||+ ||++|||++|+++|
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999 99999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=413.33 Aligned_cols=250 Identities=33% Similarity=0.623 Sum_probs=220.3
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+.++|+++++||+|+||+||+|++ +++.||||++....... ++|.+|+.++++++|||||+++|+|.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 457899999999999999999998 46789999998665543 67999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR 684 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~ 684 (786)
||+++|+|..++.. ....+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 79 Ey~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999988762 4467889999999999999999999999999999999999999999999999999876544322
Q ss_pred -CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 685 -DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 685 -~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+.. +.++..| +..+.+||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh-CCCCCCcccccHHHHHHHH
Confidence 234678999999999999999999999999999999998 7999999998887776654 4455554 346999999
Q ss_pred Hhhh-CCCCCCCHHHHHHHHHhh
Q 003919 760 DCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+||+ ||++|||+++|+++|.++
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 9999 999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=421.08 Aligned_cols=255 Identities=35% Similarity=0.580 Sum_probs=208.9
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEEC--Ce---eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWN--GT---DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP 598 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~--G~---~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~ 598 (786)
++..++|++.+.||+|+||+||+|.+. ++ .||||.+.... .....+.|.+|+++|++++|||||+++++|.+.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345678999999999999999999873 32 48888875433 4455678999999999999999999999999999
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRII 678 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l 678 (786)
.+++||||+++|+|.+++.. ..+.+++.+++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++.+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999998862 3457999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCCC-----CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCC--
Q 003919 679 TDSPMR-----DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIP-- 750 (786)
Q Consensus 679 ~~~~~~-----~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip-- 750 (786)
...... .....||+.|+|||.+.+..++.++|||||||+||||+| |+.||.+....++...+.. +.+++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcc
Confidence 543221 112457899999999999999999999999999999998 8999999988887776654 3444444
Q ss_pred -ChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 751 -EGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 751 -~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+..+.+|+.+||. ||.+|||+.+|++.|+++.
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3469999999999 9999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=428.57 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=220.3
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEECC-------eeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWNG-------TDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~G-------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g 592 (786)
..|+++.++|.++++||+|+||+||+|.+.+ ..||+|++..... ......|.+|+.++.++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4578888999999999999999999998732 2589998864432 33456899999999998 8999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcC--------------------CccchHHHHHHHHHHHHHHHHhhhhcceeec
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQ--------------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~--------------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHr 652 (786)
+|.+.+.+|+||||+++|+|.++++.... ...+++..++.++.||+.||+|||++|||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 99999999999999999999999974321 2358999999999999999999999999999
Q ss_pred cCCcccEEEcCCCeEEEEecCccccccCCCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 003919 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWE 729 (786)
Q Consensus 653 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~ 729 (786)
||||+|||++.++++||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543222 234568999999999999999999999999999999998 899999
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHH
Q 003919 730 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLL 779 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~ 779 (786)
+......+..+...+.+++.|. ..+.+||.+||+ ||++|||++||+++|.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8877777777777777776653 469999999999 9999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=416.15 Aligned_cols=258 Identities=28% Similarity=0.544 Sum_probs=220.5
Q ss_pred ccccCCCeeEeeE-EeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 523 WNIDFSELTVGTR-VGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 523 ~~i~~s~y~i~k~-LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
+.++.++|.+... ||+|+||+||+|.+. +..||||++... ......+.|.+|+++|++++|||||+++++|.++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 81 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 4456678888884 999999999999763 457999998654 3455678899999999999999999999998754
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.+|+||||+++|+|.+++. ..+..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 82 -~~~lvmE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -eEEEEEEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 5899999999999999875 2446799999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC--
Q 003919 678 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE-- 751 (786)
Q Consensus 678 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~-- 751 (786)
+..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+. .+.++..|.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~ 237 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 237 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcC
Confidence 754322 2234568999999999999999999999999999999998 899999988877766554 455555553
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhhhc
Q 003919 752 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCEYSL 785 (786)
Q Consensus 752 -~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~sL 785 (786)
..+.+||..||. ||++|||+.+|++.|+.+.+++
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 469999999999 9999999999999999876643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=424.10 Aligned_cols=246 Identities=28% Similarity=0.455 Sum_probs=214.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|++++.||+|+||+||+|.+ +|+.||||++..... ...+.|.+|+++|++++|||||++++++.+.+.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999988 578999999875532 345789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+++|+|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 90 y~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999998763 24579999999999999999999999999999999999999999999999999998764432233
Q ss_pred CCCCCCCcccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCC---ChHHHH
Q 003919 686 SSSAGTPEWMAPELIR-----NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIP---EGPLGR 756 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~-----~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip---~~~L~~ 756 (786)
....||+.|+|||++. +..|+.++|||||||+||||+||+.||.+.+..+....+...... ...+ +..+.+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 4678999999999984 456899999999999999999999999998888888777765432 2222 346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
||.+||+ ||.+|||+.|+++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999 99999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=412.19 Aligned_cols=255 Identities=34% Similarity=0.560 Sum_probs=209.5
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEECC------eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIWNG------TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~~G------~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
++..+.|++.+.||+|+||+||+|.+.+ ..||||++... .......+|.+|+.++++++|||||+++|++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4567889999999999999999998732 36999998644 3445567899999999999999999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.++++|||+.++++.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CceEEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999988763 446799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC--
Q 003919 678 ITDSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE-- 751 (786)
Q Consensus 678 l~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~P-F~~~~~~~~l~~i~~~~~~~~ip~-- 751 (786)
+..... ......||+.|+|||++.+..++.++|||||||+||||++|..| |......++.. ....+.+++.+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~ 238 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-AINDGFRLPTPMDC 238 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-HHHTTCCCCCCTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH-HHhccCCCCCchhh
Confidence 654322 22345689999999999999999999999999999999997555 55555555544 445555555554
Q ss_pred -hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 752 -GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 752 -~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+.+|+.+||. ||++|||+.+|++.|+++.
T Consensus 239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 469999999999 9999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=413.54 Aligned_cols=242 Identities=27% Similarity=0.477 Sum_probs=207.1
Q ss_pred eeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc----CCceEEE
Q 003919 530 LTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK----PPRLSMI 603 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~----~~~l~LV 603 (786)
|++.++||+|+||+||+|.+ +++.||+|++..........+.|.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 46778999999999999988 47789999998777777777889999999999999999999999864 3458999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcc--eeeccCCcccEEEc-CCCeEEEEecCccccccC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMK--IVHRDLKSANCLVN-KHWTVKICDFGLSRIITD 680 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~g--IIHrDLKpsNILLd-~~g~VKL~DFGLA~~l~~ 680 (786)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999997 3457999999999999999999999998 99999999999996 578999999999986543
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC---CChHHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL-EI---PEGPLGR 756 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~-~i---p~~~L~~ 756 (786)
. .....+||+.|+|||++.+ +|+.++|||||||++|||++|+.||.+......+......+..+ .. ....+.+
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 2 3346789999999999876 59999999999999999999999998776555554444443332 22 2346899
Q ss_pred HHHHhhh-CCCCCCCHHHHHHH
Q 003919 757 LIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 757 LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
||.+||. ||++|||++|+++|
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999 99999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=422.66 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=214.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|+||+||+|.+ +|+.||||++..... .....+.+.+|++++++++|||||++++++.+++.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999988 588999999975432 223357799999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCC-
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSP- 682 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~- 682 (786)
|||+++|+|.+++. ..+.+++..++.++.|++.||+|||++|||||||||+|||+++++.+||+|||+++.+....
T Consensus 87 mEy~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999887 34579999999999999999999999999999999999999999999999999998875332
Q ss_pred -CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHH
Q 003919 683 -MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIAD 760 (786)
Q Consensus 683 -~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~ 760 (786)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+.......+ .-...+.+||.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 233456899999999999999999999999999999999999999999988888887776543322 124578999999
Q ss_pred hhh-CCCCCCCHHHHHHH
Q 003919 761 CWA-EPQERPSCEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPSa~EIL~~ 777 (786)
||+ ||.+|||++|++++
T Consensus 244 ~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TSCSSGGGSTTSGGGTCH
T ss_pred HccCCHhHCcCHHHHcCC
Confidence 999 99999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-49 Score=420.35 Aligned_cols=242 Identities=29% Similarity=0.430 Sum_probs=213.5
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccC-hHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLT-AENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~-~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
.|++.+.||+|+||+||+|++ +|+.||||++...... ....+.|.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999987 5889999999766543 4456789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.+|+|..++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999999987665 3467999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCcccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHHH
Q 003919 686 SSSAGTPEWMAPELIRN---EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLIA 759 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~---~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI~ 759 (786)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.........+ +..+.+||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 45689999999999864 468999999999999999999999999998888887777655433322 347999999
Q ss_pred Hhhh-CCCCCCCHHHHHHH
Q 003919 760 DCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 760 ~CL~-DP~kRPSa~EIL~~ 777 (786)
+||+ ||.+|||+.|+++|
T Consensus 249 ~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTC
T ss_pred HHCcCChhHCcCHHHHHhC
Confidence 9999 99999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=425.38 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=210.2
Q ss_pred cccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 524 NIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 524 ~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
++..++|.+.+.||+|+||+||+|.+ +|+.||+|++.... .....+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567899999999999999999998 58899999987543 3344578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++++||+|||+|+.+.+
T Consensus 81 iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999999973 3579999999999999999999997 5899999999999999999999999999997654
Q ss_pred CCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--------------------
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAV-------------------- 740 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i-------------------- 740 (786)
. .....+||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+........
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 3 234678999999999999999999999999999999999999999765432211100
Q ss_pred ---------------------HhcCCCCCCC----ChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003919 741 ---------------------ANEGSRLEIP----EGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 781 (786)
Q Consensus 741 ---------------------~~~~~~~~ip----~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i 781 (786)
......+..+ +..+.+|+.+||. ||.+|||++|+|+| +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0011111122 2468899999999 99999999999986 5543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.22 Aligned_cols=245 Identities=26% Similarity=0.533 Sum_probs=207.8
Q ss_pred eEEeecCcEEEEEEEEC----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEeecc
Q 003919 534 TRVGIGFFGEVFRGIWN----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEYMEL 609 (786)
Q Consensus 534 k~LG~G~fG~VYkg~~~----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey~~g 609 (786)
++||+|+||+||+|.+. ++.||||++.....+....+.|.+|+.+|++++|||||+++++|.++ .+++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999762 45799999976655555668899999999999999999999999654 57899999999
Q ss_pred chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCC---CC
Q 003919 610 GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMR---DS 686 (786)
Q Consensus 610 GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~---~~ 686 (786)
|+|.+++. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+...... ..
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999987 4467999999999999999999999999999999999999999999999999999876543221 23
Q ss_pred CCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhh
Q 003919 687 SSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRLIADCW 762 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL 762 (786)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..++...+. .+.++..|. ..+.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999988877666554 455555553 47999999999
Q ss_pred h-CCCCCCCHHHHHHHHHhhhh
Q 003919 763 A-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 763 ~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
. ||.+|||+.+|++.|++..+
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHh
Confidence 9 99999999999999887654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-49 Score=420.42 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=200.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
+.|.+.+.||+|+||+||+|.+ +|+.||||++....... ..+.|.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999988 48899999997665433 24678899999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc---CCCeEEEEecCccccccCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN---KHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd---~~g~VKL~DFGLA~~l~~~~ 682 (786)
|++||+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999997 456899999999999999999999999999999999999995 57899999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC-----ChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP-----EGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip-----~~~L~~L 757 (786)
.....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+.........+ +..+.+|
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence 3346789999999999999999999999999999999999999999999888888887766544332 3468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.|+++|
T Consensus 244 i~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCHhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=407.57 Aligned_cols=256 Identities=31% Similarity=0.552 Sum_probs=209.6
Q ss_pred cccccCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc
Q 003919 522 EWNIDFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK 596 (786)
Q Consensus 522 e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~ 596 (786)
+|++..++|.+++.||+|+||+||+|++. +..||||++... ......+.|.+|+.++++++|||||++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 57888899999999999999999999873 345888887433 344556789999999999999999999999964
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
+.+|+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -CeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 568999999999999988753 44678999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---
Q 003919 677 IITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE--- 751 (786)
Q Consensus 677 ~l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~--- 751 (786)
.+..... ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++...+.. +..+++|.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~ 235 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCP 235 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCC
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCC
Confidence 7754322 2345568999999999999999999999999999999998 8999999888887776654 44444443
Q ss_pred hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 752 GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 752 ~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+.+||.+||. ||++|||+.+|+++|+++.
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 469999999999 9999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=412.77 Aligned_cols=259 Identities=33% Similarity=0.592 Sum_probs=213.9
Q ss_pred ccccccccCCCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC
Q 003919 519 AYEEWNIDFSELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP 597 (786)
Q Consensus 519 ~~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~ 597 (786)
..++|++++++|++++.||+|+||+||+|.+ +++.||||++...... .+.|.+|+.++++++|||||+++++|.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 4578899999999999999999999999988 4568999998655443 3679999999999999999999999865
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
+.+++||||+++|+|.+++... ....+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 4589999999999999888633 234699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcCCCCCCCC---h
Q 003919 678 ITDSPM-RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRP-WEGVLPERVVYAVANEGSRLEIPE---G 752 (786)
Q Consensus 678 l~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~P-F~~~~~~~~l~~i~~~~~~~~ip~---~ 752 (786)
+..... ......||+.|+|||++.+..++.++|||||||+||||+||..| |.+....+.+..+. .+.+.+.+. .
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCH
Confidence 654322 22346789999999999999999999999999999999997655 45555555555544 444444443 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
.+.+||.+||+ ||++|||+++|++.|+++..
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 69999999999 99999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=422.33 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=220.9
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+..++|.+++.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|+.+|++++|||||++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3467899999999999999999987 588999999976543 2234578899999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||++||+|..++. ....+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cceeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999999987 3457899999999999999999999999999999999999999999999999999987655
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIAD 760 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~ 760 (786)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+.......+. -+..+.+||.+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 55556788999999999999999999999999999999999999999999988888777765433321 23468999999
Q ss_pred hhh-CCCCCCC-----HHHHHHH
Q 003919 761 CWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 761 CL~-DP~kRPS-----a~EIL~~ 777 (786)
||+ ||.+|++ ++++++|
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hccCCchhhcccccccHHHHHcC
Confidence 999 9999994 8899875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=411.27 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=216.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcCCCceeEEecccccCCceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~ 601 (786)
+.|.+++.||+|+||+||+|.+ +|+.||||++.+..... ...+.|.+|+.+|++++|||||++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999998 48899999997654422 23578999999999999999999999999999999
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC----eEEEEecCcccc
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW----TVKICDFGLSRI 677 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g----~VKL~DFGLA~~ 677 (786)
+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999973 35799999999999999999999999999999999999998776 599999999988
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 752 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~ 752 (786)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+....+......... .+.
T Consensus 167 ~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 75432 345678999999999999999999999999999999999999999999988888877765543321 234
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.+.+||.+||. ||.+|||++|+++|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 68899999999 99999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=406.19 Aligned_cols=252 Identities=29% Similarity=0.576 Sum_probs=213.5
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCceE
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLS 601 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~l~ 601 (786)
|++..++|++++.||+|+||.||+|.++|+.||||++.... ..+.|.+|+.++++++|||||+++|+|.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 78889999999999999999999999999999999986432 24679999999999999999999999855 46689
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999999999633 2346899999999999999999999999999999999999999999999999999876442
Q ss_pred CCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHHHHH
Q 003919 682 PMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPLGRL 757 (786)
Q Consensus 682 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L~~L 757 (786)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+ ..+.+++++. ..+.+|
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCCCTTCCHHHHHH
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHH
Confidence 234578899999999999999999999999999999998 68889888777776665 4455555554 479999
Q ss_pred HHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 758 IADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
+.+||. ||.+|||+.+|+++|+++..
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 999999 99999999999999998865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-48 Score=420.82 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=217.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
.++|.+++.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999988 58999999986543 334578999999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC--CCeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK--HWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~--~g~VKL~DFGLA~~l~~~~ 682 (786)
||++||+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+++.+....
T Consensus 103 E~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999998852 3457999999999999999999999999999999999999964 5789999999998875432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+......... -+..+.+|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234568999999999999999999999999999999999999999999988888887766554432 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.|+|+|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-48 Score=413.14 Aligned_cols=245 Identities=24% Similarity=0.441 Sum_probs=217.4
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.++++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999987 488999999975433 223357899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+.||+|..++. ....+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+++.....
T Consensus 83 mE~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999999887 4557888999999999999999999999999999999999999999999999999887543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.......+ .-+..+.+++.+||
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999999999999999888888776554332 22457999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003919 763 A-EPQERP-----SCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRP-----Sa~EIL~~ 777 (786)
. ||.+|+ |+++|++|
T Consensus 237 ~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccchhhHHHHHcC
Confidence 9 999996 89999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-47 Score=399.81 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=213.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCC----ce
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RL 600 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~----~l 600 (786)
++|.+.+.||+|+||+||+|.+ +|+.||||++..... +....+.|.+|+++++.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999987 589999999976554 3455678999999999999999999999987654 38
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||++|++|.+++. ..+.+++.+++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 99999999999999886 345799999999999999999999999999999999999999999999999999876543
Q ss_pred CC---CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CCh
Q 003919 681 SP---MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEG 752 (786)
Q Consensus 681 ~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~ 752 (786)
.. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+....+......+.. -+.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 22 2334568999999999999999999999999999999999999999999988888877766554321 134
Q ss_pred HHHHHHHHhhh-CCCCCC-CHHHHHHHHHhhhh
Q 003919 753 PLGRLIADCWA-EPQERP-SCEEILSRLLDCEY 783 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRP-Sa~EIL~~L~~i~~ 783 (786)
.+.+||.+||. ||.+|| |++++++.|.++.+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 69999999999 999999 89999999988753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=405.83 Aligned_cols=263 Identities=32% Similarity=0.576 Sum_probs=214.3
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEe
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFL 591 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~ 591 (786)
..+|+++.++|.++++||+|+||+||+|.+. ++.||||++.... .....+.|.+|+.++.++ +|+|||.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3578888899999999999999999999862 3679999986443 344467888999888887 689999999
Q ss_pred cccccC-CceEEEEEeeccchhHHHHHhhcC-------------CccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 592 GACTKP-PRLSMITEYMELGSLYHLIHLSGQ-------------KKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 592 g~~~~~-~~l~LV~Ey~~gGSL~dlL~~~~~-------------~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+++... ..++++|||+++|+|.+++..... ...+++.+++.++.||+.||+|||++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 568999999999999999974321 235899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~-~PF~~~~~~ 734 (786)
||||+.++++||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||.+....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987644322 234567999999999999999999999999999999999974 588877666
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 735 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
..+......+.++..|+ ..+.+|+.+||. ||.+|||+.||+++|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 66666666666666654 469999999999 99999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-48 Score=419.08 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=217.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+++|++.+.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999988 58899999987543 233567889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEc--CCCeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVN--KHWTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd--~~g~VKL~DFGLA~~l~~~~ 682 (786)
||++||+|.+.+. .....+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||++..+....
T Consensus 106 E~~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 106 EFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp ECCCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EcCCCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999999998775 2345799999999999999999999999999999999999998 67899999999998876532
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+.......+......... -+..+.+|
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 234568999999999999999999999999999999999999999999998888887765544332 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.|+|+|
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=405.98 Aligned_cols=260 Identities=32% Similarity=0.556 Sum_probs=222.0
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecc
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGA 593 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~ 593 (786)
.+|++..++|.+.+.||+|+||+||+|++. ++.||||++... ......++|.+|+++|++++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 456777889999999999999999999874 368999998643 344556789999999999999999999999
Q ss_pred cccCCceEEEEEeeccchhHHHHHhhc---------------------CCccchHHHHHHHHHHHHHHHHhhhhcceeec
Q 003919 594 CTKPPRLSMITEYMELGSLYHLIHLSG---------------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHR 652 (786)
Q Consensus 594 ~~~~~~l~LV~Ey~~gGSL~dlL~~~~---------------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHr 652 (786)
|.+.+..+++|||+.+|+|.+++.... ....+++..++.|+.||+.||+|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999986422 12348899999999999999999999999999
Q ss_pred cCCcccEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 003919 653 DLKSANCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWE 729 (786)
Q Consensus 653 DLKpsNILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~-~PF~ 729 (786)
||||+||||+.++.+||+|||+++.+..... ......||+.|+|||.+.+..|+.++|||||||++|||++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987643322 223567889999999999999999999999999999999996 5888
Q ss_pred CCChHHHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 730 GVLPERVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 730 ~~~~~~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
+.+..+....+.. +..+.+|. ..+.+|+.+||+ ||.+||||.||++.|+++.
T Consensus 245 ~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8888887776654 44555553 469999999999 9999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=403.65 Aligned_cols=253 Identities=29% Similarity=0.550 Sum_probs=210.6
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEEC-----CeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCc
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIWN-----GTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPR 599 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~~-----G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~ 599 (786)
+.++|++.+.||+|+||+||+|.++ +..||||++..... .....++|.+|+.+|++++|||||+++|+|.++ .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence 4578999999999999999999762 23689999866544 334467899999999999999999999999764 6
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+++||||+++|++.+.+.. ....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 85 ~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred hheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8899999999999988763 34579999999999999999999999999999999999999999999999999999875
Q ss_pred CCCC---CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---h
Q 003919 680 DSPM---RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---G 752 (786)
Q Consensus 680 ~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~---~ 752 (786)
.... ......|++.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+...+.+++.+. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence 4322 1234467889999999999999999999999999999998 8999999999999988888877776654 4
Q ss_pred HHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 753 PLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 753 ~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
.+.+|+..||. ||++|||+.+|++.|++.
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 79999999999 999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-47 Score=398.73 Aligned_cols=247 Identities=25% Similarity=0.414 Sum_probs=217.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-------HHHHHHHHHHHHHhhcC-CCceeEEeccccc
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-------ENMEDFCNEISILSRLR-HPNVILFLGACTK 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-------~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~ 596 (786)
+++|.+.+.||+|+||+||+|++ +|+.||||++....... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999988 68999999997665321 22457889999999997 9999999999999
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
++.+|+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999973 4579999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRN------EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP 750 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip 750 (786)
.+.... ......||+.|+|||.+.+ ..++.++||||+||+||+|++|+.||.+.+.......+.........+
T Consensus 159 ~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 876533 3456789999999999853 457889999999999999999999999999888888777765544332
Q ss_pred -----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 -----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 -----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+|+.+||+ ||.+|||++|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 3468999999999 99999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-47 Score=414.65 Aligned_cols=245 Identities=21% Similarity=0.359 Sum_probs=216.9
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
.++|.+++.||+|+||+||+|.+ +|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999988 588999999865432 223357899999999999999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+.+|+|..++.. .+.+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++.+...
T Consensus 120 ~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999998873 357999999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-CChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-PEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-p~~~L~~LI~~CL 762 (786)
.....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.......+. -+..+.+||.+||
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 34578999999999999999999999999999999999999999999888888877765543322 2457999999999
Q ss_pred h-CCCCCC-----CHHHHHHH
Q 003919 763 A-EPQERP-----SCEEILSR 777 (786)
Q Consensus 763 ~-DP~kRP-----Sa~EIL~~ 777 (786)
. ||.+|+ |+++|++|
T Consensus 274 ~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTS
T ss_pred hhCHHhccccccccHHHHHcC
Confidence 9 999994 89999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=403.18 Aligned_cols=251 Identities=27% Similarity=0.545 Sum_probs=209.1
Q ss_pred CCCeeEeeEEeecCcEEEEEEEEC--Ce----eEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIWN--GT----DVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~~--G~----~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
.++|+++++||+|+||+||+|.+. |+ +||+|.+.... .....++|.+|+.++++++|||||+++++|.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 367999999999999999999873 33 58888875433 233467899999999999999999999999875 57
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
++++||+.+|+|.+.+.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++.+..
T Consensus 86 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 888999999999988763 456799999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC--CCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---hHH
Q 003919 681 SPMR--DSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPERVVYAVANEGSRLEIPE---GPL 754 (786)
Q Consensus 681 ~~~~--~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~~~l~~i~~~~~~~~ip~---~~L 754 (786)
.... .....||+.|+|||++.++.|+.++|||||||+||||+| |..||.+.+..++...+ ..+.+++.|. ..+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHH
Confidence 3322 234568999999999999999999999999999999998 78899888776665544 4455555553 469
Q ss_pred HHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 755 GRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 755 ~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+|+.+||. ||.+|||+.+|+++|..+.
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 999999999 9999999999999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=409.38 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=216.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEecccc-ChHHHHHHHHHHHHHh-hcCCCceeEEecccccCCceEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDL-TAENMEDFCNEISILS-RLRHPNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~-~~~~~~~f~~EI~iL~-~L~HPNIVkL~g~~~~~~~l~LV 603 (786)
++|.+++.||+|+||+||+|++ +|+.||||++.+... .....+.+..|+.++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999998 689999999975432 2233466778887765 68999999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM 683 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~ 683 (786)
|||+++|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999997 345789999999999999999999999999999999999999999999999999988765555
Q ss_pred CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC-CCChHHHHHHHHhh
Q 003919 684 RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE-IPEGPLGRLIADCW 762 (786)
Q Consensus 684 ~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~-ip~~~L~~LI~~CL 762 (786)
......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+...+...+.......+ .-+..+.+||.+||
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 56677899999999999999999999999999999999999999999998888887765544332 12457999999999
Q ss_pred h-CCCCCCCHH-HHHHH
Q 003919 763 A-EPQERPSCE-EILSR 777 (786)
Q Consensus 763 ~-DP~kRPSa~-EIL~~ 777 (786)
. ||.+||++. ++++|
T Consensus 239 ~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CSSGGGSBTTBSCGGGS
T ss_pred ccCCCCCcCHHHHHHhC
Confidence 9 999999995 77653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=399.46 Aligned_cols=261 Identities=29% Similarity=0.537 Sum_probs=225.2
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEE-------CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEec
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIW-------NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLG 592 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~-------~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g 592 (786)
..|++..++|.++++||+|+||.||+|++ .++.||||++.... .......|.+|+.+++.+ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 46888889999999999999999999976 24689999987544 344567899999999999 6999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhc---------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSG---------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~---------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+|.+...++++|||+++|+|.+++.... ....+++..++.++.||+.||+|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999987432 2236899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999988754322 2234578999999999999999999999999999999998 56667777776
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 735 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..+..+...+.++..+. ..+.+||.+||+ ||.+|||+.+|++.|++..
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 77777777777666653 479999999999 9999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=398.28 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=210.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|.++++||+|+||+||+|++ +|+.||||++..........+.+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999998 48899999997655444445789999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
|+.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 998765554433 245679999999999999999999999999999999999999999999999999998876655555
Q ss_pred CCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC----------------
Q 003919 686 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE---------------- 748 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~---------------- 748 (786)
....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+.......+......+.
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 6678999999999887765 57899999999999999999999999888777766543211100
Q ss_pred C--------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhh
Q 003919 749 I--------------PEGPLGRLIADCWA-EPQERPSCEEILSR--LLDC 781 (786)
Q Consensus 749 i--------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i 781 (786)
. -+..+.+|+.+||. ||++|||+.|+++| ++++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 02357889999999 99999999999987 5544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=399.18 Aligned_cols=243 Identities=23% Similarity=0.247 Sum_probs=203.9
Q ss_pred EeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh---HHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 532 VGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA---ENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~---~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
.+++||+|+||+||+|.+ +|+.||||++....... ...+.+.+|+.++++++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999987 58899999986544322 1235788999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+.++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99988877664 556799999999999999999999999999999999999999999999999999988766555556
Q ss_pred CCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003919 687 SSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 747 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------ 747 (786)
..+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+....+.+..+......+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999865 468999999999999999999999999988887776665321100
Q ss_pred ---C--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ---E--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ---~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ..+..+.+|+.+||+ ||++|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 012358889999999 99999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=406.04 Aligned_cols=245 Identities=21% Similarity=0.314 Sum_probs=215.2
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMIT 604 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~ 604 (786)
+++|.+++.||+|+||+||+|.+ +|+.||||++.... .....+.+|+++|+.++|||||++++++.+.+.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 68899999999999999999988 58899999996543 23356889999999999999999999999999999999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCC--CeEEEEecCccccccCCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKH--WTVKICDFGLSRIITDSP 682 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~--g~VKL~DFGLA~~l~~~~ 682 (786)
||++||+|.+++.. ....+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999999862 33479999999999999999999999999999999999999854 489999999998765432
Q ss_pred CCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC-----CChHHHHH
Q 003919 683 MRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-----PEGPLGRL 757 (786)
Q Consensus 683 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-----p~~~L~~L 757 (786)
......+|+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+.......+......++. -+..+.+|
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 234567899999999999999999999999999999999999999999998888888766544432 13468999
Q ss_pred HHHhhh-CCCCCCCHHHHHHH
Q 003919 758 IADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 758 I~~CL~-DP~kRPSa~EIL~~ 777 (786)
|.+||. ||.+|||+.|+++|
T Consensus 238 i~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999 99999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=397.40 Aligned_cols=260 Identities=30% Similarity=0.568 Sum_probs=219.2
Q ss_pred ccccccCCCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEE
Q 003919 521 EEWNIDFSELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILF 590 (786)
Q Consensus 521 ~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL 590 (786)
..|.+..++|.+++.||+|+||.||+|.+. +..||||++... .......++.+|+..+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 348888999999999999999999999762 246999998654 3445568899999999888 79999999
Q ss_pred ecccccCCceEEEEEeeccchhHHHHHhhc-------------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcc
Q 003919 591 LGACTKPPRLSMITEYMELGSLYHLIHLSG-------------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSA 657 (786)
Q Consensus 591 ~g~~~~~~~l~LV~Ey~~gGSL~dlL~~~~-------------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKps 657 (786)
+++|.+++.+++||||+.+|+|.+++.... ....+++.+++.++.||+.||+|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 999999999999999999999999996432 1346899999999999999999999999999999999
Q ss_pred cEEEcCCCeEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 003919 658 NCLVNKHWTVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCT-LNRPWEGVLPE 734 (786)
Q Consensus 658 NILLd~~g~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlT-G~~PF~~~~~~ 734 (786)
|||++.++.+||+|||+++....... ......+|+.|+|||.+.++.|+.++|||||||++|||++ |+.||.+.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999988754432 2234678999999999999999999999999999999998 68899888887
Q ss_pred HHHHHHHhcCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 735 RVVYAVANEGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 735 ~~l~~i~~~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
.+...+ ..+..+..|. ..+.+||.+||+ ||++|||+.||++.|+++.
T Consensus 245 ~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 665544 4455665553 469999999999 9999999999999998874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=398.80 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=224.4
Q ss_pred cccccccCCCeeEeeEEeecCcEEEEEEEEC-------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEec
Q 003919 520 YEEWNIDFSELTVGTRVGIGFFGEVFRGIWN-------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLG 592 (786)
Q Consensus 520 ~~e~~i~~s~y~i~k~LG~G~fG~VYkg~~~-------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g 592 (786)
.++|+++.++|.++++||+|+||+||+|.+. ++.||||++.... .......|.+|++++++++|||||++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 4679999999999999999999999999764 4689999986543 4455678999999999999999999999
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhc-------CCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSG-------QKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW 665 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~-------~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g 665 (786)
+|...+..++||||+.+|+|.+++.... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 9999999999999999999999886432 123468899999999999999999999999999999999999999
Q ss_pred eEEEEecCccccccCCCC--CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 003919 666 TVKICDFGLSRIITDSPM--RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTL-NRPWEGVLPERVVYAVAN 742 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~~--~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG-~~PF~~~~~~~~l~~i~~ 742 (786)
++||+|||+++.+..... ......||+.|+|||.+.+..++.++|||||||+||||+|| +.||.+.+..+....+..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999987644322 22345689999999999999999999999999999999998 578888888888776654
Q ss_pred cCCCCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 743 EGSRLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 743 ~~~~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
+..++.|. ..+.+||.+||+ ||++|||+.+|+++|++.
T Consensus 251 -~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 -GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 44454443 469999999999 999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=398.98 Aligned_cols=255 Identities=32% Similarity=0.591 Sum_probs=212.8
Q ss_pred ccCCCeeEeeEEeecCcEEEEEEEE--CCe--eEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEecccccCCc
Q 003919 525 IDFSELTVGTRVGIGFFGEVFRGIW--NGT--DVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTKPPR 599 (786)
Q Consensus 525 i~~s~y~i~k~LG~G~fG~VYkg~~--~G~--~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~~~~ 599 (786)
+++++|++.++||+|+||+||+|.+ +|. .||||.+.... .....+.|.+|+++|+++ +|||||+++++|.+.+.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 4568999999999999999999987 454 46777765332 233457899999999999 69999999999999999
Q ss_pred eEEEEEeeccchhHHHHHhh-------------cCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCe
Q 003919 600 LSMITEYMELGSLYHLIHLS-------------GQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWT 666 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~-------------~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~ 666 (786)
+++||||+++|+|.++++.. .....+++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999998633 23467899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcCC
Q 003919 667 VKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLN-RPWEGVLPERVVYAVANEGS 745 (786)
Q Consensus 667 VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~-~PF~~~~~~~~l~~i~~~~~ 745 (786)
+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.+.+..++...+. .+.
T Consensus 166 ~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 243 (309)
T ss_dssp EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTC
T ss_pred eEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcC
Confidence 999999999865432 2223557899999999999999999999999999999999975 5788888777766654 445
Q ss_pred CCCCCC---hHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 746 RLEIPE---GPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 746 ~~~ip~---~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
++..+. ..+.+||.+||. ||++|||+.+|+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 555553 479999999999 9999999999999998865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-46 Score=390.56 Aligned_cols=247 Identities=21% Similarity=0.286 Sum_probs=208.3
Q ss_pred CCeeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEEe
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
++|.+.++||+|+||+||+|++ +|+.||||++..........+.|.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999988 578999999976655444467899999999999999999999999999999999999
Q ss_pred eccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCCC
Q 003919 607 MELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRDS 686 (786)
Q Consensus 607 ~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~~ 686 (786)
+.++.+..+.. ..+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99888877765 457899999999999999999999999999999999999999999999999999988766555555
Q ss_pred CCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------
Q 003919 687 SSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------------------ 747 (786)
Q Consensus 687 ~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------------------ 747 (786)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 66799999999998754 57999999999999999999999999988777766654311110
Q ss_pred ------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 ------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 ------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+|+.+||+ ||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012357899999999 99999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-46 Score=406.43 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=203.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh-HHHHHHH---HHHHHHhhcCCCceeEEecccccCCce
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA-ENMEDFC---NEISILSRLRHPNVILFLGACTKPPRL 600 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~-~~~~~f~---~EI~iL~~L~HPNIVkL~g~~~~~~~l 600 (786)
.++|.+.+.||+|+||+||+|++ +|+.||||++....... .....+. .|+.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 57899999999999999999988 58899999986543321 1122334 446777778899999999999999999
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccC
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITD 680 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~ 680 (786)
|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999973 45788999999999999999999999999999999999999999999999999987755
Q ss_pred CCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCC---ChHHH
Q 003919 681 SPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVA-NEGSRLEIP---EGPLG 755 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~-~~~~~~~ip---~~~L~ 755 (786)
. .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||.+........... ........+ +..+.
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 3 3346789999999999964 568999999999999999999999998765433222111 112222233 34699
Q ss_pred HHHHHhhh-CCCCCCC-----HHHHHHH
Q 003919 756 RLIADCWA-EPQERPS-----CEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPS-----a~EIL~~ 777 (786)
+||.+||. ||.+||| ++++++|
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 99999999 9999999 7999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=392.32 Aligned_cols=250 Identities=29% Similarity=0.526 Sum_probs=206.2
Q ss_pred EeeEEeecCcEEEEEEEEC---C--eeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc-CCceEEEEE
Q 003919 532 VGTRVGIGFFGEVFRGIWN---G--TDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-PPRLSMITE 605 (786)
Q Consensus 532 i~k~LG~G~fG~VYkg~~~---G--~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-~~~l~LV~E 605 (786)
..++||+|+||+||+|.+. + ..||||++.. .......++|.+|+++|++++|||||+++|++.+ ++.+++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3678999999999999872 2 2589999864 3345667899999999999999999999999865 467999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCC--
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPM-- 683 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~-- 683 (786)
|+++|+|.+++. .....+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999886 3455678888999999999999999999999999999999999999999999999987654322
Q ss_pred --CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCC---ChHHHHHH
Q 003919 684 --RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEIP---EGPLGRLI 758 (786)
Q Consensus 684 --~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~ip---~~~L~~LI 758 (786)
......||+.|+|||.+....++.++||||||++||||+||+.||........+......+.++..| +..+.+||
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHH
Confidence 2233568999999999999999999999999999999999888776544333333333445555555 34799999
Q ss_pred HHhhh-CCCCCCCHHHHHHHHHhhhhh
Q 003919 759 ADCWA-EPQERPSCEEILSRLLDCEYS 784 (786)
Q Consensus 759 ~~CL~-DP~kRPSa~EIL~~L~~i~~s 784 (786)
.+||. ||++||++.||+++|+.+..+
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 99999 999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=390.45 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=208.7
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC---CeeEEEEEEeccccChHHHHHHHHHHHHHhhc---CCCceeEEecccc-----c
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN---GTDVAIKVFLEQDLTAENMEDFCNEISILSRL---RHPNVILFLGACT-----K 596 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~---G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L---~HPNIVkL~g~~~-----~ 596 (786)
++|.++++||+|+||+||+|++. ++.||||++............+.+|+.+|+.| +|||||+++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999873 56799999876554433334567888887766 7999999999985 3
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+++++||+.++.+..... .....+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 356899999999888765544 345678999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------
Q 003919 677 IITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL--------- 747 (786)
Q Consensus 677 ~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~--------- 747 (786)
..... .......||+.|+|||++.+.+|+.++|||||||++|||++|+.||.+.+....+..+......+
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65433 23456789999999999999999999999999999999999999999998877776654321100
Q ss_pred -------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH--HHhhhh
Q 003919 748 -------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR--LLDCEY 783 (786)
Q Consensus 748 -------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~--L~~i~~ 783 (786)
...+..+.+||.+||+ ||++|||+.|+|+| +++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0012357889999999 99999999999987 665543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=397.61 Aligned_cols=242 Identities=22% Similarity=0.395 Sum_probs=198.8
Q ss_pred CCCeeEee-EEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhc-CCCceeEEeccccc----CC
Q 003919 527 FSELTVGT-RVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRL-RHPNVILFLGACTK----PP 598 (786)
Q Consensus 527 ~s~y~i~k-~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L-~HPNIVkL~g~~~~----~~ 598 (786)
.++|.+.. .||+|+||+||+|.+ +|+.||||++... ..+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36898875 599999999999987 5889999998532 4577899987655 89999999999865 45
Q ss_pred ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCcc
Q 003919 599 RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLS 675 (786)
Q Consensus 599 ~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA 675 (786)
.+|+|||||+||+|.+++... ....+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 689999999999999999732 2457999999999999999999999999999999999999985 567999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCC---
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGS--RLEIP--- 750 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~--~~~ip--- 750 (786)
+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+.......+..... ....|
T Consensus 162 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 162 KETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp EECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 8876543 34567899999999999999999999999999999999999999987665444443332221 11222
Q ss_pred ----ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 751 ----EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 751 ----~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+..+.+||.+||+ ||.+|||+.|+++|
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2358899999999 99999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=388.48 Aligned_cols=239 Identities=25% Similarity=0.413 Sum_probs=200.2
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccCh----HHHHHHHHHHHHHhhcC--CCceeEEecccccCCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTA----ENMEDFCNEISILSRLR--HPNVILFLGACTKPPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~----~~~~~f~~EI~iL~~L~--HPNIVkL~g~~~~~~~ 599 (786)
++|.+++.||+|+||+||+|.+ +|+.||||++....... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999988 58899999987654321 11244678999999997 8999999999999999
Q ss_pred eEEEEEeecc-chhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-CCeEEEEecCcccc
Q 003919 600 LSMITEYMEL-GSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-HWTVKICDFGLSRI 677 (786)
Q Consensus 600 l~LV~Ey~~g-GSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-~g~VKL~DFGLA~~ 677 (786)
+|+||||+.+ +++.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999975 57777776 3457999999999999999999999999999999999999985 57999999999987
Q ss_pred ccCCCCCCCCCCCCCcccCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCCChHHH
Q 003919 678 ITDSPMRDSSSAGTPEWMAPELIRNEPF-TEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR-LEIPEGPLG 755 (786)
Q Consensus 678 l~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~-~~ip~~~L~ 755 (786)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.+.. .+...... ...-+..+.
T Consensus 161 ~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred cccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 6543 3356789999999999987765 577999999999999999999997632 12222221 122245799
Q ss_pred HHHHHhhh-CCCCCCCHHHHHHH
Q 003919 756 RLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 756 ~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
+||.+||. ||.+|||++|+++|
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999 99999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=386.16 Aligned_cols=247 Identities=28% Similarity=0.487 Sum_probs=199.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHH--HHHHHhhcCCCceeEEecccccCC----ceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCN--EISILSRLRHPNVILFLGACTKPP----RLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~--EI~iL~~L~HPNIVkL~g~~~~~~----~l~ 601 (786)
.+|.+.++||+|+||+||+|+++|+.||||++.... .+.+.. |+..+.+++|||||+++++|.+.+ .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 468899999999999999999999999999985432 234444 445556789999999999997653 589
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh--------cceeeccCCcccEEEcCCCeEEEEecC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR--------MKIVHRDLKSANCLVNKHWTVKICDFG 673 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs--------~gIIHrDLKpsNILLd~~g~VKL~DFG 673 (786)
+||||+++|+|.++++. ..+++..++.++.|++.||+|||+ +|||||||||+||||+.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999973 368999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCCC----CCCCCCCCCcccCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCC-------------
Q 003919 674 LSRIITDSPM----RDSSSAGTPEWMAPELIRNEP------FTEKCDIFSLGVIMWELCTLNRPWEG------------- 730 (786)
Q Consensus 674 LA~~l~~~~~----~~~~~~GT~~Y~APEvl~~~~------~s~ksDVWSLGvIL~ELlTG~~PF~~------------- 730 (786)
+++....... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9988754322 233568999999999987642 57789999999999999999877632
Q ss_pred --CChHHHHHHHHhcCCCCCCCCh--------HHHHHHHHhhh-CCCCCCCHHHHHHHHHhhhh
Q 003919 731 --VLPERVVYAVANEGSRLEIPEG--------PLGRLIADCWA-EPQERPSCEEILSRLLDCEY 783 (786)
Q Consensus 731 --~~~~~~l~~i~~~~~~~~ip~~--------~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~~ 783 (786)
...............++.++.. .+.+|+.+||+ ||.+|||+.||+++|+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1233344444444555555432 37899999999 99999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=372.10 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=210.8
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCCceEEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPPRLSMITE 605 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~~l~LV~E 605 (786)
++|+++++||+|+||+||+|++ +|+.||||++..........+++.+|+.+|+.++|||||++++++.+...++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999998 57889999997776666667899999999999999999999999999999999999
Q ss_pred eeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCCCCCC
Q 003919 606 YMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDSPMRD 685 (786)
Q Consensus 606 y~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~~~~~ 685 (786)
++.+++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999988876 45678899999999999999999999999999999999999999999999999999886655555
Q ss_pred CCCCCCCcccCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCC---------------
Q 003919 686 SSSAGTPEWMAPELIRNEP-FTEKCDIFSLGVIMWELCTLNRPWE-GVLPERVVYAVANEGSRLE--------------- 748 (786)
Q Consensus 686 ~~~~GT~~Y~APEvl~~~~-~s~ksDVWSLGvIL~ELlTG~~PF~-~~~~~~~l~~i~~~~~~~~--------------- 748 (786)
....+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+....+......+.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 5667888999999987665 6899999999999999999999864 4454444444332111100
Q ss_pred ------------C---CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 ------------I---PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 ------------i---p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. -+..+.+|+.+||+ ||.+|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 02257789999999 99999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=379.72 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=202.6
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc--------
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK-------- 596 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~-------- 596 (786)
.++|+++++||+|+||+||+|++ +|+.||||++..........+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999998 58899999987665555556788999999999999999999998754
Q ss_pred CCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccc
Q 003919 597 PPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSR 676 (786)
Q Consensus 597 ~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~ 676 (786)
...+|++|||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 346899999999887765543 45678899999999999999999999999999999999999999999999999998
Q ss_pred cccCCC----CCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--
Q 003919 677 IITDSP----MRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLEI-- 749 (786)
Q Consensus 677 ~l~~~~----~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~i-- 749 (786)
.+.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 765322 122345799999999998765 6899999999999999999999999988877766555432111100
Q ss_pred -------------------------------CChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 750 -------------------------------PEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 750 -------------------------------p~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
....+.+||.+||+ ||++|||++|+|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 01235679999999 99999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=383.19 Aligned_cols=242 Identities=23% Similarity=0.280 Sum_probs=201.1
Q ss_pred CeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc------CCce
Q 003919 529 ELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPRL 600 (786)
Q Consensus 529 ~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~------~~~l 600 (786)
+|+..++||+|+||+||+|++ +|+.||||++...... +.+|+++|++++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999998 5889999999755432 3479999999999999999999843 3347
Q ss_pred EEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCcccccc
Q 003919 601 SMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIIT 679 (786)
Q Consensus 601 ~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~ 679 (786)
++||||++++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999999876666655444667899999999999999999999999999999999999999775 89999999998775
Q ss_pred CCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------ 746 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~------------ 746 (786)
... ......||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...+....+..+......
T Consensus 175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred CCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 433 3346789999999998865 56899999999999999999999999988877766655421000
Q ss_pred ---C---------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ---L---------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ---~---------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. ...+..+.+|+.+||. ||.+|||+.|+|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0113358899999999 99999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=382.73 Aligned_cols=246 Identities=27% Similarity=0.351 Sum_probs=202.3
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC--
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP-- 598 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~-- 598 (786)
|++ .++|.++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+++|+.++|||||+++++|...+
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 444 47899999999999999999998 4899999999876666667789999999999999999999999987654
Q ss_pred ----ceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCc
Q 003919 599 ----RLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGL 674 (786)
Q Consensus 599 ----~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGL 674 (786)
.+|+||||+ +.+|..+.+ ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 479999999 567777664 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCcccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Q 003919 675 SRIITDSPMRDSSSAGTPEWMAPELIRN-EPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL------ 747 (786)
Q Consensus 675 A~~l~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~------ 747 (786)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 9877543 346789999999999876 457899999999999999999999999887666554433211110
Q ss_pred --------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
...+..+.+||.+||. ||.+|||+.|+|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0112357889999999 99999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=377.17 Aligned_cols=245 Identities=27% Similarity=0.344 Sum_probs=199.4
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccCC----ceE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKPP----RLS 601 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~~----~l~ 601 (786)
++|.+++.||+|+||+||+|++ +|+.||||++.... .....+.+.+|+.+|++++|||||++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5799999999999999999988 58999999986543 3455678999999999999999999999986543 245
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCccccccCC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIITDS 681 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~~~ 681 (786)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||++++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 55667789999999862 36999999999999999999999999999999999999999999999999999876433
Q ss_pred CC---CCCCCCCCCcccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------
Q 003919 682 PM---RDSSSAGTPEWMAPELIR-NEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRL---------- 747 (786)
Q Consensus 682 ~~---~~~~~~GT~~Y~APEvl~-~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~---------- 747 (786)
.. .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+................+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 21 234567999999999984 4567899999999999999999999998877655544433211000
Q ss_pred --------------C--------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 748 --------------E--------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 748 --------------~--------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
. .-+..+.+|+.+||. ||.+|||+.|+|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 012357899999999 99999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-42 Score=362.91 Aligned_cols=247 Identities=19% Similarity=0.261 Sum_probs=194.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCce-eEEecccccCCceEEEE
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNV-ILFLGACTKPPRLSMIT 604 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNI-VkL~g~~~~~~~l~LV~ 604 (786)
++|++++.||+|+||+||+|.+ +|+.||||++...... +++..|+++++.++|+|+ +.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999988 4889999998754432 357889999999987665 45556667778899999
Q ss_pred EeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC---CCeEEEEecCccccccCC
Q 003919 605 EYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK---HWTVKICDFGLSRIITDS 681 (786)
Q Consensus 605 Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~---~g~VKL~DFGLA~~l~~~ 681 (786)
||+.+ +|.+.+.. ....+++..++.++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+.+...
T Consensus 83 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99965 45444432 4567999999999999999999999999999999999999863 557999999999987543
Q ss_pred CC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---cCCCC----
Q 003919 682 PM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVAN---EGSRL---- 747 (786)
Q Consensus 682 ~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~---~~~~~---- 747 (786)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 22356799999999999999999999999999999999999999987655443322211 11001
Q ss_pred --CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhh
Q 003919 748 --EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDC 781 (786)
Q Consensus 748 --~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i 781 (786)
..-+..+.+|+..||. ||.+||++.+|.+.|+++
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1123568999999999 999999999998888765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=375.57 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=205.3
Q ss_pred ccccCCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEecccccC---
Q 003919 523 WNIDFSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTKP--- 597 (786)
Q Consensus 523 ~~i~~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~~--- 597 (786)
|++ .++|.+.++||+|+||+||+|++ +|+.||||++..........+.+.+|+++|++++|||||++++++...
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 444 37899999999999999999987 589999999987766666778899999999999999999999988532
Q ss_pred --CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcc
Q 003919 598 --PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLS 675 (786)
Q Consensus 598 --~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA 675 (786)
...+++++|+.+|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ccCceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 34567778888999999985 346999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Q 003919 676 RIITDSPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSRLE------ 748 (786)
Q Consensus 676 ~~l~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~~~------ 748 (786)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 76543 33467789999999987665 468999999999999999999999998887766665543221110
Q ss_pred --------------------------CCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 749 --------------------------IPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 749 --------------------------ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
-.+..+.+||.+||. ||.+|||+.|+|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 012357889999999 99999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=374.69 Aligned_cols=243 Identities=24% Similarity=0.307 Sum_probs=195.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCceeEEeccccc------CCc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVILFLGACTK------PPR 599 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIVkL~g~~~~------~~~ 599 (786)
++|+++++||+|+||+||+|.+ +|+.||||++..........+.+.+|+.++++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999998 48999999998777677777889999999999999999999999853 367
Q ss_pred eEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccccc
Q 003919 600 LSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRIIT 679 (786)
Q Consensus 600 l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~l~ 679 (786)
+|+||||+.++.+..+ . ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 8999999987665543 2 358899999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-------------
Q 003919 680 DSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANEGSR------------- 746 (786)
Q Consensus 680 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~~~~------------- 746 (786)
.. ......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 249 (355)
T d2b1pa1 171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred cc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence 43 2345668999999999999999999999999999999999999999988766655444321110
Q ss_pred ---------CC------------CC---------ChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 747 ---------LE------------IP---------EGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 747 ---------~~------------ip---------~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. .+ ...+.+||.+||. ||++|||++|+|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 1246789999999 99999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.8e-42 Score=366.24 Aligned_cols=239 Identities=20% Similarity=0.314 Sum_probs=195.3
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEeccccc--CCceE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTK--PPRLS 601 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~--~~~l~ 601 (786)
.++|+++++||+|+||+||+|++ +|+.||||++.... .+++.+|+++|+.++ ||||+++++++.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 36899999999999999999998 58999999986432 367889999999996 9999999999864 45699
Q ss_pred EEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCC-eEEEEecCccccccC
Q 003919 602 MITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHW-TVKICDFGLSRIITD 680 (786)
Q Consensus 602 LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g-~VKL~DFGLA~~l~~ 680 (786)
+||||+.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||++.....
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999999987654 3689999999999999999999999999999999999998654 799999999987754
Q ss_pred CCCCCCCCCCCCcccCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh------------c-CC
Q 003919 681 SPMRDSSSAGTPEWMAPELIRNE-PFTEKCDIFSLGVIMWELCTLNRPWEGVLPER-VVYAVAN------------E-GS 745 (786)
Q Consensus 681 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~-~l~~i~~------------~-~~ 745 (786)
.. .....++|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ....+.. . ..
T Consensus 183 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 GQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp TC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 34567899999999998765 57999999999999999999999997654322 1111110 0 00
Q ss_pred CC-------------------------CCCChHHHHHHHHhhh-CCCCCCCHHHHHHH
Q 003919 746 RL-------------------------EIPEGPLGRLIADCWA-EPQERPSCEEILSR 777 (786)
Q Consensus 746 ~~-------------------------~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~ 777 (786)
.. ..-+..+.+||.+||. ||.+|||++|+|+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0012357889999999 99999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=379.37 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCCCeeEeeEEeecCcEEEEEEEE-----CCeeEEEEEEecccc--ChHHHHHHHHHHHHHhhcCC-CceeEEecccccC
Q 003919 526 DFSELTVGTRVGIGFFGEVFRGIW-----NGTDVAIKVFLEQDL--TAENMEDFCNEISILSRLRH-PNVILFLGACTKP 597 (786)
Q Consensus 526 ~~s~y~i~k~LG~G~fG~VYkg~~-----~G~~VAVKvl~~~~~--~~~~~~~f~~EI~iL~~L~H-PNIVkL~g~~~~~ 597 (786)
..++|.+++.||+|+||+||+|.+ +|+.||||++..... +....+.+.+|++++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 357899999999999999999976 378899999865432 12224668899999999976 8999999999999
Q ss_pred CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 598 PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
..++++|||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999999873 34677889999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-CCCCCCCCCCcccCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCC---
Q 003919 678 ITDSP-MRDSSSAGTPEWMAPELIRNE--PFTEKCDIFSLGVIMWELCTLNRPWEGVLPERVVYAVANE--GSRLEI--- 749 (786)
Q Consensus 678 l~~~~-~~~~~~~GT~~Y~APEvl~~~--~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~~~l~~i~~~--~~~~~i--- 749 (786)
+.... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.........+... ...+.+
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 64332 223456799999999999764 4788999999999999999999999776443333333221 112222
Q ss_pred CChHHHHHHHHhhh-CCCCCC-----CHHHHHHH
Q 003919 750 PEGPLGRLIADCWA-EPQERP-----SCEEILSR 777 (786)
Q Consensus 750 p~~~L~~LI~~CL~-DP~kRP-----Sa~EIL~~ 777 (786)
.+..+.+|+.+||. ||.+|| +++|+++|
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 24579999999999 999999 48999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.8e-41 Score=356.51 Aligned_cols=249 Identities=18% Similarity=0.235 Sum_probs=203.5
Q ss_pred CCCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCC-CceeEEecccccCCceEEE
Q 003919 527 FSELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRH-PNVILFLGACTKPPRLSMI 603 (786)
Q Consensus 527 ~s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~H-PNIVkL~g~~~~~~~l~LV 603 (786)
..+|++++.||+|+||+||+|++ +|+.||||++...... ..+.+|+++++.++| +||+.+++++.+....++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999987 5889999998654322 346788999999975 8999999999999999999
Q ss_pred EEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcC-----CCeEEEEecCccccc
Q 003919 604 TEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNK-----HWTVKICDFGLSRII 678 (786)
Q Consensus 604 ~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~-----~g~VKL~DFGLA~~l 678 (786)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+++.+
T Consensus 80 me~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 5788888763 3457899999999999999999999999999999999999974 578999999999887
Q ss_pred cCCCC-------CCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCC-
Q 003919 679 TDSPM-------RDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLP---ERVVYAVANEGSRL- 747 (786)
Q Consensus 679 ~~~~~-------~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~---~~~l~~i~~~~~~~- 747 (786)
..... .....+||+.|+|||.+.+..++.++|||||||++|||+||+.||.+... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 54311 22356799999999999999999999999999999999999999975432 22222222111111
Q ss_pred -----CCCChHHHHHHHHhhh-CCCCCCCHHHHHHHHHhhh
Q 003919 748 -----EIPEGPLGRLIADCWA-EPQERPSCEEILSRLLDCE 782 (786)
Q Consensus 748 -----~ip~~~L~~LI~~CL~-DP~kRPSa~EIL~~L~~i~ 782 (786)
..-+..+.+|+..|+. +|++||+++.+.+.|+++.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1113468999999999 9999999999988887653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.9e-37 Score=329.02 Aligned_cols=244 Identities=19% Similarity=0.298 Sum_probs=187.0
Q ss_pred CCeeEeeEEeecCcEEEEEEEE--CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-----------CCceeEEeccc
Q 003919 528 SELTVGTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-----------HPNVILFLGAC 594 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-----------HPNIVkL~g~~ 594 (786)
.+|+++++||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.+++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999987 58999999986442 33467788999988875 57899999887
Q ss_pred ccC--CceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhh-cceeeccCCcccEEEcCCC------
Q 003919 595 TKP--PRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHR-MKIVHRDLKSANCLVNKHW------ 665 (786)
Q Consensus 595 ~~~--~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs-~gIIHrDLKpsNILLd~~g------ 665 (786)
... ...+++++++..+..............+++..++.++.||+.||+|||+ .||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 543 4566677776655444333334466788999999999999999999997 8999999999999998665
Q ss_pred eEEEEecCccccccCCCCCCCCCCCCCcccCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHH
Q 003919 666 TVKICDFGLSRIITDSPMRDSSSAGTPEWMAPELIRNEPFTEKCDIFSLGVIMWELCTLNRPWEGVLPE------RVVYA 739 (786)
Q Consensus 666 ~VKL~DFGLA~~l~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDVWSLGvIL~ELlTG~~PF~~~~~~------~~l~~ 739 (786)
.++++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||...... .....
T Consensus 170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 499999999987643 234678999999999999999999999999999999999999999754321 11111
Q ss_pred HHh-cC---------------------CCCC------------------CC---ChHHHHHHHHhhh-CCCCCCCHHHHH
Q 003919 740 VAN-EG---------------------SRLE------------------IP---EGPLGRLIADCWA-EPQERPSCEEIL 775 (786)
Q Consensus 740 i~~-~~---------------------~~~~------------------ip---~~~L~~LI~~CL~-DP~kRPSa~EIL 775 (786)
... -+ .... .+ ...+.+|+.+||. ||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 100 00 0000 00 1247789999999 999999999999
Q ss_pred HH
Q 003919 776 SR 777 (786)
Q Consensus 776 ~~ 777 (786)
+|
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6.5e-23 Score=201.56 Aligned_cols=165 Identities=19% Similarity=0.162 Sum_probs=121.4
Q ss_pred eeEeeEEeecCcEEEEEEEE-CCeeEEEEEEeccccC----------------hHHHHHHHHHHHHHhhcCCCceeEEec
Q 003919 530 LTVGTRVGIGFFGEVFRGIW-NGTDVAIKVFLEQDLT----------------AENMEDFCNEISILSRLRHPNVILFLG 592 (786)
Q Consensus 530 y~i~k~LG~G~fG~VYkg~~-~G~~VAVKvl~~~~~~----------------~~~~~~f~~EI~iL~~L~HPNIVkL~g 592 (786)
+.++++||+|+||+||+|.+ +|+.||||++...... ......+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46899999999999999987 7899999987532110 111244567889999999999998876
Q ss_pred ccccCCceEEEEEeeccchhHHHHHhhcCCccchHHHHHHHHHHHHHHHHhhhhcceeeccCCcccEEEcCCCeEEEEec
Q 003919 593 ACTKPPRLSMITEYMELGSLYHLIHLSGQKKKLSWRRKLKMLRDICRGLMCIHRMKIVHRDLKSANCLVNKHWTVKICDF 672 (786)
Q Consensus 593 ~~~~~~~l~LV~Ey~~gGSL~dlL~~~~~~~~Ls~~~i~~Ia~QIa~gL~yLHs~gIIHrDLKpsNILLd~~g~VKL~DF 672 (786)
+.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 532 379999999865543 3334456789999999999999999999999999999965 5899999
Q ss_pred CccccccCCCCCCCCCCCCCcccCc------cccccCCCCchhhHHHHHHHH
Q 003919 673 GLSRIITDSPMRDSSSAGTPEWMAP------ELIRNEPFTEKCDIFSLGVIM 718 (786)
Q Consensus 673 GLA~~l~~~~~~~~~~~GT~~Y~AP------Evl~~~~~s~ksDVWSLGvIL 718 (786)
|+|.....+.. ..|... +. ..+.|..++|+||+.--+
T Consensus 147 G~a~~~~~~~~--------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW--------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH--------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc--------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99976543211 112211 11 134578889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.20 E-value=1.7e-06 Score=85.85 Aligned_cols=86 Identities=8% Similarity=-0.094 Sum_probs=58.1
Q ss_pred CCeeEeeEEeecCcEEEEEEEECCeeEEEEEEeccccChHHHHHHHHHHHHHhhcC-CCceeEEecccccCCceEEEEEe
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWNGTDVAIKVFLEQDLTAENMEDFCNEISILSRLR-HPNVILFLGACTKPPRLSMITEY 606 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~-HPNIVkL~g~~~~~~~l~LV~Ey 606 (786)
+.|++.+..+-++.+.||+...+++.++||+....... ....+.+|...+..+. +--+-+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45666665544555789999888888999987543321 1234667888877764 22234555666777889999999
Q ss_pred eccchhHHH
Q 003919 607 MELGSLYHL 615 (786)
Q Consensus 607 ~~gGSL~dl 615 (786)
++|.++...
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 998877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=0.00011 Score=71.97 Aligned_cols=73 Identities=22% Similarity=0.162 Sum_probs=49.4
Q ss_pred EEeecCc-EEEEEEEEC-CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc--eeEEecccccCCceEEEEEeeccc
Q 003919 535 RVGIGFF-GEVFRGIWN-GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN--VILFLGACTKPPRLSMITEYMELG 610 (786)
Q Consensus 535 ~LG~G~f-G~VYkg~~~-G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN--IVkL~g~~~~~~~l~LV~Ey~~gG 610 (786)
.+..|.. +.||+...+ +..+++|....... ..+..|+..++.+.... +-+++.++.+++..+++|++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 679998775 55678887543322 34667888887774322 445667777778899999999876
Q ss_pred hh
Q 003919 611 SL 612 (786)
Q Consensus 611 SL 612 (786)
++
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 65
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.17 E-value=0.00037 Score=74.05 Aligned_cols=77 Identities=18% Similarity=0.065 Sum_probs=46.5
Q ss_pred eeEEeecCcEEEEEEEE--CCeeEEEEEEeccc-c----ChHHHHHHHHHHHHHhhcC-C-C-ceeEEecccccCCceEE
Q 003919 533 GTRVGIGFFGEVFRGIW--NGTDVAIKVFLEQD-L----TAENMEDFCNEISILSRLR-H-P-NVILFLGACTKPPRLSM 602 (786)
Q Consensus 533 ~k~LG~G~fG~VYkg~~--~G~~VAVKvl~~~~-~----~~~~~~~f~~EI~iL~~L~-H-P-NIVkL~g~~~~~~~l~L 602 (786)
.+.||.|....||++.. .++.++||.-.... . -.....+...|.+.|+.+. + | .+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45789999999999965 46688898643210 0 0111234456888877663 2 3 344555443 345678
Q ss_pred EEEeeccch
Q 003919 603 ITEYMELGS 611 (786)
Q Consensus 603 V~Ey~~gGS 611 (786)
+||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0035 Score=64.31 Aligned_cols=70 Identities=11% Similarity=0.089 Sum_probs=44.0
Q ss_pred cCcEEEEEEEE-CCeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCc-----eeEEec--ccccCCceEEEEEeeccc
Q 003919 539 GFFGEVFRGIW-NGTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPN-----VILFLG--ACTKPPRLSMITEYMELG 610 (786)
Q Consensus 539 G~fG~VYkg~~-~G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPN-----IVkL~g--~~~~~~~l~LV~Ey~~gG 610 (786)
+.-..||++.. +|+.|++|+......+. +++..|...+..|...+ .+..-+ .+...+..+.++++++|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 34468999976 68889999986554433 55677888877774221 111111 123345678899998764
Q ss_pred h
Q 003919 611 S 611 (786)
Q Consensus 611 S 611 (786)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.37 E-value=0.01 Score=59.74 Aligned_cols=31 Identities=19% Similarity=0.186 Sum_probs=27.5
Q ss_pred cceeeccCCcccEEEcCCCeEEEEecCcccc
Q 003919 647 MKIVHRDLKSANCLVNKHWTVKICDFGLSRI 677 (786)
Q Consensus 647 ~gIIHrDLKpsNILLd~~g~VKL~DFGLA~~ 677 (786)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.04 E-value=0.0089 Score=62.79 Aligned_cols=76 Identities=18% Similarity=0.284 Sum_probs=49.9
Q ss_pred CCeeEeeEEeecCcEEEEEEEEC---------CeeEEEEEEeccccChHHHHHHHHHHHHHhhcCCCcee-EEecccccC
Q 003919 528 SELTVGTRVGIGFFGEVFRGIWN---------GTDVAIKVFLEQDLTAENMEDFCNEISILSRLRHPNVI-LFLGACTKP 597 (786)
Q Consensus 528 s~y~i~k~LG~G~fG~VYkg~~~---------G~~VAVKvl~~~~~~~~~~~~f~~EI~iL~~L~HPNIV-kL~g~~~~~ 597 (786)
+++.+ +.|+.|-.-.+|++... ...|.+++.-. ... .....+|..+++.+.-.++. ++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 44444 57888999999999763 24577777642 212 23455788898888533443 66766643
Q ss_pred CceEEEEEeeccchh
Q 003919 598 PRLSMITEYMELGSL 612 (786)
Q Consensus 598 ~~l~LV~Ey~~gGSL 612 (786)
.+|+||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 688999987554
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.00 E-value=0.0038 Score=53.89 Aligned_cols=57 Identities=14% Similarity=0.240 Sum_probs=47.9
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|++++..|+..+..+|+|++|.|+ ...+.+.+++...+...+++.+++.+.+.
T Consensus 11 g~i~R~eAe~~L~~~g~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~h~~i~~~ 67 (104)
T d1g83a2 11 GKLGRKDAERQLLSFGNPRGTFLIRESE----TTKGAYSLSIRDWDDMKGDHVKHYKIRKL 67 (104)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTCEEEEEEEECSSSCEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEeccC----CCCCCeEEEEEEeecCcCCeEEEEEEEEc
Confidence 5689999999999999999999999997 56777888888877777777888776543
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.27 E-value=0.0045 Score=53.31 Aligned_cols=57 Identities=12% Similarity=0.173 Sum_probs=45.4
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|+..+..||+|++|.|+ +.++.+.+++...+...++..+++.+.+.
T Consensus 6 g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~ 62 (103)
T d1qcfa2 6 KGISRKDAERQLLAPGNMLGSFMIRDSE----TTKGSYSLSVRDYDPRQGDTVKHYKIRTL 62 (103)
T ss_dssp TTCCHHHHHHHHHSTTCCTTCEEEEECS----SSTTSEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCCcEEEEccC----CCCCCeEEEEEecCCCcCceEEEEEEEEc
Confidence 5689999999999999999999999998 66777888887655555566777766553
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.97 E-value=0.0052 Score=53.15 Aligned_cols=56 Identities=11% Similarity=0.207 Sum_probs=44.5
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.+++..|+..++.+|+|++|.|+ ..++.+.+++...+...+.+..++.+.+
T Consensus 9 g~isR~eAe~~L~~~~~~~GtFLVR~S~----~~~g~~~lsv~~~~~~~~~~v~h~~i~~ 64 (105)
T d1lkka_ 9 KNLSRKDAERQLLAPGNTHGSFLIRESE----STAGSFSLSVRDFDQNQGEVVKHYKIRN 64 (105)
T ss_dssp TTCCHHHHHHHHTSTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEE
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccC----CCCCCEEEEEEEcccCCCccEEEEEEEE
Confidence 5789999999999999999999999997 5677788888765555555566666544
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.70 E-value=0.017 Score=50.58 Aligned_cols=57 Identities=14% Similarity=0.178 Sum_probs=43.8
Q ss_pred HHHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 402 VRAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 402 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
.+.|+|.+++++|+..++.||+|++|.++ +.++.+.+++.... ..+...+|+.+.+.
T Consensus 16 ~g~isR~eAe~~L~~~~~~~G~FLVR~S~----~~~g~~~Lsv~~~~-~~~~~v~H~~i~~~ 72 (114)
T d1blja_ 16 FRTISRKDAERQLLAPMNKAGSFLIRESE----SNKGAFSLSVKDIT-TQGEVVKHYKIRSL 72 (114)
T ss_dssp CCSCCHHHHHHHHSSTTCCTTCEEBCBCT----TCSSCEEEEECBCC-TTTCBCCCEEEEEE
T ss_pred CCCCCHHHHHHHHHhcCCCCceEEEeccC----CCCCCeEEEEEeec-cCCCEEEEEEEEEc
Confidence 35789999999999999999999999997 66788888876532 22445677766553
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.77 E-value=0.019 Score=49.22 Aligned_cols=52 Identities=13% Similarity=0.163 Sum_probs=42.4
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|+..+..+|+|++|.++ ...+.+.+++.. +++.+|+.+.+.
T Consensus 7 g~isR~~Ae~~L~~~~~~~G~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 58 (100)
T d1rjaa_ 7 GCISRSEAVRRLQAEGNATGAFLIRVSE----KPSADYVLSVRD-----TQAVRHYKIWRR 58 (100)
T ss_dssp TTCCHHHHHHHHSSTTCSSCCEEEEECS----SSSSCEEEEECT-----TSSCEEEEEEEC
T ss_pred CCCCHHHHHHHHhccCCCCCeEEeecCC----CCCCCEEEEEEc-----CCCceEEEEEEC
Confidence 4689999999999999999999999997 556778888875 346788877653
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.56 E-value=0.012 Score=50.95 Aligned_cols=57 Identities=14% Similarity=0.195 Sum_probs=45.0
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|++++..|+..++.||+|++|.++ ...+.+.+++...+...+.+..++.+.+.
T Consensus 10 g~i~R~eAe~lL~~~~~~~G~FLVR~S~----~~~g~y~LSv~~~~~~~~~~i~h~~i~~~ 66 (106)
T d1o48a_ 10 GKITRRESERLLLNAENPRGTFLVRESE----TTKGAYCLSVSDFDNAKGLNVKHYKIRKL 66 (106)
T ss_dssp ESCCHHHHHHHHCCTTCCTTCEEEEECS----SSTTCEEEEEEEEETTTEEEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCCcEEEEccc----CCCCCEEEEEEecccCcccceEEEEEEEe
Confidence 4689999999999999999999999997 56677888887766555556666665543
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.03 E-value=0.04 Score=47.28 Aligned_cols=52 Identities=10% Similarity=-0.005 Sum_probs=40.7
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|..++..|...|..||+|++|.|+ ...+.+.+++.. ++...++.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (105)
T d1nrva_ 10 GRISREESHRIIKQQGLVDGLFLLRDSQ----SNPKAFVLTLCH-----HQKIKNFQILPC 61 (105)
T ss_dssp TTCCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHhhcCCCCceEEEEeCC----CCCCCEEEEEEE-----CCceeEEEEEEe
Confidence 4689999999999999999999999987 445667787765 345677776654
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.88 E-value=0.033 Score=50.10 Aligned_cols=52 Identities=12% Similarity=0.173 Sum_probs=42.8
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|..++..|+..|..||+|++|.|+ ..++.+.+++.. +++.+|+.+.+.
T Consensus 10 g~isR~~Ae~lL~~~g~~dG~FLVR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~~ 61 (129)
T d1a81a1 10 GNITREEAEDYLVQGGMSDGLYLLRQSR----NYLGGFALSVAH-----GRKAHHYTIERE 61 (129)
T ss_dssp SSCCHHHHHHHHHHTTCCTTEEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhcCCCCccEEEEccC----CCCcceEEEeee-----cccceEEEEEEc
Confidence 4689999999999999999999999998 456778888765 456788887764
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.01 E-value=0.078 Score=46.15 Aligned_cols=51 Identities=12% Similarity=-0.016 Sum_probs=40.2
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|.++++.|+..|..||+|++|.++ ...+.+.+++.. +++..|+.+..
T Consensus 15 g~isR~~Ae~lL~~~g~~dG~FLvR~S~----~~~g~y~LSv~~-----~~~v~H~~I~~ 65 (113)
T d2qmsa1 15 GRISREESQRLIGQQGLVDGLFLVRESQ----RNPQGFVLSLCH-----LQKVKHYLILP 65 (113)
T ss_dssp EEBCHHHHHHHHHHTTCCTTEEEEEECS----SCTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHhccCCCCccEEEEecc----CCCCCEEEEEEe-----CCeEEEEEEEE
Confidence 4689999999999999999999999997 444567777754 34577777654
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.64 E-value=0.084 Score=47.27 Aligned_cols=51 Identities=12% Similarity=0.018 Sum_probs=41.6
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCcccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSR 462 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R 462 (786)
+.|+|..|+..|+..|+.+|+|++|.|+ +..+.+.+++.. +++.+|+.+.+
T Consensus 11 g~i~R~~Ae~~L~~~g~~~G~FLVR~S~----~~~g~yvLSv~~-----~~~v~H~~I~~ 61 (130)
T d2oq1a1 11 GSISRAEAEEHLKLAGMADGLFLLRQCL----RSLGGYVLSLVH-----DVRFHHFPIER 61 (130)
T ss_dssp BSCCHHHHHHHHHHTTCCTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEEEE
T ss_pred CCCCHHHHHHHHHhcCCCCceEEEEecC----CCCccEEEEEee-----CCceEEEEEEE
Confidence 4688999999999999999999999997 556667888775 44678887765
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=85.07 E-value=0.065 Score=44.23 Aligned_cols=52 Identities=10% Similarity=0.123 Sum_probs=39.1
Q ss_pred HHhhHHHHHhhhhhhc-CCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQER-GEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|..++..|+..+ ..||+|++|.|+ ...+.+.+++.. .++.+++.+.+.
T Consensus 10 g~isR~~Ae~lL~~~~~~~dG~FLvR~S~----~~~g~~~Lsv~~-----~~~v~h~~I~~~ 62 (86)
T d1rpya_ 10 GTLSRVKAAQLVLAGGPRSHGLFVIRQSE----TRPGECVLTFNF-----QGKAKHLRLSLN 62 (86)
T ss_dssp TTCCHHHHHHHHHTTGGGGTTCEEEEECS----SSTTCEEEEEEE-----TTEEEEEEC---
T ss_pred CCCCHHHHHHHHHhCCCCCCceEEEEecC----CCCCcEEEEEEE-----CCceEEEEEEEc
Confidence 5789999999999887 489999999997 456777788775 245777776654
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.68 E-value=0.086 Score=45.04 Aligned_cols=51 Identities=16% Similarity=0.144 Sum_probs=38.3
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|..||..|++. +.||+|++|.|+ ...+.+.+++.. +++.+|+.+.+.
T Consensus 8 g~isR~~AE~lL~~~-~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (103)
T d1i3za_ 8 GCLTKRECEALLLKG-GVDGNFLIRDSE----SVPGALCLCVSF-----KKLVYSYRIFRE 58 (103)
T ss_dssp SSCCHHHHHHHHHTT-CSTTEEEEEECS----SSTTCEEEEEEC-----SSSEEEEEEEEC
T ss_pred CCCCHHHHHHHHHhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCeEEEEEeEEc
Confidence 458899999777554 489999999997 445778888776 345788887654
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.79 E-value=0.093 Score=44.41 Aligned_cols=51 Identities=12% Similarity=0.196 Sum_probs=38.6
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|.+++..|++. +.+|+|++|.++ ..++.+.+++.. +++.+++.+.+.
T Consensus 8 g~isR~~Ae~lL~~~-~~~G~FLvR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 58 (96)
T d1jyra_ 8 GKIPRAKAEEMLSKQ-RHDGAFLIRESE----SAPGDFSLSVKF-----GNDVQHFKVLRD 58 (96)
T ss_dssp CSCCHHHHHHHHHTC-CSTTBEEEEECS----SSTTCEEEEEEE-----TTEEEEEECEEC
T ss_pred CCCCHHHHHHHHhhC-CCCCeEEEEecC----CCCCCEEEEEEe-----CCceEEEEEEEC
Confidence 468999999888664 479999999997 456667787775 345778877654
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.48 E-value=0.16 Score=42.93 Aligned_cols=50 Identities=10% Similarity=0.137 Sum_probs=38.8
Q ss_pred HHhhHHHHHhhhhhhcCCCCCccccCCCCCCCCCCCCccccCCCCCcccCCCccccccccc
Q 003919 403 RAMNETLKQNRLLQERGEDRPFTRSSNDNTSDLPKNASNFHLGTHDEISGGRSALYNLSRD 463 (786)
Q Consensus 403 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~g~rs~~~~l~R~ 463 (786)
+.|+|..++..|. +..+|+|++|.|+ ..++.+.+++.. .++.+++.+.+.
T Consensus 11 g~isR~~Ae~lL~--~~~~G~FLVR~S~----~~~g~~~LSv~~-----~~~v~H~~I~~~ 60 (97)
T d1r1qa_ 11 EGLSRHQAENLLM--GKDIGFFIIRASQ----SSPGDFSISVRH-----EDDVQHFKVMRD 60 (97)
T ss_dssp TTCCHHHHHHHHH--TSCTTCEEEEECS----SSTTCEEEEEEC-----SSSEEEEECEEC
T ss_pred CCCCHHHHHHHHh--cCCCCCEEEeecC----CCCCCEEEEEEe-----cCCeEEEEEEEc
Confidence 5789999998886 4679999999997 566777888775 335788877664
|